data_6a4c_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6a4c _Structure_validation_residue.Date_analyzed 2019-06-14 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -96.91 148.02 23.37 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.46 137.07 47.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.612 0.72 . . . . 0.0 111.828 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.71 151.35 49.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.621 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.6 130.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -91.73 122.11 33.98 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.712 0.768 . . . . 0.0 110.81 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -138.57 152.48 48.21 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.02 127.51 56.77 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 12.0 tmm? -85.78 84.42 7.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.56 112.47 3.72 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.528 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.39 -45.92 3.98 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.258 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.97 -12.26 59.92 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.02 120.72 2.11 Favored Glycine 0 N--CA 1.409 -3.119 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.659 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -70.76 152.13 44.12 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mt -78.49 101.4 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -72.73 -42.28 64.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.189 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 41.1 ttmt -133.01 141.78 48.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.32 132.37 95.32 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.73 167.55 26.85 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.891 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -54.5 124.64 16.77 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 112.727 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.99 68.51 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.287 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -85.65 133.26 42.2 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.47 165.53 32.44 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.294 2.663 . . . . 0.0 109.948 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 p -51.92 149.46 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.23 -50.45 3.61 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 128.243 2.617 . . . . 0.0 113.684 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -85.89 -25.89 25.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.966 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -80.57 -15.38 56.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.649 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -44.83 -47.55 11.01 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.624 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 2.8 m-70 -127.01 30.12 5.5 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.76 -1.213 . . . . 0.0 109.869 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -92.88 101.99 14.36 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -9.23 0.31 Allowed Glycine 0 CA--C 1.54 1.603 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.23 168.2 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 118.779 1.289 . . . . 0.0 112.801 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 t -97.09 154.48 17.31 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.5 mt -102.38 10.64 38.93 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.441 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.36 -29.55 70.54 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.726 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -13.73 38.41 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -114.98 -21.97 9.8 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.29 134.81 20.36 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.87 127.47 25.26 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.278 2.652 . . . . 0.0 113.268 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.53 115.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.24 22.91 50.38 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.971 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.56 -167.32 26.47 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.01 141.85 49.34 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 117.511 0.656 . . . . 0.0 109.265 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.41 ' CG2' HG13 ' A' ' 114' ' ' ILE . 31.1 m -133.71 165.92 30.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.0 t -153.07 153.85 33.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.183 0.516 . . . . 0.0 111.211 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.95 117.93 19.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.889 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' A' ' 39' ' ' LYS . 12.8 p . . . . . 0 N--CA 1.417 -2.102 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . 0.27 90.6 m-20 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 122.048 0.927 . . . . 0.0 112.872 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -88.61 -154.88 0.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.954 1.301 . . . . 0.0 111.336 -169.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.67 -167.46 1.63 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.937 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -87.31 150.69 23.69 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.372 0.669 . . . . 0.0 112.089 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -105.83 -159.55 0.71 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -71.37 -42.18 68.77 Favored 'General case' 0 CA--C 1.48 -1.749 0 CA-C-N 119.086 0.857 . . . . 0.0 110.624 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -120.83 135.69 55.1 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 35.5 tp60 -116.4 117.99 37.91 Favored Pre-proline 0 C--N 1.28 -2.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.59 162.62 27.34 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.939 2.426 . . . . 0.0 112.058 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -163.81 174.32 11.71 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.181 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.25 -6.47 10.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.444 0.64 . . . . 0.0 110.311 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -96.55 -174.78 3.13 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.847 -0.533 . . . . 0.0 111.273 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -96.41 43.88 1.07 Allowed 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.214 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -138.33 151.33 47.45 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.01 138.85 54.58 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 51.7 tp -105.96 129.61 54.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.184 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.08 140.36 49.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.054 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -70.82 167.3 19.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.063 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.47 -37.67 92.86 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.502 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -72.25 -37.43 69.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.35 -30.52 62.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.351 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.403 ' HG3' ' CE3' ' A' ' 109' ' ' TRP . 49.3 ttp180 -58.41 -48.71 79.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.099 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 10.2 tmtt? -62.43 -37.44 85.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.936 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.79 -53.21 59.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 120.583 0.23 . . . . 0.0 111.105 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.2 -41.5 87.01 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.17 -31.14 71.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.313 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -71.42 -22.08 61.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.54 -19.81 32.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.96 0.41 . . . . 0.0 110.551 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.06 48.05 7.19 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.269 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.1 t -78.97 114.57 19.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.4 t -80.03 158.24 26.55 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.137 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 78.5 19.19 0.95 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.316 1.01 . . . . 0.0 110.406 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.03 134.03 50.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.498 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.9 tp10 -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE3' ' HG3' ' A' ' 96' ' ' ARG . 52.2 m95 -117.0 118.62 32.92 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 123.459 0.475 . . . . 0.0 110.082 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.12 102.49 43.52 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.99 129.98 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.744 2.296 . . . . 0.0 113.683 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.1 m -142.87 172.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.359 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.72 116.23 29.53 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 126' ' ' TYR . 4.4 mp -101.59 124.93 55.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.468 0.651 . . . . 0.0 110.966 -176.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 87.3 mttt -97.35 132.14 43.36 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.6 -161.56 0.24 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -62.6 -31.57 72.42 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.44 -4.27 55.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.739 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.74 14.75 79.22 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.709 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 20.1 pttp -104.84 140.06 38.68 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.534 0.333 . . . . 0.0 110.247 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.23 107.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.43 -0.29 6.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.417 0.627 . . . . 0.0 110.905 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.87 75.95 0.34 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.45 -27.68 2.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.093 1.862 . . . . 0.0 113.773 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -118.53 23.38 11.55 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.813 1.292 . . . . 0.0 109.285 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.45 ' HB2' HD11 ' A' ' 114' ' ' ILE . 2.9 m-85 -88.66 144.86 26.01 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.528 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.77 46.43 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.758 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.7 126.88 32.32 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.534 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 tt -90.54 125.28 35.56 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.846 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.624 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 28.2 m-80 -107.15 137.03 45.98 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.955 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.21 120.58 42.96 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.9 172.96 6.52 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 124.029 0.83 . . . . 0.0 110.649 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 22.78 64.24 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.54 131.19 37.87 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -147.88 151.61 36.18 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -52.89 115.19 1.71 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.966 0.791 . . . . 0.0 112.09 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 164' ' ' ASP . . . -131.93 -26.36 1.97 Allowed 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -167.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 17.7 mt -62.36 125.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.72 125.74 26.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 23.0 ttt -118.83 1.88 11.57 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.737 0.78 . . . . 0.0 109.718 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.57 -32.56 11.04 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.73 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -108.02 -10.87 15.41 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.182 0.593 . . . . 0.0 110.552 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.5 m -93.84 110.6 22.25 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.362 0.601 . . . . 0.0 110.603 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -78.61 100.72 7.09 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.379 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.49 145.46 27.93 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.239 0.543 . . . . 0.0 111.904 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -101.3 127.97 47.67 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.496 ' HE3' ' O ' ' A' ' 152' ' ' LYS . 71.8 mtp -100.73 154.56 18.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 24.0 t70 90.71 85.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 127.269 2.228 . . . . 0.0 114.1 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.7 m -100.43 -26.77 13.76 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.322 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -145.99 -48.05 0.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 14.3 pt-20 -139.75 177.79 7.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.496 ' O ' ' HE3' ' A' ' 147' ' ' MET . 38.0 ttmt -59.16 -38.58 80.09 Favored 'General case' 0 C--O 1.214 -0.782 0 O-C-N 124.292 0.995 . . . . 0.0 111.102 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 25.7 m-20 -85.97 26.11 1.04 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.401 ' NE2' ' HG3' ' A' ' 181' ' ' ARG . 21.2 mm-40 -123.46 113.31 18.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.0 mt -87.03 132.29 32.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 124.238 1.015 . . . . 0.0 109.946 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.05 -72.51 0.95 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.478 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -90.76 133.11 35.42 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.65 124.51 59.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.84 -34.55 8.49 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.04 136.87 20.55 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.85 123.73 29.67 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.84 143.2 32.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.67 139.64 57.07 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.767 0.794 . . . . 0.0 112.96 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.551 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 18.7 p-10 -94.33 15.55 17.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.112 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.7 p -67.45 -5.22 13.88 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.892 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.1 m -61.57 -38.14 86.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.959 0.903 . . . . 0.0 110.673 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.63 -30.5 7.08 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.788 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 73.8 mt -85.82 139.2 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -54.79 117.96 15.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 O-C-N 123.189 0.306 . . . . 0.0 111.243 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.16 -13.18 33.97 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.419 2.746 . . . . 0.0 114.037 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.84 -12.73 60.22 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.76 129.06 38.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.075 0.464 . . . . 0.0 109.83 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -83.63 -17.0 43.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.794 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -154.38 128.16 8.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -153.36 178.52 9.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -128.47 142.43 51.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.422 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 58.2 m -86.52 140.48 29.87 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 123.832 0.708 . . . . 0.0 109.483 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.3 p -68.75 -44.56 73.5 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.745 2.868 . . . . 0.0 118.745 -168.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -89.19 23.7 2.38 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.544 0.611 . . . . 0.0 112.333 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 9.0 tp10 -154.94 135.6 13.53 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.401 ' HG3' ' NE2' ' A' ' 154' ' ' GLN . 69.8 mtt180 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.9 mtm-85 -83.81 -7.37 59.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.767 -167.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.422 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 26.2 tp -82.42 100.63 10.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.819 0.818 . . . . 0.0 110.973 -174.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.1 mt -117.84 124.38 72.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 43.4 mt -103.94 134.71 46.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.523 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.68 157.74 29.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.597 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -86.06 162.43 18.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.62 -44.63 26.95 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.199 1.399 . . . . 0.0 111.996 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.22 -43.56 70.94 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.439 1.096 . . . . 0.0 111.301 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.31 -53.19 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.178 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.544 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 13.7 p80 -75.31 -26.54 58.76 Favored 'General case' 0 C--O 1.195 -1.804 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.714 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.99 83.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 0.0 110.351 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.77 72.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.552 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.445 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 21.0 m-85 -73.57 -36.43 65.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.247 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -56.92 -50.75 71.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 121.625 0.726 . . . . 0.0 109.218 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.91 -26.67 61.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.21 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.53 -27.47 62.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.425 0.155 . . . . 0.0 111.046 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.9 47.51 13.85 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.05 165.87 18.2 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.8 p -42.15 -72.83 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -165.96 144.43 9.19 Favored Glycine 0 CA--C 1.488 -1.637 0 C-N-CA 118.998 -1.572 . . . . 0.0 113.118 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 194' ' ' PHE . 74.5 m-85 -137.37 152.78 50.05 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 22.4 tptm -132.21 121.84 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 24.7 m -116.43 139.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.563 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -121.68 151.44 40.47 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.62 133.39 40.9 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.207 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.13 -38.34 31.73 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.936 0.874 . . . . 0.0 108.642 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.74 104.8 13.26 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.004 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.55 35.33 47.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.523 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -54.31 102.18 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.082 1.353 . . . . 0.0 111.217 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.55 109.89 21.74 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.73 2.94 31.82 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 167.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.14 145.37 24.74 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 117.902 0.851 . . . . 0.0 109.738 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.2 0.524 . . . . 0.0 111.459 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.997 178.42 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG13 ' NE ' ' A' ' 187' ' ' ARG . 45.0 t . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -87.01 155.8 20.01 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.317 0.579 . . . . 0.0 112.3 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -112.06 138.45 48.7 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.158 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.85 150.92 49.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.46 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.8 130.0 36.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -95.72 128.86 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.512 0.507 . . . . 0.0 111.141 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -150.12 149.58 30.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.94 115.56 41.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 57.0 ttp -85.28 101.61 12.67 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 173.56 177.19 0.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.144 1.778 . . . . 0.0 107.56 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.17 -36.21 1.53 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 122.04 0.924 . . . . 0.0 110.147 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -0.85 57.79 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.962 1.305 . . . . 0.0 111.46 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.18 58.5 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.57 82.69 1.14 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.253 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -95.01 164.61 12.82 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.31 102.21 13.41 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.87 -55.42 29.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.917 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -137.03 176.47 8.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.37 125.74 60.08 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.44 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 123.031 2.487 . . . . 0.0 111.344 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -55.8 117.16 3.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.889 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 9.11 83.52 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.281 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m -85.79 139.32 35.22 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -67.59 166.28 24.52 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.686 2.924 . . . . 0.0 112.619 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 p -53.23 152.01 4.77 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.09 -58.74 2.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 127.534 2.333 . . . . 0.0 113.975 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -80.55 -25.39 38.62 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.431 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.476 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 45.1 tptt -80.52 -16.77 53.43 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -172.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -45.51 -43.37 11.69 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 176' ' ' ARG . 55.9 m170 -126.98 24.16 6.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.978 -1.076 . . . . 0.0 111.097 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -93.45 102.7 14.93 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.063 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.29 -8.95 0.59 Allowed Glycine 0 CA--C 1.538 1.495 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.99 171.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 118.499 1.149 . . . . 0.0 113.648 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -98.55 137.93 36.49 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.56 -0.78 48.4 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.07 -23.22 67.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.021 0.438 . . . . 0.0 111.381 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -88.74 -27.88 20.88 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -112.69 -15.53 12.97 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -110.21 135.75 20.55 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.95 123.94 13.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.635 2.223 . . . . 0.0 113.36 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.4 t -95.02 107.68 19.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.47 23.54 28.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.15 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.22 -153.85 25.24 Favored Glycine 0 C--O 1.24 0.507 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.46 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -131.81 132.2 43.53 Favored 'General case' 0 C--O 1.248 0.981 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 m -134.03 168.33 24.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -149.15 158.28 44.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -84.85 106.69 16.57 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 121.568 0.699 . . . . 0.0 109.409 178.405 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 . . . . . 0 C--O 1.246 0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -90.68 -151.36 0.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -165.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -84.88 -171.19 3.5 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.645 1.578 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HG ' ' OE1' ' A' ' 82' ' ' GLN . 8.6 mp -100.12 150.21 22.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.171 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.461 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 18.3 m-85 -125.4 -165.74 1.45 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.208 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -52.49 -51.59 58.64 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 123.499 0.719 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -116.2 142.89 46.22 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.918 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.461 ' NE2' ' H ' ' A' ' 79' ' ' TYR . 24.6 mm-40 -121.34 111.89 33.24 Favored Pre-proline 0 C--N 1.285 -2.224 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.025 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 167.3 27.68 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.458 2.106 . . . . 0.0 111.35 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -142.69 156.39 45.03 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.4 mt -91.12 -19.48 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -99.02 -179.07 4.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 33.5 t -97.82 66.1 1.88 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.712 -1.195 . . . . 0.0 114.057 -174.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -140.13 121.05 14.54 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.491 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 138.12 31.71 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.354 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 64.9 tp -111.57 127.12 55.63 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.79 141.24 45.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.53 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -78.95 170.2 17.05 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.74 -16.37 79.23 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -69.71 -58.62 3.69 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -25.59 63.33 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.101 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -60.22 -40.89 91.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.509 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HA ' ' CE ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.29 -29.5 65.13 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.508 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.82 -57.84 10.98 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.49 -42.74 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.427 0.691 . . . . 0.0 112.562 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.12 -27.48 62.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 p -78.3 -13.0 60.04 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.497 0.665 . . . . 0.0 111.39 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.423 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -88.73 -25.57 22.24 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.592 173.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.28 48.36 8.28 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.38 107.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.582 0.706 . . . . 0.0 111.671 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -66.92 137.3 56.45 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.151 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 79.94 11.55 1.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.493 1.917 . . . . 0.0 113.667 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.75 114.32 26.04 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -107.5 144.63 34.19 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.415 ' CH2' HD11 ' A' ' 129' ' ' LEU . 67.0 m95 -116.46 121.43 41.82 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 123.586 0.554 . . . . 0.0 110.238 -174.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.57 96.51 43.87 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.38 139.75 16.72 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.549 2.166 . . . . 0.0 112.868 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.14 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.319 0.648 . . . . 0.0 109.804 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.18 116.55 28.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.9 mt -110.54 131.14 62.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.613 0.72 . . . . 0.0 112.865 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -104.76 148.75 26.27 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.548 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -89.32 -160.69 0.7 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.316 0.579 . . . . 0.0 111.241 -174.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -63.85 -34.3 77.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.62 1.168 . . . . 0.0 110.507 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.53 -19.42 29.51 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.66 19.7 24.12 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.548 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 52.2 pttt -99.29 146.35 26.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.71 81.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.681 0.753 . . . . 0.0 110.148 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 m -105.4 8.19 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.429 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.78 50.76 0.88 Allowed Glycine 0 CA--C 1.542 1.757 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.73 -6.76 9.7 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 121.097 2.449 . . . . 0.0 112.285 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -103.11 -0.99 29.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.0 147.87 24.06 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 122.002 0.906 . . . . 0.0 112.86 -170.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.28 139.5 42.72 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.702 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -79.67 124.3 28.44 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.046 0.451 . . . . 0.0 110.111 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.415 HD11 ' CH2' ' A' ' 109' ' ' TRP . 8.0 tt -96.86 125.98 41.68 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.759 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.88 134.62 54.37 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.848 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.78 31.94 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.719 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.07 174.12 6.39 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 124.87 1.356 . . . . 0.0 109.016 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.78 28.9 25.12 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.592 -0.814 . . . . 0.0 115.114 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.89 131.79 55.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.151 -1.019 . . . . 0.0 110.984 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.78 111.66 6.13 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.724 -1.125 . . . . 0.0 107.99 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.0 t70 71.21 -52.34 0.69 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 125.978 1.711 . . . . 0.0 112.253 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.36 -100.58 0.06 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 125.961 1.704 . . . . 0.0 114.484 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mt -64.12 125.08 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 O-C-N 123.686 0.616 . . . . 0.0 110.405 -172.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 100.64 1.94 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.519 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 21.6 ttt -75.81 -12.75 60.23 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.353 -171.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.53 -39.89 67.19 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -101.21 4.55 42.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.347 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 77.7 p -92.54 115.65 28.29 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.767 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -92.53 104.53 16.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.32 164.02 32.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.529 0.681 . . . . 0.0 112.532 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.87 117.95 31.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 26.3 ttt -100.28 107.48 19.3 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.883 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.6 t70 170.41 89.33 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.909 1.683 . . . . 0.0 108.589 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.8 p -101.07 -56.88 2.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.294 0.568 . . . . 0.0 110.358 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.17 -59.94 1.9 Allowed 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.54 -177.07 3.21 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.537 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 152' ' ' LYS . 1.2 tpmt? -76.01 -26.51 56.75 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.224 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.46 11.4 14.78 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.613 1.196 . . . . 0.0 110.025 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -124.68 127.84 47.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 48.5 mt -84.79 143.84 10.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -119.42 -70.44 0.33 Allowed Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.425 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.37 118.93 28.34 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 59.1 mt -118.29 132.23 68.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -106.67 -42.29 5.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -154.65 110.62 3.19 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.64 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -88.15 124.71 34.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.75 24.42 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.74 146.46 52.34 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -96.06 -9.15 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -68.0 -6.02 20.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.567 1.147 . . . . 0.0 111.035 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.9 m -65.39 -38.19 89.25 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -110.52 -30.98 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.373 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.83 151.52 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 171' ' ' ASP . 55.5 mtt180 -62.44 126.65 88.56 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 122.267 0.227 . . . . 0.0 111.471 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.86 -10.12 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.139 1.892 . . . . 0.0 110.816 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 169' ' ' ARG . 4.3 p-10 -85.21 2.14 45.1 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.091 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.99 134.73 33.88 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 67.8 mttm -84.01 -27.44 28.38 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.4 ' HG3' HG21 ' A' ' 186' ' ' ILE . 26.0 ttt -150.76 128.05 11.31 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.56 -179.19 7.03 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 123.559 0.537 . . . . 0.0 110.004 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -136.12 154.7 50.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 63.4 m -87.48 143.82 27.03 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.206 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.5 p -82.91 -9.61 59.22 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -105.87 23.74 13.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.72 -0.613 . . . . 0.0 111.853 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 175.05 134.16 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 17.1 mmt180 -89.53 -31.05 17.8 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.495 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -77.85 -20.13 53.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.269 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.3 tp -83.85 100.35 10.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.067 0.937 . . . . 0.0 110.64 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.3 mt -116.46 119.41 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 55.2 mt -104.89 136.04 45.12 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.608 0.718 . . . . 0.0 111.723 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.4 HG21 ' HG3' ' A' ' 174' ' ' MET . 43.6 pt -119.3 153.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.417 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 10.6 mtp180 -86.06 161.3 19.0 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.487 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.7 pt-20 -55.42 -40.02 70.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.7 -26.34 66.97 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.465 0.706 . . . . 0.0 111.829 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.2 t -71.31 -51.01 37.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.797 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.555 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 19.3 p80 -73.17 -21.91 60.6 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.089 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.9 76.82 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.063 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.24 75.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.511 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -71.18 -33.35 69.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.272 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 62.9 mm-40 -59.6 -47.93 83.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.491 0.663 . . . . 0.0 109.811 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -78.03 -12.76 60.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.516 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.06 -28.42 20.14 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.083 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.39 47.7 87.61 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 202' ' ' PHE . 66.5 mt -77.9 164.18 25.37 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.5 p -41.41 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.45 135.06 6.81 Favored Glycine 0 CA--C 1.493 -1.322 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.809 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 199' ' ' LEU . 70.5 m-85 -146.37 161.94 39.28 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 58.1 tptt -153.59 122.26 6.34 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 18.0 m -112.66 134.46 55.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.054 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 73.4 m-85 -118.26 140.05 50.39 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.95 115.51 9.26 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.08 -35.05 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.382 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.97 92.67 0.52 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.062 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.99 35.6 17.97 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.399 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -53.12 115.01 1.66 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.802 0.841 . . . . 0.0 110.061 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.23 99.78 11.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.47 -1.59 9.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 117.832 1.893 . . . . 0.0 117.832 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 88.0 mt -94.56 143.2 26.62 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 118.029 0.914 . . . . 0.0 112.327 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.48 132.36 52.59 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.466 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 2.5 pt? . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.047 0.842 . . . . 0.0 112.387 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.22 -0.499 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -80.55 152.95 28.36 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -167.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.28 141.1 48.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.972 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.7 141.0 52.24 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 62.0 t -72.73 120.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.3 115.11 27.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.857 0.723 . . . . 0.0 110.7 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -140.3 120.16 13.51 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.9 t -72.66 129.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.419 ' HB3' ' HG3' ' A' ' 203' ' ' LYS 0.268 20.8 ptt? -102.01 66.68 1.04 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.73 1.252 . . . . 0.0 112.619 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.46 110.72 12.1 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -106.66 -17.24 14.29 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 122.19 0.995 . . . . 0.0 108.721 -171.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -86.97 -25.85 24.12 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.698 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.32 80.68 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.89 137.41 3.36 Favored Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.216 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -65.9 156.63 32.86 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.38 102.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -51.73 -52.19 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.832 1.332 . . . . 0.0 112.205 -169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -139.69 172.03 13.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.46 124.63 56.33 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.09 166.77 28.41 Favored 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 122.664 2.243 . . . . 0.0 112.198 172.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.15 121.4 6.74 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 125.109 1.364 . . . . 0.0 112.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.09 0.2 68.4 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.649 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.7 m -85.88 137.87 35.47 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.93 166.49 23.2 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 123.416 2.744 . . . . 0.0 109.795 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.0 p -48.22 153.01 0.75 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.46 ' OD1' ' HG3' ' A' ' 86' ' ' MET . 16.2 m-20 -37.68 -57.03 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 C-N-CA 126.863 2.065 . . . . 0.0 114.955 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -80.47 -30.33 37.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.419 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.72 -11.58 59.84 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.725 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 27.8 m-85 -45.84 -46.01 15.36 Favored 'General case' 0 C--O 1.209 -1.048 0 O-C-N 123.559 0.537 . . . . 0.0 111.347 174.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 17.4 m170 -129.41 17.0 5.98 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.19 101.34 13.41 Favored 'General case' 0 N--CA 1.425 -1.688 0 C-N-CA 117.76 -1.576 . . . . 0.0 108.373 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.03 -9.17 55.05 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.59 173.77 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 119.814 1.807 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -98.88 157.15 16.5 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.38 5.95 49.02 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.36 68.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.972 0.415 . . . . 0.0 111.792 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -88.37 -32.57 18.31 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.1 -22.61 15.13 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -102.53 136.97 19.26 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.37 123.86 13.95 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.063 2.509 . . . . 0.0 112.571 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.63 115.98 40.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.76 23.65 45.31 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.41 -159.33 25.01 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 121.453 -0.403 . . . . 0.0 112.315 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -133.31 135.68 44.99 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.41 172.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 t -155.64 154.47 31.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.52 119.84 16.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.424 -1.738 0 O-C-N 123.719 0.637 . . . . 0.0 109.671 177.002 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 . . . . . 0 CA--C 1.499 -1.017 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -98.68 -159.37 0.74 Allowed 'General case' 0 C--O 1.262 1.716 0 CA-C-O 121.361 0.6 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.39 -167.59 1.88 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.614 1.566 . . . . 0.0 112.42 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.79 147.39 25.18 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.573 0.749 . . . . 0.0 111.76 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.87 -171.52 1.86 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.17 0.988 . . . . 0.0 109.416 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.04 -46.09 71.79 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.546 0.688 . . . . 0.0 110.517 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.0 131.14 53.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 48.0 tp60 -111.44 116.21 50.99 Favored Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 121.053 0.454 . . . . 0.0 109.96 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.12 164.91 21.92 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.82 2.347 . . . . 0.0 112.413 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -157.36 173.61 16.67 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 mt -90.37 3.02 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 121.608 0.718 . . . . 0.0 110.33 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.46 ' HG3' ' OD1' ' A' ' 47' ' ' ASP . 4.1 mpp? -104.98 -175.7 2.87 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.88 -0.513 . . . . 0.0 110.321 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 22.6 t -92.58 16.41 12.12 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 120.989 0.423 . . . . 0.0 112.065 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -115.67 151.1 35.67 Favored 'General case' 0 C--O 1.205 -1.238 0 O-C-N 121.082 -1.012 . . . . 0.0 109.321 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.9 139.86 50.13 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 119.009 -1.077 . . . . 0.0 110.803 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 55.1 tp -109.1 126.39 53.14 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.38 140.97 47.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.6 p -73.4 162.49 29.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.09 -31.92 82.39 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.211 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -72.34 -36.12 68.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.794 0.331 . . . . 0.0 110.753 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.26 -27.62 56.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -60.26 -39.32 86.37 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.112 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.7 mmtp -60.09 -44.18 94.99 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.15 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.63 -51.7 68.81 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.745 0.653 . . . . 0.0 110.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.93 -44.07 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.031 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.98 -20.35 60.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.8 t -72.06 -32.08 66.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.92 -2.07 57.91 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.396 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.69 47.86 82.65 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.555 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -75.24 110.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -75.84 151.79 37.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.188 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 79.58 12.77 1.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.231 1.413 . . . . 0.0 111.972 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.8 tp10 -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -113.27 126.14 55.07 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.51 99.75 42.28 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.33 125.47 6.38 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.501 2.134 . . . . 0.0 112.93 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -143.07 170.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -104.93 116.84 32.65 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.1 mp -103.99 133.55 47.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.424 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.627 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -97.34 144.36 27.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -85.53 -163.8 0.91 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.107 0.48 . . . . 0.0 111.515 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -67.16 -29.64 69.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.235 0.614 . . . . 0.0 110.503 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -87.56 -5.49 58.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.65 18.86 64.97 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 114.402 0.521 . . . . 0.0 114.402 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -105.27 152.67 22.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 117.417 0.609 . . . . 0.0 110.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.12 85.71 2.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.405 0.621 . . . . 0.0 109.894 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.4 ' C ' ' HD3' ' A' ' 124' ' ' PRO . 11.6 m -110.13 6.67 8.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -125.37 59.17 0.65 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.679 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 10.6 Cg_endo -85.26 -19.68 3.63 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.41 2.073 . . . . 0.0 113.152 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.0 6.8 21.26 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.017 0.527 . . . . 0.0 110.688 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 1.5 m-85 -88.29 145.28 25.94 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.221 0.534 . . . . 0.0 110.158 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.38 144.29 48.12 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.408 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.99 128.27 34.32 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 tt -97.68 126.93 43.28 Favored 'General case' 0 C--O 1.268 2.06 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 25.7 m-80 -111.13 127.22 55.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.757 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.96 122.6 38.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.85 174.42 5.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 124.148 0.905 . . . . 0.0 109.478 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.39 26.19 28.65 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.99 41.22 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.037 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.88 170.14 18.3 Favored 'General case' 0 C--N 1.263 -3.169 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.57 107.99 0.23 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.908 1.231 . . . . 0.0 111.995 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.48 -71.19 0.47 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.034 -1.894 . . . . 0.0 115.686 -163.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.21 124.67 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 O-C-N 123.804 0.69 . . . . 0.0 111.669 -170.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 141' ' ' GLU . 11.8 t70 -82.67 128.16 34.09 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.62 -22.91 32.08 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.427 ' HG2' ' OD2' ' A' ' 139' ' ' ASP . 11.1 pt-20 -95.37 -27.29 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.421 0.555 . . . . 0.0 111.157 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -86.81 -5.76 59.01 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.488 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -121.12 168.45 11.54 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -137.2 106.78 6.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -159.67 164.4 34.05 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.649 0.261 . . . . 0.0 111.148 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.89 129.75 51.49 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.509 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 62.2 mtt -92.26 107.63 19.35 Favored 'General case' 0 C--O 1.201 -1.455 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.202 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 165.45 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.026 1.73 . . . . 0.0 111.028 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.6 p -100.93 -56.47 2.31 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.848 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.9 mt -110.14 -31.84 7.21 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.553 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.79 -174.84 1.94 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 147' ' ' MET . 39.4 ttpt -63.02 -43.71 97.96 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.821 0.737 . . . . 0.0 112.852 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.26 26.01 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.152 0.977 . . . . 0.0 112.358 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 152' ' ' LYS . 17.5 mm-40 -139.12 114.25 9.52 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.3 mt -85.03 144.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.12 -77.6 0.77 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -78.79 118.85 21.24 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 39.8 mt -126.34 116.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -100.79 -39.03 8.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.309 0.576 . . . . 0.0 109.769 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.18 128.88 24.67 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.72 111.18 17.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 147.18 24.11 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.75 129.45 39.84 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.189 0.931 . . . . 0.0 110.585 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -84.68 11.6 8.68 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 124.413 1.085 . . . . 0.0 110.775 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.0 p -71.69 -4.94 30.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.139 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -73.76 -34.7 64.83 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.498 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.65 -33.62 8.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.719 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.8 mt -91.47 153.52 3.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.0 124.33 73.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 118.074 0.397 . . . . 0.0 111.037 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.43 -5.34 15.75 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.6 2.867 . . . . 0.0 113.908 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.68 -0.28 51.8 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.93 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.25 120.71 14.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.107 0.479 . . . . 0.0 110.457 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -73.99 -28.64 61.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.03 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.4 ttt -147.68 125.66 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -152.56 175.55 12.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 51' ' ' HIS . 0.2 OUTLIER -152.07 162.23 41.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.37 160.69 20.6 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.3 p -82.24 -49.29 10.25 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 124.134 0.974 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.75 4.68 31.66 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.31 138.08 47.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 87' ' ' SER . 11.4 mtm180 -90.14 -30.16 17.82 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.818 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.0 -28.07 13.95 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.2 tp -71.05 100.63 2.05 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-O 122.133 0.968 . . . . 0.0 112.76 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.23 132.87 64.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.94 122.25 43.74 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.604 0.716 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 34.2 pt -112.08 151.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -85.08 159.99 20.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 11.3 pt-20 -54.44 -39.77 67.72 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -73.13 -27.89 61.94 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.105 0.562 . . . . 0.0 111.454 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.47 -47.42 72.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.634 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.7 p80 -71.21 -26.05 62.77 Favored 'General case' 0 C--O 1.196 -1.748 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.742 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.91 71.24 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.492 0.495 . . . . 0.0 110.7 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.55 -39.25 74.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.99 -32.41 70.6 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 65.6 mm-40 -58.25 -53.5 57.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.679 0.791 . . . . 0.0 109.678 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.52 -23.5 58.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.785 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.75 60.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.261 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.12 47.85 10.56 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.962 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.9 mt -80.32 161.78 24.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.6 p -38.8 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.87 128.81 1.53 Allowed Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.91 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -136.17 150.85 49.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 30' ' ' MET . 53.7 mtmt -106.99 128.45 54.36 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 15.6 m -118.84 129.24 75.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 123.797 0.686 . . . . 0.0 109.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.2 m-85 -118.44 154.52 32.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.17 116.06 12.15 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.98 -36.98 67.2 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.428 0.455 . . . . 0.0 111.646 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.28 102.07 1.02 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.18 60.32 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.657 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -57.45 100.62 0.05 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.974 1.31 . . . . 0.0 111.888 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.0 133.96 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -26.56 0.29 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 118.809 2.283 . . . . 0.0 118.809 167.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.47 134.12 45.17 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 118.313 1.057 . . . . 0.0 112.141 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -86.81 131.57 34.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.2 pt? . . . . . 0 C--N 1.299 -1.589 0 O-C-N 123.336 0.398 . . . . 0.0 110.563 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 122.301 1.048 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -117.71 157.53 26.33 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.059 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -107.58 137.77 45.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.673 0.749 . . . . 0.0 113.002 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -126.66 151.15 48.45 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.788 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -84.2 126.46 40.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -98.8 129.44 45.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.131 0.491 . . . . 0.0 112.323 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 29' ' ' VAL . 81.7 tttt -150.5 163.95 37.15 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.438 ' N ' ' HG2' ' A' ' 28' ' ' LYS . 48.2 t -103.77 131.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.412 ' HB3' ' HB2' ' A' ' 203' ' ' LYS . 14.1 ptp -91.01 97.29 11.09 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . . . 167.82 134.88 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 125.099 1.36 . . . . 0.0 109.467 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.17 -17.83 31.8 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 9.6 mm-40 -88.75 0.2 56.71 Favored 'General case' 0 C--O 1.199 -1.604 0 C-N-CA 125.341 1.456 . . . . 0.0 111.851 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . . . -69.9 -12.53 61.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.383 -0.823 . . . . 0.0 112.779 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.28 1.18 Allowed Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.832 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 72.2 m-85 -89.27 145.46 25.37 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.1 mt -78.16 101.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -61.64 -41.22 97.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.177 0.923 . . . . 0.0 112.001 -169.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -141.79 170.56 15.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mp -52.88 123.51 32.65 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 125.108 1.363 . . . . 0.0 113.457 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -72.41 166.54 29.49 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.539 2.16 . . . . 0.0 111.776 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.77 115.83 1.84 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.57 6.59 58.39 Favored Glycine 0 C--O 1.225 -0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.653 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 33.4 m -85.95 140.98 35.2 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -76.28 166.27 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.36 2.706 . . . . 0.0 110.158 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -49.49 151.73 1.52 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -40.66 -53.44 2.77 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 127.281 2.232 . . . . 0.0 114.521 -173.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -83.25 -29.18 28.65 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.743 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -81.09 -12.06 59.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.062 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 16.0 m-85 -43.89 -49.03 8.49 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.519 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 42.6 m80 -129.38 27.21 5.33 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.247 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.99 102.04 14.38 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.84 -9.93 35.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.01 161.76 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.986 1.393 . . . . 0.0 112.032 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -98.68 159.5 14.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.08 12.94 26.41 Favored 'General case' 0 C--O 1.206 -1.184 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.78 75.33 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 121.953 0.882 . . . . 0.0 111.17 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -89.52 -27.92 19.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.171 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.68 -22.23 19.54 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -114.21 144.74 32.25 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 123.16 12.26 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.774 2.316 . . . . 0.0 112.95 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -97.88 116.27 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.5 23.34 58.58 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.829 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.43 -160.22 30.1 Favored Glycine 0 C--O 1.245 0.814 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.814 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 46.6 mt-10 -127.48 130.08 48.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.462 0.305 . . . . 0.0 110.184 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.3 m -132.75 166.69 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 23.5 t -143.1 149.36 38.04 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.85 114.69 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.7 p . . . . . 0 C--N 1.296 -1.726 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 29.9 t-20 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 5.9 mmp_? -78.96 -165.48 0.75 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 122.031 0.92 . . . . 0.0 113.369 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.3 p-10 -93.7 -162.91 0.98 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.796 1.639 . . . . 0.0 110.372 -175.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.1 mp -91.73 135.98 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.727 0.298 . . . . 0.0 111.703 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 1.4 m-30 -99.36 -105.49 0.21 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.708 0.403 . . . . 0.0 110.542 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -117.0 -47.67 2.68 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.31 129.54 53.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 124.996 1.318 . . . . 0.0 107.616 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 15.8 mm100 -105.88 116.35 59.89 Favored Pre-proline 0 C--N 1.295 -1.786 0 O-C-N 123.436 0.46 . . . . 0.0 112.053 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 83.6 Cg_endo -83.19 168.11 13.55 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.79 2.327 . . . . 0.0 111.36 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -163.66 -178.55 5.84 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.51 -13.47 9.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.19 178.45 5.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.209 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.454 ' OG ' ' HG3' ' A' ' 181' ' ' ARG . 3.7 m -90.48 46.67 1.36 Allowed 'General case' 0 C--O 1.251 1.182 0 CA-C-O 121.22 0.533 . . . . 0.0 110.41 -176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -136.73 145.26 44.44 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.7 tp -122.79 141.37 51.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.262 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 56.6 tp -113.7 125.91 54.65 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.1 t -126.63 142.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -72.99 164.1 27.18 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -71.68 -18.51 77.35 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -65.1 -58.3 6.39 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.14 60.39 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.049 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 47.7 ttt180 -57.25 -47.9 80.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.927 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 1.2 mmmp? -61.88 -38.74 89.42 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 109.859 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.28 -53.53 56.2 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.601 0.563 . . . . 0.0 110.746 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.03 -41.85 87.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 123.716 0.806 . . . . 0.0 111.506 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 49.4 mt-10 -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.0 m -64.32 -30.58 71.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.145 0.497 . . . . 0.0 111.599 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.465 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.8 mp -84.44 -10.1 57.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.985 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.05 43.03 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.455 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.5 t -77.73 100.62 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 m -76.95 156.35 32.05 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.842 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 80.81 13.84 0.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.652 1.581 . . . . 0.0 110.838 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.59 122.69 47.19 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.021 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -115.81 144.68 43.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -114.66 122.25 45.88 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.173 0.589 . . . . 0.0 110.466 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' HG ' HD22 ' A' ' 130' ' ' ASN . 78.6 mt -115.27 98.81 51.39 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.88 138.71 13.34 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.421 2.081 . . . . 0.0 113.185 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.9 m -145.89 173.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.496 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.441 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.49 116.91 33.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 173.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 23.0 mt -111.34 134.19 54.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.315 0.579 . . . . 0.0 112.248 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.2 mptp? -98.11 148.38 23.6 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 5.9 p-10 -92.91 -160.49 0.76 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.474 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 71.8 m80 -71.84 -18.96 62.04 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.944 0.498 . . . . 0.0 111.554 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.8 -19.41 24.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.17 51.63 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.242 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.3 ptmt -98.32 138.61 35.32 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 91.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.148 0.499 . . . . 0.0 109.758 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.413 ' C ' ' HD3' ' A' ' 124' ' ' PRO . 11.9 m -115.98 12.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.012 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -123.91 65.42 0.53 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.523 173.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 8.3 Cg_endo -85.37 -23.58 2.26 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.494 2.129 . . . . 0.0 113.224 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.55 4.08 21.84 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.441 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.401 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 6.9 m-85 -84.74 140.8 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.554 0.692 . . . . 0.0 110.972 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -129.85 141.44 50.82 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.928 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -79.8 127.26 32.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 tt -93.41 124.79 37.64 Favored 'General case' 0 C--O 1.282 2.81 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.519 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 36.7 m-80 -104.58 128.84 52.69 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.106 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 114.37 27.66 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.4 169.63 9.93 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.133 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.09 22.52 78.79 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.915 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.7 131.67 34.39 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.21 169.26 18.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -58.15 105.71 0.3 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -127.52 -33.68 2.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.407 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 24.3 mt -59.36 119.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.037 -173.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.58 128.15 35.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.416 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 64.1 mtp -109.66 -25.64 10.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.931 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.51 -29.67 18.79 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.868 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -96.17 -11.59 25.93 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.522 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 m -104.56 149.74 25.23 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -114.34 104.83 12.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.416 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 4.3 p90 -154.19 150.95 28.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.399 0.619 . . . . 0.0 112.364 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 51.7 mm-40 -108.92 139.66 43.47 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.234 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 90.7 mtp -100.84 155.23 18.05 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.161 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 151' ' ' GLU . 16.7 t70 85.85 78.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.916 1.686 . . . . 0.0 113.766 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.59 ' OG ' ' HA3' ' A' ' 156' ' ' GLY . 49.9 m -103.19 -57.21 2.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.174 166.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.7 mt -94.02 -45.21 7.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 2.3 pp20? -147.01 171.78 14.73 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.567 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -54.75 -44.98 74.09 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.458 1.103 . . . . 0.0 113.548 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.457 ' HB3' HH12 ' A' ' 181' ' ' ARG . 7.0 t70 -92.38 15.1 14.66 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.011 0.91 . . . . 0.0 110.496 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 9.8 mm-40 -102.38 119.37 38.7 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 124.121 0.969 . . . . 0.0 110.308 175.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 50.7 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.59 ' HA3' ' OG ' ' A' ' 149' ' ' SER . . . -115.52 -65.05 0.39 Allowed Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.5 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 6.4 t30 -84.86 119.08 24.93 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 52.2 mt -128.12 127.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.47 -29.37 8.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.919 0.39 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.08 130.08 16.33 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.07 118.9 24.3 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.76 139.59 38.14 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.5 mt -57.77 145.42 34.84 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.437 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 15.1 p-10 -94.61 15.1 18.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.683 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.55 -5.21 18.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.596 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -61.4 -35.72 78.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.212 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.79 -31.82 6.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.252 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 78.3 mt -90.02 154.13 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -50.15 122.92 15.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 123.91 0.884 . . . . 0.0 112.708 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.4 -6.0 17.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.025 1.816 . . . . 0.0 110.512 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.484 ' HA ' ' NH2' ' A' ' 187' ' ' ARG . 5.8 p-10 -99.67 6.3 45.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.092 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -85.62 132.03 34.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 187' ' ' ARG . 76.7 mttt -84.93 -16.51 40.79 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.138 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 185' ' ' LEU . 26.4 ttt -159.77 127.72 4.82 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.37 164.3 38.39 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 142.43 34.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.511 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 38.6 m -93.01 120.47 33.34 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -53.45 -46.46 69.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -79.2 24.32 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.43 ' OE2' ' HD3' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.21 158.33 44.02 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.457 HH12 ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -91.27 -51.54 5.25 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.762 174.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.43 ' HD3' ' OE2' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -92.54 -13.41 29.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.239 -167.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.511 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 37.3 tp -77.78 101.16 6.58 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 122.017 0.913 . . . . 0.0 111.841 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.5 mt -120.87 121.36 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 174' ' ' MET . 66.7 mt -97.15 133.59 41.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 120.933 0.397 . . . . 0.0 110.66 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 42.7 pt -120.97 158.02 23.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.282 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.484 ' NH2' ' HA ' ' A' ' 171' ' ' ASP . 93.7 mtt180 -83.14 162.53 21.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.789 0.804 . . . . 0.0 111.068 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -55.56 -47.4 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.268 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.16 -26.94 69.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.115 0.259 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.465 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 61.9 t -65.21 -54.35 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.743 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -74.89 -26.43 59.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.232 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.35 -34.14 77.62 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.446 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.19 -37.34 78.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.231 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -69.65 -38.06 76.97 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.823 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -65.12 -40.79 95.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -77.04 -25.64 52.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.419 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.41 -27.49 46.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 121.176 0.513 . . . . 0.0 109.912 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.54 47.5 4.84 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.066 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.99 165.32 19.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.98 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -161.07 125.26 1.42 Allowed Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.361 -1.399 . . . . 0.0 112.347 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -120.66 145.34 47.54 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 28' ' ' LYS . 50.2 tptt -105.18 121.37 43.68 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.88 129.72 71.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.342 0.591 . . . . 0.0 111.185 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -111.29 141.18 45.16 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.04 106.17 1.0 Allowed 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.82 74.47 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.163 0.506 . . . . 0.0 111.451 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -77.35 89.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.317 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.6 35.13 6.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.438 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -63.82 99.16 0.22 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.668 0.747 . . . . 0.0 111.802 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.16 130.5 51.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.36 -26.51 0.27 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 165.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.26 141.3 41.74 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.384 1.092 . . . . 0.0 111.451 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.23 130.32 38.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.673 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 36.7 tp . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.362 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -118.22 145.26 45.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.203 0.525 . . . . 0.0 110.341 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -114.2 132.63 56.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.647 -172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 78.8 m-85 -116.62 141.63 47.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.2 t -78.32 121.79 31.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -96.24 129.86 43.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -173.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -150.47 153.92 36.76 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.8 t -87.82 145.61 7.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.55 140.98 31.04 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.187 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 88.91 128.48 0.03 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.742 2.017 . . . . 0.0 112.472 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 33.0 tt0 -73.21 -26.38 61.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.938 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 -0.25 43.82 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.069 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -77.05 11.64 1.73 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.17 65.88 0.95 Allowed Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.352 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 10.4 m-85 -79.79 142.01 35.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.032 0.444 . . . . 0.0 110.415 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -89.41 104.66 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 170.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -61.85 -57.23 12.61 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.083 -172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -117.49 176.47 5.15 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.04 132.17 88.55 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.15 166.49 29.44 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.271 1.981 . . . . 0.0 112.124 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -52.46 124.71 14.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.86 1.264 . . . . 0.0 112.476 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.44 81.75 Favored Glycine 0 CA--C 1.516 0.133 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.093 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 50.8 m -85.83 139.46 35.15 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.71 165.77 24.47 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.295 2.663 . . . . 0.0 110.878 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 p -54.17 150.59 8.13 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 181' ' ' ARG . 3.8 m-20 -41.34 -59.18 1.63 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.707 2.003 . . . . 0.0 114.786 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -79.11 -30.53 43.82 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.853 0.359 . . . . 0.0 111.705 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -79.01 -11.93 60.02 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.637 -173.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.5 m-85 -44.72 -44.54 9.27 Favored 'General case' 0 C--O 1.194 -1.84 0 C-N-CA 123.517 0.727 . . . . 0.0 112.205 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.428 ' CG ' ' HD2' ' A' ' 176' ' ' ARG . 65.5 m80 -129.4 21.57 5.62 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.48 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -91.91 101.32 13.89 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.29 -5.83 4.83 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.38 164.32 21.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -97.97 142.86 29.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 50' ' ' PHE . 4.4 mp -99.28 -4.94 30.7 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.639 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.12 -21.59 66.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.116 0.484 . . . . 0.0 111.822 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.31 -21.13 24.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -116.86 -22.98 8.27 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -94.35 139.13 22.32 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.06 123.22 11.83 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.558 2.172 . . . . 0.0 112.812 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.07 107.55 21.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 23.56 30.24 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.434 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.85 -157.75 31.17 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.813 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.75 132.75 46.67 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.12 170.68 19.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -145.39 152.56 40.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.847 -0.533 . . . . 0.0 111.264 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -77.24 107.4 9.61 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p . . . . . 0 C--N 1.294 -1.837 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.231 177.381 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.514 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 13.3 t-20 . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -77.28 -165.46 0.59 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.687 0.755 . . . . 0.0 112.839 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.6 -165.28 1.13 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.238 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.48 150.37 21.83 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.767 0.794 . . . . 0.0 113.114 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 29.4 m-85 -121.85 -149.24 0.42 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.741 2.017 . . . . 0.0 106.977 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -81.14 -31.91 33.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.878 0.763 . . . . 0.0 110.929 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.43 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 59.0 m-85 -134.97 148.19 49.93 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 11.0 mm100 -121.82 120.98 28.33 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 93.5 Cg_endo -87.1 170.62 7.01 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.26 1.973 . . . . 0.0 110.474 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -155.9 179.19 9.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.993 -0.442 . . . . 0.0 110.984 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.5 mt -86.97 -22.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -86.25 -92.3 0.09 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -168.68 -40.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -67.43 117.1 8.95 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 120.956 0.408 . . . . 0.0 112.035 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.2 tp -87.43 133.75 33.69 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.462 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 40.9 tp -105.33 121.32 43.63 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.768 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.33 137.07 56.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 p -76.49 172.73 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.433 0.293 . . . . 0.0 110.904 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.37 -20.48 79.33 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -65.59 -58.29 6.11 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.22 -28.93 64.56 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.562 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.448 ' HE ' ' CD ' ' A' ' 100' ' ' GLU . 54.6 ttt180 -57.9 -43.69 86.31 Favored 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.356 0.41 . . . . 0.0 110.108 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -67.26 -28.32 67.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.82 -54.02 22.31 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.39 -46.26 92.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 C-N-CA 123.744 0.818 . . . . 0.0 112.039 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' CD ' ' HE ' ' A' ' 96' ' ' ARG . 50.2 mt-10 -62.07 -31.84 72.31 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.423 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -78.33 -11.27 59.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.24 -13.94 51.27 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.679 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.78 33.89 26.17 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.72 101.21 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.989 0.899 . . . . 0.0 109.853 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.0 m -86.76 150.3 24.26 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 80.51 10.05 1.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.606 1.162 . . . . 0.0 111.348 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.05 26.18 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.4 tp10 -94.62 144.83 25.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -125.88 108.66 11.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.3 mt -109.32 95.63 19.21 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.35 140.83 12.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.775 2.317 . . . . 0.0 113.37 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.62 169.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.961 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.95 116.82 29.4 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.1 mt -113.97 128.45 70.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.184 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.37 146.1 24.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.412 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 8.8 p-10 -84.83 -160.51 0.49 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 122.48 0.312 . . . . 0.0 110.436 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.514 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 56.8 m80 -73.69 -19.55 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.562 0.345 . . . . 0.0 110.452 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -93.19 -20.06 20.83 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.068 0.461 . . . . 0.0 110.22 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.04 22.1 12.57 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.12 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.412 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 61.0 pttt -105.15 146.82 28.69 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.92 89.94 2.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 121.638 0.732 . . . . 0.0 110.146 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 m -114.12 10.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.088 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.36 42.35 1.37 Allowed Glycine 0 CA--C 1.549 2.159 0 C-N-CA 119.304 -1.426 . . . . 0.0 116.496 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.0 -1.69 9.99 Favored 'Trans proline' 0 C--N 1.376 1.981 0 CA-C-N 122.049 2.924 . . . . 0.0 112.107 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.9 -7.31 37.09 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 125.139 1.375 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -98.92 144.04 28.55 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.374 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.92 143.51 50.18 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.299 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.7 119.85 24.36 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 3.9 tt -91.85 125.01 36.4 Favored 'General case' 0 C--O 1.281 2.737 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.255 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.4 ' OD1' HD13 ' A' ' 56' ' ' LEU . 26.9 m-80 -123.83 141.64 51.85 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.785 -1.552 . . . . 0.0 107.393 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.29 132.94 49.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.479 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.45 170.47 8.38 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.63 16.96 67.07 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 132.11 43.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.45 169.09 18.62 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.01 108.59 5.99 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.155 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -132.18 -12.83 3.17 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -167.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.5 120.04 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.37 115.0 6.52 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.0 ttt -95.37 -7.79 37.51 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.378 0.609 . . . . 0.0 110.169 -172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.33 -49.81 6.15 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.182 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -87.08 -16.25 36.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.167 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 104.7 16.65 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.768 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.41 103.7 2.99 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.949 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.85 161.6 42.4 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.97 129.79 51.51 Favored 'General case' 0 N--CA 1.402 -2.854 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.795 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 56.0 mtt -92.66 108.21 19.8 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -151.51 -25.27 0.2 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -167.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 53.6 m -70.59 -56.38 6.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.16 -35.52 4.67 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.677 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -164.18 -174.39 3.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 147' ' ' MET . 10.2 tmtt? -65.04 -33.64 76.52 Favored 'General case' 0 C--O 1.196 -1.737 0 O-C-N 123.84 0.713 . . . . 0.0 111.022 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.26 23.72 4.27 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.331 0.586 . . . . 0.0 111.904 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.423 ' HA ' ' NE2' ' A' ' 154' ' ' GLN . 17.1 mm-40 -125.62 114.28 18.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.452 0.644 . . . . 0.0 111.197 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 56.9 mt -84.86 134.13 27.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.856 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -110.34 -70.88 0.64 Allowed Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -84.22 127.4 33.92 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.81 127.65 66.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -112.87 -24.16 9.71 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.1 0.476 . . . . 0.0 110.905 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.54 136.22 17.1 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -131.25 108.27 9.56 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.35 138.0 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.1 mt -54.37 140.23 34.34 Favored 'General case' 0 C--O 1.253 1.251 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.515 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.1 p-10 -87.99 6.28 36.67 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.226 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -68.27 -6.14 22.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.878 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.0 m -61.03 -40.82 95.05 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 124.614 1.166 . . . . 0.0 110.046 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.419 ' HB1' ' CB ' ' A' ' 137' ' ' ALA . . . -112.53 -32.21 6.54 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.384 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.511 HG13 ' CB ' ' A' ' 137' ' ' ALA . 83.3 mt -82.94 147.24 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -54.03 118.13 14.8 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 122.908 0.483 . . . . 0.0 112.041 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.64 -11.89 30.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.409 2.072 . . . . 0.0 111.653 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -88.97 0.47 56.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.475 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.04 127.65 33.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -76.34 -22.53 54.8 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.7 ttt -155.77 122.45 5.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -148.51 -179.23 6.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.428 ' HD2' ' CG ' ' A' ' 51' ' ' HIS . 12.2 ptp180 -151.43 164.73 36.1 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.469 ' SG ' HD21 ' A' ' 183' ' ' LEU . 61.6 m -86.5 152.32 22.75 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 124.206 0.941 . . . . 0.0 112.082 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.7 p -82.12 -50.77 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -85.19 2.62 42.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.66 104.04 5.0 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.535 ' NH1' ' HB3' ' A' ' 47' ' ' ASP . 27.7 ptt180 -68.0 -27.12 66.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.004 -170.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 184' ' ' ILE . 17.9 mtm-85 -88.85 -33.55 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.064 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 177' ' ' CYS . 3.9 tt -62.34 105.75 0.66 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.448 1.099 . . . . 0.0 111.24 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 182' ' ' ARG . 67.1 mt -110.6 130.46 63.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 45.0 mt -107.78 121.86 45.59 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.397 0.618 . . . . 0.0 110.564 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 43.5 pt -111.36 143.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.27 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -77.11 154.71 33.0 Favored 'General case' 0 C--O 1.259 1.57 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 2.8 pm0 -55.16 -39.4 69.45 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.474 0.71 . . . . 0.0 112.357 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -54.01 -43.42 70.06 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.463 1.505 . . . . 0.0 111.718 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.7 -48.32 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.435 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 20.7 p80 -72.21 -25.25 61.58 Favored 'General case' 0 C--O 1.196 -1.743 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.108 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.0 73.09 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.452 0.47 . . . . 0.0 110.526 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.19 -35.62 71.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.427 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.2 m-85 -68.6 -35.69 77.68 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.693 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -59.1 -51.54 69.6 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.812 0.695 . . . . 0.0 110.219 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.07 -16.51 59.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.071 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.85 -27.34 36.45 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.02 47.94 17.35 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.516 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.12 165.0 25.16 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.417 -0.113 . . . . 0.0 111.041 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.4 p -43.37 -77.03 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -171.0 138.4 4.92 Favored Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.719 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.43 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 35.2 m-85 -136.36 153.46 51.12 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -112.86 122.02 46.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.97 129.32 68.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.214 0.53 . . . . 0.0 109.642 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -114.1 137.39 51.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.75 109.53 3.88 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.04 -33.11 57.36 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.495 0.497 . . . . 0.0 112.088 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.41 92.52 1.08 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.296 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.52 35.05 14.71 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.423 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 16.3 t90 -67.51 101.03 0.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.923 0.889 . . . . 0.0 112.164 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -104.35 152.03 22.75 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.94 -25.67 0.3 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 166.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.423 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 86.4 mt -94.68 145.72 24.65 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 117.956 0.878 . . . . 0.0 112.659 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.4 132.85 52.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' HE3' ' OE2' ' A' ' 208' ' ' GLU . 20.8 ptmt -79.44 156.06 28.04 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.2 0.524 . . . . 0.0 111.699 -175.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -109.68 141.29 42.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.738 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -124.22 146.0 49.0 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.022 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.79 117.82 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -105.7 123.11 47.4 Favored 'General case' 0 C--N 1.282 -2.358 0 O-C-N 123.638 0.586 . . . . 0.0 110.506 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -139.32 139.43 37.28 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.8 t -86.6 110.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.74 98.7 9.5 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 119.509 -0.876 . . . . 0.0 108.906 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.63 110.84 5.76 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.43 -35.12 8.9 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.919 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.24 -23.93 57.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.124 0.487 . . . . 0.0 110.462 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . . . -79.73 -28.06 40.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.71 156.06 22.02 Favored Glycine 0 N--CA 1.413 -2.892 0 CA-C-N 113.635 -1.621 . . . . 0.0 114.381 174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -87.1 156.13 19.84 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.822 -1.189 . . . . 0.0 108.119 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.426 HG12 ' CE2' ' A' ' 68' ' ' PHE . 22.4 mt -79.52 101.85 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -57.9 -45.16 86.86 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -131.82 176.19 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.62 119.58 74.87 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 124.004 0.815 . . . . 0.0 110.981 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -66.94 166.75 21.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.671 2.248 . . . . 0.0 111.946 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -49.97 117.51 2.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.226 1.011 . . . . 0.0 113.697 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.36 66.21 Favored Glycine 0 C--O 1.206 -1.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.731 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.4 m -86.44 137.49 34.42 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.81 166.67 26.89 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 124.062 3.174 . . . . 0.0 111.154 169.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 p -53.47 150.69 6.4 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.39 -57.21 1.44 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 128.25 2.62 . . . . 0.0 114.522 -174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -85.86 -21.02 28.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.703 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -79.1 -20.03 49.71 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.625 0.37 . . . . 0.0 111.926 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 57.9 m-85 -45.11 -33.24 2.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.532 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 4.5 m-70 -129.11 16.07 6.19 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 120.577 -1.327 . . . . 0.0 109.95 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 101.28 13.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.378 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.55 -9.38 1.28 Allowed Glycine 0 CA--C 1.549 2.181 0 N-CA-C 118.066 1.986 . . . . 0.0 118.066 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.128 1.964 . . . . 0.0 112.152 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.2 t -97.45 150.01 21.52 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 50' ' ' PHE . 77.4 mt -86.25 -3.14 58.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.514 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.48 66.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.48 -20.52 25.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -114.62 -22.89 9.53 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -108.11 136.54 19.78 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.61 123.09 11.45 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.69 2.26 . . . . 0.0 112.183 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.02 116.78 34.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.64 21.39 58.11 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.2 -162.94 29.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.382 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -116.85 137.85 51.92 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.22 172.78 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -148.96 155.61 41.08 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.426 ' CE2' HG12 ' A' ' 37' ' ' ILE . 7.8 m-85 -75.02 104.83 5.75 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.12 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -81.13 -161.48 0.41 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.95 0.9 . . . . 0.0 111.872 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -81.95 -168.24 1.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.191 0.996 . . . . 0.0 112.615 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.8 142.61 27.68 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.765 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 21.8 m-85 -107.76 -167.57 1.27 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.78 -42.85 89.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.37 138.18 53.88 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 16.2 mm100 -119.25 131.5 24.34 Favored Pre-proline 0 C--O 1.261 1.679 0 O-C-N 123.531 0.519 . . . . 0.0 110.471 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.67 177.68 2.15 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.141 2.561 . . . . 0.0 111.967 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -163.49 179.11 7.5 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.91 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.1 mm -91.93 3.22 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 CA-C-O 122.542 1.163 . . . . 0.0 108.701 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -109.98 -102.37 0.39 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.238 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 64.7 p -173.51 -14.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.557 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -69.63 116.75 10.39 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.44 132.02 34.61 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.101 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 34.3 tp -104.28 119.55 39.21 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.628 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.42 136.98 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.503 -173.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -71.38 172.04 10.13 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.276 0.63 . . . . 0.0 111.649 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 97' ' ' LYS . . . -68.03 -34.02 80.56 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -64.52 -55.56 19.8 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.509 0.723 . . . . 0.0 110.085 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.51 69.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.464 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 58.7 ttt180 -58.39 -48.36 80.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.979 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 7.6 mtpm? -62.18 -32.36 72.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.796 0.685 . . . . 0.0 112.047 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.84 -53.06 61.96 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.982 0.42 . . . . 0.0 110.349 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.44 -36.32 75.78 Favored 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.921 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 51.6 mt-10 -68.87 -38.66 79.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.124 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.3 m -70.53 -28.7 65.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.965 0.412 . . . . 0.0 111.764 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.35 -14.98 57.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.647 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.52 48.42 68.46 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.93 109.06 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.66 0.743 . . . . 0.0 111.421 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -64.33 136.64 57.34 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 75.67 7.87 3.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.118 1.367 . . . . 0.0 114.391 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.21 114.12 26.56 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 9.1 tp10 -103.39 146.58 28.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -114.15 120.94 42.24 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.607 0.567 . . . . 0.0 110.631 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.62 97.28 50.68 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.51 140.78 17.23 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.872 2.381 . . . . 0.0 112.9 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 m -148.66 167.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.528 0.731 . . . . 0.0 110.005 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.48 116.61 30.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 33.9 mt -112.92 132.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.172 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -92.86 134.91 34.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -80.0 -160.81 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.432 ' HE1' ' O ' ' A' ' 34' ' ' ALA . 58.8 m80 -68.56 -26.89 65.63 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.898 -0.501 . . . . 0.0 110.922 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.39 -19.19 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.327 0.651 . . . . 0.0 110.907 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.12 14.06 27.35 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.518 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -101.85 139.76 37.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.355 0.578 . . . . 0.0 110.289 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 58.7 t -83.0 84.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.312 1.053 . . . . 0.0 110.539 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 m -111.21 16.83 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.474 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -130.84 45.4 1.14 Allowed Glycine 0 CA--C 1.547 2.089 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.828 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.07 -5.05 9.63 Favored 'Trans proline' 0 C--N 1.383 2.342 0 CA-C-N 121.416 2.608 . . . . 0.0 112.506 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -108.47 0.03 20.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.807 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.439 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 6.8 m-85 -92.16 134.84 34.48 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.239 -174.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.69 142.36 51.45 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.975 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -83.87 112.47 20.15 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.6 tt -88.35 129.95 35.26 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.532 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -123.88 141.03 52.4 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.525 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.24 131.85 51.11 Favored 'General case' 0 CA--C 1.486 -1.511 0 O-C-N 123.799 0.687 . . . . 0.0 110.356 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.34 173.08 6.48 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 124.719 1.262 . . . . 0.0 108.361 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.54 13.63 64.98 Favored Glycine 0 C--N 1.305 -1.145 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.725 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.82 130.07 45.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.28 107.94 3.83 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.291 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.74 -46.59 0.63 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 125.854 1.661 . . . . 0.0 112.682 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.439 ' C ' ' HB2' ' A' ' 164' ' ' ASP . . . 65.34 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 126.558 1.943 . . . . 0.0 115.912 171.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.1 mm -55.23 124.29 7.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.274 1.03 . . . . 0.0 111.083 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.62 95.26 3.33 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.3 ttm -76.74 -4.14 41.79 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.996 -170.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.74 -50.22 9.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.494 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -99.68 1.36 43.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.988 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.5 p -94.32 119.06 32.53 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.28 100.9 12.87 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -155.27 161.65 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.306 0.574 . . . . 0.0 112.511 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -118.28 145.58 44.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.748 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 59.2 mtt -100.7 155.67 17.77 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.343 33.7 t70 93.07 86.4 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.23 2.212 . . . . 0.0 115.952 174.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.7 m -101.48 -37.38 8.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.41 168.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.0 mt -135.23 -45.27 0.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.111 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.413 ' CD ' HH22 ' A' ' 181' ' ' ARG . 40.0 mt-10 -139.65 177.24 8.08 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.552 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.437 ' HZ3' ' HB3' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -66.81 -31.25 71.76 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -96.51 24.01 6.3 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.481 1.134 . . . . 0.0 110.074 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.443 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 21.3 mm-40 -114.66 115.19 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.5 mt -78.32 139.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 -84.85 1.75 Allowed Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -82.31 121.38 26.6 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.33 109.86 26.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.19 -43.67 12.81 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.85 110.66 4.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -85.33 121.22 27.75 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -93.99 132.0 38.89 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.82 136.05 51.47 Favored 'General case' 0 C--O 1.257 1.487 0 O-C-N 124.185 0.928 . . . . 0.0 111.708 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.439 ' HB2' ' C ' ' A' ' 137' ' ' ALA . 21.5 p-10 -87.22 1.62 52.55 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.988 -175.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.1 p -68.27 -4.53 14.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.031 1.333 . . . . 0.0 111.203 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.2 m -67.61 -34.37 76.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.264 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.13 -31.69 6.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.403 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.3 mt -91.89 141.68 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.439 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 48.3 mtp180 -53.96 121.5 29.68 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 123.415 0.686 . . . . 0.0 111.435 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.17 -6.85 18.29 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.876 2.384 . . . . 0.0 112.603 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.05 -10.0 55.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.291 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.47 120.3 15.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.98 -30.79 65.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.998 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.421 ' HG3' HG23 ' A' ' 186' ' ' ILE . 26.9 ttt -153.35 129.59 10.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.24 -178.92 7.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 22.9 ttp180 -138.53 142.08 39.31 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.78 144.6 52.63 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.6 p -81.07 -35.88 31.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.47 -7.39 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.06 117.85 13.2 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 176' ' ' ARG . 6.2 ptp180 -76.48 -24.76 53.82 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.303 -173.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -89.77 -15.72 31.8 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.77 99.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.685 -174.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.42 123.08 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -107.64 124.45 50.0 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.845 0.831 . . . . 0.0 111.251 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.421 HG23 ' HG3' ' A' ' 174' ' ' MET . 36.3 pt -116.07 155.27 17.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.987 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -85.98 158.59 19.84 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -47.82 -42.46 26.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.35 1.06 . . . . 0.0 113.097 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.92 -40.47 69.91 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 125.445 1.498 . . . . 0.0 112.291 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.45 -46.97 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.558 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 33.1 p80 -71.01 -31.74 68.33 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.02 70.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.0 -34.77 61.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.13 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.7 m-85 -73.21 -35.52 66.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.008 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 47.7 mt-10 -60.75 -53.38 58.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.523 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.65 -24.17 66.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.56 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -79.76 -27.41 40.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.344 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.47 36.61 43.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.82 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.32 157.11 32.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.4 p -102.03 137.11 40.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.55 71.35 0.92 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.369 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 55.5 m-85 -141.96 149.54 40.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 118.175 0.988 . . . . 0.0 112.795 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -161.71 121.51 2.53 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.07 156.14 38.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -140.72 161.89 36.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 123.558 0.743 . . . . 0.0 109.934 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.04 117.69 20.33 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -26.98 62.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.576 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.461 ' OE2' ' HE3' ' A' ' 23' ' ' LYS . 35.3 mt-10 -67.58 97.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.304 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 70.65 35.65 67.26 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.741 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.6 t90 -52.92 102.71 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.969 0.908 . . . . 0.0 110.304 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.24 113.14 26.48 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.02 -25.02 0.25 Allowed Glycine 0 CA--C 1.539 1.575 0 N-CA-C 119.999 2.76 . . . . 0.0 119.999 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.13 114.93 21.0 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 119.019 1.41 . . . . 0.0 110.74 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.99 132.36 42.32 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.482 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.241 174.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 C--O 1.237 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -98.2 127.9 44.38 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.41 141.89 44.37 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.429 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -124.47 143.49 50.62 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.5 111.14 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -92.06 132.39 36.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.409 0.624 . . . . 0.0 110.952 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HE2' ' OXT' ' A' ' 215' ' ' LEU . 0.4 OUTLIER -148.77 156.45 42.37 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 103.193 -2.892 . . . . 0.0 103.193 177.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -94.64 131.38 41.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.9 ptp -70.2 173.57 6.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.833 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 77.44 112.42 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.273 1.829 . . . . 0.0 112.375 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.91 -16.83 34.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.624 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -13.62 43.16 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.93 -35.76 77.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 90.65 145.45 13.95 Favored Glycine 0 N--CA 1.401 -3.684 0 CA-C-N 113.775 -1.557 . . . . 0.0 114.754 171.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 21.9 m-85 -95.92 166.08 11.96 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 113.436 -1.382 . . . . 0.0 107.863 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.1 mt -78.3 101.34 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 162.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -62.59 -51.66 66.45 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 124.504 1.127 . . . . 0.0 112.234 -169.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.6 176.14 8.7 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -60.68 126.94 86.3 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -73.68 167.7 26.62 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.079 2.519 . . . . 0.0 112.284 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.6 112.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 124.28 1.032 . . . . 0.0 112.712 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.68 66.98 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 115.691 1.037 . . . . 0.0 115.691 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 81.1 p -85.94 146.94 44.38 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 118.204 1.002 . . . . 0.0 113.213 -176.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.38 166.36 15.28 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.913 3.075 . . . . 0.0 111.741 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -56.85 155.16 8.23 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.39 -56.06 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 127.925 2.49 . . . . 0.0 112.915 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -85.86 -19.67 30.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.495 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -84.17 -17.14 40.97 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 44' ' ' SER . 30.3 m-85 -45.18 -40.53 7.27 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.557 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 12.4 m170 -128.98 20.71 5.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 111.396 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.95 102.57 14.93 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.49 -2.93 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.464 1.345 . . . . 0.0 116.464 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.83 160.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.097 0.949 . . . . 0.0 113.219 -173.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -98.12 134.53 41.06 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.67 -10.78 55.32 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.84 63.03 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.13 -17.88 28.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.58 -21.24 9.25 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.415 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 58.4 t80 -105.92 138.8 19.75 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 123.29 11.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.029 1.82 . . . . 0.0 112.572 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.46 122.69 44.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.57 75.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.63 -165.92 29.5 Favored Glycine 0 CA--C 1.502 -0.736 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.319 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -117.93 130.09 56.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 60' ' ' PHE . 35.6 m -126.78 160.93 34.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 p -142.33 150.02 40.23 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.959 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -75.27 107.33 7.3 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.296 -1.758 0 O-C-N 124.881 1.363 . . . . 0.0 112.792 178.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 61.5 t30 . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 77' ' ' ASN 0.272 20.4 mmt180 -69.17 -174.17 0.61 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 -164.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.413 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 4.1 p-10 -82.47 -172.75 4.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.861 -172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.71 150.7 22.48 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.389 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -114.63 -159.89 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.441 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.31 -37.42 85.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.481 0.582 . . . . 0.0 111.099 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -126.36 157.14 39.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -141.53 136.41 15.55 Favored Pre-proline 0 C--O 1.26 1.636 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.87 178.12 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.441 2.094 . . . . 0.0 113.441 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.9 p30 -160.98 173.98 14.47 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.2 mm -90.54 -14.59 8.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.907 0.86 . . . . 0.0 109.849 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -94.67 -151.75 0.33 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.372 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 2.1 m -102.58 0.91 34.12 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.469 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 4.0 p-10 -92.62 167.31 12.0 Favored 'General case' 0 C--O 1.201 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 112.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.71 141.64 51.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.66 126.4 55.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.72 141.45 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -79.53 172.57 13.61 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.353 0.261 . . . . 0.0 110.61 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.93 93.41 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -64.08 -47.22 80.91 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 122.762 0.425 . . . . 0.0 112.003 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.36 -28.74 66.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -56.99 -47.56 80.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.944 0.497 . . . . 0.0 110.442 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.8 -28.75 68.63 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.795 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.51 -54.19 46.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.33 -43.88 87.17 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.53 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -66.12 -35.01 79.35 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -68.24 -21.75 64.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.024 0.44 . . . . 0.0 111.441 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -86.29 -2.8 58.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.811 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.44 37.17 85.4 Favored Glycine 0 N--CA 1.438 -1.18 0 O-C-N 123.952 0.782 . . . . 0.0 112.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.17 116.67 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.375 0.607 . . . . 0.0 109.628 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -88.01 157.77 18.81 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.205 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 78.0 15.48 1.46 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.903 0.881 . . . . 0.0 112.243 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.18 114.98 29.44 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 7.1 tp10 -105.73 140.77 38.27 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.431 ' CH2' HD12 ' A' ' 129' ' ' LEU . 43.8 m95 -116.87 121.94 42.93 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.804 0.842 . . . . 0.0 109.7 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -113.43 109.13 51.47 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.597 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.48 137.1 16.24 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 122.54 2.16 . . . . 0.0 113.407 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 172.27 2.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.401 1.08 . . . . 0.0 109.586 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -103.16 116.51 32.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.1 mt -107.53 142.69 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.186 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -118.38 135.35 54.38 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.623 1.169 . . . . 0.0 108.128 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.427 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.9 p30 -86.19 -162.29 0.73 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.1 m80 -74.4 -12.61 60.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.384 1.074 . . . . 0.0 111.815 -174.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.51 -19.48 29.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.07 1.29 63.04 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.174 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -89.65 154.77 19.71 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.748 -0.266 . . . . 0.0 110.412 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.57 126.17 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 116' ' ' ASP . 11.3 p -129.81 -32.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.921 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.95 73.14 0.47 Allowed Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.491 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.08 -0.99 9.76 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 CA-C-N 119.673 1.736 . . . . 0.0 109.746 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.61 -12.19 17.92 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.203 1.401 . . . . 0.0 111.158 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -92.57 149.26 21.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.539 0.685 . . . . 0.0 112.528 -172.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.39 143.02 49.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.368 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.23 120.38 27.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.564 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.431 HD12 ' CH2' ' A' ' 109' ' ' TRP . 7.0 tt -91.61 131.83 36.75 Favored 'General case' 0 C--O 1.259 1.573 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.405 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.557 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 7.9 p30 -124.42 140.96 52.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.217 174.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.43 141.05 32.72 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.573 0.546 . . . . 0.0 110.462 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.5 173.02 6.67 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 124.656 1.222 . . . . 0.0 108.412 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.72 17.18 73.6 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 132.89 33.97 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.295 0.569 . . . . 0.0 109.779 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -137.07 168.98 18.55 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.9 103.1 0.14 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.716 1.143 . . . . 0.0 111.27 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.66 -54.9 3.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.026 -1.897 . . . . 0.0 115.497 -163.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.9 mt -51.22 113.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 124.366 1.041 . . . . 0.0 113.758 -169.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -70.93 107.07 3.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.517 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.427 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 46.7 mtt -91.3 8.84 34.05 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -85.84 -50.39 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -93.21 -4.9 51.17 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.484 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 61.0 p -91.74 151.02 20.82 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.995 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.58 97.81 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -147.78 163.42 36.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.16 140.79 49.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.506 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.16 155.65 20.66 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.998 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.321 34.6 t70 96.0 95.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.455 2.302 . . . . 0.0 115.783 174.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.0 m -100.57 -56.16 2.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 167.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -128.33 -41.05 1.58 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.063 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 47.8 mt-10 -125.83 -179.08 4.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.058 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -71.71 -44.23 64.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 124.201 0.938 . . . . 0.0 111.07 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -82.91 26.01 0.63 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.894 0.854 . . . . 0.0 112.241 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -113.21 122.05 46.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.28 116.17 21.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -84.02 -61.55 1.83 Allowed Glycine 0 CA--C 1.493 -1.315 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -111.02 132.86 53.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.2 mp -119.8 113.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -89.34 -39.19 13.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.614 -0.835 . . . . 0.0 109.994 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.19 117.4 3.5 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.173 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.36 145.08 26.48 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.95 146.02 47.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.457 ' HG ' ' OE2' ' A' ' 208' ' ' GLU . 93.8 mt -53.78 136.55 39.83 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.512 1.133 . . . . 0.0 112.559 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -96.5 10.44 38.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.166 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.2 p -68.19 -5.16 16.65 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.938 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.8 m -61.14 -40.53 94.17 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.147 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.52 -33.68 6.31 Favored 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.255 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.26 151.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -44.41 117.61 2.97 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.046 0.938 . . . . 0.0 110.934 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.34 -16.04 39.04 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.461 2.107 . . . . 0.0 111.856 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.62 11.43 31.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.496 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.04 143.38 39.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -95.99 -28.95 14.41 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.444 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -143.75 124.57 14.24 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.35 178.23 10.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.61 163.25 40.31 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.138 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.448 ' SG ' HD22 ' A' ' 183' ' ' LEU . 71.2 m -83.3 149.93 26.46 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.125 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.5 p -81.44 -51.51 8.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -89.5 20.65 3.8 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.92 134.32 21.9 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 171.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' SER . 15.3 mmt180 -89.96 -33.16 16.49 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 123.821 0.701 . . . . 0.0 112.386 -168.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -91.67 -12.11 35.03 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.971 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.448 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.5 tt -86.68 109.13 18.99 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.433 0.635 . . . . 0.0 110.401 -173.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.19 129.06 75.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.7 121.54 43.8 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.801 0.81 . . . . 0.0 111.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 48.7 pt -111.29 147.77 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.007 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.35 150.11 38.51 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.15 -39.2 27.99 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.52 -30.28 69.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 111.73 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.486 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.7 t -66.4 -49.48 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.999 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.581 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 17.1 p80 -70.87 -29.73 65.92 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.085 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.486 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -59.35 -34.84 72.86 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.37 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.38 61.65 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 19.2 m-30 -68.98 -34.55 75.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.696 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 39.5 mt-10 -65.48 -49.11 70.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.493 0.717 . . . . 0.0 111.146 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -69.92 -29.89 67.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.48 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 109.897 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 78.72 45.22 9.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.661 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.9 mt -81.4 154.14 26.58 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 27.5 p -101.45 129.82 47.56 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.69 71.71 0.75 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.756 -0.657 . . . . 0.0 114.582 172.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 14.9 m-85 -124.7 145.77 49.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.061 0.93 . . . . 0.0 112.666 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -144.0 121.94 12.04 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.03 128.9 69.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 69.2 m-85 -120.46 137.97 54.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.06 111.03 3.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.22 86.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.526 0.516 . . . . 0.0 112.175 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.457 ' OE2' ' HG ' ' A' ' 163' ' ' LEU . 30.1 mm-40 -68.07 100.61 1.02 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.345 0.593 . . . . 0.0 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.56 32.85 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.066 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.66 104.64 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.967 . . . . 0.0 110.129 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.91 103.78 13.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -173.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -7.41 2.96 Favored Glycine 0 N--CA 1.471 1.005 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.14 117.46 23.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.548 1.174 . . . . 0.0 110.552 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.99 125.79 29.78 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.444 ' OXT' ' HE2' ' A' ' 28' ' ' LYS . 1.3 pt? . . . . . 0 C--N 1.31 -1.112 0 O-C-N 124.263 0.977 . . . . 0.0 112.313 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.409 -2.517 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.515 ' HB2' ' OE2' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -112.04 155.8 23.22 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -114.57 142.78 45.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.253 0.549 . . . . 0.0 111.128 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.11 147.38 49.04 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.772 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -80.74 123.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -91.94 133.67 35.48 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.502 0.668 . . . . 0.0 110.733 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -150.18 151.35 32.94 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.22 121.35 45.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 26.9 ttt -79.23 81.29 5.51 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.299 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 178.74 111.72 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 124.734 1.271 . . . . 0.0 108.41 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.47 -23.54 25.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 47.0 mt-10 -82.54 -4.11 57.06 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.055 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.39 -35.33 78.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 97.0 92.62 1.87 Allowed Glycine 0 N--CA 1.397 -3.96 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.755 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.09 141.01 57.74 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -70.85 101.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 169.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.2 -33.99 49.72 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.274 0.559 . . . . 0.0 111.411 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -122.41 161.77 22.86 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.9 124.97 91.91 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 122.618 0.367 . . . . 0.0 111.874 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.74 168.98 21.56 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.075 2.516 . . . . 0.0 111.417 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -39.8 118.85 0.91 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.234 1.413 . . . . 0.0 113.303 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 13.53 83.15 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.8 m -85.51 138.52 35.97 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.57 166.71 23.04 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.513 3.475 . . . . 0.0 111.037 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -60.01 145.92 44.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -38.09 -53.78 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 127.171 2.188 . . . . 0.0 114.121 -174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.426 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 56.5 p-90 -85.77 -23.18 27.37 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.582 -173.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -86.93 -11.77 49.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.979 -171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CD2' ' HB2' ' A' ' 88' ' ' ASN . 20.9 m-85 -43.28 -51.46 6.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.079 0.862 . . . . 0.0 112.743 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.512 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.0 m-70 -128.43 32.45 4.85 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.339 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -92.38 101.24 13.71 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.67 -10.65 12.18 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.6 169.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.944 1.872 . . . . 0.0 114.108 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -98.28 160.16 14.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.362 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -112.76 14.42 19.94 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.3 -22.9 64.7 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.683 0.754 . . . . 0.0 110.434 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -88.95 -20.8 24.03 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.555 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.6 -22.95 12.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.58 140.78 23.51 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 122.41 9.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.914 1.743 . . . . 0.0 112.095 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.72 123.7 49.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.14 24.32 52.36 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.707 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.09 -168.3 22.22 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.406 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 113' ' ' ALA . 40.7 mt-10 -123.56 128.25 49.46 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.36 174.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 p -146.39 151.98 38.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.05 113.97 8.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.409 -2.515 0 CA-C-O 122.013 0.911 . . . . 0.0 111.551 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 83.8 m-20 . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -90.26 -164.32 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.849 0.833 . . . . 0.0 112.075 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.5 -170.43 2.94 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 125.614 1.566 . . . . 0.0 110.392 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -88.17 149.54 23.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.296 0.57 . . . . 0.0 111.621 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -120.9 -165.31 1.2 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -66.09 -44.08 85.41 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.924 0.784 . . . . 0.0 111.24 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -113.53 142.25 46.17 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.853 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -128.4 128.62 23.62 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.592 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -91.42 175.6 2.26 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.892 2.395 . . . . 0.0 113.108 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -163.54 172.16 14.8 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.099 0.959 . . . . 0.0 108.419 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.94 -16.94 9.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.975 0.893 . . . . 0.0 109.723 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -85.48 -164.04 0.95 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.811 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.424 ' CB ' HH21 ' A' ' 176' ' ' ARG . 26.4 p -122.08 54.1 1.19 Allowed 'General case' 0 C--O 1.252 1.205 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 2.6 t30 -137.39 153.42 50.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -109.66 141.96 41.5 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.7 tp -108.33 125.9 52.23 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.625 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.5 p -74.48 172.44 11.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.634 0.774 . . . . 0.0 110.626 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.07 -37.65 94.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.556 -0.354 . . . . 0.0 112.655 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -61.39 -52.63 63.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.783 0.801 . . . . 0.0 109.71 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.35 -32.76 73.92 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.42 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.34 -39.97 84.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.233 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 8.9 mmpt? -64.69 -38.73 91.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.672 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.22 -52.99 62.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.054 0.454 . . . . 0.0 110.296 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.4 mt -61.54 -43.55 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.109 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.39 -41.34 85.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -70.29 -25.28 63.26 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.35 -21.23 59.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.91 47.82 6.06 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.9 t -74.02 101.24 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.616 0.722 . . . . 0.0 109.588 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 m -70.05 147.1 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.965 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 79.45 9.14 1.65 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.362 1.065 . . . . 0.0 111.999 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.58 114.71 29.16 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 8.7 tp10 -111.75 146.85 36.84 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -116.6 120.91 40.18 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.039 0.136 . . . . 0.0 111.092 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.7 mt -106.2 101.98 37.55 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.17 132.4 12.61 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.666 2.244 . . . . 0.0 112.814 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.0 m -144.64 170.27 7.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.581 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.404 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . . . -102.79 116.55 32.8 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.8 mt -109.82 133.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.496 0.665 . . . . 0.0 112.409 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -95.6 143.67 26.7 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -83.22 -160.7 0.44 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.455 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 35.5 m80 -70.15 -30.87 68.14 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.768 0.827 . . . . 0.0 110.137 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -81.78 -19.98 40.12 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.7 14.88 33.29 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.119 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 17.9 ptpt -95.36 140.51 30.13 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.94 89.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.571 0.701 . . . . 0.0 110.024 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.38 11.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.614 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.1 54.43 0.76 Allowed Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.669 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.71 -17.44 5.04 Favored 'Trans proline' 0 C--N 1.368 1.594 0 CA-C-N 120.629 2.215 . . . . 0.0 112.342 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.71 7.65 44.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.199 0.523 . . . . 0.0 110.346 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -95.1 144.32 25.84 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 121.515 0.674 . . . . 0.0 110.601 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -133.58 141.63 47.77 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.023 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.408 ' HB3' ' ND2' ' A' ' 88' ' ' ASN . 55.5 m-85 -80.75 119.76 23.76 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tt -86.45 121.25 28.74 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.512 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 91.8 m-20 -97.91 125.81 43.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.08 121.71 42.29 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.401 0.438 . . . . 0.0 110.02 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.66 172.9 6.55 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.855 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 20.29 65.33 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.278 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.03 40.61 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.61 169.32 17.86 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -53.71 104.96 0.11 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 164' ' ' ASP . . . -131.58 -27.34 1.94 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 -164.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 179' ' ' LYS . 24.3 mt -63.01 122.86 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.533 1.06 . . . . 0.0 110.874 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.43 107.74 7.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.787 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -77.32 -9.44 58.83 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -70.33 -50.06 43.0 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.436 0.636 . . . . 0.0 109.759 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.69 -2.5 35.21 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.307 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.8 p -99.88 142.38 31.43 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.489 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 14.7 mm-40 -122.61 107.5 12.04 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -161.71 161.28 29.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.747 0.308 . . . . 0.0 111.681 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -125.46 142.07 51.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 58.7 mtt -100.43 108.32 20.28 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.67 7.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.7 p -72.67 -56.67 4.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.204 -0.599 . . . . 0.0 112.051 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -117.82 -39.23 3.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.687 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -158.24 -176.34 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -68.93 -13.3 62.35 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.6 23.24 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.215 0.531 . . . . 0.0 112.15 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.37 120.81 26.2 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 72.1 mt -72.91 133.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.061 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -115.79 -70.6 0.47 Allowed Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -79.17 122.14 25.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.2 mt -126.91 106.85 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 33.9 t70 -90.25 -44.74 9.52 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.791 0.805 . . . . 0.0 109.088 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.66 110.88 3.92 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.797 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.32 125.64 39.09 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.66 146.87 27.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.0 140.02 57.7 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.867 0.842 . . . . 0.0 112.484 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 18.4 p-10 -94.46 6.64 48.17 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.46 -5.5 19.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.632 1.173 . . . . 0.0 109.866 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -62.0 -39.49 92.39 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.651 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.24 -31.84 6.72 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.697 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 64.5 mt -83.16 150.62 4.18 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -60.95 120.19 51.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 118.208 0.458 . . . . 0.0 109.96 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.97 -16.35 45.12 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.405 2.07 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.56 -6.15 58.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.19 127.35 32.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.12 -33.36 71.74 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.429 ' HG3' HG21 ' A' ' 186' ' ' ILE . 26.7 ttt -151.1 130.08 12.55 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -153.79 -178.72 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.136 0.574 . . . . 0.0 109.585 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.424 HH21 ' CB ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -136.76 145.68 44.89 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.404 ' HG ' ' CG ' ' A' ' 164' ' ' ASP . 58.5 m -73.52 152.63 40.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.835 0.709 . . . . 0.0 110.374 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -81.94 -45.36 15.51 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.413 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.4 mmpt? -73.45 -20.01 60.81 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.553 -173.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.68 134.8 52.75 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 175.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.426 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 52.1 mmt-85 -89.59 -36.59 15.22 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -85.77 -19.83 30.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.173 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.9 100.64 2.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.962 0.887 . . . . 0.0 110.914 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.75 124.95 62.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 57.7 mt -112.14 133.67 54.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.45 0.643 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' ' 174' ' ' MET . 43.4 pt -121.87 159.48 24.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.176 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -86.15 161.43 18.86 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.775 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -49.0 -47.71 44.19 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.994 1.718 . . . . 0.0 109.717 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.12 -45.75 22.59 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.997 2.119 . . . . 0.0 113.525 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -46.42 75.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.605 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 11.5 p80 -77.35 -21.6 53.08 Favored 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.006 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.86 81.63 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.31 -40.82 94.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.71 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 191' ' ' HIS . 22.7 m-85 -65.91 -37.62 86.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.09 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.7 mm-40 -55.36 -51.51 66.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.651 0.78 . . . . 0.0 109.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.62 -10.65 59.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.504 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.01 -27.88 20.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.48 62.91 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.946 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.461 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 61.0 mt -84.5 160.28 20.55 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.1 p -94.65 121.75 36.53 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 105.3 63.82 0.64 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.796 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 46.2 m-85 -127.14 135.06 50.18 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 117.938 0.869 . . . . 0.0 112.782 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 50.9 tptt -144.02 121.54 11.75 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.2 m -126.11 129.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.5 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -110.62 165.02 12.15 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -68.64 122.96 19.61 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.37 -35.64 35.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 23' ' ' LYS . 14.7 mt-10 -75.14 97.85 3.56 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.447 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.06 35.37 34.8 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.678 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.504 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 9.9 t90 -55.21 106.61 0.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.131 0.972 . . . . 0.0 109.712 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -103.23 99.02 8.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.55 15.22 68.18 Favored Glycine 0 N--CA 1.47 0.965 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.504 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 95.5 mt -93.97 156.38 16.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.167 0.984 . . . . 0.0 110.991 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.81 131.64 48.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.065 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.051 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -107.2 144.78 33.47 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.694 0.283 . . . . 0.0 110.398 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -116.56 139.75 50.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.671 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.97 136.42 54.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -72.97 107.73 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -99.76 134.2 42.99 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.525 0.679 . . . . 0.0 112.453 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -151.1 165.36 34.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.97 141.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.71 82.76 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . 162.27 137.1 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 127.637 2.375 . . . . 0.0 107.655 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -80.48 -29.29 37.39 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.011 0.91 . . . . 0.0 109.185 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 11.4 pt-20 -83.17 0.73 43.95 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.578 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 79' ' ' TYR . . . -66.75 -20.69 66.01 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.895 0.379 . . . . 0.0 110.441 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 66.86 0.29 Allowed Glycine 1 N--CA 1.393 -4.208 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.574 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 19.1 m-85 -70.83 133.06 46.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.856 172.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.49 101.9 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 171.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -59.16 -41.77 89.14 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.681 -171.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -148.0 173.39 12.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 46' ' ' THR . 5.8 mp -60.62 124.61 79.7 Favored Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 124.269 1.027 . . . . 0.0 113.333 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 167.76 25.65 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.803 2.335 . . . . 0.0 112.275 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -45.92 113.76 0.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.898 1.679 . . . . 0.0 112.761 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.61 7.72 87.06 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.522 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.33 132.18 45.87 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 117.21 0.505 . . . . 0.0 111.814 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.42 165.64 12.76 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.693 2.929 . . . . 0.0 111.958 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.409 ' HA ' HD22 ' A' ' 40' ' ' LEU . 10.9 p -52.94 150.14 5.78 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -39.35 -54.91 1.82 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 127.991 2.516 . . . . 0.0 113.708 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.456 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 53.7 p-90 -83.52 -24.3 31.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.151 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 51.5 tptt -85.41 -12.82 51.11 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.524 -172.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -45.11 -43.94 10.13 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -128.96 25.24 5.6 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -92.96 100.9 13.26 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 118.113 -1.435 . . . . 0.0 107.422 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.11 -9.58 3.92 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.0 172.09 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 120.452 2.126 . . . . 0.0 113.752 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.7 t -98.06 150.48 21.36 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.011 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.7 mt -98.33 -4.36 35.14 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.02 47.23 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -22.41 22.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -101.2 -22.17 14.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -96.31 140.81 22.4 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.38 122.59 10.08 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.932 1.754 . . . . 0.0 110.913 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -101.45 119.3 49.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.05 16.86 66.39 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.29 -150.26 26.69 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.84 133.54 44.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.96 167.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -145.74 154.07 41.66 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.156 -0.34 . . . . 0.0 110.448 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 115.59 15.53 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 170.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--N 1.303 -1.429 0 O-C-N 124.268 0.98 . . . . 0.0 112.755 -176.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 48.6 t-20 . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -83.51 -165.37 1.09 Allowed 'General case' 0 C--O 1.262 1.762 0 CA-C-O 122.013 0.911 . . . . 0.0 112.844 -168.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.27 -160.83 0.73 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.637 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 mp -92.89 138.75 31.21 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.114 0.483 . . . . 0.0 111.768 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 2.4 m-30 -108.23 -155.93 0.57 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.957 1.703 . . . . 0.0 108.432 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -64.21 -49.54 71.57 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.515 0.674 . . . . 0.0 110.381 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.15 139.3 53.48 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.825 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 14.3 mm100 -107.39 119.0 52.16 Favored Pre-proline 0 N--CA 1.431 -1.387 0 O-C-N 123.745 0.653 . . . . 0.0 111.309 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 90.6 Cg_endo -84.08 168.12 12.17 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 122.713 2.275 . . . . 0.0 111.259 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -159.35 169.79 23.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.18 -7.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 124.103 0.877 . . . . 0.0 110.286 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -98.99 -168.56 1.64 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.333 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 p -101.97 21.95 13.86 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -173.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -116.43 162.97 16.74 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.541 -0.724 . . . . 0.0 109.316 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.3 tp -123.49 141.7 51.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.968 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 54.1 tp -114.47 127.14 55.66 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -126.92 144.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.76 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -76.55 168.77 19.48 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.58 0.352 . . . . 0.0 110.173 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.83 -36.08 90.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -65.2 -45.27 85.48 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -30.38 64.3 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.387 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -58.78 -45.09 90.59 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -57.48 -42.16 82.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.057 0.848 . . . . 0.0 110.617 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.72 -54.26 48.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.354 0.409 . . . . 0.0 110.887 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.14 -41.4 86.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 C-N-CA 123.513 0.725 . . . . 0.0 111.818 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.99 -34.29 75.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.626 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -68.01 -27.55 66.65 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.966 0.412 . . . . 0.0 111.027 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.2 -7.34 59.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.608 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.84 42.73 98.35 Favored Glycine 0 N--CA 1.441 -0.98 0 O-C-N 123.563 0.539 . . . . 0.0 112.321 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -72.07 112.61 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -79.86 155.37 27.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 75.69 15.17 2.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.96 1.304 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.3 113.85 25.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.2 tp10 -109.35 138.7 45.32 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.505 ' CZ3' ' HG ' ' A' ' 129' ' ' LEU . 59.7 m95 -119.6 114.5 22.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.4 mt -110.73 96.59 29.21 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.76 146.23 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.336 2.024 . . . . 0.0 112.239 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.73 169.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.714 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -90.74 115.35 27.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.2 mt -108.49 126.55 65.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.49 0.662 . . . . 0.0 112.029 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -99.49 136.15 39.85 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.648 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.8 p-10 -81.1 -160.47 0.33 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.866 0.365 . . . . 0.0 110.817 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.665 0.786 . . . . 0.0 110.028 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -79.88 -19.83 47.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.515 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.26 38.17 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.725 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.648 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.9 ptmt -93.92 133.48 37.3 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.0 t -77.35 93.11 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.132 0.491 . . . . 0.0 109.738 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.31 11.89 6.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.547 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.27 51.8 0.82 Allowed Glycine 0 C--O 1.201 -1.943 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.393 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 90.6 Cg_endo -84.34 -1.97 9.87 Favored 'Trans proline' 0 C--N 1.368 1.584 0 CA-C-N 121.542 2.671 . . . . 0.0 112.209 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -113.54 7.26 17.37 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.591 1.186 . . . . 0.0 109.124 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -93.98 137.31 33.32 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.842 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.8 139.94 53.08 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.693 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -79.45 115.41 19.06 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HG ' ' CZ3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -87.28 119.9 28.01 Favored 'General case' 0 C--O 1.274 2.369 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -176.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -101.67 122.07 43.2 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.51 113.25 24.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.14 173.42 7.03 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 124.21 0.944 . . . . 0.0 109.5 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.27 63.86 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.113 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.65 130.94 34.61 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -148.09 100.26 3.15 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.081 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.464 ' O ' ' HE2' ' A' ' 179' ' ' LYS . 16.9 t70 72.41 -48.53 0.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.138 1.775 . . . . 0.0 111.614 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 67.49 -95.82 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.6 mt -65.15 123.19 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -166.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.1 129.18 37.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.335 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 51.5 ttm -107.43 1.01 23.28 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.487 0.661 . . . . 0.0 110.932 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.3 -49.21 7.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.684 0.754 . . . . 0.0 110.93 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -99.4 10.91 40.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.242 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.7 p -114.44 162.58 16.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -160.27 160.33 32.46 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.407 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -123.53 132.99 54.05 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.82 0.848 . . . . 0.0 109.525 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 57.5 mtt -92.64 126.3 37.66 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.927 0.491 . . . . 0.0 109.986 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -164.36 -26.23 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -168.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.477 ' OG ' ' HA2' ' A' ' 156' ' ' GLY . 50.0 m -56.59 -55.9 28.16 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 90.6 mt -135.96 -80.71 0.41 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.035 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.95 178.02 5.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -60.33 -34.24 73.54 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-O 120.98 0.419 . . . . 0.0 110.236 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.64 26.54 1.99 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.83 0.824 . . . . 0.0 111.503 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 149' ' ' SER . 38.7 mm-40 -116.99 115.04 24.67 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.747 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 51.5 mt -81.12 121.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.018 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.477 ' HA2' ' OG ' ' A' ' 149' ' ' SER . . . -88.47 -45.31 5.0 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.92 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -124.08 125.41 44.46 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mp -116.89 122.34 69.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -99.34 -51.18 3.87 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.55 0.69 . . . . 0.0 109.886 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.49 110.52 5.94 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.7 124.13 33.81 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -95.23 146.47 24.31 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.02 141.47 58.76 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.864 0.84 . . . . 0.0 112.59 -173.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -85.9 -2.04 57.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.279 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.7 p -68.89 -5.72 22.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.642 1.177 . . . . 0.0 110.01 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.8 m -65.15 -35.08 79.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.19 -30.51 7.43 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.36 144.99 7.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -59.2 120.9 51.67 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.13 0.572 . . . . 0.0 110.817 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 -5.78 16.89 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.426 2.751 . . . . 0.0 114.269 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.91 -3.38 57.37 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.134 -0.354 . . . . 0.0 110.811 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.65 137.39 38.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -90.93 -25.18 19.91 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 91.4 mtp -140.84 131.05 24.89 Favored 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -153.43 153.29 32.23 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.477 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.709 ' CZ ' HG21 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -113.03 143.88 43.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.419 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 39.9 m -88.13 131.98 34.5 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.4 0.438 . . . . 0.0 110.302 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.2 p -81.97 -9.35 59.6 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 136' ' ' ASP . 73.5 mmtt -99.04 0.61 44.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.372 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.417 ' OE2' ' HD2' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -157.01 143.46 18.2 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.456 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 19.6 mmt180 -90.28 -25.89 20.3 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.615 0.245 . . . . 0.0 111.488 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.417 ' HD2' ' OE2' ' A' ' 180' ' ' GLU . 54.3 mtt180 -78.19 -38.06 44.22 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.419 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 18.9 tp -69.62 100.7 1.5 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 123.247 1.499 . . . . 0.0 113.94 -168.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 176' ' ' ARG . 19.8 mt -113.53 116.1 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 112.296 -2.229 . . . . 0.0 106.597 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.25 131.93 54.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 121.833 0.825 . . . . 0.0 113.001 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.99 155.89 24.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.305 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -80.14 156.77 26.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.74 -37.32 70.85 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -57.17 -37.72 72.54 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.94 0.896 . . . . 0.0 111.062 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.33 -51.19 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.938 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.502 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.8 p80 -72.47 -26.7 61.9 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.24 -35.68 77.91 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.136 0.494 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.45 -33.78 69.66 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -71.22 -33.03 69.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.097 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 54.1 mm-40 -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.07 -7.43 58.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.007 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.95 24.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 77.99 47.42 8.5 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.779 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.52 165.48 18.02 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.283 20.0 p -67.34 -87.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -169.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.68 124.93 2.01 Favored Glycine 0 CA--C 1.492 -1.384 0 C-N-CA 119.443 -1.36 . . . . 0.0 112.676 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.35 162.82 29.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -108.84 138.51 45.06 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.47 129.35 35.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 124.662 1.226 . . . . 0.0 109.278 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 74.0 m-85 -125.4 143.12 51.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 115.52 9.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.58 75.82 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.89 96.8 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.987 0.804 . . . . 0.0 109.505 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.79 32.19 41.66 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.982 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -57.73 112.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.559 0.744 . . . . 0.0 110.061 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -102.15 74.99 1.47 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.6 14.57 65.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 116.924 1.53 . . . . 0.0 116.924 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.53 114.76 16.69 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 118.585 1.193 . . . . 0.0 110.341 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -68.37 133.01 48.05 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.191 0.996 . . . . 0.0 110.388 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.402 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 5.5 mp . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.865 0.364 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.466 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.6 ptmt -96.45 139.07 33.09 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.21 0.529 . . . . 0.0 109.84 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -121.03 142.66 49.6 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.737 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 64.8 m-85 -119.84 143.43 47.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.667 0.746 . . . . 0.0 112.926 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.27 112.92 16.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -94.68 127.64 40.8 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -150.2 139.35 21.17 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 t -88.55 142.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.4 mtt -86.4 75.88 9.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.469 0.652 . . . . 0.0 109.819 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.16 112.47 2.04 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -128.72 -50.88 1.25 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.172 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -1.4 57.1 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.27 1.033 . . . . 0.0 108.621 170.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.14 27.67 8.41 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.263 2.225 . . . . 0.0 110.507 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.574 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 124.45 68.63 0.2 Allowed Glycine 0 N--CA 1.421 -2.352 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -94.66 131.66 40.21 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 166.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -83.01 106.92 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 101.814 -3.402 . . . . 0.0 101.814 162.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -76.87 -50.49 13.25 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.282 0.563 . . . . 0.0 111.126 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -116.08 166.25 12.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.672 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.15 134.61 94.86 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 123.682 0.614 . . . . 0.0 111.641 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.91 162.64 41.94 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.675 2.25 . . . . 0.0 112.282 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -64.24 119.16 9.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.95 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.5 3.58 66.69 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.546 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 m -85.61 146.41 44.04 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.21 166.79 17.98 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 0.0 111.504 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.9 p -59.59 161.29 6.16 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.91 -52.17 35.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.204 1.402 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.404 ' CH2' ' HE2' ' A' ' 49' ' ' LYS . 9.0 p-90 -72.12 -32.96 67.45 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HE2' ' CH2' ' A' ' 48' ' ' TRP . 4.8 mptp? -65.67 -23.65 66.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.403 ' HA ' HD21 ' A' ' 56' ' ' LEU . 72.4 m-85 -60.66 -21.36 62.72 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.029 0.442 . . . . 0.0 111.548 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 11.6 m80 -127.15 -10.38 5.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.33 102.3 14.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.129 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.43 -10.97 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 N-CA-C 121.867 3.507 . . . . 0.0 121.867 166.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 173.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.651 2.726 . . . . 0.0 112.667 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -91.2 142.8 27.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.403 HD21 ' HA ' ' A' ' 50' ' ' PHE . 62.3 mt -91.66 -4.68 54.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.125 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.65 -33.79 71.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.87 -5.3 58.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -111.89 -21.33 11.66 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -102.0 137.31 19.46 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.76 123.74 12.49 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.815 2.343 . . . . 0.0 112.347 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.5 114.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 17.13 57.2 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.23 -157.39 25.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.061 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.8 mt-10 -129.63 137.08 50.47 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.82 173.75 14.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 t -144.24 153.41 42.03 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.697 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -69.01 150.18 47.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--N 1.276 -2.602 0 O-C-N 123.671 0.607 . . . . 0.0 109.6 177.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -66.75 -168.77 0.07 Allowed 'General case' 0 C--O 1.256 1.411 0 CA-C-O 123.018 1.39 . . . . 0.0 114.695 -167.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -70.69 -168.5 0.26 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 112.351 -2.204 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -110.5 151.97 26.93 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -109.7 -154.38 0.53 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.929 0.891 . . . . 0.0 109.093 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.46 -47.1 74.21 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.086 0.469 . . . . 0.0 111.62 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.21 140.49 51.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.574 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 21.8 tp60 -124.7 120.97 25.71 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.738 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -88.85 -174.46 1.02 Allowed 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.396 2.064 . . . . 0.0 111.553 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -163.67 177.92 8.34 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.87 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.48 -13.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 123.641 0.588 . . . . 0.0 109.426 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.99 -70.72 0.52 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.461 ' CB ' ' HB3' ' A' ' 181' ' ' ARG . 22.8 t -179.81 -53.73 0.01 OUTLIER 'General case' 0 C--N 1.362 1.116 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.41 -167.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.63 166.39 12.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.4 132.17 56.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 56.6 tp -104.77 132.42 51.04 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.6 136.86 58.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 O-C-N 122.408 -0.183 . . . . 0.0 110.718 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.8 p -76.32 170.07 17.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.853 0.461 . . . . 0.0 109.87 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.0 81.05 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.54 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -64.44 -53.39 49.18 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.152 0.501 . . . . 0.0 110.21 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -30.58 70.39 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.129 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.32 -44.1 97.28 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.587 0.755 . . . . 0.0 110.321 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -62.39 -39.46 93.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.934 0.771 . . . . 0.0 109.897 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 102' ' ' LEU . 4.1 mm? -57.62 -59.73 4.75 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.429 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -55.84 -41.34 66.13 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 123.234 0.614 . . . . 0.0 112.578 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.55 -42.52 78.29 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 p -71.49 -27.38 63.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 98' ' ' LEU . 9.5 mp -67.58 -25.4 65.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.863 0.363 . . . . 0.0 111.567 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.03 42.41 5.98 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.17 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.3 t -81.93 101.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 m -74.87 146.99 41.45 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.609 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 80.02 12.27 1.07 Allowed 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.28 1.432 . . . . 0.0 112.56 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.48 113.89 21.54 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.02 131.48 51.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.47 ' CZ3' HD13 ' A' ' 129' ' ' LEU . 53.2 m95 -111.37 123.13 49.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.454 -174.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.2 mt -108.92 95.11 16.19 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.8 132.98 8.97 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -150.3 167.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.98 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.92 116.71 33.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.4 mt -106.24 136.28 41.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.784 -172.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -95.46 146.76 24.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.59 -160.35 0.72 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -70.58 -23.16 62.54 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.377 1.071 . . . . 0.0 110.385 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -92.98 -19.71 21.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.838 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.57 12.97 33.84 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.094 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -99.42 151.16 21.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 117.691 0.745 . . . . 0.0 109.348 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.73 81.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.666 0.746 . . . . 0.0 110.244 -175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.7 m -104.45 11.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.086 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -127.39 48.11 0.99 Allowed Glycine 0 N--CA 1.422 -2.25 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.312 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.95 -2.52 9.63 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 121.405 2.602 . . . . 0.0 111.634 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -114.12 14.27 18.23 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.819 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.424 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 19.6 m-85 -112.8 138.24 49.92 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 111.646 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.96 138.82 52.19 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.965 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.89 125.44 29.72 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.47 HD13 ' CZ3' ' A' ' 109' ' ' TRP . 6.4 tt -102.09 125.95 48.91 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.798 0.809 . . . . 0.0 110.354 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.19 140.55 52.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.317 170.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 176' ' ' ARG . 2.8 mm? -95.79 143.64 26.85 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.204 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.64 173.29 6.37 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 122.992 0.517 . . . . 0.0 109.897 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.25 7.52 84.92 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.39 132.35 40.53 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.63 0.728 . . . . 0.0 110.464 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -132.66 170.45 15.2 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -47.85 107.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.191 0.932 . . . . 0.0 111.391 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 164' ' ' ASP . . . -94.29 -55.58 3.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -163.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.58 117.97 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.126 0.891 . . . . 0.0 112.886 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -67.0 109.84 3.13 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.57 -1.92 58.26 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.438 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 12.9 pt-20 -100.05 -30.26 12.06 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.032 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.438 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 59.9 mtt85 -102.18 -12.65 17.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 m -97.75 131.44 44.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.872 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -109.42 115.29 29.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.75 174.52 14.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.011 0.434 . . . . 0.0 111.492 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -129.46 128.62 43.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 91.2 mtp -100.79 155.13 18.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.261 19.4 t70 88.71 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.121 2.169 . . . . 0.0 113.076 177.027 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.0 p -101.57 -57.47 2.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.232 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -112.91 -24.4 9.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.784 0.802 . . . . 0.0 109.284 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 32.5 mt-10 -151.95 175.96 11.97 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 126.401 1.88 . . . . 0.0 106.47 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.578 ' N ' ' HE2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -70.53 -38.32 74.22 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -98.79 26.53 5.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.114 1.435 . . . . 0.0 110.607 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.631 ' NE2' ' HD3' ' A' ' 181' ' ' ARG . 9.7 mm-40 -108.2 121.46 44.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.093 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.46 132.59 31.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -97.8 -55.98 1.11 Allowed Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.887 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -112.12 133.3 54.35 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.724 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.47 123.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.4 -39.27 9.27 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.977 0.417 . . . . 0.0 110.447 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.91 117.04 6.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.625 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.98 123.14 45.37 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.36 142.46 30.81 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.87 133.68 56.24 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 122.456 1.122 . . . . 0.0 113.001 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 137' ' ' ALA . 18.7 p-10 -88.43 6.22 38.59 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.096 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.2 p -68.9 -4.67 17.35 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.215 1.406 . . . . 0.0 109.979 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.9 m -68.56 -40.68 80.52 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.935 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.6 -33.25 9.06 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.196 -0.315 . . . . 0.0 110.864 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.8 146.01 6.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.458 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 1.6 mpp_? -64.85 125.79 89.7 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -4.77 9.86 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.976 3.117 . . . . 0.0 114.658 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 3.9 p30 -83.56 -10.68 58.13 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.244 -0.285 . . . . 0.0 111.177 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.53 138.74 53.56 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.284 0.564 . . . . 0.0 111.076 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.97 -30.0 24.61 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.214 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.1 ttt -148.99 130.42 14.77 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.68 178.45 8.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.296 0.373 . . . . 0.0 110.609 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.553 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 ppt_? -148.54 138.26 22.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 59.6 m -78.17 153.37 32.11 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.973 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 51' ' ' HIS . 7.3 p -81.52 -50.38 9.46 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -97.81 30.13 3.12 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -155.64 127.17 7.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.631 ' HD3' ' NE2' ' A' ' 154' ' ' GLN . 1.8 mpt_? -81.0 -40.99 23.41 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.043 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -86.51 -7.12 58.65 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.175 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.8 tp -88.2 104.2 16.49 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 122.094 0.95 . . . . 0.0 111.902 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.71 123.18 69.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.22 128.85 51.99 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.343 0.592 . . . . 0.0 110.54 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 45.8 pt -112.0 148.86 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.736 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -80.73 156.18 26.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.56 -38.22 43.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.955 0.902 . . . . 0.0 112.487 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.63 -39.79 85.5 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.112 1.365 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.45 -51.34 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.737 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 18.3 p80 -68.92 -27.86 66.14 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.387 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.41 -32.18 72.12 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.562 0.539 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.9 59.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.201 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -71.72 -32.12 67.42 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.218 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 70.2 mm-40 -55.68 -53.85 51.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.815 0.846 . . . . 0.0 109.149 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -76.88 -20.72 55.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.246 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.81 -27.98 44.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.61 0.243 . . . . 0.0 110.66 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.04 47.76 12.72 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.225 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.78 165.3 23.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.75 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -159.83 132.76 3.08 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.67 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.84 165.31 25.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -128.47 131.81 48.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.59 130.25 71.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.009 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -113.04 153.16 28.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.64 112.02 9.34 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.9 -36.96 84.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 123.829 0.705 . . . . 0.0 112.068 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.63 94.92 1.04 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.51 35.19 14.52 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.622 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -58.64 100.63 0.07 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.513 0.725 . . . . 0.0 111.492 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -104.39 126.54 51.58 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.39 -26.49 0.21 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 120.298 2.879 . . . . 0.0 120.298 163.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.22 115.15 24.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 118.899 1.349 . . . . 0.0 111.602 -172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -82.69 134.66 35.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.753 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.794 1.638 . . . . 0.0 111.577 171.071 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.0 155.57 37.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.043 0.449 . . . . 0.0 112.111 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.35 138.33 46.89 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.929 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CD2' ' HB ' ' A' ' 204' ' ' VAL . 65.1 m-85 -125.76 147.52 49.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.31 0.576 . . . . 0.0 112.156 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.1 t -78.3 124.85 37.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -96.43 135.24 38.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.601 0.715 . . . . 0.0 112.154 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -149.78 162.95 39.27 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 81' ' ' PHE . 21.8 t -104.59 143.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.437 ' HE3' ' O ' ' A' ' 202' ' ' PHE . 49.4 ttm -96.55 80.55 3.13 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.47 114.75 4.16 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.018 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.43 -33.67 2.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.86 -0.53 57.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.37 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.98 -31.96 20.32 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 172.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.6 161.1 33.43 Favored Glycine 1 N--CA 1.383 -4.862 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.902 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 47.9 m-85 -95.97 164.14 12.84 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.06 101.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -54.0 -51.18 64.79 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 125.131 1.519 . . . . 0.0 113.174 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -146.81 153.61 40.39 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -48.98 121.16 10.18 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.016 1.326 . . . . 0.0 113.593 -175.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -75.59 167.03 27.34 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.472 2.115 . . . . 0.0 111.161 173.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -54.66 128.82 34.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.539 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.26 3.57 81.94 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.585 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m -85.47 128.93 57.21 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.73 165.7 3.39 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.616 3.544 . . . . 0.0 112.799 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 p -54.2 147.08 13.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 50' ' ' PHE . 4.0 m-20 -38.19 -56.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 127.059 2.143 . . . . 0.0 114.32 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 23.9 p-90 -85.88 -16.08 39.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.835 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -86.66 -13.19 46.26 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.019 -171.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HD2' ' O ' ' A' ' 47' ' ' ASP . 65.9 m-85 -48.66 -27.64 2.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -127.84 1.24 6.02 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.582 -0.699 . . . . 0.0 111.319 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.84 102.15 14.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.587 -167.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.14 -9.84 0.98 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.18 164.81 30.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 119.516 1.658 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -91.38 143.7 26.35 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.8 0.12 56.82 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.206 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.56 -37.97 52.16 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -90.38 -15.39 31.13 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 178.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.49 -23.1 12.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.631 -0.668 . . . . 0.0 112.66 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -97.46 134.71 22.27 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.8 122.09 9.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.462 1.441 . . . . 0.0 110.805 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.12 127.59 54.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.49 66.91 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.3 -167.44 27.81 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.613 -177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.96 137.75 52.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.48 163.1 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.7 t -146.29 148.16 32.14 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.046 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.59 116.59 9.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.411 -2.407 0 O-C-N 124.026 0.829 . . . . 0.0 111.71 -176.568 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 19.7 t-20 . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -84.19 -162.2 0.63 Allowed 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -86.41 -170.16 2.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.873 1.269 . . . . 0.0 113.143 -176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 5.1 mp -87.89 144.51 26.54 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.367 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -103.82 -175.9 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -57.58 -41.28 80.81 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.591 0.71 . . . . 0.0 112.18 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.422 ' O ' HG12 ' A' ' 29' ' ' VAL . 95.8 m-85 -118.36 134.91 54.66 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 172.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.463 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -121.77 129.5 25.15 Favored Pre-proline 0 C--N 1.283 -2.307 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.182 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.22 171.72 13.57 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.463 2.108 . . . . 0.0 111.734 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.1 p30 -160.08 173.65 15.49 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -96.7 14.89 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-O 123.109 1.433 . . . . 0.0 109.184 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -121.3 -176.09 3.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.722 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 m -98.09 46.9 1.0 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -127.63 162.02 27.49 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.539 -0.726 . . . . 0.0 109.603 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.8 tp -122.99 129.86 52.06 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.2 tp -102.27 123.79 46.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.61 138.05 54.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 122.791 0.436 . . . . 0.0 110.014 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -76.99 174.0 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.639 0.376 . . . . 0.0 111.119 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.61 -37.25 67.95 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.396 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.96 -35.0 66.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.103 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.38 -34.38 70.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -57.84 -46.24 85.05 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.02 174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -55.17 -38.4 68.26 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.28 -51.21 69.86 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.53 -41.66 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.069 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -69.19 -36.79 77.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.222 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -74.9 -29.6 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.26 -19.66 56.23 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.245 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.45 48.71 5.2 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.804 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.2 t -82.69 101.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.0 m -77.04 150.44 35.76 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.332 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.1 9.2 1.4 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.391 1.476 . . . . 0.0 113.3 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.49 113.8 25.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 9.1 tp10 -99.41 139.82 34.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.456 ' CZ3' HD11 ' A' ' 129' ' ' LEU . 57.0 m95 -116.96 121.74 42.27 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -116.41 93.31 39.49 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.1 139.82 21.91 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.858 2.372 . . . . 0.0 113.894 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.3 m -150.75 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 124.52 1.128 . . . . 0.0 109.522 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -96.95 116.21 28.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -108.36 130.17 61.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.423 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -96.7 135.27 38.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -169.82 2.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.983 0.356 . . . . 0.0 110.528 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 63.2 m80 -59.59 -31.15 69.2 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.022 0.929 . . . . 0.0 111.147 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -87.52 -3.01 59.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.46 64.47 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -105.34 147.73 27.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 118.461 1.13 . . . . 0.0 110.553 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.65 90.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.715 0.769 . . . . 0.0 110.34 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.9 6.22 7.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.076 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.06 45.28 1.17 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 119.309 -1.424 . . . . 0.0 116.072 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 78.3 Cg_endo -84.04 -1.44 9.9 Favored 'Trans proline' 0 C--N 1.381 2.251 0 CA-C-N 122.222 3.011 . . . . 0.0 111.02 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.64 -9.22 41.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -98.43 149.55 22.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.637 0.732 . . . . 0.0 112.707 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.0 140.18 45.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.472 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.23 122.89 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.456 HD11 ' CZ3' ' A' ' 109' ' ' TRP . 6.9 tt -99.71 128.55 45.81 Favored 'General case' 0 C--O 1.275 2.434 0 CA-C-O 121.819 0.819 . . . . 0.0 110.914 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.444 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.19 140.65 52.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.611 174.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.7 140.09 36.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.99 173.76 6.59 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.183 0.927 . . . . 0.0 109.39 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.88 22.13 50.59 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.134 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.43 132.96 45.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.416 0.627 . . . . 0.0 111.164 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -132.72 150.64 52.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -50.13 105.43 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.139 0.971 . . . . 0.0 113.453 -170.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 164' ' ' ASP . . . -117.14 -34.1 4.47 Favored 'General case' 0 N--CA 1.398 -3.068 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -167.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.2 mt -54.62 112.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.517 0.675 . . . . 0.0 111.67 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.85 128.88 36.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.668 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.4 mtt -101.79 4.62 40.61 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.437 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 11.4 pt-20 -88.93 -30.09 19.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.797 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.437 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 3.1 mmp_? -109.55 -28.07 9.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.875 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -83.09 138.68 33.6 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.661 0.743 . . . . 0.0 112.471 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.97 113.87 17.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -153.67 163.17 40.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.199 0.312 . . . . 0.0 111.244 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.66 139.15 52.39 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.299 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 60.2 mtt -100.63 108.57 20.5 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -173.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.7 t70 169.4 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.423 1.889 . . . . 0.0 108.198 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 34.8 t -99.0 -57.17 2.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.0 mt -107.58 -51.98 2.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 -165.97 2.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.571 175.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 147' ' ' MET . 53.8 pttt -59.68 -27.77 66.7 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.11 12.53 35.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.716 0.77 . . . . 0.0 111.892 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 26.0 mm-40 -111.96 116.09 30.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.51 131.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -109.22 -72.25 0.73 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -82.91 127.19 33.29 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.98 121.55 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.06 -39.3 13.75 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.98 134.35 16.2 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.59 120.76 37.64 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.14 146.79 26.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.95 135.18 57.16 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.828 0.705 . . . . 0.0 111.255 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 13.0 p-10 -92.76 14.04 18.43 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.279 1.038 . . . . 0.0 111.082 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 p -68.56 -5.14 18.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.755 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.4 m -62.8 -35.51 80.11 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 124.187 0.995 . . . . 0.0 110.457 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.42 -31.15 6.9 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.104 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.456 HG13 ' HB1' ' A' ' 137' ' ' ALA . 85.7 mt -90.64 154.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.447 ' HD2' ' OD1' ' A' ' 171' ' ' ASP . 8.3 mmt180 -45.07 119.38 4.01 Favored Pre-proline 0 C--O 1.225 -0.23 0 C-N-CA 123.466 0.706 . . . . 0.0 112.542 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.05 -16.54 25.46 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.093 1.862 . . . . 0.0 111.109 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.447 ' OD1' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -98.06 9.69 42.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.537 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.76 142.55 58.39 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.181 0.515 . . . . 0.0 109.834 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 173' ' ' LYS . 24.9 ttmt -90.06 -36.07 15.11 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.971 -174.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.6 ttt -153.19 118.9 5.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -140.33 -179.7 6.15 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.74 145.01 50.66 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 39.5 m -82.47 147.95 28.42 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 40.6 p -80.54 -45.66 17.07 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -79.62 17.62 0.87 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.5 150.18 34.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -91.95 -43.59 9.37 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.875 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -83.66 -33.84 25.15 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.394 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.88 102.3 0.19 Allowed 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.416 1.072 . . . . 0.0 113.187 -170.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 87.1 mt -112.88 126.83 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.18 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.98 122.94 46.26 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 49.2 pt -111.66 151.08 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -86.72 163.11 17.51 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.547 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.421 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 15.0 tp10 -50.44 -48.38 56.42 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.187 1.395 . . . . 0.0 111.872 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -63.98 -31.17 72.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.329 0.652 . . . . 0.0 111.558 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.83 -48.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.75 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.575 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 24.9 p80 -71.52 -33.04 68.85 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.699 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.09 72.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.554 0.534 . . . . 0.0 110.457 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.15 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.616 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.77 -40.57 75.98 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.442 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 37.8 mt-10 -62.08 -47.55 84.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.149 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.87 -19.27 61.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.24 47.14 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.656 0.265 . . . . 0.0 111.033 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.91 47.74 5.46 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.304 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.6 mt -89.63 165.83 13.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -50.27 -91.11 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.66 143.42 11.44 Favored Glycine 0 CA--C 1.497 -1.086 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.935 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.437 ' O ' ' HE3' ' A' ' 30' ' ' MET . 10.2 m-85 -134.79 165.73 24.61 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -133.06 128.59 36.57 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 170.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.47 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 15.6 m -132.53 129.92 59.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 123.687 0.617 . . . . 0.0 110.092 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.08 147.05 49.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.63 114.76 3.17 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.019 0.824 . . . . 0.0 109.68 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.57 61.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.104 0.253 . . . . 0.0 111.618 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.64 98.69 1.54 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.27 35.73 16.81 Favored Glycine 0 N--CA 1.422 -2.284 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.594 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -52.74 106.3 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.694 0.759 . . . . 0.0 110.045 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.72 99.65 10.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.837 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.93 -23.16 0.31 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 119.022 2.369 . . . . 0.0 119.022 167.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 69.6 mt -68.11 147.08 52.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.31 134.6 50.15 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 125.674 1.59 . . . . 0.0 112.426 -174.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.419 -1.977 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 7.7 ptpp? -81.17 147.84 29.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.444 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -109.17 133.15 53.39 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.629 -174.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 76.3 m-85 -118.79 145.09 45.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.656 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 58.5 t -75.99 124.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -97.81 124.37 42.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.428 0.455 . . . . 0.0 111.591 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -137.46 147.44 45.31 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.7 133.73 40.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.5 ttt -91.19 82.18 5.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.783 0.801 . . . . 0.0 110.01 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.58 116.88 5.68 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.207 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.49 -36.54 2.07 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -83.25 -23.3 32.78 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.133 0.973 . . . . 0.0 109.982 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' A' ' 79' ' ' TYR . . . -67.22 -34.49 77.59 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 154.12 30.79 Favored Glycine 1 N--CA 1.392 -4.259 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.909 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.13 166.95 11.5 Favored 'General case' 0 C--N 1.254 -3.571 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -75.74 101.73 2.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 165.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -63.36 -45.64 90.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.676 -1.602 . . . . 0.0 112.659 -167.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.38 177.08 7.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.041 0.536 . . . . 0.0 110.163 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.38 122.82 84.74 Favored Pre-proline 0 C--N 1.32 -0.687 0 O-C-N 123.808 0.692 . . . . 0.0 112.604 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.402 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 14.1 Cg_exo -69.82 166.7 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.776 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -48.92 113.51 0.8 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.95 1.3 . . . . 0.0 113.395 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.78 72.88 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.975 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.13 143.31 39.41 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.52 165.86 16.84 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.931 3.087 . . . . 0.0 111.503 172.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.1 p -62.09 155.82 23.16 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 87' ' ' SER . 4.2 m-20 -46.07 -52.71 11.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.096 1.358 . . . . 0.0 113.027 -175.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.7 p-90 -73.35 -23.72 60.25 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -74.53 -23.68 58.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.41 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -58.79 -24.9 62.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 9.0 m80 -114.61 2.29 14.49 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.79 100.65 12.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.468 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.97 -11.79 0.01 OUTLIER Glycine 0 CA--C 1.555 2.542 0 N-CA-C 121.238 3.255 . . . . 0.0 121.238 166.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.06 166.04 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 121.15 2.475 . . . . 0.0 112.191 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.414 ' HB2' ' HG ' ' A' ' 132' ' ' LEU . 32.5 t -84.54 153.73 23.09 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.56 11.6 39.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -170.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.55 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -13.24 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.925 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.32 -22.8 13.29 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.479 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -109.51 137.37 20.3 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.88 122.62 10.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.14 1.893 . . . . 0.0 111.979 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.49 115.64 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.34 55.66 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.8 -156.28 27.39 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 33.9 mt-10 -128.83 133.31 47.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 122.468 -0.431 . . . . 0.0 110.894 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' ' 41' ' ' PRO . 18.8 m -131.81 166.61 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.457 ' OG ' ' HE2' ' A' ' 115' ' ' LYS . 20.0 m -145.62 156.52 43.72 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -74.84 105.8 6.07 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.938 0.774 . . . . 0.0 109.805 175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.41 -2.44 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -82.69 -161.81 0.52 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.4 -176.22 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.659 1.184 . . . . 0.0 112.59 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.403 HD12 HG12 ' A' ' 122' ' ' VAL . 8.4 mp -94.04 150.99 19.85 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 34' ' ' ALA . 20.9 m-85 -110.06 -154.7 0.54 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.761 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -71.11 -38.34 72.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.156 0.503 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.54 138.98 52.52 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -122.53 114.08 30.33 Favored Pre-proline 0 N--CA 1.414 -2.231 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.5 159.33 28.93 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 122.171 1.914 . . . . 0.0 111.356 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.47 171.8 8.82 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.5 mm -88.71 -18.34 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.459 ' HG3' ' OD2' ' A' ' 47' ' ' ASP . 4.7 mpp? -80.74 -95.91 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.151 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 43.2 t -175.89 34.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.485 1.136 . . . . 0.0 110.048 -174.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -136.86 154.33 50.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.714 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.81 139.9 48.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.18 130.02 56.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.16 135.95 61.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.257 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.8 p -71.51 169.63 15.04 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.94 97.85 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.149 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -75.74 -32.7 60.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.058 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.48 -28.19 63.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.876 0.37 . . . . 0.0 110.048 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.45 ' HG2' ' CZ3' ' A' ' 109' ' ' TRP . 69.1 mtp180 -58.81 -43.12 90.49 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.854 172.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.9 mmpt? -61.47 -35.31 77.27 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 123.527 0.517 . . . . 0.0 111.359 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.85 -58.29 7.92 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.884 0.373 . . . . 0.0 110.115 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.16 -44.25 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.042 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.22 -37.42 87.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.0 p -75.65 -27.4 58.36 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.018 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.3 -24.38 61.32 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.738 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.11 48.45 6.92 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.8 104.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-O 121.818 0.818 . . . . 0.0 110.944 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m -55.31 123.87 15.22 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.799 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 78.21 15.08 1.41 Allowed 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.521 1.528 . . . . 0.0 113.835 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.2 114.24 21.67 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.5 tp10 -105.84 144.92 31.9 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.237 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.518 ' CZ3' HD13 ' A' ' 129' ' ' LEU . 64.9 m95 -116.3 119.66 36.44 Favored 'General case' 0 N--CA 1.425 -1.702 0 O-C-N 124.363 1.04 . . . . 0.0 109.009 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 66.3 mt -110.92 93.36 17.11 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.46 139.49 10.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.647 2.231 . . . . 0.0 112.73 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 m -147.5 173.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 108.777 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . . . -99.66 116.16 31.11 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 172.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mt -108.44 132.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.2 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 mppt? -101.12 132.3 46.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.434 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . 2.8 p-10 -82.19 -160.37 0.37 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.54 0.736 . . . . 0.0 112.524 -172.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -67.55 -32.77 73.77 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.746 0.818 . . . . 0.0 110.391 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -77.11 -21.21 54.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.52 36.91 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.109 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.62 157.66 16.31 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.47 103.44 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 116' ' ' ASP . 12.9 p -103.38 -29.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.901 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -127.98 76.52 0.4 Allowed Glycine 0 N--CA 1.407 -3.292 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.869 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.72 -23.03 7.3 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 CA-C-N 119.478 1.639 . . . . 0.0 112.651 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -116.96 4.16 12.82 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.652 0.739 . . . . 0.0 111.049 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -72.33 142.05 48.82 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.81 49.56 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.649 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -81.45 127.93 33.33 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.495 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.518 HD13 ' CZ3' ' A' ' 109' ' ' TRP . 6.8 tt -103.85 126.28 50.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.568 0.699 . . . . 0.0 110.417 -176.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.79 141.74 51.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.203 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.79 129.22 45.87 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.414 ' HG ' ' HB2' ' A' ' 55' ' ' SER . 7.4 mp -87.62 173.1 9.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.344 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.9 78.61 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.305 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.27 131.94 47.04 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.11 0.481 . . . . 0.0 109.85 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.48 170.71 15.21 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.593 ' OD2' ' HE2' ' A' ' 179' ' ' LYS . 23.6 t70 -56.04 104.96 0.16 Allowed 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.164 0.915 . . . . 0.0 110.712 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 164' ' ' ASP . . . -125.03 -36.13 2.58 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 -166.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.2 116.13 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.199 0.909 . . . . 0.0 111.123 -175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.11 128.95 36.03 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.998 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.0 ttm -105.21 1.42 28.19 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 121.061 0.457 . . . . 0.0 111.93 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.24 -50.64 5.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.987 0.899 . . . . 0.0 109.778 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -82.26 -4.9 58.03 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.37 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 p -106.2 162.97 13.18 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.183 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -126.75 93.71 3.85 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -150.94 161.97 41.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -121.98 141.62 51.14 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.358 1.463 . . . . 0.0 108.252 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.465 ' HE1' ' O ' ' A' ' 152' ' ' LYS . 81.8 mtp -100.84 107.57 19.14 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.61 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 t -69.6 -55.76 9.2 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.793 -0.567 . . . . 0.0 112.03 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.1 mt -136.56 -62.24 0.66 Allowed 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -116.82 170.36 8.67 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 111.8 -2.455 . . . . 0.0 105.796 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.465 ' O ' ' HE1' ' A' ' 147' ' ' MET . 0.0 OUTLIER -61.03 -39.6 90.4 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 124.09 0.956 . . . . 0.0 109.502 -176.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.89 -10.31 59.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.862 1.265 . . . . 0.0 111.683 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -102.01 115.5 30.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 46.3 mt -72.07 130.62 35.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.904 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -105.3 -75.57 1.01 Allowed Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.021 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -82.97 120.43 25.7 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.11 113.1 34.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.32 -29.82 15.45 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.98 2.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.185 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.11 121.87 33.27 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.02 140.65 30.46 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.96 140.34 58.85 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 124.258 0.974 . . . . 0.0 113.605 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 19.9 p-10 -93.46 6.51 47.93 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.254 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.0 p -67.44 -4.8 12.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.909 1.283 . . . . 0.0 110.401 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.1 m -63.85 -38.33 90.69 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.702 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.57 -31.37 6.8 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.875 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 78.5 mt -89.37 139.06 18.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -59.92 122.61 67.06 Favored Pre-proline 0 C--N 1.316 -0.858 0 O-C-N 123.489 0.493 . . . . 0.0 109.94 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -69.46 -7.97 22.37 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.486 2.124 . . . . 0.0 113.265 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.36 1.86 56.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.364 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.16 125.42 26.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 17.7 tttt -72.31 -27.18 62.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.372 0.606 . . . . 0.0 112.066 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.5 ttt -154.16 131.43 11.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -141.6 171.19 14.41 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.102 0.477 . . . . 0.0 111.475 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.619 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.3 OUTLIER -136.69 126.83 26.21 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.715 -176.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 25.6 m -74.54 142.91 44.7 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.635 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.7 p -81.51 -39.52 24.59 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.593 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 69.2 mmtt -74.43 11.2 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -174.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.94 140.69 4.64 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 7.1 mmt180 -90.18 -31.66 16.95 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -83.95 -28.96 27.44 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.61 111.0 5.13 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.305 1.05 . . . . 0.0 113.237 -173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.57 129.73 74.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.91 129.85 56.79 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.382 0.611 . . . . 0.0 111.288 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 45.4 pt -116.1 157.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.017 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.45 ' CD ' ' HA ' ' A' ' 173' ' ' LYS . 48.2 mtp180 -85.85 162.33 18.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.482 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.8 pt-20 -57.44 -36.22 71.11 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.426 ' OD2' ' HE2' ' A' ' 173' ' ' LYS . 5.1 p-10 -64.33 -32.38 73.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.43 0.456 . . . . 0.0 111.615 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 -48.9 79.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.637 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.519 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 17.8 p80 -73.62 -25.46 60.32 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.749 -1.181 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.03 74.1 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.414 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.12 -36.08 69.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -70.43 -33.25 71.12 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.3 mm-40 -58.51 -45.61 88.42 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.707 0.765 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -85.81 -12.42 50.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.225 -175.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -85.42 -27.92 25.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.88 48.37 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.09 165.34 19.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.8 p -41.49 -62.5 0.86 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -173.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.42 140.35 5.17 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 118.431 -1.842 . . . . 0.0 113.21 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -142.31 161.91 36.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.9 mmpt? -139.16 122.05 16.61 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.1 m -124.19 142.35 41.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.45 142.25 50.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.04 108.83 3.23 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.31 -30.42 66.22 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.432 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.67 92.11 1.15 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.88 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.17 31.12 26.44 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.588 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -58.19 101.62 0.08 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 110.967 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -104.01 120.95 42.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.67 -25.43 1.43 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 118.684 2.234 . . . . 0.0 118.684 168.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.53 143.67 36.35 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.619 1.209 . . . . 0.0 112.923 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.63 134.57 49.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.478 0.971 0 O-C-N 124.259 0.974 . . . . 0.0 110.67 178.099 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -87.61 134.4 33.64 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.885 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -109.67 145.23 36.87 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.199 0.523 . . . . 0.0 111.33 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -128.53 150.84 50.0 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.425 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 61.7 t -80.99 126.31 39.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -95.0 117.42 30.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.458 0.474 . . . . 0.0 110.719 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HG3' ' C ' ' A' ' 215' ' ' LEU . 1.2 tmtp? -135.68 139.28 43.57 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.64 122.98 49.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.6 ptp -76.07 84.58 2.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.976 0.893 . . . . 0.0 111.438 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.17 112.38 6.08 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.274 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 38.2 mt-10 -131.18 -37.19 1.27 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -84.41 -31.48 24.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.016 176.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.21 68.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 167.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.46 26.97 Favored Glycine 0 N--CA 1.42 -2.421 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.478 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.416 ' CE2' ' HG2' ' A' ' 32' ' ' GLU . 88.7 m-85 -90.68 166.94 12.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.413 HG12 ' CE1' ' A' ' 68' ' ' PHE . 49.5 mt -78.24 100.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 161.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -59.0 -63.66 1.22 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.483 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -125.22 175.42 7.43 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.717 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -59.81 123.7 72.92 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.26 0.975 . . . . 0.0 112.838 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -65.06 166.86 17.44 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.897 2.398 . . . . 0.0 112.878 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 66' ' ' VAL . 6.9 t30 -53.88 114.43 1.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.352 1.061 . . . . 0.0 112.419 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.71 12.31 62.66 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.128 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.6 m -86.38 139.71 34.01 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 167.24 24.93 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.096 3.197 . . . . 0.0 111.449 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -51.96 149.05 5.29 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.42 -49.56 7.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.661 2.384 . . . . 0.0 114.141 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -86.15 -30.05 22.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.863 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -80.28 -12.47 59.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.629 -171.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 51.9 m-85 -48.54 -33.71 10.08 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.648 0.593 . . . . 0.0 112.23 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -128.36 9.46 6.11 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -87.92 102.66 14.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.37 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.65 -8.96 0.17 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.91 171.29 14.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 119.181 1.491 . . . . 0.0 112.828 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -98.5 150.54 21.57 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.79 14.53 31.36 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.498 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.78 -32.39 60.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.82 -24.14 22.66 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.3 -22.04 14.21 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -110.79 138.38 21.07 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.75 123.4 12.59 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.291 1.994 . . . . 0.0 111.967 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.71 113.67 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 16.37 60.33 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.99 -149.56 20.35 Favored Glycine 0 C--O 1.241 0.556 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.909 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.4 mt-10 -132.68 138.53 47.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.098 0.475 . . . . 0.0 110.51 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 42' ' ' ASN . 29.6 m -131.15 174.51 12.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 p -147.31 152.72 38.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 116' ' ' ASP . 21.2 m-85 -79.36 123.63 27.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.266 1.942 0 O-C-N 124.339 1.024 . . . . 0.0 109.835 174.412 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 CA--C 1.508 -0.653 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -85.83 -154.62 0.21 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 121.578 0.704 . . . . 0.0 112.023 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.17 -169.54 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.585 1.554 . . . . 0.0 112.355 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -94.11 150.73 20.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.96 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -102.35 -163.07 0.97 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.727 1.211 . . . . 0.0 109.244 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -68.75 -30.12 68.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.506 0.67 . . . . 0.0 109.604 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.4 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 64.8 m-85 -134.85 148.39 50.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.851 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -129.93 126.55 22.52 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.0 175.26 5.04 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.315 2.01 . . . . 0.0 111.117 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.19 -178.4 5.45 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.02 -19.98 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -84.66 -92.39 0.08 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.397 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 60.2 p -174.11 -29.06 0.01 OUTLIER 'General case' 0 C--N 1.369 1.421 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -70.96 115.53 10.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.022 0.915 . . . . 0.0 111.985 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.33 126.66 33.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.671 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.54 122.4 35.94 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.414 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -71.88 156.4 39.32 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.16 -34.61 84.88 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.994 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -68.92 -41.78 77.7 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 120.838 0.351 . . . . 0.0 111.203 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.77 -28.92 61.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.958 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -59.9 -42.44 93.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.944 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 10.0 mmpt? -64.42 -32.56 74.23 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.21 -55.43 33.86 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 120.68 0.276 . . . . 0.0 110.385 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.73 -41.11 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.592 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -70.79 -27.18 63.71 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.8 m -71.92 -27.09 62.59 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.516 0.674 . . . . 0.0 110.557 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.8 -9.93 59.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.077 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.74 47.94 58.43 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.16 103.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.782 0.801 . . . . 0.0 110.094 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 m -77.26 146.82 36.67 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.838 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 80.39 1.18 1.93 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 126.008 1.723 . . . . 0.0 113.001 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.62 23.28 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.8 tp10 -99.13 142.74 30.23 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -117.86 113.49 21.84 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.986 0.804 . . . . 0.0 108.887 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.34 100.98 32.62 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.3 134.56 9.1 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.718 2.279 . . . . 0.0 112.846 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -149.88 174.63 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -108.85 116.94 32.94 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.3 mp -96.43 133.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.832 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.403 ' HG2' HG22 ' A' ' 121' ' ' VAL . 61.8 mttm -92.9 129.5 38.8 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.5 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 41.8 p-10 -76.17 -163.92 0.34 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.51 -24.94 67.26 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.523 0.729 . . . . 0.0 110.679 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.16 -19.96 24.84 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.038 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 11.85 41.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.093 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -101.28 142.66 32.37 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.427 -0.455 . . . . 0.0 110.462 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 115' ' ' LYS . 13.7 t -78.9 88.56 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.2 m -110.59 1.38 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.774 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.94 64.5 0.54 Allowed Glycine 0 C--O 1.203 -1.806 0 C-N-CA 119.406 -1.378 . . . . 0.0 113.244 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -84.0 -19.72 4.7 Favored 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 120.375 2.087 . . . . 0.0 112.61 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -103.65 7.76 37.45 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.218 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -96.34 143.41 27.42 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.136 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.34 147.65 52.4 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.71 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.4 123.53 33.04 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 5.0 tt -91.11 128.14 36.81 Favored 'General case' 0 C--O 1.263 1.793 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -120.74 140.91 51.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.68 119.3 38.56 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.17 173.04 6.55 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.714 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.87 27.47 72.23 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.168 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.08 131.72 44.91 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.14 159.91 34.52 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 105.304 -2.109 . . . . 0.0 105.304 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.4 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 13.2 t70 -66.67 112.5 4.21 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.268 0.556 . . . . 0.0 111.344 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -129.83 -14.26 4.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.4 mt -61.29 117.61 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.305 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -63.84 129.12 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.764 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 65.6 mtt -116.34 5.9 13.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.868 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.5 -50.21 5.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.07 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -98.53 -31.51 11.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.373 0.606 . . . . 0.0 109.998 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 m -73.54 128.49 35.63 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.87 112.36 24.95 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -162.01 165.39 27.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.193 0.308 . . . . 0.0 111.085 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -127.3 146.17 50.54 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 124.583 1.177 . . . . 0.0 107.946 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.463 ' SD ' HG12 ' A' ' 155' ' ' ILE . 23.1 mmt -100.44 106.7 18.3 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.028 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.6 t70 170.3 76.39 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.384 1.074 . . . . 0.0 111.184 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 154' ' ' GLN . 5.7 p -101.53 -49.13 4.11 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.9 mt -131.57 -58.83 0.98 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.08 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.43 -179.26 3.58 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.345 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -33.99 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.377 174.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 9.1 p-10 -98.73 25.09 6.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 109.539 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.486 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 24.8 mm-40 -126.14 115.44 19.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.463 HG12 ' SD ' ' A' ' 147' ' ' MET . 23.6 mt -79.36 141.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -113.95 -73.44 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.78 121.15 26.06 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.3 mt -126.94 119.33 52.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.45 -42.28 7.8 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.576 0.703 . . . . 0.0 109.312 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.66 140.19 25.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.64 117.05 20.54 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.24 147.6 25.56 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 144.28 56.01 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.466 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.7 p-10 -93.99 10.69 32.47 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.126 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.4 p -69.69 -4.96 21.9 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.966 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.8 m -60.82 -39.21 88.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 124.297 1.039 . . . . 0.0 109.879 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.408 ' HB1' ' CB ' ' A' ' 137' ' ' ALA . . . -112.32 -31.84 6.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.322 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.458 HG13 ' CB ' ' A' ' 137' ' ' ALA . 70.2 mt -89.45 146.09 6.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.474 ' HD3' ' OD1' ' A' ' 171' ' ' ASP . 44.8 mtt180 -46.56 125.12 7.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 124.645 1.178 . . . . 0.0 113.401 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.46 -5.54 14.22 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.302 2.001 . . . . 0.0 109.93 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.474 ' OD1' ' HD3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.97 -8.54 57.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.875 175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.84 136.13 50.39 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.443 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 87.5 mttt -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.406 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.9 ttt -148.9 127.05 12.06 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -150.91 -178.66 6.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.91 148.77 40.96 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.538 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.454 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 34.9 m -84.97 121.85 28.37 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 124.326 1.016 . . . . 0.0 109.136 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 19.5 p -55.99 -50.3 71.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -169.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -82.47 9.74 8.6 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -173.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -137.99 113.29 9.37 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.484 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 11.2 ptp180 -57.53 -39.17 76.02 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -83.4 -30.58 27.24 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.731 0.812 . . . . 0.0 111.791 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.454 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 22.2 tp -63.79 101.32 0.35 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.03 126.15 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.647 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.63 133.81 51.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.432 0.634 . . . . 0.0 110.634 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.4 pt -116.47 154.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.439 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.463 ' HD3' ' OD2' ' A' ' 189' ' ' ASP . 76.3 mtt180 -79.5 163.39 24.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.816 173.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 13.3 pt-20 -58.75 -36.67 74.74 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.721 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.463 ' OD2' ' HD3' ' A' ' 187' ' ' ARG . 23.3 m-20 -54.99 -45.08 75.0 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.26 1.024 . . . . 0.0 110.087 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.4 t -64.38 -50.32 76.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.754 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.533 ' CD2' ' HA ' ' A' ' 188' ' ' GLU . 21.5 p80 -70.75 -29.86 66.21 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.595 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.71 80.81 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 122.549 0.34 . . . . 0.0 110.491 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.7 80.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.45 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.64 -33.1 64.37 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.6 mm-40 -60.03 -47.06 87.39 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.23 -21.22 54.13 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.194 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.06 -27.15 59.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.728 0.299 . . . . 0.0 110.648 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.63 39.62 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.878 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.9 mt -82.04 166.0 20.15 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.7 p -53.35 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -152.51 130.75 3.15 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.316 -1.421 . . . . 0.0 112.899 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.4 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 66.2 m-85 -124.26 157.63 34.41 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.38 120.59 30.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.94 139.32 44.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.343 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 75.2 m-85 -118.59 143.17 46.97 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.96 102.95 4.97 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.69 97.26 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 123.987 0.804 . . . . 0.0 112.182 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.12 87.02 3.59 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 98.85 35.4 4.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -68.54 100.31 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.831 0.452 . . . . 0.0 110.576 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -103.74 133.97 47.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.52 -25.58 0.28 Allowed Glycine 0 N--CA 1.478 1.485 0 N-CA-C 119.344 2.498 . . . . 0.0 119.344 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.45 146.64 24.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 118.647 1.224 . . . . 0.0 113.937 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.28 133.08 41.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.515 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 1.7 pt? . . . . . 0 C--N 1.314 -0.936 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.397 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--O 1.249 1.04 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.64 155.99 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 169.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.36 151.21 30.03 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.297 0.57 . . . . 0.0 111.466 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -127.93 144.36 51.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 79.1 t -76.8 118.02 22.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -97.94 126.1 43.18 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.536 0.684 . . . . 0.0 110.935 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -143.51 155.03 44.22 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.2 t -106.39 128.44 60.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.8 ptp -79.73 85.45 5.42 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.931 0.872 . . . . 0.0 110.248 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.54 113.39 4.46 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.684 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 -58.15 2.0 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.688 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 9.9 pt-20 -88.99 -7.12 56.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.96 11.16 23.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.652 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 105.39 102.67 2.81 Favored Glycine 0 N--CA 1.406 -3.358 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -97.22 166.19 11.69 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 162.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.5 mt -93.94 101.4 12.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 161.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -60.46 -50.25 74.33 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 124.523 1.139 . . . . 0.0 110.507 -172.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.13 156.24 44.75 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.494 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.44 129.08 75.07 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 126.062 1.745 . . . . 0.0 114.16 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.15 167.33 27.15 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 123.022 2.482 . . . . 0.0 111.456 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.78 123.89 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -10.97 52.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.297 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 m -86.92 126.98 61.45 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.05 165.07 31.41 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.6 2.867 . . . . 0.0 111.027 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 p -48.23 149.4 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 -172.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -40.01 -54.19 2.27 Favored 'General case' 0 N--CA 1.507 2.421 0 C-N-CA 126.594 1.958 . . . . 0.0 113.141 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -82.3 -24.87 34.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.411 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 49.7 tptt -85.0 -14.73 46.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.434 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 28.9 m-85 -44.44 -45.76 9.25 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.824 0.703 . . . . 0.0 112.823 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.456 ' HB3' ' NH1' ' A' ' 176' ' ' ARG 0.334 35.9 m-70 -129.64 24.94 5.4 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -83.1 101.09 10.93 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.96 4.91 1.84 Allowed Glycine 0 CA--C 1.553 2.449 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.03 164.16 28.26 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 CA-C-N 119.118 1.459 . . . . 0.0 113.987 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.4 t -98.85 141.42 31.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 50' ' ' PHE . 82.7 mt -90.16 -2.04 58.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.112 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.01 68.95 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -89.66 -22.66 22.16 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -107.29 -24.06 12.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -101.69 132.56 21.57 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 122.72 9.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.96 1.774 . . . . 0.0 110.857 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -98.8 136.56 29.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 17.86 79.77 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.32 -163.0 30.62 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -126.31 132.82 51.55 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.38 167.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 32.7 t -154.55 153.51 31.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -97.06 110.48 23.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.2 p . . . . . 0 C--N 1.316 -0.86 0 O-C-N 123.49 0.493 . . . . 0.0 110.728 -179.188 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 2.5 mpt_? -90.37 -168.69 2.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -73.65 178.62 4.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 114.061 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.37 152.28 22.03 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.141 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -122.23 -161.56 0.94 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -58.56 -32.83 69.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.425 0.631 . . . . 0.0 111.95 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.87 147.82 52.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.474 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -133.4 111.51 12.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 84.0 Cg_endo -81.81 -179.43 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.793 2.328 . . . . 0.0 111.639 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -164.21 179.18 7.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.141 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.6 mt -93.47 9.08 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 122.25 1.024 . . . . 0.0 109.018 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.4 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 29.6 mtm -115.42 -159.14 0.7 Allowed 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.418 -171.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -117.91 35.34 4.76 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.782 0.719 . . . . 0.0 112.177 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -133.31 158.07 43.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.608 -0.682 . . . . 0.0 109.828 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.8 tp -122.69 141.9 51.26 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 52.4 tp -110.83 129.32 55.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.11 141.34 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.806 0.691 . . . . 0.0 110.385 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.4 p -76.14 168.39 20.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.366 0.666 . . . . 0.0 111.402 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.54 98.78 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.441 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.21 -37.99 66.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.057 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.82 -32.88 71.54 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.986 0.422 . . . . 0.0 109.906 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -57.57 -45.43 85.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.774 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -64.82 -28.89 69.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.13 -54.84 27.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.74 -43.29 91.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 111.263 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -65.95 -41.17 91.6 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.2 p -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.57 -13.24 59.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.467 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.42 47.34 10.64 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.167 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.74 104.31 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.7 t -72.59 159.83 33.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.948 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 77.87 13.78 1.69 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 124.442 1.097 . . . . 0.0 111.157 173.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.35 114.43 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.605 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -106.55 139.18 41.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -114.77 115.64 27.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 123.853 0.721 . . . . 0.0 109.108 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.8 mt -111.83 96.9 35.47 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.18 143.13 12.51 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.488 2.126 . . . . 0.0 113.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.3 168.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.833 1.253 . . . . 0.0 108.842 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.37 116.08 28.65 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.4 mt -107.89 127.46 63.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.759 0.79 . . . . 0.0 112.236 -173.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 67' ' ' SER . 85.3 mttt -101.48 131.51 47.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.4 p-10 -76.37 -160.49 0.15 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.29 0.567 . . . . 0.0 111.401 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.057 0.543 . . . . 0.0 110.353 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.59 -20.4 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.73 0.643 . . . . 0.0 109.73 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.55 12.65 40.6 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.235 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.2 ptpt -95.81 145.02 25.68 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.99 82.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.584 0.707 . . . . 0.0 110.046 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 m -106.18 4.34 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.364 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.77 61.84 0.65 Allowed Glycine 0 C--O 1.204 -1.73 0 C-N-CA 120.545 -0.835 . . . . 0.0 113.025 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -83.93 -18.87 5.16 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 120.449 2.125 . . . . 0.0 113.652 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.75 20.84 13.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.439 1.114 . . . . 0.0 110.457 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.11 133.48 35.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.41 139.18 52.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.497 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -80.04 119.22 22.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.293 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 tt -86.65 128.3 34.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.9 m-80 -114.28 125.58 54.05 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -99.6 118.07 35.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.55 172.96 6.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.698 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.85 7.85 86.7 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.84 132.28 43.58 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.34 169.67 17.35 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.46 108.86 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.93 0.769 . . . . 0.0 109.366 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.479 ' CB ' HG13 ' A' ' 168' ' ' ILE . . . -135.49 -30.77 0.99 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -167.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 179' ' ' LYS . 52.5 mt -64.41 114.99 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.087 -176.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.36 115.38 5.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.446 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 mmt -77.67 -1.94 33.53 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.23 -50.82 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.38 -30.91 29.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.1 m -92.74 104.22 16.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.67 117.3 34.52 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -158.39 157.96 33.31 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.82 127.16 51.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 66.1 mtp -102.59 106.94 17.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.7 t70 177.57 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.623 1.169 . . . . 0.0 112.319 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 -30.99 11.95 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.5 mt -139.21 -58.4 0.59 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.19 -167.14 2.48 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.186 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 7.9 mmpt? -66.84 -18.44 65.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -172.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.477 ' HB2' HH21 ' A' ' 181' ' ' ARG . 1.4 p30 -87.0 -2.24 58.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.677 0.671 . . . . 0.0 111.146 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -107.61 125.88 51.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.35 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 73.7 mt -82.73 115.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.07 -56.52 1.59 Allowed Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.674 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.67 121.87 46.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.67 126.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -102.3 -43.33 5.73 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.302 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.26 142.21 26.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.68 119.9 23.08 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -109.28 147.53 32.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.65 131.0 49.53 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.251 0.969 . . . . 0.0 112.353 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.401 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 26.4 p-10 -96.52 16.6 18.28 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.035 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -68.52 -6.19 23.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.74 1.216 . . . . 0.0 110.908 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.0 m -63.95 -40.45 96.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.292 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.54 -31.8 6.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.479 HG13 ' CB ' ' A' ' 137' ' ' ALA . 61.2 mt -83.57 138.93 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.432 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 48.6 mtm180 -58.65 119.49 37.24 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.61 -4.68 13.59 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.485 2.79 . . . . 0.0 112.908 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 1.7 p-10 -79.44 -14.61 58.81 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.15 116.16 12.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.79 -19.73 60.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.409 ' HG3' HG23 ' A' ' 186' ' ' ILE . 27.5 ttt -146.73 123.59 11.3 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.52 -179.01 6.56 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.456 ' NH1' ' HB3' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -148.73 146.49 28.11 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 66.8 m -75.74 150.06 37.9 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.439 1.087 . . . . 0.0 112.736 -173.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -82.11 -24.79 34.94 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.411 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.9 mmtt -85.75 -4.56 59.2 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.126 -176.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.82 151.25 33.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 153' ' ' ASP . 3.0 mmt180 -90.65 -39.86 12.23 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 123.793 0.837 . . . . 0.0 111.018 -171.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -84.62 -19.29 33.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.557 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.76 100.95 5.63 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.6 mt -110.63 135.07 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.76 122.56 44.81 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.441 0.638 . . . . 0.0 109.94 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.409 HG23 ' HG3' ' A' ' 174' ' ' MET . 38.9 pt -112.8 162.72 10.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.839 0.828 . . . . 0.0 111.467 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -78.8 143.67 35.84 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.472 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 6.5 pt-20 -54.53 -40.94 69.14 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.394 0.616 . . . . 0.0 111.873 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.87 -33.92 76.29 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 124.436 1.094 . . . . 0.0 112.01 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.24 -44.74 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.392 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 26.7 p80 -73.13 -22.8 60.46 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.211 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.61 72.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -73.48 -32.49 64.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.24 -36.81 74.73 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.69 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 72.3 mm-40 -56.26 -53.7 54.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.485 0.714 . . . . 0.0 110.715 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -73.23 -12.37 60.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.219 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.28 -27.52 24.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.889 0.376 . . . . 0.0 110.07 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.03 47.87 22.6 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.945 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 71.4 mt -82.66 157.25 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.255 5.2 p -41.95 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.72 125.66 2.26 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.431 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -120.8 156.33 32.13 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.336 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -129.99 120.63 25.07 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 16.2 m -133.88 142.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.262 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.39 155.46 49.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.195 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -65.18 129.55 40.11 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.461 0.476 . . . . 0.0 110.526 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -85.41 -40.5 16.38 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.297 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.84 101.02 3.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.496 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.78 29.88 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.522 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.13 108.78 0.64 Allowed 'General case' 0 CA--C 1.574 1.878 0 C-N-CA 124.171 0.988 . . . . 0.0 110.137 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -102.02 102.43 12.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 73.96 -22.16 1.23 Allowed Glycine 0 N--CA 1.475 1.252 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 167.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.37 148.8 46.64 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.494 0.647 . . . . 0.0 111.245 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -108.55 132.87 53.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 O-C-N 124.318 1.011 . . . . 0.0 113.123 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG2' ' OE2' ' A' ' 188' ' ' GLU . 7.8 ptpp? -93.88 141.9 27.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.891 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -109.45 138.58 45.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -124.4 142.73 51.07 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.712 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -80.1 116.35 24.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -92.23 125.56 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.48 0.657 . . . . 0.0 111.795 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 0.0 OUTLIER -141.05 165.13 28.4 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.343 1.457 . . . . 0.0 107.11 175.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.47 144.49 20.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttm -91.06 85.87 6.06 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.38 133.66 13.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.153 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -123.25 -64.07 1.2 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -84.8 -21.47 29.9 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.559 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.54 25.61 1.21 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.005 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' HE21 ' A' ' 82' ' ' GLN . . . 123.77 60.7 0.19 Allowed Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 118.58 -1.772 . . . . 0.0 117.376 173.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 3.2 m-85 -92.3 127.96 37.97 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.563 0.681 . . . . 0.0 110.458 166.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -87.71 103.37 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.17 -50.95 19.76 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.275 0.56 . . . . 0.0 111.887 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -115.04 169.42 9.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 5.3 mp -71.55 133.89 84.61 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 123.141 0.577 . . . . 0.0 112.132 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.07 168.4 24.84 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.321 2.681 . . . . 0.0 113.355 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -48.32 115.72 1.31 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.441 1.497 . . . . 0.0 112.665 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.3 14.36 71.63 Favored Glycine 0 C--O 1.208 -1.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.0 m -84.54 145.13 44.14 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 118.124 0.962 . . . . 0.0 111.74 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.24 165.53 21.83 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.387 2.725 . . . . 0.0 111.119 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.4 p -58.35 153.19 16.02 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -46.19 -58.3 3.77 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.311 1.444 . . . . 0.0 112.99 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.402 ' CZ3' ' HG3' ' A' ' 52' ' ' GLU . 13.1 p-90 -71.2 -23.01 61.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.007 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -77.3 -21.85 52.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.187 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 70.6 m-85 -52.83 -26.51 14.75 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.249 0.547 . . . . 0.0 112.379 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -120.26 -0.16 10.5 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.402 ' HG3' ' CZ3' ' A' ' 48' ' ' TRP . 3.6 tm-20 -94.27 101.3 13.27 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.027 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -10.51 0.01 OUTLIER Glycine 0 CA--C 1.559 2.815 0 N-CA-C 120.711 3.044 . . . . 0.0 120.711 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.1 174.58 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.066 2.433 . . . . 0.0 114.04 -173.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -88.05 148.29 24.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.251 -1.34 . . . . 0.0 107.776 171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.0 mt -98.29 -1.73 41.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.588 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.62 68.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.166 0.508 . . . . 0.0 112.324 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.1 -14.95 52.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.742 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.95 -22.52 9.54 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -101.07 139.05 20.17 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.29 122.94 9.46 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.123 1.882 . . . . 0.0 112.632 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.71 122.88 43.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.48 62.51 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.5 -168.03 27.66 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.5 131.14 55.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.99 165.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -139.42 141.72 37.5 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 23.1 m-85 -69.52 122.89 19.94 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 123.857 0.723 . . . . 0.0 109.092 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.404 -2.771 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.28 -177.84 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.403 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 8.7 t-20 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -94.02 -148.58 0.27 Allowed 'General case' 0 C--O 1.256 1.44 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.95 -167.8 0.32 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.162 2.185 . . . . 0.0 114.525 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.02 149.94 27.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.171 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -114.04 -169.15 1.46 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.169 0.988 . . . . 0.0 109.006 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -65.84 -34.24 77.7 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.748 0.785 . . . . 0.0 110.274 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.444 ' CD1' ' HE1' ' A' ' 202' ' ' PHE . 57.1 m-85 -134.18 153.74 51.66 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.411 HE21 ' HA3' ' A' ' 35' ' ' GLY . 56.0 mt-30 -134.42 134.76 22.8 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.512 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.07 -179.26 1.74 Allowed 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.811 2.341 . . . . 0.0 111.36 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -163.48 171.52 15.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -101.12 21.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.88 1.324 . . . . 0.0 108.294 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 40' ' ' LEU . 63.4 mtm -102.31 -93.71 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.102 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.457 ' HB2' ' CB ' ' A' ' 50' ' ' PHE . 17.9 m -167.17 -33.3 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.85 174.66 7.84 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.3 tp -116.13 142.1 47.27 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.804 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.86 127.45 55.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.55 142.38 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.05 0.54 . . . . 0.0 110.169 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 p -83.8 168.91 15.72 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -66.04 -32.3 82.03 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.837 -0.22 . . . . 0.0 113.093 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -67.12 -41.15 86.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.528 0.68 . . . . 0.0 110.372 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.9 -24.3 52.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.112 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -61.4 -42.08 98.17 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.2 mmtp -60.94 -39.35 89.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.95 -55.8 29.64 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.393 0.433 . . . . 0.0 110.26 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.75 -45.35 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 112.075 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.33 -36.37 83.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -70.86 -22.03 62.35 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.5 mp -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.672 0.272 . . . . 0.0 110.949 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 47.18 13.62 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.8 t -79.74 100.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-O 121.427 0.632 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 m -80.88 154.26 27.16 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 84.5 m-20 80.63 15.21 0.7 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.62 1.568 . . . . 0.0 110.964 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.94 114.17 28.23 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 7.7 tp10 -104.34 133.1 49.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.408 ' CH2' HD13 ' A' ' 129' ' ' LEU . 68.5 m95 -109.21 123.55 49.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.278 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -111.4 93.49 19.2 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 135.1 15.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.698 2.266 . . . . 0.0 112.416 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.09 167.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.42 115.98 28.57 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mt -106.84 128.16 61.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -97.25 142.06 29.6 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.431 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 9.1 p-10 -80.68 -162.35 0.46 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.861 0.362 . . . . 0.0 110.937 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 69.6 m80 -75.44 -9.44 58.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.522 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -109.34 2.01 20.43 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.807 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.3 7.14 80.26 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.55 139.06 32.36 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 118.602 1.201 . . . . 0.0 110.477 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.95 90.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.497 0.665 . . . . 0.0 109.803 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.66 8.55 5.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.714 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.84 45.06 1.15 Allowed Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.847 -1.168 . . . . 0.0 114.76 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -83.32 -0.37 9.85 Favored 'Trans proline' 0 C--N 1.368 1.585 0 CA-C-N 121.278 2.539 . . . . 0.0 111.924 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -92.88 -12.18 31.64 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.832 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -92.24 147.2 23.11 Favored 'General case' 0 C--O 1.255 1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.343 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.66 137.93 47.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.386 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -81.27 125.64 30.58 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.408 HD13 ' CH2' ' A' ' 109' ' ' TRP . 7.3 tt -99.75 125.13 45.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.41 0.624 . . . . 0.0 110.365 -176.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.413 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.2 141.37 52.14 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.622 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.512 ' HB2' ' HD2' ' A' ' 176' ' ' ARG . 3.0 mm? -98.92 144.28 28.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.85 174.72 5.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.29 1.436 . . . . 0.0 109.388 176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.81 17.24 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.39 132.1 42.26 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 122.12 0.962 . . . . 0.0 113.341 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.0 165.5 30.56 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 168.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -53.57 101.9 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.228 1.376 . . . . 0.0 111.89 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -78.93 -66.59 0.85 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.161 -164.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.1 126.83 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 O-C-N 123.955 0.785 . . . . 0.0 112.251 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -69.1 122.77 19.44 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 tpt -90.51 -16.33 29.08 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.14 -35.61 9.95 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -91.69 -6.2 52.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.092 0.472 . . . . 0.0 111.265 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.2 p -89.41 143.81 26.54 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.71 103.4 7.8 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -151.24 168.03 26.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.391 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -116.78 144.03 44.96 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 124.317 1.047 . . . . 0.0 110.239 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.42 155.22 20.11 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 35.9 t70 91.94 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.067 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.5 m -101.06 -22.98 14.58 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 166.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 99.5 mt -160.87 -47.84 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.926 1.691 . . . . 0.0 107.245 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 42.7 mt-10 -131.97 179.61 5.98 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.093 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -72.0 -24.4 61.56 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 123.675 0.609 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -98.25 25.27 6.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.287 1.042 . . . . 0.0 109.946 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -122.29 116.2 23.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.86 120.8 36.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 123.131 0.27 . . . . 0.0 110.45 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -83.13 -48.25 5.47 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.305 -175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -134.09 139.24 45.82 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 45.3 mt -125.05 134.06 67.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -103.24 -42.33 5.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.15 114.88 8.99 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.08 119.89 38.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 129.69 35.97 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.87 137.81 56.31 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 124.27 0.981 . . . . 0.0 112.62 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.407 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.9 p-10 -88.23 -0.2 56.83 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.708 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -67.1 -6.13 16.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.893 1.277 . . . . 0.0 109.967 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -64.05 -35.79 81.87 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.376 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.64 -33.26 6.18 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.82 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.12 154.33 5.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -67.45 117.12 44.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.3 -13.25 35.51 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.808 2.339 . . . . 0.0 112.462 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.99 -2.51 58.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.711 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 130.52 40.6 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 15.4 tppt? -68.68 -33.94 74.83 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.054 0.454 . . . . 0.0 111.395 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.2 ttt -149.25 135.4 19.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -151.62 -178.19 6.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.138 0.575 . . . . 0.0 110.18 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.512 ' HD2' ' HB2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -151.91 142.96 23.16 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.341 -176.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.546 ' SG ' HD23 ' A' ' 183' ' ' LEU . 83.8 m -69.61 146.23 51.88 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.335 0.397 . . . . 0.0 111.751 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.7 p -81.54 -48.68 11.5 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -72.23 -20.76 61.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.728 0.411 . . . . 0.0 111.563 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.48 133.67 55.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.437 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 10.7 mmt180 -90.58 -34.95 15.3 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.856 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -87.76 -20.92 25.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.376 0.608 . . . . 0.0 110.648 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.546 HD23 ' SG ' ' A' ' 177' ' ' CYS . 3.3 tt -84.13 114.07 21.51 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.5 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 71.2 mt -120.91 132.37 70.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 59.6 mt -111.17 124.18 51.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.319 1.056 . . . . 0.0 113.263 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 48.1 pt -112.68 154.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.966 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 17.3 mtp180 -83.63 162.26 20.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.431 ' OE2' ' HG2' ' A' ' 23' ' ' LYS . 7.8 pt-20 -51.74 -35.51 43.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.15 0.58 . . . . 0.0 111.824 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -46.19 -51.08 14.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.441 1.896 . . . . 0.0 111.335 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.57 -53.43 42.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.595 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 12.8 p80 -72.23 -25.4 61.62 Favored 'General case' 0 C--O 1.194 -1.816 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.334 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -34.72 73.64 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.855 0.359 . . . . 0.0 110.628 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.12 73.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.176 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -70.52 -32.91 70.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.171 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 53.6 mm-40 -59.12 -49.82 76.42 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-O 121.62 0.724 . . . . 0.0 109.136 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.38 -22.41 54.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.964 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.17 58.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.214 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.09 46.52 50.76 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.87 164.85 24.13 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.663 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 4.5 p -43.37 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.66 136.15 5.14 Favored Glycine 0 CA--C 1.493 -1.311 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.099 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.444 ' HE1' ' CD1' ' A' ' 81' ' ' PHE . 60.6 m-85 -135.68 162.62 32.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.73 122.12 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.64 133.48 66.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.079 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -126.51 132.52 51.36 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.48 115.02 6.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.13 65.08 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 124.021 0.826 . . . . 0.0 112.217 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.73 90.73 1.08 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.512 0.673 . . . . 0.0 110.258 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 81.19 35.1 24.7 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 19.8 t90 -59.87 98.63 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.7 0.8 . . . . 0.0 110.206 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -103.98 132.31 50.35 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.81 -9.09 2.06 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 165.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 95.4 mt -94.83 135.73 35.98 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 118.382 1.091 . . . . 0.0 112.819 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.15 133.04 36.15 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.417 ' HB2' ' HG3' ' A' ' 28' ' ' LYS 0.27 0.9 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 67.3 t . . . . . 0 C--O 1.243 0.713 0 CA-C-O 120.683 0.278 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -103.28 150.72 23.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.177 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -125.85 155.93 40.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -138.06 142.47 40.3 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.357 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 20.6 t -81.91 121.32 35.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.5 131.48 37.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -150.73 164.68 35.57 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.7 t -99.66 128.33 51.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 27.3 ttt -88.32 100.36 12.95 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.095 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 166.7 142.96 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 126.203 1.801 . . . . 0.0 108.719 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -94.53 -31.5 13.88 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 30.7 mt-10 -84.44 -0.26 52.18 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.003 -175.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -78.15 0.46 24.83 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.22 103.43 1.05 Allowed Glycine 0 N--CA 1.402 -3.628 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -95.58 147.04 23.99 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 39' ' ' LYS . 12.6 mt -85.07 101.31 9.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 102.864 -3.013 . . . . 0.0 102.864 166.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.72 -37.99 64.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.765 -172.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 37' ' ' ILE . 35.4 mmtp -114.46 176.47 5.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.54 ' HG ' ' SD ' ' A' ' 86' ' ' MET . 4.6 mp -83.94 129.26 59.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.53 166.43 21.91 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.581 2.187 . . . . 0.0 112.892 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.87 127.1 30.38 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 124.065 0.946 . . . . 0.0 112.031 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.67 1.25 89.16 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 116.158 -0.474 . . . . 0.0 113.54 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.2 m -85.55 136.57 37.09 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.29 166.74 24.29 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.306 3.337 . . . . 0.0 112.096 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -50.88 148.88 3.8 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -45.9 -56.0 5.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.657 1.983 . . . . 0.0 113.448 -174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.518 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 17.2 p-90 -75.48 -26.53 58.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.343 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -78.7 -21.02 48.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.243 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' HA ' HD22 ' A' ' 56' ' ' LEU . 33.1 m-85 -45.76 -38.92 7.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -128.44 22.1 6.04 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.574 -0.704 . . . . 0.0 111.128 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 1.2 tm-20 -93.99 100.85 12.91 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.898 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.24 -3.51 0.07 OUTLIER Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 52' ' ' GLU . 2.4 pp -123.0 173.7 8.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -171.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -98.31 135.88 39.28 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.103 170.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 50' ' ' PHE . 91.7 mt -84.11 -1.72 55.46 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -24.84 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 111.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -88.08 -22.82 23.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -116.31 -21.88 9.09 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -103.48 138.15 19.45 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.77 123.22 12.24 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.656 2.237 . . . . 0.0 112.682 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.06 114.73 33.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.31 19.46 45.64 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.396 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.62 -166.54 34.91 Favored Glycine 0 C--N 1.307 -1.062 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.198 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.83 128.56 42.54 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.94 169.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -148.19 162.55 39.22 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.907 -0.496 . . . . 0.0 110.177 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 19.8 m-85 -75.98 163.97 26.63 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.25 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.402 -2.86 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.555 177.235 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.571 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 8.0 t-20 . . . . . 0 C--O 1.244 0.78 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 34.2 mtp180 -78.47 -172.51 2.92 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.86 -165.73 0.87 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.46 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HA ' HE21 ' A' ' 82' ' ' GLN . 4.6 mp -87.74 150.58 23.5 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.277 0.561 . . . . 0.0 111.758 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 5.5 m-85 -114.79 -163.58 0.88 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.51 -44.2 93.19 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.481 0.658 . . . . 0.0 110.725 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.84 151.65 41.48 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.515 -1.22 . . . . 0.0 107.881 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.429 HE21 ' HA ' ' A' ' 78' ' ' LEU . 3.8 mm-40 -121.81 114.93 30.94 Favored Pre-proline 0 C--N 1.289 -2.036 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.51 168.08 7.35 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.548 2.832 . . . . 0.0 112.322 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -163.89 174.92 10.91 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 121.997 -0.44 . . . . 0.0 110.864 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.55 7.34 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.204 0 CA-C-O 123.103 1.43 . . . . 0.0 109.098 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.54 ' SD ' ' HG ' ' A' ' 40' ' ' LEU . 50.6 mtm -104.58 -164.19 1.03 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 m -121.4 53.68 1.16 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.813 -0.555 . . . . 0.0 110.991 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -136.84 155.11 50.21 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.7 tp -119.5 141.19 49.41 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.264 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.2 tp -117.16 130.17 56.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.84 139.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 122.56 0.344 . . . . 0.0 110.084 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.2 p -76.27 174.56 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.33 0.252 . . . . 0.0 110.691 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.95 -38.81 59.93 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -69.01 -38.57 79.33 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.08 0.467 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.4 63.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -62.15 -39.94 94.3 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.738 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -55.37 -40.36 71.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.812 0.695 . . . . 0.0 112.412 178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.14 -52.78 63.86 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.186 174.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.5 -45.03 99.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 C-N-CA 123.295 0.638 . . . . 0.0 112.2 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.4 -37.8 88.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -68.71 -22.14 64.37 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.211 0.529 . . . . 0.0 111.295 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.58 -8.55 58.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.806 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.28 44.5 74.83 Favored Glycine 0 CA--C 1.495 -1.195 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.115 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.88 104.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.504 0.668 . . . . 0.0 110.403 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 m -79.27 150.62 31.49 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 79.53 1.43 2.23 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.564 . . . . 0.0 112.878 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.51 114.74 25.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.2 tp10 -99.49 137.73 37.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.449 ' CH2' HD12 ' A' ' 129' ' ' LEU . 66.9 m95 -115.6 121.51 42.83 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.079 0.862 . . . . 0.0 109.209 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.67 98.31 49.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.26 124.9 6.14 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.497 2.131 . . . . 0.0 114.023 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.74 172.24 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.9 116.69 33.36 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -100.54 130.16 50.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -103.74 139.45 38.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.483 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 32.8 p-10 -83.91 -159.94 0.41 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 60.0 m80 -67.99 -14.87 63.31 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.079 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -19.48 16.53 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.2 20.18 21.35 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.703 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.4 ptpt -95.79 147.86 23.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.1 t -82.2 84.5 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.6 m -111.84 12.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.105 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.51 51.81 0.85 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.35 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -84.72 -14.66 6.35 Favored 'Trans proline' 0 C--N 1.375 1.967 0 CA-C-N 120.795 2.298 . . . . 0.0 112.885 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -97.12 7.73 46.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.359 0.599 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.412 ' HB2' HD11 ' A' ' 114' ' ' ILE . 3.9 m-85 -102.02 148.35 25.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.569 0.699 . . . . 0.0 112.272 -170.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.6 142.63 41.26 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.608 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -82.47 131.05 35.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.452 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.9 tt -105.19 126.11 51.73 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.816 0.817 . . . . 0.0 110.091 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.39 141.2 52.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.051 174.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.59 141.78 30.21 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -123.6 174.47 7.41 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.318 1.047 . . . . 0.0 108.685 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 14.61 81.26 Favored Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.714 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.66 132.86 43.72 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.75 105.16 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 119.106 0.866 . . . . 0.0 112.015 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.23 -35.26 3.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.72 115.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.841 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.11 111.95 4.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.2 ttt -97.89 17.65 17.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.774 0.797 . . . . 0.0 110.23 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.55 -50.09 4.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.076 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 142' ' ' ARG . 2.7 mmp_? -97.12 11.43 36.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.191 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.0 p -104.88 154.38 20.14 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.154 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -133.81 117.37 16.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -166.0 172.34 11.56 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.58 0.55 . . . . 0.0 111.196 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.84 133.21 49.37 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.514 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 38.7 mtt -101.34 108.66 20.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.5 t70 172.78 73.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.705 2.002 . . . . 0.0 108.868 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 22.8 t -101.15 -49.45 4.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.05 -67.09 0.76 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.524 ' OE2' ' HG2' ' A' ' 154' ' ' GLN . 3.0 pp20? -109.07 -176.19 2.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 174.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 147' ' ' MET . 11.0 mmpt? -66.78 -30.88 71.2 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -171.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -104.85 26.27 9.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.673 1.225 . . . . 0.0 109.429 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.524 ' HG2' ' OE2' ' A' ' 151' ' ' GLU . 15.3 mm-40 -106.8 123.55 48.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.194 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.6 124.33 39.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.824 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -103.35 -66.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.634 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -94.85 135.37 36.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.5 mt -131.9 145.14 35.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -110.44 -51.96 2.82 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 172.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.87 118.85 7.65 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.573 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.27 121.6 35.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.87 132.4 37.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -54.98 137.26 46.47 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.54 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.2 p-10 -92.69 -0.28 57.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.978 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.9 p -68.22 -6.16 22.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.07 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.6 m -63.84 -39.43 94.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.687 173.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -110.8 -31.31 7.23 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 119.701 -0.799 . . . . 0.0 112.288 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 52.7 mt -89.03 150.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.48 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 27.7 mtp180 -57.92 122.37 57.09 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 122.535 0.334 . . . . 0.0 111.832 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.22 -5.76 17.72 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 123.419 2.746 . . . . 0.0 112.311 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 8.3 p-10 -96.47 -7.99 33.34 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.712 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.36 132.85 47.78 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -73.75 -40.24 63.66 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.206 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -142.85 123.98 14.51 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -146.39 -178.33 6.09 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.481 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -146.62 142.32 27.8 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.526 ' SG ' HD21 ' A' ' 183' ' ' LEU . 65.3 m -70.69 145.7 50.39 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 124.161 0.913 . . . . 0.0 111.607 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.8 p -82.21 -18.92 40.91 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -108.96 20.79 18.02 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.749 -173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 9.5 tp10 -172.6 116.63 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HD2' ' NE2' ' A' ' 154' ' ' GLN 0.275 0.0 OUTLIER -89.29 -11.19 44.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -173.012 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -90.56 -25.9 19.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.526 HD21 ' SG ' ' A' ' 177' ' ' CYS . 3.3 tt -77.74 100.85 6.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.3 mt -108.08 120.56 59.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 30.7 mt -93.05 125.5 37.67 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 121.706 0.765 . . . . 0.0 111.615 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.8 pt -110.85 139.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.883 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -81.38 162.4 23.39 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 22' ' ' VAL . 7.1 pt-20 -43.68 -44.24 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.463 1.105 . . . . 0.0 112.546 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -56.33 -44.83 80.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.64 1.576 . . . . 0.0 110.725 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.33 -48.05 82.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.591 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 9.3 p80 -74.02 -29.26 61.84 Favored 'General case' 0 C--O 1.197 -1.672 0 C-N-CA 118.061 -1.456 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.0 77.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.18 83.38 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.174 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -72.11 -34.81 68.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.211 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 56.5 mm-40 -62.33 -47.24 85.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.322 0.582 . . . . 0.0 109.555 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -75.06 -15.89 60.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.565 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -83.75 -27.12 29.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.782 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 72.61 47.65 26.34 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.462 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.74 164.58 25.12 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -46.46 -76.54 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 116.933 2.198 . . . . 0.0 116.933 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.66 130.79 1.91 Allowed Glycine 0 CA--C 1.498 -0.978 0 C-N-CA 119.029 -1.557 . . . . 0.0 113.213 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -129.19 159.37 36.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 122.418 0.287 . . . . 0.0 110.273 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 77.4 tttt -120.78 121.67 38.69 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.2 130.43 72.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.118 0.485 . . . . 0.0 111.058 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.411 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 85.0 m-85 -107.04 138.97 42.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.72 115.97 9.57 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.62 -45.37 37.76 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.591 0.557 . . . . 0.0 112.285 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.19 95.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.988 0.805 . . . . 0.0 109.547 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.63 35.65 28.21 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.882 -1.152 . . . . 0.0 111.922 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.418 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 9.3 t90 -46.06 107.12 0.09 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.528 1.131 . . . . 0.0 110.368 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -82.78 71.53 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.11 15.16 67.12 Favored Glycine 0 C--N 1.31 -0.9 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 167.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 92.1 mt -89.89 146.35 24.48 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 118.365 1.082 . . . . 0.0 109.875 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.1 134.09 35.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.244 0.778 0 O-C-N 124.335 1.022 . . . . 0.0 108.894 174.187 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 21.4 ptmt -93.15 154.43 18.08 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.34 135.46 50.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.368 0.604 . . . . 0.0 111.764 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -122.19 143.92 49.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.31 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.69 121.64 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -97.78 114.03 25.95 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 111.038 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -135.26 150.86 50.14 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.42 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.54 84.67 7.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.09 113.69 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.96 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.609 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 34.1 tt0 -112.94 -66.97 1.03 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -0.91 55.89 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.05 0.929 . . . . 0.0 109.5 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . . . -94.81 25.41 4.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 119.42 39.21 0.68 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 168.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.609 ' CD1' ' HA ' ' A' ' 32' ' ' GLU . 11.3 m-85 -69.22 128.36 36.36 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 120.233 2.017 . . . . 0.0 112.889 170.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.495 HG12 ' CE2' ' A' ' 68' ' ' PHE . 9.4 mt -84.37 101.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.47 -59.62 3.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.924 0.869 . . . . 0.0 109.366 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' O ' HG21 ' A' ' 37' ' ' ILE . 13.7 mptt -108.7 162.26 14.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.285 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 5.8 mp -70.31 139.75 87.29 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 124.639 1.212 . . . . 0.0 114.054 -171.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.8 166.43 29.3 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.449 2.766 . . . . 0.0 111.345 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -53.15 122.27 9.12 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.324 1.049 . . . . 0.0 112.856 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.01 7.22 70.69 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 114.734 0.654 . . . . 0.0 114.734 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.0 m -85.33 142.79 38.24 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD2' ' CE1' ' A' ' 50' ' ' PHE . 1.6 Cg_endo -75.51 166.08 29.3 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.848 3.032 . . . . 0.0 111.139 172.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -52.92 148.85 7.08 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.37 -52.55 4.53 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 127.243 2.217 . . . . 0.0 114.894 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -85.68 -30.08 23.46 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.747 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 52.6 tptt -81.16 -12.21 59.26 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.387 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 88' ' ' ASN . 40.7 m-85 -44.29 -50.31 9.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.688 0.617 . . . . 0.0 111.952 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 65.3 m-70 -128.91 32.33 4.78 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.58 -0.848 . . . . 0.0 113.257 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 7.8 tm-20 -92.45 101.37 13.82 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.52 -8.83 17.47 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.01 170.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.0 t -98.89 158.2 15.8 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.054 -1.884 . . . . 0.0 106.876 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.3 mt -113.07 15.5 19.53 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.91 67.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.068 0.461 . . . . 0.0 110.916 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -88.23 -21.85 24.29 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.453 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.19 -22.6 12.03 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.83 140.09 21.27 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.32 123.8 12.75 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.914 2.409 . . . . 0.0 112.73 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.89 117.09 45.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.91 14.99 61.92 Favored Glycine 0 C--N 1.318 -0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.55 -167.26 36.61 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.664 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.76 128.86 50.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 23.6 m -127.92 173.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 33.2 t -153.98 149.21 26.99 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CE2' HG12 ' A' ' 37' ' ' ILE . 1.1 m-30 -76.76 128.86 35.42 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 167.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p . . . . . 0 C--N 1.288 -2.079 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.625 177.977 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 C--O 1.241 0.639 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.32 -175.58 1.6 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.45 -176.22 3.6 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.915 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.4 mp -98.0 151.84 19.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -167.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 34' ' ' ALA . 5.9 m-85 -111.4 -163.35 0.84 Allowed 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.87 -45.06 96.06 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 119.308 0.958 . . . . 0.0 110.611 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.13 145.31 47.95 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.524 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 27.8 tp60 -124.74 120.93 25.67 Favored Pre-proline 0 N--CA 1.416 -2.15 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.874 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.97 166.93 9.75 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 122.846 2.364 . . . . 0.0 112.326 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -157.58 168.98 25.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.501 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -90.0 0.52 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 122.759 1.266 . . . . 0.0 108.544 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.5 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 37.9 mtm -94.47 -147.33 0.26 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 36.8 p -144.99 27.26 1.31 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . 61.0 t30 -114.51 118.33 33.47 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.13 141.36 30.26 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.751 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 47.1 tp -108.75 123.05 48.41 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -128.52 139.13 52.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.483 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.1 p -78.89 175.33 10.62 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.972 0.509 . . . . 0.0 110.967 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.59 73.17 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -61.66 -47.73 84.04 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.524 0.729 . . . . 0.0 111.324 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -31.47 68.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.08 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -60.1 -42.74 95.35 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.736 0.414 . . . . 0.0 110.28 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -56.51 -45.5 81.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 124.221 0.951 . . . . 0.0 110.496 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -58.8 -52.89 63.77 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.471 0.482 . . . . 0.0 111.797 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.9 mt -58.93 -44.47 90.96 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 C-N-CA 123.46 0.704 . . . . 0.0 111.776 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.21 -25.77 61.78 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.0 m -70.33 -26.35 63.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.34 -21.4 33.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.7 48.0 7.49 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.62 109.96 4.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.24 0.543 . . . . 0.0 110.019 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 m -75.36 146.96 40.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.678 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.07 12.05 1.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.504 1.522 . . . . 0.0 112.873 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.43 113.93 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.2 tp10 -111.0 141.87 43.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -116.26 119.19 34.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.408 ' HG ' HD22 ' A' ' 130' ' ' ASN . 68.8 mt -109.33 100.71 42.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.42 139.53 18.52 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.58 2.186 . . . . 0.0 113.418 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -148.22 162.26 6.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 124.552 1.141 . . . . 0.0 108.774 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.21 123.59 42.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -120.1 135.71 59.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -169.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.5 mptp? -98.09 150.63 21.23 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.589 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.3 p-10 -91.53 -163.05 0.98 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.903 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -66.02 -36.96 84.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 0.0 109.73 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.13 -19.25 47.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.32 14.69 29.77 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.722 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.589 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 17.2 ptpt -97.44 145.96 25.68 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.8 t -81.43 90.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 m -114.97 13.78 8.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.813 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.459 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -135.54 46.9 1.01 Allowed Glycine 0 CA--C 1.545 1.947 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.879 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.09 -13.99 7.47 Favored 'Trans proline' 0 C--N 1.379 2.166 0 CA-C-N 121.565 2.682 . . . . 0.0 111.426 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.1 -4.13 43.4 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.784 1.634 . . . . 0.0 110.438 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.459 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 5.5 m-85 -98.89 149.51 22.85 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.66 -171.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.5 147.54 43.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.208 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -85.13 128.7 34.76 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.926 0.393 . . . . 0.0 110.55 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.67 125.62 37.38 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.852 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.507 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 35.7 m-80 -101.03 132.4 46.47 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.337 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.91 114.47 28.77 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.25 172.6 7.69 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.855 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.68 16.86 80.4 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.8 132.72 34.52 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.13 169.22 19.16 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.24 112.06 4.93 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 164' ' ' ASP . . . -134.11 -17.71 2.09 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -165.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.7 mt -63.32 122.48 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 118.969 0.804 . . . . 0.0 111.023 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.49 128.14 35.52 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.189 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.405 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 63.2 mtt -119.53 10.35 11.78 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.709 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.66 -38.63 8.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.892 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -113.99 3.7 15.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 p -90.77 155.84 18.5 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 120.682 0.277 . . . . 0.0 111.396 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.425 ' CB ' ' HB2' ' A' ' 159' ' ' ASP . 64.6 mm-40 -122.04 106.04 10.84 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.405 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 6.2 p90 -164.35 162.87 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.96 0.409 . . . . 0.0 111.938 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.61 125.79 47.54 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 85.8 mtp -91.05 153.46 20.1 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.307 17.9 t70 88.57 82.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.663 1.585 . . . . 0.0 113.152 -177.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' CA ' ' A' ' 156' ' ' GLY . 11.7 p -100.83 -56.08 2.42 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.123 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.0 mt -99.8 -45.3 5.78 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 11.9 pt-20 -155.46 176.11 13.01 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.97 -21.59 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 119.689 1.132 . . . . 0.0 113.691 -170.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.46 12.35 10.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.101 0.953 . . . . 0.0 110.534 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.525 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 22.8 mm-40 -125.38 115.82 20.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.65 147.13 5.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.407 ' CA ' ' HB3' ' A' ' 149' ' ' SER . . . -110.77 -78.69 0.98 Allowed Glycine 0 CA--C 1.491 -1.431 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.698 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.28 123.01 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 44.0 mt -128.59 106.98 15.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 144' ' ' GLU . 20.2 m-20 -86.63 -34.73 19.72 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.04 110.61 2.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.293 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -84.26 124.01 30.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.37 147.04 25.65 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.62 139.44 55.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.117 0.886 . . . . 0.0 113.375 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 23.0 p-10 -93.61 3.51 55.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.06 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.9 p -66.22 -3.94 6.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.737 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -64.0 -39.95 95.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 123.534 0.733 . . . . 0.0 109.959 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -108.14 -32.82 7.36 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 118.601 -1.24 . . . . 0.0 111.269 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.417 HG13 ' CB ' ' A' ' 137' ' ' ALA . 74.0 mt -85.81 149.95 4.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.421 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 69.3 mtp180 -51.73 127.4 33.93 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.02 0.528 . . . . 0.0 112.01 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.93 -13.67 23.97 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.393 2.062 . . . . 0.0 111.33 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 7.9 p-10 -96.59 7.27 46.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.325 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 151.01 44.14 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.868 0.842 . . . . 0.0 109.78 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -102.19 -30.44 11.12 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.4 ttt -160.65 128.33 4.42 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -153.75 -179.2 7.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.128 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -137.05 139.24 41.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 60.4 m -72.75 146.64 46.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.767 0.667 . . . . 0.0 110.17 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.9 p -73.05 -50.42 23.09 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.51 15.45 17.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.79 110.13 6.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.525 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 13.2 ptt180 -76.85 -22.36 53.63 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.807 -170.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -86.82 -16.63 35.61 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.289 -0.257 . . . . 0.0 110.948 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.6 tp -87.06 99.76 12.15 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.802 0.81 . . . . 0.0 111.484 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.23 123.78 59.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.16 133.18 52.78 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.041 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 41.1 pt -121.58 158.61 24.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.989 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.605 ' HD3' ' OD1' ' A' ' 189' ' ' ASP . 9.1 ptp180 -85.07 162.06 19.45 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.9 pt-20 -54.13 -39.85 66.85 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.605 ' OD1' ' HD3' ' A' ' 187' ' ' ARG . 7.5 m-20 -52.53 -42.21 64.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.21 1.004 . . . . 0.0 111.304 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.04 -50.34 77.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.684 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.564 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 21.9 p80 -71.67 -31.06 66.39 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.525 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.97 73.31 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 111.025 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.43 -36.8 68.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.733 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -69.0 -35.57 76.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.345 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 18.8 mm-40 -55.65 -49.15 73.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -79.79 -22.8 42.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.295 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.32 -27.89 59.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.658 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 80.55 42.44 10.18 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.46 166.53 18.25 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 17.1 p -57.75 -164.1 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.71 134.83 12.88 Favored Glycine 0 CA--C 1.49 -1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 113.427 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -129.47 159.59 35.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -117.49 120.86 39.4 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.89 135.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -128.89 147.62 50.84 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.03 107.82 7.35 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.81 -33.95 77.21 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.684 0.793 . . . . 0.0 111.929 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.82 100.54 0.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.854 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 73.9 30.03 62.09 Favored Glycine 0 C--O 1.219 -0.824 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.424 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.65 104.58 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.182 0.993 . . . . 0.0 110.911 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.88 126.91 51.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.46 -25.58 0.27 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 119.362 2.505 . . . . 0.0 119.362 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 142.28 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -172.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.5 131.43 34.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.171 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 C--N 1.314 -0.935 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.481 -177.745 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 7.4 ptpp? -108.11 146.06 33.2 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -118.88 143.96 46.67 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.038 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 97.6 m-85 -126.87 151.3 48.57 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 -176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.89 129.9 37.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -95.92 135.3 37.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -150.61 158.79 44.56 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.23 131.11 60.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -103.54 105.87 16.23 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.521 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 161.53 123.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.085 2.154 . . . . 0.0 108.662 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -86.84 -23.28 25.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.54 -13.94 62.31 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.394 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.53 64.64 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 77.82 1.08 Allowed Glycine 1 N--CA 1.391 -4.3 0 C-N-CA 118.943 -1.599 . . . . 0.0 114.127 177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -63.71 136.02 57.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mt -68.36 104.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 40.1 mm-40 -54.29 -70.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.2 1.562 . . . . 0.0 111.283 -173.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 176.5 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.427 0.691 . . . . 0.0 110.022 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -72.14 130.92 85.77 Favored Pre-proline 0 C--O 1.252 1.22 0 O-C-N 123.93 0.769 . . . . 0.0 111.044 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.402 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 1.1 Cg_endo -78.62 167.4 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.912 2.408 . . . . 0.0 111.658 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.03 129.33 41.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.686 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.76 0.72 90.34 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.712 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 m -84.97 137.39 37.71 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 117.172 0.486 . . . . 0.0 110.183 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.31 165.55 10.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.306 2.67 . . . . 0.0 112.238 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -55.66 155.09 6.03 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -45.28 -51.47 10.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.232 1.413 . . . . 0.0 111.595 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.6 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 27.1 p-90 -85.94 -16.48 38.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.042 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . 0.423 54.4 mttt -86.75 -11.24 51.66 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 45.3 m-85 -49.87 -34.1 19.07 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 123.705 0.628 . . . . 0.0 111.944 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -128.04 20.33 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.579 -0.701 . . . . 0.0 112.616 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 0.9 OUTLIER -93.03 101.17 13.49 Favored 'General case' 0 C--O 1.2 -1.525 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.179 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.16 -10.98 0.01 OUTLIER Glycine 0 CA--C 1.556 2.612 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 168.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.52 173.84 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 121.12 2.46 . . . . 0.0 112.277 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -85.93 141.97 29.17 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.8 mt -87.79 -2.78 58.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.495 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.38 66.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.227 0.537 . . . . 0.0 111.904 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -87.63 -39.18 15.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.138 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.93 -21.33 18.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -99.06 141.48 22.95 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.01 122.8 9.69 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.053 1.835 . . . . 0.0 111.898 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.36 110.18 23.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.26 21.17 39.17 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.45 -153.55 30.33 Favored Glycine 0 C--O 1.252 1.262 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -141.61 139.1 33.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 28.9 m -133.73 166.44 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 m -144.09 150.31 37.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 120.771 0.32 . . . . 0.0 111.248 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -80.52 120.58 24.68 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 38' ' ' GLU . 14.1 p . . . . . 0 C--N 1.294 -1.815 0 O-C-N 123.697 0.623 . . . . 0.0 109.918 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.42 -165.89 1.41 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -164.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.22 -172.94 4.25 Favored 'General case' 0 C--O 1.194 -1.867 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.438 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.604 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 4.6 mp -87.64 143.8 26.99 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -100.14 -178.72 3.92 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.19 0.596 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -60.56 -35.25 75.59 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.515 0.674 . . . . 0.0 110.116 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -129.58 126.98 39.75 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.604 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -115.92 125.35 28.73 Favored Pre-proline 0 C--N 1.279 -2.462 0 O-C-N 123.515 0.509 . . . . 0.0 110.35 -174.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 175.34 8.71 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -163.37 166.63 22.7 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 123.261 0.624 . . . . 0.0 109.586 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -99.91 28.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.4 mtm -116.24 -79.86 0.59 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 50' ' ' PHE . 35.2 t -179.18 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.349 0.565 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -77.66 164.45 25.29 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.598 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.29 141.48 36.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.451 0.569 . . . . 0.0 110.1 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.5 tp -110.8 125.26 53.38 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -125.42 147.09 30.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.2 p -77.91 170.2 17.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.742 0.306 . . . . 0.0 110.342 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.9 -18.7 79.4 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -74.31 -52.53 11.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.56 -23.61 63.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.472 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' ' CH2' ' A' ' 109' ' ' TRP . 54.9 ttt180 -57.74 -43.97 85.74 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.041 174.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.6 mmpt? -65.07 -39.41 93.2 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.23 -54.58 45.13 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.368 0.418 . . . . 0.0 110.326 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.1 -46.51 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.461 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.26 -26.91 65.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -72.66 -25.0 61.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.033 0.444 . . . . 0.0 111.156 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.1 -1.51 57.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.305 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.06 47.78 63.32 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.542 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.4 t -73.69 112.73 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -80.27 141.19 35.76 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.739 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 78.32 15.85 1.3 Allowed 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 125.282 1.433 . . . . 0.0 112.263 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.62 113.97 19.18 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 8.4 tp10 -104.72 124.81 50.04 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.52 ' CH2' HD12 ' A' ' 129' ' ' LEU . 61.9 m95 -108.55 120.15 41.6 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.235 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -109.75 94.13 16.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.72 133.57 12.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.601 2.201 . . . . 0.0 112.532 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.79 160.08 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.625 0.77 . . . . 0.0 109.977 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.82 116.73 29.22 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -108.96 136.98 43.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -100.06 146.47 26.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.8 p-10 -90.12 -163.96 1.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.766 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -67.16 -32.39 73.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.139 0.975 . . . . 0.0 111.138 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -83.59 -18.5 38.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.204 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.12 20.54 20.49 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.063 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 20.0 ptmt -105.55 153.42 21.79 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -86.7 90.18 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.531 0.681 . . . . 0.0 109.24 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.26 13.23 6.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.088 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -127.78 39.72 1.87 Allowed Glycine 0 CA--C 1.552 2.361 0 C-N-CA 119.437 -1.364 . . . . 0.0 116.335 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.76 -0.58 8.7 Favored 'Trans proline' 0 C--N 1.375 1.923 0 CA-C-N 122.013 2.907 . . . . 0.0 112.624 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.54 -9.67 24.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.946 0.899 . . . . 0.0 110.662 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.489 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 16.5 m-85 -103.59 153.99 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.363 -165.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.28 142.81 35.68 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.6 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.29 122.33 26.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.52 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.4 tt -101.16 122.14 43.09 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.325 0.583 . . . . 0.0 110.007 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.36 140.02 53.17 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.393 172.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.52 141.05 29.5 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.52 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.37 173.55 6.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.08 11.51 72.85 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.987 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.02 132.99 35.08 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -137.36 170.22 16.45 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.24 113.21 1.47 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 164' ' ' ASP . . . -139.38 -19.16 0.97 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.2 mt -64.17 112.86 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.279 0.561 . . . . 0.0 110.981 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.58 115.22 10.51 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.084 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.6 mtt -99.07 6.17 46.69 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.181 0.515 . . . . 0.0 110.594 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -84.7 -46.28 11.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -102.72 -11.96 18.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.283 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 m -90.76 148.21 22.71 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.833 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -135.0 112.75 10.85 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -158.17 173.17 17.11 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.19 138.16 53.07 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.052 0.541 . . . . 0.0 109.708 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.9 mmt -87.16 108.06 18.74 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -175.51 63.74 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.9 m -102.82 -56.31 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.074 170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 75.6 mt -134.58 -57.16 0.84 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.07 -173.69 2.31 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.902 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -95.07 4.83 53.28 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -103.59 16.52 26.23 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -133.34 125.01 28.24 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.255 -174.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 76.0 mt -84.47 119.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 123.365 0.416 . . . . 0.0 110.212 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -98.82 -62.68 0.85 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.246 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.76 133.1 42.74 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.32 -34.73 5.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.672 0.749 . . . . 0.0 109.892 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.97 117.0 18.58 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -98.32 146.8 25.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.24 146.66 52.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.86 0.838 . . . . 0.0 112.012 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 18.5 p-10 -90.08 8.92 30.25 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.3 p -69.38 -6.27 28.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.343 172.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -60.96 -39.97 91.58 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 124.623 1.169 . . . . 0.0 109.662 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -31.98 6.65 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.263 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.56 141.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 62.9 mmt-85 -60.61 118.34 33.52 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 123.28 0.363 . . . . 0.0 110.132 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -5.37 11.25 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.977 3.118 . . . . 0.0 115.012 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.07 -9.71 58.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.431 0.158 . . . . 0.0 111.377 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.14 114.06 13.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -80.6 -8.69 59.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -152.64 118.75 5.49 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.421 ' HE2' ' OD1' ' A' ' 164' ' ' ASP . 35.9 p90 -148.48 -179.47 6.98 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.861 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -143.88 147.32 33.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.422 ' HG ' ' CG ' ' A' ' 164' ' ' ASP . 44.4 m -80.61 151.49 29.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 124.22 0.95 . . . . 0.0 111.19 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.1 p -81.42 -50.28 9.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -85.52 30.27 0.64 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.531 ' N ' HH21 ' A' ' 181' ' ' ARG . 0.3 OUTLIER -160.27 147.24 15.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.6 ' HD2' ' O ' ' A' ' 48' ' ' TRP . 8.7 mmp_? -91.18 -39.0 12.36 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -14.72 17.68 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.122 0.264 . . . . 0.0 110.785 -170.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.03 100.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.243 1.02 . . . . 0.0 109.813 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.45 122.95 67.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.6 mt -107.39 130.02 54.85 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.182 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 46.5 pt -118.24 149.77 20.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.361 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -82.27 152.97 26.11 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.451 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 10.4 pt-20 -49.04 -41.23 34.3 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.419 0.688 . . . . 0.0 112.338 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -53.12 -40.86 64.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.628 1.571 . . . . 0.0 112.462 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.17 -49.3 62.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.891 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.566 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 25.5 p80 -71.42 -24.55 62.06 Favored 'General case' 0 C--O 1.198 -1.641 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.067 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.34 80.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.001 0.52 . . . . 0.0 110.604 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 196' ' ' GLN . . . -69.22 -33.2 72.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.188 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 16.6 m-85 -73.35 -32.83 64.75 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.879 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 59.2 mm-40 -63.24 -42.96 99.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 193' ' ' ALA . 2.8 pt20 -77.55 -24.69 49.8 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.159 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 -27.3 43.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.233 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.1 42.79 75.26 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.663 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.61 165.19 24.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.611 0.364 . . . . 0.0 110.995 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.9 p -39.14 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.97 141.19 9.18 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.391 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.31 165.21 28.06 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -157.29 121.84 4.38 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 25' ' ' PHE . 26.8 m -125.29 146.96 30.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.448 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -125.11 142.44 51.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.112 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.86 114.65 2.18 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.16 -35.03 61.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.81 94.55 2.77 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.812 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.72 35.12 7.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.19 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -67.77 97.49 0.64 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.14 0.495 . . . . 0.0 110.583 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.06 132.24 51.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.01 -25.44 0.25 Allowed Glycine 0 N--CA 1.479 1.55 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 165.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.85 127.13 32.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 117.777 0.788 . . . . 0.0 112.618 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.6 131.19 37.69 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.611 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 C--N 1.308 -1.227 0 O-C-N 124.026 0.829 . . . . 0.0 109.728 -178.238 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.426 HG13 ' HD3' ' A' ' 187' ' ' ARG . 58.0 t . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -94.01 152.81 18.54 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.298 0.57 . . . . 0.0 111.635 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 140.73 43.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.523 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -124.0 151.08 44.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.467 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.26 118.04 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -92.18 117.99 30.4 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -136.47 139.81 42.62 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 83' ' ' PRO . 97.1 t -89.54 120.86 38.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 120.723 0.297 . . . . 0.0 110.422 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 49.6 ttp -82.44 86.42 6.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.0 0.905 . . . . 0.0 110.224 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.79 112.76 6.37 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -119.47 -58.7 1.89 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.398 -173.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.94 -21.52 43.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . . . -67.02 -35.76 80.63 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 95.92 158.02 32.02 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 114.064 -1.426 . . . . 0.0 114.501 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 46.4 m-85 -96.57 166.06 11.86 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.09 101.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 101.501 -3.518 . . . . 0.0 101.501 163.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -65.64 -44.29 86.86 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.055 0.847 . . . . 0.0 111.892 -167.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -132.44 176.03 8.77 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.72 119.55 71.86 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.622 0.769 . . . . 0.0 112.725 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.76 167.75 24.85 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.759 2.306 . . . . 0.0 113.02 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -42.47 114.54 0.59 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.138 1.775 . . . . 0.0 113.421 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.61 79.23 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.551 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.6 m -85.54 139.62 35.81 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.63 165.96 23.67 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 123.79 2.993 . . . . 0.0 111.554 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.7 p -49.15 146.33 3.65 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -37.83 -56.73 1.07 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.114 2.565 . . . . 0.0 113.595 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -86.23 -22.06 27.09 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.825 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 47.0 tptt -86.61 -12.24 49.14 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.398 -169.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 53.0 m-85 -44.05 -49.54 8.74 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.646 0.591 . . . . 0.0 112.571 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.279 30.8 m-70 -127.92 31.68 5.07 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.1 tm-20 -92.84 100.71 13.13 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.36 -10.25 3.76 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 174.76 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.354 2.077 . . . . 0.0 113.295 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 t -96.37 158.48 15.42 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.484 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.5 -13.33 40.51 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.845 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.07 -26.55 49.82 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.74 -20.17 25.12 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -116.51 -22.07 8.89 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.583 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -100.17 138.51 20.27 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.29 123.06 10.15 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.175 1.917 . . . . 0.0 112.581 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.41 114.85 29.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.26 18.28 59.34 Favored Glycine 0 C--N 1.311 -0.843 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.25 -161.84 37.52 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.178 -0.534 . . . . 0.0 111.985 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -129.14 131.75 47.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.38 170.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 t -147.11 147.13 30.27 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.4 110.25 2.2 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.838 171.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.412 -2.363 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.975 -179.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.9 0.381 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -90.94 -154.25 0.34 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.606 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -86.2 -177.44 6.26 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.054 1.342 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.15 150.45 23.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.855 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.474 ' CE1' ' HB3' ' A' ' 34' ' ' ALA . 20.8 m-85 -114.14 -166.68 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.69 -40.94 94.07 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.773 0.715 . . . . 0.0 111.844 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -118.58 147.71 43.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.608 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -132.54 126.77 20.29 Favored Pre-proline 0 C--O 1.249 1.039 0 C-N-CA 123.069 0.548 . . . . 0.0 110.361 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 63.4 Cg_endo -92.53 178.56 1.39 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.575 2.183 . . . . 0.0 112.503 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 6.5 p30 -163.94 173.74 12.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.62 -9.49 10.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.336 1.065 . . . . 0.0 109.619 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -95.25 -178.1 4.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.501 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 5.7 p -93.02 39.17 1.04 Allowed 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.9 159.56 34.54 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.427 ' HB2' ' NH2' ' A' ' 176' ' ' ARG . 53.6 tp -124.19 141.53 51.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.15 118.33 36.46 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.44 144.28 29.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 p -75.08 167.37 22.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.08 -20.46 79.68 Favored Glycine 0 C--N 1.31 -0.868 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -70.79 -57.64 4.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -25.61 67.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.265 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 50.9 ttt180 -54.94 -51.1 67.16 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 124.02 0.928 . . . . 0.0 110.171 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -69.27 -25.32 64.2 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.749 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.26 -49.55 77.42 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.897 0.379 . . . . 0.0 110.189 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.1 -37.06 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.526 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 61.2 mt-10 -67.37 -33.34 75.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.205 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.0 m -65.74 -33.84 76.81 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.028 0.531 . . . . 0.0 111.548 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.38 -6.8 58.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.244 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.32 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.85 109.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.541 0.686 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.9 m -80.3 154.85 27.57 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 80.31 14.21 0.84 Allowed 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.76 114.11 27.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.5 tp10 -112.91 138.93 49.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -119.75 116.31 25.67 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -172.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.7 mt -109.11 99.46 35.89 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.27 145.16 23.9 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.448 2.099 . . . . 0.0 112.584 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.4 m -149.57 166.3 3.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 123.633 0.773 . . . . 0.0 109.226 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.05 28.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.3 mt -113.07 132.46 61.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -98.08 147.55 24.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.13 -160.66 0.43 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.452 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 67.0 m80 -74.63 -22.73 58.77 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 122.265 -0.272 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -87.56 -18.8 28.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.449 0.468 . . . . 0.0 110.194 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.65 36.92 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.033 173.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -101.8 148.49 25.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.634 0.717 . . . . 0.0 110.563 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.16 89.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.468 0.651 . . . . 0.0 110.493 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.4 m -115.6 13.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.433 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.19 49.96 0.9 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 119.97 -1.109 . . . . 0.0 115.245 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.49 -8.28 9.58 Favored 'Trans proline' 0 C--N 1.376 2.025 0 CA-C-N 121.335 2.568 . . . . 0.0 111.458 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -92.06 -14.29 29.53 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.41 1.484 . . . . 0.0 110.788 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.03 150.89 21.25 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.883 0.849 . . . . 0.0 112.958 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.46 143.52 39.68 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.438 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.23 117.95 20.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.27 127.59 37.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.92 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.5 m-80 -110.42 127.54 55.15 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.655 -177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.33 125.59 47.98 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.31 172.9 6.55 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 -7.91 81.07 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.82 129.56 34.83 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.85 0.833 . . . . 0.0 109.153 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -148.56 170.11 18.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -46.4 108.82 0.15 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.988 0.805 . . . . 0.0 110.127 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.34 -47.21 1.6 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -165.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 26.2 mt -61.69 118.82 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 119.353 0.979 . . . . 0.0 112.611 -172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.76 127.92 34.31 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.713 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.4 mtt -94.46 -0.41 54.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.32 -50.63 5.55 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.559 0.695 . . . . 0.0 110.12 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -93.75 -9.36 37.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.216 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -108.14 140.5 41.25 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -120.73 100.51 7.15 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -145.74 165.03 30.0 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.703 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -120.82 147.72 44.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.167 0.917 . . . . 0.0 109.611 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 53.0 mtt -100.47 154.18 18.75 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.291 36.3 t70 90.76 84.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.844 2.457 . . . . 0.0 112.108 -176.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.2 t -99.49 -36.62 9.49 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.611 -1.631 . . . . 0.0 107.621 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.9 mt -136.65 -54.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 12.7 pt-20 -137.32 -179.82 5.96 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.583 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -48.19 -49.48 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.302 1.841 . . . . 0.0 114.634 -171.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.454 ' HB2' HH21 ' A' ' 181' ' ' ARG . 7.7 p-10 -90.09 10.93 22.4 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -102.42 116.57 32.9 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.473 ' H ' ' HG2' ' A' ' 180' ' ' GLU . 70.2 mt -74.31 129.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -108.5 -60.14 0.54 Allowed Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.988 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -92.83 119.15 31.87 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.0 109.91 27.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.03 -34.31 16.85 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.75 138.95 20.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.86 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.8 114.85 15.84 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.78 147.64 25.83 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 140.42 57.33 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.816 0.817 . . . . 0.0 112.916 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -94.65 16.14 16.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.286 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 168' ' ' ILE . 18.2 p -67.01 -5.77 14.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.034 175.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.8 m -64.65 -33.43 75.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.323 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -32.95 6.34 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.249 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 165' ' ' THR . 66.7 mt -92.45 122.23 43.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -56.47 127.82 72.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 118.023 0.374 . . . . 0.0 111.504 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.06 -5.36 6.22 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.601 2.867 . . . . 0.0 115.427 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -80.24 -9.21 59.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.062 0.392 . . . . 0.0 111.13 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 127.2 31.82 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.112 0.482 . . . . 0.0 110.098 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.51 -36.75 76.76 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.036 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' MET . . . . . 0.401 ' HG3' HG21 ' A' ' 186' ' ' ILE . 26.5 ttt -148.29 132.03 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.3 -179.79 7.85 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.507 0.504 . . . . 0.0 109.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' A' ' 89' ' ' LEU . 14.6 ttm180 -136.12 139.56 43.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 183' ' ' LEU . 63.9 m -74.63 139.44 43.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 O-C-N 124.062 0.851 . . . . 0.0 110.105 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 p -82.7 -12.75 57.35 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -90.24 -5.0 56.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.866 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -151.32 142.77 23.49 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.454 HH21 ' HB2' ' A' ' 153' ' ' ASP . 17.5 mmt180 -89.35 -30.41 18.42 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -170.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -86.39 -25.35 25.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.093 0.473 . . . . 0.0 110.561 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.49 HD23 ' SG ' ' A' ' 177' ' ' CYS . 3.0 tt -75.18 102.54 5.01 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.812 -172.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.89 142.2 19.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.2 mt -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.376 0.608 . . . . 0.0 111.1 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.401 HG21 ' HG3' ' A' ' 174' ' ' MET . 44.9 pt -124.72 157.7 32.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.652 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.426 ' HD3' HG13 ' A' ' 22' ' ' VAL . 97.0 mtt180 -80.25 159.63 25.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.469 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 7.5 pt-20 -52.82 -37.56 60.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.729 0.812 . . . . 0.0 110.799 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.43 -42.93 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.282 1.833 . . . . 0.0 111.629 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.67 -45.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.771 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 16.3 p80 -69.6 -30.56 68.34 Favored 'General case' 0 C--O 1.2 -1.538 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.425 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -61.35 -32.03 71.91 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.301 0.572 . . . . 0.0 111.044 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.19 61.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.4 m-85 -74.52 -33.91 62.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.956 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 42.2 mt-10 -63.03 -48.89 76.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.149 0.58 . . . . 0.0 110.585 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.43 -18.57 63.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.926 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.59 -22.26 22.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.673 0.273 . . . . 0.0 111.294 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.25 46.12 66.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.58 158.72 20.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 38.4 p -106.31 139.69 40.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 108.29 56.41 0.58 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.732 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 46.1 m-85 -135.36 142.16 45.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 118.62 1.21 . . . . 0.0 112.464 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 21.1 tptm -146.24 122.77 11.07 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.47 137.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.416 0.627 . . . . 0.0 111.999 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.1 m-85 -129.0 143.68 50.95 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.276 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.7 66.81 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -69.86 100.32 1.53 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.069 0.461 . . . . 0.0 110.556 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.07 28.03 38.71 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.566 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -54.85 102.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.604 1.161 . . . . 0.0 110.893 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -103.88 111.53 24.11 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.22 1.98 23.45 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 165.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 58.3 mt -95.06 131.57 40.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 118.452 1.126 . . . . 0.0 110.103 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -90.26 132.49 35.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.547 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.8 pt? . . . . . 0 C--N 1.305 -1.369 0 O-C-N 123.717 0.635 . . . . 0.0 111.904 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 84.3 t . . . . . 0 N--CA 1.436 -1.135 0 CA-C-O 120.997 0.427 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.37 151.49 49.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.587 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -111.22 134.54 52.73 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.028 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.3 144.09 44.27 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.151 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.1 119.16 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -91.55 124.89 36.06 Favored 'General case' 0 N--CA 1.422 -1.838 0 O-C-N 123.809 0.693 . . . . 0.0 109.454 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -150.3 159.28 44.56 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.413 HG13 ' CA ' ' A' ' 201' ' ' GLY . 91.3 t -101.69 129.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.8 ptp -69.85 160.91 30.92 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.84 0.712 . . . . 0.0 111.139 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 70.76 118.96 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 124.996 1.435 . . . . 0.0 112.214 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.82 -20.12 62.6 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.008 0.909 . . . . 0.0 109.524 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.75 -16.29 62.75 Favored 'General case' 0 C--O 1.206 -1.21 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.972 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.57 -30.0 62.67 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.551 0.74 . . . . 0.0 112.63 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.56 79.0 1.24 Allowed Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 119.412 -1.375 . . . . 0.0 112.043 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -69.66 151.9 45.33 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' A' ' 68' ' ' PHE . 28.7 mt -73.91 101.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 166.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.19 -41.64 75.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.863 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.22 160.27 43.92 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -51.16 136.72 29.1 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 33.3 Cg_endo -78.52 166.84 23.54 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.208 2.605 . . . . 0.0 111.606 173.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -53.94 117.02 2.87 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.54 1.136 . . . . 0.0 113.274 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.31 10.37 64.05 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.2 p -86.01 148.37 47.81 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.66 165.67 30.08 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.508 2.805 . . . . 0.0 110.212 169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -59.88 155.6 16.09 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -39.93 -54.86 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 127.556 2.343 . . . . 0.0 114.015 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 34.6 p-90 -86.51 -20.9 27.35 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.379 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -86.43 -12.64 48.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.483 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.509 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 52.4 m-85 -46.04 -34.27 3.99 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.457 ' NE2' ' HA ' ' A' ' 88' ' ' ASN . 40.2 m-70 -129.82 15.54 5.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.31 101.82 14.07 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.072 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.12 -9.99 2.75 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.64 172.9 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.63 1.715 . . . . 0.0 111.466 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 t -98.33 157.05 16.43 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.21 -16.73 48.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -23.67 58.78 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -86.86 -22.12 25.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -115.83 -22.87 8.88 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -96.85 135.62 22.04 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 124.05 11.73 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.917 2.411 . . . . 0.0 112.176 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.61 125.6 50.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.94 23.01 62.51 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.756 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.97 -157.05 24.18 Favored Glycine 0 C--O 1.25 1.131 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.154 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.4 130.86 46.53 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 33.1 m -126.19 166.5 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 19.9 m -149.17 149.91 31.79 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CE2' HG12 ' A' ' 37' ' ' ILE . 11.1 m-30 -71.92 117.03 13.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.432 -1.341 0 CA-C-O 121.221 0.534 . . . . 0.0 112.228 -176.307 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.079 0.466 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.7 mmm-85 -79.23 -173.93 3.89 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 121.901 0.858 . . . . 0.0 112.044 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -81.24 -171.96 3.53 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.146 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.36 150.69 21.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.649 0.738 . . . . 0.0 111.859 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.92 -161.19 0.75 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.869 1.268 . . . . 0.0 107.783 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -75.08 -34.62 61.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 118.762 0.71 . . . . 0.0 111.127 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.25 134.35 55.26 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 33.4 tp60 -119.31 127.55 26.41 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.45 -179.79 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.042 2.495 . . . . 0.0 113.577 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -163.57 178.84 7.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.292 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.2 mt -103.85 34.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.5 mtp -129.56 -155.92 0.73 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.509 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 40.0 p -119.73 -11.06 9.44 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.457 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 25.9 p-10 -88.19 159.36 18.19 Favored 'General case' 0 C--O 1.201 -1.448 0 O-C-N 121.669 -0.644 . . . . 0.0 110.838 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.75 135.11 54.98 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 61.1 tp -100.13 120.66 40.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.12 139.07 48.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.506 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.4 p -73.98 164.34 26.75 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.64 -21.65 77.84 Favored Glycine 0 C--N 1.327 0.074 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -75.4 -48.35 23.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.18 73.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.249 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 73.1 ttt180 -56.17 -44.16 79.08 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.382 1.073 . . . . 0.0 110.277 174.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -46.68 83.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 124.071 0.857 . . . . 0.0 110.407 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.71 -55.24 31.93 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.312 1.008 . . . . 0.0 111.234 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.13 -40.27 80.55 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 C-N-CA 123.692 0.797 . . . . 0.0 111.637 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 81.5 mt-10 -68.69 -35.12 76.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -69.46 -30.47 68.38 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.17 -17.1 57.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.44 20.9 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.698 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.8 113.73 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.9 t -82.6 153.6 25.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 73.58 16.85 3.86 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 124.684 1.194 . . . . 0.0 112.227 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.47 113.5 26.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -105.38 143.45 33.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.449 ' CH2' HD12 ' A' ' 129' ' ' LEU . 58.9 m95 -117.35 119.78 36.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -174.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.1 mt -111.82 96.04 31.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.84 134.44 14.84 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.75 2.3 . . . . 0.0 113.031 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 m -150.2 172.59 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.223 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.96 116.18 28.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -97.45 121.05 47.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.406 0.622 . . . . 0.0 111.145 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' SER . 94.4 mttt -96.28 133.82 40.16 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.614 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.4 p-10 -78.22 -160.31 0.2 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.258 0.551 . . . . 0.0 111.205 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -61.28 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.261 1.024 . . . . 0.0 110.765 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -84.66 -19.56 32.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.323 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.7 21.86 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.24 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.614 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.3 ptmt -102.99 142.31 34.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.7 84.31 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.526 0.679 . . . . 0.0 110.213 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.46 0.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.312 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.89 58.77 0.7 Allowed Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.52 -11.38 8.22 Favored 'Trans proline' 0 C--N 1.367 1.5 0 CA-C-N 120.623 2.211 . . . . 0.0 111.631 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.71 -5.28 39.12 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 124.837 1.255 . . . . 0.0 109.762 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.482 ' HB2' HD13 ' A' ' 114' ' ' ILE . 1.8 m-85 -93.14 152.23 19.37 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.608 -172.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.15 146.64 40.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.123 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.27 118.81 25.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.305 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.5 tt -91.65 128.68 37.57 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.11 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 121.09 34.37 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.153 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.58 128.47 33.43 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.422 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -102.98 174.95 5.64 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 125.573 1.795 . . . . 0.0 107.625 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.6 20.55 63.7 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.542 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.59 131.95 36.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.84 158.1 43.92 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.71 106.83 0.39 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.265 0.939 . . . . 0.0 111.399 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.68 -18.44 7.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.99 113.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.029 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.57 127.77 33.91 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.688 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.4 ttm -117.93 7.61 12.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.25 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -95.34 -34.93 11.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.057 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -94.31 -31.48 14.04 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.6 m -75.71 158.51 32.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.748 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -137.09 105.52 5.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.04 165.63 33.52 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.771 0.319 . . . . 0.0 111.753 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -118.18 134.29 55.14 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' MET . . . . . 0.458 ' SD ' HG12 ' A' ' 155' ' ' ILE . 11.5 mmt -74.01 156.38 37.59 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.145 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.556 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.336 16.3 t70 100.41 99.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 172.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 m -100.49 -55.78 2.51 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 165.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.1 -42.94 2.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.795 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 5.4 pt-20 -142.99 -178.59 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -46.37 -49.39 17.93 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 125.87 1.668 . . . . 0.0 115.164 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.4 27.58 1.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.814 1.293 . . . . 0.0 112.318 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -123.71 115.78 21.98 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 104.654 -2.351 . . . . 0.0 104.654 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.458 HG12 ' SD ' ' A' ' 147' ' ' MET . 57.1 mt -84.63 124.92 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 118.388 0.54 . . . . 0.0 110.775 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.93 -66.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.131 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -93.0 119.5 32.32 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.3 mt -125.12 125.12 68.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -103.86 -34.21 8.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.372 0.606 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.07 137.07 14.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -127.18 119.3 26.11 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.71 147.21 24.59 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.65 145.91 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.54 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 30.6 p-10 -89.42 4.54 48.72 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.156 0.983 . . . . 0.0 110.63 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -66.1 -6.48 13.32 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.374 1.07 . . . . 0.0 109.997 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -59.3 -40.98 87.9 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.66 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.77 -32.85 6.28 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.172 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 81.0 mt -81.23 141.99 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -55.47 114.61 7.58 Favored Pre-proline 0 N--CA 1.45 -0.446 0 O-C-N 123.409 0.443 . . . . 0.0 110.763 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.45 -19.3 67.04 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 123.261 2.641 . . . . 0.0 113.867 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.59 -11.72 60.52 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.903 0.481 . . . . 0.0 112.074 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.41 48.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 123.654 0.597 . . . . 0.0 110.67 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.5 -38.56 14.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.9 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.7 ttt -141.47 125.27 16.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.46 -177.96 6.69 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.012 0.925 . . . . 0.0 108.64 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.453 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -142.65 151.63 41.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 118.444 0.565 . . . . 0.0 111.76 -177.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.592 ' SG ' HD23 ' A' ' 183' ' ' LEU . 67.2 m -82.86 129.98 35.07 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 124.157 0.911 . . . . 0.0 109.479 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.5 p -64.06 -51.07 65.82 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.31 22.91 2.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.32 139.68 39.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.474 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 16.2 mmt180 -91.28 -27.29 18.52 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.924 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.69 -0.4 20.12 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.329 -172.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.592 HD23 ' SG ' ' A' ' 177' ' ' CYS . 1.8 tt -95.11 103.66 15.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.562 0.696 . . . . 0.0 109.315 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.2 mt -111.84 140.47 31.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.409 HD13 ' OD2' ' A' ' 164' ' ' ASP . 53.0 mt -116.78 137.24 52.34 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 118.584 0.629 . . . . 0.0 112.412 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.0 pt -129.36 151.8 36.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.653 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -80.29 163.44 23.95 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.739 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 0.2 OUTLIER -55.36 -42.08 73.41 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.493 0.717 . . . . 0.0 110.534 176.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -50.49 -39.72 49.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.872 1.669 . . . . 0.0 112.135 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.24 -46.88 76.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.922 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.519 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 14.8 p80 -77.2 -21.94 53.13 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.089 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.67 80.07 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.523 0.678 . . . . 0.0 110.38 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.47 73.97 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.093 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.71 -32.48 67.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.0 mm-40 -57.1 -49.63 75.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -81.51 -7.02 59.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.88 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.57 -27.28 18.29 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 122.097 -0.377 . . . . 0.0 110.167 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 66.98 43.31 91.56 Favored Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 155.72 21.2 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.0 p -106.15 139.37 40.77 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.413 ' CA ' HG13 ' A' ' 29' ' ' VAL . . . 106.44 56.6 0.64 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.634 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -126.95 147.61 50.09 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 121.206 0.527 . . . . 0.0 111.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -156.85 121.76 4.56 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.6 139.53 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.728 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 97.3 m-85 -128.55 151.33 49.57 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 210' ' ' TRP . 20.3 mm-40 -64.66 121.28 14.12 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.27 45.74 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.21 90.12 2.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.347 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.39 32.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.95 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.481 ' HB2' ' O ' ' A' ' 206' ' ' GLU . 19.6 t90 -58.77 105.35 0.3 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.851 0.861 . . . . 0.0 110.618 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.84 105.55 15.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.8 -24.42 0.3 Allowed Glycine 0 N--CA 1.474 1.172 0 N-CA-C 119.177 2.431 . . . . 0.0 119.177 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.87 115.34 3.33 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.117 0.958 . . . . 0.0 110.567 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.52 125.6 28.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.566 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.103 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tmm? . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.98 46.01 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.112 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 m -124.92 6.56 8.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.591 0.196 . . . . 0.0 110.737 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t 60.82 -149.22 0.42 Allowed 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -112.8 102.8 10.8 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.448 ' O ' ' HD2' ' A' ' 8' ' ' HIS . 34.2 t-80 -77.73 128.35 33.91 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -71.37 100.89 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.075 0.464 . . . . 0.0 111.137 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 6' ' ' HIS . 1.9 p80 -160.98 163.22 31.9 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -99.62 -173.52 2.48 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -116.14 33.32 5.59 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.411 ' HB3' ' CD ' ' A' ' 206' ' ' GLU . 48.9 m 71.75 -162.81 0.13 Allowed 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.771 -168.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 m -139.34 -62.31 0.53 Allowed 'General case' 0 C--O 1.246 0.891 0 CA-C-N 120.077 1.308 . . . . 0.0 112.063 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.44 29.55 65.85 Favored Glycine 0 CA--C 1.486 -1.726 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.4 mt -105.11 127.33 52.84 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 86.1 t -83.09 -52.33 0.64 Allowed Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.815 170.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 8.9 Cg_endo -90.52 103.62 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 121.904 1.736 . . . . 0.0 112.129 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -156.97 -45.83 0.07 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.22 -61.88 0.19 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.654 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -98.75 134.76 41.19 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 122.686 -0.302 . . . . 0.0 110.338 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.254 0.3 OUTLIER 71.25 151.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.708 2.403 . . . . 0.0 113.485 -178.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ttp -112.14 -39.08 4.56 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.44 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.898 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -96.91 148.02 23.37 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.46 137.07 47.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.612 0.72 . . . . 0.0 111.828 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.71 151.35 49.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.621 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.8 t -81.6 130.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -91.73 122.11 33.98 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.712 0.768 . . . . 0.0 110.81 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -138.57 152.48 48.21 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.02 127.51 56.77 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 12.0 tmm? -85.78 84.42 7.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.56 112.47 3.72 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.528 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.39 -45.92 3.98 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.258 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.97 -12.26 59.92 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.02 120.72 2.11 Favored Glycine 0 N--CA 1.409 -3.119 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.659 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -70.76 152.13 44.12 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mt -78.49 101.4 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -72.73 -42.28 64.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.189 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 41.1 ttmt -133.01 141.78 48.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.32 132.37 95.32 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.73 167.55 26.85 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.891 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -54.5 124.64 16.77 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 112.727 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.99 68.51 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.287 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -85.65 133.26 42.2 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.47 165.53 32.44 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.294 2.663 . . . . 0.0 109.948 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 p -51.92 149.46 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.23 -50.45 3.61 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 128.243 2.617 . . . . 0.0 113.684 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -85.89 -25.89 25.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.966 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -80.57 -15.38 56.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.649 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -44.83 -47.55 11.01 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.624 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 2.8 m-70 -127.01 30.12 5.5 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.76 -1.213 . . . . 0.0 109.869 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -92.88 101.99 14.36 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -9.23 0.31 Allowed Glycine 0 CA--C 1.54 1.603 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.23 168.2 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 118.779 1.289 . . . . 0.0 112.801 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 t -97.09 154.48 17.31 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.5 mt -102.38 10.64 38.93 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.441 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.36 -29.55 70.54 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.726 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -13.73 38.41 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -114.98 -21.97 9.8 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.29 134.81 20.36 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.87 127.47 25.26 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.278 2.652 . . . . 0.0 113.268 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.53 115.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.24 22.91 50.38 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.971 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.56 -167.32 26.47 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.01 141.85 49.34 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 117.511 0.656 . . . . 0.0 109.265 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.41 ' CG2' HG13 ' A' ' 114' ' ' ILE . 31.1 m -133.71 165.92 30.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.0 t -153.07 153.85 33.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.183 0.516 . . . . 0.0 111.211 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.95 117.93 19.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.889 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' A' ' 39' ' ' LYS . 12.8 p -75.41 138.88 41.98 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -82.23 82.24 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.028 0.918 . . . . 0.0 111.618 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -86.1 -32.02 21.58 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -117.21 131.78 23.84 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.56 -31.55 50.3 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.195 2.597 . . . . 0.0 114.756 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.88 -158.32 0.65 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.862 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . 0.27 90.6 m-20 85.52 142.84 0.06 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -88.61 -154.88 0.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.954 1.301 . . . . 0.0 111.336 -169.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.67 -167.46 1.63 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.937 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -87.31 150.69 23.69 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.372 0.669 . . . . 0.0 112.089 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -105.83 -159.55 0.71 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -71.37 -42.18 68.77 Favored 'General case' 0 CA--C 1.48 -1.749 0 CA-C-N 119.086 0.857 . . . . 0.0 110.624 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -120.83 135.69 55.1 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 35.5 tp60 -116.4 117.99 37.91 Favored Pre-proline 0 C--N 1.28 -2.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.59 162.62 27.34 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.939 2.426 . . . . 0.0 112.058 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -163.81 174.32 11.71 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.181 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.25 -6.47 10.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.444 0.64 . . . . 0.0 110.311 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -96.55 -174.78 3.13 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.847 -0.533 . . . . 0.0 111.273 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -96.41 43.88 1.07 Allowed 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.214 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -138.33 151.33 47.45 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.01 138.85 54.58 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 51.7 tp -105.96 129.61 54.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.184 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.08 140.36 49.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.054 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -70.82 167.3 19.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.063 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.47 -37.67 92.86 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.502 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -72.25 -37.43 69.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.35 -30.52 62.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.351 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.403 ' HG3' ' CE3' ' A' ' 109' ' ' TRP . 49.3 ttp180 -58.41 -48.71 79.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.099 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 10.2 tmtt? -62.43 -37.44 85.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.936 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.79 -53.21 59.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 120.583 0.23 . . . . 0.0 111.105 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.2 -41.5 87.01 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.17 -31.14 71.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.313 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -71.42 -22.08 61.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.54 -19.81 32.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.96 0.41 . . . . 0.0 110.551 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.06 48.05 7.19 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.269 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.1 t -78.97 114.57 19.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.4 t -80.03 158.24 26.55 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.137 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 78.5 19.19 0.95 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.316 1.01 . . . . 0.0 110.406 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.03 134.03 50.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.498 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.9 tp10 -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.403 ' CE3' ' HG3' ' A' ' 96' ' ' ARG . 52.2 m95 -117.0 118.62 32.92 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 123.459 0.475 . . . . 0.0 110.082 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.12 102.49 43.52 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.99 129.98 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.744 2.296 . . . . 0.0 113.683 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.1 m -142.87 172.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.359 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.72 116.23 29.53 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 126' ' ' TYR . 4.4 mp -101.59 124.93 55.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.468 0.651 . . . . 0.0 110.966 -176.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 87.3 mttt -97.35 132.14 43.36 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.6 -161.56 0.24 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -62.6 -31.57 72.42 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.44 -4.27 55.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.739 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.74 14.75 79.22 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.709 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 20.1 pttp -104.84 140.06 38.68 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.534 0.333 . . . . 0.0 110.247 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.23 107.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.43 -0.29 6.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.417 0.627 . . . . 0.0 110.905 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.87 75.95 0.34 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.45 -27.68 2.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.093 1.862 . . . . 0.0 113.773 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -118.53 23.38 11.55 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.813 1.292 . . . . 0.0 109.285 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.45 ' HB2' HD11 ' A' ' 114' ' ' ILE . 2.9 m-85 -88.66 144.86 26.01 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.528 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.77 46.43 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.758 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.7 126.88 32.32 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.534 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 tt -90.54 125.28 35.56 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.846 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.624 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 28.2 m-80 -107.15 137.03 45.98 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.955 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.21 120.58 42.96 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.9 172.96 6.52 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 124.029 0.83 . . . . 0.0 110.649 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 22.78 64.24 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.54 131.19 37.87 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -147.88 151.61 36.18 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -52.89 115.19 1.71 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.966 0.791 . . . . 0.0 112.09 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 164' ' ' ASP . . . -131.93 -26.36 1.97 Allowed 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -167.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 17.7 mt -62.36 125.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.72 125.74 26.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 23.0 ttt -118.83 1.88 11.57 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.737 0.78 . . . . 0.0 109.718 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.57 -32.56 11.04 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.73 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -108.02 -10.87 15.41 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.182 0.593 . . . . 0.0 110.552 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.5 m -93.84 110.6 22.25 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.362 0.601 . . . . 0.0 110.603 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -78.61 100.72 7.09 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.379 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.49 145.46 27.93 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.239 0.543 . . . . 0.0 111.904 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -101.3 127.97 47.67 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.496 ' HE3' ' O ' ' A' ' 152' ' ' LYS . 71.8 mtp -100.73 154.56 18.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 24.0 t70 90.71 85.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 127.269 2.228 . . . . 0.0 114.1 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.7 m -100.43 -26.77 13.76 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.322 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -145.99 -48.05 0.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 14.3 pt-20 -139.75 177.79 7.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.496 ' O ' ' HE3' ' A' ' 147' ' ' MET . 38.0 ttmt -59.16 -38.58 80.09 Favored 'General case' 0 C--O 1.214 -0.782 0 O-C-N 124.292 0.995 . . . . 0.0 111.102 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 25.7 m-20 -85.97 26.11 1.04 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.401 ' NE2' ' HG3' ' A' ' 181' ' ' ARG . 21.2 mm-40 -123.46 113.31 18.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.0 mt -87.03 132.29 32.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 124.238 1.015 . . . . 0.0 109.946 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.05 -72.51 0.95 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.478 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -90.76 133.11 35.42 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.65 124.51 59.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.84 -34.55 8.49 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.04 136.87 20.55 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.85 123.73 29.67 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.84 143.2 32.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.67 139.64 57.07 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.767 0.794 . . . . 0.0 112.96 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.551 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 18.7 p-10 -94.33 15.55 17.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.112 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.7 p -67.45 -5.22 13.88 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.892 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.1 m -61.57 -38.14 86.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.959 0.903 . . . . 0.0 110.673 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.63 -30.5 7.08 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.788 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 73.8 mt -85.82 139.2 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -54.79 117.96 15.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 O-C-N 123.189 0.306 . . . . 0.0 111.243 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.16 -13.18 33.97 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.419 2.746 . . . . 0.0 114.037 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.84 -12.73 60.22 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.76 129.06 38.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.075 0.464 . . . . 0.0 109.83 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -83.63 -17.0 43.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.794 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -154.38 128.16 8.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -153.36 178.52 9.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -128.47 142.43 51.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.422 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 58.2 m -86.52 140.48 29.87 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 123.832 0.708 . . . . 0.0 109.483 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.3 p -68.75 -44.56 73.5 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.745 2.868 . . . . 0.0 118.745 -168.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -89.19 23.7 2.38 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.544 0.611 . . . . 0.0 112.333 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 9.0 tp10 -154.94 135.6 13.53 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.401 ' HG3' ' NE2' ' A' ' 154' ' ' GLN . 69.8 mtt180 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.9 mtm-85 -83.81 -7.37 59.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.767 -167.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.422 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 26.2 tp -82.42 100.63 10.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.819 0.818 . . . . 0.0 110.973 -174.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.1 mt -117.84 124.38 72.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 43.4 mt -103.94 134.71 46.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.523 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 43.0 pt -123.68 157.74 29.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.597 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -86.06 162.43 18.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.62 -44.63 26.95 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.199 1.399 . . . . 0.0 111.996 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.22 -43.56 70.94 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.439 1.096 . . . . 0.0 111.301 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.31 -53.19 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.178 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.544 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 13.7 p80 -75.31 -26.54 58.76 Favored 'General case' 0 C--O 1.195 -1.804 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.714 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.99 83.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 0.0 110.351 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.77 72.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.552 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.445 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 21.0 m-85 -73.57 -36.43 65.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.247 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -56.92 -50.75 71.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 121.625 0.726 . . . . 0.0 109.218 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.91 -26.67 61.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.21 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.53 -27.47 62.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.425 0.155 . . . . 0.0 111.046 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.9 47.51 13.85 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.05 165.87 18.2 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.8 p -42.15 -72.83 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -165.96 144.43 9.19 Favored Glycine 0 CA--C 1.488 -1.637 0 C-N-CA 118.998 -1.572 . . . . 0.0 113.118 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.445 ' CE2' ' HB3' ' A' ' 194' ' ' PHE . 74.5 m-85 -137.37 152.78 50.05 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 22.4 tptm -132.21 121.84 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 24.7 m -116.43 139.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.563 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -121.68 151.44 40.47 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.411 ' CD ' ' HB3' ' A' ' 11' ' ' SER . 49.6 mt-10 -75.62 133.39 40.9 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.207 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.13 -38.34 31.73 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.936 0.874 . . . . 0.0 108.642 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.74 104.8 13.26 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.004 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.55 35.33 47.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.523 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -54.31 102.18 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.082 1.353 . . . . 0.0 111.217 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.55 109.89 21.74 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.73 2.94 31.82 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 167.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.14 145.37 24.74 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 117.902 0.851 . . . . 0.0 109.738 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.2 0.524 . . . . 0.0 111.459 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.997 178.42 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.506 -0.729 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.49 142.55 8.94 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.112 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.9 t -73.73 -42.4 61.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 m -110.08 105.37 14.45 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -77.57 -40.76 41.24 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -165.47 94.09 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.555 1.142 . . . . 0.0 109.308 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -167.0 -40.11 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.228 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 68.68 112.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.614 1.166 . . . . 0.0 110.232 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -84.56 152.85 23.61 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 76.89 25.47 0.84 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.233 0.958 . . . . 0.0 110.91 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 m -74.03 -51.74 14.9 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m 61.97 173.21 0.13 Allowed 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.857 1.263 . . . . 0.0 113.565 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.66 85.18 1.16 Allowed Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.89 71.41 10.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.896 0.855 . . . . 0.0 110.557 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.69 134.25 24.87 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.11 107.28 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.484 2.123 . . . . 0.0 111.091 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -152.09 123.62 7.83 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.22 -25.39 1.57 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.653 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -60.97 -43.59 98.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 117.073 0.437 . . . . 0.0 111.785 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -145.95 101.31 3.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.319 0.58 . . . . 0.0 109.573 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -98.94 160.44 14.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG13 ' NE ' ' A' ' 187' ' ' ARG . 45.0 t -94.96 119.06 42.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 118.75 0.704 . . . . 0.0 110.469 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -87.01 155.8 20.01 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.317 0.579 . . . . 0.0 112.3 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -112.06 138.45 48.7 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.158 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.85 150.92 49.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.46 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.8 130.0 36.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -95.72 128.86 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.512 0.507 . . . . 0.0 111.141 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -150.12 149.58 30.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.94 115.56 41.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 57.0 ttp -85.28 101.61 12.67 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 173.56 177.19 0.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.144 1.778 . . . . 0.0 107.56 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.17 -36.21 1.53 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 122.04 0.924 . . . . 0.0 110.147 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -0.85 57.79 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.962 1.305 . . . . 0.0 111.46 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.18 58.5 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.57 82.69 1.14 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.253 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -95.01 164.61 12.82 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.31 102.21 13.41 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 72' ' ' TYR . 2.2 mm-40 -61.87 -55.42 29.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.917 -172.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -137.03 176.47 8.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -55.37 125.74 60.08 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.44 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 123.031 2.487 . . . . 0.0 111.344 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -55.8 117.16 3.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.889 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 9.11 83.52 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.281 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m -85.79 139.32 35.22 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -67.59 166.28 24.52 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.686 2.924 . . . . 0.0 112.619 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 p -53.23 152.01 4.77 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.09 -58.74 2.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 127.534 2.333 . . . . 0.0 113.975 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -80.55 -25.39 38.62 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.431 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.476 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 45.1 tptt -80.52 -16.77 53.43 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -172.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -45.51 -43.37 11.69 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 176' ' ' ARG . 55.9 m170 -126.98 24.16 6.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.978 -1.076 . . . . 0.0 111.097 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -93.45 102.7 14.93 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.063 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.29 -8.95 0.59 Allowed Glycine 0 CA--C 1.538 1.495 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.99 171.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 118.499 1.149 . . . . 0.0 113.648 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -98.55 137.93 36.49 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.56 -0.78 48.4 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.07 -23.22 67.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.021 0.438 . . . . 0.0 111.381 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -88.74 -27.88 20.88 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -112.69 -15.53 12.97 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -110.21 135.75 20.55 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.95 123.94 13.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.635 2.223 . . . . 0.0 113.36 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.4 t -95.02 107.68 19.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.47 23.54 28.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.15 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.22 -153.85 25.24 Favored Glycine 0 C--O 1.24 0.507 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.46 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -131.81 132.2 43.53 Favored 'General case' 0 C--O 1.248 0.981 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 m -134.03 168.33 24.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -149.15 158.28 44.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -84.85 106.69 16.57 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 p -69.41 120.89 15.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.568 0.699 . . . . 0.0 109.409 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -74.45 106.51 6.09 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.161 -173.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -104.05 -38.03 7.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.881 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.422 ' HB3' ' OE1' ' A' ' 38' ' ' GLU . 72.7 t80 -111.46 131.61 22.22 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.68 154.02 23.42 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.447 2.098 . . . . 0.0 114.36 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 79.42 2.0 2.27 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.152 1.381 . . . . 0.0 114.556 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -73.52 137.42 44.4 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -90.68 -151.36 0.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -165.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -84.88 -171.19 3.5 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.645 1.578 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HG ' ' OE1' ' A' ' 82' ' ' GLN . 8.6 mp -100.12 150.21 22.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.171 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.461 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 18.3 m-85 -125.4 -165.74 1.45 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.208 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -52.49 -51.59 58.64 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 123.499 0.719 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -116.2 142.89 46.22 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.918 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.461 ' NE2' ' H ' ' A' ' 79' ' ' TYR . 24.6 mm-40 -121.34 111.89 33.24 Favored Pre-proline 0 C--N 1.285 -2.224 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.025 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 167.3 27.68 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.458 2.106 . . . . 0.0 111.35 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -142.69 156.39 45.03 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.4 mt -91.12 -19.48 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -99.02 -179.07 4.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 33.5 t -97.82 66.1 1.88 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.712 -1.195 . . . . 0.0 114.057 -174.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -140.13 121.05 14.54 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.491 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 138.12 31.71 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.354 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 64.9 tp -111.57 127.12 55.63 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.79 141.24 45.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.53 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -78.95 170.2 17.05 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.74 -16.37 79.23 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -69.71 -58.62 3.69 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -25.59 63.33 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.101 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -60.22 -40.89 91.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.509 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HA ' ' CE ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.29 -29.5 65.13 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.508 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.82 -57.84 10.98 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.49 -42.74 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.427 0.691 . . . . 0.0 112.562 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.12 -27.48 62.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 p -78.3 -13.0 60.04 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.497 0.665 . . . . 0.0 111.39 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.423 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -88.73 -25.57 22.24 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.592 173.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.28 48.36 8.28 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.38 107.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.582 0.706 . . . . 0.0 111.671 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -66.92 137.3 56.45 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.151 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 79.94 11.55 1.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.493 1.917 . . . . 0.0 113.667 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.75 114.32 26.04 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -107.5 144.63 34.19 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.415 ' CH2' HD11 ' A' ' 129' ' ' LEU . 67.0 m95 -116.46 121.43 41.82 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 123.586 0.554 . . . . 0.0 110.238 -174.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.57 96.51 43.87 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.38 139.75 16.72 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.549 2.166 . . . . 0.0 112.868 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.14 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.319 0.648 . . . . 0.0 109.804 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.18 116.55 28.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.9 mt -110.54 131.14 62.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.613 0.72 . . . . 0.0 112.865 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -104.76 148.75 26.27 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.548 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -89.32 -160.69 0.7 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.316 0.579 . . . . 0.0 111.241 -174.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -63.85 -34.3 77.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.62 1.168 . . . . 0.0 110.507 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.53 -19.42 29.51 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.66 19.7 24.12 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.548 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 52.2 pttt -99.29 146.35 26.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.71 81.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.681 0.753 . . . . 0.0 110.148 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 m -105.4 8.19 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.429 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.78 50.76 0.88 Allowed Glycine 0 CA--C 1.542 1.757 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.73 -6.76 9.7 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 121.097 2.449 . . . . 0.0 112.285 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -103.11 -0.99 29.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.0 147.87 24.06 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 122.002 0.906 . . . . 0.0 112.86 -170.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.28 139.5 42.72 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.702 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -79.67 124.3 28.44 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.046 0.451 . . . . 0.0 110.111 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.415 HD11 ' CH2' ' A' ' 109' ' ' TRP . 8.0 tt -96.86 125.98 41.68 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.759 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.88 134.62 54.37 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.848 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.78 31.94 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.719 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.07 174.12 6.39 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 124.87 1.356 . . . . 0.0 109.016 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.78 28.9 25.12 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.592 -0.814 . . . . 0.0 115.114 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.89 131.79 55.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.151 -1.019 . . . . 0.0 110.984 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.78 111.66 6.13 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.724 -1.125 . . . . 0.0 107.99 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.0 t70 71.21 -52.34 0.69 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 125.978 1.711 . . . . 0.0 112.253 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.36 -100.58 0.06 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 125.961 1.704 . . . . 0.0 114.484 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.8 mt -64.12 125.08 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 O-C-N 123.686 0.616 . . . . 0.0 110.405 -172.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 100.64 1.94 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.519 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 21.6 ttt -75.81 -12.75 60.23 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.353 -171.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.53 -39.89 67.19 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -101.21 4.55 42.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.347 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 77.7 p -92.54 115.65 28.29 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.767 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -92.53 104.53 16.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.32 164.02 32.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.529 0.681 . . . . 0.0 112.532 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.87 117.95 31.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 26.3 ttt -100.28 107.48 19.3 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.883 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.6 t70 170.41 89.33 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.909 1.683 . . . . 0.0 108.589 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.8 p -101.07 -56.88 2.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.294 0.568 . . . . 0.0 110.358 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.17 -59.94 1.9 Allowed 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.54 -177.07 3.21 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.537 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 152' ' ' LYS . 1.2 tpmt? -76.01 -26.51 56.75 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.224 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.46 11.4 14.78 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.613 1.196 . . . . 0.0 110.025 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -124.68 127.84 47.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 48.5 mt -84.79 143.84 10.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -119.42 -70.44 0.33 Allowed Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.425 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.37 118.93 28.34 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 59.1 mt -118.29 132.23 68.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -106.67 -42.29 5.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -154.65 110.62 3.19 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.64 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -88.15 124.71 34.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.75 24.42 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.74 146.46 52.34 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -96.06 -9.15 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -68.0 -6.02 20.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.567 1.147 . . . . 0.0 111.035 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.9 m -65.39 -38.19 89.25 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -110.52 -30.98 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.373 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.83 151.52 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 171' ' ' ASP . 55.5 mtt180 -62.44 126.65 88.56 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 122.267 0.227 . . . . 0.0 111.471 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.86 -10.12 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.139 1.892 . . . . 0.0 110.816 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 169' ' ' ARG . 4.3 p-10 -85.21 2.14 45.1 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.091 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.99 134.73 33.88 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 67.8 mttm -84.01 -27.44 28.38 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.4 ' HG3' HG21 ' A' ' 186' ' ' ILE . 26.0 ttt -150.76 128.05 11.31 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.56 -179.19 7.03 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 123.559 0.537 . . . . 0.0 110.004 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -136.12 154.7 50.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 63.4 m -87.48 143.82 27.03 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.206 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.5 p -82.91 -9.61 59.22 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -105.87 23.74 13.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.72 -0.613 . . . . 0.0 111.853 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 175.05 134.16 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 17.1 mmt180 -89.53 -31.05 17.8 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.495 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -77.85 -20.13 53.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.269 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.3 tp -83.85 100.35 10.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.067 0.937 . . . . 0.0 110.64 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.3 mt -116.46 119.41 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 55.2 mt -104.89 136.04 45.12 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.608 0.718 . . . . 0.0 111.723 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.4 HG21 ' HG3' ' A' ' 174' ' ' MET . 43.6 pt -119.3 153.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.417 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 10.6 mtp180 -86.06 161.3 19.0 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.487 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.7 pt-20 -55.42 -40.02 70.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.7 -26.34 66.97 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.465 0.706 . . . . 0.0 111.829 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.2 t -71.31 -51.01 37.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.797 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.555 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 19.3 p80 -73.17 -21.91 60.6 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.089 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.9 76.82 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.063 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.24 75.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.511 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -71.18 -33.35 69.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.272 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 62.9 mm-40 -59.6 -47.93 83.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.491 0.663 . . . . 0.0 109.811 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -78.03 -12.76 60.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.516 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.06 -28.42 20.14 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.083 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.39 47.7 87.61 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 202' ' ' PHE . 66.5 mt -77.9 164.18 25.37 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.5 p -41.41 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.45 135.06 6.81 Favored Glycine 0 CA--C 1.493 -1.322 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.809 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 199' ' ' LEU . 70.5 m-85 -146.37 161.94 39.28 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 58.1 tptt -153.59 122.26 6.34 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 18.0 m -112.66 134.46 55.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.054 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 73.4 m-85 -118.26 140.05 50.39 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.95 115.51 9.26 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.08 -35.05 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.382 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.97 92.67 0.52 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.062 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.99 35.6 17.97 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.399 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -53.12 115.01 1.66 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.802 0.841 . . . . 0.0 110.061 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.23 99.78 11.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.47 -1.59 9.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 117.832 1.893 . . . . 0.0 117.832 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 88.0 mt -94.56 143.2 26.62 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 118.029 0.914 . . . . 0.0 112.327 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.48 132.36 52.59 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.466 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 2.5 pt? . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.047 0.842 . . . . 0.0 112.387 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.89 153.7 6.51 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m 65.79 98.48 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.468 1.107 . . . . 0.0 112.084 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -59.31 -42.91 92.49 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 112.01 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -71.91 131.54 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -58.65 -46.78 86.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -152.45 156.76 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.414 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.418 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 22.5 m80 -77.05 107.83 9.69 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.685 0.616 . . . . 0.0 110.475 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -126.39 7.54 7.05 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -114.06 13.76 18.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.306 1.05 . . . . 0.0 108.594 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 8' ' ' HIS . 48.9 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.393 0.616 . . . . 0.0 111.116 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -102.57 150.35 23.5 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.309 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.35 104.02 3.09 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.52 156.78 36.5 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.3 t -65.3 121.21 73.41 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' A' ' 17' ' ' ARG . 30.4 Cg_endo -64.77 95.29 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.324 2.682 . . . . 0.0 114.811 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 4.5 mpt_? -136.2 86.53 2.23 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.029 1.332 . . . . 0.0 108.146 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.61 -83.37 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.357 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.849 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m 71.58 -56.28 0.64 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.713 1.605 . . . . 0.0 109.515 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.98 92.48 2.4 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -86.9 114.48 23.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.39 115.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -80.55 152.95 28.36 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -167.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.28 141.1 48.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.972 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.7 141.0 52.24 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 62.0 t -72.73 120.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.3 115.11 27.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.857 0.723 . . . . 0.0 110.7 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -140.3 120.16 13.51 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.9 t -72.66 129.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.419 ' HB3' ' HG3' ' A' ' 203' ' ' LYS 0.268 20.8 ptt? -102.01 66.68 1.04 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.73 1.252 . . . . 0.0 112.619 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.46 110.72 12.1 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -106.66 -17.24 14.29 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 122.19 0.995 . . . . 0.0 108.721 -171.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -86.97 -25.85 24.12 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.698 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.32 80.68 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.89 137.41 3.36 Favored Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.216 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -65.9 156.63 32.86 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.38 102.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -51.73 -52.19 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.832 1.332 . . . . 0.0 112.205 -169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -139.69 172.03 13.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.46 124.63 56.33 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.09 166.77 28.41 Favored 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 122.664 2.243 . . . . 0.0 112.198 172.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.15 121.4 6.74 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 125.109 1.364 . . . . 0.0 112.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.09 0.2 68.4 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.649 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.7 m -85.88 137.87 35.47 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.93 166.49 23.2 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 123.416 2.744 . . . . 0.0 109.795 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.0 p -48.22 153.01 0.75 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.46 ' OD1' ' HG3' ' A' ' 86' ' ' MET . 16.2 m-20 -37.68 -57.03 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 C-N-CA 126.863 2.065 . . . . 0.0 114.955 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -80.47 -30.33 37.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.419 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.72 -11.58 59.84 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.725 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 27.8 m-85 -45.84 -46.01 15.36 Favored 'General case' 0 C--O 1.209 -1.048 0 O-C-N 123.559 0.537 . . . . 0.0 111.347 174.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 17.4 m170 -129.41 17.0 5.98 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.19 101.34 13.41 Favored 'General case' 0 N--CA 1.425 -1.688 0 C-N-CA 117.76 -1.576 . . . . 0.0 108.373 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.03 -9.17 55.05 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.59 173.77 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 119.814 1.807 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -98.88 157.15 16.5 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.38 5.95 49.02 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.36 68.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.972 0.415 . . . . 0.0 111.792 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -88.37 -32.57 18.31 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.1 -22.61 15.13 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -102.53 136.97 19.26 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.37 123.86 13.95 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.063 2.509 . . . . 0.0 112.571 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.63 115.98 40.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.76 23.65 45.31 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.41 -159.33 25.01 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 121.453 -0.403 . . . . 0.0 112.315 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -133.31 135.68 44.99 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.41 172.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 t -155.64 154.47 31.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.52 119.84 16.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -73.07 137.45 45.29 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 123.719 0.637 . . . . 0.0 109.671 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -85.02 73.9 10.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -90.88 -22.38 20.96 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 172.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -147.24 98.59 3.99 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 112.839 -1.982 . . . . 0.0 105.781 170.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.58 -27.59 6.09 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.519 2.146 . . . . 0.0 114.827 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.92 86.4 7.32 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -171.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -153.99 -176.24 5.76 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 125.041 1.337 . . . . 0.0 108.344 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -98.68 -159.37 0.74 Allowed 'General case' 0 C--O 1.262 1.716 0 CA-C-O 121.361 0.6 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.39 -167.59 1.88 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.614 1.566 . . . . 0.0 112.42 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.79 147.39 25.18 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.573 0.749 . . . . 0.0 111.76 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.87 -171.52 1.86 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.17 0.988 . . . . 0.0 109.416 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.04 -46.09 71.79 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.546 0.688 . . . . 0.0 110.517 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.0 131.14 53.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 48.0 tp60 -111.44 116.21 50.99 Favored Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 121.053 0.454 . . . . 0.0 109.96 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.12 164.91 21.92 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.82 2.347 . . . . 0.0 112.413 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -157.36 173.61 16.67 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 mt -90.37 3.02 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 121.608 0.718 . . . . 0.0 110.33 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.46 ' HG3' ' OD1' ' A' ' 47' ' ' ASP . 4.1 mpp? -104.98 -175.7 2.87 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.88 -0.513 . . . . 0.0 110.321 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 22.6 t -92.58 16.41 12.12 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 120.989 0.423 . . . . 0.0 112.065 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -115.67 151.1 35.67 Favored 'General case' 0 C--O 1.205 -1.238 0 O-C-N 121.082 -1.012 . . . . 0.0 109.321 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.9 139.86 50.13 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 119.009 -1.077 . . . . 0.0 110.803 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 55.1 tp -109.1 126.39 53.14 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.38 140.97 47.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.6 p -73.4 162.49 29.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.09 -31.92 82.39 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.211 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -72.34 -36.12 68.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.794 0.331 . . . . 0.0 110.753 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.26 -27.62 56.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -60.26 -39.32 86.37 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.112 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.7 mmtp -60.09 -44.18 94.99 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.15 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.63 -51.7 68.81 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.745 0.653 . . . . 0.0 110.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.93 -44.07 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.031 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.98 -20.35 60.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.8 t -72.06 -32.08 66.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.92 -2.07 57.91 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.396 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.69 47.86 82.65 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.555 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -75.24 110.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -75.84 151.79 37.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.188 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 79.58 12.77 1.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.231 1.413 . . . . 0.0 111.972 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.8 tp10 -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -113.27 126.14 55.07 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.51 99.75 42.28 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.33 125.47 6.38 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.501 2.134 . . . . 0.0 112.93 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -143.07 170.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -104.93 116.84 32.65 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.1 mp -103.99 133.55 47.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.424 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.627 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -97.34 144.36 27.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -85.53 -163.8 0.91 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.107 0.48 . . . . 0.0 111.515 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -67.16 -29.64 69.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.235 0.614 . . . . 0.0 110.503 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -87.56 -5.49 58.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.65 18.86 64.97 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 114.402 0.521 . . . . 0.0 114.402 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -105.27 152.67 22.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 117.417 0.609 . . . . 0.0 110.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.12 85.71 2.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.405 0.621 . . . . 0.0 109.894 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.4 ' C ' ' HD3' ' A' ' 124' ' ' PRO . 11.6 m -110.13 6.67 8.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -125.37 59.17 0.65 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.679 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 10.6 Cg_endo -85.26 -19.68 3.63 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.41 2.073 . . . . 0.0 113.152 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.0 6.8 21.26 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.017 0.527 . . . . 0.0 110.688 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 1.5 m-85 -88.29 145.28 25.94 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.221 0.534 . . . . 0.0 110.158 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.38 144.29 48.12 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.408 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.99 128.27 34.32 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 tt -97.68 126.93 43.28 Favored 'General case' 0 C--O 1.268 2.06 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 25.7 m-80 -111.13 127.22 55.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.757 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.96 122.6 38.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.85 174.42 5.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 124.148 0.905 . . . . 0.0 109.478 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.39 26.19 28.65 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.99 41.22 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.037 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.88 170.14 18.3 Favored 'General case' 0 C--N 1.263 -3.169 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.57 107.99 0.23 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.908 1.231 . . . . 0.0 111.995 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -80.48 -71.19 0.47 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.034 -1.894 . . . . 0.0 115.686 -163.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.21 124.67 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 O-C-N 123.804 0.69 . . . . 0.0 111.669 -170.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.427 ' OD2' ' HG2' ' A' ' 141' ' ' GLU . 11.8 t70 -82.67 128.16 34.09 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.62 -22.91 32.08 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.427 ' HG2' ' OD2' ' A' ' 139' ' ' ASP . 11.1 pt-20 -95.37 -27.29 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.421 0.555 . . . . 0.0 111.157 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -86.81 -5.76 59.01 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.488 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -121.12 168.45 11.54 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -137.2 106.78 6.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -159.67 164.4 34.05 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.649 0.261 . . . . 0.0 111.148 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.89 129.75 51.49 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.509 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 62.2 mtt -92.26 107.63 19.35 Favored 'General case' 0 C--O 1.201 -1.455 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.202 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 165.45 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.026 1.73 . . . . 0.0 111.028 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.6 p -100.93 -56.47 2.31 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.848 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.9 mt -110.14 -31.84 7.21 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.553 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.79 -174.84 1.94 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 147' ' ' MET . 39.4 ttpt -63.02 -43.71 97.96 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.821 0.737 . . . . 0.0 112.852 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.26 26.01 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.152 0.977 . . . . 0.0 112.358 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 152' ' ' LYS . 17.5 mm-40 -139.12 114.25 9.52 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.3 mt -85.03 144.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.12 -77.6 0.77 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -78.79 118.85 21.24 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 39.8 mt -126.34 116.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -100.79 -39.03 8.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.309 0.576 . . . . 0.0 109.769 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.18 128.88 24.67 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.72 111.18 17.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 147.18 24.11 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.75 129.45 39.84 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.189 0.931 . . . . 0.0 110.585 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -84.68 11.6 8.68 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 124.413 1.085 . . . . 0.0 110.775 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.0 p -71.69 -4.94 30.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.139 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -73.76 -34.7 64.83 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.498 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.65 -33.62 8.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.719 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.8 mt -91.47 153.52 3.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.0 124.33 73.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 118.074 0.397 . . . . 0.0 111.037 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.43 -5.34 15.75 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.6 2.867 . . . . 0.0 113.908 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.68 -0.28 51.8 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.93 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.25 120.71 14.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.107 0.479 . . . . 0.0 110.457 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -73.99 -28.64 61.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.03 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.4 ttt -147.68 125.66 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -152.56 175.55 12.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 51' ' ' HIS . 0.2 OUTLIER -152.07 162.23 41.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.37 160.69 20.6 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.3 p -82.24 -49.29 10.25 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 124.134 0.974 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.75 4.68 31.66 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.31 138.08 47.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 87' ' ' SER . 11.4 mtm180 -90.14 -30.16 17.82 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.818 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.0 -28.07 13.95 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.2 tp -71.05 100.63 2.05 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-O 122.133 0.968 . . . . 0.0 112.76 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.23 132.87 64.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.94 122.25 43.74 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.604 0.716 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 34.2 pt -112.08 151.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -85.08 159.99 20.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 11.3 pt-20 -54.44 -39.77 67.72 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -73.13 -27.89 61.94 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.105 0.562 . . . . 0.0 111.454 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.47 -47.42 72.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.634 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.7 p80 -71.21 -26.05 62.77 Favored 'General case' 0 C--O 1.196 -1.748 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.742 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.91 71.24 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.492 0.495 . . . . 0.0 110.7 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.55 -39.25 74.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.99 -32.41 70.6 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 65.6 mm-40 -58.25 -53.5 57.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.679 0.791 . . . . 0.0 109.678 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.52 -23.5 58.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.785 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.75 60.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.261 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.12 47.85 10.56 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.962 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.9 mt -80.32 161.78 24.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.6 p -38.8 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.87 128.81 1.53 Allowed Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.91 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -136.17 150.85 49.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 30' ' ' MET . 53.7 mtmt -106.99 128.45 54.36 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 15.6 m -118.84 129.24 75.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 123.797 0.686 . . . . 0.0 109.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.2 m-85 -118.44 154.52 32.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.17 116.06 12.15 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.98 -36.98 67.2 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.428 0.455 . . . . 0.0 111.646 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.28 102.07 1.02 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.18 60.32 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.657 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -57.45 100.62 0.05 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.974 1.31 . . . . 0.0 111.888 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.0 133.96 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -26.56 0.29 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 118.809 2.283 . . . . 0.0 118.809 167.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.47 134.12 45.17 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 118.313 1.057 . . . . 0.0 112.141 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -86.81 131.57 34.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.2 pt? . . . . . 0 C--N 1.299 -1.589 0 O-C-N 123.336 0.398 . . . . 0.0 110.563 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.38 175.25 45.59 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.351 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -86.09 28.57 0.8 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 123.7 0.8 . . . . 0.0 112.823 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -63.19 -42.51 99.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -85.47 97.15 9.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 168.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -68.18 -36.11 79.08 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.728 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -146.15 99.41 3.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -149.84 -70.27 0.19 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -141.63 65.08 1.39 Allowed 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 167.36 125.38 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 t 63.94 36.83 9.84 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -70.63 -19.65 62.8 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.816 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.57 -102.14 1.03 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.55 35.71 20.06 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.858 0.863 . . . . 0.0 110.029 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.15 -45.51 93.86 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.19 97.57 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 120.894 1.355 . . . . 0.0 110.868 172.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -99.59 -20.68 16.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.86 -137.78 48.34 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.837 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 m -103.23 118.82 37.65 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -80.33 88.44 5.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.667 0.746 . . . . 0.0 109.394 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -110.89 165.22 12.03 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.288 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.84 109.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.301 1.048 . . . . 0.0 112.883 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -117.71 157.53 26.33 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.059 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -107.58 137.77 45.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.673 0.749 . . . . 0.0 113.002 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -126.66 151.15 48.45 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.788 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -84.2 126.46 40.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -98.8 129.44 45.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.131 0.491 . . . . 0.0 112.323 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 29' ' ' VAL . 81.7 tttt -150.5 163.95 37.15 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.438 ' N ' ' HG2' ' A' ' 28' ' ' LYS . 48.2 t -103.77 131.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.412 ' HB3' ' HB2' ' A' ' 203' ' ' LYS . 14.1 ptp -91.01 97.29 11.09 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . . . 167.82 134.88 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 125.099 1.36 . . . . 0.0 109.467 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.17 -17.83 31.8 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.586 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 9.6 mm-40 -88.75 0.2 56.71 Favored 'General case' 0 C--O 1.199 -1.604 0 C-N-CA 125.341 1.456 . . . . 0.0 111.851 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . . . -69.9 -12.53 61.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.383 -0.823 . . . . 0.0 112.779 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.28 1.18 Allowed Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.832 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 72.2 m-85 -89.27 145.46 25.37 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.1 mt -78.16 101.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -61.64 -41.22 97.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.177 0.923 . . . . 0.0 112.001 -169.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -141.79 170.56 15.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mp -52.88 123.51 32.65 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 125.108 1.363 . . . . 0.0 113.457 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -72.41 166.54 29.49 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.539 2.16 . . . . 0.0 111.776 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.77 115.83 1.84 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.57 6.59 58.39 Favored Glycine 0 C--O 1.225 -0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.653 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 33.4 m -85.95 140.98 35.2 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -76.28 166.27 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.36 2.706 . . . . 0.0 110.158 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -49.49 151.73 1.52 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -40.66 -53.44 2.77 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 127.281 2.232 . . . . 0.0 114.521 -173.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -83.25 -29.18 28.65 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.743 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -81.09 -12.06 59.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.062 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 16.0 m-85 -43.89 -49.03 8.49 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.519 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 42.6 m80 -129.38 27.21 5.33 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.247 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.99 102.04 14.38 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.84 -9.93 35.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.01 161.76 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.986 1.393 . . . . 0.0 112.032 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -98.68 159.5 14.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.08 12.94 26.41 Favored 'General case' 0 C--O 1.206 -1.184 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.78 75.33 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 121.953 0.882 . . . . 0.0 111.17 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -89.52 -27.92 19.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.171 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.68 -22.23 19.54 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -114.21 144.74 32.25 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 123.16 12.26 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.774 2.316 . . . . 0.0 112.95 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -97.88 116.27 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.5 23.34 58.58 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.829 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.43 -160.22 30.1 Favored Glycine 0 C--O 1.245 0.814 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.814 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 46.6 mt-10 -127.48 130.08 48.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.462 0.305 . . . . 0.0 110.184 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.3 m -132.75 166.69 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.416 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 23.5 t -143.1 149.36 38.04 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.85 114.69 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.7 p -65.68 132.65 49.3 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -85.83 58.12 4.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.22 0.533 . . . . 0.0 112.388 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -76.39 -28.82 56.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.003 0.906 . . . . 0.0 108.677 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -114.44 106.27 52.76 Favored Pre-proline 0 N--CA 1.417 -2.113 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -48.26 -69.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.045 3.164 . . . . 0.0 115.513 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.81 103.05 14.94 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.4 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 29.9 t-20 -139.43 155.33 47.67 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 5.9 mmp_? -78.96 -165.48 0.75 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 122.031 0.92 . . . . 0.0 113.369 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.3 p-10 -93.7 -162.91 0.98 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.796 1.639 . . . . 0.0 110.372 -175.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.1 mp -91.73 135.98 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.727 0.298 . . . . 0.0 111.703 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 1.4 m-30 -99.36 -105.49 0.21 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.708 0.403 . . . . 0.0 110.542 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -117.0 -47.67 2.68 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.31 129.54 53.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 124.996 1.318 . . . . 0.0 107.616 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 15.8 mm100 -105.88 116.35 59.89 Favored Pre-proline 0 C--N 1.295 -1.786 0 O-C-N 123.436 0.46 . . . . 0.0 112.053 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 83.6 Cg_endo -83.19 168.11 13.55 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.79 2.327 . . . . 0.0 111.36 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -163.66 -178.55 5.84 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.51 -13.47 9.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.19 178.45 5.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.209 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.454 ' OG ' ' HG3' ' A' ' 181' ' ' ARG . 3.7 m -90.48 46.67 1.36 Allowed 'General case' 0 C--O 1.251 1.182 0 CA-C-O 121.22 0.533 . . . . 0.0 110.41 -176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -136.73 145.26 44.44 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.7 tp -122.79 141.37 51.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.262 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 56.6 tp -113.7 125.91 54.65 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.1 t -126.63 142.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -72.99 164.1 27.18 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.483 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -71.68 -18.51 77.35 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -65.1 -58.3 6.39 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.14 60.39 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.049 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 47.7 ttt180 -57.25 -47.9 80.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.927 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 1.2 mmmp? -61.88 -38.74 89.42 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 109.859 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.28 -53.53 56.2 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.601 0.563 . . . . 0.0 110.746 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.03 -41.85 87.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 123.716 0.806 . . . . 0.0 111.506 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 49.4 mt-10 -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.0 m -64.32 -30.58 71.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.145 0.497 . . . . 0.0 111.599 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.465 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.8 mp -84.44 -10.1 57.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.985 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.05 43.03 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.455 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.5 t -77.73 100.62 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 m -76.95 156.35 32.05 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.842 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 80.81 13.84 0.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.652 1.581 . . . . 0.0 110.838 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.59 122.69 47.19 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.021 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -115.81 144.68 43.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -114.66 122.25 45.88 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.173 0.589 . . . . 0.0 110.466 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' HG ' HD22 ' A' ' 130' ' ' ASN . 78.6 mt -115.27 98.81 51.39 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.88 138.71 13.34 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.421 2.081 . . . . 0.0 113.185 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.9 m -145.89 173.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.496 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.441 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.49 116.91 33.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 173.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 23.0 mt -111.34 134.19 54.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.315 0.579 . . . . 0.0 112.248 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.2 mptp? -98.11 148.38 23.6 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 5.9 p-10 -92.91 -160.49 0.76 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.474 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 71.8 m80 -71.84 -18.96 62.04 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.944 0.498 . . . . 0.0 111.554 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.8 -19.41 24.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.17 51.63 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.242 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.3 ptmt -98.32 138.61 35.32 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 91.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.148 0.499 . . . . 0.0 109.758 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.413 ' C ' ' HD3' ' A' ' 124' ' ' PRO . 11.9 m -115.98 12.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.012 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -123.91 65.42 0.53 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.523 173.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 8.3 Cg_endo -85.37 -23.58 2.26 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.494 2.129 . . . . 0.0 113.224 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.55 4.08 21.84 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.441 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.401 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 6.9 m-85 -84.74 140.8 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.554 0.692 . . . . 0.0 110.972 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -129.85 141.44 50.82 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.928 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -79.8 127.26 32.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.4 tt -93.41 124.79 37.64 Favored 'General case' 0 C--O 1.282 2.81 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.519 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 36.7 m-80 -104.58 128.84 52.69 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.106 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 114.37 27.66 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.4 169.63 9.93 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.133 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.09 22.52 78.79 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.915 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.7 131.67 34.39 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.21 169.26 18.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -58.15 105.71 0.3 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -127.52 -33.68 2.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.407 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 24.3 mt -59.36 119.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.037 -173.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.58 128.15 35.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.416 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 64.1 mtp -109.66 -25.64 10.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.931 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.51 -29.67 18.79 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.868 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -96.17 -11.59 25.93 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.522 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 m -104.56 149.74 25.23 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -114.34 104.83 12.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.416 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 4.3 p90 -154.19 150.95 28.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.399 0.619 . . . . 0.0 112.364 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 51.7 mm-40 -108.92 139.66 43.47 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.234 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 90.7 mtp -100.84 155.23 18.05 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.161 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 151' ' ' GLU . 16.7 t70 85.85 78.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.916 1.686 . . . . 0.0 113.766 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.59 ' OG ' ' HA3' ' A' ' 156' ' ' GLY . 49.9 m -103.19 -57.21 2.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.174 166.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.7 mt -94.02 -45.21 7.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 2.3 pp20? -147.01 171.78 14.73 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.567 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -54.75 -44.98 74.09 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.458 1.103 . . . . 0.0 113.548 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.457 ' HB3' HH12 ' A' ' 181' ' ' ARG . 7.0 t70 -92.38 15.1 14.66 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.011 0.91 . . . . 0.0 110.496 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 9.8 mm-40 -102.38 119.37 38.7 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 124.121 0.969 . . . . 0.0 110.308 175.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 50.7 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.59 ' HA3' ' OG ' ' A' ' 149' ' ' SER . . . -115.52 -65.05 0.39 Allowed Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.5 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 6.4 t30 -84.86 119.08 24.93 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 52.2 mt -128.12 127.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.47 -29.37 8.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.919 0.39 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.08 130.08 16.33 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.07 118.9 24.3 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.76 139.59 38.14 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.5 mt -57.77 145.42 34.84 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.437 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 15.1 p-10 -94.61 15.1 18.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.683 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.55 -5.21 18.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.596 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -61.4 -35.72 78.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.212 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.79 -31.82 6.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.252 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 78.3 mt -90.02 154.13 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -50.15 122.92 15.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 123.91 0.884 . . . . 0.0 112.708 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.4 -6.0 17.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.025 1.816 . . . . 0.0 110.512 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.484 ' HA ' ' NH2' ' A' ' 187' ' ' ARG . 5.8 p-10 -99.67 6.3 45.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.092 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -85.62 132.03 34.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 187' ' ' ARG . 76.7 mttt -84.93 -16.51 40.79 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.138 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 185' ' ' LEU . 26.4 ttt -159.77 127.72 4.82 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.37 164.3 38.39 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 142.43 34.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.511 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 38.6 m -93.01 120.47 33.34 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -53.45 -46.46 69.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -79.2 24.32 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.43 ' OE2' ' HD3' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.21 158.33 44.02 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.457 HH12 ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -91.27 -51.54 5.25 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.762 174.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.43 ' HD3' ' OE2' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -92.54 -13.41 29.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.239 -167.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.511 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 37.3 tp -77.78 101.16 6.58 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 122.017 0.913 . . . . 0.0 111.841 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.5 mt -120.87 121.36 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 174' ' ' MET . 66.7 mt -97.15 133.59 41.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 120.933 0.397 . . . . 0.0 110.66 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 42.7 pt -120.97 158.02 23.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.282 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.484 ' NH2' ' HA ' ' A' ' 171' ' ' ASP . 93.7 mtt180 -83.14 162.53 21.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.789 0.804 . . . . 0.0 111.068 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -55.56 -47.4 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.268 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.16 -26.94 69.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.115 0.259 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.465 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 61.9 t -65.21 -54.35 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.743 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -74.89 -26.43 59.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.232 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.35 -34.14 77.62 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.446 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.19 -37.34 78.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.231 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -69.65 -38.06 76.97 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.823 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -65.12 -40.79 95.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -77.04 -25.64 52.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.419 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.41 -27.49 46.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 121.176 0.513 . . . . 0.0 109.912 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.54 47.5 4.84 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.066 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.99 165.32 19.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.98 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -161.07 125.26 1.42 Allowed Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.361 -1.399 . . . . 0.0 112.347 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -120.66 145.34 47.54 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 28' ' ' LYS . 50.2 tptt -105.18 121.37 43.68 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.88 129.72 71.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.342 0.591 . . . . 0.0 111.185 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -111.29 141.18 45.16 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.04 106.17 1.0 Allowed 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.82 74.47 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.163 0.506 . . . . 0.0 111.451 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -77.35 89.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.317 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.6 35.13 6.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.438 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -63.82 99.16 0.22 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.668 0.747 . . . . 0.0 111.802 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.16 130.5 51.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.36 -26.51 0.27 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 165.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.26 141.3 41.74 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.384 1.092 . . . . 0.0 111.451 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.23 130.32 38.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.673 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 36.7 tp . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.362 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.04 -148.85 20.54 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -91.73 16.23 11.15 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.867 0.841 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 124.654 1.182 . . . . 0.0 112.449 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -76.07 39.9 0.19 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -103.67 117.64 34.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.282 33.2 m170 -96.61 72.31 2.68 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -164.59 146.23 8.26 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.716 2.407 . . . . 0.0 105.625 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -138.54 133.97 33.28 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -81.75 82.46 7.44 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t 74.13 -56.35 0.64 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.178 1.791 . . . . 0.0 112.562 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.252 54.8 p 58.76 97.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.66 125.51 39.43 Favored Glycine 0 C--O 1.249 1.04 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.507 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.0 mt -104.12 151.59 23.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t -126.14 93.43 43.56 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -88.49 -20.77 1.6 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 122.479 2.12 . . . . 0.0 111.327 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -117.36 119.39 34.96 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.166 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.21 -107.94 0.37 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.1 m -127.2 20.07 6.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -131.55 119.93 22.19 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.282 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 88.4 mtp -113.21 160.91 17.78 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.3 115.4 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -118.22 145.26 45.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.203 0.525 . . . . 0.0 110.341 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -114.2 132.63 56.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.647 -172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 78.8 m-85 -116.62 141.63 47.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.2 t -78.32 121.79 31.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -96.24 129.86 43.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -173.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -150.47 153.92 36.76 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.8 t -87.82 145.61 7.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.55 140.98 31.04 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.187 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 88.91 128.48 0.03 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.742 2.017 . . . . 0.0 112.472 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 33.0 tt0 -73.21 -26.38 61.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.938 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 -0.25 43.82 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.069 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -77.05 11.64 1.73 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.17 65.88 0.95 Allowed Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.352 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 10.4 m-85 -79.79 142.01 35.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.032 0.444 . . . . 0.0 110.415 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -89.41 104.66 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 170.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -61.85 -57.23 12.61 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.083 -172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -117.49 176.47 5.15 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.04 132.17 88.55 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.15 166.49 29.44 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.271 1.981 . . . . 0.0 112.124 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -52.46 124.71 14.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.86 1.264 . . . . 0.0 112.476 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.44 81.75 Favored Glycine 0 CA--C 1.516 0.133 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.093 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 50.8 m -85.83 139.46 35.15 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.71 165.77 24.47 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.295 2.663 . . . . 0.0 110.878 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 p -54.17 150.59 8.13 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 181' ' ' ARG . 3.8 m-20 -41.34 -59.18 1.63 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.707 2.003 . . . . 0.0 114.786 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -79.11 -30.53 43.82 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.853 0.359 . . . . 0.0 111.705 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -79.01 -11.93 60.02 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.637 -173.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.5 m-85 -44.72 -44.54 9.27 Favored 'General case' 0 C--O 1.194 -1.84 0 C-N-CA 123.517 0.727 . . . . 0.0 112.205 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.428 ' CG ' ' HD2' ' A' ' 176' ' ' ARG . 65.5 m80 -129.4 21.57 5.62 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.48 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -91.91 101.32 13.89 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.29 -5.83 4.83 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.38 164.32 21.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -97.97 142.86 29.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 50' ' ' PHE . 4.4 mp -99.28 -4.94 30.7 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.639 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.12 -21.59 66.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.116 0.484 . . . . 0.0 111.822 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.31 -21.13 24.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -116.86 -22.98 8.27 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -94.35 139.13 22.32 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.06 123.22 11.83 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.558 2.172 . . . . 0.0 112.812 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.07 107.55 21.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 23.56 30.24 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.434 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.85 -157.75 31.17 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.813 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.75 132.75 46.67 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.12 170.68 19.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -145.39 152.56 40.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.847 -0.533 . . . . 0.0 111.264 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -77.24 107.4 9.61 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -58.79 130.12 45.38 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.231 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -86.6 70.26 10.41 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.6 -38.11 34.69 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -119.44 90.77 43.18 Favored Pre-proline 0 N--CA 1.425 -1.708 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.11 -20.07 63.21 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.225 2.617 . . . . 0.0 114.111 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.33 9.67 19.73 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.514 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 13.3 t-20 -74.52 139.15 43.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -77.28 -165.46 0.59 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.687 0.755 . . . . 0.0 112.839 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.6 -165.28 1.13 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.238 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.1 mp -90.48 150.37 21.83 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.767 0.794 . . . . 0.0 113.114 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.494 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 29.4 m-85 -121.85 -149.24 0.42 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.741 2.017 . . . . 0.0 106.977 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -81.14 -31.91 33.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.878 0.763 . . . . 0.0 110.929 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.43 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 59.0 m-85 -134.97 148.19 49.93 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 11.0 mm100 -121.82 120.98 28.33 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 93.5 Cg_endo -87.1 170.62 7.01 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.26 1.973 . . . . 0.0 110.474 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -155.9 179.19 9.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.993 -0.442 . . . . 0.0 110.984 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.5 mt -86.97 -22.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -86.25 -92.3 0.09 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -168.68 -40.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -67.43 117.1 8.95 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 120.956 0.408 . . . . 0.0 112.035 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.2 tp -87.43 133.75 33.69 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.462 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 40.9 tp -105.33 121.32 43.63 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.768 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.33 137.07 56.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 p -76.49 172.73 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.433 0.293 . . . . 0.0 110.904 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.37 -20.48 79.33 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -65.59 -58.29 6.11 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.22 -28.93 64.56 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.562 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.448 ' HE ' ' CD ' ' A' ' 100' ' ' GLU . 54.6 ttt180 -57.9 -43.69 86.31 Favored 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.356 0.41 . . . . 0.0 110.108 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -67.26 -28.32 67.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.82 -54.02 22.31 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.39 -46.26 92.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 C-N-CA 123.744 0.818 . . . . 0.0 112.039 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' CD ' ' HE ' ' A' ' 96' ' ' ARG . 50.2 mt-10 -62.07 -31.84 72.31 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.423 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -78.33 -11.27 59.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.24 -13.94 51.27 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.679 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.78 33.89 26.17 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.72 101.21 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.989 0.899 . . . . 0.0 109.853 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.0 m -86.76 150.3 24.26 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 80.51 10.05 1.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.606 1.162 . . . . 0.0 111.348 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.05 26.18 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.4 tp10 -94.62 144.83 25.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -125.88 108.66 11.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.3 mt -109.32 95.63 19.21 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.35 140.83 12.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.775 2.317 . . . . 0.0 113.37 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.62 169.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.961 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.95 116.82 29.4 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.1 mt -113.97 128.45 70.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.184 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.37 146.1 24.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.412 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 8.8 p-10 -84.83 -160.51 0.49 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 122.48 0.312 . . . . 0.0 110.436 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.514 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 56.8 m80 -73.69 -19.55 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.562 0.345 . . . . 0.0 110.452 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -93.19 -20.06 20.83 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.068 0.461 . . . . 0.0 110.22 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.04 22.1 12.57 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.12 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.412 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 61.0 pttt -105.15 146.82 28.69 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.92 89.94 2.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 121.638 0.732 . . . . 0.0 110.146 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.3 m -114.12 10.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.088 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.36 42.35 1.37 Allowed Glycine 0 CA--C 1.549 2.159 0 C-N-CA 119.304 -1.426 . . . . 0.0 116.496 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.0 -1.69 9.99 Favored 'Trans proline' 0 C--N 1.376 1.981 0 CA-C-N 122.049 2.924 . . . . 0.0 112.107 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.9 -7.31 37.09 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 125.139 1.375 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -98.92 144.04 28.55 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.374 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.92 143.51 50.18 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.299 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.7 119.85 24.36 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.643 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 3.9 tt -91.85 125.01 36.4 Favored 'General case' 0 C--O 1.281 2.737 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.255 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.4 ' OD1' HD13 ' A' ' 56' ' ' LEU . 26.9 m-80 -123.83 141.64 51.85 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.785 -1.552 . . . . 0.0 107.393 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.29 132.94 49.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.479 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.45 170.47 8.38 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.63 16.96 67.07 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 132.11 43.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.45 169.09 18.62 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.01 108.59 5.99 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.155 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -132.18 -12.83 3.17 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -167.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.5 120.04 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.37 115.0 6.52 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.0 ttt -95.37 -7.79 37.51 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.378 0.609 . . . . 0.0 110.169 -172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.33 -49.81 6.15 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.182 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -87.08 -16.25 36.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.167 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 104.7 16.65 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.768 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.41 103.7 2.99 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.949 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.85 161.6 42.4 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.97 129.79 51.51 Favored 'General case' 0 N--CA 1.402 -2.854 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.795 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 56.0 mtt -92.66 108.21 19.8 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -151.51 -25.27 0.2 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -167.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 53.6 m -70.59 -56.38 6.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.16 -35.52 4.67 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.677 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -164.18 -174.39 3.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 147' ' ' MET . 10.2 tmtt? -65.04 -33.64 76.52 Favored 'General case' 0 C--O 1.196 -1.737 0 O-C-N 123.84 0.713 . . . . 0.0 111.022 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.26 23.72 4.27 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.331 0.586 . . . . 0.0 111.904 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.423 ' HA ' ' NE2' ' A' ' 154' ' ' GLN . 17.1 mm-40 -125.62 114.28 18.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.452 0.644 . . . . 0.0 111.197 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 56.9 mt -84.86 134.13 27.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.856 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -110.34 -70.88 0.64 Allowed Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -84.22 127.4 33.92 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.81 127.65 66.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -112.87 -24.16 9.71 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.1 0.476 . . . . 0.0 110.905 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.54 136.22 17.1 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -131.25 108.27 9.56 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.35 138.0 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.1 mt -54.37 140.23 34.34 Favored 'General case' 0 C--O 1.253 1.251 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.515 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.1 p-10 -87.99 6.28 36.67 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.226 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -68.27 -6.14 22.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.878 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.0 m -61.03 -40.82 95.05 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 124.614 1.166 . . . . 0.0 110.046 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.419 ' HB1' ' CB ' ' A' ' 137' ' ' ALA . . . -112.53 -32.21 6.54 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.384 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.511 HG13 ' CB ' ' A' ' 137' ' ' ALA . 83.3 mt -82.94 147.24 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -54.03 118.13 14.8 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 122.908 0.483 . . . . 0.0 112.041 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.64 -11.89 30.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.409 2.072 . . . . 0.0 111.653 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -88.97 0.47 56.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.475 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.04 127.65 33.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -76.34 -22.53 54.8 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.7 ttt -155.77 122.45 5.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -148.51 -179.23 6.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.428 ' HD2' ' CG ' ' A' ' 51' ' ' HIS . 12.2 ptp180 -151.43 164.73 36.1 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.469 ' SG ' HD21 ' A' ' 183' ' ' LEU . 61.6 m -86.5 152.32 22.75 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 124.206 0.941 . . . . 0.0 112.082 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.7 p -82.12 -50.77 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -85.19 2.62 42.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.66 104.04 5.0 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.535 ' NH1' ' HB3' ' A' ' 47' ' ' ASP . 27.7 ptt180 -68.0 -27.12 66.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.004 -170.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 184' ' ' ILE . 17.9 mtm-85 -88.85 -33.55 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.064 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 177' ' ' CYS . 3.9 tt -62.34 105.75 0.66 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.448 1.099 . . . . 0.0 111.24 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 182' ' ' ARG . 67.1 mt -110.6 130.46 63.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 45.0 mt -107.78 121.86 45.59 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.397 0.618 . . . . 0.0 110.564 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 43.5 pt -111.36 143.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.27 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -77.11 154.71 33.0 Favored 'General case' 0 C--O 1.259 1.57 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 2.8 pm0 -55.16 -39.4 69.45 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.474 0.71 . . . . 0.0 112.357 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -54.01 -43.42 70.06 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.463 1.505 . . . . 0.0 111.718 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.7 -48.32 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.435 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 20.7 p80 -72.21 -25.25 61.58 Favored 'General case' 0 C--O 1.196 -1.743 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.108 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.0 73.09 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.452 0.47 . . . . 0.0 110.526 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.19 -35.62 71.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.427 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.2 m-85 -68.6 -35.69 77.68 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.693 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -59.1 -51.54 69.6 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.812 0.695 . . . . 0.0 110.219 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.07 -16.51 59.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.071 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.85 -27.34 36.45 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.02 47.94 17.35 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.516 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.12 165.0 25.16 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.417 -0.113 . . . . 0.0 111.041 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.4 p -43.37 -77.03 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -171.0 138.4 4.92 Favored Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.719 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.43 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 35.2 m-85 -136.36 153.46 51.12 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -112.86 122.02 46.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.97 129.32 68.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.214 0.53 . . . . 0.0 109.642 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -114.1 137.39 51.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.75 109.53 3.88 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.04 -33.11 57.36 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.495 0.497 . . . . 0.0 112.088 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.41 92.52 1.08 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.296 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.52 35.05 14.71 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.423 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 16.3 t90 -67.51 101.03 0.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.923 0.889 . . . . 0.0 112.164 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -104.35 152.03 22.75 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.94 -25.67 0.3 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 166.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.423 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 86.4 mt -94.68 145.72 24.65 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 117.956 0.878 . . . . 0.0 112.659 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.4 132.85 52.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.16 53.28 0.33 Allowed Glycine 0 C--N 1.301 -1.38 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.3 m -54.93 -41.58 71.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.819 1.248 . . . . 0.0 112.74 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.416 ' HA ' ' CE1' ' A' ' 7' ' ' HIS . 20.0 t -95.33 -20.2 19.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.916 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -64.71 -45.86 84.78 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.702 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -94.83 102.16 14.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.145 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.416 ' CE1' ' HA ' ' A' ' 4' ' ' SER . 22.6 m170 -143.33 110.86 5.85 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.22 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -85.8 -29.15 24.02 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 170.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -167.73 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.497 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -124.77 -79.52 0.61 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 p -78.94 -28.07 43.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.132 0.491 . . . . 0.0 110.19 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m 73.34 -45.94 0.63 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.223 1.809 . . . . 0.0 113.977 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.8 83.84 1.27 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.52 128.62 47.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.721 0.296 . . . . 0.0 110.262 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.78 116.11 65.55 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.37 28.02 0.59 Allowed 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.95 2.433 . . . . 0.0 112.327 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 68.61 -70.12 0.14 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.913 1.685 . . . . 0.0 110.769 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.82 -156.17 27.85 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -131.31 130.41 42.71 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -122.68 95.91 4.82 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.241 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -84.17 157.91 21.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.5 t -81.83 110.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' HE3' ' OE2' ' A' ' 208' ' ' GLU . 20.8 ptmt -79.44 156.06 28.04 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.2 0.524 . . . . 0.0 111.699 -175.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -109.68 141.29 42.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.738 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -124.22 146.0 49.0 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.022 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.79 117.82 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -105.7 123.11 47.4 Favored 'General case' 0 C--N 1.282 -2.358 0 O-C-N 123.638 0.586 . . . . 0.0 110.506 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -139.32 139.43 37.28 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.8 t -86.6 110.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.74 98.7 9.5 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 119.509 -0.876 . . . . 0.0 108.906 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.63 110.84 5.76 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.43 -35.12 8.9 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.919 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.24 -23.93 57.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.124 0.487 . . . . 0.0 110.462 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . . . -79.73 -28.06 40.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.71 156.06 22.02 Favored Glycine 0 N--CA 1.413 -2.892 0 CA-C-N 113.635 -1.621 . . . . 0.0 114.381 174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -87.1 156.13 19.84 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.822 -1.189 . . . . 0.0 108.119 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.426 HG12 ' CE2' ' A' ' 68' ' ' PHE . 22.4 mt -79.52 101.85 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -57.9 -45.16 86.86 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -131.82 176.19 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.62 119.58 74.87 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 124.004 0.815 . . . . 0.0 110.981 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -66.94 166.75 21.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.671 2.248 . . . . 0.0 111.946 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -49.97 117.51 2.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.226 1.011 . . . . 0.0 113.697 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.36 66.21 Favored Glycine 0 C--O 1.206 -1.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.731 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.4 m -86.44 137.49 34.42 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.81 166.67 26.89 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 124.062 3.174 . . . . 0.0 111.154 169.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 p -53.47 150.69 6.4 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.39 -57.21 1.44 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 128.25 2.62 . . . . 0.0 114.522 -174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -85.86 -21.02 28.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.703 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -79.1 -20.03 49.71 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.625 0.37 . . . . 0.0 111.926 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 57.9 m-85 -45.11 -33.24 2.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.532 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 4.5 m-70 -129.11 16.07 6.19 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 120.577 -1.327 . . . . 0.0 109.95 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 101.28 13.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.378 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.55 -9.38 1.28 Allowed Glycine 0 CA--C 1.549 2.181 0 N-CA-C 118.066 1.986 . . . . 0.0 118.066 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.128 1.964 . . . . 0.0 112.152 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.2 t -97.45 150.01 21.52 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 50' ' ' PHE . 77.4 mt -86.25 -3.14 58.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.514 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.48 66.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.48 -20.52 25.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -114.62 -22.89 9.53 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -108.11 136.54 19.78 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.61 123.09 11.45 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.69 2.26 . . . . 0.0 112.183 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.02 116.78 34.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.64 21.39 58.11 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.2 -162.94 29.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.382 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -116.85 137.85 51.92 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.22 172.78 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -148.96 155.61 41.08 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.426 ' CE2' HG12 ' A' ' 37' ' ' ILE . 7.8 m-85 -75.02 104.83 5.75 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p -81.7 117.29 21.92 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -85.54 119.62 26.09 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.735 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -71.49 -37.94 71.22 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -177.05 -48.37 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.451 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.18 135.48 34.61 Favored 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.825 1.683 . . . . 0.0 112.249 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.52 149.26 40.91 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -154.51 -171.4 3.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.781 0.432 . . . . 0.0 111.35 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -81.13 -161.48 0.41 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.95 0.9 . . . . 0.0 111.872 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -81.95 -168.24 1.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.191 0.996 . . . . 0.0 112.615 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -87.8 142.61 27.68 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.765 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.551 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 21.8 m-85 -107.76 -167.57 1.27 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.78 -42.85 89.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.37 138.18 53.88 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 16.2 mm100 -119.25 131.5 24.34 Favored Pre-proline 0 C--O 1.261 1.679 0 O-C-N 123.531 0.519 . . . . 0.0 110.471 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.67 177.68 2.15 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.141 2.561 . . . . 0.0 111.967 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -163.49 179.11 7.5 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.91 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.1 mm -91.93 3.22 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 CA-C-O 122.542 1.163 . . . . 0.0 108.701 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -109.98 -102.37 0.39 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.238 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 64.7 p -173.51 -14.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.557 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -69.63 116.75 10.39 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.44 132.02 34.61 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.101 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 34.3 tp -104.28 119.55 39.21 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.628 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.42 136.98 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.503 -173.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -71.38 172.04 10.13 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.276 0.63 . . . . 0.0 111.649 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 97' ' ' LYS . . . -68.03 -34.02 80.56 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -64.52 -55.56 19.8 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.509 0.723 . . . . 0.0 110.085 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.51 69.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.464 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 58.7 ttt180 -58.39 -48.36 80.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.979 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 7.6 mtpm? -62.18 -32.36 72.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.796 0.685 . . . . 0.0 112.047 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.84 -53.06 61.96 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.982 0.42 . . . . 0.0 110.349 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.44 -36.32 75.78 Favored 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.921 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 51.6 mt-10 -68.87 -38.66 79.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.124 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.3 m -70.53 -28.7 65.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.965 0.412 . . . . 0.0 111.764 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.35 -14.98 57.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.647 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.52 48.42 68.46 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.93 109.06 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.66 0.743 . . . . 0.0 111.421 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -64.33 136.64 57.34 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 75.67 7.87 3.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.118 1.367 . . . . 0.0 114.391 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.21 114.12 26.56 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 9.1 tp10 -103.39 146.58 28.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -114.15 120.94 42.24 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.607 0.567 . . . . 0.0 110.631 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.62 97.28 50.68 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.51 140.78 17.23 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.872 2.381 . . . . 0.0 112.9 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 m -148.66 167.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.528 0.731 . . . . 0.0 110.005 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.48 116.61 30.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 33.9 mt -112.92 132.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.172 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -92.86 134.91 34.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -80.0 -160.81 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.432 ' HE1' ' O ' ' A' ' 34' ' ' ALA . 58.8 m80 -68.56 -26.89 65.63 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.898 -0.501 . . . . 0.0 110.922 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.39 -19.19 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.327 0.651 . . . . 0.0 110.907 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.12 14.06 27.35 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.518 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -101.85 139.76 37.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.355 0.578 . . . . 0.0 110.289 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 58.7 t -83.0 84.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.312 1.053 . . . . 0.0 110.539 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 m -111.21 16.83 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.474 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.439 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -130.84 45.4 1.14 Allowed Glycine 0 CA--C 1.547 2.089 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.828 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.07 -5.05 9.63 Favored 'Trans proline' 0 C--N 1.383 2.342 0 CA-C-N 121.416 2.608 . . . . 0.0 112.506 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -108.47 0.03 20.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.807 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.439 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 6.8 m-85 -92.16 134.84 34.48 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.239 -174.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.69 142.36 51.45 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.975 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -83.87 112.47 20.15 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.6 tt -88.35 129.95 35.26 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.532 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -123.88 141.03 52.4 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.525 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.24 131.85 51.11 Favored 'General case' 0 CA--C 1.486 -1.511 0 O-C-N 123.799 0.687 . . . . 0.0 110.356 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.34 173.08 6.48 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 124.719 1.262 . . . . 0.0 108.361 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.54 13.63 64.98 Favored Glycine 0 C--N 1.305 -1.145 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.725 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.82 130.07 45.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.28 107.94 3.83 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.291 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.74 -46.59 0.63 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 125.854 1.661 . . . . 0.0 112.682 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.439 ' C ' ' HB2' ' A' ' 164' ' ' ASP . . . 65.34 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 126.558 1.943 . . . . 0.0 115.912 171.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.1 mm -55.23 124.29 7.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.274 1.03 . . . . 0.0 111.083 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.62 95.26 3.33 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.3 ttm -76.74 -4.14 41.79 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.996 -170.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.74 -50.22 9.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.494 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -99.68 1.36 43.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.988 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.5 p -94.32 119.06 32.53 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.28 100.9 12.87 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -155.27 161.65 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.306 0.574 . . . . 0.0 112.511 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -118.28 145.58 44.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.748 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 59.2 mtt -100.7 155.67 17.77 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.343 33.7 t70 93.07 86.4 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.23 2.212 . . . . 0.0 115.952 174.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.7 m -101.48 -37.38 8.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.41 168.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.0 mt -135.23 -45.27 0.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.111 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.413 ' CD ' HH22 ' A' ' 181' ' ' ARG . 40.0 mt-10 -139.65 177.24 8.08 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.552 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.437 ' HZ3' ' HB3' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -66.81 -31.25 71.76 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -96.51 24.01 6.3 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.481 1.134 . . . . 0.0 110.074 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.443 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 21.3 mm-40 -114.66 115.19 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.5 mt -78.32 139.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 -84.85 1.75 Allowed Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -82.31 121.38 26.6 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.33 109.86 26.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.19 -43.67 12.81 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.85 110.66 4.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -85.33 121.22 27.75 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -93.99 132.0 38.89 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.82 136.05 51.47 Favored 'General case' 0 C--O 1.257 1.487 0 O-C-N 124.185 0.928 . . . . 0.0 111.708 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.439 ' HB2' ' C ' ' A' ' 137' ' ' ALA . 21.5 p-10 -87.22 1.62 52.55 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.988 -175.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.1 p -68.27 -4.53 14.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.031 1.333 . . . . 0.0 111.203 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.2 m -67.61 -34.37 76.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.264 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.13 -31.69 6.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.403 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.3 mt -91.89 141.68 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.439 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 48.3 mtp180 -53.96 121.5 29.68 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 123.415 0.686 . . . . 0.0 111.435 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.17 -6.85 18.29 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.876 2.384 . . . . 0.0 112.603 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.05 -10.0 55.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.291 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.47 120.3 15.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.98 -30.79 65.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.998 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.421 ' HG3' HG23 ' A' ' 186' ' ' ILE . 26.9 ttt -153.35 129.59 10.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.24 -178.92 7.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 22.9 ttp180 -138.53 142.08 39.31 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.78 144.6 52.63 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.6 p -81.07 -35.88 31.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.47 -7.39 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.06 117.85 13.2 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.503 ' O ' ' HD2' ' A' ' 176' ' ' ARG . 6.2 ptp180 -76.48 -24.76 53.82 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.303 -173.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -89.77 -15.72 31.8 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.77 99.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.685 -174.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.42 123.08 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -107.64 124.45 50.0 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.845 0.831 . . . . 0.0 111.251 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.421 HG23 ' HG3' ' A' ' 174' ' ' MET . 36.3 pt -116.07 155.27 17.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.987 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -85.98 158.59 19.84 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -47.82 -42.46 26.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.35 1.06 . . . . 0.0 113.097 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.92 -40.47 69.91 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 125.445 1.498 . . . . 0.0 112.291 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.45 -46.97 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.558 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 33.1 p80 -71.01 -31.74 68.33 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.02 70.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.0 -34.77 61.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.13 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.7 m-85 -73.21 -35.52 66.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.008 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 47.7 mt-10 -60.75 -53.38 58.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.523 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.65 -24.17 66.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.56 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -79.76 -27.41 40.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.344 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.47 36.61 43.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.82 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.32 157.11 32.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.4 p -102.03 137.11 40.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.55 71.35 0.92 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.369 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 55.5 m-85 -141.96 149.54 40.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 118.175 0.988 . . . . 0.0 112.795 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -161.71 121.51 2.53 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.07 156.14 38.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -140.72 161.89 36.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 123.558 0.743 . . . . 0.0 109.934 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.04 117.69 20.33 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -26.98 62.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.576 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.461 ' OE2' ' HE3' ' A' ' 23' ' ' LYS . 35.3 mt-10 -67.58 97.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.304 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 70.65 35.65 67.26 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.741 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.6 t90 -52.92 102.71 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.969 0.908 . . . . 0.0 110.304 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.24 113.14 26.48 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.02 -25.02 0.25 Allowed Glycine 0 CA--C 1.539 1.575 0 N-CA-C 119.999 2.76 . . . . 0.0 119.999 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.13 114.93 21.0 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 119.019 1.41 . . . . 0.0 110.74 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.99 132.36 42.32 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.482 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.241 174.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.76 81.22 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -76.79 -10.87 59.68 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.887 0.475 . . . . 0.0 111.498 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -65.44 109.27 2.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 69.3 10.86 7.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.014 0.926 . . . . 0.0 113.025 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -122.15 79.43 1.59 Allowed 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -114.13 161.11 18.18 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -78.55 77.52 5.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.735 0.779 . . . . 0.0 108.954 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -147.03 97.45 2.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.685 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -141.87 155.68 45.53 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 m -90.88 -21.31 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m 70.19 -49.48 0.64 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.637 1.575 . . . . 0.0 114.677 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.16 101.1 2.47 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -136.05 108.18 7.22 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 123.038 0.535 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.14 119.27 76.51 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 172.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.24 -28.15 64.15 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.232 1.955 . . . . 0.0 112.908 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -131.39 83.37 2.1 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.394 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 90.01 1.65 Allowed Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.124 -2.391 . . . . 0.0 107.124 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.5 m -139.6 94.13 2.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 65.44 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.82 134.07 36.56 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 169.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 t -81.13 120.28 32.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.929 0.395 . . . . 0.0 110.33 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -98.2 127.9 44.38 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.41 141.89 44.37 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.429 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -124.47 143.49 50.62 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.5 111.14 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -92.06 132.39 36.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.409 0.624 . . . . 0.0 110.952 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HE2' ' OXT' ' A' ' 215' ' ' LEU . 0.4 OUTLIER -148.77 156.45 42.37 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 103.193 -2.892 . . . . 0.0 103.193 177.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -94.64 131.38 41.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.9 ptp -70.2 173.57 6.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.833 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 77.44 112.42 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.273 1.829 . . . . 0.0 112.375 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.91 -16.83 34.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.624 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -13.62 43.16 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.93 -35.76 77.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 90.65 145.45 13.95 Favored Glycine 0 N--CA 1.401 -3.684 0 CA-C-N 113.775 -1.557 . . . . 0.0 114.754 171.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 21.9 m-85 -95.92 166.08 11.96 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 113.436 -1.382 . . . . 0.0 107.863 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.1 mt -78.3 101.34 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 162.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -62.59 -51.66 66.45 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 124.504 1.127 . . . . 0.0 112.234 -169.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.6 176.14 8.7 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -60.68 126.94 86.3 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -73.68 167.7 26.62 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.079 2.519 . . . . 0.0 112.284 173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.6 112.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 124.28 1.032 . . . . 0.0 112.712 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.68 66.98 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 115.691 1.037 . . . . 0.0 115.691 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 81.1 p -85.94 146.94 44.38 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 118.204 1.002 . . . . 0.0 113.213 -176.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.38 166.36 15.28 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.913 3.075 . . . . 0.0 111.741 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -56.85 155.16 8.23 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.39 -56.06 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 127.925 2.49 . . . . 0.0 112.915 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -85.86 -19.67 30.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.495 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -84.17 -17.14 40.97 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 44' ' ' SER . 30.3 m-85 -45.18 -40.53 7.27 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.557 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 12.4 m170 -128.98 20.71 5.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 111.396 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.95 102.57 14.93 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.49 -2.93 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.464 1.345 . . . . 0.0 116.464 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.83 160.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.097 0.949 . . . . 0.0 113.219 -173.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -98.12 134.53 41.06 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.67 -10.78 55.32 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.84 63.03 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.13 -17.88 28.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.58 -21.24 9.25 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.415 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 58.4 t80 -105.92 138.8 19.75 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 123.29 11.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.029 1.82 . . . . 0.0 112.572 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.46 122.69 44.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.57 75.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.63 -165.92 29.5 Favored Glycine 0 CA--C 1.502 -0.736 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.319 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -117.93 130.09 56.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 60' ' ' PHE . 35.6 m -126.78 160.93 34.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 p -142.33 150.02 40.23 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.959 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -75.27 107.33 7.3 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.2 p -49.29 131.03 20.12 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 124.881 1.363 . . . . 0.0 112.792 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -81.64 50.9 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.15 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -76.83 -24.6 52.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -134.17 91.4 23.52 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.296 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.53 145.85 38.27 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.849 2.366 . . . . 0.0 111.089 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.9 t70 70.14 15.59 7.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.482 1.134 . . . . 0.0 110.656 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 61.5 t30 -77.03 152.13 35.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 77' ' ' ASN 0.272 20.4 mmt180 -69.17 -174.17 0.61 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 -164.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.413 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 4.1 p-10 -82.47 -172.75 4.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.861 -172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.71 150.7 22.48 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.389 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -114.63 -159.89 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.441 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.31 -37.42 85.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.481 0.582 . . . . 0.0 111.099 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -126.36 157.14 39.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -141.53 136.41 15.55 Favored Pre-proline 0 C--O 1.26 1.636 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.87 178.12 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.441 2.094 . . . . 0.0 113.441 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.9 p30 -160.98 173.98 14.47 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.2 mm -90.54 -14.59 8.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.907 0.86 . . . . 0.0 109.849 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -94.67 -151.75 0.33 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.372 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 2.1 m -102.58 0.91 34.12 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.469 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 4.0 p-10 -92.62 167.31 12.0 Favored 'General case' 0 C--O 1.201 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 112.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.71 141.64 51.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.66 126.4 55.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.72 141.45 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -79.53 172.57 13.61 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.353 0.261 . . . . 0.0 110.61 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.93 93.41 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -64.08 -47.22 80.91 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 122.762 0.425 . . . . 0.0 112.003 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.36 -28.74 66.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -56.99 -47.56 80.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.944 0.497 . . . . 0.0 110.442 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.8 -28.75 68.63 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.795 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.51 -54.19 46.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.33 -43.88 87.17 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.53 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -66.12 -35.01 79.35 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -68.24 -21.75 64.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.024 0.44 . . . . 0.0 111.441 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -86.29 -2.8 58.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.811 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.44 37.17 85.4 Favored Glycine 0 N--CA 1.438 -1.18 0 O-C-N 123.952 0.782 . . . . 0.0 112.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.17 116.67 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.375 0.607 . . . . 0.0 109.628 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -88.01 157.77 18.81 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.205 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 78.0 15.48 1.46 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.903 0.881 . . . . 0.0 112.243 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.18 114.98 29.44 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 7.1 tp10 -105.73 140.77 38.27 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.431 ' CH2' HD12 ' A' ' 129' ' ' LEU . 43.8 m95 -116.87 121.94 42.93 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.804 0.842 . . . . 0.0 109.7 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -113.43 109.13 51.47 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.597 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.48 137.1 16.24 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 122.54 2.16 . . . . 0.0 113.407 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 172.27 2.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.401 1.08 . . . . 0.0 109.586 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -103.16 116.51 32.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 22.1 mt -107.53 142.69 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.186 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -118.38 135.35 54.38 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.623 1.169 . . . . 0.0 108.128 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.427 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.9 p30 -86.19 -162.29 0.73 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.1 m80 -74.4 -12.61 60.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.384 1.074 . . . . 0.0 111.815 -174.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.51 -19.48 29.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.07 1.29 63.04 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.174 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -89.65 154.77 19.71 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.748 -0.266 . . . . 0.0 110.412 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.57 126.17 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 116' ' ' ASP . 11.3 p -129.81 -32.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.921 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.95 73.14 0.47 Allowed Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.491 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.08 -0.99 9.76 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 CA-C-N 119.673 1.736 . . . . 0.0 109.746 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.61 -12.19 17.92 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.203 1.401 . . . . 0.0 111.158 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -92.57 149.26 21.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.539 0.685 . . . . 0.0 112.528 -172.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.39 143.02 49.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.368 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.23 120.38 27.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.564 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.431 HD12 ' CH2' ' A' ' 109' ' ' TRP . 7.0 tt -91.61 131.83 36.75 Favored 'General case' 0 C--O 1.259 1.573 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.405 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.557 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 7.9 p30 -124.42 140.96 52.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.217 174.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.43 141.05 32.72 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.573 0.546 . . . . 0.0 110.462 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.5 173.02 6.67 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 124.656 1.222 . . . . 0.0 108.412 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.72 17.18 73.6 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 132.89 33.97 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.295 0.569 . . . . 0.0 109.779 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -137.07 168.98 18.55 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.9 103.1 0.14 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.716 1.143 . . . . 0.0 111.27 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -88.66 -54.9 3.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.026 -1.897 . . . . 0.0 115.497 -163.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.9 mt -51.22 113.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 124.366 1.041 . . . . 0.0 113.758 -169.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -70.93 107.07 3.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.517 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.427 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 46.7 mtt -91.3 8.84 34.05 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -85.84 -50.39 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -93.21 -4.9 51.17 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.484 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 61.0 p -91.74 151.02 20.82 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.995 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.58 97.81 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -147.78 163.42 36.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.16 140.79 49.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.506 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.16 155.65 20.66 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.998 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.321 34.6 t70 96.0 95.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.455 2.302 . . . . 0.0 115.783 174.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.0 m -100.57 -56.16 2.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 167.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -128.33 -41.05 1.58 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.063 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 47.8 mt-10 -125.83 -179.08 4.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.058 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -71.71 -44.23 64.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 124.201 0.938 . . . . 0.0 111.07 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -82.91 26.01 0.63 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.894 0.854 . . . . 0.0 112.241 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -113.21 122.05 46.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.28 116.17 21.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -84.02 -61.55 1.83 Allowed Glycine 0 CA--C 1.493 -1.315 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -111.02 132.86 53.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.2 mp -119.8 113.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -89.34 -39.19 13.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.614 -0.835 . . . . 0.0 109.994 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.19 117.4 3.5 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.173 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.36 145.08 26.48 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.95 146.02 47.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.457 ' HG ' ' OE2' ' A' ' 208' ' ' GLU . 93.8 mt -53.78 136.55 39.83 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.512 1.133 . . . . 0.0 112.559 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -96.5 10.44 38.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.166 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.2 p -68.19 -5.16 16.65 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.938 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.8 m -61.14 -40.53 94.17 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.147 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.52 -33.68 6.31 Favored 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.255 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.26 151.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -44.41 117.61 2.97 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.046 0.938 . . . . 0.0 110.934 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.34 -16.04 39.04 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.461 2.107 . . . . 0.0 111.856 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.62 11.43 31.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.496 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.04 143.38 39.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -95.99 -28.95 14.41 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.444 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -143.75 124.57 14.24 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.35 178.23 10.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.61 163.25 40.31 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.138 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.448 ' SG ' HD22 ' A' ' 183' ' ' LEU . 71.2 m -83.3 149.93 26.46 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.125 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.5 p -81.44 -51.51 8.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -89.5 20.65 3.8 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.92 134.32 21.9 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 171.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' SER . 15.3 mmt180 -89.96 -33.16 16.49 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 123.821 0.701 . . . . 0.0 112.386 -168.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -91.67 -12.11 35.03 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.971 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.448 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.5 tt -86.68 109.13 18.99 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.433 0.635 . . . . 0.0 110.401 -173.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.19 129.06 75.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.7 121.54 43.8 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.801 0.81 . . . . 0.0 111.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 48.7 pt -111.29 147.77 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.007 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.35 150.11 38.51 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.15 -39.2 27.99 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.52 -30.28 69.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 111.73 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.486 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.7 t -66.4 -49.48 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.999 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.581 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 17.1 p80 -70.87 -29.73 65.92 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.085 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.486 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -59.35 -34.84 72.86 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.37 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.38 61.65 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 19.2 m-30 -68.98 -34.55 75.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.696 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 39.5 mt-10 -65.48 -49.11 70.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.493 0.717 . . . . 0.0 111.146 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -69.92 -29.89 67.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.48 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 109.897 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 78.72 45.22 9.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.661 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.9 mt -81.4 154.14 26.58 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 27.5 p -101.45 129.82 47.56 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.69 71.71 0.75 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.756 -0.657 . . . . 0.0 114.582 172.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 14.9 m-85 -124.7 145.77 49.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.061 0.93 . . . . 0.0 112.666 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -144.0 121.94 12.04 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.03 128.9 69.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 69.2 m-85 -120.46 137.97 54.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.06 111.03 3.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.22 86.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.526 0.516 . . . . 0.0 112.175 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.457 ' OE2' ' HG ' ' A' ' 163' ' ' LEU . 30.1 mm-40 -68.07 100.61 1.02 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.345 0.593 . . . . 0.0 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.56 32.85 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.066 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.66 104.64 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.967 . . . . 0.0 110.129 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.91 103.78 13.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -173.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -7.41 2.96 Favored Glycine 0 N--CA 1.471 1.005 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.14 117.46 23.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.548 1.174 . . . . 0.0 110.552 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.99 125.79 29.78 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.444 ' OXT' ' HE2' ' A' ' 28' ' ' LYS . 1.3 pt? . . . . . 0 C--N 1.31 -1.112 0 O-C-N 124.263 0.977 . . . . 0.0 112.313 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 C--O 1.243 0.719 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.12 101.89 0.23 Allowed Glycine 0 C--O 1.239 0.406 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.426 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 p -110.93 177.92 4.51 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -110.74 30.6 6.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.596 0.712 . . . . 0.0 110.543 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -71.76 -16.95 62.21 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -70.64 -29.6 66.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.2 m80 59.8 41.54 17.99 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.305 1.042 . . . . 0.0 112.674 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -81.37 65.92 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.158 0.98 . . . . 0.0 109.581 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -133.85 0.21 3.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.228 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.21 127.43 21.11 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -176.56 107.65 0.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.7 t -111.65 -48.71 3.05 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.83 -76.23 0.81 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt 66.86 -69.96 0.12 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.225 1.41 . . . . 0.0 113.95 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.91 115.75 65.41 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.03 -56.97 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.217 1.944 . . . . 0.0 111.228 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -130.19 -55.78 1.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.56 -166.75 20.98 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -108.67 13.51 25.09 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.765 0.793 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -82.07 0.77 38.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.788 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.3 ttp -48.54 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.746 1.219 . . . . 0.0 114.001 -169.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.96 118.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' HB2' ' OE2' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -112.04 155.8 23.22 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -114.57 142.78 45.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.253 0.549 . . . . 0.0 111.128 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.11 147.38 49.04 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.772 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -80.74 123.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -91.94 133.67 35.48 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.502 0.668 . . . . 0.0 110.733 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -150.18 151.35 32.94 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.22 121.35 45.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 26.9 ttt -79.23 81.29 5.51 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.299 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 178.74 111.72 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 124.734 1.271 . . . . 0.0 108.41 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.47 -23.54 25.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 47.0 mt-10 -82.54 -4.11 57.06 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.055 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.39 -35.33 78.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 97.0 92.62 1.87 Allowed Glycine 0 N--CA 1.397 -3.96 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.755 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.09 141.01 57.74 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -70.85 101.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 169.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 71' ' ' ASN . 26.5 mt-10 -78.2 -33.99 49.72 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.274 0.559 . . . . 0.0 111.411 -170.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -122.41 161.77 22.86 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.9 124.97 91.91 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 122.618 0.367 . . . . 0.0 111.874 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.74 168.98 21.56 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.075 2.516 . . . . 0.0 111.417 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -39.8 118.85 0.91 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.234 1.413 . . . . 0.0 113.303 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 13.53 83.15 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.8 m -85.51 138.52 35.97 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.57 166.71 23.04 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.513 3.475 . . . . 0.0 111.037 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -60.01 145.92 44.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -38.09 -53.78 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 127.171 2.188 . . . . 0.0 114.121 -174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.426 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 56.5 p-90 -85.77 -23.18 27.37 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.582 -173.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -86.93 -11.77 49.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.979 -171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CD2' ' HB2' ' A' ' 88' ' ' ASN . 20.9 m-85 -43.28 -51.46 6.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.079 0.862 . . . . 0.0 112.743 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.512 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.0 m-70 -128.43 32.45 4.85 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.339 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -92.38 101.24 13.71 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.67 -10.65 12.18 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.6 169.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.944 1.872 . . . . 0.0 114.108 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -98.28 160.16 14.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.362 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.9 mt -112.76 14.42 19.94 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.3 -22.9 64.7 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.683 0.754 . . . . 0.0 110.434 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -88.95 -20.8 24.03 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.555 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.6 -22.95 12.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.58 140.78 23.51 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 122.41 9.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.914 1.743 . . . . 0.0 112.095 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.9 t -96.72 123.7 49.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.14 24.32 52.36 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.707 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.09 -168.3 22.22 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.406 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 113' ' ' ALA . 40.7 mt-10 -123.56 128.25 49.46 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.36 174.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 p -146.39 151.98 38.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.05 113.97 8.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 p -64.8 118.83 9.56 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-O 122.013 0.911 . . . . 0.0 111.551 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -85.59 74.44 10.29 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 2.6 t30 -74.56 -39.74 62.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.491 ' HB3' ' HD3' ' A' ' 73' ' ' PRO 0.257 41.2 t80 -159.71 -63.68 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.953 171.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 72' ' ' TYR . 12.5 Cg_exo -73.45 121.59 7.26 Favored 'Trans proline' 0 C--N 1.373 1.832 0 CA-C-N 121.302 1.501 . . . . 0.0 109.7 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.78 -41.85 64.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.256 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 83.8 m-20 65.3 -162.12 0.26 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -90.26 -164.32 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.849 0.833 . . . . 0.0 112.075 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.5 -170.43 2.94 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 125.614 1.566 . . . . 0.0 110.392 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -88.17 149.54 23.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.296 0.57 . . . . 0.0 111.621 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -120.9 -165.31 1.2 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -66.09 -44.08 85.41 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.924 0.784 . . . . 0.0 111.24 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -113.53 142.25 46.17 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.853 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -128.4 128.62 23.62 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.592 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -91.42 175.6 2.26 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.892 2.395 . . . . 0.0 113.108 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -163.54 172.16 14.8 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.099 0.959 . . . . 0.0 108.419 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.94 -16.94 9.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.975 0.893 . . . . 0.0 109.723 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -85.48 -164.04 0.95 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.811 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.424 ' CB ' HH21 ' A' ' 176' ' ' ARG . 26.4 p -122.08 54.1 1.19 Allowed 'General case' 0 C--O 1.252 1.205 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 2.6 t30 -137.39 153.42 50.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -109.66 141.96 41.5 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.7 tp -108.33 125.9 52.23 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.625 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.5 p -74.48 172.44 11.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.634 0.774 . . . . 0.0 110.626 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.07 -37.65 94.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.556 -0.354 . . . . 0.0 112.655 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -61.39 -52.63 63.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.783 0.801 . . . . 0.0 109.71 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.35 -32.76 73.92 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.42 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.34 -39.97 84.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.233 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 8.9 mmpt? -64.69 -38.73 91.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.672 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.22 -52.99 62.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.054 0.454 . . . . 0.0 110.296 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.4 mt -61.54 -43.55 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.109 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.39 -41.34 85.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -70.29 -25.28 63.26 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.35 -21.23 59.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.91 47.82 6.06 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.9 t -74.02 101.24 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.616 0.722 . . . . 0.0 109.588 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 m -70.05 147.1 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.965 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 79.45 9.14 1.65 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.362 1.065 . . . . 0.0 111.999 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.58 114.71 29.16 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 8.7 tp10 -111.75 146.85 36.84 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -116.6 120.91 40.18 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.039 0.136 . . . . 0.0 111.092 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 50.7 mt -106.2 101.98 37.55 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.17 132.4 12.61 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.666 2.244 . . . . 0.0 112.814 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.0 m -144.64 170.27 7.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.581 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.404 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . . . -102.79 116.55 32.8 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.8 mt -109.82 133.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.496 0.665 . . . . 0.0 112.409 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -95.6 143.67 26.7 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -83.22 -160.7 0.44 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.455 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 35.5 m80 -70.15 -30.87 68.14 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.768 0.827 . . . . 0.0 110.137 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -81.78 -19.98 40.12 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.7 14.88 33.29 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.119 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 17.9 ptpt -95.36 140.51 30.13 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.7 t -77.94 89.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.571 0.701 . . . . 0.0 110.024 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.38 11.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.614 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.1 54.43 0.76 Allowed Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.669 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.71 -17.44 5.04 Favored 'Trans proline' 0 C--N 1.368 1.594 0 CA-C-N 120.629 2.215 . . . . 0.0 112.342 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.71 7.65 44.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.199 0.523 . . . . 0.0 110.346 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -95.1 144.32 25.84 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 121.515 0.674 . . . . 0.0 110.601 -177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -133.58 141.63 47.77 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.023 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.408 ' HB3' ' ND2' ' A' ' 88' ' ' ASN . 55.5 m-85 -80.75 119.76 23.76 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 tt -86.45 121.25 28.74 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.512 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 91.8 m-20 -97.91 125.81 43.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.08 121.71 42.29 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.401 0.438 . . . . 0.0 110.02 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.66 172.9 6.55 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.855 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 20.29 65.33 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.278 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.03 40.61 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.61 169.32 17.86 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -53.71 104.96 0.11 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 164' ' ' ASP . . . -131.58 -27.34 1.94 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 -164.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 179' ' ' LYS . 24.3 mt -63.01 122.86 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.533 1.06 . . . . 0.0 110.874 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.43 107.74 7.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.787 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -77.32 -9.44 58.83 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -70.33 -50.06 43.0 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.436 0.636 . . . . 0.0 109.759 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.69 -2.5 35.21 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.307 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.8 p -99.88 142.38 31.43 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.489 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 14.7 mm-40 -122.61 107.5 12.04 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -161.71 161.28 29.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.747 0.308 . . . . 0.0 111.681 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -125.46 142.07 51.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.436 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 58.7 mtt -100.43 108.32 20.28 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.67 7.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.7 p -72.67 -56.67 4.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.204 -0.599 . . . . 0.0 112.051 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -117.82 -39.23 3.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.687 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -158.24 -176.34 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -68.93 -13.3 62.35 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.6 23.24 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.215 0.531 . . . . 0.0 112.15 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.37 120.81 26.2 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 72.1 mt -72.91 133.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.061 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -115.79 -70.6 0.47 Allowed Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -79.17 122.14 25.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.2 mt -126.91 106.85 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 33.9 t70 -90.25 -44.74 9.52 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.791 0.805 . . . . 0.0 109.088 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.66 110.88 3.92 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.797 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.32 125.64 39.09 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.66 146.87 27.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.0 140.02 57.7 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.867 0.842 . . . . 0.0 112.484 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 18.4 p-10 -94.46 6.64 48.17 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.46 -5.5 19.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.632 1.173 . . . . 0.0 109.866 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -62.0 -39.49 92.39 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.651 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.24 -31.84 6.72 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.697 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 64.5 mt -83.16 150.62 4.18 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -60.95 120.19 51.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 118.208 0.458 . . . . 0.0 109.96 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.97 -16.35 45.12 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.405 2.07 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.56 -6.15 58.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.19 127.35 32.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.12 -33.36 71.74 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.429 ' HG3' HG21 ' A' ' 186' ' ' ILE . 26.7 ttt -151.1 130.08 12.55 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -153.79 -178.72 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.136 0.574 . . . . 0.0 109.585 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.424 HH21 ' CB ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -136.76 145.68 44.89 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.404 ' HG ' ' CG ' ' A' ' 164' ' ' ASP . 58.5 m -73.52 152.63 40.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.835 0.709 . . . . 0.0 110.374 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -81.94 -45.36 15.51 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.413 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.4 mmpt? -73.45 -20.01 60.81 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.553 -173.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.68 134.8 52.75 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 175.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.426 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 52.1 mmt-85 -89.59 -36.59 15.22 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -85.77 -19.83 30.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.173 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.9 100.64 2.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.962 0.887 . . . . 0.0 110.914 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.75 124.95 62.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 57.7 mt -112.14 133.67 54.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.45 0.643 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' ' 174' ' ' MET . 43.4 pt -121.87 159.48 24.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.176 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -86.15 161.43 18.86 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.775 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -49.0 -47.71 44.19 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.994 1.718 . . . . 0.0 109.717 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.12 -45.75 22.59 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.997 2.119 . . . . 0.0 113.525 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -46.42 75.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.605 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 11.5 p80 -77.35 -21.6 53.08 Favored 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.006 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.86 81.63 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.31 -40.82 94.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.71 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 191' ' ' HIS . 22.7 m-85 -65.91 -37.62 86.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.09 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.7 mm-40 -55.36 -51.51 66.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.651 0.78 . . . . 0.0 109.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.62 -10.65 59.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.504 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.01 -27.88 20.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.48 62.91 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.946 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.461 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 61.0 mt -84.5 160.28 20.55 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.1 p -94.65 121.75 36.53 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 105.3 63.82 0.64 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.796 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 46.2 m-85 -127.14 135.06 50.18 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 117.938 0.869 . . . . 0.0 112.782 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 50.9 tptt -144.02 121.54 11.75 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.2 m -126.11 129.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.5 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -110.62 165.02 12.15 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -68.64 122.96 19.61 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.37 -35.64 35.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 23' ' ' LYS . 14.7 mt-10 -75.14 97.85 3.56 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.447 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.06 35.37 34.8 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.678 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.504 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 9.9 t90 -55.21 106.61 0.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.131 0.972 . . . . 0.0 109.712 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -103.23 99.02 8.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.55 15.22 68.18 Favored Glycine 0 N--CA 1.47 0.965 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.504 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 95.5 mt -93.97 156.38 16.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.167 0.984 . . . . 0.0 110.991 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.81 131.64 48.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.065 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.051 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.99 -19.06 7.88 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.631 -1.271 . . . . 0.0 114.67 -174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -84.96 -7.71 59.04 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.898 0.849 . . . . 0.0 112.549 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 m -121.72 169.15 11.02 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -88.32 124.37 33.83 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -72.89 113.24 9.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -64.13 149.26 48.07 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.992 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -102.66 131.74 49.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -68.35 132.68 47.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -50.56 105.86 0.11 Allowed 'General case' 0 C--N 1.345 0.41 0 O-C-N 124.304 1.002 . . . . 0.0 109.105 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 t -81.94 136.43 35.3 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.026 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 m -82.83 89.49 6.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.04 87.18 0.45 Allowed Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.44 67.87 2.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 122.114 0.959 . . . . 0.0 112.014 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.411 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 40.7 t -93.79 -48.14 0.28 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.643 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 16.9 Cg_exo -69.53 110.39 2.5 Favored 'Trans proline' 0 C--N 1.396 3.072 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -78.86 119.14 21.62 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.886 0.85 . . . . 0.0 113.161 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.87 71.06 0.23 Allowed Glycine 0 N--CA 1.418 -2.554 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.181 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -65.42 -39.31 91.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -104.99 105.38 15.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.92 108.35 12.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.275 0.56 . . . . 0.0 111.049 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.77 145.78 18.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -107.2 144.78 33.47 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.694 0.283 . . . . 0.0 110.398 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -116.56 139.75 50.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.671 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.97 136.42 54.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -72.97 107.73 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -99.76 134.2 42.99 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.525 0.679 . . . . 0.0 112.453 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -151.1 165.36 34.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.97 141.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.71 82.76 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . 162.27 137.1 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 127.637 2.375 . . . . 0.0 107.655 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -80.48 -29.29 37.39 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.011 0.91 . . . . 0.0 109.185 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.413 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 11.4 pt-20 -83.17 0.73 43.95 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.578 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 79' ' ' TYR . . . -66.75 -20.69 66.01 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.895 0.379 . . . . 0.0 110.441 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 66.86 0.29 Allowed Glycine 1 N--CA 1.393 -4.208 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.574 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 19.1 m-85 -70.83 133.06 46.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.856 172.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.49 101.9 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 171.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -59.16 -41.77 89.14 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.681 -171.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -148.0 173.39 12.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 46' ' ' THR . 5.8 mp -60.62 124.61 79.7 Favored Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 124.269 1.027 . . . . 0.0 113.333 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 167.76 25.65 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.803 2.335 . . . . 0.0 112.275 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -45.92 113.76 0.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.898 1.679 . . . . 0.0 112.761 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.61 7.72 87.06 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.522 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.33 132.18 45.87 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 117.21 0.505 . . . . 0.0 111.814 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.42 165.64 12.76 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.693 2.929 . . . . 0.0 111.958 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.409 ' HA ' HD22 ' A' ' 40' ' ' LEU . 10.9 p -52.94 150.14 5.78 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -39.35 -54.91 1.82 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 127.991 2.516 . . . . 0.0 113.708 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.456 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 53.7 p-90 -83.52 -24.3 31.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.151 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 51.5 tptt -85.41 -12.82 51.11 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.524 -172.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -45.11 -43.94 10.13 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -128.96 25.24 5.6 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -92.96 100.9 13.26 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 118.113 -1.435 . . . . 0.0 107.422 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.11 -9.58 3.92 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.0 172.09 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 120.452 2.126 . . . . 0.0 113.752 -175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.7 t -98.06 150.48 21.36 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.011 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.7 mt -98.33 -4.36 35.14 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.02 47.23 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -22.41 22.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -101.2 -22.17 14.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -96.31 140.81 22.4 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.38 122.59 10.08 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.932 1.754 . . . . 0.0 110.913 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -101.45 119.3 49.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.05 16.86 66.39 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.29 -150.26 26.69 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.84 133.54 44.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.96 167.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -145.74 154.07 41.66 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.156 -0.34 . . . . 0.0 110.448 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 115.59 15.53 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 170.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.7 p -55.02 152.27 7.85 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.268 0.98 . . . . 0.0 112.755 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -81.95 19.38 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.297 1.039 . . . . 0.0 110.41 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.3 -37.74 81.48 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -134.83 103.8 10.86 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.85 171.19 14.6 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.343 2.029 . . . . 0.0 111.466 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t0 56.01 81.4 0.12 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.957 1.703 . . . . 0.0 111.536 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 48.6 t-20 -157.75 159.64 37.02 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -83.51 -165.37 1.09 Allowed 'General case' 0 C--O 1.262 1.762 0 CA-C-O 122.013 0.911 . . . . 0.0 112.844 -168.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.27 -160.83 0.73 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.637 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 mp -92.89 138.75 31.21 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.114 0.483 . . . . 0.0 111.768 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 2.4 m-30 -108.23 -155.93 0.57 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.957 1.703 . . . . 0.0 108.432 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -64.21 -49.54 71.57 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.515 0.674 . . . . 0.0 110.381 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.15 139.3 53.48 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.825 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 14.3 mm100 -107.39 119.0 52.16 Favored Pre-proline 0 N--CA 1.431 -1.387 0 O-C-N 123.745 0.653 . . . . 0.0 111.309 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 90.6 Cg_endo -84.08 168.12 12.17 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 122.713 2.275 . . . . 0.0 111.259 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -159.35 169.79 23.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.18 -7.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 124.103 0.877 . . . . 0.0 110.286 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -98.99 -168.56 1.64 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.333 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 p -101.97 21.95 13.86 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -173.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -116.43 162.97 16.74 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.541 -0.724 . . . . 0.0 109.316 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.3 tp -123.49 141.7 51.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.968 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 54.1 tp -114.47 127.14 55.66 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -126.92 144.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.76 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -76.55 168.77 19.48 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.58 0.352 . . . . 0.0 110.173 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.83 -36.08 90.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -65.2 -45.27 85.48 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -30.38 64.3 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.387 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -58.78 -45.09 90.59 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -57.48 -42.16 82.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.057 0.848 . . . . 0.0 110.617 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.72 -54.26 48.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.354 0.409 . . . . 0.0 110.887 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.14 -41.4 86.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 C-N-CA 123.513 0.725 . . . . 0.0 111.818 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.99 -34.29 75.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.626 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -68.01 -27.55 66.65 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.966 0.412 . . . . 0.0 111.027 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.2 -7.34 59.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.608 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.84 42.73 98.35 Favored Glycine 0 N--CA 1.441 -0.98 0 O-C-N 123.563 0.539 . . . . 0.0 112.321 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -72.07 112.61 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -79.86 155.37 27.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 75.69 15.17 2.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.96 1.304 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.3 113.85 25.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.2 tp10 -109.35 138.7 45.32 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.505 ' CZ3' ' HG ' ' A' ' 129' ' ' LEU . 59.7 m95 -119.6 114.5 22.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.4 mt -110.73 96.59 29.21 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.76 146.23 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.336 2.024 . . . . 0.0 112.239 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.73 169.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.714 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -90.74 115.35 27.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.2 mt -108.49 126.55 65.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.49 0.662 . . . . 0.0 112.029 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -99.49 136.15 39.85 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.648 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.8 p-10 -81.1 -160.47 0.33 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.866 0.365 . . . . 0.0 110.817 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.665 0.786 . . . . 0.0 110.028 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -79.88 -19.83 47.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.515 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.26 38.17 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.725 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.648 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.9 ptmt -93.92 133.48 37.3 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.0 t -77.35 93.11 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.132 0.491 . . . . 0.0 109.738 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.31 11.89 6.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.547 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.27 51.8 0.82 Allowed Glycine 0 C--O 1.201 -1.943 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.393 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 90.6 Cg_endo -84.34 -1.97 9.87 Favored 'Trans proline' 0 C--N 1.368 1.584 0 CA-C-N 121.542 2.671 . . . . 0.0 112.209 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -113.54 7.26 17.37 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.591 1.186 . . . . 0.0 109.124 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -93.98 137.31 33.32 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.842 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.8 139.94 53.08 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.693 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -79.45 115.41 19.06 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HG ' ' CZ3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -87.28 119.9 28.01 Favored 'General case' 0 C--O 1.274 2.369 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -176.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -101.67 122.07 43.2 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.51 113.25 24.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.14 173.42 7.03 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 124.21 0.944 . . . . 0.0 109.5 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.27 63.86 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.113 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.65 130.94 34.61 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -148.09 100.26 3.15 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.081 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.464 ' O ' ' HE2' ' A' ' 179' ' ' LYS . 16.9 t70 72.41 -48.53 0.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.138 1.775 . . . . 0.0 111.614 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 67.49 -95.82 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.6 mt -65.15 123.19 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -166.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.1 129.18 37.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.335 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 51.5 ttm -107.43 1.01 23.28 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.487 0.661 . . . . 0.0 110.932 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.3 -49.21 7.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.684 0.754 . . . . 0.0 110.93 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -99.4 10.91 40.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.242 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.7 p -114.44 162.58 16.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -160.27 160.33 32.46 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.407 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -123.53 132.99 54.05 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.82 0.848 . . . . 0.0 109.525 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 57.5 mtt -92.64 126.3 37.66 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.927 0.491 . . . . 0.0 109.986 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -164.36 -26.23 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -168.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.477 ' OG ' ' HA2' ' A' ' 156' ' ' GLY . 50.0 m -56.59 -55.9 28.16 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 90.6 mt -135.96 -80.71 0.41 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.035 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.95 178.02 5.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -60.33 -34.24 73.54 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-O 120.98 0.419 . . . . 0.0 110.236 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.64 26.54 1.99 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.83 0.824 . . . . 0.0 111.503 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 149' ' ' SER . 38.7 mm-40 -116.99 115.04 24.67 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.747 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 51.5 mt -81.12 121.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.018 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.477 ' HA2' ' OG ' ' A' ' 149' ' ' SER . . . -88.47 -45.31 5.0 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.92 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -124.08 125.41 44.46 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mp -116.89 122.34 69.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -99.34 -51.18 3.87 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.55 0.69 . . . . 0.0 109.886 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.49 110.52 5.94 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.7 124.13 33.81 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -95.23 146.47 24.31 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.02 141.47 58.76 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.864 0.84 . . . . 0.0 112.59 -173.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -85.9 -2.04 57.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.279 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.7 p -68.89 -5.72 22.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.642 1.177 . . . . 0.0 110.01 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.8 m -65.15 -35.08 79.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.19 -30.51 7.43 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.36 144.99 7.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -59.2 120.9 51.67 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.13 0.572 . . . . 0.0 110.817 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 -5.78 16.89 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.426 2.751 . . . . 0.0 114.269 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.91 -3.38 57.37 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.134 -0.354 . . . . 0.0 110.811 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.65 137.39 38.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -90.93 -25.18 19.91 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 91.4 mtp -140.84 131.05 24.89 Favored 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -153.43 153.29 32.23 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.477 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.709 ' CZ ' HG21 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -113.03 143.88 43.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.419 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 39.9 m -88.13 131.98 34.5 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.4 0.438 . . . . 0.0 110.302 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.2 p -81.97 -9.35 59.6 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 136' ' ' ASP . 73.5 mmtt -99.04 0.61 44.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.372 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.417 ' OE2' ' HD2' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -157.01 143.46 18.2 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.456 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 19.6 mmt180 -90.28 -25.89 20.3 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.615 0.245 . . . . 0.0 111.488 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.417 ' HD2' ' OE2' ' A' ' 180' ' ' GLU . 54.3 mtt180 -78.19 -38.06 44.22 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.419 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 18.9 tp -69.62 100.7 1.5 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 123.247 1.499 . . . . 0.0 113.94 -168.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.709 HG21 ' CZ ' ' A' ' 176' ' ' ARG . 19.8 mt -113.53 116.1 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 112.296 -2.229 . . . . 0.0 106.597 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.25 131.93 54.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 121.833 0.825 . . . . 0.0 113.001 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.99 155.89 24.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.305 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -80.14 156.77 26.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.74 -37.32 70.85 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -57.17 -37.72 72.54 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.94 0.896 . . . . 0.0 111.062 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.33 -51.19 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.938 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.502 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.8 p80 -72.47 -26.7 61.9 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.24 -35.68 77.91 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.136 0.494 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.45 -33.78 69.66 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -71.22 -33.03 69.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.097 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 54.1 mm-40 -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.07 -7.43 58.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.007 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.95 24.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 77.99 47.42 8.5 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.779 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.52 165.48 18.02 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.283 20.0 p -67.34 -87.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -169.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.68 124.93 2.01 Favored Glycine 0 CA--C 1.492 -1.384 0 C-N-CA 119.443 -1.36 . . . . 0.0 112.676 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.35 162.82 29.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -108.84 138.51 45.06 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.47 129.35 35.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 124.662 1.226 . . . . 0.0 109.278 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 74.0 m-85 -125.4 143.12 51.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 115.52 9.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.58 75.82 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.89 96.8 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.987 0.804 . . . . 0.0 109.505 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.79 32.19 41.66 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.982 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -57.73 112.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.559 0.744 . . . . 0.0 110.061 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -102.15 74.99 1.47 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.6 14.57 65.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 116.924 1.53 . . . . 0.0 116.924 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.53 114.76 16.69 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 118.585 1.193 . . . . 0.0 110.341 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -68.37 133.01 48.05 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.191 0.996 . . . . 0.0 110.388 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.402 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 5.5 mp . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.92 31.49 8.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.64 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -144.16 101.9 3.79 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.5 t -134.82 153.3 52.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.139 0.495 . . . . 0.0 109.831 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -137.5 88.65 2.36 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.94 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -106.55 -3.4 20.83 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.249 0.547 . . . . 0.0 110.167 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -95.63 87.43 4.71 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.136 0.493 . . . . 0.0 110.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -120.19 82.38 1.89 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -125.68 110.58 13.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -99.79 107.3 19.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.631 0.729 . . . . 0.0 111.327 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 p -95.2 44.28 1.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 123.993 0.917 . . . . 0.0 109.313 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 m 68.39 85.25 0.14 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.444 1.098 . . . . 0.0 109.733 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.97 101.84 2.41 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -78.08 -40.44 38.46 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.914 0.387 . . . . 0.0 110.045 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.43 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 60.2 t -77.52 -56.64 1.14 Allowed Pre-proline 0 CA--C 1.56 1.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.83 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 33.2 Cg_endo -93.96 49.31 0.31 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.888 1.726 . . . . 0.0 111.221 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -67.31 115.61 7.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.151 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.15 -83.97 1.64 Allowed Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.5 p -171.91 154.25 3.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -85.78 130.48 34.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -73.27 105.07 4.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.1 130.12 36.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.103 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.466 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.6 ptmt -96.45 139.07 33.09 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.21 0.529 . . . . 0.0 109.84 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -121.03 142.66 49.6 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.737 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 64.8 m-85 -119.84 143.43 47.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.667 0.746 . . . . 0.0 112.926 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.27 112.92 16.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -94.68 127.64 40.8 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -150.2 139.35 21.17 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 t -88.55 142.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.4 mtt -86.4 75.88 9.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.469 0.652 . . . . 0.0 109.819 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.16 112.47 2.04 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -128.72 -50.88 1.25 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.172 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -1.4 57.1 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.27 1.033 . . . . 0.0 108.621 170.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.14 27.67 8.41 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.263 2.225 . . . . 0.0 110.507 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.574 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 124.45 68.63 0.2 Allowed Glycine 0 N--CA 1.421 -2.352 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -94.66 131.66 40.21 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 166.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -83.01 106.92 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 101.814 -3.402 . . . . 0.0 101.814 162.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -76.87 -50.49 13.25 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.282 0.563 . . . . 0.0 111.126 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -116.08 166.25 12.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.672 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.15 134.61 94.86 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 123.682 0.614 . . . . 0.0 111.641 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.91 162.64 41.94 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.675 2.25 . . . . 0.0 112.282 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -64.24 119.16 9.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.95 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.5 3.58 66.69 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.546 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 m -85.61 146.41 44.04 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.21 166.79 17.98 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 0.0 111.504 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.9 p -59.59 161.29 6.16 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.91 -52.17 35.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.204 1.402 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.404 ' CH2' ' HE2' ' A' ' 49' ' ' LYS . 9.0 p-90 -72.12 -32.96 67.45 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HE2' ' CH2' ' A' ' 48' ' ' TRP . 4.8 mptp? -65.67 -23.65 66.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.403 ' HA ' HD21 ' A' ' 56' ' ' LEU . 72.4 m-85 -60.66 -21.36 62.72 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.029 0.442 . . . . 0.0 111.548 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.553 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 11.6 m80 -127.15 -10.38 5.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.33 102.3 14.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.129 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.43 -10.97 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 N-CA-C 121.867 3.507 . . . . 0.0 121.867 166.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 173.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.651 2.726 . . . . 0.0 112.667 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -91.2 142.8 27.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.403 HD21 ' HA ' ' A' ' 50' ' ' PHE . 62.3 mt -91.66 -4.68 54.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.125 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.65 -33.79 71.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.87 -5.3 58.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -111.89 -21.33 11.66 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -102.0 137.31 19.46 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.76 123.74 12.49 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.815 2.343 . . . . 0.0 112.347 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.5 114.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 17.13 57.2 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.23 -157.39 25.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.061 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.8 mt-10 -129.63 137.08 50.47 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.2 m -133.82 173.75 14.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 t -144.24 153.41 42.03 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.697 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -69.01 150.18 47.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 p -72.15 130.35 40.65 Favored 'General case' 0 C--N 1.276 -2.602 0 O-C-N 123.671 0.607 . . . . 0.0 109.6 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -85.83 73.72 10.31 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -105.09 -38.51 6.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -128.88 100.53 20.99 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.33 -18.36 49.98 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.425 2.75 . . . . 0.0 113.986 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.47 5.75 43.92 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 120.997 0.427 . . . . 0.0 112.092 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -77.51 127.21 32.14 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -66.75 -168.77 0.07 Allowed 'General case' 0 C--O 1.256 1.411 0 CA-C-O 123.018 1.39 . . . . 0.0 114.695 -167.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -70.69 -168.5 0.26 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 112.351 -2.204 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -110.5 151.97 26.93 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -109.7 -154.38 0.53 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.929 0.891 . . . . 0.0 109.093 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.46 -47.1 74.21 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.086 0.469 . . . . 0.0 111.62 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.21 140.49 51.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.574 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 21.8 tp60 -124.7 120.97 25.71 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.738 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -88.85 -174.46 1.02 Allowed 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.396 2.064 . . . . 0.0 111.553 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -163.67 177.92 8.34 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.87 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.48 -13.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 123.641 0.588 . . . . 0.0 109.426 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.99 -70.72 0.52 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.461 ' CB ' ' HB3' ' A' ' 181' ' ' ARG . 22.8 t -179.81 -53.73 0.01 OUTLIER 'General case' 0 C--N 1.362 1.116 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.41 -167.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.63 166.39 12.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.4 132.17 56.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 56.6 tp -104.77 132.42 51.04 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.6 136.86 58.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 O-C-N 122.408 -0.183 . . . . 0.0 110.718 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.8 p -76.32 170.07 17.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.853 0.461 . . . . 0.0 109.87 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.0 81.05 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.54 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -64.44 -53.39 49.18 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.152 0.501 . . . . 0.0 110.21 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -30.58 70.39 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.129 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.32 -44.1 97.28 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.587 0.755 . . . . 0.0 110.321 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -62.39 -39.46 93.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.934 0.771 . . . . 0.0 109.897 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 102' ' ' LEU . 4.1 mm? -57.62 -59.73 4.75 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.429 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -55.84 -41.34 66.13 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 123.234 0.614 . . . . 0.0 112.578 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.55 -42.52 78.29 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 p -71.49 -27.38 63.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 98' ' ' LEU . 9.5 mp -67.58 -25.4 65.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.863 0.363 . . . . 0.0 111.567 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.03 42.41 5.98 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.17 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.3 t -81.93 101.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 m -74.87 146.99 41.45 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.609 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 80.02 12.27 1.07 Allowed 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.28 1.432 . . . . 0.0 112.56 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.48 113.89 21.54 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.02 131.48 51.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.47 ' CZ3' HD13 ' A' ' 129' ' ' LEU . 53.2 m95 -111.37 123.13 49.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.454 -174.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.2 mt -108.92 95.11 16.19 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.8 132.98 8.97 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -150.3 167.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.98 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.439 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.92 116.71 33.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.4 mt -106.24 136.28 41.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.784 -172.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -95.46 146.76 24.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.59 -160.35 0.72 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -70.58 -23.16 62.54 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.377 1.071 . . . . 0.0 110.385 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -92.98 -19.71 21.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.838 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.57 12.97 33.84 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.094 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -99.42 151.16 21.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 117.691 0.745 . . . . 0.0 109.348 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.6 t -84.73 81.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.666 0.746 . . . . 0.0 110.244 -175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.7 m -104.45 11.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.086 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -127.39 48.11 0.99 Allowed Glycine 0 N--CA 1.422 -2.25 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.312 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.95 -2.52 9.63 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 121.405 2.602 . . . . 0.0 111.634 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -114.12 14.27 18.23 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.819 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.424 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 19.6 m-85 -112.8 138.24 49.92 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 111.646 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.96 138.82 52.19 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.965 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.89 125.44 29.72 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.47 HD13 ' CZ3' ' A' ' 109' ' ' TRP . 6.4 tt -102.09 125.95 48.91 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.798 0.809 . . . . 0.0 110.354 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.19 140.55 52.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.317 170.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 176' ' ' ARG . 2.8 mm? -95.79 143.64 26.85 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.204 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.64 173.29 6.37 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 122.992 0.517 . . . . 0.0 109.897 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.25 7.52 84.92 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.39 132.35 40.53 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.63 0.728 . . . . 0.0 110.464 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -132.66 170.45 15.2 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -47.85 107.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.191 0.932 . . . . 0.0 111.391 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 164' ' ' ASP . . . -94.29 -55.58 3.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -163.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.58 117.97 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.126 0.891 . . . . 0.0 112.886 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -67.0 109.84 3.13 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.57 -1.92 58.26 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.438 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 12.9 pt-20 -100.05 -30.26 12.06 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.032 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.438 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 59.9 mtt85 -102.18 -12.65 17.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 m -97.75 131.44 44.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.872 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -109.42 115.29 29.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.75 174.52 14.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.011 0.434 . . . . 0.0 111.492 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -129.46 128.62 43.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 91.2 mtp -100.79 155.13 18.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.261 19.4 t70 88.71 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.121 2.169 . . . . 0.0 113.076 177.027 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.0 p -101.57 -57.47 2.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.232 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -112.91 -24.4 9.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.784 0.802 . . . . 0.0 109.284 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 32.5 mt-10 -151.95 175.96 11.97 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 126.401 1.88 . . . . 0.0 106.47 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.578 ' N ' ' HE2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -70.53 -38.32 74.22 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -98.79 26.53 5.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.114 1.435 . . . . 0.0 110.607 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.631 ' NE2' ' HD3' ' A' ' 181' ' ' ARG . 9.7 mm-40 -108.2 121.46 44.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.093 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.46 132.59 31.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -97.8 -55.98 1.11 Allowed Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.887 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -112.12 133.3 54.35 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.724 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.47 123.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.4 -39.27 9.27 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.977 0.417 . . . . 0.0 110.447 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.91 117.04 6.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.625 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.98 123.14 45.37 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.36 142.46 30.81 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.87 133.68 56.24 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 122.456 1.122 . . . . 0.0 113.001 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 137' ' ' ALA . 18.7 p-10 -88.43 6.22 38.59 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.096 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.2 p -68.9 -4.67 17.35 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.215 1.406 . . . . 0.0 109.979 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.9 m -68.56 -40.68 80.52 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.935 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.6 -33.25 9.06 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.196 -0.315 . . . . 0.0 110.864 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.8 146.01 6.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.458 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 1.6 mpp_? -64.85 125.79 89.7 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -4.77 9.86 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.976 3.117 . . . . 0.0 114.658 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 3.9 p30 -83.56 -10.68 58.13 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.244 -0.285 . . . . 0.0 111.177 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.53 138.74 53.56 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.284 0.564 . . . . 0.0 111.076 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.97 -30.0 24.61 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.214 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.1 ttt -148.99 130.42 14.77 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.68 178.45 8.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.296 0.373 . . . . 0.0 110.609 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.553 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 ppt_? -148.54 138.26 22.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 59.6 m -78.17 153.37 32.11 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.973 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 51' ' ' HIS . 7.3 p -81.52 -50.38 9.46 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -97.81 30.13 3.12 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -155.64 127.17 7.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.631 ' HD3' ' NE2' ' A' ' 154' ' ' GLN . 1.8 mpt_? -81.0 -40.99 23.41 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.043 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -86.51 -7.12 58.65 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.175 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.8 tp -88.2 104.2 16.49 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 122.094 0.95 . . . . 0.0 111.902 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.71 123.18 69.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.22 128.85 51.99 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.343 0.592 . . . . 0.0 110.54 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 45.8 pt -112.0 148.86 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.736 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -80.73 156.18 26.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.56 -38.22 43.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.955 0.902 . . . . 0.0 112.487 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.63 -39.79 85.5 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.112 1.365 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.45 -51.34 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.737 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 18.3 p80 -68.92 -27.86 66.14 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.387 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.41 -32.18 72.12 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.562 0.539 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.9 59.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.201 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -71.72 -32.12 67.42 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.218 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 70.2 mm-40 -55.68 -53.85 51.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.815 0.846 . . . . 0.0 109.149 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -76.88 -20.72 55.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.246 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.81 -27.98 44.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.61 0.243 . . . . 0.0 110.66 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.04 47.76 12.72 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.225 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.78 165.3 23.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.75 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -159.83 132.76 3.08 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.67 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.84 165.31 25.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -128.47 131.81 48.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.59 130.25 71.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.009 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -113.04 153.16 28.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.64 112.02 9.34 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.9 -36.96 84.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 123.829 0.705 . . . . 0.0 112.068 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.63 94.92 1.04 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.51 35.19 14.52 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.622 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -58.64 100.63 0.07 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.513 0.725 . . . . 0.0 111.492 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -104.39 126.54 51.58 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.39 -26.49 0.21 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 120.298 2.879 . . . . 0.0 120.298 163.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.22 115.15 24.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 118.899 1.349 . . . . 0.0 111.602 -172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -82.69 134.66 35.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.753 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.794 1.638 . . . . 0.0 111.577 171.071 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.26 93.33 1.27 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -85.96 -51.87 6.08 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t -163.1 100.49 0.97 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 110.818 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -115.14 -33.6 5.31 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -129.1 140.53 51.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -103.57 156.39 17.81 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.673 0.273 . . . . 0.0 110.512 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -78.69 133.9 37.16 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.0 t60 72.4 106.85 0.07 Allowed 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 125.078 1.351 . . . . 0.0 110.525 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.292 3.0 p-80 80.29 121.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.388 2.275 . . . . 0.0 113.042 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 m -94.01 -37.64 11.55 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -93.34 127.09 38.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.86 -5.66 47.24 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.479 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.75 110.28 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.68 105.96 30.15 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.31 -71.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.912 1.742 . . . . 0.0 114.726 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 60.62 75.79 0.39 Allowed 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.526 1.13 . . . . 0.0 109.355 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.99 71.37 0.9 Allowed Glycine 0 C--N 1.306 -1.094 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.184 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m 73.13 -33.58 0.27 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.741 1.617 . . . . 0.0 113.979 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 m80 63.59 -108.29 0.22 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 86.3 mmm 59.35 22.33 10.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.002 0.906 . . . . 0.0 111.108 -171.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.5 110.48 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.0 155.57 37.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.043 0.449 . . . . 0.0 112.111 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.35 138.33 46.89 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.929 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CD2' ' HB ' ' A' ' 204' ' ' VAL . 65.1 m-85 -125.76 147.52 49.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.31 0.576 . . . . 0.0 112.156 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.1 t -78.3 124.85 37.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -96.43 135.24 38.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.601 0.715 . . . . 0.0 112.154 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -149.78 162.95 39.27 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 81' ' ' PHE . 21.8 t -104.59 143.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.437 ' HE3' ' O ' ' A' ' 202' ' ' PHE . 49.4 ttm -96.55 80.55 3.13 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.47 114.75 4.16 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.018 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.43 -33.67 2.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.86 -0.53 57.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.37 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.98 -31.96 20.32 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 172.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.6 161.1 33.43 Favored Glycine 1 N--CA 1.383 -4.862 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.902 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 47.9 m-85 -95.97 164.14 12.84 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.06 101.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -54.0 -51.18 64.79 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 125.131 1.519 . . . . 0.0 113.174 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -146.81 153.61 40.39 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -48.98 121.16 10.18 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.016 1.326 . . . . 0.0 113.593 -175.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -75.59 167.03 27.34 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.472 2.115 . . . . 0.0 111.161 173.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -54.66 128.82 34.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.539 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.26 3.57 81.94 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.585 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m -85.47 128.93 57.21 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.73 165.7 3.39 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.616 3.544 . . . . 0.0 112.799 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 p -54.2 147.08 13.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 50' ' ' PHE . 4.0 m-20 -38.19 -56.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 127.059 2.143 . . . . 0.0 114.32 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 23.9 p-90 -85.88 -16.08 39.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.835 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -86.66 -13.19 46.26 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.019 -171.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HD2' ' O ' ' A' ' 47' ' ' ASP . 65.9 m-85 -48.66 -27.64 2.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -127.84 1.24 6.02 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.582 -0.699 . . . . 0.0 111.319 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.84 102.15 14.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.587 -167.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.14 -9.84 0.98 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.18 164.81 30.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 119.516 1.658 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -91.38 143.7 26.35 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.8 0.12 56.82 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.206 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.56 -37.97 52.16 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -90.38 -15.39 31.13 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 178.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.49 -23.1 12.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.631 -0.668 . . . . 0.0 112.66 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -97.46 134.71 22.27 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.8 122.09 9.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.462 1.441 . . . . 0.0 110.805 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.12 127.59 54.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.49 66.91 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.3 -167.44 27.81 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.613 -177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.96 137.75 52.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.48 163.1 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.7 t -146.29 148.16 32.14 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.046 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.59 116.59 9.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -68.94 151.32 46.69 Favored 'General case' 0 N--CA 1.411 -2.407 0 O-C-N 124.026 0.829 . . . . 0.0 111.71 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -83.61 58.84 4.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.251 1.024 . . . . 0.0 109.823 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -95.2 -29.53 14.48 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.017 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -131.37 106.11 14.62 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.85 142.63 32.04 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.567 2.178 . . . . 0.0 112.434 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.81 88.79 0.1 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.062 1.345 . . . . 0.0 112.387 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 19.7 t-20 -152.52 154.91 36.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -84.19 -162.2 0.63 Allowed 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -86.41 -170.16 2.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.873 1.269 . . . . 0.0 113.143 -176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 5.1 mp -87.89 144.51 26.54 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.367 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -103.82 -175.9 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -57.58 -41.28 80.81 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.591 0.71 . . . . 0.0 112.18 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.422 ' O ' HG12 ' A' ' 29' ' ' VAL . 95.8 m-85 -118.36 134.91 54.66 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 172.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.463 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -121.77 129.5 25.15 Favored Pre-proline 0 C--N 1.283 -2.307 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.182 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.22 171.72 13.57 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.463 2.108 . . . . 0.0 111.734 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.1 p30 -160.08 173.65 15.49 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -96.7 14.89 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-O 123.109 1.433 . . . . 0.0 109.184 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -121.3 -176.09 3.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.722 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 m -98.09 46.9 1.0 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -127.63 162.02 27.49 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.539 -0.726 . . . . 0.0 109.603 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.8 tp -122.99 129.86 52.06 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.2 tp -102.27 123.79 46.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.61 138.05 54.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 122.791 0.436 . . . . 0.0 110.014 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -76.99 174.0 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.639 0.376 . . . . 0.0 111.119 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.61 -37.25 67.95 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.396 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.96 -35.0 66.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.103 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.38 -34.38 70.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -57.84 -46.24 85.05 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.02 174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -55.17 -38.4 68.26 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.28 -51.21 69.86 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.53 -41.66 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.069 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -69.19 -36.79 77.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.222 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -74.9 -29.6 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.26 -19.66 56.23 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.245 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.45 48.71 5.2 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.804 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.2 t -82.69 101.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.0 m -77.04 150.44 35.76 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.332 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.1 9.2 1.4 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.391 1.476 . . . . 0.0 113.3 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.49 113.8 25.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 9.1 tp10 -99.41 139.82 34.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.456 ' CZ3' HD11 ' A' ' 129' ' ' LEU . 57.0 m95 -116.96 121.74 42.27 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -116.41 93.31 39.49 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.1 139.82 21.91 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.858 2.372 . . . . 0.0 113.894 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.3 m -150.75 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 124.52 1.128 . . . . 0.0 109.522 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -96.95 116.21 28.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -108.36 130.17 61.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.423 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -96.7 135.27 38.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -169.82 2.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.983 0.356 . . . . 0.0 110.528 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 63.2 m80 -59.59 -31.15 69.2 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.022 0.929 . . . . 0.0 111.147 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -87.52 -3.01 59.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.46 64.47 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -105.34 147.73 27.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 118.461 1.13 . . . . 0.0 110.553 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.65 90.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.715 0.769 . . . . 0.0 110.34 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.9 6.22 7.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.076 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.06 45.28 1.17 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 119.309 -1.424 . . . . 0.0 116.072 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 78.3 Cg_endo -84.04 -1.44 9.9 Favored 'Trans proline' 0 C--N 1.381 2.251 0 CA-C-N 122.222 3.011 . . . . 0.0 111.02 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.64 -9.22 41.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -98.43 149.55 22.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.637 0.732 . . . . 0.0 112.707 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.0 140.18 45.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.472 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.23 122.89 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.456 HD11 ' CZ3' ' A' ' 109' ' ' TRP . 6.9 tt -99.71 128.55 45.81 Favored 'General case' 0 C--O 1.275 2.434 0 CA-C-O 121.819 0.819 . . . . 0.0 110.914 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.444 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.19 140.65 52.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.611 174.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.7 140.09 36.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.99 173.76 6.59 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.183 0.927 . . . . 0.0 109.39 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.88 22.13 50.59 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.134 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.43 132.96 45.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.416 0.627 . . . . 0.0 111.164 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -132.72 150.64 52.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -50.13 105.43 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.139 0.971 . . . . 0.0 113.453 -170.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 164' ' ' ASP . . . -117.14 -34.1 4.47 Favored 'General case' 0 N--CA 1.398 -3.068 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -167.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.2 mt -54.62 112.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.517 0.675 . . . . 0.0 111.67 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.85 128.88 36.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.668 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.4 mtt -101.79 4.62 40.61 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.437 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 11.4 pt-20 -88.93 -30.09 19.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.797 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.437 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 3.1 mmp_? -109.55 -28.07 9.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.875 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -83.09 138.68 33.6 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.661 0.743 . . . . 0.0 112.471 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.97 113.87 17.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -153.67 163.17 40.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.199 0.312 . . . . 0.0 111.244 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.66 139.15 52.39 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.299 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 60.2 mtt -100.63 108.57 20.5 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -173.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.7 t70 169.4 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.423 1.889 . . . . 0.0 108.198 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 34.8 t -99.0 -57.17 2.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.0 mt -107.58 -51.98 2.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 -165.97 2.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.571 175.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 147' ' ' MET . 53.8 pttt -59.68 -27.77 66.7 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.11 12.53 35.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.716 0.77 . . . . 0.0 111.892 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 26.0 mm-40 -111.96 116.09 30.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.51 131.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -109.22 -72.25 0.73 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -82.91 127.19 33.29 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.98 121.55 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.06 -39.3 13.75 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.98 134.35 16.2 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.59 120.76 37.64 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.14 146.79 26.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.95 135.18 57.16 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.828 0.705 . . . . 0.0 111.255 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 13.0 p-10 -92.76 14.04 18.43 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.279 1.038 . . . . 0.0 111.082 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 p -68.56 -5.14 18.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.755 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.4 m -62.8 -35.51 80.11 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 124.187 0.995 . . . . 0.0 110.457 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.42 -31.15 6.9 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.104 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.456 HG13 ' HB1' ' A' ' 137' ' ' ALA . 85.7 mt -90.64 154.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.447 ' HD2' ' OD1' ' A' ' 171' ' ' ASP . 8.3 mmt180 -45.07 119.38 4.01 Favored Pre-proline 0 C--O 1.225 -0.23 0 C-N-CA 123.466 0.706 . . . . 0.0 112.542 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.05 -16.54 25.46 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.093 1.862 . . . . 0.0 111.109 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.447 ' OD1' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -98.06 9.69 42.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.537 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.76 142.55 58.39 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.181 0.515 . . . . 0.0 109.834 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.404 ' HB2' ' HE3' ' A' ' 173' ' ' LYS . 24.9 ttmt -90.06 -36.07 15.11 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.971 -174.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.6 ttt -153.19 118.9 5.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -140.33 -179.7 6.15 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.74 145.01 50.66 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 39.5 m -82.47 147.95 28.42 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 40.6 p -80.54 -45.66 17.07 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -79.62 17.62 0.87 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.5 150.18 34.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -91.95 -43.59 9.37 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.875 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -83.66 -33.84 25.15 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.394 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.88 102.3 0.19 Allowed 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.416 1.072 . . . . 0.0 113.187 -170.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 87.1 mt -112.88 126.83 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.18 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.98 122.94 46.26 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 49.2 pt -111.66 151.08 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -86.72 163.11 17.51 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.547 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.421 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 15.0 tp10 -50.44 -48.38 56.42 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.187 1.395 . . . . 0.0 111.872 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -63.98 -31.17 72.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.329 0.652 . . . . 0.0 111.558 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.83 -48.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.75 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.575 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 24.9 p80 -71.52 -33.04 68.85 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.699 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.09 72.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.554 0.534 . . . . 0.0 110.457 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.15 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.616 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.77 -40.57 75.98 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.442 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 37.8 mt-10 -62.08 -47.55 84.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.149 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.87 -19.27 61.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.24 47.14 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.656 0.265 . . . . 0.0 111.033 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.91 47.74 5.46 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.304 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.6 mt -89.63 165.83 13.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -50.27 -91.11 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.66 143.42 11.44 Favored Glycine 0 CA--C 1.497 -1.086 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.935 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.437 ' O ' ' HE3' ' A' ' 30' ' ' MET . 10.2 m-85 -134.79 165.73 24.61 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -133.06 128.59 36.57 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 170.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.47 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 15.6 m -132.53 129.92 59.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 123.687 0.617 . . . . 0.0 110.092 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.08 147.05 49.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.63 114.76 3.17 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.019 0.824 . . . . 0.0 109.68 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.57 61.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.104 0.253 . . . . 0.0 111.618 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.64 98.69 1.54 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.27 35.73 16.81 Favored Glycine 0 N--CA 1.422 -2.284 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.594 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -52.74 106.3 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.694 0.759 . . . . 0.0 110.045 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.72 99.65 10.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.837 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.93 -23.16 0.31 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 119.022 2.369 . . . . 0.0 119.022 167.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 69.6 mt -68.11 147.08 52.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.31 134.6 50.15 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 125.674 1.59 . . . . 0.0 112.426 -174.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 C--O 1.236 0.388 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.63 100.24 2.04 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 m -87.62 -75.3 0.41 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.659 0.23 . . . . 0.0 110.608 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -78.9 -48.89 13.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 120.84 0.352 . . . . 0.0 110.152 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.306 13.0 p80 -94.02 46.71 1.18 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.406 1.098 . . . . 0.0 112.466 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -77.12 -20.8 55.14 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -119.6 114.23 21.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.269 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 178.15 -61.83 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -143.86 79.09 1.61 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.47 0.652 . . . . 0.0 109.25 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -137.27 77.04 1.62 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 m -135.51 96.67 3.5 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 p -83.68 174.21 10.69 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.684 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.77 -120.83 0.8 Allowed Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp 56.1 43.86 26.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.665 0.745 . . . . 0.0 110.254 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -89.12 118.01 68.78 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.406 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.11 108.72 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.968 2.445 . . . . 0.0 109.352 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -153.33 138.49 17.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.837 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 168.04 11.25 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -71.08 -47.83 56.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -138.88 97.0 3.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -73.37 138.39 45.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.4 t -93.71 109.74 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 7.7 ptpp? -81.17 147.84 29.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.444 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -109.17 133.15 53.39 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.629 -174.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 76.3 m-85 -118.79 145.09 45.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.656 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 58.5 t -75.99 124.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -97.81 124.37 42.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.428 0.455 . . . . 0.0 111.591 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -137.46 147.44 45.31 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.7 133.73 40.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.5 ttt -91.19 82.18 5.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.783 0.801 . . . . 0.0 110.01 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.58 116.88 5.68 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.207 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.49 -36.54 2.07 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -83.25 -23.3 32.78 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.133 0.973 . . . . 0.0 109.982 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' A' ' 79' ' ' TYR . . . -67.22 -34.49 77.59 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 154.12 30.79 Favored Glycine 1 N--CA 1.392 -4.259 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.909 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.13 166.95 11.5 Favored 'General case' 0 C--N 1.254 -3.571 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -75.74 101.73 2.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 165.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -63.36 -45.64 90.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.676 -1.602 . . . . 0.0 112.659 -167.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.38 177.08 7.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.041 0.536 . . . . 0.0 110.163 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.38 122.82 84.74 Favored Pre-proline 0 C--N 1.32 -0.687 0 O-C-N 123.808 0.692 . . . . 0.0 112.604 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 14.1 Cg_exo -69.82 166.7 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.776 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -48.92 113.51 0.8 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.95 1.3 . . . . 0.0 113.395 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.78 72.88 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.975 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.13 143.31 39.41 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.52 165.86 16.84 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.931 3.087 . . . . 0.0 111.503 172.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.1 p -62.09 155.82 23.16 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 87' ' ' SER . 4.2 m-20 -46.07 -52.71 11.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.096 1.358 . . . . 0.0 113.027 -175.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.7 p-90 -73.35 -23.72 60.25 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -74.53 -23.68 58.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.41 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -58.79 -24.9 62.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 9.0 m80 -114.61 2.29 14.49 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.79 100.65 12.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.468 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.97 -11.79 0.01 OUTLIER Glycine 0 CA--C 1.555 2.542 0 N-CA-C 121.238 3.255 . . . . 0.0 121.238 166.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.06 166.04 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 121.15 2.475 . . . . 0.0 112.191 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.414 ' HB2' ' HG ' ' A' ' 132' ' ' LEU . 32.5 t -84.54 153.73 23.09 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.56 11.6 39.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -170.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.55 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -13.24 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.925 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.32 -22.8 13.29 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.479 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -109.51 137.37 20.3 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.88 122.62 10.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.14 1.893 . . . . 0.0 111.979 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.49 115.64 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.34 55.66 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.8 -156.28 27.39 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 33.9 mt-10 -128.83 133.31 47.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 122.468 -0.431 . . . . 0.0 110.894 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.402 ' HB ' ' CB ' ' A' ' 41' ' ' PRO . 18.8 m -131.81 166.61 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.457 ' OG ' ' HE2' ' A' ' 115' ' ' LYS . 20.0 m -145.62 156.52 43.72 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -74.84 105.8 6.07 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.938 0.774 . . . . 0.0 109.805 175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p -84.15 131.33 34.78 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' HZ1' ' CG ' ' A' ' 74' ' ' ASP . 84.0 mttt -86.02 143.24 28.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.937 -172.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -97.07 -39.32 9.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -176.66 -54.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.1 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.94 114.16 3.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 121.496 1.464 . . . . 0.0 111.644 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CG ' ' HZ1' ' A' ' 70' ' ' LYS . 45.6 t0 -90.72 88.77 7.22 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -90.04 -172.58 3.55 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.644 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -82.69 -161.81 0.52 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.4 -176.22 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.659 1.184 . . . . 0.0 112.59 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.403 HD12 HG12 ' A' ' 122' ' ' VAL . 8.4 mp -94.04 150.99 19.85 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 34' ' ' ALA . 20.9 m-85 -110.06 -154.7 0.54 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.761 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -71.11 -38.34 72.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.156 0.503 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.54 138.98 52.52 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -122.53 114.08 30.33 Favored Pre-proline 0 N--CA 1.414 -2.231 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.5 159.33 28.93 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 122.171 1.914 . . . . 0.0 111.356 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.47 171.8 8.82 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.5 mm -88.71 -18.34 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.459 ' HG3' ' OD2' ' A' ' 47' ' ' ASP . 4.7 mpp? -80.74 -95.91 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.151 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 43.2 t -175.89 34.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.485 1.136 . . . . 0.0 110.048 -174.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -136.86 154.33 50.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.714 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.81 139.9 48.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.3 tp -112.18 130.02 56.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.16 135.95 61.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.257 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.8 p -71.51 169.63 15.04 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.94 97.85 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.149 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -75.74 -32.7 60.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.058 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.48 -28.19 63.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.876 0.37 . . . . 0.0 110.048 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.45 ' HG2' ' CZ3' ' A' ' 109' ' ' TRP . 69.1 mtp180 -58.81 -43.12 90.49 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.854 172.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.9 mmpt? -61.47 -35.31 77.27 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 123.527 0.517 . . . . 0.0 111.359 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.85 -58.29 7.92 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.884 0.373 . . . . 0.0 110.115 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.16 -44.25 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.042 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.22 -37.42 87.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.0 p -75.65 -27.4 58.36 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.018 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.3 -24.38 61.32 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.738 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.11 48.45 6.92 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.8 104.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-O 121.818 0.818 . . . . 0.0 110.944 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m -55.31 123.87 15.22 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.799 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 78.21 15.08 1.41 Allowed 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.521 1.528 . . . . 0.0 113.835 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.2 114.24 21.67 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.5 tp10 -105.84 144.92 31.9 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.237 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.518 ' CZ3' HD13 ' A' ' 129' ' ' LEU . 64.9 m95 -116.3 119.66 36.44 Favored 'General case' 0 N--CA 1.425 -1.702 0 O-C-N 124.363 1.04 . . . . 0.0 109.009 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 66.3 mt -110.92 93.36 17.11 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.46 139.49 10.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.647 2.231 . . . . 0.0 112.73 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 m -147.5 173.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 108.777 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . . . -99.66 116.16 31.11 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 172.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mt -108.44 132.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.2 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 mppt? -101.12 132.3 46.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.434 ' HB3' ' CG1' ' A' ' 122' ' ' VAL . 2.8 p-10 -82.19 -160.37 0.37 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.54 0.736 . . . . 0.0 112.524 -172.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -67.55 -32.77 73.77 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.746 0.818 . . . . 0.0 110.391 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -77.11 -21.21 54.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.52 36.91 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.109 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.62 157.66 16.31 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.47 103.44 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 116' ' ' ASP . 12.9 p -103.38 -29.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.901 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -127.98 76.52 0.4 Allowed Glycine 0 N--CA 1.407 -3.292 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.869 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.72 -23.03 7.3 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 CA-C-N 119.478 1.639 . . . . 0.0 112.651 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -116.96 4.16 12.82 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.652 0.739 . . . . 0.0 111.049 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -72.33 142.05 48.82 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.81 49.56 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.649 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -81.45 127.93 33.33 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.495 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.518 HD13 ' CZ3' ' A' ' 109' ' ' TRP . 6.8 tt -103.85 126.28 50.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.568 0.699 . . . . 0.0 110.417 -176.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.79 141.74 51.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.203 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.79 129.22 45.87 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.999 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.414 ' HG ' ' HB2' ' A' ' 55' ' ' SER . 7.4 mp -87.62 173.1 9.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.344 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.9 78.61 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.305 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.27 131.94 47.04 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.11 0.481 . . . . 0.0 109.85 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.48 170.71 15.21 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.593 ' OD2' ' HE2' ' A' ' 179' ' ' LYS . 23.6 t70 -56.04 104.96 0.16 Allowed 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.164 0.915 . . . . 0.0 110.712 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 164' ' ' ASP . . . -125.03 -36.13 2.58 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 -166.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.6 mt -63.2 116.13 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.199 0.909 . . . . 0.0 111.123 -175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.11 128.95 36.03 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.998 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.0 ttm -105.21 1.42 28.19 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 121.061 0.457 . . . . 0.0 111.93 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.24 -50.64 5.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.987 0.899 . . . . 0.0 109.778 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -82.26 -4.9 58.03 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.37 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 p -106.2 162.97 13.18 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.183 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -126.75 93.71 3.85 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -150.94 161.97 41.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -121.98 141.62 51.14 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.358 1.463 . . . . 0.0 108.252 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.465 ' HE1' ' O ' ' A' ' 152' ' ' LYS . 81.8 mtp -100.84 107.57 19.14 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.61 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 t -69.6 -55.76 9.2 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.793 -0.567 . . . . 0.0 112.03 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.1 mt -136.56 -62.24 0.66 Allowed 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -116.82 170.36 8.67 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 111.8 -2.455 . . . . 0.0 105.796 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.465 ' O ' ' HE1' ' A' ' 147' ' ' MET . 0.0 OUTLIER -61.03 -39.6 90.4 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 124.09 0.956 . . . . 0.0 109.502 -176.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.89 -10.31 59.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.862 1.265 . . . . 0.0 111.683 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -102.01 115.5 30.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 46.3 mt -72.07 130.62 35.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.904 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -105.3 -75.57 1.01 Allowed Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.021 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -82.97 120.43 25.7 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.11 113.1 34.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.32 -29.82 15.45 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.98 2.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.185 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.11 121.87 33.27 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.02 140.65 30.46 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.96 140.34 58.85 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 124.258 0.974 . . . . 0.0 113.605 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 19.9 p-10 -93.46 6.51 47.93 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.254 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.0 p -67.44 -4.8 12.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.909 1.283 . . . . 0.0 110.401 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.1 m -63.85 -38.33 90.69 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.702 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.57 -31.37 6.8 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.875 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 78.5 mt -89.37 139.06 18.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -59.92 122.61 67.06 Favored Pre-proline 0 C--N 1.316 -0.858 0 O-C-N 123.489 0.493 . . . . 0.0 109.94 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -69.46 -7.97 22.37 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.486 2.124 . . . . 0.0 113.265 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.36 1.86 56.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.364 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.16 125.42 26.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 17.7 tttt -72.31 -27.18 62.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.372 0.606 . . . . 0.0 112.066 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.5 ttt -154.16 131.43 11.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -141.6 171.19 14.41 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.102 0.477 . . . . 0.0 111.475 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.619 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.3 OUTLIER -136.69 126.83 26.21 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.715 -176.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 25.6 m -74.54 142.91 44.7 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.635 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.7 p -81.51 -39.52 24.59 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.593 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 69.2 mmtt -74.43 11.2 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -174.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.94 140.69 4.64 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 7.1 mmt180 -90.18 -31.66 16.95 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -83.95 -28.96 27.44 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.61 111.0 5.13 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.305 1.05 . . . . 0.0 113.237 -173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.57 129.73 74.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.91 129.85 56.79 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.382 0.611 . . . . 0.0 111.288 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 45.4 pt -116.1 157.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.017 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.45 ' CD ' ' HA ' ' A' ' 173' ' ' LYS . 48.2 mtp180 -85.85 162.33 18.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.482 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.8 pt-20 -57.44 -36.22 71.11 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.426 ' OD2' ' HE2' ' A' ' 173' ' ' LYS . 5.1 p-10 -64.33 -32.38 73.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.43 0.456 . . . . 0.0 111.615 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 -48.9 79.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.637 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.519 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 17.8 p80 -73.62 -25.46 60.32 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.749 -1.181 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.03 74.1 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.414 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.12 -36.08 69.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -70.43 -33.25 71.12 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.3 mm-40 -58.51 -45.61 88.42 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.707 0.765 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -85.81 -12.42 50.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.225 -175.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -85.42 -27.92 25.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.88 48.37 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.09 165.34 19.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.8 p -41.49 -62.5 0.86 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -173.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.42 140.35 5.17 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 118.431 -1.842 . . . . 0.0 113.21 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -142.31 161.91 36.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.9 mmpt? -139.16 122.05 16.61 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.1 m -124.19 142.35 41.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.45 142.25 50.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.04 108.83 3.23 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.31 -30.42 66.22 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.432 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.67 92.11 1.15 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.88 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.17 31.12 26.44 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.588 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -58.19 101.62 0.08 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 110.967 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -104.01 120.95 42.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.67 -25.43 1.43 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 118.684 2.234 . . . . 0.0 118.684 168.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.53 143.67 36.35 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.619 1.209 . . . . 0.0 112.923 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.63 134.57 49.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.478 0.971 0 O-C-N 124.259 0.974 . . . . 0.0 110.67 178.099 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.9 49.25 0.79 Allowed Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -81.6 125.66 30.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.006 -0.597 . . . . 0.0 109.504 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -132.12 145.93 51.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -71.93 114.31 9.89 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -78.96 112.67 16.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.799 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -80.04 -26.39 39.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.838 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -89.73 9.7 26.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.589 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.91 103.54 16.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -140.4 113.59 8.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 m -84.95 -73.66 0.43 Allowed 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.2 t 178.34 160.62 0.59 Allowed 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.95 70.43 2.54 Favored Glycine 0 C--N 1.317 -0.501 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.26 87.49 7.39 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.542 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.57 130.9 14.72 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.56 91.1 0.59 Allowed 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 122.118 1.879 . . . . 0.0 111.155 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.04 -64.61 1.28 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.244 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.88 -113.51 4.79 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -173.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -118.44 124.09 46.8 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -136.77 131.21 33.08 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -86.1 111.49 20.38 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.36 139.08 37.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -87.61 134.4 33.64 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.885 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -109.67 145.23 36.87 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.199 0.523 . . . . 0.0 111.33 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -128.53 150.84 50.0 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.425 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 61.7 t -80.99 126.31 39.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -95.0 117.42 30.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.458 0.474 . . . . 0.0 110.719 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HG3' ' C ' ' A' ' 215' ' ' LEU . 1.2 tmtp? -135.68 139.28 43.57 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.64 122.98 49.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.6 ptp -76.07 84.58 2.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.976 0.893 . . . . 0.0 111.438 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.17 112.38 6.08 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.274 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 38.2 mt-10 -131.18 -37.19 1.27 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -84.41 -31.48 24.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.016 176.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.16 -35.21 68.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 167.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.46 26.97 Favored Glycine 0 N--CA 1.42 -2.421 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.478 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.416 ' CE2' ' HG2' ' A' ' 32' ' ' GLU . 88.7 m-85 -90.68 166.94 12.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.413 HG12 ' CE1' ' A' ' 68' ' ' PHE . 49.5 mt -78.24 100.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 161.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -59.0 -63.66 1.22 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.483 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -125.22 175.42 7.43 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.717 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -59.81 123.7 72.92 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.26 0.975 . . . . 0.0 112.838 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -65.06 166.86 17.44 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.897 2.398 . . . . 0.0 112.878 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 66' ' ' VAL . 6.9 t30 -53.88 114.43 1.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.352 1.061 . . . . 0.0 112.419 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.71 12.31 62.66 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.128 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.6 m -86.38 139.71 34.01 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 167.24 24.93 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.096 3.197 . . . . 0.0 111.449 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -51.96 149.05 5.29 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.42 -49.56 7.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.661 2.384 . . . . 0.0 114.141 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -86.15 -30.05 22.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.863 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -80.28 -12.47 59.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.629 -171.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 51.9 m-85 -48.54 -33.71 10.08 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.648 0.593 . . . . 0.0 112.23 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -128.36 9.46 6.11 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -87.92 102.66 14.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.37 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.65 -8.96 0.17 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.91 171.29 14.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 119.181 1.491 . . . . 0.0 112.828 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -98.5 150.54 21.57 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.79 14.53 31.36 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.498 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.78 -32.39 60.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.82 -24.14 22.66 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.3 -22.04 14.21 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -110.79 138.38 21.07 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.75 123.4 12.59 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.291 1.994 . . . . 0.0 111.967 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.71 113.67 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 16.37 60.33 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.99 -149.56 20.35 Favored Glycine 0 C--O 1.241 0.556 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.909 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.4 mt-10 -132.68 138.53 47.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.098 0.475 . . . . 0.0 110.51 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 42' ' ' ASN . 29.6 m -131.15 174.51 12.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 p -147.31 152.72 38.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 116' ' ' ASP . 21.2 m-85 -79.36 123.63 27.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 p -56.17 135.17 53.28 Favored 'General case' 0 C--O 1.266 1.942 0 O-C-N 124.339 1.024 . . . . 0.0 109.835 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.39 66.64 3.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.211 1.005 . . . . 0.0 112.114 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -95.34 -30.31 13.99 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.537 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -143.78 89.82 7.2 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.655 172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.06 6.01 5.93 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.991 2.461 . . . . 0.0 111.134 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.82 -4.22 37.24 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.247 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -82.07 162.9 22.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -85.83 -154.62 0.21 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 121.578 0.704 . . . . 0.0 112.023 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.17 -169.54 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.585 1.554 . . . . 0.0 112.355 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -94.11 150.73 20.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.96 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -102.35 -163.07 0.97 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.727 1.211 . . . . 0.0 109.244 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -68.75 -30.12 68.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.506 0.67 . . . . 0.0 109.604 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.4 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 64.8 m-85 -134.85 148.39 50.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.851 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -129.93 126.55 22.52 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.0 175.26 5.04 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.315 2.01 . . . . 0.0 111.117 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.19 -178.4 5.45 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.02 -19.98 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -84.66 -92.39 0.08 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.397 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 60.2 p -174.11 -29.06 0.01 OUTLIER 'General case' 0 C--N 1.369 1.421 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -70.96 115.53 10.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.022 0.915 . . . . 0.0 111.985 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.33 126.66 33.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.671 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 38.6 tp -93.54 122.4 35.94 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.414 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -71.88 156.4 39.32 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.16 -34.61 84.88 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.994 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -68.92 -41.78 77.7 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 120.838 0.351 . . . . 0.0 111.203 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.77 -28.92 61.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.958 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -59.9 -42.44 93.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.944 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 10.0 mmpt? -64.42 -32.56 74.23 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.21 -55.43 33.86 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 120.68 0.276 . . . . 0.0 110.385 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.73 -41.11 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.592 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -70.79 -27.18 63.71 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.8 m -71.92 -27.09 62.59 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.516 0.674 . . . . 0.0 110.557 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.8 -9.93 59.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.077 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.74 47.94 58.43 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.16 103.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.782 0.801 . . . . 0.0 110.094 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 m -77.26 146.82 36.67 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.838 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 80.39 1.18 1.93 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 126.008 1.723 . . . . 0.0 113.001 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.62 23.28 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.8 tp10 -99.13 142.74 30.23 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -117.86 113.49 21.84 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.986 0.804 . . . . 0.0 108.887 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.34 100.98 32.62 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.3 134.56 9.1 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.718 2.279 . . . . 0.0 112.846 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -149.88 174.63 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -108.85 116.94 32.94 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.3 mp -96.43 133.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.832 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.403 ' HG2' HG22 ' A' ' 121' ' ' VAL . 61.8 mttm -92.9 129.5 38.8 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.5 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 41.8 p-10 -76.17 -163.92 0.34 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.51 -24.94 67.26 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.523 0.729 . . . . 0.0 110.679 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.16 -19.96 24.84 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.038 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 11.85 41.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.093 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -101.28 142.66 32.37 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.427 -0.455 . . . . 0.0 110.462 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 115' ' ' LYS . 13.7 t -78.9 88.56 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.2 m -110.59 1.38 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.774 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.94 64.5 0.54 Allowed Glycine 0 C--O 1.203 -1.806 0 C-N-CA 119.406 -1.378 . . . . 0.0 113.244 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -84.0 -19.72 4.7 Favored 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 120.375 2.087 . . . . 0.0 112.61 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -103.65 7.76 37.45 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.218 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -96.34 143.41 27.42 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.136 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.34 147.65 52.4 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.71 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.4 123.53 33.04 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 5.0 tt -91.11 128.14 36.81 Favored 'General case' 0 C--O 1.263 1.793 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -120.74 140.91 51.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.68 119.3 38.56 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.17 173.04 6.55 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.714 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.87 27.47 72.23 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.168 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.08 131.72 44.91 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.14 159.91 34.52 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 105.304 -2.109 . . . . 0.0 105.304 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.4 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 13.2 t70 -66.67 112.5 4.21 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.268 0.556 . . . . 0.0 111.344 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -129.83 -14.26 4.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.4 mt -61.29 117.61 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.305 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -63.84 129.12 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.764 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 65.6 mtt -116.34 5.9 13.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.868 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.5 -50.21 5.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.07 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -98.53 -31.51 11.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.373 0.606 . . . . 0.0 109.998 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 m -73.54 128.49 35.63 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -107.87 112.36 24.95 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -162.01 165.39 27.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.193 0.308 . . . . 0.0 111.085 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -127.3 146.17 50.54 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 124.583 1.177 . . . . 0.0 107.946 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.463 ' SD ' HG12 ' A' ' 155' ' ' ILE . 23.1 mmt -100.44 106.7 18.3 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.028 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.6 t70 170.3 76.39 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.384 1.074 . . . . 0.0 111.184 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 154' ' ' GLN . 5.7 p -101.53 -49.13 4.11 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.9 mt -131.57 -58.83 0.98 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.08 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -114.43 -179.26 3.58 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.345 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -33.99 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.377 174.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 9.1 p-10 -98.73 25.09 6.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 109.539 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.486 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 24.8 mm-40 -126.14 115.44 19.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.463 HG12 ' SD ' ' A' ' 147' ' ' MET . 23.6 mt -79.36 141.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -113.95 -73.44 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.78 121.15 26.06 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.3 mt -126.94 119.33 52.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.45 -42.28 7.8 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.576 0.703 . . . . 0.0 109.312 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.66 140.19 25.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.64 117.05 20.54 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.24 147.6 25.56 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 144.28 56.01 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.466 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.7 p-10 -93.99 10.69 32.47 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.126 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.4 p -69.69 -4.96 21.9 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.966 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.8 m -60.82 -39.21 88.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 124.297 1.039 . . . . 0.0 109.879 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.408 ' HB1' ' CB ' ' A' ' 137' ' ' ALA . . . -112.32 -31.84 6.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.322 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.458 HG13 ' CB ' ' A' ' 137' ' ' ALA . 70.2 mt -89.45 146.09 6.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.474 ' HD3' ' OD1' ' A' ' 171' ' ' ASP . 44.8 mtt180 -46.56 125.12 7.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 124.645 1.178 . . . . 0.0 113.401 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.46 -5.54 14.22 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.302 2.001 . . . . 0.0 109.93 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.474 ' OD1' ' HD3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.97 -8.54 57.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.875 175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.84 136.13 50.39 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.443 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 87.5 mttt -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.406 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.9 ttt -148.9 127.05 12.06 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -150.91 -178.66 6.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.91 148.77 40.96 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.538 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.454 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 34.9 m -84.97 121.85 28.37 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 124.326 1.016 . . . . 0.0 109.136 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.417 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 19.5 p -55.99 -50.3 71.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -169.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -82.47 9.74 8.6 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -173.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -137.99 113.29 9.37 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.484 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 11.2 ptp180 -57.53 -39.17 76.02 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -83.4 -30.58 27.24 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.731 0.812 . . . . 0.0 111.791 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.454 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 22.2 tp -63.79 101.32 0.35 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.03 126.15 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.647 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.63 133.81 51.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.432 0.634 . . . . 0.0 110.634 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.4 pt -116.47 154.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.439 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.463 ' HD3' ' OD2' ' A' ' 189' ' ' ASP . 76.3 mtt180 -79.5 163.39 24.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.816 173.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 13.3 pt-20 -58.75 -36.67 74.74 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.721 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.463 ' OD2' ' HD3' ' A' ' 187' ' ' ARG . 23.3 m-20 -54.99 -45.08 75.0 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.26 1.024 . . . . 0.0 110.087 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.4 t -64.38 -50.32 76.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.754 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.533 ' CD2' ' HA ' ' A' ' 188' ' ' GLU . 21.5 p80 -70.75 -29.86 66.21 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.595 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.71 80.81 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 122.549 0.34 . . . . 0.0 110.491 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.7 80.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.45 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.64 -33.1 64.37 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.6 mm-40 -60.03 -47.06 87.39 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.23 -21.22 54.13 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.194 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.06 -27.15 59.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.728 0.299 . . . . 0.0 110.648 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.63 39.62 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.878 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.9 mt -82.04 166.0 20.15 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.7 p -53.35 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -152.51 130.75 3.15 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.316 -1.421 . . . . 0.0 112.899 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.4 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 66.2 m-85 -124.26 157.63 34.41 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.38 120.59 30.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.94 139.32 44.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.343 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 75.2 m-85 -118.59 143.17 46.97 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.96 102.95 4.97 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.69 97.26 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 123.987 0.804 . . . . 0.0 112.182 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.12 87.02 3.59 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 98.85 35.4 4.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -68.54 100.31 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.831 0.452 . . . . 0.0 110.576 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -103.74 133.97 47.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.52 -25.58 0.28 Allowed Glycine 0 N--CA 1.478 1.485 0 N-CA-C 119.344 2.498 . . . . 0.0 119.344 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.45 146.64 24.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 118.647 1.224 . . . . 0.0 113.937 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.28 133.08 41.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.515 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 1.7 pt? . . . . . 0 C--N 1.314 -0.936 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.397 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.33 -74.37 1.24 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 t -92.36 158.86 15.86 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 m 67.34 98.32 0.05 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.777 1.631 . . . . 0.0 112.2 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -102.15 -27.89 12.63 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.1 m80 68.55 158.23 0.15 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.27 1.428 . . . . 0.0 113.346 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -140.44 110.18 6.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -83.9 -39.44 19.82 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.42 -173.02 3.16 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.688 0.795 . . . . 0.0 109.793 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -137.99 160.05 40.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -68.75 129.34 39.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -119.76 139.35 52.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.94 -40.65 5.82 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -87.19 79.03 8.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.612 0.72 . . . . 0.0 111.183 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.25 114.96 45.43 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -66.25 88.46 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.293 1.995 . . . . 0.0 114.449 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -147.82 153.39 39.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.63 76.7 0.55 Allowed Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.089 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -121.8 100.43 6.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.764 0.316 . . . . 0.0 111.481 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 177.9 -49.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.718 1.607 . . . . 0.0 108.748 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 tmt? 177.15 142.09 0.08 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.53 113.62 38.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.64 155.99 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 169.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.36 151.21 30.03 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.297 0.57 . . . . 0.0 111.466 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -127.93 144.36 51.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 79.1 t -76.8 118.02 22.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -97.94 126.1 43.18 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.536 0.684 . . . . 0.0 110.935 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -143.51 155.03 44.22 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.2 t -106.39 128.44 60.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.8 ptp -79.73 85.45 5.42 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.931 0.872 . . . . 0.0 110.248 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.54 113.39 4.46 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.684 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 -58.15 2.0 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.688 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 9.9 pt-20 -88.99 -7.12 56.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.96 11.16 23.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.652 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 105.39 102.67 2.81 Favored Glycine 0 N--CA 1.406 -3.358 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -97.22 166.19 11.69 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 162.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.5 mt -93.94 101.4 12.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 161.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 3.1 mm-40 -60.46 -50.25 74.33 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 124.523 1.139 . . . . 0.0 110.507 -172.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.13 156.24 44.75 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.494 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.8 mp -56.44 129.08 75.07 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 126.062 1.745 . . . . 0.0 114.16 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.15 167.33 27.15 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 123.022 2.482 . . . . 0.0 111.456 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.78 123.89 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -10.97 52.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.297 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 m -86.92 126.98 61.45 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.05 165.07 31.41 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.6 2.867 . . . . 0.0 111.027 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 p -48.23 149.4 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 -172.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -40.01 -54.19 2.27 Favored 'General case' 0 N--CA 1.507 2.421 0 C-N-CA 126.594 1.958 . . . . 0.0 113.141 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -82.3 -24.87 34.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.411 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 49.7 tptt -85.0 -14.73 46.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.434 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 28.9 m-85 -44.44 -45.76 9.25 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.824 0.703 . . . . 0.0 112.823 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.456 ' HB3' ' NH1' ' A' ' 176' ' ' ARG 0.334 35.9 m-70 -129.64 24.94 5.4 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -83.1 101.09 10.93 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.96 4.91 1.84 Allowed Glycine 0 CA--C 1.553 2.449 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.03 164.16 28.26 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 CA-C-N 119.118 1.459 . . . . 0.0 113.987 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.4 t -98.85 141.42 31.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 50' ' ' PHE . 82.7 mt -90.16 -2.04 58.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.112 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.01 68.95 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -89.66 -22.66 22.16 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -107.29 -24.06 12.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -101.69 132.56 21.57 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 122.72 9.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.96 1.774 . . . . 0.0 110.857 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -98.8 136.56 29.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 17.86 79.77 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.32 -163.0 30.62 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -126.31 132.82 51.55 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.38 167.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 32.7 t -154.55 153.51 31.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -97.06 110.48 23.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.2 p -71.65 153.12 42.3 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.49 0.493 . . . . 0.0 110.728 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -81.7 110.25 16.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 21.7 t-20 -97.63 -38.64 9.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 163.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -106.19 111.74 64.23 Favored Pre-proline 0 N--CA 1.421 -1.908 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.85 -58.23 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 123.58 2.853 . . . . 0.0 114.612 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.33 84.3 3.44 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.558 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -117.37 146.18 43.57 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 2.5 mpt_? -90.37 -168.69 2.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -73.65 178.62 4.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 114.061 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.37 152.28 22.03 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.141 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -122.23 -161.56 0.94 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -58.56 -32.83 69.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.425 0.631 . . . . 0.0 111.95 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.87 147.82 52.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.474 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -133.4 111.51 12.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 84.0 Cg_endo -81.81 -179.43 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.793 2.328 . . . . 0.0 111.639 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -164.21 179.18 7.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.141 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.6 mt -93.47 9.08 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 122.25 1.024 . . . . 0.0 109.018 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.4 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 29.6 mtm -115.42 -159.14 0.7 Allowed 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.418 -171.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -117.91 35.34 4.76 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.782 0.719 . . . . 0.0 112.177 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -133.31 158.07 43.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.608 -0.682 . . . . 0.0 109.828 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.8 tp -122.69 141.9 51.26 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 52.4 tp -110.83 129.32 55.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -129.11 141.34 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.806 0.691 . . . . 0.0 110.385 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.4 p -76.14 168.39 20.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.366 0.666 . . . . 0.0 111.402 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.54 98.78 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.441 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.21 -37.99 66.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.057 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.82 -32.88 71.54 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.986 0.422 . . . . 0.0 109.906 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -57.57 -45.43 85.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.774 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -64.82 -28.89 69.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.13 -54.84 27.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.74 -43.29 91.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 111.263 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -65.95 -41.17 91.6 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.2 p -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.57 -13.24 59.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.467 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.42 47.34 10.64 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.167 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.74 104.31 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.7 t -72.59 159.83 33.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.948 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 77.87 13.78 1.69 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 124.442 1.097 . . . . 0.0 111.157 173.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.35 114.43 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.605 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -106.55 139.18 41.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -114.77 115.64 27.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 123.853 0.721 . . . . 0.0 109.108 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.8 mt -111.83 96.9 35.47 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.18 143.13 12.51 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.488 2.126 . . . . 0.0 113.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.3 168.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.833 1.253 . . . . 0.0 108.842 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.37 116.08 28.65 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.4 mt -107.89 127.46 63.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.759 0.79 . . . . 0.0 112.236 -173.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 67' ' ' SER . 85.3 mttt -101.48 131.51 47.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.478 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.4 p-10 -76.37 -160.49 0.15 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.29 0.567 . . . . 0.0 111.401 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.057 0.543 . . . . 0.0 110.353 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.59 -20.4 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.73 0.643 . . . . 0.0 109.73 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.55 12.65 40.6 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.235 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.2 ptpt -95.81 145.02 25.68 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.99 82.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.584 0.707 . . . . 0.0 110.046 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 m -106.18 4.34 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.364 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.77 61.84 0.65 Allowed Glycine 0 C--O 1.204 -1.73 0 C-N-CA 120.545 -0.835 . . . . 0.0 113.025 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -83.93 -18.87 5.16 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 120.449 2.125 . . . . 0.0 113.652 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.75 20.84 13.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.439 1.114 . . . . 0.0 110.457 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.11 133.48 35.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.41 139.18 52.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.497 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -80.04 119.22 22.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.293 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 tt -86.65 128.3 34.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.9 m-80 -114.28 125.58 54.05 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -99.6 118.07 35.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.55 172.96 6.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.698 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.85 7.85 86.7 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.84 132.28 43.58 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.34 169.67 17.35 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.46 108.86 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.93 0.769 . . . . 0.0 109.366 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.479 ' CB ' HG13 ' A' ' 168' ' ' ILE . . . -135.49 -30.77 0.99 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -167.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 179' ' ' LYS . 52.5 mt -64.41 114.99 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.087 -176.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.36 115.38 5.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.446 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 mmt -77.67 -1.94 33.53 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.23 -50.82 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.38 -30.91 29.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.1 m -92.74 104.22 16.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.67 117.3 34.52 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -158.39 157.96 33.31 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.82 127.16 51.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 66.1 mtp -102.59 106.94 17.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.7 t70 177.57 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.623 1.169 . . . . 0.0 112.319 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 -30.99 11.95 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.5 mt -139.21 -58.4 0.59 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.19 -167.14 2.48 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.186 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 7.9 mmpt? -66.84 -18.44 65.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -172.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.477 ' HB2' HH21 ' A' ' 181' ' ' ARG . 1.4 p30 -87.0 -2.24 58.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.677 0.671 . . . . 0.0 111.146 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -107.61 125.88 51.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.35 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 73.7 mt -82.73 115.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.07 -56.52 1.59 Allowed Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.674 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.67 121.87 46.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.67 126.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -102.3 -43.33 5.73 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.302 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.26 142.21 26.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.68 119.9 23.08 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -109.28 147.53 32.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.65 131.0 49.53 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.251 0.969 . . . . 0.0 112.353 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.401 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 26.4 p-10 -96.52 16.6 18.28 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.035 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -68.52 -6.19 23.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.74 1.216 . . . . 0.0 110.908 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.0 m -63.95 -40.45 96.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.292 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.54 -31.8 6.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.479 HG13 ' CB ' ' A' ' 137' ' ' ALA . 61.2 mt -83.57 138.93 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.432 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 48.6 mtm180 -58.65 119.49 37.24 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.61 -4.68 13.59 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.485 2.79 . . . . 0.0 112.908 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.432 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 1.7 p-10 -79.44 -14.61 58.81 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.15 116.16 12.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.79 -19.73 60.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.409 ' HG3' HG23 ' A' ' 186' ' ' ILE . 27.5 ttt -146.73 123.59 11.3 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.52 -179.01 6.56 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.456 ' NH1' ' HB3' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -148.73 146.49 28.11 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 66.8 m -75.74 150.06 37.9 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.439 1.087 . . . . 0.0 112.736 -173.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -82.11 -24.79 34.94 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.411 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.9 mmtt -85.75 -4.56 59.2 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.126 -176.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.82 151.25 33.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.477 HH21 ' HB2' ' A' ' 153' ' ' ASP . 3.0 mmt180 -90.65 -39.86 12.23 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 123.793 0.837 . . . . 0.0 111.018 -171.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -84.62 -19.29 33.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.557 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.76 100.95 5.63 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.6 mt -110.63 135.07 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.76 122.56 44.81 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.441 0.638 . . . . 0.0 109.94 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.409 HG23 ' HG3' ' A' ' 174' ' ' MET . 38.9 pt -112.8 162.72 10.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.839 0.828 . . . . 0.0 111.467 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -78.8 143.67 35.84 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.472 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 6.5 pt-20 -54.53 -40.94 69.14 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.394 0.616 . . . . 0.0 111.873 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.87 -33.92 76.29 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 124.436 1.094 . . . . 0.0 112.01 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.24 -44.74 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.392 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 26.7 p80 -73.13 -22.8 60.46 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.211 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.61 72.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -73.48 -32.49 64.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.24 -36.81 74.73 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.69 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 72.3 mm-40 -56.26 -53.7 54.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.485 0.714 . . . . 0.0 110.715 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -73.23 -12.37 60.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.219 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.28 -27.52 24.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.889 0.376 . . . . 0.0 110.07 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.03 47.87 22.6 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.945 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 71.4 mt -82.66 157.25 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.255 5.2 p -41.95 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.72 125.66 2.26 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.431 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -120.8 156.33 32.13 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.336 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -129.99 120.63 25.07 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 16.2 m -133.88 142.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.262 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.39 155.46 49.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.195 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -65.18 129.55 40.11 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.461 0.476 . . . . 0.0 110.526 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -85.41 -40.5 16.38 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.297 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.84 101.02 3.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.496 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.78 29.88 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.522 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.13 108.78 0.64 Allowed 'General case' 0 CA--C 1.574 1.878 0 C-N-CA 124.171 0.988 . . . . 0.0 110.137 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -102.02 102.43 12.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 73.96 -22.16 1.23 Allowed Glycine 0 N--CA 1.475 1.252 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 167.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.37 148.8 46.64 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.494 0.647 . . . . 0.0 111.245 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -108.55 132.87 53.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 O-C-N 124.318 1.011 . . . . 0.0 113.123 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.94 40.57 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.666 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 m -96.59 92.29 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.186 0.517 . . . . 0.0 109.715 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.7 t -150.73 138.98 20.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -88.69 121.22 30.84 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -84.2 89.88 7.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.076 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -157.64 105.22 2.02 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 124.935 1.294 . . . . 0.0 108.844 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.49 98.76 4.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 m80 80.12 109.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.792 1.637 . . . . 0.0 111.765 -170.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -72.86 -24.44 60.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.1 m -60.84 109.0 0.94 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.122 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 t -145.39 109.28 4.78 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.31 130.12 6.95 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.406 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -121.53 102.35 8.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.9 t -92.0 111.23 48.9 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.39 153.74 35.55 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.89 2.394 . . . . 0.0 112.769 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.04 116.56 11.31 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.13 92.63 1.59 Allowed Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.948 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 m -82.13 85.27 6.81 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -88.25 -30.05 19.97 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.607 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.278 26.0 ptt? 51.49 80.1 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.42 1.488 . . . . 0.0 111.482 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.96 119.49 11.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.065 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG2' ' OE2' ' A' ' 188' ' ' GLU . 7.8 ptpp? -93.88 141.9 27.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.891 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -109.45 138.58 45.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -124.4 142.73 51.07 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.712 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -80.1 116.35 24.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -92.23 125.56 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.48 0.657 . . . . 0.0 111.795 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 0.0 OUTLIER -141.05 165.13 28.4 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.343 1.457 . . . . 0.0 107.11 175.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.47 144.49 20.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttm -91.06 85.87 6.06 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.38 133.66 13.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.153 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.477 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -123.25 -64.07 1.2 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -84.8 -21.47 29.9 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.559 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.54 25.61 1.21 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.005 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' HE21 ' A' ' 82' ' ' GLN . . . 123.77 60.7 0.19 Allowed Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 118.58 -1.772 . . . . 0.0 117.376 173.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 3.2 m-85 -92.3 127.96 37.97 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.563 0.681 . . . . 0.0 110.458 166.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -87.71 103.37 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.17 -50.95 19.76 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.275 0.56 . . . . 0.0 111.887 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -115.04 169.42 9.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 5.3 mp -71.55 133.89 84.61 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 123.141 0.577 . . . . 0.0 112.132 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.07 168.4 24.84 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.321 2.681 . . . . 0.0 113.355 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -48.32 115.72 1.31 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.441 1.497 . . . . 0.0 112.665 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.3 14.36 71.63 Favored Glycine 0 C--O 1.208 -1.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.0 m -84.54 145.13 44.14 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 118.124 0.962 . . . . 0.0 111.74 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.24 165.53 21.83 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.387 2.725 . . . . 0.0 111.119 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.4 p -58.35 153.19 16.02 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -46.19 -58.3 3.77 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.311 1.444 . . . . 0.0 112.99 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.402 ' CZ3' ' HG3' ' A' ' 52' ' ' GLU . 13.1 p-90 -71.2 -23.01 61.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.007 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -77.3 -21.85 52.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.187 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 70.6 m-85 -52.83 -26.51 14.75 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.249 0.547 . . . . 0.0 112.379 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -120.26 -0.16 10.5 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.402 ' HG3' ' CZ3' ' A' ' 48' ' ' TRP . 3.6 tm-20 -94.27 101.3 13.27 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.027 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -10.51 0.01 OUTLIER Glycine 0 CA--C 1.559 2.815 0 N-CA-C 120.711 3.044 . . . . 0.0 120.711 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.1 174.58 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.066 2.433 . . . . 0.0 114.04 -173.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -88.05 148.29 24.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.251 -1.34 . . . . 0.0 107.776 171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.0 mt -98.29 -1.73 41.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.588 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.62 68.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.166 0.508 . . . . 0.0 112.324 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.1 -14.95 52.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.742 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.95 -22.52 9.54 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -101.07 139.05 20.17 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.29 122.94 9.46 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.123 1.882 . . . . 0.0 112.632 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.71 122.88 43.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.48 62.51 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.5 -168.03 27.66 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.5 131.14 55.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.99 165.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -139.42 141.72 37.5 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 23.1 m-85 -69.52 122.89 19.94 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 123.857 0.723 . . . . 0.0 109.092 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 p -69.9 118.53 12.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.28 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -86.15 93.2 8.97 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 170.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -91.06 -37.69 13.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . 0.258 76.5 t80 -131.62 -70.76 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 175.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -90.18 170.33 4.04 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 CA-C-N 121.128 1.439 . . . . 0.0 112.246 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.46 80.24 9.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 8.7 t-20 -70.36 153.23 43.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.06 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -94.02 -148.58 0.27 Allowed 'General case' 0 C--O 1.256 1.44 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.95 -167.8 0.32 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.162 2.185 . . . . 0.0 114.525 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.02 149.94 27.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.171 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -114.04 -169.15 1.46 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.169 0.988 . . . . 0.0 109.006 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -65.84 -34.24 77.7 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.748 0.785 . . . . 0.0 110.274 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.444 ' CD1' ' HE1' ' A' ' 202' ' ' PHE . 57.1 m-85 -134.18 153.74 51.66 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.411 HE21 ' HA3' ' A' ' 35' ' ' GLY . 56.0 mt-30 -134.42 134.76 22.8 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.512 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.07 -179.26 1.74 Allowed 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.811 2.341 . . . . 0.0 111.36 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -163.48 171.52 15.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -101.12 21.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.88 1.324 . . . . 0.0 108.294 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 40' ' ' LEU . 63.4 mtm -102.31 -93.71 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.102 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.457 ' HB2' ' CB ' ' A' ' 50' ' ' PHE . 17.9 m -167.17 -33.3 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.85 174.66 7.84 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.3 tp -116.13 142.1 47.27 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.804 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.86 127.45 55.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.55 142.38 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.05 0.54 . . . . 0.0 110.169 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 p -83.8 168.91 15.72 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -66.04 -32.3 82.03 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.837 -0.22 . . . . 0.0 113.093 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -67.12 -41.15 86.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.528 0.68 . . . . 0.0 110.372 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.9 -24.3 52.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.112 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -61.4 -42.08 98.17 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.2 mmtp -60.94 -39.35 89.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.95 -55.8 29.64 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.393 0.433 . . . . 0.0 110.26 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.75 -45.35 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 112.075 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.33 -36.37 83.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -70.86 -22.03 62.35 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.5 mp -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.672 0.272 . . . . 0.0 110.949 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 47.18 13.62 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.8 t -79.74 100.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-O 121.427 0.632 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 m -80.88 154.26 27.16 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 84.5 m-20 80.63 15.21 0.7 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.62 1.568 . . . . 0.0 110.964 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.94 114.17 28.23 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 7.7 tp10 -104.34 133.1 49.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.408 ' CH2' HD13 ' A' ' 129' ' ' LEU . 68.5 m95 -109.21 123.55 49.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.278 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -111.4 93.49 19.2 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 135.1 15.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.698 2.266 . . . . 0.0 112.416 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.09 167.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.42 115.98 28.57 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.8 mt -106.84 128.16 61.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -97.25 142.06 29.6 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.431 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 9.1 p-10 -80.68 -162.35 0.46 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.861 0.362 . . . . 0.0 110.937 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.403 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 69.6 m80 -75.44 -9.44 58.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.522 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -109.34 2.01 20.43 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.807 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.3 7.14 80.26 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.55 139.06 32.36 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 118.602 1.201 . . . . 0.0 110.477 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.95 90.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.497 0.665 . . . . 0.0 109.803 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.66 8.55 5.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.714 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.84 45.06 1.15 Allowed Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.847 -1.168 . . . . 0.0 114.76 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -83.32 -0.37 9.85 Favored 'Trans proline' 0 C--N 1.368 1.585 0 CA-C-N 121.278 2.539 . . . . 0.0 111.924 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -92.88 -12.18 31.64 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.832 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -92.24 147.2 23.11 Favored 'General case' 0 C--O 1.255 1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.343 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.66 137.93 47.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.386 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -81.27 125.64 30.58 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.408 HD13 ' CH2' ' A' ' 109' ' ' TRP . 7.3 tt -99.75 125.13 45.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.41 0.624 . . . . 0.0 110.365 -176.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.413 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.2 141.37 52.14 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.622 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.512 ' HB2' ' HD2' ' A' ' 176' ' ' ARG . 3.0 mm? -98.92 144.28 28.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.85 174.72 5.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.29 1.436 . . . . 0.0 109.388 176.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.81 17.24 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.39 132.1 42.26 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 122.12 0.962 . . . . 0.0 113.341 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.0 165.5 30.56 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 168.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -53.57 101.9 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.228 1.376 . . . . 0.0 111.89 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -78.93 -66.59 0.85 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.161 -164.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.1 126.83 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 O-C-N 123.955 0.785 . . . . 0.0 112.251 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -69.1 122.77 19.44 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 tpt -90.51 -16.33 29.08 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.14 -35.61 9.95 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -91.69 -6.2 52.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.092 0.472 . . . . 0.0 111.265 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.2 p -89.41 143.81 26.54 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.71 103.4 7.8 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -151.24 168.03 26.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.391 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -116.78 144.03 44.96 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 124.317 1.047 . . . . 0.0 110.239 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.42 155.22 20.11 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 35.9 t70 91.94 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.067 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.5 m -101.06 -22.98 14.58 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 166.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 99.5 mt -160.87 -47.84 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.926 1.691 . . . . 0.0 107.245 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 42.7 mt-10 -131.97 179.61 5.98 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.093 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -72.0 -24.4 61.56 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 123.675 0.609 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -98.25 25.27 6.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.287 1.042 . . . . 0.0 109.946 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -122.29 116.2 23.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 59.3 mt -84.86 120.8 36.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 123.131 0.27 . . . . 0.0 110.45 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -83.13 -48.25 5.47 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.305 -175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -134.09 139.24 45.82 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 45.3 mt -125.05 134.06 67.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -103.24 -42.33 5.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.15 114.88 8.99 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.08 119.89 38.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 129.69 35.97 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.87 137.81 56.31 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 124.27 0.981 . . . . 0.0 112.62 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.407 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.9 p-10 -88.23 -0.2 56.83 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.708 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -67.1 -6.13 16.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.893 1.277 . . . . 0.0 109.967 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -64.05 -35.79 81.87 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.376 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.64 -33.26 6.18 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.82 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.12 154.33 5.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -67.45 117.12 44.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.3 -13.25 35.51 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.808 2.339 . . . . 0.0 112.462 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.99 -2.51 58.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.711 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 130.52 40.6 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 15.4 tppt? -68.68 -33.94 74.83 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.054 0.454 . . . . 0.0 111.395 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.2 ttt -149.25 135.4 19.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -151.62 -178.19 6.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.138 0.575 . . . . 0.0 110.18 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.512 ' HD2' ' HB2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -151.91 142.96 23.16 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.341 -176.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.546 ' SG ' HD23 ' A' ' 183' ' ' LEU . 83.8 m -69.61 146.23 51.88 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.335 0.397 . . . . 0.0 111.751 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.7 p -81.54 -48.68 11.5 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -72.23 -20.76 61.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.728 0.411 . . . . 0.0 111.563 -174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.48 133.67 55.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.437 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 10.7 mmt180 -90.58 -34.95 15.3 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.856 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -87.76 -20.92 25.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.376 0.608 . . . . 0.0 110.648 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.546 HD23 ' SG ' ' A' ' 177' ' ' CYS . 3.3 tt -84.13 114.07 21.51 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.5 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 71.2 mt -120.91 132.37 70.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 59.6 mt -111.17 124.18 51.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.319 1.056 . . . . 0.0 113.263 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 48.1 pt -112.68 154.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.966 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 17.3 mtp180 -83.63 162.26 20.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.431 ' OE2' ' HG2' ' A' ' 23' ' ' LYS . 7.8 pt-20 -51.74 -35.51 43.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.15 0.58 . . . . 0.0 111.824 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -46.19 -51.08 14.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.441 1.896 . . . . 0.0 111.335 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.57 -53.43 42.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.595 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 12.8 p80 -72.23 -25.4 61.62 Favored 'General case' 0 C--O 1.194 -1.816 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.334 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -34.72 73.64 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.855 0.359 . . . . 0.0 110.628 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.12 73.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.176 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -70.52 -32.91 70.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.171 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 53.6 mm-40 -59.12 -49.82 76.42 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-O 121.62 0.724 . . . . 0.0 109.136 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.38 -22.41 54.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.964 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.17 58.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.214 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.09 46.52 50.76 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.87 164.85 24.13 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.663 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 4.5 p -43.37 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.66 136.15 5.14 Favored Glycine 0 CA--C 1.493 -1.311 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.099 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.444 ' HE1' ' CD1' ' A' ' 81' ' ' PHE . 60.6 m-85 -135.68 162.62 32.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.73 122.12 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.64 133.48 66.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.079 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -126.51 132.52 51.36 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.48 115.02 6.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.13 65.08 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 124.021 0.826 . . . . 0.0 112.217 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.73 90.73 1.08 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.512 0.673 . . . . 0.0 110.258 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 81.19 35.1 24.7 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.475 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 19.8 t90 -59.87 98.63 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.7 0.8 . . . . 0.0 110.206 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -103.98 132.31 50.35 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.81 -9.09 2.06 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 165.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.475 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 95.4 mt -94.83 135.73 35.98 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 118.382 1.091 . . . . 0.0 112.819 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.15 133.04 36.15 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.417 ' HB2' ' HG3' ' A' ' 28' ' ' LYS 0.27 0.9 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptm . . . . . 0 C--O 1.241 0.653 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.19 -40.87 1.48 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -88.99 138.67 31.19 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 m 72.69 99.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.415 1.486 . . . . 0.0 110.864 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -100.2 162.19 13.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.8 t60 65.01 -78.8 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.965 1.306 . . . . 0.0 110.95 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.8 t60 166.98 84.84 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -123.52 96.8 5.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -173.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 53.0 t-80 -121.56 -92.05 0.55 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m170 175.37 127.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.995 2.118 . . . . 0.0 106.789 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 t 58.6 38.0 25.28 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.712 1.258 . . . . 0.0 109.082 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 9' ' ' HIS . 15.4 m -95.59 82.37 3.63 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.344 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.95 58.76 9.87 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.635 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -93.24 102.26 14.54 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.65 -0.324 . . . . 0.0 110.914 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.89 88.95 17.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.83 120.96 3.96 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.627 2.218 . . . . 0.0 111.834 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.92 96.28 7.63 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.202 0.525 . . . . 0.0 111.376 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.25 85.38 0.39 Allowed Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 p -76.63 -15.13 59.9 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.594 0.758 . . . . 0.0 112.253 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -168.28 -178.43 3.61 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -60.33 110.26 1.2 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.913 0.758 . . . . 0.0 110.258 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.483 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 67.3 t -84.79 122.22 37.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.628 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -103.28 150.72 23.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.177 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -125.85 155.93 40.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -138.06 142.47 40.3 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.357 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 20.6 t -81.91 121.32 35.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.5 131.48 37.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -150.73 164.68 35.57 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.7 t -99.66 128.33 51.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.467 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 27.3 ttt -88.32 100.36 12.95 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.095 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 166.7 142.96 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 126.203 1.801 . . . . 0.0 108.719 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -94.53 -31.5 13.88 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 30.7 mt-10 -84.44 -0.26 52.18 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.003 -175.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -78.15 0.46 24.83 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.22 103.43 1.05 Allowed Glycine 0 N--CA 1.402 -3.628 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -95.58 147.04 23.99 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 39' ' ' LYS . 12.6 mt -85.07 101.31 9.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 102.864 -3.013 . . . . 0.0 102.864 166.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.72 -37.99 64.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.765 -172.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 37' ' ' ILE . 35.4 mmtp -114.46 176.47 5.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.54 ' HG ' ' SD ' ' A' ' 86' ' ' MET . 4.6 mp -83.94 129.26 59.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.53 166.43 21.91 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.581 2.187 . . . . 0.0 112.892 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.87 127.1 30.38 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 124.065 0.946 . . . . 0.0 112.031 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.67 1.25 89.16 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 116.158 -0.474 . . . . 0.0 113.54 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.2 m -85.55 136.57 37.09 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.29 166.74 24.29 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.306 3.337 . . . . 0.0 112.096 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -50.88 148.88 3.8 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -45.9 -56.0 5.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.657 1.983 . . . . 0.0 113.448 -174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.518 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 17.2 p-90 -75.48 -26.53 58.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.343 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -78.7 -21.02 48.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.243 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' HA ' HD22 ' A' ' 56' ' ' LEU . 33.1 m-85 -45.76 -38.92 7.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -128.44 22.1 6.04 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.574 -0.704 . . . . 0.0 111.128 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 1.2 tm-20 -93.99 100.85 12.91 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.898 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.24 -3.51 0.07 OUTLIER Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 52' ' ' GLU . 2.4 pp -123.0 173.7 8.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -171.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -98.31 135.88 39.28 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.103 170.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 50' ' ' PHE . 91.7 mt -84.11 -1.72 55.46 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -24.84 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 111.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -88.08 -22.82 23.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -116.31 -21.88 9.09 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -103.48 138.15 19.45 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.77 123.22 12.24 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.656 2.237 . . . . 0.0 112.682 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.06 114.73 33.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.31 19.46 45.64 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.396 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -95.62 -166.54 34.91 Favored Glycine 0 C--N 1.307 -1.062 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.198 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.83 128.56 42.54 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.94 169.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -148.19 162.55 39.22 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.907 -0.496 . . . . 0.0 110.177 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 19.8 m-85 -75.98 163.97 26.63 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.25 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 p -92.47 137.04 32.7 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.555 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -86.05 51.53 2.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.703 -0.623 . . . . 0.0 110.934 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.31 -37.92 51.67 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -131.01 90.27 39.89 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.12 -30.96 73.26 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.864 3.043 . . . . 0.0 114.122 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.43 -6.65 51.13 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.087 0.47 . . . . 0.0 112.249 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.571 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 8.0 t-20 -71.52 145.5 49.1 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 34.2 mtp180 -78.47 -172.51 2.92 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.86 -165.73 0.87 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.46 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HA ' HE21 ' A' ' 82' ' ' GLN . 4.6 mp -87.74 150.58 23.5 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.277 0.561 . . . . 0.0 111.758 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 5.5 m-85 -114.79 -163.58 0.88 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.51 -44.2 93.19 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.481 0.658 . . . . 0.0 110.725 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.84 151.65 41.48 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.515 -1.22 . . . . 0.0 107.881 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.429 HE21 ' HA ' ' A' ' 78' ' ' LEU . 3.8 mm-40 -121.81 114.93 30.94 Favored Pre-proline 0 C--N 1.289 -2.036 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.51 168.08 7.35 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.548 2.832 . . . . 0.0 112.322 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -163.89 174.92 10.91 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 121.997 -0.44 . . . . 0.0 110.864 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.55 7.34 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.204 0 CA-C-O 123.103 1.43 . . . . 0.0 109.098 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.54 ' SD ' ' HG ' ' A' ' 40' ' ' LEU . 50.6 mtm -104.58 -164.19 1.03 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 m -121.4 53.68 1.16 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.813 -0.555 . . . . 0.0 110.991 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -136.84 155.11 50.21 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.7 tp -119.5 141.19 49.41 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.264 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.2 tp -117.16 130.17 56.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.84 139.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 122.56 0.344 . . . . 0.0 110.084 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.2 p -76.27 174.56 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.33 0.252 . . . . 0.0 110.691 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.95 -38.81 59.93 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -69.01 -38.57 79.33 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.08 0.467 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.4 63.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -62.15 -39.94 94.3 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.738 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -55.37 -40.36 71.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.812 0.695 . . . . 0.0 112.412 178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.14 -52.78 63.86 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.186 174.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.5 -45.03 99.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 C-N-CA 123.295 0.638 . . . . 0.0 112.2 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.4 -37.8 88.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -68.71 -22.14 64.37 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.211 0.529 . . . . 0.0 111.295 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.58 -8.55 58.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.806 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.28 44.5 74.83 Favored Glycine 0 CA--C 1.495 -1.195 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.115 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.88 104.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.504 0.668 . . . . 0.0 110.403 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 m -79.27 150.62 31.49 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 79.53 1.43 2.23 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.564 . . . . 0.0 112.878 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.51 114.74 25.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.2 tp10 -99.49 137.73 37.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.449 ' CH2' HD12 ' A' ' 129' ' ' LEU . 66.9 m95 -115.6 121.51 42.83 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.079 0.862 . . . . 0.0 109.209 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.67 98.31 49.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.26 124.9 6.14 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.497 2.131 . . . . 0.0 114.023 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.74 172.24 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.9 116.69 33.36 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -100.54 130.16 50.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -103.74 139.45 38.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 32.8 p-10 -83.91 -159.94 0.41 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 60.0 m80 -67.99 -14.87 63.31 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.079 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -19.48 16.53 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.2 20.18 21.35 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.703 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.4 ptpt -95.79 147.86 23.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.1 t -82.2 84.5 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.6 m -111.84 12.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.105 177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.51 51.81 0.85 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.35 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -84.72 -14.66 6.35 Favored 'Trans proline' 0 C--N 1.375 1.967 0 CA-C-N 120.795 2.298 . . . . 0.0 112.885 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -97.12 7.73 46.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.359 0.599 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.412 ' HB2' HD11 ' A' ' 114' ' ' ILE . 3.9 m-85 -102.02 148.35 25.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.569 0.699 . . . . 0.0 112.272 -170.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.6 142.63 41.26 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.608 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -82.47 131.05 35.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.452 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.9 tt -105.19 126.11 51.73 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.816 0.817 . . . . 0.0 110.091 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.39 141.2 52.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.051 174.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.59 141.78 30.21 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -123.6 174.47 7.41 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.318 1.047 . . . . 0.0 108.685 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 14.61 81.26 Favored Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.714 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.66 132.86 43.72 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.75 105.16 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 119.106 0.866 . . . . 0.0 112.015 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.23 -35.26 3.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -64.72 115.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.841 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.11 111.95 4.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.2 ttt -97.89 17.65 17.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.774 0.797 . . . . 0.0 110.23 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.55 -50.09 4.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.076 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 142' ' ' ARG . 2.7 mmp_? -97.12 11.43 36.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.191 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.0 p -104.88 154.38 20.14 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.154 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -133.81 117.37 16.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -166.0 172.34 11.56 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.58 0.55 . . . . 0.0 111.196 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.84 133.21 49.37 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.514 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 38.7 mtt -101.34 108.66 20.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.5 t70 172.78 73.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.705 2.002 . . . . 0.0 108.868 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 22.8 t -101.15 -49.45 4.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.05 -67.09 0.76 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.524 ' OE2' ' HG2' ' A' ' 154' ' ' GLN . 3.0 pp20? -109.07 -176.19 2.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 174.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 147' ' ' MET . 11.0 mmpt? -66.78 -30.88 71.2 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -171.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -104.85 26.27 9.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.673 1.225 . . . . 0.0 109.429 -176.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.524 ' HG2' ' OE2' ' A' ' 151' ' ' GLU . 15.3 mm-40 -106.8 123.55 48.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.194 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.6 124.33 39.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.824 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -103.35 -66.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.634 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -94.85 135.37 36.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.5 mt -131.9 145.14 35.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -110.44 -51.96 2.82 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 172.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.87 118.85 7.65 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.573 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.27 121.6 35.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.87 132.4 37.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -54.98 137.26 46.47 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.54 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.2 p-10 -92.69 -0.28 57.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.978 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.9 p -68.22 -6.16 22.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.07 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.6 m -63.84 -39.43 94.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.687 173.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 137' ' ' ALA . . . -110.8 -31.31 7.23 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 119.701 -0.799 . . . . 0.0 112.288 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 52.7 mt -89.03 150.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.48 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 27.7 mtp180 -57.92 122.37 57.09 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 122.535 0.334 . . . . 0.0 111.832 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.22 -5.76 17.72 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 123.419 2.746 . . . . 0.0 112.311 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 8.3 p-10 -96.47 -7.99 33.34 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.712 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.36 132.85 47.78 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -73.75 -40.24 63.66 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.206 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -142.85 123.98 14.51 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -146.39 -178.33 6.09 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.481 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -146.62 142.32 27.8 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.526 ' SG ' HD21 ' A' ' 183' ' ' LEU . 65.3 m -70.69 145.7 50.39 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 124.161 0.913 . . . . 0.0 111.607 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.8 p -82.21 -18.92 40.91 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -108.96 20.79 18.02 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.749 -173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 9.5 tp10 -172.6 116.63 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HD2' ' NE2' ' A' ' 154' ' ' GLN 0.275 0.0 OUTLIER -89.29 -11.19 44.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -173.012 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -90.56 -25.9 19.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.526 HD21 ' SG ' ' A' ' 177' ' ' CYS . 3.3 tt -77.74 100.85 6.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.3 mt -108.08 120.56 59.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 30.7 mt -93.05 125.5 37.67 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 121.706 0.765 . . . . 0.0 111.615 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.8 pt -110.85 139.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.883 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -81.38 162.4 23.39 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 22' ' ' VAL . 7.1 pt-20 -43.68 -44.24 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.463 1.105 . . . . 0.0 112.546 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -56.33 -44.83 80.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.64 1.576 . . . . 0.0 110.725 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.33 -48.05 82.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.591 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 9.3 p80 -74.02 -29.26 61.84 Favored 'General case' 0 C--O 1.197 -1.672 0 C-N-CA 118.061 -1.456 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.0 77.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.18 83.38 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.174 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -72.11 -34.81 68.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.211 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 56.5 mm-40 -62.33 -47.24 85.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.322 0.582 . . . . 0.0 109.555 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -75.06 -15.89 60.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.565 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -83.75 -27.12 29.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.782 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 72.61 47.65 26.34 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.462 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.74 164.58 25.12 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -46.46 -76.54 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 116.933 2.198 . . . . 0.0 116.933 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.66 130.79 1.91 Allowed Glycine 0 CA--C 1.498 -0.978 0 C-N-CA 119.029 -1.557 . . . . 0.0 113.213 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -129.19 159.37 36.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 122.418 0.287 . . . . 0.0 110.273 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 77.4 tttt -120.78 121.67 38.69 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.2 130.43 72.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.118 0.485 . . . . 0.0 111.058 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.411 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 85.0 m-85 -107.04 138.97 42.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.72 115.97 9.57 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.62 -45.37 37.76 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.591 0.557 . . . . 0.0 112.285 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.19 95.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.988 0.805 . . . . 0.0 109.547 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.63 35.65 28.21 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.882 -1.152 . . . . 0.0 111.922 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.418 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 9.3 t90 -46.06 107.12 0.09 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.528 1.131 . . . . 0.0 110.368 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -82.78 71.53 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.11 15.16 67.12 Favored Glycine 0 C--N 1.31 -0.9 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 167.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 92.1 mt -89.89 146.35 24.48 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 118.365 1.082 . . . . 0.0 109.875 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.1 134.09 35.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.244 0.778 0 O-C-N 124.335 1.022 . . . . 0.0 108.894 174.187 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.22 45.83 0.03 OUTLIER Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 108.196 -1.961 . . . . 0.0 108.196 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -103.55 13.67 32.88 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.885 -0.658 . . . . 0.0 111.662 -171.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -99.44 89.55 4.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.589 0.709 . . . . 0.0 111.407 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -107.79 -24.45 11.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.19 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -76.26 -26.13 55.65 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.918 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -81.16 84.47 6.54 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -177.42 -49.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.7 t60 67.18 -58.82 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.836 2.054 . . . . 0.0 113.606 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -76.7 82.79 3.33 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.938 0.495 . . . . 0.0 110.026 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -127.07 94.56 4.05 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -158.32 -36.35 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.049 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.46 -117.08 1.73 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 61.08 82.66 0.16 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.532 1.133 . . . . 0.0 112.021 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.5 t -111.11 106.36 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.82 95.49 0.24 Allowed 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.067 2.511 . . . . 0.0 113.393 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.37 84.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.998 1.319 . . . . 0.0 108.254 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.64 141.98 15.88 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.689 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 m -83.47 95.6 8.32 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -116.1 130.14 56.66 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.031 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.2 ttm -69.7 118.68 12.87 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.89 109.52 26.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 21.4 ptmt -93.15 154.43 18.08 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.34 135.46 50.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.368 0.604 . . . . 0.0 111.764 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -122.19 143.92 49.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.31 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.69 121.64 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -97.78 114.03 25.95 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 111.038 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -135.26 150.86 50.14 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.42 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.54 84.67 7.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.09 113.69 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.96 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.609 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 34.1 tt0 -112.94 -66.97 1.03 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -0.91 55.89 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.05 0.929 . . . . 0.0 109.5 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . . . -94.81 25.41 4.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 119.42 39.21 0.68 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 168.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.609 ' CD1' ' HA ' ' A' ' 32' ' ' GLU . 11.3 m-85 -69.22 128.36 36.36 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 120.233 2.017 . . . . 0.0 112.889 170.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.495 HG12 ' CE2' ' A' ' 68' ' ' PHE . 9.4 mt -84.37 101.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.47 -59.62 3.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.924 0.869 . . . . 0.0 109.366 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' O ' HG21 ' A' ' 37' ' ' ILE . 13.7 mptt -108.7 162.26 14.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.285 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 5.8 mp -70.31 139.75 87.29 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 124.639 1.212 . . . . 0.0 114.054 -171.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.8 166.43 29.3 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.449 2.766 . . . . 0.0 111.345 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -53.15 122.27 9.12 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.324 1.049 . . . . 0.0 112.856 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.01 7.22 70.69 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 114.734 0.654 . . . . 0.0 114.734 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.0 m -85.33 142.79 38.24 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD2' ' CE1' ' A' ' 50' ' ' PHE . 1.6 Cg_endo -75.51 166.08 29.3 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.848 3.032 . . . . 0.0 111.139 172.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -52.92 148.85 7.08 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.37 -52.55 4.53 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 127.243 2.217 . . . . 0.0 114.894 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -85.68 -30.08 23.46 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.747 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 52.6 tptt -81.16 -12.21 59.26 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.387 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 88' ' ' ASN . 40.7 m-85 -44.29 -50.31 9.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.688 0.617 . . . . 0.0 111.952 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 65.3 m-70 -128.91 32.33 4.78 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.58 -0.848 . . . . 0.0 113.257 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 7.8 tm-20 -92.45 101.37 13.82 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.52 -8.83 17.47 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.01 170.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.0 t -98.89 158.2 15.8 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.054 -1.884 . . . . 0.0 106.876 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.3 mt -113.07 15.5 19.53 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.91 67.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.068 0.461 . . . . 0.0 110.916 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -88.23 -21.85 24.29 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.453 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.19 -22.6 12.03 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.83 140.09 21.27 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.32 123.8 12.75 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.914 2.409 . . . . 0.0 112.73 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.89 117.09 45.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.91 14.99 61.92 Favored Glycine 0 C--N 1.318 -0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.55 -167.26 36.61 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.664 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.76 128.86 50.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 23.6 m -127.92 173.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 33.2 t -153.98 149.21 26.99 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' CE2' HG12 ' A' ' 37' ' ' ILE . 1.1 m-30 -76.76 128.86 35.42 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 167.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 71' ' ' ASN . 15.0 p -74.67 168.71 19.28 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.625 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -80.93 47.97 1.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 123.501 1.619 . . . . 0.0 109.355 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 69' ' ' SER . 20.1 p30 -71.41 -34.1 70.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.589 -2.096 . . . . 0.0 110.597 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -125.19 109.94 26.9 Favored Pre-proline 0 N--CA 1.417 -2.099 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 124.11 13.67 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.759 2.306 . . . . 0.0 113.662 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.19 15.48 9.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.111 1.364 . . . . 0.0 113.464 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -66.86 134.59 52.38 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.32 -175.58 1.6 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.45 -176.22 3.6 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.915 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.4 mp -98.0 151.84 19.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -167.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 34' ' ' ALA . 5.9 m-85 -111.4 -163.35 0.84 Allowed 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.87 -45.06 96.06 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 119.308 0.958 . . . . 0.0 110.611 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.13 145.31 47.95 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.524 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 27.8 tp60 -124.74 120.93 25.67 Favored Pre-proline 0 N--CA 1.416 -2.15 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.874 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.97 166.93 9.75 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 122.846 2.364 . . . . 0.0 112.326 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -157.58 168.98 25.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.501 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -90.0 0.52 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 122.759 1.266 . . . . 0.0 108.544 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.5 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 37.9 mtm -94.47 -147.33 0.26 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 36.8 p -144.99 27.26 1.31 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . 61.0 t30 -114.51 118.33 33.47 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.13 141.36 30.26 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.751 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 47.1 tp -108.75 123.05 48.41 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.2 t -128.52 139.13 52.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.483 -173.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.1 p -78.89 175.33 10.62 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.972 0.509 . . . . 0.0 110.967 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.59 73.17 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -61.66 -47.73 84.04 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.524 0.729 . . . . 0.0 111.324 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -31.47 68.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.08 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -60.1 -42.74 95.35 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.736 0.414 . . . . 0.0 110.28 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -56.51 -45.5 81.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 124.221 0.951 . . . . 0.0 110.496 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -58.8 -52.89 63.77 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.471 0.482 . . . . 0.0 111.797 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.9 mt -58.93 -44.47 90.96 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 C-N-CA 123.46 0.704 . . . . 0.0 111.776 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.21 -25.77 61.78 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.0 m -70.33 -26.35 63.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.34 -21.4 33.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.7 48.0 7.49 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.62 109.96 4.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.24 0.543 . . . . 0.0 110.019 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 m -75.36 146.96 40.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.678 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.07 12.05 1.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.504 1.522 . . . . 0.0 112.873 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.43 113.93 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.2 tp10 -111.0 141.87 43.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -116.26 119.19 34.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.408 ' HG ' HD22 ' A' ' 130' ' ' ASN . 68.8 mt -109.33 100.71 42.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.42 139.53 18.52 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.58 2.186 . . . . 0.0 113.418 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -148.22 162.26 6.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 124.552 1.141 . . . . 0.0 108.774 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.21 123.59 42.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -120.1 135.71 59.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -169.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.5 mptp? -98.09 150.63 21.23 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.589 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.3 p-10 -91.53 -163.05 0.98 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.903 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -66.02 -36.96 84.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 0.0 109.73 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.13 -19.25 47.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.32 14.69 29.77 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.722 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.589 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 17.2 ptpt -97.44 145.96 25.68 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.8 t -81.43 90.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.9 m -114.97 13.78 8.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.813 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.459 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -135.54 46.9 1.01 Allowed Glycine 0 CA--C 1.545 1.947 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.879 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.09 -13.99 7.47 Favored 'Trans proline' 0 C--N 1.379 2.166 0 CA-C-N 121.565 2.682 . . . . 0.0 111.426 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.1 -4.13 43.4 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.784 1.634 . . . . 0.0 110.438 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.459 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 5.5 m-85 -98.89 149.51 22.85 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.66 -171.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.5 147.54 43.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.208 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -85.13 128.7 34.76 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.926 0.393 . . . . 0.0 110.55 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.67 125.62 37.38 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.852 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.507 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 35.7 m-80 -101.03 132.4 46.47 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.337 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.91 114.47 28.77 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.25 172.6 7.69 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.855 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.68 16.86 80.4 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.8 132.72 34.52 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.13 169.22 19.16 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.24 112.06 4.93 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 164' ' ' ASP . . . -134.11 -17.71 2.09 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -165.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.7 mt -63.32 122.48 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 118.969 0.804 . . . . 0.0 111.023 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.49 128.14 35.52 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.189 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.405 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 63.2 mtt -119.53 10.35 11.78 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.709 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.66 -38.63 8.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.892 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -113.99 3.7 15.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.8 p -90.77 155.84 18.5 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 120.682 0.277 . . . . 0.0 111.396 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.425 ' CB ' ' HB2' ' A' ' 159' ' ' ASP . 64.6 mm-40 -122.04 106.04 10.84 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.405 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 6.2 p90 -164.35 162.87 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.96 0.409 . . . . 0.0 111.938 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.61 125.79 47.54 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 85.8 mtp -91.05 153.46 20.1 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.307 17.9 t70 88.57 82.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.663 1.585 . . . . 0.0 113.152 -177.243 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' CA ' ' A' ' 156' ' ' GLY . 11.7 p -100.83 -56.08 2.42 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.123 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.0 mt -99.8 -45.3 5.78 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 11.9 pt-20 -155.46 176.11 13.01 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.97 -21.59 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 119.689 1.132 . . . . 0.0 113.691 -170.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.46 12.35 10.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.101 0.953 . . . . 0.0 110.534 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.525 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 22.8 mm-40 -125.38 115.82 20.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.65 147.13 5.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.407 ' CA ' ' HB3' ' A' ' 149' ' ' SER . . . -110.77 -78.69 0.98 Allowed Glycine 0 CA--C 1.491 -1.431 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.698 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.28 123.01 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 44.0 mt -128.59 106.98 15.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 144' ' ' GLU . 20.2 m-20 -86.63 -34.73 19.72 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.04 110.61 2.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.293 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -84.26 124.01 30.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.37 147.04 25.65 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.62 139.44 55.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.117 0.886 . . . . 0.0 113.375 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 23.0 p-10 -93.61 3.51 55.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.06 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.9 p -66.22 -3.94 6.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.737 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -64.0 -39.95 95.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 123.534 0.733 . . . . 0.0 109.959 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -108.14 -32.82 7.36 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 118.601 -1.24 . . . . 0.0 111.269 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.417 HG13 ' CB ' ' A' ' 137' ' ' ALA . 74.0 mt -85.81 149.95 4.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.421 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 69.3 mtp180 -51.73 127.4 33.93 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.02 0.528 . . . . 0.0 112.01 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.93 -13.67 23.97 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.393 2.062 . . . . 0.0 111.33 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 7.9 p-10 -96.59 7.27 46.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.325 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 151.01 44.14 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.868 0.842 . . . . 0.0 109.78 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -102.19 -30.44 11.12 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.4 ttt -160.65 128.33 4.42 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -153.75 -179.2 7.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.128 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -137.05 139.24 41.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 60.4 m -72.75 146.64 46.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.767 0.667 . . . . 0.0 110.17 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.9 p -73.05 -50.42 23.09 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.51 15.45 17.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.79 110.13 6.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.525 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 13.2 ptt180 -76.85 -22.36 53.63 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.807 -170.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -86.82 -16.63 35.61 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.289 -0.257 . . . . 0.0 110.948 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.6 tp -87.06 99.76 12.15 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.802 0.81 . . . . 0.0 111.484 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.23 123.78 59.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.16 133.18 52.78 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.041 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 41.1 pt -121.58 158.61 24.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.989 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.605 ' HD3' ' OD1' ' A' ' 189' ' ' ASP . 9.1 ptp180 -85.07 162.06 19.45 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.9 pt-20 -54.13 -39.85 66.85 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.605 ' OD1' ' HD3' ' A' ' 187' ' ' ARG . 7.5 m-20 -52.53 -42.21 64.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.21 1.004 . . . . 0.0 111.304 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.04 -50.34 77.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.684 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.564 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 21.9 p80 -71.67 -31.06 66.39 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.525 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.97 73.31 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 111.025 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.43 -36.8 68.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.733 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -69.0 -35.57 76.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.345 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 18.8 mm-40 -55.65 -49.15 73.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -79.79 -22.8 42.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.295 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.32 -27.89 59.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.658 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 80.55 42.44 10.18 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.46 166.53 18.25 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 17.1 p -57.75 -164.1 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.71 134.83 12.88 Favored Glycine 0 CA--C 1.49 -1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 113.427 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -129.47 159.59 35.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -117.49 120.86 39.4 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.89 135.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -128.89 147.62 50.84 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.03 107.82 7.35 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.81 -33.95 77.21 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.684 0.793 . . . . 0.0 111.929 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.82 100.54 0.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.854 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 73.9 30.03 62.09 Favored Glycine 0 C--O 1.219 -0.824 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.424 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.65 104.58 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.182 0.993 . . . . 0.0 110.911 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.88 126.91 51.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.46 -25.58 0.27 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 119.362 2.505 . . . . 0.0 119.362 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 142.28 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -172.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.5 131.43 34.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.171 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 C--N 1.314 -0.935 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.481 -177.745 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.3 -165.7 48.89 Favored Glycine 0 C--O 1.253 1.309 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.8 m -91.75 91.62 8.04 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.501 0.667 . . . . 0.0 109.453 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -152.93 148.68 27.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -74.26 -57.51 3.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -152.61 -64.75 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -93.16 -20.5 20.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 64.91 11.81 7.3 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.818 0.847 . . . . 0.0 111.718 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . 0.383 28.6 m80 -92.23 75.54 5.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -173.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -141.65 38.13 1.66 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 m -48.15 138.92 8.92 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.385 2.274 . . . . 0.0 114.698 -172.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 m -136.51 -156.0 0.67 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.54 93.27 0.2 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.86 95.53 10.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.8 t -113.18 109.18 52.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.34 97.74 1.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 121.92 1.747 . . . . 0.0 109.263 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -78.98 132.68 36.76 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.521 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.61 -66.32 2.91 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 p -67.31 -70.48 0.25 Allowed 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 123.74 0.816 . . . . 0.0 111.681 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 73.1 -35.82 0.34 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.45 1.5 . . . . 0.0 113.435 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.2 ttp 65.9 79.88 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.36 137.72 21.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.911 -173.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 7.4 ptpp? -108.11 146.06 33.2 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -118.88 143.96 46.67 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.038 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 97.6 m-85 -126.87 151.3 48.57 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 -176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.0 t -85.89 129.9 37.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -95.92 135.3 37.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -150.61 158.79 44.56 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.23 131.11 60.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 13.4 tmm? -103.54 105.87 16.23 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.521 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 161.53 123.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.085 2.154 . . . . 0.0 108.662 173.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -86.84 -23.28 25.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.54 -13.94 62.31 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.394 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.53 64.64 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 77.82 1.08 Allowed Glycine 1 N--CA 1.391 -4.3 0 C-N-CA 118.943 -1.599 . . . . 0.0 114.127 177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -63.71 136.02 57.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.8 mt -68.36 104.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 40.1 mm-40 -54.29 -70.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.2 1.562 . . . . 0.0 111.283 -173.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 176.5 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.427 0.691 . . . . 0.0 110.022 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -72.14 130.92 85.77 Favored Pre-proline 0 C--O 1.252 1.22 0 O-C-N 123.93 0.769 . . . . 0.0 111.044 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 1.1 Cg_endo -78.62 167.4 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.912 2.408 . . . . 0.0 111.658 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.03 129.33 41.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.686 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.76 0.72 90.34 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.712 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 m -84.97 137.39 37.71 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 117.172 0.486 . . . . 0.0 110.183 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.31 165.55 10.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.306 2.67 . . . . 0.0 112.238 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -55.66 155.09 6.03 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -45.28 -51.47 10.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.232 1.413 . . . . 0.0 111.595 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.6 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 27.1 p-90 -85.94 -16.48 38.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.042 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . 0.423 54.4 mttt -86.75 -11.24 51.66 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 45.3 m-85 -49.87 -34.1 19.07 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 123.705 0.628 . . . . 0.0 111.944 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -128.04 20.33 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.579 -0.701 . . . . 0.0 112.616 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 0.9 OUTLIER -93.03 101.17 13.49 Favored 'General case' 0 C--O 1.2 -1.525 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.179 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.16 -10.98 0.01 OUTLIER Glycine 0 CA--C 1.556 2.612 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 168.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.52 173.84 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 121.12 2.46 . . . . 0.0 112.277 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -85.93 141.97 29.17 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.8 mt -87.79 -2.78 58.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.495 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.38 66.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.227 0.537 . . . . 0.0 111.904 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -87.63 -39.18 15.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.138 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.93 -21.33 18.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -99.06 141.48 22.95 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.01 122.8 9.69 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.053 1.835 . . . . 0.0 111.898 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.36 110.18 23.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.26 21.17 39.17 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.45 -153.55 30.33 Favored Glycine 0 C--O 1.252 1.262 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -141.61 139.1 33.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 28.9 m -133.73 166.44 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 m -144.09 150.31 37.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 120.771 0.32 . . . . 0.0 111.248 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -80.52 120.58 24.68 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 38' ' ' GLU . 14.1 p -61.32 139.87 58.09 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.697 0.623 . . . . 0.0 109.918 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.14 43.17 0.77 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.617 0.723 . . . . 0.0 112.537 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -70.07 -30.18 67.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.854 0.835 . . . . 0.0 110.067 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.458 ' CD1' ' HB2' ' A' ' 75' ' ' ASN . 2.7 t80 -106.92 113.15 62.94 Favored Pre-proline 0 N--CA 1.423 -1.775 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.98 -58.58 0.87 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.17 2.58 . . . . 0.0 113.202 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -112.91 92.28 3.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.79 0.805 . . . . 0.0 110.293 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 72' ' ' TYR . 36.2 t-20 -133.1 151.31 52.02 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.42 -165.89 1.41 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -164.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.22 -172.94 4.25 Favored 'General case' 0 C--O 1.194 -1.867 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.438 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.604 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 4.6 mp -87.64 143.8 26.99 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -100.14 -178.72 3.92 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.19 0.596 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -60.56 -35.25 75.59 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.515 0.674 . . . . 0.0 110.116 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -129.58 126.98 39.75 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.604 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -115.92 125.35 28.73 Favored Pre-proline 0 C--N 1.279 -2.462 0 O-C-N 123.515 0.509 . . . . 0.0 110.35 -174.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 175.34 8.71 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -163.37 166.63 22.7 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 123.261 0.624 . . . . 0.0 109.586 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -99.91 28.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.4 mtm -116.24 -79.86 0.59 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 50' ' ' PHE . 35.2 t -179.18 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.349 0.565 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -77.66 164.45 25.29 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.598 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.29 141.48 36.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.451 0.569 . . . . 0.0 110.1 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.5 tp -110.8 125.26 53.38 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -125.42 147.09 30.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.2 p -77.91 170.2 17.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.742 0.306 . . . . 0.0 110.342 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.9 -18.7 79.4 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -74.31 -52.53 11.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.56 -23.61 63.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.472 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' ' CH2' ' A' ' 109' ' ' TRP . 54.9 ttt180 -57.74 -43.97 85.74 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.041 174.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.6 mmpt? -65.07 -39.41 93.2 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.23 -54.58 45.13 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.368 0.418 . . . . 0.0 110.326 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.1 -46.51 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.461 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.26 -26.91 65.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -72.66 -25.0 61.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.033 0.444 . . . . 0.0 111.156 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.1 -1.51 57.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.305 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.06 47.78 63.32 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.542 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.4 t -73.69 112.73 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -80.27 141.19 35.76 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.739 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 78.32 15.85 1.3 Allowed 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 125.282 1.433 . . . . 0.0 112.263 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.62 113.97 19.18 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 8.4 tp10 -104.72 124.81 50.04 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.52 ' CH2' HD12 ' A' ' 129' ' ' LEU . 61.9 m95 -108.55 120.15 41.6 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.235 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -109.75 94.13 16.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.72 133.57 12.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.601 2.201 . . . . 0.0 112.532 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.79 160.08 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.625 0.77 . . . . 0.0 109.977 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.82 116.73 29.22 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -108.96 136.98 43.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -100.06 146.47 26.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.8 p-10 -90.12 -163.96 1.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.766 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -67.16 -32.39 73.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.139 0.975 . . . . 0.0 111.138 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -83.59 -18.5 38.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.204 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.12 20.54 20.49 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.063 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 20.0 ptmt -105.55 153.42 21.79 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -86.7 90.18 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.531 0.681 . . . . 0.0 109.24 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.26 13.23 6.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.088 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.489 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -127.78 39.72 1.87 Allowed Glycine 0 CA--C 1.552 2.361 0 C-N-CA 119.437 -1.364 . . . . 0.0 116.335 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.76 -0.58 8.7 Favored 'Trans proline' 0 C--N 1.375 1.923 0 CA-C-N 122.013 2.907 . . . . 0.0 112.624 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.54 -9.67 24.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.946 0.899 . . . . 0.0 110.662 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.489 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 16.5 m-85 -103.59 153.99 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.363 -165.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.28 142.81 35.68 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.6 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.29 122.33 26.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.52 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.4 tt -101.16 122.14 43.09 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.325 0.583 . . . . 0.0 110.007 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.401 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.36 140.02 53.17 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.393 172.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.52 141.05 29.5 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.52 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.37 173.55 6.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.08 11.51 72.85 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.987 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.02 132.99 35.08 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -137.36 170.22 16.45 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.24 113.21 1.47 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 164' ' ' ASP . . . -139.38 -19.16 0.97 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.2 mt -64.17 112.86 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.279 0.561 . . . . 0.0 110.981 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.58 115.22 10.51 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.084 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.6 mtt -99.07 6.17 46.69 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.181 0.515 . . . . 0.0 110.594 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -84.7 -46.28 11.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -102.72 -11.96 18.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.283 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 m -90.76 148.21 22.71 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.833 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -135.0 112.75 10.85 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -158.17 173.17 17.11 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.19 138.16 53.07 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.052 0.541 . . . . 0.0 109.708 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.9 mmt -87.16 108.06 18.74 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -175.51 63.74 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.9 m -102.82 -56.31 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.074 170.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 75.6 mt -134.58 -57.16 0.84 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.07 -173.69 2.31 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.902 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -95.07 4.83 53.28 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -103.59 16.52 26.23 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.496 HE22 ' HB2' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -133.34 125.01 28.24 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.255 -174.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 76.0 mt -84.47 119.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 123.365 0.416 . . . . 0.0 110.212 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -98.82 -62.68 0.85 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.246 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.76 133.1 42.74 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.32 -34.73 5.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.672 0.749 . . . . 0.0 109.892 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.97 117.0 18.58 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -98.32 146.8 25.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.24 146.66 52.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.86 0.838 . . . . 0.0 112.012 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 18.5 p-10 -90.08 8.92 30.25 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.3 p -69.38 -6.27 28.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.343 172.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -60.96 -39.97 91.58 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 124.623 1.169 . . . . 0.0 109.662 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -31.98 6.65 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.263 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.56 141.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 62.9 mmt-85 -60.61 118.34 33.52 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 123.28 0.363 . . . . 0.0 110.132 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -5.37 11.25 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.977 3.118 . . . . 0.0 115.012 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.07 -9.71 58.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.431 0.158 . . . . 0.0 111.377 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.14 114.06 13.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -80.6 -8.69 59.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -152.64 118.75 5.49 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.421 ' HE2' ' OD1' ' A' ' 164' ' ' ASP . 35.9 p90 -148.48 -179.47 6.98 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.861 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -143.88 147.32 33.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.422 ' HG ' ' CG ' ' A' ' 164' ' ' ASP . 44.4 m -80.61 151.49 29.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 124.22 0.95 . . . . 0.0 111.19 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.1 p -81.42 -50.28 9.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -85.52 30.27 0.64 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.531 ' N ' HH21 ' A' ' 181' ' ' ARG . 0.3 OUTLIER -160.27 147.24 15.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.6 ' HD2' ' O ' ' A' ' 48' ' ' TRP . 8.7 mmp_? -91.18 -39.0 12.36 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -14.72 17.68 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.122 0.264 . . . . 0.0 110.785 -170.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.03 100.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.243 1.02 . . . . 0.0 109.813 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.45 122.95 67.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.6 mt -107.39 130.02 54.85 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.182 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 46.5 pt -118.24 149.77 20.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.361 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -82.27 152.97 26.11 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.451 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 10.4 pt-20 -49.04 -41.23 34.3 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.419 0.688 . . . . 0.0 112.338 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -53.12 -40.86 64.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.628 1.571 . . . . 0.0 112.462 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.17 -49.3 62.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.891 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.566 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 25.5 p80 -71.42 -24.55 62.06 Favored 'General case' 0 C--O 1.198 -1.641 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.067 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.34 80.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.001 0.52 . . . . 0.0 110.604 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 196' ' ' GLN . . . -69.22 -33.2 72.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.188 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 16.6 m-85 -73.35 -32.83 64.75 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.879 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 59.2 mm-40 -63.24 -42.96 99.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 193' ' ' ALA . 2.8 pt20 -77.55 -24.69 49.8 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.159 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 -27.3 43.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.233 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.1 42.79 75.26 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.663 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.61 165.19 24.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.611 0.364 . . . . 0.0 110.995 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.9 p -39.14 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.97 141.19 9.18 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.391 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.31 165.21 28.06 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -157.29 121.84 4.38 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 25' ' ' PHE . 26.8 m -125.29 146.96 30.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.448 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -125.11 142.44 51.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.112 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.86 114.65 2.18 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.16 -35.03 61.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.81 94.55 2.77 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.812 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.72 35.12 7.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.19 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -67.77 97.49 0.64 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.14 0.495 . . . . 0.0 110.583 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.06 132.24 51.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.01 -25.44 0.25 Allowed Glycine 0 N--CA 1.479 1.55 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 165.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.85 127.13 32.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 117.777 0.788 . . . . 0.0 112.618 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.6 131.19 37.69 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.611 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 C--N 1.308 -1.227 0 O-C-N 124.026 0.829 . . . . 0.0 109.728 -178.238 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 C--O 1.218 -0.558 0 N-CA-C 110.685 -0.117 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.16 14.86 9.46 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 119.649 -1.262 . . . . 0.0 114.092 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -98.99 96.95 8.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -101.16 149.91 23.49 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -79.37 79.92 5.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.879 0.847 . . . . 0.0 110.591 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -90.42 135.03 33.94 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.205 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -126.81 103.82 7.72 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.628 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -78.55 -24.01 45.86 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.352 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -147.01 -86.12 0.1 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.634 168.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 50.45 65.02 1.57 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.345 1.458 . . . . 0.0 110.606 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.6 t -109.09 -162.97 0.84 Allowed 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.771 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.8 m 66.08 29.07 10.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.201 1.0 . . . . 0.0 111.029 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.85 73.08 0.63 Allowed Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -92.99 165.02 13.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.116 0.484 . . . . 0.0 111.262 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.67 91.46 25.48 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.44 117.51 5.16 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.104 1.869 . . . . 0.0 110.923 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -106.91 122.86 47.26 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.846 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.78 -53.07 3.29 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.0 m 64.11 160.08 0.1 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -179.09 174.24 1.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.6 ptm -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.528 1.058 . . . . 0.0 109.529 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.426 HG13 ' HD3' ' A' ' 187' ' ' ARG . 58.0 t -85.11 120.77 36.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.309 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -94.01 152.81 18.54 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.298 0.57 . . . . 0.0 111.635 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 140.73 43.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.523 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -124.0 151.08 44.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.467 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.26 118.04 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -92.18 117.99 30.4 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -136.47 139.81 42.62 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 83' ' ' PRO . 97.1 t -89.54 120.86 38.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 120.723 0.297 . . . . 0.0 110.422 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 49.6 ttp -82.44 86.42 6.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.0 0.905 . . . . 0.0 110.224 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.79 112.76 6.37 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -119.47 -58.7 1.89 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.398 -173.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.94 -21.52 43.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB3' ' CE1' ' A' ' 79' ' ' TYR . . . -67.02 -35.76 80.63 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 95.92 158.02 32.02 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 114.064 -1.426 . . . . 0.0 114.501 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 46.4 m-85 -96.57 166.06 11.86 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.09 101.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 101.501 -3.518 . . . . 0.0 101.501 163.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -65.64 -44.29 86.86 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.055 0.847 . . . . 0.0 111.892 -167.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -132.44 176.03 8.77 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.72 119.55 71.86 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.622 0.769 . . . . 0.0 112.725 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.76 167.75 24.85 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.759 2.306 . . . . 0.0 113.02 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -42.47 114.54 0.59 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.138 1.775 . . . . 0.0 113.421 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.61 79.23 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.551 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.6 m -85.54 139.62 35.81 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.63 165.96 23.67 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 123.79 2.993 . . . . 0.0 111.554 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.7 p -49.15 146.33 3.65 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -37.83 -56.73 1.07 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.114 2.565 . . . . 0.0 113.595 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -86.23 -22.06 27.09 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.825 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 47.0 tptt -86.61 -12.24 49.14 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.398 -169.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 53.0 m-85 -44.05 -49.54 8.74 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.646 0.591 . . . . 0.0 112.571 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.279 30.8 m-70 -127.92 31.68 5.07 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.1 tm-20 -92.84 100.71 13.13 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.36 -10.25 3.76 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 174.76 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.354 2.077 . . . . 0.0 113.295 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 t -96.37 158.48 15.42 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.484 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.5 -13.33 40.51 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.845 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.07 -26.55 49.82 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.74 -20.17 25.12 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -116.51 -22.07 8.89 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.583 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -100.17 138.51 20.27 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.29 123.06 10.15 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.175 1.917 . . . . 0.0 112.581 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.41 114.85 29.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.26 18.28 59.34 Favored Glycine 0 C--N 1.311 -0.843 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.25 -161.84 37.52 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.178 -0.534 . . . . 0.0 111.985 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -129.14 131.75 47.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.38 170.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 t -147.11 147.13 30.27 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.4 110.25 2.2 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.838 171.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 p -62.31 123.86 19.35 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.975 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -85.63 81.26 8.72 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.47 -39.14 91.63 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.143 0.497 . . . . 0.0 110.827 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -170.84 -53.35 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.396 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.39 118.57 5.76 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 120.898 1.065 . . . . 0.0 111.494 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.47 99.75 8.93 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.6 178.49 4.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.674 -174.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -90.94 -154.25 0.34 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.606 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -86.2 -177.44 6.26 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.054 1.342 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.15 150.45 23.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.855 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.474 ' CE1' ' HB3' ' A' ' 34' ' ' ALA . 20.8 m-85 -114.14 -166.68 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.69 -40.94 94.07 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.773 0.715 . . . . 0.0 111.844 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -118.58 147.71 43.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.608 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -132.54 126.77 20.29 Favored Pre-proline 0 C--O 1.249 1.039 0 C-N-CA 123.069 0.548 . . . . 0.0 110.361 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 63.4 Cg_endo -92.53 178.56 1.39 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.575 2.183 . . . . 0.0 112.503 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 6.5 p30 -163.94 173.74 12.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.62 -9.49 10.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.336 1.065 . . . . 0.0 109.619 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -95.25 -178.1 4.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.501 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 5.7 p -93.02 39.17 1.04 Allowed 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.9 159.56 34.54 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.427 ' HB2' ' NH2' ' A' ' 176' ' ' ARG . 53.6 tp -124.19 141.53 51.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.15 118.33 36.46 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.44 144.28 29.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 p -75.08 167.37 22.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.08 -20.46 79.68 Favored Glycine 0 C--N 1.31 -0.868 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -70.79 -57.64 4.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -25.61 67.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.265 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 50.9 ttt180 -54.94 -51.1 67.16 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 124.02 0.928 . . . . 0.0 110.171 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -69.27 -25.32 64.2 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.749 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.26 -49.55 77.42 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.897 0.379 . . . . 0.0 110.189 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.1 -37.06 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.526 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 61.2 mt-10 -67.37 -33.34 75.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.205 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.0 m -65.74 -33.84 76.81 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.028 0.531 . . . . 0.0 111.548 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.38 -6.8 58.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.244 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.32 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.85 109.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.541 0.686 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.9 m -80.3 154.85 27.57 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 80.31 14.21 0.84 Allowed 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.76 114.11 27.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.5 tp10 -112.91 138.93 49.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -119.75 116.31 25.67 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -172.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.7 mt -109.11 99.46 35.89 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.27 145.16 23.9 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.448 2.099 . . . . 0.0 112.584 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.4 m -149.57 166.3 3.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 123.633 0.773 . . . . 0.0 109.226 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.05 28.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.3 mt -113.07 132.46 61.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -98.08 147.55 24.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.13 -160.66 0.43 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.452 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 67.0 m80 -74.63 -22.73 58.77 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 122.265 -0.272 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -87.56 -18.8 28.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.449 0.468 . . . . 0.0 110.194 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.65 36.92 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.033 173.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -101.8 148.49 25.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.634 0.717 . . . . 0.0 110.563 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.16 89.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.468 0.651 . . . . 0.0 110.493 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.4 m -115.6 13.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.433 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.19 49.96 0.9 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 119.97 -1.109 . . . . 0.0 115.245 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.49 -8.28 9.58 Favored 'Trans proline' 0 C--N 1.376 2.025 0 CA-C-N 121.335 2.568 . . . . 0.0 111.458 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -92.06 -14.29 29.53 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.41 1.484 . . . . 0.0 110.788 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.03 150.89 21.25 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.883 0.849 . . . . 0.0 112.958 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.46 143.52 39.68 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.438 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.23 117.95 20.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.27 127.59 37.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.92 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.5 m-80 -110.42 127.54 55.15 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.655 -177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.33 125.59 47.98 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.31 172.9 6.55 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 -7.91 81.07 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.82 129.56 34.83 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.85 0.833 . . . . 0.0 109.153 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -148.56 170.11 18.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -46.4 108.82 0.15 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.988 0.805 . . . . 0.0 110.127 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -126.34 -47.21 1.6 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -165.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 26.2 mt -61.69 118.82 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 119.353 0.979 . . . . 0.0 112.611 -172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.76 127.92 34.31 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.713 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.4 mtt -94.46 -0.41 54.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.32 -50.63 5.55 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.559 0.695 . . . . 0.0 110.12 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -93.75 -9.36 37.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.216 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -108.14 140.5 41.25 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -120.73 100.51 7.15 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -145.74 165.03 30.0 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.703 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -120.82 147.72 44.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.167 0.917 . . . . 0.0 109.611 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 53.0 mtt -100.47 154.18 18.75 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.291 36.3 t70 90.76 84.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.844 2.457 . . . . 0.0 112.108 -176.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.2 t -99.49 -36.62 9.49 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.611 -1.631 . . . . 0.0 107.621 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.9 mt -136.65 -54.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 12.7 pt-20 -137.32 -179.82 5.96 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.583 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -48.19 -49.48 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.302 1.841 . . . . 0.0 114.634 -171.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.454 ' HB2' HH21 ' A' ' 181' ' ' ARG . 7.7 p-10 -90.09 10.93 22.4 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -102.42 116.57 32.9 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.473 ' H ' ' HG2' ' A' ' 180' ' ' GLU . 70.2 mt -74.31 129.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -108.5 -60.14 0.54 Allowed Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.988 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -92.83 119.15 31.87 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.0 109.91 27.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.03 -34.31 16.85 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.75 138.95 20.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.86 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.8 114.85 15.84 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.78 147.64 25.83 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 140.42 57.33 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.816 0.817 . . . . 0.0 112.916 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -94.65 16.14 16.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.286 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 168' ' ' ILE . 18.2 p -67.01 -5.77 14.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.034 175.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.8 m -64.65 -33.43 75.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.323 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -32.95 6.34 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.249 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 165' ' ' THR . 66.7 mt -92.45 122.23 43.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -56.47 127.82 72.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 118.023 0.374 . . . . 0.0 111.504 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.06 -5.36 6.22 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.601 2.867 . . . . 0.0 115.427 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -80.24 -9.21 59.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.062 0.392 . . . . 0.0 111.13 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 127.2 31.82 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.112 0.482 . . . . 0.0 110.098 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.51 -36.75 76.76 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.036 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' MET . . . . . 0.401 ' HG3' HG21 ' A' ' 186' ' ' ILE . 26.5 ttt -148.29 132.03 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.3 -179.79 7.85 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.507 0.504 . . . . 0.0 109.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' A' ' 89' ' ' LEU . 14.6 ttm180 -136.12 139.56 43.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 183' ' ' LEU . 63.9 m -74.63 139.44 43.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 O-C-N 124.062 0.851 . . . . 0.0 110.105 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 p -82.7 -12.75 57.35 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -90.24 -5.0 56.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.866 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -151.32 142.77 23.49 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.454 HH21 ' HB2' ' A' ' 153' ' ' ASP . 17.5 mmt180 -89.35 -30.41 18.42 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -170.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -86.39 -25.35 25.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.093 0.473 . . . . 0.0 110.561 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.49 HD23 ' SG ' ' A' ' 177' ' ' CYS . 3.0 tt -75.18 102.54 5.01 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.812 -172.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.89 142.2 19.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.2 mt -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.376 0.608 . . . . 0.0 111.1 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.401 HG21 ' HG3' ' A' ' 174' ' ' MET . 44.9 pt -124.72 157.7 32.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.652 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.426 ' HD3' HG13 ' A' ' 22' ' ' VAL . 97.0 mtt180 -80.25 159.63 25.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.469 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 7.5 pt-20 -52.82 -37.56 60.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.729 0.812 . . . . 0.0 110.799 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.43 -42.93 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.282 1.833 . . . . 0.0 111.629 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.67 -45.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.771 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 16.3 p80 -69.6 -30.56 68.34 Favored 'General case' 0 C--O 1.2 -1.538 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.425 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -61.35 -32.03 71.91 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.301 0.572 . . . . 0.0 111.044 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.19 61.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.4 m-85 -74.52 -33.91 62.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.956 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 42.2 mt-10 -63.03 -48.89 76.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.149 0.58 . . . . 0.0 110.585 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.43 -18.57 63.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.926 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.59 -22.26 22.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.673 0.273 . . . . 0.0 111.294 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.25 46.12 66.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.58 158.72 20.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 38.4 p -106.31 139.69 40.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 108.29 56.41 0.58 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.732 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 46.1 m-85 -135.36 142.16 45.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 118.62 1.21 . . . . 0.0 112.464 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 21.1 tptm -146.24 122.77 11.07 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.47 137.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.416 0.627 . . . . 0.0 111.999 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.1 m-85 -129.0 143.68 50.95 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.276 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.7 66.81 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -69.86 100.32 1.53 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.069 0.461 . . . . 0.0 110.556 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.07 28.03 38.71 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.566 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -54.85 102.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.604 1.161 . . . . 0.0 110.893 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -103.88 111.53 24.11 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.22 1.98 23.45 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 165.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 58.3 mt -95.06 131.57 40.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 118.452 1.126 . . . . 0.0 110.103 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -90.26 132.49 35.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.547 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.8 pt? . . . . . 0 C--N 1.305 -1.369 0 O-C-N 123.717 0.635 . . . . 0.0 111.904 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.78 -80.68 0.64 Allowed Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 p 57.19 179.06 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.344 1.457 . . . . 0.0 114.167 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -82.02 93.46 6.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -98.18 76.95 2.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.442 0.639 . . . . 0.0 109.59 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -166.97 34.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -81.78 74.85 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.903 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -61.67 162.4 8.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.34 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -100.78 133.76 44.77 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -87.2 135.96 33.11 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t 73.65 140.29 0.06 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.794 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -64.8 -32.22 73.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.911 -176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.47 20.36 76.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.2 mt -128.36 128.05 43.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.09 117.73 36.66 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.15 98.52 0.54 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.826 1.684 . . . . 0.0 110.388 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -76.87 -46.21 25.42 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.821 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.26 148.12 19.35 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -83.3 84.51 7.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.814 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -83.47 114.66 21.63 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.431 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 25.5 mmt -70.54 -27.28 64.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -171.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 84.3 t -81.77 115.93 25.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.093 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.37 151.49 49.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.587 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -111.22 134.54 52.73 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.028 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.3 144.09 44.27 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.151 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.1 119.16 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -91.55 124.89 36.06 Favored 'General case' 0 N--CA 1.422 -1.838 0 O-C-N 123.809 0.693 . . . . 0.0 109.454 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -150.3 159.28 44.56 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.413 HG13 ' CA ' ' A' ' 201' ' ' GLY . 91.3 t -101.69 129.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.8 ptp -69.85 160.91 30.92 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.84 0.712 . . . . 0.0 111.139 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 70.76 118.96 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 124.996 1.435 . . . . 0.0 112.214 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.82 -20.12 62.6 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.008 0.909 . . . . 0.0 109.524 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.75 -16.29 62.75 Favored 'General case' 0 C--O 1.206 -1.21 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.972 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.57 -30.0 62.67 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.551 0.74 . . . . 0.0 112.63 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.56 79.0 1.24 Allowed Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 119.412 -1.375 . . . . 0.0 112.043 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -69.66 151.9 45.33 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' A' ' 68' ' ' PHE . 28.7 mt -73.91 101.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 166.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.19 -41.64 75.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.863 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.22 160.27 43.92 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -51.16 136.72 29.1 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 33.3 Cg_endo -78.52 166.84 23.54 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.208 2.605 . . . . 0.0 111.606 173.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -53.94 117.02 2.87 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.54 1.136 . . . . 0.0 113.274 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.31 10.37 64.05 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.2 p -86.01 148.37 47.81 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.66 165.67 30.08 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.508 2.805 . . . . 0.0 110.212 169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -59.88 155.6 16.09 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -39.93 -54.86 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 127.556 2.343 . . . . 0.0 114.015 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 34.6 p-90 -86.51 -20.9 27.35 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.379 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -86.43 -12.64 48.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.483 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.509 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 52.4 m-85 -46.04 -34.27 3.99 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.457 ' NE2' ' HA ' ' A' ' 88' ' ' ASN . 40.2 m-70 -129.82 15.54 5.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.31 101.82 14.07 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.072 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.12 -9.99 2.75 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.64 172.9 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.63 1.715 . . . . 0.0 111.466 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 t -98.33 157.05 16.43 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.21 -16.73 48.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -23.67 58.78 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -86.86 -22.12 25.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -115.83 -22.87 8.88 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -96.85 135.62 22.04 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 124.05 11.73 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.917 2.411 . . . . 0.0 112.176 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.61 125.6 50.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.94 23.01 62.51 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.756 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.97 -157.05 24.18 Favored Glycine 0 C--O 1.25 1.131 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.154 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.4 130.86 46.53 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 33.1 m -126.19 166.5 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 19.9 m -149.17 149.91 31.79 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CE2' HG12 ' A' ' 37' ' ' ILE . 11.1 m-30 -71.92 117.03 13.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -63.89 147.37 52.08 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.221 0.534 . . . . 0.0 112.228 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -69.59 76.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.562 1.173 . . . . 0.0 113.649 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -106.78 -37.32 6.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.812 -1.54 . . . . 0.0 106.878 171.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -142.75 124.64 8.69 Favored Pre-proline 0 N--CA 1.435 -1.181 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.964 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.79 15.64 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.86 2.374 . . . . 0.0 109.339 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.05 -164.87 1.12 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.673 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 73.78 167.0 0.3 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.953 1.301 . . . . 0.0 112.213 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.7 mmm-85 -79.23 -173.93 3.89 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 121.901 0.858 . . . . 0.0 112.044 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -81.24 -171.96 3.53 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.146 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.36 150.69 21.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.649 0.738 . . . . 0.0 111.859 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.92 -161.19 0.75 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.869 1.268 . . . . 0.0 107.783 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -75.08 -34.62 61.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 118.762 0.71 . . . . 0.0 111.127 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.25 134.35 55.26 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 33.4 tp60 -119.31 127.55 26.41 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.45 -179.79 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.042 2.495 . . . . 0.0 113.577 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -163.57 178.84 7.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.292 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.2 mt -103.85 34.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.5 mtp -129.56 -155.92 0.73 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.509 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 40.0 p -119.73 -11.06 9.44 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.457 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 25.9 p-10 -88.19 159.36 18.19 Favored 'General case' 0 C--O 1.201 -1.448 0 O-C-N 121.669 -0.644 . . . . 0.0 110.838 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.75 135.11 54.98 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 61.1 tp -100.13 120.66 40.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.12 139.07 48.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.506 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.4 p -73.98 164.34 26.75 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.64 -21.65 77.84 Favored Glycine 0 C--N 1.327 0.074 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -75.4 -48.35 23.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.18 73.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.249 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 73.1 ttt180 -56.17 -44.16 79.08 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.382 1.073 . . . . 0.0 110.277 174.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -46.68 83.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 124.071 0.857 . . . . 0.0 110.407 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.71 -55.24 31.93 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.312 1.008 . . . . 0.0 111.234 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.13 -40.27 80.55 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 C-N-CA 123.692 0.797 . . . . 0.0 111.637 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 81.5 mt-10 -68.69 -35.12 76.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -69.46 -30.47 68.38 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.17 -17.1 57.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.44 20.9 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.698 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.8 113.73 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.9 t -82.6 153.6 25.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 73.58 16.85 3.86 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 124.684 1.194 . . . . 0.0 112.227 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.47 113.5 26.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -105.38 143.45 33.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.449 ' CH2' HD12 ' A' ' 129' ' ' LEU . 58.9 m95 -117.35 119.78 36.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -174.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.1 mt -111.82 96.04 31.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.84 134.44 14.84 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.75 2.3 . . . . 0.0 113.031 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 m -150.2 172.59 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.223 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.96 116.18 28.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -97.45 121.05 47.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.406 0.622 . . . . 0.0 111.145 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 67' ' ' SER . 94.4 mttt -96.28 133.82 40.16 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.614 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.4 p-10 -78.22 -160.31 0.2 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.258 0.551 . . . . 0.0 111.205 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -61.28 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.261 1.024 . . . . 0.0 110.765 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -84.66 -19.56 32.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.323 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.7 21.86 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.24 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.614 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.3 ptmt -102.99 142.31 34.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.3 t -83.7 84.31 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.526 0.679 . . . . 0.0 110.213 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.46 0.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.312 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.89 58.77 0.7 Allowed Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.52 -11.38 8.22 Favored 'Trans proline' 0 C--N 1.367 1.5 0 CA-C-N 120.623 2.211 . . . . 0.0 111.631 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.71 -5.28 39.12 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 124.837 1.255 . . . . 0.0 109.762 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.482 ' HB2' HD13 ' A' ' 114' ' ' ILE . 1.8 m-85 -93.14 152.23 19.37 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.608 -172.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.15 146.64 40.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.123 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.27 118.81 25.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.305 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.5 tt -91.65 128.68 37.57 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.11 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 121.09 34.37 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.153 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.58 128.47 33.43 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.422 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -102.98 174.95 5.64 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 125.573 1.795 . . . . 0.0 107.625 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.6 20.55 63.7 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.542 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.59 131.95 36.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.84 158.1 43.92 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.71 106.83 0.39 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.265 0.939 . . . . 0.0 111.399 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.68 -18.44 7.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.99 113.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.029 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.57 127.77 33.91 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.688 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.4 ttm -117.93 7.61 12.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.25 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -95.34 -34.93 11.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.057 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -94.31 -31.48 14.04 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.6 m -75.71 158.51 32.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.748 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -137.09 105.52 5.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.04 165.63 33.52 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.771 0.319 . . . . 0.0 111.753 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -118.18 134.29 55.14 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' MET . . . . . 0.458 ' SD ' HG12 ' A' ' 155' ' ' ILE . 11.5 mmt -74.01 156.38 37.59 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.145 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.556 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.336 16.3 t70 100.41 99.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 172.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 m -100.49 -55.78 2.51 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 165.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.1 -42.94 2.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.795 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 5.4 pt-20 -142.99 -178.59 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -46.37 -49.39 17.93 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 125.87 1.668 . . . . 0.0 115.164 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.4 27.58 1.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.814 1.293 . . . . 0.0 112.318 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -123.71 115.78 21.98 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 104.654 -2.351 . . . . 0.0 104.654 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.458 HG12 ' SD ' ' A' ' 147' ' ' MET . 57.1 mt -84.63 124.92 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 118.388 0.54 . . . . 0.0 110.775 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.93 -66.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.131 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -93.0 119.5 32.32 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.3 mt -125.12 125.12 68.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -103.86 -34.21 8.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.372 0.606 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.07 137.07 14.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -127.18 119.3 26.11 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.71 147.21 24.59 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.65 145.91 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.54 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 30.6 p-10 -89.42 4.54 48.72 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.156 0.983 . . . . 0.0 110.63 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -66.1 -6.48 13.32 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.374 1.07 . . . . 0.0 109.997 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -59.3 -40.98 87.9 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.66 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.77 -32.85 6.28 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.172 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 81.0 mt -81.23 141.99 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -55.47 114.61 7.58 Favored Pre-proline 0 N--CA 1.45 -0.446 0 O-C-N 123.409 0.443 . . . . 0.0 110.763 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.45 -19.3 67.04 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 123.261 2.641 . . . . 0.0 113.867 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.59 -11.72 60.52 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.903 0.481 . . . . 0.0 112.074 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.41 48.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 123.654 0.597 . . . . 0.0 110.67 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.5 -38.56 14.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.9 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.7 ttt -141.47 125.27 16.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.46 -177.96 6.69 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.012 0.925 . . . . 0.0 108.64 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.453 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -142.65 151.63 41.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 118.444 0.565 . . . . 0.0 111.76 -177.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.592 ' SG ' HD23 ' A' ' 183' ' ' LEU . 67.2 m -82.86 129.98 35.07 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 124.157 0.911 . . . . 0.0 109.479 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.5 p -64.06 -51.07 65.82 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.31 22.91 2.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.32 139.68 39.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.474 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 16.2 mmt180 -91.28 -27.29 18.52 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.924 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.69 -0.4 20.12 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.329 -172.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.592 HD23 ' SG ' ' A' ' 177' ' ' CYS . 1.8 tt -95.11 103.66 15.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.562 0.696 . . . . 0.0 109.315 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.2 mt -111.84 140.47 31.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.409 HD13 ' OD2' ' A' ' 164' ' ' ASP . 53.0 mt -116.78 137.24 52.34 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 118.584 0.629 . . . . 0.0 112.412 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.0 pt -129.36 151.8 36.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.653 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -80.29 163.44 23.95 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.739 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 0.2 OUTLIER -55.36 -42.08 73.41 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.493 0.717 . . . . 0.0 110.534 176.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -50.49 -39.72 49.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.872 1.669 . . . . 0.0 112.135 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.24 -46.88 76.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.922 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.519 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 14.8 p80 -77.2 -21.94 53.13 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.089 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.67 80.07 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.523 0.678 . . . . 0.0 110.38 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.47 73.97 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.093 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.71 -32.48 67.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.0 mm-40 -57.1 -49.63 75.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -81.51 -7.02 59.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.88 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.57 -27.28 18.29 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 122.097 -0.377 . . . . 0.0 110.167 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 66.98 43.31 91.56 Favored Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 155.72 21.2 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.0 p -106.15 139.37 40.77 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.413 ' CA ' HG13 ' A' ' 29' ' ' VAL . . . 106.44 56.6 0.64 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.634 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -126.95 147.61 50.09 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 121.206 0.527 . . . . 0.0 111.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -156.85 121.76 4.56 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.6 139.53 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.728 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 97.3 m-85 -128.55 151.33 49.57 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 210' ' ' TRP . 20.3 mm-40 -64.66 121.28 14.12 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.27 45.74 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.21 90.12 2.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.347 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.39 32.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.95 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.481 ' HB2' ' O ' ' A' ' 206' ' ' GLU . 19.6 t90 -58.77 105.35 0.3 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.851 0.861 . . . . 0.0 110.618 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.84 105.55 15.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.8 -24.42 0.3 Allowed Glycine 0 N--CA 1.474 1.172 0 N-CA-C 119.177 2.431 . . . . 0.0 119.177 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.87 115.34 3.33 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.117 0.958 . . . . 0.0 110.567 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.52 125.6 28.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.566 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.103 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -96.91 148.02 23.37 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.46 137.07 47.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.612 0.72 . . . . 0.0 111.828 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.71 151.35 49.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.621 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG13 HD12 ' A' ' 183' ' ' LEU . 80.8 t -81.6 130.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 172.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -91.73 122.11 33.98 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.712 0.768 . . . . 0.0 110.81 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -138.57 152.48 48.21 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.02 127.51 56.77 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.556 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 12.0 tmm? -85.78 84.42 7.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.56 112.47 3.72 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.528 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.39 -45.92 3.98 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.258 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.97 -12.26 59.92 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.02 120.72 2.11 Favored Glycine 0 N--CA 1.409 -3.119 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.659 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -70.76 152.13 44.12 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mt -78.49 101.4 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -72.73 -42.28 64.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.189 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.526 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 41.1 ttmt -133.01 141.78 48.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.32 132.37 95.32 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 55.6 Cg_endo -74.73 167.55 26.85 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.891 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -54.5 124.64 16.77 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 112.727 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.99 68.51 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.287 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -85.65 133.26 42.2 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.47 165.53 32.44 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.294 2.663 . . . . 0.0 109.948 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 p -51.92 149.46 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.23 -50.45 3.61 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 128.243 2.617 . . . . 0.0 113.684 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -85.89 -25.89 25.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.966 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -80.57 -15.38 56.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.649 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -44.83 -47.55 11.01 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.634 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 2.8 m-70 -127.01 30.12 5.5 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.76 -1.213 . . . . 0.0 109.869 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HA ' HH21 ' A' ' 176' ' ' ARG . 2.1 tm-20 -92.88 101.99 14.36 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -9.23 0.31 Allowed Glycine 0 CA--C 1.54 1.603 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.23 168.2 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 118.779 1.289 . . . . 0.0 112.801 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 t -97.09 154.48 17.31 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.5 mt -102.38 10.64 38.93 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.441 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.36 -29.55 70.54 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.726 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.9 -13.73 38.41 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.119 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -114.98 -21.97 9.8 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.29 134.81 20.36 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.87 127.47 25.26 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.278 2.652 . . . . 0.0 113.268 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.53 115.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.24 22.91 50.38 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.971 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -102.56 -167.32 26.47 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.01 141.85 49.34 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 117.511 0.656 . . . . 0.0 109.265 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 31.1 m -133.71 165.92 30.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.0 t -153.07 153.85 33.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.183 0.516 . . . . 0.0 111.211 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.95 117.93 19.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.889 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.526 ' OG ' ' HB3' ' A' ' 39' ' ' LYS . 12.8 p . . . . . 0 N--CA 1.417 -2.102 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . 0.27 90.6 m-20 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 122.048 0.927 . . . . 0.0 112.872 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -88.61 -154.88 0.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.954 1.301 . . . . 0.0 111.336 -169.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.67 -167.46 1.63 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.937 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -87.31 150.69 23.69 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.372 0.669 . . . . 0.0 112.089 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -105.83 -159.55 0.71 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -71.37 -42.18 68.77 Favored 'General case' 0 CA--C 1.48 -1.749 0 CA-C-N 119.086 0.857 . . . . 0.0 110.624 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -120.83 135.69 55.1 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 35.5 tp60 -116.4 117.99 37.91 Favored Pre-proline 0 C--N 1.28 -2.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.59 162.62 27.34 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.939 2.426 . . . . 0.0 112.058 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -163.81 174.32 11.71 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.181 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.25 -6.47 10.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.444 0.64 . . . . 0.0 110.311 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -96.55 -174.78 3.13 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.847 -0.533 . . . . 0.0 111.273 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -96.41 43.88 1.07 Allowed 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.214 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -138.33 151.33 47.45 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.01 138.85 54.58 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 51.7 tp -105.96 129.61 54.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.184 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.08 140.36 49.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.054 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -70.82 167.3 19.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.063 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.47 -37.67 92.86 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.502 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -72.25 -37.43 69.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.35 -30.52 62.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.351 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.406 ' HG3' ' CE3' ' A' ' 109' ' ' TRP . 49.3 ttp180 -58.41 -48.71 79.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.099 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 10.2 tmtt? -62.43 -37.44 85.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.936 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.79 -53.21 59.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 120.583 0.23 . . . . 0.0 111.105 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.2 -41.5 87.01 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.17 -31.14 71.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.313 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -71.42 -22.08 61.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.54 -19.81 32.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.96 0.41 . . . . 0.0 110.551 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.06 48.05 7.19 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.269 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.1 t -78.97 114.57 19.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.4 t -80.03 158.24 26.55 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.137 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 78.5 19.19 0.95 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.316 1.01 . . . . 0.0 110.406 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.03 134.03 50.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.498 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.9 tp10 -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE3' ' HG3' ' A' ' 96' ' ' ARG . 52.2 m95 -117.0 118.62 32.92 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 123.459 0.475 . . . . 0.0 110.082 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.12 102.49 43.52 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.99 129.98 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.744 2.296 . . . . 0.0 113.683 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' GLY . 12.1 m -142.87 172.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.359 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.72 116.23 29.53 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.529 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.4 mp -101.59 124.93 55.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.468 0.651 . . . . 0.0 110.966 -176.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 87.3 mttt -97.35 132.14 43.36 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.6 -161.56 0.24 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -62.6 -31.57 72.42 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.44 -4.27 55.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.739 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.74 14.75 79.22 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.709 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 20.1 pttp -104.84 140.06 38.68 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.534 0.333 . . . . 0.0 110.247 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.23 107.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.43 -0.29 6.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.417 0.627 . . . . 0.0 110.905 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.87 75.95 0.34 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.45 -27.68 2.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.093 1.862 . . . . 0.0 113.773 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -118.53 23.38 11.55 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.813 1.292 . . . . 0.0 109.285 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.529 ' HB2' HD13 ' A' ' 114' ' ' ILE . 2.9 m-85 -88.66 144.86 26.01 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.528 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.77 46.43 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.758 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.7 126.88 32.32 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.534 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 tt -90.54 125.28 35.56 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.846 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.634 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 14.8 m120 -107.15 137.03 45.98 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.955 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.21 120.58 42.96 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.9 172.96 6.52 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 124.029 0.83 . . . . 0.0 110.649 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 22.78 64.24 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.54 131.19 37.87 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -147.88 151.61 36.18 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -52.89 115.19 1.71 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.966 0.791 . . . . 0.0 112.09 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -131.93 -26.36 1.97 Allowed 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -167.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 17.7 mt -62.36 125.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.72 125.74 26.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 23.0 ttt -118.83 1.88 11.57 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.737 0.78 . . . . 0.0 109.718 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.4 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 11.2 pt-20 -99.57 -32.56 11.04 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.73 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.4 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 68.0 mtt85 -108.02 -10.87 15.41 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.182 0.593 . . . . 0.0 110.552 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.5 m -93.84 110.6 22.25 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.362 0.601 . . . . 0.0 110.603 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -78.61 100.72 7.09 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.379 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.49 145.46 27.93 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.239 0.543 . . . . 0.0 111.904 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -101.3 127.97 47.67 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 71.8 mtp -100.73 154.56 18.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 24.0 t70 90.71 85.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 127.269 2.228 . . . . 0.0 114.1 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.7 m -100.43 -26.77 13.76 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.322 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -145.99 -48.05 0.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 14.3 pt-20 -139.75 177.79 7.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.16 -38.58 80.09 Favored 'General case' 0 C--O 1.214 -0.782 0 O-C-N 124.292 0.995 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 25.7 m-20 -85.97 26.11 1.04 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -123.46 113.31 18.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.0 mt -87.03 132.29 32.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 124.238 1.015 . . . . 0.0 109.946 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.05 -72.51 0.95 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.478 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -90.76 133.11 35.42 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.65 124.51 59.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.84 -34.55 8.49 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.04 136.87 20.55 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.85 123.73 29.67 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.84 143.2 32.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.67 139.64 57.07 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.767 0.794 . . . . 0.0 112.96 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.58 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.7 p-10 -94.33 15.55 17.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.112 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.7 p -67.45 -5.22 13.88 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.892 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.1 m -61.57 -38.14 86.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.959 0.903 . . . . 0.0 110.673 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.406 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.63 -30.5 7.08 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.788 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 137' ' ' ALA . 73.8 mt -85.82 139.2 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -54.79 117.96 15.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 O-C-N 123.189 0.306 . . . . 0.0 111.243 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.16 -13.18 33.97 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.419 2.746 . . . . 0.0 114.037 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.84 -12.73 60.22 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.76 129.06 38.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.075 0.464 . . . . 0.0 109.83 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -83.63 -17.0 43.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.794 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.424 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.0 ttt -154.38 128.16 8.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -153.36 178.52 9.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 178' ' ' THR . 1.6 ppt_? -128.47 142.43 51.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.414 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 58.2 m -86.52 140.48 29.87 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 123.832 0.708 . . . . 0.0 109.483 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 176' ' ' ARG . 19.3 p -68.75 -44.56 73.5 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.745 2.868 . . . . 0.0 118.745 -168.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -89.19 23.7 2.38 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.544 0.611 . . . . 0.0 112.333 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 9.0 tp10 -154.94 135.6 13.53 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.418 HH21 ' CD ' ' A' ' 151' ' ' GLU . 69.8 mtt180 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.9 mtm-85 -83.81 -7.37 59.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.767 -167.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 180' ' ' GLU . 26.2 tp -82.42 100.63 10.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.819 0.818 . . . . 0.0 110.973 -174.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.1 mt -117.84 124.38 72.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 207' ' ' ALA . 43.4 mt -103.94 134.71 46.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.523 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.0 pt -123.68 157.74 29.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.597 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -86.06 162.43 18.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.62 -44.63 26.95 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.199 1.399 . . . . 0.0 111.996 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.22 -43.56 70.94 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.439 1.096 . . . . 0.0 111.301 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.31 -53.19 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.178 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 13.7 p80 -75.31 -26.54 58.76 Favored 'General case' 0 C--O 1.195 -1.804 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.714 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.99 83.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 0.0 110.351 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.77 72.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.552 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.457 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 21.0 m-85 -73.57 -36.43 65.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.247 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -56.92 -50.75 71.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 121.625 0.726 . . . . 0.0 109.218 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.91 -26.67 61.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.21 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.53 -27.47 62.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.425 0.155 . . . . 0.0 111.046 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.9 47.51 13.85 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.05 165.87 18.2 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.8 p -42.15 -72.83 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -165.96 144.43 9.19 Favored Glycine 0 CA--C 1.488 -1.637 0 C-N-CA 118.998 -1.572 . . . . 0.0 113.118 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 194' ' ' PHE . 74.5 m-85 -137.37 152.78 50.05 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 22.4 tptm -132.21 121.84 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 24.7 m -116.43 139.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.563 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -121.68 151.44 40.47 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.62 133.39 40.9 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.207 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.405 ' HB2' HD22 ' A' ' 185' ' ' LEU . . . -80.13 -38.34 31.73 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.936 0.874 . . . . 0.0 108.642 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.74 104.8 13.26 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.004 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.55 35.33 47.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.523 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.439 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 8.7 t90 -54.31 102.18 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.082 1.353 . . . . 0.0 111.217 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.55 109.89 21.74 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.73 2.94 31.82 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 167.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.439 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 82.7 mt -94.14 145.37 24.74 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 117.902 0.851 . . . . 0.0 109.738 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.2 0.524 . . . . 0.0 111.459 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.997 178.42 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.455 HG11 ' NE ' ' A' ' 187' ' ' ARG . 45.0 t . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -87.01 155.8 20.01 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.317 0.579 . . . . 0.0 112.3 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -112.06 138.45 48.7 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.158 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.85 150.92 49.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.46 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.8 130.0 36.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -95.72 128.86 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.512 0.507 . . . . 0.0 111.141 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -150.12 149.58 30.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.94 115.56 41.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.657 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 57.0 ttp -85.28 101.61 12.67 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 173.56 177.19 0.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.144 1.778 . . . . 0.0 107.56 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.17 -36.21 1.53 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 122.04 0.924 . . . . 0.0 110.147 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -89.64 -0.85 57.79 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.962 1.305 . . . . 0.0 111.46 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.18 58.5 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.57 82.69 1.14 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.253 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -95.01 164.61 12.82 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.31 102.21 13.41 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.87 -55.42 29.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.917 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -137.03 176.47 8.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 46' ' ' THR . 7.8 mp -55.37 125.74 60.08 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HB3' ' HB ' ' A' ' 66' ' ' VAL . 16.4 Cg_exo -71.44 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 123.031 2.487 . . . . 0.0 111.344 169.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -55.8 117.16 3.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.889 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 9.11 83.52 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.281 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m -85.79 139.32 35.22 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -67.59 166.28 24.52 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.686 2.924 . . . . 0.0 112.619 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.406 ' HA ' HD21 ' A' ' 40' ' ' LEU . 5.3 p -53.23 152.01 4.77 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.09 -58.74 2.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 127.534 2.333 . . . . 0.0 113.975 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -80.55 -25.39 38.62 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.431 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 45.1 tptt -80.52 -16.77 53.43 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -172.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -45.51 -43.37 11.69 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.462 ' HB3' ' HG3' ' A' ' 176' ' ' ARG . 55.9 m170 -126.98 24.16 6.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.978 -1.076 . . . . 0.0 111.097 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -93.45 102.7 14.93 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.063 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.29 -8.95 0.59 Allowed Glycine 0 CA--C 1.538 1.495 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.99 171.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 118.499 1.149 . . . . 0.0 113.648 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -98.55 137.93 36.49 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.56 -0.78 48.4 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.07 -23.22 67.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.021 0.438 . . . . 0.0 111.381 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -88.74 -27.88 20.88 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -112.69 -15.53 12.97 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -110.21 135.75 20.55 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.95 123.94 13.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.635 2.223 . . . . 0.0 113.36 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.4 t -95.02 107.68 19.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.47 23.54 28.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.15 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.22 -153.85 25.24 Favored Glycine 0 C--O 1.24 0.507 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.46 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -131.81 132.2 43.53 Favored 'General case' 0 C--O 1.248 0.981 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 41' ' ' PRO . 21.3 m -134.03 168.33 24.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -149.15 158.28 44.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -84.85 106.69 16.57 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 121.568 0.699 . . . . 0.0 109.409 178.405 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 . . . . . 0 C--O 1.246 0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -90.68 -151.36 0.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -165.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -84.88 -171.19 3.5 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.645 1.578 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.488 HD13 HG23 ' A' ' 122' ' ' VAL . 8.6 mp -100.12 150.21 22.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.171 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.505 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 18.3 m-85 -125.4 -165.74 1.45 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.208 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -52.49 -51.59 58.64 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 123.499 0.719 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -116.2 142.89 46.22 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.918 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 24.6 mm-40 -121.34 111.89 33.24 Favored Pre-proline 0 C--N 1.285 -2.224 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.025 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 167.3 27.68 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.458 2.106 . . . . 0.0 111.35 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -142.69 156.39 45.03 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.4 mt -91.12 -19.48 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -99.02 -179.07 4.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 33.5 t -97.82 66.1 1.88 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.712 -1.195 . . . . 0.0 114.057 -174.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -140.13 121.05 14.54 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.491 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 138.12 31.71 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.354 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 64.9 tp -111.57 127.12 55.63 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.79 141.24 45.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.53 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -78.95 170.2 17.05 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.74 -16.37 79.23 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -69.71 -58.62 3.69 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -25.59 63.33 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.101 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -60.22 -40.89 91.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.509 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HA ' ' CE ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.29 -29.5 65.13 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.508 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.82 -57.84 10.98 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.49 -42.74 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.427 0.691 . . . . 0.0 112.562 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.12 -27.48 62.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 p -78.3 -13.0 60.04 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.497 0.665 . . . . 0.0 111.39 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -88.73 -25.57 22.24 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.592 173.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.28 48.36 8.28 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.38 107.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.582 0.706 . . . . 0.0 111.671 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -66.92 137.3 56.45 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.151 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 79.94 11.55 1.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.493 1.917 . . . . 0.0 113.667 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.75 114.32 26.04 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -107.5 144.63 34.19 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.429 ' CH2' HD12 ' A' ' 129' ' ' LEU . 67.0 m95 -116.46 121.43 41.82 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 123.586 0.554 . . . . 0.0 110.238 -174.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.57 96.51 43.87 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.38 139.75 16.72 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.549 2.166 . . . . 0.0 112.868 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.14 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.319 0.648 . . . . 0.0 109.804 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.18 116.55 28.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 126' ' ' TYR . 54.9 mt -110.54 131.14 62.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.613 0.72 . . . . 0.0 112.865 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.488 ' HG2' HG22 ' A' ' 121' ' ' VAL . 93.0 mttt -104.76 148.75 26.27 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.571 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -89.32 -160.69 0.7 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.316 0.579 . . . . 0.0 111.241 -174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -63.85 -34.3 77.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.62 1.168 . . . . 0.0 110.507 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.53 -19.42 29.51 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.66 19.7 24.12 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.571 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 52.2 pttt -99.29 146.35 26.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.488 HG22 ' HG2' ' A' ' 115' ' ' LYS . 17.6 t -82.71 81.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.681 0.753 . . . . 0.0 110.148 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 HD13 ' A' ' 78' ' ' LEU . 10.1 m -105.4 8.19 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.429 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.78 50.76 0.88 Allowed Glycine 0 CA--C 1.542 1.757 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.73 -6.76 9.7 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 121.097 2.449 . . . . 0.0 112.285 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -103.11 -0.99 29.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.438 ' HB2' HD12 ' A' ' 114' ' ' ILE . 2.7 m-85 -98.0 147.87 24.06 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 122.002 0.906 . . . . 0.0 112.86 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.28 139.5 42.72 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.702 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -79.67 124.3 28.44 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.046 0.451 . . . . 0.0 110.111 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.429 HD12 ' CH2' ' A' ' 109' ' ' TRP . 8.0 tt -96.86 125.98 41.68 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.759 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -122.88 134.62 54.37 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.848 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.78 31.94 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.719 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.07 174.12 6.39 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 124.87 1.356 . . . . 0.0 109.016 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.78 28.9 25.12 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.592 -0.814 . . . . 0.0 115.114 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.407 ' HB3' ' NH2' ' A' ' 176' ' ' ARG . . . -112.89 131.79 55.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.151 -1.019 . . . . 0.0 110.984 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.78 111.66 6.13 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.724 -1.125 . . . . 0.0 107.99 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.0 t70 71.21 -52.34 0.69 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 125.978 1.711 . . . . 0.0 112.253 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.36 -100.58 0.06 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 125.961 1.704 . . . . 0.0 114.484 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 179' ' ' LYS . 46.8 mt -64.12 125.08 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 O-C-N 123.686 0.616 . . . . 0.0 110.405 -172.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 100.64 1.94 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.538 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 21.6 ttt -75.81 -12.75 60.23 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.353 -171.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.53 -39.89 67.19 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -101.21 4.55 42.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.347 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.538 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 77.7 p -92.54 115.65 28.29 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.767 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -92.53 104.53 16.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.32 164.02 32.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.529 0.681 . . . . 0.0 112.532 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.87 117.95 31.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 26.3 ttt -100.28 107.48 19.3 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.883 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.6 t70 170.41 89.33 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.909 1.683 . . . . 0.0 108.589 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB3' ' HA2' ' A' ' 156' ' ' GLY . 7.8 p -101.07 -56.88 2.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.294 0.568 . . . . 0.0 110.358 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.17 -59.94 1.9 Allowed 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.54 -177.07 3.21 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.537 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 152' ' ' LYS . 1.2 tpmt? -76.01 -26.51 56.75 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.224 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.46 11.4 14.78 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.613 1.196 . . . . 0.0 110.025 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -124.68 127.84 47.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 48.5 mt -84.79 143.84 10.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 149' ' ' SER . . . -119.42 -70.44 0.33 Allowed Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.425 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.37 118.93 28.34 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 59.1 mt -118.29 132.23 68.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -106.67 -42.29 5.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -154.65 110.62 3.19 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.64 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -88.15 124.71 34.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.75 24.42 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.74 146.46 52.34 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -96.06 -9.15 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -68.0 -6.02 20.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.567 1.147 . . . . 0.0 111.035 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.9 m -65.39 -38.19 89.25 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -110.52 -30.98 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.373 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.83 151.52 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.491 ' HD3' ' OD2' ' A' ' 171' ' ' ASP . 55.5 mtt180 -62.44 126.65 88.56 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 122.267 0.227 . . . . 0.0 111.471 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.86 -10.12 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.139 1.892 . . . . 0.0 110.816 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' A' ' 169' ' ' ARG . 4.3 p-10 -85.21 2.14 45.1 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.091 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.99 134.73 33.88 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.52 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 67.8 mttm -84.01 -27.44 28.38 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.507 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.0 ttt -150.76 128.05 11.31 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.56 -179.19 7.03 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 123.559 0.537 . . . . 0.0 110.004 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -136.12 154.7 50.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 63.4 m -87.48 143.82 27.03 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.206 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.5 p -82.91 -9.61 59.22 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.447 ' HB2' HD12 ' A' ' 138' ' ' ILE . 58.9 mttp -105.87 23.74 13.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.72 -0.613 . . . . 0.0 111.853 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 183' ' ' LEU . 7.4 tp10 175.05 134.16 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 17.1 mmt180 -89.53 -31.05 17.8 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.495 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -77.85 -20.13 53.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.269 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 180' ' ' GLU . 20.3 tp -83.85 100.35 10.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.067 0.937 . . . . 0.0 110.64 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.3 mt -116.46 119.41 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 55.2 mt -104.89 136.04 45.12 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.608 0.718 . . . . 0.0 111.723 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.6 pt -119.3 153.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.417 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 10.6 mtp180 -86.06 161.3 19.0 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.498 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.7 pt-20 -55.42 -40.02 70.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.7 -26.34 66.97 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.465 0.706 . . . . 0.0 111.829 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.2 t -71.31 -51.01 37.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.797 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.548 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 19.3 p80 -73.17 -21.91 60.6 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.089 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.9 76.82 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.063 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.24 75.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.511 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.7 m-85 -71.18 -33.35 69.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.272 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 62.9 mm-40 -59.6 -47.93 83.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.491 0.663 . . . . 0.0 109.811 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -78.03 -12.76 60.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.516 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.06 -28.42 20.14 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.083 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.39 47.7 87.61 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.443 ' HB2' ' CE1' ' A' ' 202' ' ' PHE . 66.5 mt -77.9 164.18 25.37 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.5 p -41.41 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.45 135.06 6.81 Favored Glycine 0 CA--C 1.493 -1.322 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.809 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 199' ' ' LEU . 70.5 m-85 -146.37 161.94 39.28 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 58.1 tptt -153.59 122.26 6.34 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 18.0 m -112.66 134.46 55.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.054 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 73.4 m-85 -118.26 140.05 50.39 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.95 115.51 9.26 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.08 -35.05 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.382 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.97 92.67 0.52 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.062 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.99 35.6 17.97 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.399 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.405 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 8.3 t90 -53.12 115.01 1.66 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.802 0.841 . . . . 0.0 110.061 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.23 99.78 11.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.47 -1.59 9.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 117.832 1.893 . . . . 0.0 117.832 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.405 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 88.0 mt -94.56 143.2 26.62 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 118.029 0.914 . . . . 0.0 112.327 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.48 132.36 52.59 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.488 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 2.5 pt? . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.047 0.842 . . . . 0.0 112.387 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.22 -0.499 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -80.55 152.95 28.36 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -167.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.28 141.1 48.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.972 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.7 141.0 52.24 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 62.0 t -72.73 120.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.3 115.11 27.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.857 0.723 . . . . 0.0 110.7 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -140.3 120.16 13.51 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.9 t -72.66 129.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.461 ' HB3' ' HG3' ' A' ' 203' ' ' LYS 0.268 20.8 ptt? -102.01 66.68 1.04 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.73 1.252 . . . . 0.0 112.619 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.46 110.72 12.1 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -106.66 -17.24 14.29 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 122.19 0.995 . . . . 0.0 108.721 -171.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -86.97 -25.85 24.12 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.698 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.32 80.68 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.89 137.41 3.36 Favored Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.216 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -65.9 156.63 32.86 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.38 102.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -51.73 -52.19 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.832 1.332 . . . . 0.0 112.205 -169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -139.69 172.03 13.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 46' ' ' THR . 8.9 mp -55.46 124.63 56.33 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 18.8 Cg_endo -75.09 166.77 28.41 Favored 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 122.664 2.243 . . . . 0.0 112.198 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.15 121.4 6.74 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 125.109 1.364 . . . . 0.0 112.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.09 0.2 68.4 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.649 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.7 m -85.88 137.87 35.47 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.93 166.49 23.2 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 123.416 2.744 . . . . 0.0 109.795 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.473 ' HA ' HD21 ' A' ' 40' ' ' LEU . 18.0 p -48.22 153.01 0.75 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' OD1' ' HG3' ' A' ' 86' ' ' MET . 16.2 m-20 -37.68 -57.03 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 C-N-CA 126.863 2.065 . . . . 0.0 114.955 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -80.47 -30.33 37.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.419 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.72 -11.58 59.84 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.725 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 27.8 m-85 -45.84 -46.01 15.36 Favored 'General case' 0 C--O 1.209 -1.048 0 O-C-N 123.559 0.537 . . . . 0.0 111.347 174.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 17.4 m170 -129.41 17.0 5.98 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.19 101.34 13.41 Favored 'General case' 0 N--CA 1.425 -1.688 0 C-N-CA 117.76 -1.576 . . . . 0.0 108.373 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.03 -9.17 55.05 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.59 173.77 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 119.814 1.807 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -98.88 157.15 16.5 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.38 5.95 49.02 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.36 68.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.972 0.415 . . . . 0.0 111.792 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -88.37 -32.57 18.31 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.1 -22.61 15.13 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -102.53 136.97 19.26 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.37 123.86 13.95 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.063 2.509 . . . . 0.0 112.571 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.63 115.98 40.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.76 23.65 45.31 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.445 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -103.41 -159.33 25.01 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 121.453 -0.403 . . . . 0.0 112.315 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -133.31 135.68 44.99 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 27.2 m -133.41 172.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 t -155.64 154.47 31.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.52 119.84 16.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.424 -1.738 0 O-C-N 123.719 0.637 . . . . 0.0 109.671 177.002 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 . . . . . 0 CA--C 1.499 -1.017 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -98.68 -159.37 0.74 Allowed 'General case' 0 C--O 1.262 1.716 0 CA-C-O 121.361 0.6 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.39 -167.59 1.88 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.614 1.566 . . . . 0.0 112.42 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.79 147.39 25.18 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.573 0.749 . . . . 0.0 111.76 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.87 -171.52 1.86 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.17 0.988 . . . . 0.0 109.416 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.04 -46.09 71.79 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.546 0.688 . . . . 0.0 110.517 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.0 131.14 53.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 48.0 tp60 -111.44 116.21 50.99 Favored Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 121.053 0.454 . . . . 0.0 109.96 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.12 164.91 21.92 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.82 2.347 . . . . 0.0 112.413 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -157.36 173.61 16.67 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.417 HG22 HH21 ' A' ' 181' ' ' ARG . 16.0 mt -90.37 3.02 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 121.608 0.718 . . . . 0.0 110.33 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.47 ' HG3' ' OD1' ' A' ' 47' ' ' ASP . 4.1 mpp? -104.98 -175.7 2.87 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.88 -0.513 . . . . 0.0 110.321 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 22.6 t -92.58 16.41 12.12 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 120.989 0.423 . . . . 0.0 112.065 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -115.67 151.1 35.67 Favored 'General case' 0 C--O 1.205 -1.238 0 O-C-N 121.082 -1.012 . . . . 0.0 109.321 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.9 139.86 50.13 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 119.009 -1.077 . . . . 0.0 110.803 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 55.1 tp -109.1 126.39 53.14 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 129' ' ' LEU . 47.6 t -126.38 140.97 47.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.6 p -73.4 162.49 29.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.09 -31.92 82.39 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.211 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -72.34 -36.12 68.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.794 0.331 . . . . 0.0 110.753 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.26 -27.62 56.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -60.26 -39.32 86.37 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.112 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.7 mmtp -60.09 -44.18 94.99 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.15 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.63 -51.7 68.81 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.745 0.653 . . . . 0.0 110.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.93 -44.07 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.031 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.98 -20.35 60.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.8 t -72.06 -32.08 66.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.92 -2.07 57.91 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.396 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.69 47.86 82.65 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.555 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -75.24 110.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -75.84 151.79 37.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.188 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 79.58 12.77 1.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.231 1.413 . . . . 0.0 111.972 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.8 tp10 -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -113.27 126.14 55.07 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.51 99.75 42.28 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.33 125.47 6.38 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.501 2.134 . . . . 0.0 112.93 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 64' ' ' GLY . 12.6 m -143.07 170.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -104.93 116.84 32.65 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.1 mp -103.99 133.55 47.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.424 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.641 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -97.34 144.36 27.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -85.53 -163.8 0.91 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.107 0.48 . . . . 0.0 111.515 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -67.16 -29.64 69.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.235 0.614 . . . . 0.0 110.503 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -87.56 -5.49 58.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.65 18.86 64.97 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 114.402 0.521 . . . . 0.0 114.402 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -105.27 152.67 22.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 117.417 0.609 . . . . 0.0 110.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.12 85.71 2.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.405 0.621 . . . . 0.0 109.894 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.412 ' C ' ' HD3' ' A' ' 124' ' ' PRO . 11.6 m -110.13 6.67 8.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.497 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -125.37 59.17 0.65 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.679 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 10.6 Cg_endo -85.26 -19.68 3.63 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.41 2.073 . . . . 0.0 113.152 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.0 6.8 21.26 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.017 0.527 . . . . 0.0 110.688 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.497 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 1.5 m-85 -88.29 145.28 25.94 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.221 0.534 . . . . 0.0 110.158 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.38 144.29 48.12 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.408 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.99 128.27 34.32 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 91' ' ' VAL . 1.3 tt -97.68 126.93 43.28 Favored 'General case' 0 C--O 1.268 2.06 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 25.7 m-80 -111.13 127.22 55.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.757 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.96 122.6 38.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.85 174.42 5.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 124.148 0.905 . . . . 0.0 109.478 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.39 26.19 28.65 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.99 41.22 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.037 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.88 170.14 18.3 Favored 'General case' 0 C--N 1.263 -3.169 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.57 107.99 0.23 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.908 1.231 . . . . 0.0 111.995 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -80.48 -71.19 0.47 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.034 -1.894 . . . . 0.0 115.686 -163.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.21 124.67 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 O-C-N 123.804 0.69 . . . . 0.0 111.669 -170.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 141' ' ' GLU . 11.8 t70 -82.67 128.16 34.09 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.62 -22.91 32.08 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.437 ' HG2' ' OD2' ' A' ' 139' ' ' ASP . 11.1 pt-20 -95.37 -27.29 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.421 0.555 . . . . 0.0 111.157 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -86.81 -5.76 59.01 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.488 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -121.12 168.45 11.54 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -137.2 106.78 6.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -159.67 164.4 34.05 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.649 0.261 . . . . 0.0 111.148 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.89 129.75 51.49 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 62.2 mtt -92.26 107.63 19.35 Favored 'General case' 0 C--O 1.201 -1.455 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.202 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 165.45 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.026 1.73 . . . . 0.0 111.028 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.6 p -100.93 -56.47 2.31 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.848 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.9 mt -110.14 -31.84 7.21 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.553 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.79 -174.84 1.94 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 147' ' ' MET . 39.4 ttpt -63.02 -43.71 97.96 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.821 0.737 . . . . 0.0 112.852 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.26 26.01 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.152 0.977 . . . . 0.0 112.358 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -139.12 114.25 9.52 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.3 mt -85.03 144.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.12 -77.6 0.77 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -78.79 118.85 21.24 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 39.8 mt -126.34 116.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -100.79 -39.03 8.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.309 0.576 . . . . 0.0 109.769 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.18 128.88 24.67 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.72 111.18 17.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 147.18 24.11 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.75 129.45 39.84 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.189 0.931 . . . . 0.0 110.585 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.421 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.0 p-10 -84.68 11.6 8.68 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 124.413 1.085 . . . . 0.0 110.775 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.0 p -71.69 -4.94 30.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.139 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -73.76 -34.7 64.83 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.498 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.65 -33.62 8.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.719 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.8 mt -91.47 153.52 3.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.0 124.33 73.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 118.074 0.397 . . . . 0.0 111.037 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.43 -5.34 15.75 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.6 2.867 . . . . 0.0 113.908 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.68 -0.28 51.8 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.93 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.25 120.71 14.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.107 0.479 . . . . 0.0 110.457 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -73.99 -28.64 61.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.03 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.421 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.4 ttt -147.68 125.66 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -152.56 175.55 12.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 51' ' ' HIS . 0.2 OUTLIER -152.07 162.23 41.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.37 160.69 20.6 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.3 p -82.24 -49.29 10.25 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 124.134 0.974 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.75 4.68 31.66 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.31 138.08 47.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' SER . 11.4 mtm180 -90.14 -30.16 17.82 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.818 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.0 -28.07 13.95 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.2 tp -71.05 100.63 2.05 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-O 122.133 0.968 . . . . 0.0 112.76 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.23 132.87 64.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.94 122.25 43.74 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.604 0.716 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 191' ' ' HIS . 34.2 pt -112.08 151.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -85.08 159.99 20.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.439 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 11.3 pt-20 -54.44 -39.77 67.72 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -73.13 -27.89 61.94 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.105 0.562 . . . . 0.0 111.454 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.47 -47.42 72.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.631 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.7 p80 -71.21 -26.05 62.77 Favored 'General case' 0 C--O 1.196 -1.748 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.742 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.91 71.24 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.492 0.495 . . . . 0.0 110.7 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.55 -39.25 74.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.99 -32.41 70.6 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 65.6 mm-40 -58.25 -53.5 57.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.679 0.791 . . . . 0.0 109.678 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.52 -23.5 58.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.785 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.75 60.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.261 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.12 47.85 10.56 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.962 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.9 mt -80.32 161.78 24.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.6 p -38.8 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.87 128.81 1.53 Allowed Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.91 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -136.17 150.85 49.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 30' ' ' MET . 53.7 mtmt -106.99 128.45 54.36 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 15.6 m -118.84 129.24 75.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 123.797 0.686 . . . . 0.0 109.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.2 m-85 -118.44 154.52 32.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.17 116.06 12.15 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.98 -36.98 67.2 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.428 0.455 . . . . 0.0 111.646 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.28 102.07 1.02 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.18 60.32 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.657 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -57.45 100.62 0.05 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.974 1.31 . . . . 0.0 111.888 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.0 133.96 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -26.56 0.29 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 118.809 2.283 . . . . 0.0 118.809 167.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.47 134.12 45.17 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 118.313 1.057 . . . . 0.0 112.141 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -86.81 131.57 34.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.2 pt? . . . . . 0 C--N 1.299 -1.589 0 O-C-N 123.336 0.398 . . . . 0.0 110.563 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 122.301 1.048 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 157.53 26.33 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.059 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -107.58 137.77 45.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.673 0.749 . . . . 0.0 113.002 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -126.66 151.15 48.45 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.788 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -84.2 126.46 40.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -98.8 129.44 45.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.131 0.491 . . . . 0.0 112.323 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 203' ' ' LYS . 81.7 tttt -150.5 163.95 37.15 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.448 ' N ' ' HG2' ' A' ' 28' ' ' LYS . 48.2 t -103.77 131.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.465 ' HB3' ' HB2' ' A' ' 203' ' ' LYS . 14.1 ptp -91.01 97.29 11.09 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 167.82 134.88 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 125.099 1.36 . . . . 0.0 109.467 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.17 -17.83 31.8 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 9.6 mm-40 -88.75 0.2 56.71 Favored 'General case' 0 C--O 1.199 -1.604 0 C-N-CA 125.341 1.456 . . . . 0.0 111.851 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -69.9 -12.53 61.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.383 -0.823 . . . . 0.0 112.779 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.28 1.18 Allowed Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.832 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -89.27 145.46 25.37 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.1 mt -78.16 101.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -61.64 -41.22 97.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.177 0.923 . . . . 0.0 112.001 -169.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -141.79 170.56 15.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mp -52.88 123.51 32.65 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 125.108 1.363 . . . . 0.0 113.457 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -72.41 166.54 29.49 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.539 2.16 . . . . 0.0 111.776 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.77 115.83 1.84 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.57 6.59 58.39 Favored Glycine 0 C--O 1.225 -0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.653 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 33.4 m -85.95 140.98 35.2 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 44' ' ' SER . 1.5 Cg_endo -76.28 166.27 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.36 2.706 . . . . 0.0 110.158 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -49.49 151.73 1.52 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -40.66 -53.44 2.77 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 127.281 2.232 . . . . 0.0 114.521 -173.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -83.25 -29.18 28.65 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.743 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -81.09 -12.06 59.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.062 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 16.0 m-85 -43.89 -49.03 8.49 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.511 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 42.6 m80 -129.38 27.21 5.33 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.247 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.99 102.04 14.38 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.84 -9.93 35.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.01 161.76 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.986 1.393 . . . . 0.0 112.032 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -98.68 159.5 14.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.08 12.94 26.41 Favored 'General case' 0 C--O 1.206 -1.184 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.78 75.33 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 121.953 0.882 . . . . 0.0 111.17 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -89.52 -27.92 19.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.171 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.68 -22.23 19.54 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -114.21 144.74 32.25 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 123.16 12.26 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.774 2.316 . . . . 0.0 112.95 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -97.88 116.27 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.5 23.34 58.58 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.829 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -98.43 -160.22 30.1 Favored Glycine 0 C--O 1.245 0.814 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.814 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 46.6 mt-10 -127.48 130.08 48.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.462 0.305 . . . . 0.0 110.184 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.3 m -132.75 166.69 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 23.5 t -143.1 149.36 38.04 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.85 114.69 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.7 p . . . . . 0 C--N 1.296 -1.726 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 29.9 t-20 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 5.9 mmp_? -78.96 -165.48 0.75 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 122.031 0.92 . . . . 0.0 113.369 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.405 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.3 p-10 -93.7 -162.91 0.98 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.796 1.639 . . . . 0.0 110.372 -175.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.1 mp -91.73 135.98 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.727 0.298 . . . . 0.0 111.703 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 1.4 m-30 -99.36 -105.49 0.21 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.708 0.403 . . . . 0.0 110.542 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -117.0 -47.67 2.68 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.31 129.54 53.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 124.996 1.318 . . . . 0.0 107.616 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 15.8 mm100 -105.88 116.35 59.89 Favored Pre-proline 0 C--N 1.295 -1.786 0 O-C-N 123.436 0.46 . . . . 0.0 112.053 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.19 168.11 13.55 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.79 2.327 . . . . 0.0 111.36 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -163.66 -178.55 5.84 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.51 -13.47 9.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.19 178.45 5.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.209 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' HG3' ' A' ' 181' ' ' ARG . 3.7 m -90.48 46.67 1.36 Allowed 'General case' 0 C--O 1.251 1.182 0 CA-C-O 121.22 0.533 . . . . 0.0 110.41 -176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -136.73 145.26 44.44 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.7 tp -122.79 141.37 51.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.262 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 56.6 tp -113.7 125.91 54.65 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 129' ' ' LEU . 50.1 t -126.63 142.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -72.99 164.1 27.18 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -71.68 -18.51 77.35 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -65.1 -58.3 6.39 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.14 60.39 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.049 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 47.7 ttt180 -57.25 -47.9 80.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.927 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 1.2 mmmp? -61.88 -38.74 89.42 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 109.859 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.28 -53.53 56.2 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.601 0.563 . . . . 0.0 110.746 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.03 -41.85 87.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 123.716 0.806 . . . . 0.0 111.506 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 49.4 mt-10 -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.0 m -64.32 -30.58 71.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.145 0.497 . . . . 0.0 111.599 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.467 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.8 mp -84.44 -10.1 57.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.985 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.05 43.03 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.455 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.5 t -77.73 100.62 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 m -76.95 156.35 32.05 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.842 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 80.81 13.84 0.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.652 1.581 . . . . 0.0 110.838 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.59 122.69 47.19 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.021 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -115.81 144.68 43.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -114.66 122.25 45.88 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.173 0.589 . . . . 0.0 110.466 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HG ' HD21 ' A' ' 130' ' ' ASN . 78.6 mt -115.27 98.81 51.39 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.88 138.71 13.34 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.421 2.081 . . . . 0.0 113.185 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 64' ' ' GLY . 6.9 m -145.89 173.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.496 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.49 116.91 33.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 173.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 23.0 mt -111.34 134.19 54.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.315 0.579 . . . . 0.0 112.248 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.2 mptp? -98.11 148.38 23.6 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 5.9 p-10 -92.91 -160.49 0.76 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 71.8 m80 -71.84 -18.96 62.04 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.944 0.498 . . . . 0.0 111.554 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.8 -19.41 24.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.17 51.63 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.242 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.3 ptmt -98.32 138.61 35.32 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 91.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.148 0.499 . . . . 0.0 109.758 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.439 HG23 HD13 ' A' ' 78' ' ' LEU . 11.9 m -115.98 12.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.012 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.419 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -123.91 65.42 0.53 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.523 173.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 8.3 Cg_endo -85.37 -23.58 2.26 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.494 2.129 . . . . 0.0 113.224 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.55 4.08 21.84 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.441 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.419 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 6.9 m-85 -84.74 140.8 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.554 0.692 . . . . 0.0 110.972 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -129.85 141.44 50.82 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.928 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -79.8 127.26 32.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 91' ' ' VAL . 4.4 tt -93.41 124.79 37.64 Favored 'General case' 0 C--O 1.282 2.81 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.511 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 36.7 m-80 -104.58 128.84 52.69 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.106 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 114.37 27.66 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.4 169.63 9.93 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.133 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.09 22.52 78.79 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.915 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.7 131.67 34.39 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.21 169.26 18.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -58.15 105.71 0.3 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -127.52 -33.68 2.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 24.3 mt -59.36 119.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.037 -173.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.58 128.15 35.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.423 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 64.1 mtp -109.66 -25.64 10.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.931 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.51 -29.67 18.79 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.868 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -96.17 -11.59 25.93 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.522 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 m -104.56 149.74 25.23 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -114.34 104.83 12.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.423 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 4.3 p90 -154.19 150.95 28.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.399 0.619 . . . . 0.0 112.364 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 51.7 mm-40 -108.92 139.66 43.47 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.234 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 90.7 mtp -100.84 155.23 18.05 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.161 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 151' ' ' GLU . 16.7 t70 85.85 78.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.916 1.686 . . . . 0.0 113.766 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.601 ' OG ' ' HA3' ' A' ' 156' ' ' GLY . 49.9 m -103.19 -57.21 2.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.174 166.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.7 mt -94.02 -45.21 7.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 2.3 pp20? -147.01 171.78 14.73 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.567 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -54.75 -44.98 74.09 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.458 1.103 . . . . 0.0 113.548 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.554 ' HB3' HH12 ' A' ' 181' ' ' ARG . 7.0 t70 -92.38 15.1 14.66 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.011 0.91 . . . . 0.0 110.496 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 9.8 mm-40 -102.38 119.37 38.7 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 124.121 0.969 . . . . 0.0 110.308 175.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 50.7 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.601 ' HA3' ' OG ' ' A' ' 149' ' ' SER . . . -115.52 -65.05 0.39 Allowed Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.5 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 6.4 t30 -84.86 119.08 24.93 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 52.2 mt -128.12 127.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.47 -29.37 8.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.919 0.39 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.08 130.08 16.33 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.07 118.9 24.3 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.76 139.59 38.14 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.5 mt -57.77 145.42 34.84 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 138' ' ' ILE . 15.1 p-10 -94.61 15.1 18.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.683 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.55 -5.21 18.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.596 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -61.4 -35.72 78.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.212 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.79 -31.82 6.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.252 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 137' ' ' ALA . 78.3 mt -90.02 154.13 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -50.15 122.92 15.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 123.91 0.884 . . . . 0.0 112.708 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.4 -6.0 17.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.025 1.816 . . . . 0.0 110.512 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.493 ' HA ' ' NH2' ' A' ' 187' ' ' ARG . 5.8 p-10 -99.67 6.3 45.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.092 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -85.62 132.03 34.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.466 ' HG2' ' HD2' ' A' ' 187' ' ' ARG . 76.7 mttt -84.93 -16.51 40.79 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.138 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 185' ' ' LEU . 26.4 ttt -159.77 127.72 4.82 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.37 164.3 38.39 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 142.43 34.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.512 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 38.6 m -93.01 120.47 33.34 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -53.45 -46.46 69.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.476 ' HB2' HD12 ' A' ' 138' ' ' ILE . 41.2 mttp -79.2 24.32 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.21 158.33 44.02 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.554 HH12 ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -91.27 -51.54 5.25 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.762 174.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.433 ' HD3' ' OE2' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -92.54 -13.41 29.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.239 -167.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.512 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 37.3 tp -77.78 101.16 6.58 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 122.017 0.913 . . . . 0.0 111.841 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.5 mt -120.87 121.36 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 174' ' ' MET . 66.7 mt -97.15 133.59 41.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 120.933 0.397 . . . . 0.0 110.66 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.449 HG22 ' HG3' ' A' ' 174' ' ' MET . 42.7 pt -120.97 158.02 23.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.282 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.493 ' NH2' ' HA ' ' A' ' 171' ' ' ASP . 93.7 mtt180 -83.14 162.53 21.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.789 0.804 . . . . 0.0 111.068 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -55.56 -47.4 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.268 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.16 -26.94 69.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.115 0.259 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.467 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 61.9 t -65.21 -54.35 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.743 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -74.89 -26.43 59.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.232 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.35 -34.14 77.62 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.446 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.19 -37.34 78.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.231 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -69.65 -38.06 76.97 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.823 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -65.12 -40.79 95.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -77.04 -25.64 52.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.419 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.41 -27.49 46.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 121.176 0.513 . . . . 0.0 109.912 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.54 47.5 4.84 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.066 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.99 165.32 19.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.98 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -161.07 125.26 1.42 Allowed Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.361 -1.399 . . . . 0.0 112.347 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -120.66 145.34 47.54 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 30' ' ' MET . 50.2 tptt -105.18 121.37 43.68 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.88 129.72 71.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.342 0.591 . . . . 0.0 111.185 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -111.29 141.18 45.16 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.04 106.17 1.0 Allowed 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.82 74.47 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.163 0.506 . . . . 0.0 111.451 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -77.35 89.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.317 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.6 35.13 6.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.438 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.413 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 16.1 t90 -63.82 99.16 0.22 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.668 0.747 . . . . 0.0 111.802 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.16 130.5 51.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.36 -26.51 0.27 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 165.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.413 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 86.4 mt -76.26 141.3 41.74 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.384 1.092 . . . . 0.0 111.451 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.23 130.32 38.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.673 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HB2' ' CH2' ' A' ' 210' ' ' TRP . 36.7 tp . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -118.22 145.26 45.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.203 0.525 . . . . 0.0 110.341 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -114.2 132.63 56.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.647 -172.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 78.8 m-85 -116.62 141.63 47.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 17.2 t -78.32 121.79 31.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -96.24 129.86 43.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -173.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -150.47 153.92 36.76 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.8 t -87.82 145.61 7.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.55 140.98 31.04 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.187 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 88.91 128.48 0.03 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.742 2.017 . . . . 0.0 112.472 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 33.0 tt0 -73.21 -26.38 61.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.938 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 -0.25 43.82 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.069 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -77.05 11.64 1.73 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.17 65.88 0.95 Allowed Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.352 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 10.4 m-85 -79.79 142.01 35.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.032 0.444 . . . . 0.0 110.415 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.431 HD12 HD22 ' A' ' 84' ' ' ASN . 23.0 mt -89.41 104.66 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 170.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -61.85 -57.23 12.61 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.083 -172.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -117.49 176.47 5.15 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.04 132.17 88.55 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.15 166.49 29.44 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.271 1.981 . . . . 0.0 112.124 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -52.46 124.71 14.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.86 1.264 . . . . 0.0 112.476 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.44 81.75 Favored Glycine 0 CA--C 1.516 0.133 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.093 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 50.8 m -85.83 139.46 35.15 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.71 165.77 24.47 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.295 2.663 . . . . 0.0 110.878 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 p -54.17 150.59 8.13 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.55 ' HB3' ' NH1' ' A' ' 181' ' ' ARG . 3.8 m-20 -41.34 -59.18 1.63 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.707 2.003 . . . . 0.0 114.786 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -79.11 -30.53 43.82 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.853 0.359 . . . . 0.0 111.705 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 17.8 tppt? -79.01 -11.93 60.02 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.637 -173.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' O ' HD11 ' A' ' 56' ' ' LEU . 8.5 m-85 -44.72 -44.54 9.27 Favored 'General case' 0 C--O 1.194 -1.84 0 C-N-CA 123.517 0.727 . . . . 0.0 112.205 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.44 ' CG ' ' HD2' ' A' ' 176' ' ' ARG . 65.5 m80 -129.4 21.57 5.62 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.48 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 49' ' ' LYS . 1.8 tm-20 -91.91 101.32 13.89 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.29 -5.83 4.83 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.38 164.32 21.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -97.97 142.86 29.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.555 HD13 ' ND2' ' A' ' 130' ' ' ASN . 4.4 mp -99.28 -4.94 30.7 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.639 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.12 -21.59 66.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.116 0.484 . . . . 0.0 111.822 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.31 -21.13 24.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -116.86 -22.98 8.27 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -94.35 139.13 22.32 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.06 123.22 11.83 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.558 2.172 . . . . 0.0 112.812 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 HD22 ' A' ' 110' ' ' LEU . 30.1 t -100.07 107.55 21.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 23.56 30.24 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.434 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -96.85 -157.75 31.17 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.813 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.75 132.75 46.67 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.12 170.68 19.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -145.39 152.56 40.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.847 -0.533 . . . . 0.0 111.264 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -77.24 107.4 9.61 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p . . . . . 0 C--N 1.294 -1.837 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.231 177.381 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 13.3 t-20 . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -77.28 -165.46 0.59 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.687 0.755 . . . . 0.0 112.839 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -84.6 -165.28 1.13 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.238 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 122' ' ' VAL . 8.1 mp -90.48 150.37 21.83 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.767 0.794 . . . . 0.0 113.114 -173.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 29.4 m-85 -121.85 -149.24 0.42 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.741 2.017 . . . . 0.0 106.977 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -81.14 -31.91 33.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.878 0.763 . . . . 0.0 110.929 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.433 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 59.0 m-85 -134.97 148.19 49.93 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 11.0 mm100 -121.82 120.98 28.33 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 93.5 Cg_endo -87.1 170.62 7.01 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.26 1.973 . . . . 0.0 110.474 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.431 HD22 HD12 ' A' ' 37' ' ' ILE . 33.8 p30 -155.9 179.19 9.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.993 -0.442 . . . . 0.0 110.984 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.5 mt -86.97 -22.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -86.25 -92.3 0.09 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -168.68 -40.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -67.43 117.1 8.95 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 120.956 0.408 . . . . 0.0 112.035 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.2 tp -87.43 133.75 33.69 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.462 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 40.9 tp -105.33 121.32 43.63 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.768 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.33 137.07 56.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 p -76.49 172.73 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.433 0.293 . . . . 0.0 110.904 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.37 -20.48 79.33 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -65.59 -58.29 6.11 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.22 -28.93 64.56 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.562 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 100' ' ' GLU . 54.6 ttt180 -57.9 -43.69 86.31 Favored 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.356 0.41 . . . . 0.0 110.108 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -67.26 -28.32 67.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.82 -54.02 22.31 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.39 -46.26 92.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 C-N-CA 123.744 0.818 . . . . 0.0 112.039 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 96' ' ' ARG . 50.2 mt-10 -62.07 -31.84 72.31 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.423 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -78.33 -11.27 59.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.24 -13.94 51.27 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.679 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.78 33.89 26.17 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.72 101.21 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.989 0.899 . . . . 0.0 109.853 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.0 m -86.76 150.3 24.26 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 80.51 10.05 1.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.606 1.162 . . . . 0.0 111.348 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.05 26.18 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.661 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.4 tp10 -94.62 144.83 25.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -125.88 108.66 11.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.413 HD22 HG22 ' A' ' 62' ' ' VAL . 72.3 mt -109.32 95.63 19.21 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.35 140.83 12.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.775 2.317 . . . . 0.0 113.37 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.5 m -147.62 169.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.961 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.95 116.82 29.4 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.1 mt -113.97 128.45 70.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.184 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.37 146.1 24.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 8.8 p-10 -84.83 -160.51 0.49 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 122.48 0.312 . . . . 0.0 110.436 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.501 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 56.8 m80 -73.69 -19.55 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.562 0.345 . . . . 0.0 110.452 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -93.19 -20.06 20.83 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.068 0.461 . . . . 0.0 110.22 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.04 22.1 12.57 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.12 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.424 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 61.0 pttt -105.15 146.82 28.69 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.92 89.94 2.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 121.638 0.732 . . . . 0.0 110.146 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 78' ' ' LEU . 6.3 m -114.12 10.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.088 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.36 42.35 1.37 Allowed Glycine 0 CA--C 1.549 2.159 0 C-N-CA 119.304 -1.426 . . . . 0.0 116.496 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.0 -1.69 9.99 Favored 'Trans proline' 0 C--N 1.376 1.981 0 CA-C-N 122.049 2.924 . . . . 0.0 112.107 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.9 -7.31 37.09 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 125.139 1.375 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -98.92 144.04 28.55 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.374 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.92 143.51 50.18 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.299 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.7 119.85 24.36 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 3.9 tt -91.85 125.01 36.4 Favored 'General case' 0 C--O 1.281 2.737 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.255 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.555 ' ND2' HD13 ' A' ' 56' ' ' LEU . 17.3 m120 -123.83 141.64 51.85 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.785 -1.552 . . . . 0.0 107.393 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.401 HD23 ' HE ' ' A' ' 176' ' ' ARG . 3.3 mm? -103.29 132.94 49.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.479 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.45 170.47 8.38 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.63 16.96 67.07 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 132.11 43.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.45 169.09 18.62 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.41 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 10.9 t70 -73.01 108.59 5.99 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.155 -174.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -132.18 -12.83 3.17 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -167.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 177' ' ' CYS . 23.2 mt -65.5 120.04 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.37 115.0 6.52 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.0 ttt -95.37 -7.79 37.51 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.378 0.609 . . . . 0.0 110.169 -172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.33 -49.81 6.15 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.182 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -87.08 -16.25 36.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.167 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 104.7 16.65 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.768 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.428 ' H ' ' HB3' ' A' ' 160' ' ' ALA . 11.6 mm-40 -71.41 103.7 2.99 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.949 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.85 161.6 42.4 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.97 129.79 51.51 Favored 'General case' 0 N--CA 1.402 -2.854 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.795 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 56.0 mtt -92.66 108.21 19.8 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -151.51 -25.27 0.2 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -167.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 53.6 m -70.59 -56.38 6.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.16 -35.52 4.67 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.677 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -164.18 -174.39 3.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 147' ' ' MET . 10.2 tmtt? -65.04 -33.64 76.52 Favored 'General case' 0 C--O 1.196 -1.737 0 O-C-N 123.84 0.713 . . . . 0.0 111.022 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.26 23.72 4.27 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.331 0.586 . . . . 0.0 111.904 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.453 ' HA ' ' NE2' ' A' ' 154' ' ' GLN . 17.1 mm-40 -125.62 114.28 18.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.452 0.644 . . . . 0.0 111.197 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 56.9 mt -84.86 134.13 27.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.856 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -110.34 -70.88 0.64 Allowed Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -84.22 127.4 33.92 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.81 127.65 66.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -112.87 -24.16 9.71 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.1 0.476 . . . . 0.0 110.905 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 144' ' ' GLU . . . -151.54 136.22 17.1 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -131.25 108.27 9.56 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.35 138.0 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.1 mt -54.37 140.23 34.34 Favored 'General case' 0 C--O 1.253 1.251 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.563 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.1 p-10 -87.99 6.28 36.67 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.226 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -68.27 -6.14 22.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.878 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.0 m -61.03 -40.82 95.05 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 124.614 1.166 . . . . 0.0 110.046 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.53 -32.21 6.54 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.384 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.515 HG13 ' CB ' ' A' ' 137' ' ' ALA . 83.3 mt -82.94 147.24 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.406 ' HD2' ' OD2' ' A' ' 171' ' ' ASP . 9.3 mmt85 -54.03 118.13 14.8 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 122.908 0.483 . . . . 0.0 112.041 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 14.5 Cg_exo -70.64 -11.89 30.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.409 2.072 . . . . 0.0 111.653 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.406 ' OD2' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -88.97 0.47 56.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.475 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.04 127.65 33.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -76.34 -22.53 54.8 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.434 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.7 ttt -155.77 122.45 5.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -148.51 -179.23 6.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.44 ' HD2' ' CG ' ' A' ' 51' ' ' HIS . 12.2 ptp180 -151.43 164.73 36.1 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.49 ' HB3' HD11 ' A' ' 138' ' ' ILE . 61.6 m -86.5 152.32 22.75 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 124.206 0.941 . . . . 0.0 112.082 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 136' ' ' ASP . 3.7 p -82.12 -50.77 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.411 ' HB2' HD12 ' A' ' 138' ' ' ILE . 48.9 mmtm -85.19 2.62 42.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.66 104.04 5.0 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.55 ' NH1' ' HB3' ' A' ' 47' ' ' ASP . 27.7 ptt180 -68.0 -27.12 66.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.004 -170.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.454 ' O ' HG13 ' A' ' 184' ' ' ILE . 17.9 mtm-85 -88.85 -33.55 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.064 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.475 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.9 tt -62.34 105.75 0.66 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.448 1.099 . . . . 0.0 111.24 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 182' ' ' ARG . 67.1 mt -110.6 130.46 63.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 45.0 mt -107.78 121.86 45.59 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.397 0.618 . . . . 0.0 110.564 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.5 pt -111.36 143.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.27 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -77.11 154.71 33.0 Favored 'General case' 0 C--O 1.259 1.57 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 2.8 pm0 -55.16 -39.4 69.45 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.474 0.71 . . . . 0.0 112.357 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -54.01 -43.42 70.06 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.463 1.505 . . . . 0.0 111.718 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.7 -48.32 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.435 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.572 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 20.7 p80 -72.21 -25.25 61.58 Favored 'General case' 0 C--O 1.196 -1.743 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.108 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.0 73.09 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.452 0.47 . . . . 0.0 110.526 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.19 -35.62 71.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.2 m-85 -68.6 -35.69 77.68 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.693 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -59.1 -51.54 69.6 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.812 0.695 . . . . 0.0 110.219 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.07 -16.51 59.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.071 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.85 -27.34 36.45 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.02 47.94 17.35 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.516 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.12 165.0 25.16 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.417 -0.113 . . . . 0.0 111.041 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.4 p -43.37 -77.03 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -171.0 138.4 4.92 Favored Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.719 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.433 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 35.2 m-85 -136.36 153.46 51.12 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -112.86 122.02 46.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.97 129.32 68.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.214 0.53 . . . . 0.0 109.642 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 60.0 m-85 -114.1 137.39 51.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.75 109.53 3.88 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.04 -33.11 57.36 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.495 0.497 . . . . 0.0 112.088 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.41 92.52 1.08 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.296 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.52 35.05 14.71 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 16.3 t90 -67.51 101.03 0.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.923 0.889 . . . . 0.0 112.164 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -104.35 152.03 22.75 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.94 -25.67 0.3 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 166.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.437 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 86.4 mt -94.68 145.72 24.65 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 117.956 0.878 . . . . 0.0 112.659 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.4 132.85 52.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 215' ' ' LEU . 2.5 pt? . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 187' ' ' ARG . 41.5 t . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' OE2' ' A' ' 208' ' ' GLU . 20.8 ptmt -79.44 156.06 28.04 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.2 0.524 . . . . 0.0 111.699 -175.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -109.68 141.29 42.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.738 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -124.22 146.0 49.0 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.022 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.79 117.82 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -105.7 123.11 47.4 Favored 'General case' 0 C--N 1.282 -2.358 0 O-C-N 123.638 0.586 . . . . 0.0 110.506 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -139.32 139.43 37.28 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.8 t -86.6 110.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.74 98.7 9.5 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 119.509 -0.876 . . . . 0.0 108.906 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.63 110.84 5.76 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.43 -35.12 8.9 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.919 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.24 -23.93 57.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.124 0.487 . . . . 0.0 110.462 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . . . -79.73 -28.06 40.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.71 156.06 22.02 Favored Glycine 0 N--CA 1.413 -2.892 0 CA-C-N 113.635 -1.621 . . . . 0.0 114.381 174.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 71.7 m-85 -87.1 156.13 19.84 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.822 -1.189 . . . . 0.0 108.119 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.448 HG12 ' CE2' ' A' ' 68' ' ' PHE . 22.4 mt -79.52 101.85 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -57.9 -45.16 86.86 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -131.82 176.19 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.62 119.58 74.87 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 124.004 0.815 . . . . 0.0 110.981 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -66.94 166.75 21.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.671 2.248 . . . . 0.0 111.946 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -49.97 117.51 2.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.226 1.011 . . . . 0.0 113.697 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.36 66.21 Favored Glycine 0 C--O 1.206 -1.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.731 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.4 m -86.44 137.49 34.42 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.81 166.67 26.89 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 124.062 3.174 . . . . 0.0 111.154 169.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 p -53.47 150.69 6.4 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.39 -57.21 1.44 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 128.25 2.62 . . . . 0.0 114.522 -174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -85.86 -21.02 28.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.703 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -79.1 -20.03 49.71 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.625 0.37 . . . . 0.0 111.926 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.518 ' HA ' HD21 ' A' ' 56' ' ' LEU . 57.9 m-85 -45.11 -33.24 2.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 4.5 m-70 -129.11 16.07 6.19 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 120.577 -1.327 . . . . 0.0 109.95 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 101.28 13.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.378 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.55 -9.38 1.28 Allowed Glycine 0 CA--C 1.549 2.181 0 N-CA-C 118.066 1.986 . . . . 0.0 118.066 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.128 1.964 . . . . 0.0 112.152 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.2 t -97.45 150.01 21.52 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 50' ' ' PHE . 77.4 mt -86.25 -3.14 58.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.514 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.48 66.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.48 -20.52 25.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -114.62 -22.89 9.53 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -108.11 136.54 19.78 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.61 123.09 11.45 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.69 2.26 . . . . 0.0 112.183 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.02 116.78 34.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.64 21.39 58.11 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -99.2 -162.94 29.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.382 -177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -116.85 137.85 51.92 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.22 172.78 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -148.96 155.61 41.08 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.448 ' CE2' HG12 ' A' ' 37' ' ' ILE . 7.8 m-85 -75.02 104.83 5.75 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.12 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -81.13 -161.48 0.41 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.95 0.9 . . . . 0.0 111.872 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.443 ' HB2' HG21 ' A' ' 122' ' ' VAL . 2.6 p-10 -81.95 -168.24 1.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.191 0.996 . . . . 0.0 112.615 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD13 HG23 ' A' ' 122' ' ' VAL . 5.2 mp -87.8 142.61 27.68 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.765 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 21.8 m-85 -107.76 -167.57 1.27 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.78 -42.85 89.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.37 138.18 53.88 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 16.2 mm100 -119.25 131.5 24.34 Favored Pre-proline 0 C--O 1.261 1.679 0 O-C-N 123.531 0.519 . . . . 0.0 110.471 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.67 177.68 2.15 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.141 2.561 . . . . 0.0 111.967 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 26.6 p30 -163.49 179.11 7.5 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.91 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.1 mm -91.93 3.22 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 CA-C-O 122.542 1.163 . . . . 0.0 108.701 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -109.98 -102.37 0.39 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.238 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 64.7 p -173.51 -14.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.557 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -69.63 116.75 10.39 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.44 132.02 34.61 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.101 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 34.3 tp -104.28 119.55 39.21 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.628 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.42 136.98 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.503 -173.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -71.38 172.04 10.13 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.276 0.63 . . . . 0.0 111.649 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 97' ' ' LYS . . . -68.03 -34.02 80.56 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -64.52 -55.56 19.8 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.509 0.723 . . . . 0.0 110.085 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.51 69.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.464 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 58.7 ttt180 -58.39 -48.36 80.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.979 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 7.6 mtpm? -62.18 -32.36 72.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.796 0.685 . . . . 0.0 112.047 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.84 -53.06 61.96 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.982 0.42 . . . . 0.0 110.349 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.44 -36.32 75.78 Favored 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.921 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 51.6 mt-10 -68.87 -38.66 79.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.124 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.3 m -70.53 -28.7 65.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.965 0.412 . . . . 0.0 111.764 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.35 -14.98 57.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.647 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.52 48.42 68.46 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 173' ' ' LYS . 94.9 t -67.93 109.06 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.66 0.743 . . . . 0.0 111.421 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -64.33 136.64 57.34 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 75.67 7.87 3.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.118 1.367 . . . . 0.0 114.391 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.21 114.12 26.56 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 9.1 tp10 -103.39 146.58 28.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -114.15 120.94 42.24 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.607 0.567 . . . . 0.0 110.631 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.62 97.28 50.68 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.51 140.78 17.23 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.872 2.381 . . . . 0.0 112.9 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.8 m -148.66 167.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.528 0.731 . . . . 0.0 110.005 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.48 116.61 30.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 33.9 mt -112.92 132.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.172 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -92.86 134.91 34.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -80.0 -160.81 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.407 ' HE1' ' O ' ' A' ' 34' ' ' ALA . 58.8 m80 -68.56 -26.89 65.63 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.898 -0.501 . . . . 0.0 110.922 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.39 -19.19 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.327 0.651 . . . . 0.0 110.907 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.12 14.06 27.35 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.518 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -101.85 139.76 37.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.355 0.578 . . . . 0.0 110.289 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 58.7 t -83.0 84.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.312 1.053 . . . . 0.0 110.539 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.458 HG23 HD13 ' A' ' 78' ' ' LEU . 17.3 m -111.21 16.83 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.474 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.447 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -130.84 45.4 1.14 Allowed Glycine 0 CA--C 1.547 2.089 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.828 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.07 -5.05 9.63 Favored 'Trans proline' 0 C--N 1.383 2.342 0 CA-C-N 121.416 2.608 . . . . 0.0 112.506 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -108.47 0.03 20.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.807 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.458 ' HB3' HD11 ' A' ' 90' ' ' LEU . 6.8 m-85 -92.16 134.84 34.48 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.239 -174.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.69 142.36 51.45 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.975 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -83.87 112.47 20.15 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.6 tt -88.35 129.95 35.26 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.57 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -123.88 141.03 52.4 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.525 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.24 131.85 51.11 Favored 'General case' 0 CA--C 1.486 -1.511 0 O-C-N 123.799 0.687 . . . . 0.0 110.356 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.34 173.08 6.48 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 124.719 1.262 . . . . 0.0 108.361 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.54 13.63 64.98 Favored Glycine 0 C--N 1.305 -1.145 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.725 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.82 130.07 45.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.28 107.94 3.83 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.291 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.74 -46.59 0.63 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 125.854 1.661 . . . . 0.0 112.682 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.458 ' C ' ' HB2' ' A' ' 164' ' ' ASP . . . 65.34 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 126.558 1.943 . . . . 0.0 115.912 171.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.1 mm -55.23 124.29 7.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.274 1.03 . . . . 0.0 111.083 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.62 95.26 3.33 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.3 ttm -76.74 -4.14 41.79 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.996 -170.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.74 -50.22 9.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.494 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -99.68 1.36 43.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.988 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.5 p -94.32 119.06 32.53 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.28 100.9 12.87 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -155.27 161.65 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.306 0.574 . . . . 0.0 112.511 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -118.28 145.58 44.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.748 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 59.2 mtt -100.7 155.67 17.77 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.343 33.7 t70 93.07 86.4 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.23 2.212 . . . . 0.0 115.952 174.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.7 m -101.48 -37.38 8.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.41 168.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.0 mt -135.23 -45.27 0.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.111 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.447 ' CD ' HH22 ' A' ' 181' ' ' ARG . 40.0 mt-10 -139.65 177.24 8.08 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.552 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -31.25 71.76 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -96.51 24.01 6.3 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.481 1.134 . . . . 0.0 110.074 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.465 HE22 ' HG2' ' A' ' 181' ' ' ARG . 21.3 mm-40 -114.66 115.19 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.5 mt -78.32 139.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 -84.85 1.75 Allowed Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -82.31 121.38 26.6 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.33 109.86 26.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.19 -43.67 12.81 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.85 110.66 4.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -85.33 121.22 27.75 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -93.99 132.0 38.89 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.82 136.05 51.47 Favored 'General case' 0 C--O 1.257 1.487 0 O-C-N 124.185 0.928 . . . . 0.0 111.708 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.458 ' HB2' ' C ' ' A' ' 137' ' ' ALA . 21.5 p-10 -87.22 1.62 52.55 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.988 -175.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.1 p -68.27 -4.53 14.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.031 1.333 . . . . 0.0 111.203 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.2 m -67.61 -34.37 76.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.264 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.13 -31.69 6.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.403 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.3 mt -91.89 141.68 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.448 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 48.3 mtp180 -53.96 121.5 29.68 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 123.415 0.686 . . . . 0.0 111.435 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.17 -6.85 18.29 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.876 2.384 . . . . 0.0 112.603 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.05 -10.0 55.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.291 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.47 120.3 15.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 104' ' ' VAL . 98.8 mttt -71.98 -30.79 65.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.998 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.546 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.9 ttt -153.35 129.59 10.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.24 -178.92 7.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 22.9 ttp180 -138.53 142.08 39.31 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.78 144.6 52.63 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.6 p -81.07 -35.88 31.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.47 -7.39 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.06 117.85 13.2 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 176' ' ' ARG . 6.2 ptp180 -76.48 -24.76 53.82 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.303 -173.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -89.77 -15.72 31.8 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.77 99.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.685 -174.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.42 123.08 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -107.64 124.45 50.0 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.845 0.831 . . . . 0.0 111.251 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.546 HG22 ' HG3' ' A' ' 174' ' ' MET . 36.3 pt -116.07 155.27 17.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.987 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 22' ' ' VAL . 47.8 mtm180 -85.98 158.59 19.84 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.5 pt-20 -47.82 -42.46 26.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.35 1.06 . . . . 0.0 113.097 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.92 -40.47 69.91 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 125.445 1.498 . . . . 0.0 112.291 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.45 -46.97 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.563 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 33.1 p80 -71.01 -31.74 68.33 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.02 70.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.0 -34.77 61.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.13 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.7 m-85 -73.21 -35.52 66.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.008 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 47.7 mt-10 -60.75 -53.38 58.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.523 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.65 -24.17 66.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.56 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -79.76 -27.41 40.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.344 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.47 36.61 43.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.82 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.32 157.11 32.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.4 p -102.03 137.11 40.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.55 71.35 0.92 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.369 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 55.5 m-85 -141.96 149.54 40.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 118.175 0.988 . . . . 0.0 112.795 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -161.71 121.51 2.53 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.07 156.14 38.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -140.72 161.89 36.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 123.558 0.743 . . . . 0.0 109.934 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.04 117.69 20.33 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -26.98 62.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.576 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.472 ' OE2' ' HE3' ' A' ' 23' ' ' LYS . 35.3 mt-10 -67.58 97.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.304 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 70.65 35.65 67.26 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.741 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.6 t90 -52.92 102.71 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.969 0.908 . . . . 0.0 110.304 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.24 113.14 26.48 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.02 -25.02 0.25 Allowed Glycine 0 CA--C 1.539 1.575 0 N-CA-C 119.999 2.76 . . . . 0.0 119.999 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.13 114.93 21.0 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 119.019 1.41 . . . . 0.0 110.74 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.99 132.36 42.32 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.482 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.241 174.875 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 C--O 1.237 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -98.2 127.9 44.38 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.41 141.89 44.37 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.429 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -124.47 143.49 50.62 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.5 111.14 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -92.06 132.39 36.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.409 0.624 . . . . 0.0 110.952 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HE2' ' OXT' ' A' ' 215' ' ' LEU . 0.4 OUTLIER -148.77 156.45 42.37 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 103.193 -2.892 . . . . 0.0 103.193 177.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -94.64 131.38 41.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.9 ptp -70.2 173.57 6.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.833 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 77.44 112.42 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.273 1.829 . . . . 0.0 112.375 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.91 -16.83 34.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.624 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -13.62 43.16 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB1' HE22 ' A' ' 82' ' ' GLN . . . -68.93 -35.76 77.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 90.65 145.45 13.95 Favored Glycine 0 N--CA 1.401 -3.684 0 CA-C-N 113.775 -1.557 . . . . 0.0 114.754 171.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.446 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 21.9 m-85 -95.92 166.08 11.96 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 113.436 -1.382 . . . . 0.0 107.863 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.1 mt -78.3 101.34 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 162.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -62.59 -51.66 66.45 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 124.504 1.127 . . . . 0.0 112.234 -169.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.6 176.14 8.7 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 46' ' ' THR . 9.6 mp -60.68 126.94 86.3 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 36.7 Cg_endo -73.68 167.7 26.62 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.079 2.519 . . . . 0.0 112.284 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.6 112.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 124.28 1.032 . . . . 0.0 112.712 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.68 66.98 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 115.691 1.037 . . . . 0.0 115.691 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 81.1 p -85.94 146.94 44.38 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 118.204 1.002 . . . . 0.0 113.213 -176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.38 166.36 15.28 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.913 3.075 . . . . 0.0 111.741 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.44 ' HA ' HD21 ' A' ' 40' ' ' LEU . 35.9 p -56.85 155.16 8.23 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.39 -56.06 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 127.925 2.49 . . . . 0.0 112.915 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -85.86 -19.67 30.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.495 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -84.17 -17.14 40.97 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 30.3 m-85 -45.18 -40.53 7.27 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 12.4 m170 -128.98 20.71 5.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 111.396 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.95 102.57 14.93 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.49 -2.93 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.464 1.345 . . . . 0.0 116.464 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.83 160.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.097 0.949 . . . . 0.0 113.219 -173.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -98.12 134.53 41.06 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.67 -10.78 55.32 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.84 63.03 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.13 -17.88 28.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.58 -21.24 9.25 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 58.4 t80 -105.92 138.8 19.75 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 123.29 11.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.029 1.82 . . . . 0.0 112.572 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.46 122.69 44.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.57 75.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.63 -165.92 29.5 Favored Glycine 0 CA--C 1.502 -0.736 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.319 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mt-10 -117.93 130.09 56.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 35.6 m -126.78 160.93 34.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 p -142.33 150.02 40.23 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.959 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -75.27 107.33 7.3 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.296 -1.758 0 O-C-N 124.881 1.363 . . . . 0.0 112.792 178.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 61.5 t30 . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.272 20.4 mmt180 -69.17 -174.17 0.61 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 -164.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.47 -172.75 4.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.861 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.71 150.7 22.48 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.389 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -114.63 -159.89 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.441 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.31 -37.42 85.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.481 0.582 . . . . 0.0 111.099 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -126.36 157.14 39.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.412 HE22 ' HB1' ' A' ' 34' ' ' ALA . 34.9 tp60 -141.53 136.41 15.55 Favored Pre-proline 0 C--O 1.26 1.636 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.87 178.12 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.441 2.094 . . . . 0.0 113.441 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.9 p30 -160.98 173.98 14.47 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.2 mm -90.54 -14.59 8.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.907 0.86 . . . . 0.0 109.849 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -94.67 -151.75 0.33 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.372 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 2.1 m -102.58 0.91 34.12 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.481 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 4.0 p-10 -92.62 167.31 12.0 Favored 'General case' 0 C--O 1.201 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 112.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.71 141.64 51.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 126' ' ' TYR . 40.4 tp -112.66 126.4 55.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.72 141.45 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -79.53 172.57 13.61 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.353 0.261 . . . . 0.0 110.61 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.93 93.41 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -64.08 -47.22 80.91 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 122.762 0.425 . . . . 0.0 112.003 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.36 -28.74 66.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -56.99 -47.56 80.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.944 0.497 . . . . 0.0 110.442 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.8 -28.75 68.63 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.795 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.51 -54.19 46.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.33 -43.88 87.17 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.53 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -66.12 -35.01 79.35 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -68.24 -21.75 64.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.024 0.44 . . . . 0.0 111.441 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.497 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -86.29 -2.8 58.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.811 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.44 37.17 85.4 Favored Glycine 0 N--CA 1.438 -1.18 0 O-C-N 123.952 0.782 . . . . 0.0 112.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.17 116.67 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.375 0.607 . . . . 0.0 109.628 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -88.01 157.77 18.81 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.205 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 78.0 15.48 1.46 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.903 0.881 . . . . 0.0 112.243 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.18 114.98 29.44 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 7.1 tp10 -105.73 140.77 38.27 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.43 ' CH2' HD12 ' A' ' 129' ' ' LEU . 43.8 m95 -116.87 121.94 42.93 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.804 0.842 . . . . 0.0 109.7 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -113.43 109.13 51.47 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.597 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.48 137.1 16.24 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 122.54 2.16 . . . . 0.0 113.407 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 172.27 2.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.401 1.08 . . . . 0.0 109.586 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.502 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -103.16 116.51 32.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 126' ' ' TYR . 22.1 mt -107.53 142.69 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.186 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -118.38 135.35 54.38 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.623 1.169 . . . . 0.0 108.128 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.9 p30 -86.19 -162.29 0.73 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.1 m80 -74.4 -12.61 60.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.384 1.074 . . . . 0.0 111.815 -174.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.51 -19.48 29.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.07 1.29 63.04 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.174 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -89.65 154.77 19.71 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.748 -0.266 . . . . 0.0 110.412 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.57 126.17 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 116' ' ' ASP . 11.3 p -129.81 -32.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.921 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.95 73.14 0.47 Allowed Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.491 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.08 -0.99 9.76 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 CA-C-N 119.673 1.736 . . . . 0.0 109.746 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.61 -12.19 17.92 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.203 1.401 . . . . 0.0 111.158 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.471 ' HB2' HD12 ' A' ' 114' ' ' ILE . 10.0 m-85 -92.57 149.26 21.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.539 0.685 . . . . 0.0 112.528 -172.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.39 143.02 49.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.368 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.23 120.38 27.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.564 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.0 tt -91.61 131.83 36.75 Favored 'General case' 0 C--O 1.259 1.573 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.405 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.567 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 7.9 p30 -124.42 140.96 52.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.217 174.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.43 141.05 32.72 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.573 0.546 . . . . 0.0 110.462 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.5 173.02 6.67 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 124.656 1.222 . . . . 0.0 108.412 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.72 17.18 73.6 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 132.89 33.97 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.295 0.569 . . . . 0.0 109.779 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -137.07 168.98 18.55 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.9 103.1 0.14 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.716 1.143 . . . . 0.0 111.27 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -88.66 -54.9 3.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.026 -1.897 . . . . 0.0 115.497 -163.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 179' ' ' LYS . 45.9 mt -51.22 113.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 124.366 1.041 . . . . 0.0 113.758 -169.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -70.93 107.07 3.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.517 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 46.7 mtt -91.3 8.84 34.05 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -85.84 -50.39 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -93.21 -4.9 51.17 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.484 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 61.0 p -91.74 151.02 20.82 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.995 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.58 97.81 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -147.78 163.42 36.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.16 140.79 49.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.506 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.16 155.65 20.66 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.998 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.321 34.6 t70 96.0 95.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.455 2.302 . . . . 0.0 115.783 174.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.0 m -100.57 -56.16 2.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 167.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -128.33 -41.05 1.58 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.063 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 47.8 mt-10 -125.83 -179.08 4.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.058 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -71.71 -44.23 64.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 124.201 0.938 . . . . 0.0 111.07 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -82.91 26.01 0.63 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.894 0.854 . . . . 0.0 112.241 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -113.21 122.05 46.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.28 116.17 21.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -84.02 -61.55 1.83 Allowed Glycine 0 CA--C 1.493 -1.315 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -111.02 132.86 53.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.2 mp -119.8 113.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -89.34 -39.19 13.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.614 -0.835 . . . . 0.0 109.994 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.19 117.4 3.5 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.173 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.36 145.08 26.48 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.95 146.02 47.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HG ' ' OE2' ' A' ' 208' ' ' GLU . 93.8 mt -53.78 136.55 39.83 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.512 1.133 . . . . 0.0 112.559 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.618 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 41.0 p-10 -96.5 10.44 38.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.166 -177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.2 p -68.19 -5.16 16.65 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.938 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.8 m -61.14 -40.53 94.17 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.147 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.52 -33.68 6.31 Favored 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.255 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.26 151.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -44.41 117.61 2.97 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.046 0.938 . . . . 0.0 110.934 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.34 -16.04 39.04 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.461 2.107 . . . . 0.0 111.856 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.62 11.43 31.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.496 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.04 143.38 39.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -95.99 -28.95 14.41 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.444 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -143.75 124.57 14.24 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.35 178.23 10.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.61 163.25 40.31 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.138 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.456 ' SG ' HD22 ' A' ' 183' ' ' LEU . 71.2 m -83.3 149.93 26.46 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.125 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.5 p -81.44 -51.51 8.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.408 ' HB2' HD12 ' A' ' 138' ' ' ILE . 83.7 mttt -89.5 20.65 3.8 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 8.4 tp10 -145.92 134.32 21.9 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 171.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' SER . 15.3 mmt180 -89.96 -33.16 16.49 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 123.821 0.701 . . . . 0.0 112.386 -168.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -91.67 -12.11 35.03 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.971 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.456 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.5 tt -86.68 109.13 18.99 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.433 0.635 . . . . 0.0 110.401 -173.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.19 129.06 75.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.7 121.54 43.8 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.801 0.81 . . . . 0.0 111.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 48.7 pt -111.29 147.77 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.007 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.35 150.11 38.51 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.15 -39.2 27.99 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.52 -30.28 69.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 111.73 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.497 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.7 t -66.4 -49.48 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.999 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.568 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 17.1 p80 -70.87 -29.73 65.92 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.085 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -59.35 -34.84 72.86 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.37 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.38 61.65 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 19.2 m-30 -68.98 -34.55 75.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.696 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 39.5 mt-10 -65.48 -49.11 70.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.493 0.717 . . . . 0.0 111.146 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -69.92 -29.89 67.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.48 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 109.897 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 78.72 45.22 9.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.661 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.9 mt -81.4 154.14 26.58 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 27.5 p -101.45 129.82 47.56 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.69 71.71 0.75 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.756 -0.657 . . . . 0.0 114.582 172.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 14.9 m-85 -124.7 145.77 49.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.061 0.93 . . . . 0.0 112.666 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -144.0 121.94 12.04 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.03 128.9 69.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 69.2 m-85 -120.46 137.97 54.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.06 111.03 3.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.22 86.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.526 0.516 . . . . 0.0 112.175 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.462 ' OE2' ' HG ' ' A' ' 163' ' ' LEU . 30.1 mm-40 -68.07 100.61 1.02 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.345 0.593 . . . . 0.0 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.56 32.85 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.066 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.66 104.64 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.967 . . . . 0.0 110.129 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.91 103.78 13.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -173.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -7.41 2.96 Favored Glycine 0 N--CA 1.471 1.005 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.14 117.46 23.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.548 1.174 . . . . 0.0 110.552 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.99 125.79 29.78 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.3 pt? . . . . . 0 C--N 1.31 -1.112 0 O-C-N 124.263 0.977 . . . . 0.0 112.313 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.409 -2.517 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' OE2' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -112.04 155.8 23.22 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -114.57 142.78 45.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.253 0.549 . . . . 0.0 111.128 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 83.9 m-85 -125.11 147.38 49.04 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.772 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 85.9 t -80.74 123.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -91.94 133.67 35.48 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.502 0.668 . . . . 0.0 110.733 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -150.18 151.35 32.94 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.22 121.35 45.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 26.9 ttt -79.23 81.29 5.51 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.299 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 178.74 111.72 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 124.734 1.271 . . . . 0.0 108.41 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.47 -23.54 25.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 47.0 mt-10 -82.54 -4.11 57.06 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.055 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -62.39 -35.33 78.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 97.0 92.62 1.87 Allowed Glycine 0 N--CA 1.397 -3.96 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.755 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.09 141.01 57.74 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -70.85 101.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 169.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.2 -33.99 49.72 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.274 0.559 . . . . 0.0 111.411 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -122.41 161.77 22.86 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.9 124.97 91.91 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 122.618 0.367 . . . . 0.0 111.874 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.74 168.98 21.56 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.075 2.516 . . . . 0.0 111.417 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -39.8 118.85 0.91 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.234 1.413 . . . . 0.0 113.303 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 13.53 83.15 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 48.8 m -85.51 138.52 35.97 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 44' ' ' SER . 15.8 Cg_exo -67.57 166.71 23.04 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.513 3.475 . . . . 0.0 111.037 173.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -60.01 145.92 44.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -38.09 -53.78 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 127.171 2.188 . . . . 0.0 114.121 -174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.437 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 56.5 p-90 -85.77 -23.18 27.37 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.582 -173.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 48.6 tptt -86.93 -11.77 49.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.979 -171.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 88' ' ' ASN . 20.9 m-85 -43.28 -51.46 6.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.079 0.862 . . . . 0.0 112.743 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.493 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.0 m-70 -128.43 32.45 4.85 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.339 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.2 tm-20 -92.38 101.24 13.71 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.67 -10.65 12.18 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.6 169.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.944 1.872 . . . . 0.0 114.108 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -98.28 160.16 14.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.362 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.441 HD22 ' HG2' ' A' ' 45' ' ' PRO . 81.9 mt -112.76 14.42 19.94 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.3 -22.9 64.7 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.683 0.754 . . . . 0.0 110.434 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -88.95 -20.8 24.03 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.555 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.6 -22.95 12.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.58 140.78 23.51 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 122.41 9.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.914 1.743 . . . . 0.0 112.095 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.443 HG22 HD22 ' A' ' 110' ' ' LEU . 47.9 t -96.72 123.7 49.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.14 24.32 52.36 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.707 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -107.09 -168.3 22.22 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.406 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.7 mt-10 -123.56 128.25 49.46 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.36 174.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 p -146.39 151.98 38.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.05 113.97 8.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.409 -2.515 0 CA-C-O 122.013 0.911 . . . . 0.0 111.551 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 83.8 m-20 . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HG2' ' HB3' ' A' ' 33' ' ' GLU . 16.6 mmt180 -90.26 -164.32 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.849 0.833 . . . . 0.0 112.075 -174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.5 -170.43 2.94 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 125.614 1.566 . . . . 0.0 110.392 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -88.17 149.54 23.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.296 0.57 . . . . 0.0 111.621 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -120.9 -165.31 1.2 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -66.09 -44.08 85.41 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.924 0.784 . . . . 0.0 111.24 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -113.53 142.25 46.17 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.853 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 15.2 mm100 -128.4 128.62 23.62 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.592 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 82' ' ' GLN . 57.1 Cg_endo -91.42 175.6 2.26 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.892 2.395 . . . . 0.0 113.108 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -163.54 172.16 14.8 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.099 0.959 . . . . 0.0 108.419 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.94 -16.94 9.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.975 0.893 . . . . 0.0 109.723 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -85.48 -164.04 0.95 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.811 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.424 ' CB ' HH21 ' A' ' 176' ' ' ARG . 26.4 p -122.08 54.1 1.19 Allowed 'General case' 0 C--O 1.252 1.205 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 2.6 t30 -137.39 153.42 50.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -109.66 141.96 41.5 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.7 tp -108.33 125.9 52.23 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 129' ' ' LEU . 47.1 t -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.625 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.5 p -74.48 172.44 11.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.634 0.774 . . . . 0.0 110.626 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.07 -37.65 94.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.556 -0.354 . . . . 0.0 112.655 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -61.39 -52.63 63.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.783 0.801 . . . . 0.0 109.71 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.35 -32.76 73.92 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.42 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.34 -39.97 84.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.233 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 8.9 mmpt? -64.69 -38.73 91.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.672 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.22 -52.99 62.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.054 0.454 . . . . 0.0 110.296 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.4 mt -61.54 -43.55 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.109 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.39 -41.34 85.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -70.29 -25.28 63.26 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.35 -21.23 59.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.91 47.82 6.06 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.9 t -74.02 101.24 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.616 0.722 . . . . 0.0 109.588 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 m -70.05 147.1 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.965 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 79.45 9.14 1.65 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.362 1.065 . . . . 0.0 111.999 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.58 114.71 29.16 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 8.7 tp10 -111.75 146.85 36.84 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -116.6 120.91 40.18 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.039 0.136 . . . . 0.0 111.092 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.443 HD22 HG22 ' A' ' 62' ' ' VAL . 50.7 mt -106.2 101.98 37.55 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 173.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.17 132.4 12.61 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.666 2.244 . . . . 0.0 112.814 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 64' ' ' GLY . 5.0 m -144.64 170.27 7.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.581 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.79 116.55 32.8 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.8 mt -109.82 133.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.496 0.665 . . . . 0.0 112.409 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HG2' HG22 ' A' ' 121' ' ' VAL . 66.1 mttt -95.6 143.67 26.7 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 174.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.522 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -83.22 -160.7 0.44 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.461 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 35.5 m80 -70.15 -30.87 68.14 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.768 0.827 . . . . 0.0 110.137 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -81.78 -19.98 40.12 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.7 14.88 33.29 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.119 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 17.9 ptpt -95.36 140.51 30.13 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.46 HG22 ' HG2' ' A' ' 115' ' ' LYS . 48.7 t -77.94 89.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.571 0.701 . . . . 0.0 110.024 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.38 11.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.614 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -126.1 54.43 0.76 Allowed Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.669 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.71 -17.44 5.04 Favored 'Trans proline' 0 C--N 1.368 1.594 0 CA-C-N 120.629 2.215 . . . . 0.0 112.342 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.71 7.65 44.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.199 0.523 . . . . 0.0 110.346 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.416 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 5.8 m-85 -95.1 144.32 25.84 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 121.515 0.674 . . . . 0.0 110.601 -177.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -133.58 141.63 47.77 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.023 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.413 ' HB3' ' ND2' ' A' ' 88' ' ' ASN . 55.5 m-85 -80.75 119.76 23.76 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 91' ' ' VAL . 3.9 tt -86.45 121.25 28.74 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 12.3 m120 -97.91 125.81 43.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.08 121.71 42.29 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.401 0.438 . . . . 0.0 110.02 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.66 172.9 6.55 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.855 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 20.29 65.33 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.278 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.03 40.61 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.61 169.32 17.86 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -53.71 104.96 0.11 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -131.58 -27.34 1.94 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 -164.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 179' ' ' LYS . 24.3 mt -63.01 122.86 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.533 1.06 . . . . 0.0 110.874 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.43 107.74 7.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.787 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -77.32 -9.44 58.83 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -70.33 -50.06 43.0 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.436 0.636 . . . . 0.0 109.759 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.69 -2.5 35.21 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.307 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.8 p -99.88 142.38 31.43 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.489 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 14.7 mm-40 -122.61 107.5 12.04 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -161.71 161.28 29.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.747 0.308 . . . . 0.0 111.681 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 59.5 mm-40 -125.46 142.07 51.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 58.7 mtt -100.43 108.32 20.28 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.67 7.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.7 p -72.67 -56.67 4.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.204 -0.599 . . . . 0.0 112.051 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -117.82 -39.23 3.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.687 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 153' ' ' ASP . 10.4 pt-20 -158.24 -176.34 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -68.93 -13.3 62.35 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -114.6 23.24 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.215 0.531 . . . . 0.0 112.15 -179.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 180' ' ' GLU . 21.8 mm-40 -129.37 120.81 26.2 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 72.1 mt -72.91 133.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.061 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -115.79 -70.6 0.47 Allowed Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 8.2 t30 -79.17 122.14 25.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.2 mt -126.91 106.85 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 33.9 t70 -90.25 -44.74 9.52 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.791 0.805 . . . . 0.0 109.088 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.66 110.88 3.92 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.797 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.32 125.64 39.09 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.66 146.87 27.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.0 140.02 57.7 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.867 0.842 . . . . 0.0 112.484 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.4 p-10 -94.46 6.64 48.17 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.46 -5.5 19.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.632 1.173 . . . . 0.0 109.866 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -62.0 -39.49 92.39 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.651 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.24 -31.84 6.72 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.697 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 64.5 mt -83.16 150.62 4.18 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -60.95 120.19 51.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 118.208 0.458 . . . . 0.0 109.96 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.97 -16.35 45.12 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.405 2.07 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.56 -6.15 58.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.19 127.35 32.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.12 -33.36 71.74 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.547 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.7 ttt -151.1 130.08 12.55 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -153.79 -178.72 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.136 0.574 . . . . 0.0 109.585 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.424 HH21 ' CB ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -136.76 145.68 44.89 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.52 152.63 40.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.835 0.709 . . . . 0.0 110.374 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -81.94 -45.36 15.51 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.4 mmpt? -73.45 -20.01 60.81 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.553 -173.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.405 ' HG2' ' CG1' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.68 134.8 52.75 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 175.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.437 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 52.1 mmt-85 -89.59 -36.59 15.22 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -85.77 -19.83 30.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.173 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.9 100.64 2.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.962 0.887 . . . . 0.0 110.914 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.75 124.95 62.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 57.7 mt -112.14 133.67 54.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.45 0.643 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.547 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.4 pt -121.87 159.48 24.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.176 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -86.15 161.43 18.86 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.775 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -49.0 -47.71 44.19 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.994 1.718 . . . . 0.0 109.717 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.12 -45.75 22.59 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.997 2.119 . . . . 0.0 113.525 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -46.42 75.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.605 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 11.5 p80 -77.35 -21.6 53.08 Favored 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.006 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.86 81.63 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.31 -40.82 94.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.71 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 191' ' ' HIS . 22.7 m-85 -65.91 -37.62 86.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.09 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.7 mm-40 -55.36 -51.51 66.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.651 0.78 . . . . 0.0 109.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.62 -10.65 59.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.504 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.01 -27.88 20.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.48 62.91 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.946 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 61.0 mt -84.5 160.28 20.55 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.1 p -94.65 121.75 36.53 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 105.3 63.82 0.64 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.796 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 46.2 m-85 -127.14 135.06 50.18 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 117.938 0.869 . . . . 0.0 112.782 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 50.9 tptt -144.02 121.54 11.75 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.2 m -126.11 129.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.5 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.42 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 72.0 m-85 -110.62 165.02 12.15 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -68.64 122.96 19.61 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.37 -35.64 35.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 23' ' ' LYS . 14.7 mt-10 -75.14 97.85 3.56 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.447 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.06 35.37 34.8 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.678 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.523 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 9.9 t90 -55.21 106.61 0.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.131 0.972 . . . . 0.0 109.712 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -103.23 99.02 8.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.55 15.22 68.18 Favored Glycine 0 N--CA 1.47 0.965 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.523 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 95.5 mt -93.97 156.38 16.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.167 0.984 . . . . 0.0 110.991 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.81 131.64 48.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.065 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.051 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -107.2 144.78 33.47 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.694 0.283 . . . . 0.0 110.398 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -116.56 139.75 50.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.671 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.97 136.42 54.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 37.9 t -72.97 107.73 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -99.76 134.2 42.99 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.525 0.679 . . . . 0.0 112.453 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -151.1 165.36 34.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.97 141.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.71 82.76 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 162.27 137.1 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 127.637 2.375 . . . . 0.0 107.655 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -80.48 -29.29 37.39 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.011 0.91 . . . . 0.0 109.185 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 11.4 pt-20 -83.17 0.73 43.95 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.578 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -66.75 -20.69 66.01 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.895 0.379 . . . . 0.0 110.441 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 66.86 0.29 Allowed Glycine 1 N--CA 1.393 -4.208 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.574 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 19.1 m-85 -70.83 133.06 46.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.856 172.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.49 101.9 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 171.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -59.16 -41.77 89.14 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.681 -171.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -148.0 173.39 12.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 46' ' ' THR . 5.8 mp -60.62 124.61 79.7 Favored Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 124.269 1.027 . . . . 0.0 113.333 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 167.76 25.65 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.803 2.335 . . . . 0.0 112.275 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -45.92 113.76 0.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.898 1.679 . . . . 0.0 112.761 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.61 7.72 87.06 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.522 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.33 132.18 45.87 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 117.21 0.505 . . . . 0.0 111.814 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.48 ' HG2' HD22 ' A' ' 56' ' ' LEU . 31.1 Cg_exo -61.42 165.64 12.76 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.693 2.929 . . . . 0.0 111.958 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.516 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.9 p -52.94 150.14 5.78 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -39.35 -54.91 1.82 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 127.991 2.516 . . . . 0.0 113.708 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.45 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 53.7 p-90 -83.52 -24.3 31.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.151 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HE3' HD12 ' A' ' 54' ' ' ILE . 51.5 tptt -85.41 -12.82 51.11 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.524 -172.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -45.11 -43.94 10.13 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -128.96 25.24 5.6 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -92.96 100.9 13.26 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 118.113 -1.435 . . . . 0.0 107.422 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.11 -9.58 3.92 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.475 HD12 ' HE3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -134.0 172.09 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 120.452 2.126 . . . . 0.0 113.752 -175.539 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.7 t -98.06 150.48 21.36 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.011 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.48 HD22 ' HG2' ' A' ' 45' ' ' PRO . 43.7 mt -98.33 -4.36 35.14 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.02 47.23 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -89.14 -22.41 22.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -101.2 -22.17 14.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -96.31 140.81 22.4 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.38 122.59 10.08 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.932 1.754 . . . . 0.0 110.913 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -101.45 119.3 49.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.05 16.86 66.39 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.436 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -96.29 -150.26 26.69 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.84 133.54 44.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.96 167.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -145.74 154.07 41.66 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.156 -0.34 . . . . 0.0 110.448 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 115.59 15.53 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 170.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--N 1.303 -1.429 0 O-C-N 124.268 0.98 . . . . 0.0 112.755 -176.997 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 48.6 t-20 . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 33' ' ' GLU . 10.6 mmt180 -83.51 -165.37 1.09 Allowed 'General case' 0 C--O 1.262 1.762 0 CA-C-O 122.013 0.911 . . . . 0.0 112.844 -168.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.27 -160.83 0.73 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.637 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 mp -92.89 138.75 31.21 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.114 0.483 . . . . 0.0 111.768 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 2.4 m-30 -108.23 -155.93 0.57 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.957 1.703 . . . . 0.0 108.432 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -64.21 -49.54 71.57 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.515 0.674 . . . . 0.0 110.381 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.15 139.3 53.48 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.825 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 14.3 mm100 -107.39 119.0 52.16 Favored Pre-proline 0 N--CA 1.431 -1.387 0 O-C-N 123.745 0.653 . . . . 0.0 111.309 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 90.6 Cg_endo -84.08 168.12 12.17 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 122.713 2.275 . . . . 0.0 111.259 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -159.35 169.79 23.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.18 -7.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 124.103 0.877 . . . . 0.0 110.286 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -98.99 -168.56 1.64 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.333 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 p -101.97 21.95 13.86 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -173.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -116.43 162.97 16.74 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.541 -0.724 . . . . 0.0 109.316 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.3 tp -123.49 141.7 51.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.968 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 54.1 tp -114.47 127.14 55.66 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 129' ' ' LEU . 47.0 t -126.92 144.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.76 -172.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -76.55 168.77 19.48 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.58 0.352 . . . . 0.0 110.173 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.83 -36.08 90.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -65.2 -45.27 85.48 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -30.38 64.3 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.387 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -58.78 -45.09 90.59 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -57.48 -42.16 82.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.057 0.848 . . . . 0.0 110.617 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.72 -54.26 48.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.354 0.409 . . . . 0.0 110.887 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.14 -41.4 86.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 C-N-CA 123.513 0.725 . . . . 0.0 111.818 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.99 -34.29 75.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.626 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -68.01 -27.55 66.65 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.966 0.412 . . . . 0.0 111.027 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.2 -7.34 59.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.608 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.84 42.73 98.35 Favored Glycine 0 N--CA 1.441 -0.98 0 O-C-N 123.563 0.539 . . . . 0.0 112.321 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -72.07 112.61 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -79.86 155.37 27.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 75.69 15.17 2.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.96 1.304 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.3 113.85 25.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.2 tp10 -109.35 138.7 45.32 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.483 ' CZ3' ' HG ' ' A' ' 129' ' ' LEU . 59.7 m95 -119.6 114.5 22.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.4 mt -110.73 96.59 29.21 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.76 146.23 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.336 2.024 . . . . 0.0 112.239 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 64' ' ' GLY . 2.5 m -149.73 169.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.714 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -90.74 115.35 27.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 126' ' ' TYR . 31.2 mt -108.49 126.55 65.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.49 0.662 . . . . 0.0 112.029 -173.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.64 ' HG2' HG22 ' A' ' 121' ' ' VAL . 90.5 mttt -99.49 136.15 39.85 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.665 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.8 p-10 -81.1 -160.47 0.33 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.866 0.365 . . . . 0.0 110.817 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.665 0.786 . . . . 0.0 110.028 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -79.88 -19.83 47.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.515 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.26 38.17 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.725 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.665 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.9 ptmt -93.92 133.48 37.3 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 115' ' ' LYS . 23.0 t -77.35 93.11 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.132 0.491 . . . . 0.0 109.738 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.408 HG23 HD13 ' A' ' 78' ' ' LEU . 18.9 m -120.31 11.89 6.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.547 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.27 51.8 0.82 Allowed Glycine 0 C--O 1.201 -1.943 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.393 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 90.6 Cg_endo -84.34 -1.97 9.87 Favored 'Trans proline' 0 C--N 1.368 1.584 0 CA-C-N 121.542 2.671 . . . . 0.0 112.209 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -113.54 7.26 17.37 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.591 1.186 . . . . 0.0 109.124 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.429 ' HB2' HD12 ' A' ' 114' ' ' ILE . 3.6 m-85 -93.98 137.31 33.32 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.842 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.8 139.94 53.08 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.693 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -79.45 115.41 19.06 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.483 ' HG ' ' CZ3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -87.28 119.9 28.01 Favored 'General case' 0 C--O 1.274 2.369 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -176.081 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.539 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -101.67 122.07 43.2 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 129' ' ' LEU . 3.5 mm? -96.51 113.25 24.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.14 173.42 7.03 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 124.21 0.944 . . . . 0.0 109.5 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.27 63.86 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.113 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.65 130.94 34.61 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -148.09 100.26 3.15 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.081 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.472 ' O ' ' HE2' ' A' ' 179' ' ' LYS . 16.9 t70 72.41 -48.53 0.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.138 1.775 . . . . 0.0 111.614 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 67.49 -95.82 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 179' ' ' LYS . 28.6 mt -65.15 123.19 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -166.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.1 129.18 37.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.335 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 51.5 ttm -107.43 1.01 23.28 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.487 0.661 . . . . 0.0 110.932 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.3 -49.21 7.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.684 0.754 . . . . 0.0 110.93 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -99.4 10.91 40.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.242 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.7 p -114.44 162.58 16.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -160.27 160.33 32.46 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.407 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -123.53 132.99 54.05 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.82 0.848 . . . . 0.0 109.525 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 57.5 mtt -92.64 126.3 37.66 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.927 0.491 . . . . 0.0 109.986 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -164.36 -26.23 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -168.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HA2' ' A' ' 156' ' ' GLY . 50.0 m -56.59 -55.9 28.16 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 90.6 mt -135.96 -80.71 0.41 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.035 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.95 178.02 5.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -60.33 -34.24 73.54 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-O 120.98 0.419 . . . . 0.0 110.236 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.64 26.54 1.99 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.83 0.824 . . . . 0.0 111.503 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 149' ' ' SER . 38.7 mm-40 -116.99 115.04 24.67 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.747 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 51.5 mt -81.12 121.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.018 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.488 ' HA2' ' OG ' ' A' ' 149' ' ' SER . . . -88.47 -45.31 5.0 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.92 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -124.08 125.41 44.46 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mp -116.89 122.34 69.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -99.34 -51.18 3.87 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.55 0.69 . . . . 0.0 109.886 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.49 110.52 5.94 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.7 124.13 33.81 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -95.23 146.47 24.31 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.02 141.47 58.76 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.864 0.84 . . . . 0.0 112.59 -173.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -85.9 -2.04 57.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.279 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.7 p -68.89 -5.72 22.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.642 1.177 . . . . 0.0 110.01 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.8 m -65.15 -35.08 79.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.19 -30.51 7.43 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.36 144.99 7.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -59.2 120.9 51.67 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.13 0.572 . . . . 0.0 110.817 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 -5.78 16.89 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.426 2.751 . . . . 0.0 114.269 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.91 -3.38 57.37 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.134 -0.354 . . . . 0.0 110.811 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.65 137.39 38.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -90.93 -25.18 19.91 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 91.4 mtp -140.84 131.05 24.89 Favored 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -153.43 153.29 32.23 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.477 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.716 ' CZ ' HG23 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -113.03 143.88 43.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.425 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 39.9 m -88.13 131.98 34.5 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.4 0.438 . . . . 0.0 110.302 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.2 p -81.97 -9.35 59.6 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.5 mmtt -99.04 0.61 44.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.372 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -157.01 143.46 18.2 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.45 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 19.6 mmt180 -90.28 -25.89 20.3 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.615 0.245 . . . . 0.0 111.488 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 182' ' ' ARG . 54.3 mtt180 -78.19 -38.06 44.22 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.425 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 18.9 tp -69.62 100.7 1.5 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 123.247 1.499 . . . . 0.0 113.94 -168.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.716 HG23 ' CZ ' ' A' ' 176' ' ' ARG . 19.8 mt -113.53 116.1 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 112.296 -2.229 . . . . 0.0 106.597 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.25 131.93 54.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 121.833 0.825 . . . . 0.0 113.001 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.99 155.89 24.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.305 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -80.14 156.77 26.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.74 -37.32 70.85 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -57.17 -37.72 72.54 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.94 0.896 . . . . 0.0 111.062 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.33 -51.19 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.938 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.8 p80 -72.47 -26.7 61.9 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.24 -35.68 77.91 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.136 0.494 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.45 -33.78 69.66 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -71.22 -33.03 69.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.097 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 54.1 mm-40 -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.07 -7.43 58.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.007 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.95 24.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 77.99 47.42 8.5 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.779 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.52 165.48 18.02 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.283 20.0 p -67.34 -87.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -169.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.68 124.93 2.01 Favored Glycine 0 CA--C 1.492 -1.384 0 C-N-CA 119.443 -1.36 . . . . 0.0 112.676 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.35 162.82 29.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -108.84 138.51 45.06 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.47 129.35 35.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 124.662 1.226 . . . . 0.0 109.278 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.423 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 74.0 m-85 -125.4 143.12 51.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 115.52 9.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.58 75.82 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.89 96.8 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.987 0.804 . . . . 0.0 109.505 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.79 32.19 41.66 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.982 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -57.73 112.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.559 0.744 . . . . 0.0 110.061 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -102.15 74.99 1.47 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.6 14.57 65.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 116.924 1.53 . . . . 0.0 116.924 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.53 114.76 16.69 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 118.585 1.193 . . . . 0.0 110.341 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -68.37 133.01 48.05 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.191 0.996 . . . . 0.0 110.388 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 5.5 mp . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.865 0.364 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.478 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.6 ptmt -96.45 139.07 33.09 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.21 0.529 . . . . 0.0 109.84 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -121.03 142.66 49.6 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.737 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 64.8 m-85 -119.84 143.43 47.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.667 0.746 . . . . 0.0 112.926 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.27 112.92 16.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -94.68 127.64 40.8 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HG2' ' HD2' ' A' ' 203' ' ' LYS . 22.4 tptm -150.2 139.35 21.17 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 t -88.55 142.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.4 mtt -86.4 75.88 9.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.469 0.652 . . . . 0.0 109.819 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.16 112.47 2.04 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -128.72 -50.88 1.25 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.172 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -1.4 57.1 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.27 1.033 . . . . 0.0 108.621 170.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 79' ' ' TYR . . . -106.14 27.67 8.41 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.263 2.225 . . . . 0.0 110.507 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.585 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 124.45 68.63 0.2 Allowed Glycine 0 N--CA 1.421 -2.352 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -94.66 131.66 40.21 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 166.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -83.01 106.92 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 101.814 -3.402 . . . . 0.0 101.814 162.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -76.87 -50.49 13.25 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.282 0.563 . . . . 0.0 111.126 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -116.08 166.25 12.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.672 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.15 134.61 94.86 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 123.682 0.614 . . . . 0.0 111.641 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.91 162.64 41.94 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.675 2.25 . . . . 0.0 112.282 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -64.24 119.16 9.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.95 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.5 3.58 66.69 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.546 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 m -85.61 146.41 44.04 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.21 166.79 17.98 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 0.0 111.504 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.9 p -59.59 161.29 6.16 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.91 -52.17 35.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.204 1.402 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.403 ' CH2' ' HE2' ' A' ' 49' ' ' LYS . 9.0 p-90 -72.12 -32.96 67.45 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HE2' ' CH2' ' A' ' 48' ' ' TRP . 4.8 mptp? -65.67 -23.65 66.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.543 ' HA ' HD21 ' A' ' 56' ' ' LEU . 72.4 m-85 -60.66 -21.36 62.72 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.029 0.442 . . . . 0.0 111.548 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 11.6 m80 -127.15 -10.38 5.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.33 102.3 14.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.129 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 178' ' ' THR . . . 57.43 -10.97 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 N-CA-C 121.867 3.507 . . . . 0.0 121.867 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 173.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.651 2.726 . . . . 0.0 112.667 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -91.2 142.8 27.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 50' ' ' PHE . 62.3 mt -91.66 -4.68 54.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.125 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.65 -33.79 71.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.87 -5.3 58.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -111.89 -21.33 11.66 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -102.0 137.31 19.46 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.76 123.74 12.49 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.815 2.343 . . . . 0.0 112.347 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.5 114.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 17.13 57.2 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.23 -157.39 25.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.061 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.8 mt-10 -129.63 137.08 50.47 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.2 m -133.82 173.75 14.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 t -144.24 153.41 42.03 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.697 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -69.01 150.18 47.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--N 1.276 -2.602 0 O-C-N 123.671 0.607 . . . . 0.0 109.6 177.979 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -66.75 -168.77 0.07 Allowed 'General case' 0 C--O 1.256 1.411 0 CA-C-O 123.018 1.39 . . . . 0.0 114.695 -167.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -70.69 -168.5 0.26 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 112.351 -2.204 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -110.5 151.97 26.93 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CE1' ' HB1' ' A' ' 34' ' ' ALA . 23.0 m-85 -109.7 -154.38 0.53 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.929 0.891 . . . . 0.0 109.093 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.46 -47.1 74.21 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.086 0.469 . . . . 0.0 111.62 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.21 140.49 51.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.585 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 21.8 tp60 -124.7 120.97 25.71 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.738 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -88.85 -174.46 1.02 Allowed 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.396 2.064 . . . . 0.0 111.553 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -163.67 177.92 8.34 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.87 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.48 -13.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 123.641 0.588 . . . . 0.0 109.426 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.99 -70.72 0.52 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 181' ' ' ARG . 22.8 t -179.81 -53.73 0.01 OUTLIER 'General case' 0 C--N 1.362 1.116 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.41 -167.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.63 166.39 12.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.4 132.17 56.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 56.6 tp -104.77 132.42 51.04 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.6 136.86 58.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 O-C-N 122.408 -0.183 . . . . 0.0 110.718 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.8 p -76.32 170.07 17.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.853 0.461 . . . . 0.0 109.87 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.0 81.05 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.54 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -64.44 -53.39 49.18 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.152 0.501 . . . . 0.0 110.21 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -30.58 70.39 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.129 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.32 -44.1 97.28 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.587 0.755 . . . . 0.0 110.321 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -62.39 -39.46 93.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.934 0.771 . . . . 0.0 109.897 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 102' ' ' LEU . 4.1 mm? -57.62 -59.73 4.75 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.429 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -55.84 -41.34 66.13 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 123.234 0.614 . . . . 0.0 112.578 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.55 -42.52 78.29 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 p -71.49 -27.38 63.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 98' ' ' LEU . 9.5 mp -67.58 -25.4 65.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.863 0.363 . . . . 0.0 111.567 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.03 42.41 5.98 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.17 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.3 t -81.93 101.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 m -74.87 146.99 41.45 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.609 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 80.02 12.27 1.07 Allowed 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.28 1.432 . . . . 0.0 112.56 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.48 113.89 21.54 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.02 131.48 51.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.48 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 53.2 m95 -111.37 123.13 49.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.454 -174.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.2 mt -108.92 95.11 16.19 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.8 132.98 8.97 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -150.3 167.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.98 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.635 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.92 116.71 33.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 24.4 mt -106.24 136.28 41.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.784 -172.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HG2' HG22 ' A' ' 121' ' ' VAL . 63.1 mttp -95.46 146.76 24.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.59 -160.35 0.72 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -70.58 -23.16 62.54 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.377 1.071 . . . . 0.0 110.385 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -92.98 -19.71 21.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.838 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.57 12.97 33.84 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.094 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -99.42 151.16 21.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 117.691 0.745 . . . . 0.0 109.348 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 115' ' ' LYS . 30.6 t -84.73 81.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.666 0.746 . . . . 0.0 110.244 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.7 m -104.45 11.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.086 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -127.39 48.11 0.99 Allowed Glycine 0 N--CA 1.422 -2.25 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.312 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 95.5 Cg_endo -84.95 -2.52 9.63 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 121.405 2.602 . . . . 0.0 111.634 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -114.12 14.27 18.23 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.819 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.451 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 19.6 m-85 -112.8 138.24 49.92 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 111.646 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.96 138.82 52.19 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.965 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.89 125.44 29.72 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.48 HD12 ' CZ3' ' A' ' 109' ' ' TRP . 6.4 tt -102.09 125.95 48.91 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.798 0.809 . . . . 0.0 110.354 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.19 140.55 52.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.317 170.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 176' ' ' ARG . 2.8 mm? -95.79 143.64 26.85 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.204 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.64 173.29 6.37 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 122.992 0.517 . . . . 0.0 109.897 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.25 7.52 84.92 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.39 132.35 40.53 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.63 0.728 . . . . 0.0 110.464 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -132.66 170.45 15.2 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -47.85 107.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.191 0.932 . . . . 0.0 111.391 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.692 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -94.29 -55.58 3.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -163.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.58 117.97 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.126 0.891 . . . . 0.0 112.886 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -67.0 109.84 3.13 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.57 -1.92 58.26 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 12.9 pt-20 -100.05 -30.26 12.06 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.032 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 59.9 mtt85 -102.18 -12.65 17.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 m -97.75 131.44 44.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.872 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -109.42 115.29 29.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.75 174.52 14.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.011 0.434 . . . . 0.0 111.492 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -129.46 128.62 43.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 91.2 mtp -100.79 155.13 18.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.261 19.4 t70 88.71 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.121 2.169 . . . . 0.0 113.076 177.027 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.0 p -101.57 -57.47 2.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.232 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -112.91 -24.4 9.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.784 0.802 . . . . 0.0 109.284 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 32.5 mt-10 -151.95 175.96 11.97 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 126.401 1.88 . . . . 0.0 106.47 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.577 ' N ' ' HE2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -70.53 -38.32 74.22 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -98.79 26.53 5.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.114 1.435 . . . . 0.0 110.607 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.655 ' NE2' ' HD3' ' A' ' 181' ' ' ARG . 9.7 mm-40 -108.2 121.46 44.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.093 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.46 132.59 31.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -97.8 -55.98 1.11 Allowed Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.887 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -112.12 133.3 54.35 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.724 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.47 123.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.4 -39.27 9.27 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.977 0.417 . . . . 0.0 110.447 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.91 117.04 6.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.625 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.98 123.14 45.37 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.36 142.46 30.81 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.87 133.68 56.24 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 122.456 1.122 . . . . 0.0 113.001 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.692 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 18.7 p-10 -88.43 6.22 38.59 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.096 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.2 p -68.9 -4.67 17.35 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.215 1.406 . . . . 0.0 109.979 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.9 m -68.56 -40.68 80.52 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.935 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -103.6 -33.25 9.06 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.196 -0.315 . . . . 0.0 110.864 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.8 146.01 6.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.468 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 1.6 mpp_? -64.85 125.79 89.7 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -4.77 9.86 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.976 3.117 . . . . 0.0 114.658 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 3.9 p30 -83.56 -10.68 58.13 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.244 -0.285 . . . . 0.0 111.177 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.53 138.74 53.56 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.284 0.564 . . . . 0.0 111.076 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.97 -30.0 24.61 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.214 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.1 ttt -148.99 130.42 14.77 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.68 178.45 8.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.296 0.373 . . . . 0.0 110.609 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.563 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 ppt_? -148.54 138.26 22.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 59.6 m -78.17 153.37 32.11 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.973 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 51' ' ' HIS . 7.3 p -81.52 -50.38 9.46 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -97.81 30.13 3.12 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -155.64 127.17 7.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.655 ' HD3' ' NE2' ' A' ' 154' ' ' GLN . 1.8 mpt_? -81.0 -40.99 23.41 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.043 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -86.51 -7.12 58.65 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.175 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.8 tp -88.2 104.2 16.49 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 122.094 0.95 . . . . 0.0 111.902 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.71 123.18 69.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.22 128.85 51.99 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.343 0.592 . . . . 0.0 110.54 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 45.8 pt -112.0 148.86 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.736 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -80.73 156.18 26.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.56 -38.22 43.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.955 0.902 . . . . 0.0 112.487 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.63 -39.79 85.5 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.112 1.365 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.45 -51.34 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.737 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.575 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 18.3 p80 -68.92 -27.86 66.14 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.387 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.41 -32.18 72.12 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.562 0.539 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.9 59.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.201 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -71.72 -32.12 67.42 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.218 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 70.2 mm-40 -55.68 -53.85 51.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.815 0.846 . . . . 0.0 109.149 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -76.88 -20.72 55.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.246 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.81 -27.98 44.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.61 0.243 . . . . 0.0 110.66 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.04 47.76 12.72 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.225 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.78 165.3 23.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.75 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -159.83 132.76 3.08 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.67 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.84 165.31 25.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.4 ' HD2' ' HG2' ' A' ' 28' ' ' LYS . 16.9 ptpt -128.47 131.81 48.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 173.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.59 130.25 71.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.009 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -113.04 153.16 28.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.64 112.02 9.34 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.9 -36.96 84.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 123.829 0.705 . . . . 0.0 112.068 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.63 94.92 1.04 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.51 35.19 14.52 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.622 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -58.64 100.63 0.07 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.513 0.725 . . . . 0.0 111.492 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -104.39 126.54 51.58 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.39 -26.49 0.21 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 120.298 2.879 . . . . 0.0 120.298 163.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.22 115.15 24.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 118.899 1.349 . . . . 0.0 111.602 -172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -82.69 134.66 35.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.753 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.794 1.638 . . . . 0.0 111.577 171.071 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.0 155.57 37.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.043 0.449 . . . . 0.0 112.111 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.35 138.33 46.89 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.929 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 204' ' ' VAL . 65.1 m-85 -125.76 147.52 49.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.31 0.576 . . . . 0.0 112.156 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.1 t -78.3 124.85 37.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -96.43 135.24 38.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.601 0.715 . . . . 0.0 112.154 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -149.78 162.95 39.27 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 81' ' ' PHE . 21.8 t -104.59 143.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.4 ttm -96.55 80.55 3.13 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.47 114.75 4.16 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.018 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.43 -33.67 2.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.86 -0.53 57.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.37 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.98 -31.96 20.32 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 172.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.6 161.1 33.43 Favored Glycine 1 N--CA 1.383 -4.862 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.902 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 47.9 m-85 -95.97 164.14 12.84 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.06 101.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -54.0 -51.18 64.79 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 125.131 1.519 . . . . 0.0 113.174 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -146.81 153.61 40.39 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 40' ' ' LEU . 6.6 mp -48.98 121.16 10.18 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.016 1.326 . . . . 0.0 113.593 -175.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 67' ' ' SER . 31.1 Cg_endo -75.59 167.03 27.34 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.472 2.115 . . . . 0.0 111.161 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -54.66 128.82 34.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.539 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.26 3.57 81.94 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.585 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m -85.47 128.93 57.21 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.73 165.7 3.39 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.616 3.544 . . . . 0.0 112.799 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 p -54.2 147.08 13.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 50' ' ' PHE . 4.0 m-20 -38.19 -56.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 127.059 2.143 . . . . 0.0 114.32 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.434 ' HB2' ' HD2' ' A' ' 181' ' ' ARG . 23.9 p-90 -85.88 -16.08 39.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.835 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -86.66 -13.19 46.26 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.019 -171.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HD2' ' O ' ' A' ' 47' ' ' ASP . 65.9 m-85 -48.66 -27.64 2.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 130' ' ' ASN . 46.8 m170 -127.84 1.24 6.02 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.582 -0.699 . . . . 0.0 111.319 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.84 102.15 14.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.587 -167.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.14 -9.84 0.98 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.18 164.81 30.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 119.516 1.658 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -91.38 143.7 26.35 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.8 0.12 56.82 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.206 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.56 -37.97 52.16 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -90.38 -15.39 31.13 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 178.534 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.49 -23.1 12.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.631 -0.668 . . . . 0.0 112.66 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -97.46 134.71 22.27 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.8 122.09 9.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.462 1.441 . . . . 0.0 110.805 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.12 127.59 54.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.49 66.91 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -101.3 -167.44 27.81 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.613 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.2 mt-10 -116.96 137.75 52.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.48 163.1 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 41' ' ' PRO . 28.7 t -146.29 148.16 32.14 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.046 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.59 116.59 9.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.411 -2.407 0 O-C-N 124.026 0.829 . . . . 0.0 111.71 -176.568 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.443 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 19.7 t-20 . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 77' ' ' ASN . 6.0 mmp_? -84.19 -162.2 0.63 Allowed 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.4 p-10 -86.41 -170.16 2.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.873 1.269 . . . . 0.0 113.143 -176.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 5.1 mp -87.89 144.51 26.54 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.367 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -103.82 -175.9 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -57.58 -41.28 80.81 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.591 0.71 . . . . 0.0 112.18 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.421 ' O ' HG11 ' A' ' 29' ' ' VAL . 95.8 m-85 -118.36 134.91 54.66 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 172.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -121.77 129.5 25.15 Favored Pre-proline 0 C--N 1.283 -2.307 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.182 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.22 171.72 13.57 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.463 2.108 . . . . 0.0 111.734 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.1 p30 -160.08 173.65 15.49 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -96.7 14.89 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-O 123.109 1.433 . . . . 0.0 109.184 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -121.3 -176.09 3.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.722 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 m -98.09 46.9 1.0 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -127.63 162.02 27.49 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.539 -0.726 . . . . 0.0 109.603 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.8 tp -122.99 129.86 52.06 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.2 tp -102.27 123.79 46.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.61 138.05 54.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 122.791 0.436 . . . . 0.0 110.014 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -76.99 174.0 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.639 0.376 . . . . 0.0 111.119 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.61 -37.25 67.95 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.396 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.96 -35.0 66.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.103 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.38 -34.38 70.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 100' ' ' GLU . 64.8 ttt180 -57.84 -46.24 85.05 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.02 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -55.17 -38.4 68.26 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.28 -51.21 69.86 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.53 -41.66 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.069 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 mm-40 -69.19 -36.79 77.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.222 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -74.9 -29.6 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.26 -19.66 56.23 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.245 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.45 48.71 5.2 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.804 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 174' ' ' MET . 97.2 t -82.69 101.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.0 m -77.04 150.44 35.76 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.332 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.1 9.2 1.4 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.391 1.476 . . . . 0.0 113.3 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.49 113.8 25.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.447 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 9.1 tp10 -99.41 139.82 34.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.467 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 57.0 m95 -116.96 121.74 42.27 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -116.41 93.31 39.49 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.1 139.82 21.91 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.858 2.372 . . . . 0.0 113.894 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 64' ' ' GLY . 4.3 m -150.75 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 124.52 1.128 . . . . 0.0 109.522 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -96.95 116.21 28.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -108.36 130.17 61.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.423 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 121' ' ' VAL . 57.8 mttm -96.7 135.27 38.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -169.82 2.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.983 0.356 . . . . 0.0 110.528 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 63.2 m80 -59.59 -31.15 69.2 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.022 0.929 . . . . 0.0 111.147 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -87.52 -3.01 59.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.46 64.47 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -105.34 147.73 27.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 118.461 1.13 . . . . 0.0 110.553 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 115' ' ' LYS . 45.9 t -81.65 90.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.715 0.769 . . . . 0.0 110.34 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.9 6.22 7.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.076 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.06 45.28 1.17 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 119.309 -1.424 . . . . 0.0 116.072 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 78.3 Cg_endo -84.04 -1.44 9.9 Favored 'Trans proline' 0 C--N 1.381 2.251 0 CA-C-N 122.222 3.011 . . . . 0.0 111.02 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.64 -9.22 41.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -98.43 149.55 22.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.637 0.732 . . . . 0.0 112.707 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.0 140.18 45.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.472 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.23 122.89 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.467 HD12 ' CZ3' ' A' ' 109' ' ' TRP . 6.9 tt -99.71 128.55 45.81 Favored 'General case' 0 C--O 1.275 2.434 0 CA-C-O 121.819 0.819 . . . . 0.0 110.914 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.19 140.65 52.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.611 174.135 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.7 140.09 36.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.99 173.76 6.59 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.183 0.927 . . . . 0.0 109.39 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.88 22.13 50.59 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.134 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.43 132.96 45.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.416 0.627 . . . . 0.0 111.164 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -132.72 150.64 52.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -50.13 105.43 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.139 0.971 . . . . 0.0 113.453 -170.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -117.14 -34.1 4.47 Favored 'General case' 0 N--CA 1.398 -3.068 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -167.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 179' ' ' LYS . 41.2 mt -54.62 112.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.517 0.675 . . . . 0.0 111.67 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.85 128.88 36.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.668 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.4 mtt -101.79 4.62 40.61 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.505 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 11.4 pt-20 -88.93 -30.09 19.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.797 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.505 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 3.1 mmp_? -109.55 -28.07 9.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.875 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -83.09 138.68 33.6 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.661 0.743 . . . . 0.0 112.471 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.97 113.87 17.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -153.67 163.17 40.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.199 0.312 . . . . 0.0 111.244 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.66 139.15 52.39 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.299 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 60.2 mtt -100.63 108.57 20.5 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -173.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.7 t70 169.4 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.423 1.889 . . . . 0.0 108.198 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 34.8 t -99.0 -57.17 2.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.418 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 80.0 mt -107.58 -51.98 2.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 -165.97 2.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.571 175.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 147' ' ' MET . 53.8 pttt -59.68 -27.77 66.7 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.11 12.53 35.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.716 0.77 . . . . 0.0 111.892 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 26.0 mm-40 -111.96 116.09 30.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.51 131.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -109.22 -72.25 0.73 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -82.91 127.19 33.29 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.98 121.55 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.06 -39.3 13.75 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.98 134.35 16.2 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.59 120.76 37.64 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.14 146.79 26.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.95 135.18 57.16 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.828 0.705 . . . . 0.0 111.255 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.595 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 13.0 p-10 -92.76 14.04 18.43 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.279 1.038 . . . . 0.0 111.082 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 p -68.56 -5.14 18.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.755 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.4 m -62.8 -35.51 80.11 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 124.187 0.995 . . . . 0.0 110.457 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.42 -31.15 6.9 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.104 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.523 HG13 ' HB2' ' A' ' 137' ' ' ALA . 85.7 mt -90.64 154.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.457 ' HD2' ' OD1' ' A' ' 171' ' ' ASP . 8.3 mmt180 -45.07 119.38 4.01 Favored Pre-proline 0 C--O 1.225 -0.23 0 C-N-CA 123.466 0.706 . . . . 0.0 112.542 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.05 -16.54 25.46 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.093 1.862 . . . . 0.0 111.109 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.457 ' OD1' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -98.06 9.69 42.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.537 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.76 142.55 58.39 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.181 0.515 . . . . 0.0 109.834 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.06 -36.07 15.11 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.971 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.445 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.6 ttt -153.19 118.9 5.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -140.33 -179.7 6.15 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.74 145.01 50.66 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 39.5 m -82.47 147.95 28.42 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 40.6 p -80.54 -45.66 17.07 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.452 ' HB2' HD12 ' A' ' 138' ' ' ILE . 65.6 mttp -79.62 17.62 0.87 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.5 150.18 34.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.434 ' HD2' ' HB2' ' A' ' 48' ' ' TRP . 4.9 mmp_? -91.95 -43.59 9.37 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.875 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -83.66 -33.84 25.15 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.394 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.88 102.3 0.19 Allowed 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.416 1.072 . . . . 0.0 113.187 -170.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 51' ' ' HIS . 87.1 mt -112.88 126.83 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.18 176.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.98 122.94 46.26 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.445 HG22 ' HG3' ' A' ' 174' ' ' MET . 49.2 pt -111.66 151.08 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -86.72 163.11 17.51 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.547 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 15.0 tp10 -50.44 -48.38 56.42 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.187 1.395 . . . . 0.0 111.872 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -63.98 -31.17 72.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.329 0.652 . . . . 0.0 111.558 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.83 -48.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.75 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.571 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 24.9 p80 -71.52 -33.04 68.85 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.699 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.09 72.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.554 0.534 . . . . 0.0 110.457 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.15 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.616 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.77 -40.57 75.98 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.442 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 37.8 mt-10 -62.08 -47.55 84.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.149 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.87 -19.27 61.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.24 47.14 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.656 0.265 . . . . 0.0 111.033 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.91 47.74 5.46 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.304 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.6 mt -89.63 165.83 13.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -50.27 -91.11 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.66 143.42 11.44 Favored Glycine 0 CA--C 1.497 -1.086 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.935 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.79 165.73 24.61 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -133.06 128.59 36.57 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 170.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 15.6 m -132.53 129.92 59.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 123.687 0.617 . . . . 0.0 110.092 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.08 147.05 49.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.63 114.76 3.17 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.019 0.824 . . . . 0.0 109.68 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.57 61.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.104 0.253 . . . . 0.0 111.618 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.64 98.69 1.54 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.27 35.73 16.81 Favored Glycine 0 N--CA 1.422 -2.284 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.594 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -52.74 106.3 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.694 0.759 . . . . 0.0 110.045 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.72 99.65 10.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.837 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.93 -23.16 0.31 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 119.022 2.369 . . . . 0.0 119.022 167.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 69.6 mt -68.11 147.08 52.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.31 134.6 50.15 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 215' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 125.674 1.59 . . . . 0.0 112.426 -174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.432 HG13 ' HG2' ' A' ' 188' ' ' GLU . 52.4 t . . . . . 0 N--CA 1.419 -1.977 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 7.7 ptpp? -81.17 147.84 29.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.444 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -109.17 133.15 53.39 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.629 -174.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 76.3 m-85 -118.79 145.09 45.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.656 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 58.5 t -75.99 124.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -97.81 124.37 42.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.428 0.455 . . . . 0.0 111.591 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -137.46 147.44 45.31 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.7 133.73 40.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.5 ttt -91.19 82.18 5.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.783 0.801 . . . . 0.0 110.01 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.58 116.88 5.68 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.207 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.49 -36.54 2.07 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -83.25 -23.3 32.78 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.133 0.973 . . . . 0.0 109.982 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . . . -67.22 -34.49 77.59 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 154.12 30.79 Favored Glycine 1 N--CA 1.392 -4.259 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.909 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.13 166.95 11.5 Favored 'General case' 0 C--N 1.254 -3.571 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' ' 41' ' ' PRO . 44.6 mt -75.74 101.73 2.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 165.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -63.36 -45.64 90.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.676 -1.602 . . . . 0.0 112.659 -167.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.38 177.08 7.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.041 0.536 . . . . 0.0 110.163 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.38 122.82 84.74 Favored Pre-proline 0 C--N 1.32 -0.687 0 O-C-N 123.808 0.692 . . . . 0.0 112.604 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' ' 37' ' ' ILE . 14.1 Cg_exo -69.82 166.7 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.776 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -48.92 113.51 0.8 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.95 1.3 . . . . 0.0 113.395 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.78 72.88 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.975 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.13 143.31 39.41 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.52 165.86 16.84 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.931 3.087 . . . . 0.0 111.503 172.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.1 p -62.09 155.82 23.16 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 86' ' ' MET . 4.2 m-20 -46.07 -52.71 11.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.096 1.358 . . . . 0.0 113.027 -175.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 30.7 p-90 -73.35 -23.72 60.25 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -74.53 -23.68 58.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.41 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 96.1 m-85 -58.79 -24.9 62.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.628 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 9.0 m80 -114.61 2.29 14.49 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.79 100.65 12.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.468 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.97 -11.79 0.01 OUTLIER Glycine 0 CA--C 1.555 2.542 0 N-CA-C 121.238 3.255 . . . . 0.0 121.238 166.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.06 166.04 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 121.15 2.475 . . . . 0.0 112.191 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB2' ' HG ' ' A' ' 132' ' ' LEU . 32.5 t -84.54 153.73 23.09 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.56 11.6 39.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -170.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.55 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -13.24 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.925 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.32 -22.8 13.29 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.479 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -109.51 137.37 20.3 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.88 122.62 10.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.14 1.893 . . . . 0.0 111.979 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.49 115.64 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.34 55.66 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -100.8 -156.28 27.39 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 33.9 mt-10 -128.83 133.31 47.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 122.468 -0.431 . . . . 0.0 110.894 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 18.8 m -131.81 166.61 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.461 ' OG ' ' HE2' ' A' ' 115' ' ' LYS . 20.0 m -145.62 156.52 43.72 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 5.9 m-85 -74.84 105.8 6.07 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.938 0.774 . . . . 0.0 109.805 175.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.41 -2.44 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.514 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -82.69 -161.81 0.52 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.4 -176.22 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.659 1.184 . . . . 0.0 112.59 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 122' ' ' VAL . 8.4 mp -94.04 150.99 19.85 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 34' ' ' ALA . 20.9 m-85 -110.06 -154.7 0.54 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.761 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -71.11 -38.34 72.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.156 0.503 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.54 138.98 52.52 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 18.2 tp60 -122.53 114.08 30.33 Favored Pre-proline 0 N--CA 1.414 -2.231 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.5 159.33 28.93 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 122.171 1.914 . . . . 0.0 111.356 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.47 171.8 8.82 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.5 mm -88.71 -18.34 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.475 ' HG3' ' OD2' ' A' ' 47' ' ' ASP . 4.7 mpp? -80.74 -95.91 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.151 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 43.2 t -175.89 34.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.485 1.136 . . . . 0.0 110.048 -174.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -136.86 154.33 50.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.714 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.81 139.9 48.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 59.3 tp -112.18 130.02 56.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.16 135.95 61.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.257 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.8 p -71.51 169.63 15.04 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 96' ' ' ARG . . . -63.89 -39.94 97.85 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.149 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -75.74 -32.7 60.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.058 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.48 -28.19 63.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.876 0.37 . . . . 0.0 110.048 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 109' ' ' TRP . 69.1 mtp180 -58.81 -43.12 90.49 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.854 172.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.9 mmpt? -61.47 -35.31 77.27 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 123.527 0.517 . . . . 0.0 111.359 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.85 -58.29 7.92 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.884 0.373 . . . . 0.0 110.115 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.16 -44.25 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.042 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.22 -37.42 87.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.0 p -75.65 -27.4 58.36 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.018 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.3 -24.38 61.32 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.738 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.11 48.45 6.92 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.8 104.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-O 121.818 0.818 . . . . 0.0 110.944 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m -55.31 123.87 15.22 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.799 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 78.21 15.08 1.41 Allowed 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.521 1.528 . . . . 0.0 113.835 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.2 114.24 21.67 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.5 tp10 -105.84 144.92 31.9 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.237 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.527 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 64.9 m95 -116.3 119.66 36.44 Favored 'General case' 0 N--CA 1.425 -1.702 0 O-C-N 124.363 1.04 . . . . 0.0 109.009 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 66.3 mt -110.92 93.36 17.11 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.46 139.49 10.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.647 2.231 . . . . 0.0 112.73 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' GLY . 4.1 m -147.5 173.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 108.777 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -99.66 116.16 31.11 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 172.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 29.9 mt -108.44 132.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.2 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 mppt? -101.12 132.3 46.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.54 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.8 p-10 -82.19 -160.37 0.37 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.54 0.736 . . . . 0.0 112.524 -172.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -67.55 -32.77 73.77 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.746 0.818 . . . . 0.0 110.391 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -77.11 -21.21 54.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.52 36.91 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.109 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.62 157.66 16.31 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.47 103.44 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 116' ' ' ASP . 12.9 p -103.38 -29.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.901 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -127.98 76.52 0.4 Allowed Glycine 0 N--CA 1.407 -3.292 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.869 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.72 -23.03 7.3 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 CA-C-N 119.478 1.639 . . . . 0.0 112.651 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -116.96 4.16 12.82 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.652 0.739 . . . . 0.0 111.049 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -72.33 142.05 48.82 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.81 49.56 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.649 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -81.45 127.93 33.33 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.495 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 6.8 tt -103.85 126.28 50.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.568 0.699 . . . . 0.0 110.417 -176.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.79 141.74 51.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.203 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 176' ' ' ARG . 2.9 mm? -99.79 129.22 45.87 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.999 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 55' ' ' SER . 7.4 mp -87.62 173.1 9.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.344 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.9 78.61 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.305 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.27 131.94 47.04 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.11 0.481 . . . . 0.0 109.85 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.48 170.71 15.21 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.597 ' OD2' ' HE2' ' A' ' 179' ' ' LYS . 23.6 t70 -56.04 104.96 0.16 Allowed 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.164 0.915 . . . . 0.0 110.712 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -125.03 -36.13 2.58 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 -166.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 179' ' ' LYS . 31.6 mt -63.2 116.13 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.199 0.909 . . . . 0.0 111.123 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.11 128.95 36.03 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.998 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.0 ttm -105.21 1.42 28.19 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 121.061 0.457 . . . . 0.0 111.93 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.24 -50.64 5.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.987 0.899 . . . . 0.0 109.778 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -82.26 -4.9 58.03 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.37 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 p -106.2 162.97 13.18 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.183 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -126.75 93.71 3.85 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -150.94 161.97 41.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 9.0 mm-40 -121.98 141.62 51.14 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.358 1.463 . . . . 0.0 108.252 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 81.8 mtp -100.84 107.57 19.14 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.61 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 t -69.6 -55.76 9.2 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.793 -0.567 . . . . 0.0 112.03 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.1 mt -136.56 -62.24 0.66 Allowed 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -116.82 170.36 8.67 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 111.8 -2.455 . . . . 0.0 105.796 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 147' ' ' MET . 0.0 OUTLIER -61.03 -39.6 90.4 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 124.09 0.956 . . . . 0.0 109.502 -176.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.89 -10.31 59.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.862 1.265 . . . . 0.0 111.683 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -102.01 115.5 30.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 46.3 mt -72.07 130.62 35.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.904 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -105.3 -75.57 1.01 Allowed Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.021 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 5.6 t30 -82.97 120.43 25.7 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.11 113.1 34.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.32 -29.82 15.45 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.98 2.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.185 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.11 121.87 33.27 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.02 140.65 30.46 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.96 140.34 58.85 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 124.258 0.974 . . . . 0.0 113.605 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.479 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.9 p-10 -93.46 6.51 47.93 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.254 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.0 p -67.44 -4.8 12.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.909 1.283 . . . . 0.0 110.401 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.1 m -63.85 -38.33 90.69 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.702 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.57 -31.37 6.8 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.875 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 78.5 mt -89.37 139.06 18.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 30.1 mmt180 -59.92 122.61 67.06 Favored Pre-proline 0 C--N 1.316 -0.858 0 O-C-N 123.489 0.493 . . . . 0.0 109.94 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 6.6 Cg_exo -69.46 -7.97 22.37 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.486 2.124 . . . . 0.0 113.265 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.36 1.86 56.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.364 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.16 125.42 26.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 17.7 tttt -72.31 -27.18 62.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.372 0.606 . . . . 0.0 112.066 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.509 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.5 ttt -154.16 131.43 11.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -141.6 171.19 14.41 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.102 0.477 . . . . 0.0 111.475 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.628 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.3 OUTLIER -136.69 126.83 26.21 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.715 -176.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 25.6 m -74.54 142.91 44.7 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.635 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.7 p -81.51 -39.52 24.59 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.597 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 69.2 mmtt -74.43 11.2 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -174.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.94 140.69 4.64 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 7.1 mmt180 -90.18 -31.66 16.95 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -83.95 -28.96 27.44 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.61 111.0 5.13 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.305 1.05 . . . . 0.0 113.237 -173.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.57 129.73 74.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.91 129.85 56.79 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.382 0.611 . . . . 0.0 111.288 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 174' ' ' MET . 45.4 pt -116.1 157.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.017 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.471 ' CD ' ' HA ' ' A' ' 173' ' ' LYS . 48.2 mtp180 -85.85 162.33 18.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.509 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.8 pt-20 -57.44 -36.22 71.11 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.452 ' OD2' ' HE2' ' A' ' 173' ' ' LYS . 5.1 p-10 -64.33 -32.38 73.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.43 0.456 . . . . 0.0 111.615 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 -48.9 79.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.637 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.505 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 17.8 p80 -73.62 -25.46 60.32 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.749 -1.181 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.03 74.1 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.414 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.12 -36.08 69.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -70.43 -33.25 71.12 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.3 mm-40 -58.51 -45.61 88.42 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.707 0.765 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -85.81 -12.42 50.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.225 -175.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -85.42 -27.92 25.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.88 48.37 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.09 165.34 19.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.8 p -41.49 -62.5 0.86 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -173.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.42 140.35 5.17 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 118.431 -1.842 . . . . 0.0 113.21 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -142.31 161.91 36.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.9 mmpt? -139.16 122.05 16.61 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.1 m -124.19 142.35 41.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.45 142.25 50.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.04 108.83 3.23 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.31 -30.42 66.22 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.432 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.67 92.11 1.15 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.88 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.17 31.12 26.44 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.588 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -58.19 101.62 0.08 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 110.967 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -104.01 120.95 42.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.67 -25.43 1.43 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 118.684 2.234 . . . . 0.0 118.684 168.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.53 143.67 36.35 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.619 1.209 . . . . 0.0 112.923 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.63 134.57 49.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.532 ' H ' HD12 ' A' ' 215' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.478 0.971 0 O-C-N 124.259 0.974 . . . . 0.0 110.67 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -87.61 134.4 33.64 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.885 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -109.67 145.23 36.87 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.199 0.523 . . . . 0.0 111.33 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -128.53 150.84 50.0 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.425 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 61.7 t -80.99 126.31 39.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -95.0 117.42 30.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.458 0.474 . . . . 0.0 110.719 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HG3' ' C ' ' A' ' 215' ' ' LEU . 1.2 tmtp? -135.68 139.28 43.57 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.64 122.98 49.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.6 ptp -76.07 84.58 2.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.976 0.893 . . . . 0.0 111.438 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . -145.17 112.38 6.08 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.274 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 38.2 mt-10 -131.18 -37.19 1.27 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -84.41 -31.48 24.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.016 176.216 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.595 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . . . -72.16 -35.21 68.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 167.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.46 26.97 Favored Glycine 0 N--CA 1.42 -2.421 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.478 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 32' ' ' GLU . 88.7 m-85 -90.68 166.94 12.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.439 HG12 ' CE1' ' A' ' 68' ' ' PHE . 49.5 mt -78.24 100.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 161.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -59.0 -63.66 1.22 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.483 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -125.22 175.42 7.43 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.717 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -59.81 123.7 72.92 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.26 0.975 . . . . 0.0 112.838 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -65.06 166.86 17.44 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.897 2.398 . . . . 0.0 112.878 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' VAL . 6.9 t30 -53.88 114.43 1.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.352 1.061 . . . . 0.0 112.419 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.71 12.31 62.66 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.128 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.6 m -86.38 139.71 34.01 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 167.24 24.93 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.096 3.197 . . . . 0.0 111.449 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -51.96 149.05 5.29 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.42 -49.56 7.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.661 2.384 . . . . 0.0 114.141 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -86.15 -30.05 22.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.863 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 21.1 tptm -80.28 -12.47 59.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.629 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 51.9 m-85 -48.54 -33.71 10.08 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.648 0.593 . . . . 0.0 112.23 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -128.36 9.46 6.11 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 49' ' ' LYS . 4.3 mm-40 -87.92 102.66 14.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.37 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.65 -8.96 0.17 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.91 171.29 14.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 119.181 1.491 . . . . 0.0 112.828 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -98.5 150.54 21.57 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.79 14.53 31.36 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.498 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.78 -32.39 60.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -88.82 -24.14 22.66 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.3 -22.04 14.21 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -110.79 138.38 21.07 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.75 123.4 12.59 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.291 1.994 . . . . 0.0 111.967 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.71 113.67 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 16.37 60.33 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.99 -149.56 20.35 Favored Glycine 0 C--O 1.241 0.556 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.909 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.4 mt-10 -132.68 138.53 47.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.098 0.475 . . . . 0.0 110.51 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 42' ' ' ASN . 29.6 m -131.15 174.51 12.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 p -147.31 152.72 38.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 116' ' ' ASP . 21.2 m-85 -79.36 123.63 27.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.266 1.942 0 O-C-N 124.339 1.024 . . . . 0.0 109.835 174.412 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 CA--C 1.508 -0.653 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -85.83 -154.62 0.21 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 121.578 0.704 . . . . 0.0 112.023 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.17 -169.54 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.585 1.554 . . . . 0.0 112.355 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -94.11 150.73 20.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.96 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -102.35 -163.07 0.97 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.727 1.211 . . . . 0.0 109.244 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -68.75 -30.12 68.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.506 0.67 . . . . 0.0 109.604 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.402 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 64.8 m-85 -134.85 148.39 50.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.851 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 15.3 tp60 -129.93 126.55 22.52 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.0 175.26 5.04 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.315 2.01 . . . . 0.0 111.117 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.42 ' HB2' ' H ' ' A' ' 86' ' ' MET . 0.3 OUTLIER -140.19 -178.4 5.45 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.02 -19.98 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.42 ' H ' ' HB2' ' A' ' 84' ' ' ASN . 3.2 mpp? -84.66 -92.39 0.08 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.397 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 60.2 p -174.11 -29.06 0.01 OUTLIER 'General case' 0 C--N 1.369 1.421 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -70.96 115.53 10.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.022 0.915 . . . . 0.0 111.985 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.33 126.66 33.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.671 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 38.6 tp -93.54 122.4 35.94 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.414 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -71.88 156.4 39.32 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -60.16 -34.61 84.88 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.994 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -68.92 -41.78 77.7 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 120.838 0.351 . . . . 0.0 111.203 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.77 -28.92 61.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.958 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -59.9 -42.44 93.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.944 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 10.0 mmpt? -64.42 -32.56 74.23 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.21 -55.43 33.86 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 120.68 0.276 . . . . 0.0 110.385 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.73 -41.11 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.592 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -70.79 -27.18 63.71 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.8 m -71.92 -27.09 62.59 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.516 0.674 . . . . 0.0 110.557 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.8 -9.93 59.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.077 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.74 47.94 58.43 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.16 103.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.782 0.801 . . . . 0.0 110.094 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 m -77.26 146.82 36.67 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.838 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 80.39 1.18 1.93 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 126.008 1.723 . . . . 0.0 113.001 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.62 23.28 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.8 tp10 -99.13 142.74 30.23 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -117.86 113.49 21.84 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.986 0.804 . . . . 0.0 108.887 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.34 100.98 32.62 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.3 134.56 9.1 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.718 2.279 . . . . 0.0 112.846 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -149.88 174.63 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -108.85 116.94 32.94 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -96.43 133.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.832 -174.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' HG2' HG22 ' A' ' 121' ' ' VAL . 61.8 mttm -92.9 129.5 38.8 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 41.8 p-10 -76.17 -163.92 0.34 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.51 -24.94 67.26 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.523 0.729 . . . . 0.0 110.679 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.16 -19.96 24.84 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.038 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 11.85 41.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.093 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -101.28 142.66 32.37 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.427 -0.455 . . . . 0.0 110.462 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 115' ' ' LYS . 13.7 t -78.9 88.56 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.2 m -110.59 1.38 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.774 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.94 64.5 0.54 Allowed Glycine 0 C--O 1.203 -1.806 0 C-N-CA 119.406 -1.378 . . . . 0.0 113.244 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 8.5 Cg_endo -84.0 -19.72 4.7 Favored 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 120.375 2.087 . . . . 0.0 112.61 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -103.65 7.76 37.45 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.218 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.462 ' HB2' HD13 ' A' ' 114' ' ' ILE . 7.9 m-85 -96.34 143.41 27.42 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.136 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.34 147.65 52.4 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.71 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.4 123.53 33.04 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 5.0 tt -91.11 128.14 36.81 Favored 'General case' 0 C--O 1.263 1.793 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -120.74 140.91 51.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.68 119.3 38.56 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.17 173.04 6.55 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.714 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.87 27.47 72.23 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.168 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.08 131.72 44.91 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.14 159.91 34.52 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 105.304 -2.109 . . . . 0.0 105.304 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.407 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 13.2 t70 -66.67 112.5 4.21 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.268 0.556 . . . . 0.0 111.344 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -129.83 -14.26 4.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 177' ' ' CYS . 32.4 mt -61.29 117.61 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.305 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -63.84 129.12 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.764 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 65.6 mtt -116.34 5.9 13.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.868 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.5 -50.21 5.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.07 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -98.53 -31.51 11.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.373 0.606 . . . . 0.0 109.998 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 m -73.54 128.49 35.63 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 159' ' ' ASP . 42.7 mt-10 -107.87 112.36 24.95 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -162.01 165.39 27.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.193 0.308 . . . . 0.0 111.085 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -127.3 146.17 50.54 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 124.583 1.177 . . . . 0.0 107.946 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.485 ' SD ' HG12 ' A' ' 155' ' ' ILE . 23.1 mmt -100.44 106.7 18.3 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.028 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.6 t70 170.3 76.39 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.384 1.074 . . . . 0.0 111.184 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 154' ' ' GLN . 5.7 p -101.53 -49.13 4.11 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.9 mt -131.57 -58.83 0.98 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.08 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 154' ' ' GLN . 6.5 mm-40 -114.43 -179.26 3.58 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.345 -174.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.536 ' H ' ' HD3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -67.52 -33.99 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.377 174.15 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 9.1 p-10 -98.73 25.09 6.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 109.539 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.495 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 24.8 mm-40 -126.14 115.44 19.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.485 HG12 ' SD ' ' A' ' 147' ' ' MET . 23.6 mt -79.36 141.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -113.95 -73.44 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.78 121.15 26.06 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.3 mt -126.94 119.33 52.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 15.1 m-20 -97.45 -42.28 7.8 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.576 0.703 . . . . 0.0 109.312 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.66 140.19 25.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.64 117.05 20.54 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.24 147.6 25.56 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 144.28 56.01 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.498 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.7 p-10 -93.99 10.69 32.47 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.126 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.4 p -69.69 -4.96 21.9 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.966 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.8 m -60.82 -39.21 88.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 124.297 1.039 . . . . 0.0 109.879 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.435 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.32 -31.84 6.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.322 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' ' 137' ' ' ALA . 70.2 mt -89.45 146.09 6.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.484 ' HD3' ' OD1' ' A' ' 171' ' ' ASP . 44.8 mtt180 -46.56 125.12 7.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 124.645 1.178 . . . . 0.0 113.401 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.46 -5.54 14.22 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.302 2.001 . . . . 0.0 109.93 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.484 ' OD1' ' HD3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.97 -8.54 57.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.875 175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.84 136.13 50.39 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.469 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 87.5 mttt -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.406 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.9 ttt -148.9 127.05 12.06 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -150.91 -178.66 6.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.91 148.77 40.96 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.538 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.45 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 34.9 m -84.97 121.85 28.37 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 124.326 1.016 . . . . 0.0 109.136 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.443 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 19.5 p -55.99 -50.3 71.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -169.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -82.47 9.74 8.6 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -173.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -137.99 113.29 9.37 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.249 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.495 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 11.2 ptp180 -57.53 -39.17 76.02 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -83.4 -30.58 27.24 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.731 0.812 . . . . 0.0 111.791 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.45 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 22.2 tp -63.79 101.32 0.35 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.03 126.15 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.647 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.63 133.81 51.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.432 0.634 . . . . 0.0 110.634 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.418 HG22 ' HG3' ' A' ' 174' ' ' MET . 44.4 pt -116.47 154.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.439 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.49 ' HD3' ' OD2' ' A' ' 189' ' ' ASP . 76.3 mtt180 -79.5 163.39 24.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.816 173.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 13.3 pt-20 -58.75 -36.67 74.74 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.721 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' A' ' 187' ' ' ARG . 23.3 m-20 -54.99 -45.08 75.0 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.26 1.024 . . . . 0.0 110.087 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.4 t -64.38 -50.32 76.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.754 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.555 ' CD2' ' HA ' ' A' ' 188' ' ' GLU . 21.5 p80 -70.75 -29.86 66.21 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.595 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.71 80.81 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 122.549 0.34 . . . . 0.0 110.491 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.7 80.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.45 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.64 -33.1 64.37 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.6 mm-40 -60.03 -47.06 87.39 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.23 -21.22 54.13 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.194 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.06 -27.15 59.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.728 0.299 . . . . 0.0 110.648 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.63 39.62 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.878 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.9 mt -82.04 166.0 20.15 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.7 p -53.35 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -152.51 130.75 3.15 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.316 -1.421 . . . . 0.0 112.899 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.402 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 66.2 m-85 -124.26 157.63 34.41 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . 0.3 OUTLIER -126.38 120.59 30.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.94 139.32 44.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.343 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.531 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 75.2 m-85 -118.59 143.17 46.97 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.96 102.95 4.97 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.69 97.26 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 123.987 0.804 . . . . 0.0 112.182 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.12 87.02 3.59 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 98.85 35.4 4.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -68.54 100.31 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.831 0.452 . . . . 0.0 110.576 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -103.74 133.97 47.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.52 -25.58 0.28 Allowed Glycine 0 N--CA 1.478 1.485 0 N-CA-C 119.344 2.498 . . . . 0.0 119.344 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.45 146.64 24.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 118.647 1.224 . . . . 0.0 113.937 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.28 133.08 41.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.531 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 1.7 pt? . . . . . 0 C--N 1.314 -0.936 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.397 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--O 1.249 1.04 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.64 155.99 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 169.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.36 151.21 30.03 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.297 0.57 . . . . 0.0 111.466 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -127.93 144.36 51.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 79.1 t -76.8 118.02 22.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -97.94 126.1 43.18 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.536 0.684 . . . . 0.0 110.935 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -143.51 155.03 44.22 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.2 t -106.39 128.44 60.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.8 ptp -79.73 85.45 5.42 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.931 0.872 . . . . 0.0 110.248 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.54 113.39 4.46 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.684 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -118.5 -58.15 2.0 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.688 174.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.99 -7.12 56.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.96 11.16 23.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.652 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 105.39 102.67 2.81 Favored Glycine 0 N--CA 1.406 -3.358 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 23.3 m-85 -97.22 166.19 11.69 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 162.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 84' ' ' ASN . 45.5 mt -93.94 101.4 12.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 161.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -60.46 -50.25 74.33 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 124.523 1.139 . . . . 0.0 110.507 -172.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.13 156.24 44.75 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.494 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 40' ' ' LEU . 5.8 mp -56.44 129.08 75.07 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 126.062 1.745 . . . . 0.0 114.16 -173.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.15 167.33 27.15 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 123.022 2.482 . . . . 0.0 111.456 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.78 123.89 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -10.97 52.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.297 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 m -86.92 126.98 61.45 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.05 165.07 31.41 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.6 2.867 . . . . 0.0 111.027 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 p -48.23 149.4 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 -172.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -40.01 -54.19 2.27 Favored 'General case' 0 N--CA 1.507 2.421 0 C-N-CA 126.594 1.958 . . . . 0.0 113.141 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -82.3 -24.87 34.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.411 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 49.7 tptt -85.0 -14.73 46.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.434 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 28.9 m-85 -44.44 -45.76 9.25 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.824 0.703 . . . . 0.0 112.823 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.467 ' HB3' ' NH1' ' A' ' 176' ' ' ARG 0.334 35.9 m-70 -129.64 24.94 5.4 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -83.1 101.09 10.93 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.96 4.91 1.84 Allowed Glycine 0 CA--C 1.553 2.449 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.03 164.16 28.26 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 CA-C-N 119.118 1.459 . . . . 0.0 113.987 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.4 t -98.85 141.42 31.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 50' ' ' PHE . 82.7 mt -90.16 -2.04 58.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.112 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.01 68.95 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -89.66 -22.66 22.16 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -107.29 -24.06 12.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -101.69 132.56 21.57 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 122.72 9.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.96 1.774 . . . . 0.0 110.857 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -98.8 136.56 29.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 17.86 79.77 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -98.32 -163.0 30.62 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -126.31 132.82 51.55 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.38 167.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 32.7 t -154.55 153.51 31.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -97.06 110.48 23.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.2 p . . . . . 0 C--N 1.316 -0.86 0 O-C-N 123.49 0.493 . . . . 0.0 110.728 -179.188 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -90.37 -168.69 2.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -73.65 178.62 4.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 114.061 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.37 152.28 22.03 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.141 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -122.23 -161.56 0.94 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -58.56 -32.83 69.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.425 0.631 . . . . 0.0 111.95 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.87 147.82 52.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.474 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 6.8 tp60 -133.4 111.51 12.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 84.0 Cg_endo -81.81 -179.43 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.793 2.328 . . . . 0.0 111.639 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 3.7 p30 -164.21 179.18 7.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.141 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.6 mt -93.47 9.08 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 122.25 1.024 . . . . 0.0 109.018 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.411 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 29.6 mtm -115.42 -159.14 0.7 Allowed 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.418 -171.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 50' ' ' PHE . 1.5 m -117.91 35.34 4.76 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.782 0.719 . . . . 0.0 112.177 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -133.31 158.07 43.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.608 -0.682 . . . . 0.0 109.828 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.8 tp -122.69 141.9 51.26 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 52.4 tp -110.83 129.32 55.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 129' ' ' LEU . 45.3 t -129.11 141.34 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.806 0.691 . . . . 0.0 110.385 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.4 p -76.14 168.39 20.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.366 0.666 . . . . 0.0 111.402 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.54 98.78 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.441 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.21 -37.99 66.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.057 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.82 -32.88 71.54 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.986 0.422 . . . . 0.0 109.906 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -57.57 -45.43 85.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.774 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 73.1 mmtt -64.82 -28.89 69.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.13 -54.84 27.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.74 -43.29 91.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 111.263 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -65.95 -41.17 91.6 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.2 p -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.57 -13.24 59.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.467 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.42 47.34 10.64 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.167 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.74 104.31 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.7 t -72.59 159.83 33.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.948 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 77.87 13.78 1.69 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 124.442 1.097 . . . . 0.0 111.157 173.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.35 114.43 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.605 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -106.55 139.18 41.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -114.77 115.64 27.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 123.853 0.721 . . . . 0.0 109.108 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.8 mt -111.83 96.9 35.47 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.18 143.13 12.51 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.488 2.126 . . . . 0.0 113.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 64' ' ' GLY . 5.3 m -149.3 168.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.833 1.253 . . . . 0.0 108.842 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -92.37 116.08 28.65 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 126' ' ' TYR . 38.4 mt -107.89 127.46 63.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.759 0.79 . . . . 0.0 112.236 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 67' ' ' SER . 85.3 mttt -101.48 131.51 47.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.4 p-10 -76.37 -160.49 0.15 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.29 0.567 . . . . 0.0 111.401 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.057 0.543 . . . . 0.0 110.353 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.59 -20.4 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.73 0.643 . . . . 0.0 109.73 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.55 12.65 40.6 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.235 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.2 ptpt -95.81 145.02 25.68 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 115' ' ' LYS . 21.2 t -81.99 82.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.584 0.707 . . . . 0.0 110.046 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 m -106.18 4.34 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.364 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.77 61.84 0.65 Allowed Glycine 0 C--O 1.204 -1.73 0 C-N-CA 120.545 -0.835 . . . . 0.0 113.025 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 79.9 Cg_endo -83.93 -18.87 5.16 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 120.449 2.125 . . . . 0.0 113.652 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.75 20.84 13.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.439 1.114 . . . . 0.0 110.457 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 114' ' ' ILE . 2.0 m-85 -92.11 133.48 35.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.41 139.18 52.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.497 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -80.04 119.22 22.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.293 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 91' ' ' VAL . 2.0 tt -86.65 128.3 34.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.9 m-80 -114.28 125.58 54.05 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -99.6 118.07 35.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.55 172.96 6.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.698 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.85 7.85 86.7 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.84 132.28 43.58 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.34 169.67 17.35 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.46 108.86 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.93 0.769 . . . . 0.0 109.366 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 168' ' ' ILE . . . -135.49 -30.77 0.99 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -167.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 179' ' ' LYS . 52.5 mt -64.41 114.99 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.087 -176.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.36 115.38 5.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.446 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 mmt -77.67 -1.94 33.53 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.23 -50.82 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.38 -30.91 29.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.1 m -92.74 104.22 16.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.67 117.3 34.52 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -158.39 157.96 33.31 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.82 127.16 51.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 66.1 mtp -102.59 106.94 17.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.7 t70 177.57 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.623 1.169 . . . . 0.0 112.319 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 -30.99 11.95 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.5 mt -139.21 -58.4 0.59 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.19 -167.14 2.48 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.186 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 7.9 mmpt? -66.84 -18.44 65.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -172.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.539 ' HB2' HH21 ' A' ' 181' ' ' ARG . 1.4 p30 -87.0 -2.24 58.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.677 0.671 . . . . 0.0 111.146 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -107.61 125.88 51.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.35 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 73.7 mt -82.73 115.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.07 -56.52 1.59 Allowed Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.674 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.67 121.87 46.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.67 126.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -102.3 -43.33 5.73 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.302 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.26 142.21 26.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.68 119.9 23.08 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -109.28 147.53 32.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.65 131.0 49.53 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.251 0.969 . . . . 0.0 112.353 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.41 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 26.4 p-10 -96.52 16.6 18.28 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.035 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -68.52 -6.19 23.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.74 1.216 . . . . 0.0 110.908 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.0 m -63.95 -40.45 96.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.292 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.54 -31.8 6.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.494 HG13 ' CB ' ' A' ' 137' ' ' ALA . 61.2 mt -83.57 138.93 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.446 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 48.6 mtm180 -58.65 119.49 37.24 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 14.0 Cg_exo -68.61 -4.68 13.59 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.485 2.79 . . . . 0.0 112.908 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 1.7 p-10 -79.44 -14.61 58.81 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.15 116.16 12.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.79 -19.73 60.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.494 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.5 ttt -146.73 123.59 11.3 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.52 -179.01 6.56 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.467 ' NH1' ' HB3' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -148.73 146.49 28.11 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.439 ' HB3' HD11 ' A' ' 138' ' ' ILE . 66.8 m -75.74 150.06 37.9 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.439 1.087 . . . . 0.0 112.736 -173.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -82.11 -24.79 34.94 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.517 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.9 mmtt -85.75 -4.56 59.2 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.126 -176.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.82 151.25 33.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.539 HH21 ' HB2' ' A' ' 153' ' ' ASP . 3.0 mmt180 -90.65 -39.86 12.23 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 123.793 0.837 . . . . 0.0 111.018 -171.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.415 ' HE ' ' HB2' ' A' ' 182' ' ' ARG . 57.1 mtm180 -84.62 -19.29 33.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.557 -174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.76 100.95 5.63 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.6 mt -110.63 135.07 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.76 122.56 44.81 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.441 0.638 . . . . 0.0 109.94 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.494 HG22 ' HG3' ' A' ' 174' ' ' MET . 38.9 pt -112.8 162.72 10.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.839 0.828 . . . . 0.0 111.467 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.563 ' HB3' HG23 ' A' ' 190' ' ' VAL . 6.2 tpp180 -78.8 143.67 35.84 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.472 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 6.5 pt-20 -54.53 -40.94 69.14 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.394 0.616 . . . . 0.0 111.873 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.87 -33.92 76.29 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 124.436 1.094 . . . . 0.0 112.01 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.563 HG23 ' HB3' ' A' ' 187' ' ' ARG . 87.0 t -68.24 -44.74 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.392 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.461 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 26.7 p80 -73.13 -22.8 60.46 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.211 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.61 72.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -73.48 -32.49 64.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.24 -36.81 74.73 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.69 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 72.3 mm-40 -56.26 -53.7 54.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.485 0.714 . . . . 0.0 110.715 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -73.23 -12.37 60.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.219 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.28 -27.52 24.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.889 0.376 . . . . 0.0 110.07 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.03 47.87 22.6 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.945 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 71.4 mt -82.66 157.25 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.255 5.2 p -41.95 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.72 125.66 2.26 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.431 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 70.2 m-85 -120.8 156.33 32.13 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.336 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -129.99 120.63 25.07 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 16.2 m -133.88 142.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.262 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.39 155.46 49.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.195 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -65.18 129.55 40.11 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.461 0.476 . . . . 0.0 110.526 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -85.41 -40.5 16.38 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.297 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.84 101.02 3.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.496 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.78 29.88 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.522 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.13 108.78 0.64 Allowed 'General case' 0 CA--C 1.574 1.878 0 C-N-CA 124.171 0.988 . . . . 0.0 110.137 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -102.02 102.43 12.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 73.96 -22.16 1.23 Allowed Glycine 0 N--CA 1.475 1.252 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 167.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.37 148.8 46.64 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.494 0.647 . . . . 0.0 111.245 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -108.55 132.87 53.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 O-C-N 124.318 1.011 . . . . 0.0 113.123 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HG2' ' OE2' ' A' ' 188' ' ' GLU . 7.8 ptpp? -93.88 141.9 27.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.891 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -109.45 138.58 45.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -124.4 142.73 51.07 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.712 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -80.1 116.35 24.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -92.23 125.56 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.48 0.657 . . . . 0.0 111.795 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 0.0 OUTLIER -141.05 165.13 28.4 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.343 1.457 . . . . 0.0 107.11 175.581 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.47 144.49 20.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttm -91.06 85.87 6.06 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.38 133.66 13.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.153 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.511 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -123.25 -64.07 1.2 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -84.8 -21.47 29.9 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.559 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.54 25.61 1.21 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.005 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' HA3' HE21 ' A' ' 82' ' ' GLN . . . 123.77 60.7 0.19 Allowed Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 118.58 -1.772 . . . . 0.0 117.376 173.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 3.2 m-85 -92.3 127.96 37.97 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.563 0.681 . . . . 0.0 110.458 166.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -87.71 103.37 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.17 -50.95 19.76 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.275 0.56 . . . . 0.0 111.887 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -115.04 169.42 9.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.586 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 5.3 mp -71.55 133.89 84.61 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 123.141 0.577 . . . . 0.0 112.132 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.07 168.4 24.84 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.321 2.681 . . . . 0.0 113.355 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -48.32 115.72 1.31 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.441 1.497 . . . . 0.0 112.665 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.3 14.36 71.63 Favored Glycine 0 C--O 1.208 -1.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.0 m -84.54 145.13 44.14 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 118.124 0.962 . . . . 0.0 111.74 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.24 165.53 21.83 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.387 2.725 . . . . 0.0 111.119 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.4 p -58.35 153.19 16.02 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -46.19 -58.3 3.77 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.311 1.444 . . . . 0.0 112.99 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 13.1 p-90 -71.2 -23.01 61.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.007 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HE3' HD12 ' A' ' 54' ' ' ILE . 43.0 tptt -77.3 -21.85 52.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.187 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 70.6 m-85 -52.83 -26.51 14.75 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.249 0.547 . . . . 0.0 112.379 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -120.26 -0.16 10.5 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 3.6 tm-20 -94.27 101.3 13.27 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.027 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -10.51 0.01 OUTLIER Glycine 0 CA--C 1.559 2.815 0 N-CA-C 120.711 3.044 . . . . 0.0 120.711 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.424 HD12 ' HE3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -130.1 174.58 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.066 2.433 . . . . 0.0 114.04 -173.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -88.05 148.29 24.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.251 -1.34 . . . . 0.0 107.776 171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.0 mt -98.29 -1.73 41.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.588 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.62 68.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.166 0.508 . . . . 0.0 112.324 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.1 -14.95 52.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.742 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.95 -22.52 9.54 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -101.07 139.05 20.17 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.29 122.94 9.46 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.123 1.882 . . . . 0.0 112.632 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.71 122.88 43.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.48 62.51 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.5 -168.03 27.66 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.5 131.14 55.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.99 165.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -139.42 141.72 37.5 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 23.1 m-85 -69.52 122.89 19.94 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 123.857 0.723 . . . . 0.0 109.092 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.404 -2.771 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.28 -177.84 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 8.7 t-20 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -94.02 -148.58 0.27 Allowed 'General case' 0 C--O 1.256 1.44 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.95 -167.8 0.32 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.162 2.185 . . . . 0.0 114.525 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.02 149.94 27.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.171 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -114.04 -169.15 1.46 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.169 0.988 . . . . 0.0 109.006 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 94' ' ' ARG . 48.6 m-20 -65.84 -34.24 77.7 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.748 0.785 . . . . 0.0 110.274 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.444 ' CD1' ' HE1' ' A' ' 202' ' ' PHE . 57.1 m-85 -134.18 153.74 51.66 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.488 HE21 ' HA3' ' A' ' 35' ' ' GLY . 56.0 mt-30 -134.42 134.76 22.8 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.512 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.07 -179.26 1.74 Allowed 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.811 2.341 . . . . 0.0 111.36 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -163.48 171.52 15.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -101.12 21.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.88 1.324 . . . . 0.0 108.294 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 40' ' ' LEU . 63.4 mtm -102.31 -93.71 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.102 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.466 ' HB2' ' CB ' ' A' ' 50' ' ' PHE . 17.9 m -167.17 -33.3 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.85 174.66 7.84 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.3 tp -116.13 142.1 47.27 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.804 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.86 127.45 55.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.55 142.38 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.05 0.54 . . . . 0.0 110.169 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 p -83.8 168.91 15.72 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -66.04 -32.3 82.03 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.837 -0.22 . . . . 0.0 113.093 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.403 ' HD2' ' OD1' ' A' ' 80' ' ' ASP . 5.9 ptp180 -67.12 -41.15 86.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.528 0.68 . . . . 0.0 110.372 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.9 -24.3 52.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.112 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -61.4 -42.08 98.17 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.2 mmtp -60.94 -39.35 89.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.41 ' O ' HD13 ' A' ' 102' ' ' LEU . 4.5 mm? -59.95 -55.8 29.64 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.393 0.433 . . . . 0.0 110.26 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.75 -45.35 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 112.075 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.33 -36.37 83.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -70.86 -22.03 62.35 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 98' ' ' LEU . 10.5 mp -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.672 0.272 . . . . 0.0 110.949 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 47.18 13.62 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.8 t -79.74 100.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-O 121.427 0.632 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 m -80.88 154.26 27.16 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 84.5 m-20 80.63 15.21 0.7 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.62 1.568 . . . . 0.0 110.964 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.94 114.17 28.23 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.418 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 7.7 tp10 -104.34 133.1 49.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.415 ' CH2' HD12 ' A' ' 129' ' ' LEU . 68.5 m95 -109.21 123.55 49.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.278 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -111.4 93.49 19.2 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 135.1 15.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.698 2.266 . . . . 0.0 112.416 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.09 167.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.42 115.98 28.57 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 126' ' ' TYR . 32.8 mt -106.84 128.16 61.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HG2' HG22 ' A' ' 121' ' ' VAL . 84.0 mttt -97.25 142.06 29.6 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 9.1 p-10 -80.68 -162.35 0.46 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.861 0.362 . . . . 0.0 110.937 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.41 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 69.6 m80 -75.44 -9.44 58.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.522 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -109.34 2.01 20.43 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.807 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.3 7.14 80.26 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.55 139.06 32.36 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 118.602 1.201 . . . . 0.0 110.477 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 115' ' ' LYS . 21.2 t -76.95 90.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.497 0.665 . . . . 0.0 109.803 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.66 8.55 5.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.714 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.84 45.06 1.15 Allowed Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.847 -1.168 . . . . 0.0 114.76 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -83.32 -0.37 9.85 Favored 'Trans proline' 0 C--N 1.368 1.585 0 CA-C-N 121.278 2.539 . . . . 0.0 111.924 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -92.88 -12.18 31.64 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.832 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 114' ' ' ILE . 3.2 m-85 -92.24 147.2 23.11 Favored 'General case' 0 C--O 1.255 1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.343 -173.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.66 137.93 47.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.386 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -81.27 125.64 30.58 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.415 HD12 ' CH2' ' A' ' 109' ' ' TRP . 7.3 tt -99.75 125.13 45.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.41 0.624 . . . . 0.0 110.365 -176.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.2 141.37 52.14 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.622 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.718 ' HB2' ' HD2' ' A' ' 176' ' ' ARG . 3.0 mm? -98.92 144.28 28.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 108' ' ' GLU . 3.2 mm? -101.85 174.72 5.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.29 1.436 . . . . 0.0 109.388 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.81 17.24 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.39 132.1 42.26 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 122.12 0.962 . . . . 0.0 113.341 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.0 165.5 30.56 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 168.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -53.57 101.9 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.228 1.376 . . . . 0.0 111.89 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -78.93 -66.59 0.85 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.161 -164.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 179' ' ' LYS . 60.3 mt -59.1 126.83 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 O-C-N 123.955 0.785 . . . . 0.0 112.251 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -69.1 122.77 19.44 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 tpt -90.51 -16.33 29.08 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.14 -35.61 9.95 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -91.69 -6.2 52.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.092 0.472 . . . . 0.0 111.265 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.2 p -89.41 143.81 26.54 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.71 103.4 7.8 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -151.24 168.03 26.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.391 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -116.78 144.03 44.96 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 124.317 1.047 . . . . 0.0 110.239 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.42 155.22 20.11 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 35.9 t70 91.94 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.067 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.5 m -101.06 -22.98 14.58 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 166.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 99.5 mt -160.87 -47.84 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.926 1.691 . . . . 0.0 107.245 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 42.7 mt-10 -131.97 179.61 5.98 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.093 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -72.0 -24.4 61.56 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 123.675 0.609 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -98.25 25.27 6.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.287 1.042 . . . . 0.0 109.946 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -122.29 116.2 23.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.452 HG21 HG12 ' A' ' 158' ' ' ILE . 59.3 mt -84.86 120.8 36.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 123.131 0.27 . . . . 0.0 110.45 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -83.13 -48.25 5.47 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.305 -175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -134.09 139.24 45.82 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 155' ' ' ILE . 45.3 mt -125.05 134.06 67.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -103.24 -42.33 5.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.15 114.88 8.99 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 158' ' ' ILE . 3.2 tm? -99.08 119.89 38.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 129.69 35.97 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.87 137.81 56.31 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 124.27 0.981 . . . . 0.0 112.62 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.666 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.9 p-10 -88.23 -0.2 56.83 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.708 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -67.1 -6.13 16.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.893 1.277 . . . . 0.0 109.967 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -64.05 -35.79 81.87 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.376 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.64 -33.26 6.18 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.82 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.12 154.33 5.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -67.45 117.12 44.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.3 -13.25 35.51 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.808 2.339 . . . . 0.0 112.462 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.99 -2.51 58.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.711 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 130.52 40.6 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.532 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 15.4 tppt? -68.68 -33.94 74.83 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.054 0.454 . . . . 0.0 111.395 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.493 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.2 ttt -149.25 135.4 19.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -151.62 -178.19 6.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.138 0.575 . . . . 0.0 110.18 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.718 ' HD2' ' HB2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -151.91 142.96 23.16 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.341 -176.194 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' A' ' 183' ' ' LEU . 83.8 m -69.61 146.23 51.88 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.335 0.397 . . . . 0.0 111.751 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.7 p -81.54 -48.68 11.5 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.404 ' HB2' HD12 ' A' ' 138' ' ' ILE . 60.3 mttm -72.23 -20.76 61.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.728 0.411 . . . . 0.0 111.563 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.48 133.67 55.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.457 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 10.7 mmt180 -90.58 -34.95 15.3 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.856 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -87.76 -20.92 25.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.376 0.608 . . . . 0.0 110.648 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.553 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.3 tt -84.13 114.07 21.51 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.5 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 71.2 mt -120.91 132.37 70.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 59.6 mt -111.17 124.18 51.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.319 1.056 . . . . 0.0 113.263 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.493 HG22 ' HG3' ' A' ' 174' ' ' MET . 48.1 pt -112.68 154.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.966 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 17.3 mtp180 -83.63 162.26 20.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.446 ' OE2' ' HG2' ' A' ' 23' ' ' LYS . 7.8 pt-20 -51.74 -35.51 43.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.15 0.58 . . . . 0.0 111.824 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -46.19 -51.08 14.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.441 1.896 . . . . 0.0 111.335 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.57 -53.43 42.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.595 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 12.8 p80 -72.23 -25.4 61.62 Favored 'General case' 0 C--O 1.194 -1.816 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.334 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -34.72 73.64 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.855 0.359 . . . . 0.0 110.628 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.12 73.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.176 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -70.52 -32.91 70.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.171 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 53.6 mm-40 -59.12 -49.82 76.42 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-O 121.62 0.724 . . . . 0.0 109.136 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.38 -22.41 54.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.964 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.17 58.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.214 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.09 46.52 50.76 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.87 164.85 24.13 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.663 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 4.5 p -43.37 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.66 136.15 5.14 Favored Glycine 0 CA--C 1.493 -1.311 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.099 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.444 ' HE1' ' CD1' ' A' ' 81' ' ' PHE . 60.6 m-85 -135.68 162.62 32.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.73 122.12 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.64 133.48 66.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.079 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.406 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 72.3 m-85 -126.51 132.52 51.36 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.48 115.02 6.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.13 65.08 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 124.021 0.826 . . . . 0.0 112.217 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.73 90.73 1.08 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.512 0.673 . . . . 0.0 110.258 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 81.19 35.1 24.7 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.553 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 19.8 t90 -59.87 98.63 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.7 0.8 . . . . 0.0 110.206 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -103.98 132.31 50.35 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.81 -9.09 2.06 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 165.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.553 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 95.4 mt -94.83 135.73 35.98 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 118.382 1.091 . . . . 0.0 112.819 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.15 133.04 36.15 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 28' ' ' LYS 0.27 0.9 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.05 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 67.3 t . . . . . 0 C--O 1.243 0.713 0 CA-C-O 120.683 0.278 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -103.28 150.72 23.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.177 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -125.85 155.93 40.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 60.8 m-85 -138.06 142.47 40.3 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.357 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 20.6 t -81.91 121.32 35.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.5 131.48 37.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -150.73 164.68 35.57 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.7 t -99.66 128.33 51.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.58 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 27.3 ttt -88.32 100.36 12.95 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.095 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 166.7 142.96 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 126.203 1.801 . . . . 0.0 108.719 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -94.53 -31.5 13.88 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 30.7 mt-10 -84.44 -0.26 52.18 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.003 -175.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -78.15 0.46 24.83 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.22 103.43 1.05 Allowed Glycine 0 N--CA 1.402 -3.628 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -95.58 147.04 23.99 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 39' ' ' LYS . 12.6 mt -85.07 101.31 9.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 102.864 -3.013 . . . . 0.0 102.864 166.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.72 -37.99 64.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.765 -172.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.482 ' O ' HG22 ' A' ' 37' ' ' ILE . 35.4 mmtp -114.46 176.47 5.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.554 ' HG ' ' SD ' ' A' ' 86' ' ' MET . 4.6 mp -83.94 129.26 59.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 9.8 Cg_endo -66.53 166.43 21.91 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.581 2.187 . . . . 0.0 112.892 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.87 127.1 30.38 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 124.065 0.946 . . . . 0.0 112.031 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.67 1.25 89.16 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 116.158 -0.474 . . . . 0.0 113.54 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.2 m -85.55 136.57 37.09 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.29 166.74 24.29 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.306 3.337 . . . . 0.0 112.096 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -50.88 148.88 3.8 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -45.9 -56.0 5.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.657 1.983 . . . . 0.0 113.448 -174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 17.2 p-90 -75.48 -26.53 58.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.343 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -78.7 -21.02 48.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.243 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HA ' HD21 ' A' ' 56' ' ' LEU . 33.1 m-85 -45.76 -38.92 7.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 1.3 m-70 -128.44 22.1 6.04 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.574 -0.704 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 1.2 tm-20 -93.99 100.85 12.91 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.898 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.24 -3.51 0.07 OUTLIER Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 52' ' ' GLU . 2.4 pp -123.0 173.7 8.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -171.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -98.31 135.88 39.28 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.103 170.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 50' ' ' PHE . 91.7 mt -84.11 -1.72 55.46 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -24.84 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 111.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -88.08 -22.82 23.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -116.31 -21.88 9.09 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -103.48 138.15 19.45 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.77 123.22 12.24 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.656 2.237 . . . . 0.0 112.682 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.06 114.73 33.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.31 19.46 45.64 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.396 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -95.62 -166.54 34.91 Favored Glycine 0 C--N 1.307 -1.062 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.198 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.83 128.56 42.54 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 34.9 m -126.94 169.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -148.19 162.55 39.22 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.907 -0.496 . . . . 0.0 110.177 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 19.8 m-85 -75.98 163.97 26.63 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.25 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 13.2 p . . . . . 0 N--CA 1.402 -2.86 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.555 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.568 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 8.0 t-20 . . . . . 0 C--O 1.244 0.78 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 34.2 mtp180 -78.47 -172.51 2.92 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -79.86 -165.73 0.87 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.46 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HA ' HE21 ' A' ' 82' ' ' GLN . 4.6 mp -87.74 150.58 23.5 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.277 0.561 . . . . 0.0 111.758 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 5.5 m-85 -114.79 -163.58 0.88 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.51 -44.2 93.19 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.481 0.658 . . . . 0.0 110.725 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.84 151.65 41.48 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.515 -1.22 . . . . 0.0 107.881 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 78' ' ' LEU . 3.8 mm-40 -121.81 114.93 30.94 Favored Pre-proline 0 C--N 1.289 -2.036 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.51 168.08 7.35 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.548 2.832 . . . . 0.0 112.322 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -163.89 174.92 10.91 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 121.997 -0.44 . . . . 0.0 110.864 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.55 7.34 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.204 0 CA-C-O 123.103 1.43 . . . . 0.0 109.098 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.554 ' SD ' ' HG ' ' A' ' 40' ' ' LEU . 50.6 mtm -104.58 -164.19 1.03 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 m -121.4 53.68 1.16 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.813 -0.555 . . . . 0.0 110.991 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -136.84 155.11 50.21 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.7 tp -119.5 141.19 49.41 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.264 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 126' ' ' TYR . 58.2 tp -117.16 130.17 56.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.84 139.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 122.56 0.344 . . . . 0.0 110.084 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.2 p -76.27 174.56 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.33 0.252 . . . . 0.0 110.691 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.95 -38.81 59.93 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -69.01 -38.57 79.33 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.08 0.467 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.4 63.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -62.15 -39.94 94.3 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.738 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -55.37 -40.36 71.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.812 0.695 . . . . 0.0 112.412 178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 197' ' ' ALA . 4.0 mm? -60.14 -52.78 63.86 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.186 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.5 -45.03 99.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 C-N-CA 123.295 0.638 . . . . 0.0 112.2 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.4 -37.8 88.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -68.71 -22.14 64.37 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.211 0.529 . . . . 0.0 111.295 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.58 -8.55 58.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.806 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.28 44.5 74.83 Favored Glycine 0 CA--C 1.495 -1.195 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.115 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 173' ' ' LYS . 81.6 t -73.88 104.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.504 0.668 . . . . 0.0 110.403 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 m -79.27 150.62 31.49 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 79.53 1.43 2.23 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.564 . . . . 0.0 112.878 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.51 114.74 25.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.2 tp10 -99.49 137.73 37.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CH2' HD12 ' A' ' 129' ' ' LEU . 66.9 m95 -115.6 121.51 42.83 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.079 0.862 . . . . 0.0 109.209 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.67 98.31 49.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.26 124.9 6.14 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.497 2.131 . . . . 0.0 114.023 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 64' ' ' GLY . 16.1 m -139.74 172.24 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.9 116.69 33.36 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -100.54 130.16 50.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 121' ' ' VAL . 89.7 mttt -103.74 139.45 38.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.503 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 32.8 p-10 -83.91 -159.94 0.41 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 60.0 m80 -67.99 -14.87 63.31 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.079 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -19.48 16.53 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.2 20.18 21.35 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.703 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.439 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.4 ptpt -95.79 147.86 23.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 115' ' ' LYS . 16.1 t -82.2 84.5 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.417 HG23 HD13 ' A' ' 78' ' ' LEU . 6.6 m -111.84 12.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.105 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.51 51.81 0.85 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.35 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -84.72 -14.66 6.35 Favored 'Trans proline' 0 C--N 1.375 1.967 0 CA-C-N 120.795 2.298 . . . . 0.0 112.885 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -97.12 7.73 46.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.359 0.599 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.509 ' HB2' HD13 ' A' ' 114' ' ' ILE . 3.9 m-85 -102.02 148.35 25.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.569 0.699 . . . . 0.0 112.272 -170.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.6 142.63 41.26 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.608 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -82.47 131.05 35.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.452 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.452 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.9 tt -105.19 126.11 51.73 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.816 0.817 . . . . 0.0 110.091 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.402 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -125.39 141.2 52.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.051 174.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.59 141.78 30.21 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -123.6 174.47 7.41 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.318 1.047 . . . . 0.0 108.685 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 14.61 81.26 Favored Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.714 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.66 132.86 43.72 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.75 105.16 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 119.106 0.866 . . . . 0.0 112.015 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.23 -35.26 3.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 179' ' ' LYS . 57.0 mt -64.72 115.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.841 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.11 111.95 4.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.406 ' HA ' ' HG ' ' A' ' 143' ' ' SER . 15.2 ttt -97.89 17.65 17.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.774 0.797 . . . . 0.0 110.23 -174.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.55 -50.09 4.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.076 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 142' ' ' ARG . 2.7 mmp_? -97.12 11.43 36.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.191 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 140' ' ' MET . 50.0 p -104.88 154.38 20.14 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.154 175.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 75.2 mm-40 -133.81 117.37 16.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -166.0 172.34 11.56 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.58 0.55 . . . . 0.0 111.196 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.84 133.21 49.37 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 38.7 mtt -101.34 108.66 20.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.5 t70 172.78 73.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.705 2.002 . . . . 0.0 108.868 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 22.8 t -101.15 -49.45 4.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.05 -67.09 0.76 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 154' ' ' GLN . 3.0 pp20? -109.07 -176.19 2.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 174.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 147' ' ' MET . 11.0 mmpt? -66.78 -30.88 71.2 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -171.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.428 ' HB3' HH12 ' A' ' 181' ' ' ARG . 21.1 t70 -104.85 26.27 9.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.673 1.225 . . . . 0.0 109.429 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.545 ' HG2' ' OE2' ' A' ' 151' ' ' GLU . 15.3 mm-40 -106.8 123.55 48.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.194 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.6 124.33 39.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.824 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -103.35 -66.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.634 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -94.85 135.37 36.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.5 mt -131.9 145.14 35.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 13.2 t70 -110.44 -51.96 2.82 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 172.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.87 118.85 7.65 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.573 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.27 121.6 35.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.87 132.4 37.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -54.98 137.26 46.47 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.552 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.2 p-10 -92.69 -0.28 57.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.978 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.9 p -68.22 -6.16 22.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.07 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.6 m -63.84 -39.43 94.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.687 173.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -110.8 -31.31 7.23 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 119.701 -0.799 . . . . 0.0 112.288 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 137' ' ' ALA . 52.7 mt -89.03 150.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.492 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 27.7 mtp180 -57.92 122.37 57.09 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 122.535 0.334 . . . . 0.0 111.832 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.22 -5.76 17.72 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 123.419 2.746 . . . . 0.0 112.311 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 8.3 p-10 -96.47 -7.99 33.34 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.712 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.36 132.85 47.78 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.475 ' HB2' HG22 ' A' ' 104' ' ' VAL . 75.1 mmtt -73.75 -40.24 63.66 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.206 -174.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.45 ' HB3' HG11 ' A' ' 104' ' ' VAL . 27.0 ttt -142.85 123.98 14.51 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -146.39 -178.33 6.09 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.481 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.405 ' CD ' ' HB3' ' A' ' 51' ' ' HIS . 8.9 ttp180 -146.62 142.32 27.8 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.536 ' SG ' HD22 ' A' ' 183' ' ' LEU . 65.3 m -70.69 145.7 50.39 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 124.161 0.913 . . . . 0.0 111.607 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.8 p -82.21 -18.92 40.91 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.495 ' HB2' HD12 ' A' ' 138' ' ' ILE . 19.3 mtpp -108.96 20.79 18.02 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.749 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 9.5 tp10 -172.6 116.63 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.464 ' HD2' ' NE2' ' A' ' 154' ' ' GLN 0.275 0.0 OUTLIER -89.29 -11.19 44.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -173.012 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -90.56 -25.9 19.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 180' ' ' GLU . 3.3 tt -77.74 100.85 6.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.3 mt -108.08 120.56 59.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 30.7 mt -93.05 125.5 37.67 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 121.706 0.765 . . . . 0.0 111.615 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.8 pt -110.85 139.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.883 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -81.38 162.4 23.39 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 22' ' ' VAL . 7.1 pt-20 -43.68 -44.24 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.463 1.105 . . . . 0.0 112.546 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -56.33 -44.83 80.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.64 1.576 . . . . 0.0 110.725 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.33 -48.05 82.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 9.3 p80 -74.02 -29.26 61.84 Favored 'General case' 0 C--O 1.197 -1.672 0 C-N-CA 118.061 -1.456 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.0 77.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.18 83.38 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.174 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -72.11 -34.81 68.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.211 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 56.5 mm-40 -62.33 -47.24 85.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.322 0.582 . . . . 0.0 109.555 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -75.06 -15.89 60.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.565 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -83.75 -27.12 29.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.782 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 72.61 47.65 26.34 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.462 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.74 164.58 25.12 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -46.46 -76.54 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 116.933 2.198 . . . . 0.0 116.933 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.66 130.79 1.91 Allowed Glycine 0 CA--C 1.498 -0.978 0 C-N-CA 119.029 -1.557 . . . . 0.0 113.213 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -129.19 159.37 36.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 122.418 0.287 . . . . 0.0 110.273 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 77.4 tttt -120.78 121.67 38.69 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.2 130.43 72.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.118 0.485 . . . . 0.0 111.058 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 85.0 m-85 -107.04 138.97 42.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.72 115.97 9.57 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.62 -45.37 37.76 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.591 0.557 . . . . 0.0 112.285 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.19 95.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.988 0.805 . . . . 0.0 109.547 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.63 35.65 28.21 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.882 -1.152 . . . . 0.0 111.922 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.469 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 9.3 t90 -46.06 107.12 0.09 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.528 1.131 . . . . 0.0 110.368 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -82.78 71.53 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.11 15.16 67.12 Favored Glycine 0 C--N 1.31 -0.9 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 167.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 92.1 mt -89.89 146.35 24.48 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 118.365 1.082 . . . . 0.0 109.875 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.1 134.09 35.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.244 0.778 0 O-C-N 124.335 1.022 . . . . 0.0 108.894 174.187 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 21.4 ptmt -93.15 154.43 18.08 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.34 135.46 50.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.368 0.604 . . . . 0.0 111.764 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -122.19 143.92 49.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.31 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.69 121.64 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -97.78 114.03 25.95 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 111.038 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -135.26 150.86 50.14 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.42 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.54 84.67 7.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.09 113.69 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.96 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 34.1 tt0 -112.94 -66.97 1.03 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -0.91 55.89 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.05 0.929 . . . . 0.0 109.5 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 79' ' ' TYR . . . -94.81 25.41 4.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 119.42 39.21 0.68 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 168.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.635 ' CD1' ' HA ' ' A' ' 32' ' ' GLU . 11.3 m-85 -69.22 128.36 36.36 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 120.233 2.017 . . . . 0.0 112.889 170.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.517 HG12 ' CE2' ' A' ' 68' ' ' PHE . 9.4 mt -84.37 101.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.47 -59.62 3.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.924 0.869 . . . . 0.0 109.366 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 37' ' ' ILE . 13.7 mptt -108.7 162.26 14.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.285 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 5.8 mp -70.31 139.75 87.29 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 124.639 1.212 . . . . 0.0 114.054 -171.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 11.3 Cg_exo -74.8 166.43 29.3 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.449 2.766 . . . . 0.0 111.345 171.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -53.15 122.27 9.12 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.324 1.049 . . . . 0.0 112.856 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.01 7.22 70.69 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 114.734 0.654 . . . . 0.0 114.734 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 27.0 m -85.33 142.79 38.24 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HG2' HD22 ' A' ' 56' ' ' LEU . 1.6 Cg_endo -75.51 166.08 29.3 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.848 3.032 . . . . 0.0 111.139 172.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -52.92 148.85 7.08 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.37 -52.55 4.53 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 127.243 2.217 . . . . 0.0 114.894 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -85.68 -30.08 23.46 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.747 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 52.6 tptt -81.16 -12.21 59.26 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.387 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 88' ' ' ASN . 40.7 m-85 -44.29 -50.31 9.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.688 0.617 . . . . 0.0 111.952 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.482 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.3 m-70 -128.91 32.33 4.78 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.58 -0.848 . . . . 0.0 113.257 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 7.8 tm-20 -92.45 101.37 13.82 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.52 -8.83 17.47 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.01 170.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.0 t -98.89 158.2 15.8 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.054 -1.884 . . . . 0.0 106.876 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.475 HD22 ' HG2' ' A' ' 45' ' ' PRO . 97.3 mt -113.07 15.5 19.53 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.91 67.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.068 0.461 . . . . 0.0 110.916 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -88.23 -21.85 24.29 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.453 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.19 -22.6 12.03 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.83 140.09 21.27 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.32 123.8 12.75 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.914 2.409 . . . . 0.0 112.73 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG22 HD22 ' A' ' 110' ' ' LEU . 22.4 t -100.89 117.09 45.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.91 14.99 61.92 Favored Glycine 0 C--N 1.318 -0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.55 -167.26 36.61 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.664 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.76 128.86 50.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 23.6 m -127.92 173.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 33.2 t -153.98 149.21 26.99 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 37' ' ' ILE . 1.1 m-30 -76.76 128.86 35.42 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 167.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p . . . . . 0 C--N 1.288 -2.079 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.625 177.977 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 C--O 1.241 0.639 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.32 -175.58 1.6 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.45 -176.22 3.6 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.915 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD13 HG23 ' A' ' 122' ' ' VAL . 7.4 mp -98.0 151.84 19.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -167.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.493 ' CE2' ' HB1' ' A' ' 34' ' ' ALA . 5.9 m-85 -111.4 -163.35 0.84 Allowed 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.87 -45.06 96.06 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 119.308 0.958 . . . . 0.0 110.611 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.13 145.31 47.95 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.539 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 27.8 tp60 -124.74 120.93 25.67 Favored Pre-proline 0 N--CA 1.416 -2.15 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.874 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.97 166.93 9.75 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 122.846 2.364 . . . . 0.0 112.326 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -157.58 168.98 25.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.501 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -90.0 0.52 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 122.759 1.266 . . . . 0.0 108.544 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.51 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 37.9 mtm -94.47 -147.33 0.26 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 36.8 p -144.99 27.26 1.31 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . 61.0 t30 -114.51 118.33 33.47 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.13 141.36 30.26 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.751 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 47.1 tp -108.75 123.05 48.41 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 129' ' ' LEU . 59.2 t -128.52 139.13 52.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.483 -173.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.1 p -78.89 175.33 10.62 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.972 0.509 . . . . 0.0 110.967 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.59 73.17 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 94' ' ' ARG . 8.6 ptt180 -61.66 -47.73 84.04 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.524 0.729 . . . . 0.0 111.324 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -31.47 68.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.08 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -60.1 -42.74 95.35 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.736 0.414 . . . . 0.0 110.28 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -56.51 -45.5 81.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 124.221 0.951 . . . . 0.0 110.496 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 197' ' ' ALA . 4.6 mm? -58.8 -52.89 63.77 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.471 0.482 . . . . 0.0 111.797 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.9 mt -58.93 -44.47 90.96 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 C-N-CA 123.46 0.704 . . . . 0.0 111.776 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.21 -25.77 61.78 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.0 m -70.33 -26.35 63.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.34 -21.4 33.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.7 48.0 7.49 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.62 109.96 4.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.24 0.543 . . . . 0.0 110.019 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 m -75.36 146.96 40.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.678 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.07 12.05 1.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.504 1.522 . . . . 0.0 112.873 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.43 113.93 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.2 tp10 -111.0 141.87 43.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -116.26 119.19 34.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.501 ' HG ' HD21 ' A' ' 130' ' ' ASN . 68.8 mt -109.33 100.71 42.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.42 139.53 18.52 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.58 2.186 . . . . 0.0 113.418 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -148.22 162.26 6.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 124.552 1.141 . . . . 0.0 108.774 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.21 123.59 42.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -120.1 135.71 59.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -169.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.5 mptp? -98.09 150.63 21.23 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.613 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.3 p-10 -91.53 -163.05 0.98 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.903 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -66.02 -36.96 84.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 0.0 109.73 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.13 -19.25 47.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.32 14.69 29.77 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.722 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.613 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 17.2 ptpt -97.44 145.96 25.68 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.8 t -81.43 90.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.504 HG23 HD13 ' A' ' 78' ' ' LEU . 3.9 m -114.97 13.78 8.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.813 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.472 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -135.54 46.9 1.01 Allowed Glycine 0 CA--C 1.545 1.947 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.879 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.09 -13.99 7.47 Favored 'Trans proline' 0 C--N 1.379 2.166 0 CA-C-N 121.565 2.682 . . . . 0.0 111.426 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.1 -4.13 43.4 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.784 1.634 . . . . 0.0 110.438 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.472 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 5.5 m-85 -98.89 149.51 22.85 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.66 -171.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.5 147.54 43.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.208 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -85.13 128.7 34.76 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.926 0.393 . . . . 0.0 110.55 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.472 HD12 HG21 ' A' ' 91' ' ' VAL . 4.5 tt -92.67 125.62 37.38 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.852 -176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.501 HD21 ' HG ' ' A' ' 110' ' ' LEU . 35.7 m-80 -101.03 132.4 46.47 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.337 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.91 114.47 28.77 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.25 172.6 7.69 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.855 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.68 16.86 80.4 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.8 132.72 34.52 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.13 169.22 19.16 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.24 112.06 4.93 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -134.11 -17.71 2.09 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -165.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.7 mt -63.32 122.48 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 118.969 0.804 . . . . 0.0 111.023 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.49 128.14 35.52 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.189 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.425 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 63.2 mtt -119.53 10.35 11.78 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.709 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.66 -38.63 8.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.892 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -113.99 3.7 15.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 16.8 p -90.77 155.84 18.5 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 120.682 0.277 . . . . 0.0 111.396 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.443 ' CB ' ' HB2' ' A' ' 159' ' ' ASP . 64.6 mm-40 -122.04 106.04 10.84 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.425 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 6.2 p90 -164.35 162.87 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.96 0.409 . . . . 0.0 111.938 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.61 125.79 47.54 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 85.8 mtp -91.05 153.46 20.1 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.307 17.9 t70 88.57 82.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.663 1.585 . . . . 0.0 113.152 -177.243 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.416 ' HB3' ' CA ' ' A' ' 156' ' ' GLY . 11.7 p -100.83 -56.08 2.42 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.123 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.0 mt -99.8 -45.3 5.78 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 11.9 pt-20 -155.46 176.11 13.01 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.97 -21.59 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 119.689 1.132 . . . . 0.0 113.691 -170.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.46 12.35 10.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.101 0.953 . . . . 0.0 110.534 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.538 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 22.8 mm-40 -125.38 115.82 20.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.65 147.13 5.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 149' ' ' SER . . . -110.77 -78.69 0.98 Allowed Glycine 0 CA--C 1.491 -1.431 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.698 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.28 123.01 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 44.0 mt -128.59 106.98 15.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 144' ' ' GLU . 20.2 m-20 -86.63 -34.73 19.72 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.04 110.61 2.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.293 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -84.26 124.01 30.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 143' ' ' SER . . . -99.37 147.04 25.65 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.62 139.44 55.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.117 0.886 . . . . 0.0 113.375 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.567 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.0 p-10 -93.61 3.51 55.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.06 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.9 p -66.22 -3.94 6.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.737 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -64.0 -39.95 95.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 123.534 0.733 . . . . 0.0 109.959 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -108.14 -32.82 7.36 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 118.601 -1.24 . . . . 0.0 111.269 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.422 HG13 ' CB ' ' A' ' 137' ' ' ALA . 74.0 mt -85.81 149.95 4.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.428 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 69.3 mtp180 -51.73 127.4 33.93 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.02 0.528 . . . . 0.0 112.01 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.93 -13.67 23.97 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.393 2.062 . . . . 0.0 111.33 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 7.9 p-10 -96.59 7.27 46.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.325 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 151.01 44.14 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.868 0.842 . . . . 0.0 109.78 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -102.19 -30.44 11.12 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.479 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.4 ttt -160.65 128.33 4.42 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -153.75 -179.2 7.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.128 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -137.05 139.24 41.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 60.4 m -72.75 146.64 46.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.767 0.667 . . . . 0.0 110.17 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.9 p -73.05 -50.42 23.09 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.51 15.45 17.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.79 110.13 6.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.538 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 13.2 ptt180 -76.85 -22.36 53.63 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.807 -170.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -86.82 -16.63 35.61 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.289 -0.257 . . . . 0.0 110.948 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.6 tp -87.06 99.76 12.15 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.802 0.81 . . . . 0.0 111.484 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.23 123.78 59.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.16 133.18 52.78 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.041 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' A' ' 174' ' ' MET . 41.1 pt -121.58 158.61 24.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.989 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.617 ' HD3' ' OD1' ' A' ' 189' ' ' ASP . 9.1 ptp180 -85.07 162.06 19.45 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.504 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.9 pt-20 -54.13 -39.85 66.85 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.617 ' OD1' ' HD3' ' A' ' 187' ' ' ARG . 7.5 m-20 -52.53 -42.21 64.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.21 1.004 . . . . 0.0 111.304 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.04 -50.34 77.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.684 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.576 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 21.9 p80 -71.67 -31.06 66.39 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.525 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.97 73.31 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 111.025 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.43 -36.8 68.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.733 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -69.0 -35.57 76.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.345 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 18.8 mm-40 -55.65 -49.15 73.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -79.79 -22.8 42.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.295 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -75.32 -27.89 59.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.658 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 80.55 42.44 10.18 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.46 166.53 18.25 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 17.1 p -57.75 -164.1 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.71 134.83 12.88 Favored Glycine 0 CA--C 1.49 -1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 113.427 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -129.47 159.59 35.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -117.49 120.86 39.4 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.89 135.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -128.89 147.62 50.84 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.03 107.82 7.35 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.81 -33.95 77.21 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.684 0.793 . . . . 0.0 111.929 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.82 100.54 0.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.854 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 73.9 30.03 62.09 Favored Glycine 0 C--O 1.219 -0.824 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.424 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.65 104.58 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.182 0.993 . . . . 0.0 110.911 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.88 126.91 51.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.46 -25.58 0.27 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 119.362 2.505 . . . . 0.0 119.362 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 142.28 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -172.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.5 131.43 34.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.171 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 215' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.314 -0.935 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.481 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 7.4 ptpp? -108.11 146.06 33.2 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -118.88 143.96 46.67 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.038 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB3' ' HB ' ' A' ' 204' ' ' VAL . 97.6 m-85 -126.87 151.3 48.57 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 -176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 HD12 ' A' ' 183' ' ' LEU . 14.0 t -85.89 129.9 37.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -95.92 135.3 37.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -150.61 158.79 44.56 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.23 131.11 60.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.485 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 13.4 tmm? -103.54 105.87 16.23 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.521 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 161.53 123.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.085 2.154 . . . . 0.0 108.662 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -86.84 -23.28 25.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.54 -13.94 62.31 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.394 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -73.32 -32.53 64.64 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 77.82 1.08 Allowed Glycine 1 N--CA 1.391 -4.3 0 C-N-CA 118.943 -1.599 . . . . 0.0 114.127 177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -63.71 136.02 57.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 68' ' ' PHE . 29.8 mt -68.36 104.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 40.1 mm-40 -54.29 -70.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.2 1.562 . . . . 0.0 111.283 -173.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 176.5 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.427 0.691 . . . . 0.0 110.022 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.8 mp -72.14 130.92 85.77 Favored Pre-proline 0 C--O 1.252 1.22 0 O-C-N 123.93 0.769 . . . . 0.0 111.044 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 1.1 Cg_endo -78.62 167.4 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.912 2.408 . . . . 0.0 111.658 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.03 129.33 41.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.686 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.76 0.72 90.34 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.712 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 m -84.97 137.39 37.71 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 117.172 0.486 . . . . 0.0 110.183 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.31 165.55 10.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.306 2.67 . . . . 0.0 112.238 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -55.66 155.09 6.03 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -45.28 -51.47 10.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.232 1.413 . . . . 0.0 111.595 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.611 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 27.1 p-90 -85.94 -16.48 38.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.042 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . 0.423 54.4 mttt -86.75 -11.24 51.66 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.607 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 45.3 m-85 -49.87 -34.1 19.07 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 123.705 0.628 . . . . 0.0 111.944 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -128.04 20.33 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.579 -0.701 . . . . 0.0 112.616 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 0.9 OUTLIER -93.03 101.17 13.49 Favored 'General case' 0 C--O 1.2 -1.525 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.179 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.16 -10.98 0.01 OUTLIER Glycine 0 CA--C 1.556 2.612 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 168.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.52 173.84 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 121.12 2.46 . . . . 0.0 112.277 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -85.93 141.97 29.17 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.8 mt -87.79 -2.78 58.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.495 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.38 66.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.227 0.537 . . . . 0.0 111.904 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -87.63 -39.18 15.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.138 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.93 -21.33 18.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -99.06 141.48 22.95 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.01 122.8 9.69 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.053 1.835 . . . . 0.0 111.898 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.36 110.18 23.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.26 21.17 39.17 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.45 -153.55 30.33 Favored Glycine 0 C--O 1.252 1.262 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 35.4 mt-10 -141.61 139.1 33.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 28.9 m -133.73 166.44 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 m -144.09 150.31 37.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 120.771 0.32 . . . . 0.0 111.248 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' HG12 ' A' ' 37' ' ' ILE . 13.1 m-85 -80.52 120.58 24.68 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 38' ' ' GLU . 14.1 p . . . . . 0 C--N 1.294 -1.815 0 O-C-N 123.697 0.623 . . . . 0.0 109.918 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.42 -165.89 1.41 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -164.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.22 -172.94 4.25 Favored 'General case' 0 C--O 1.194 -1.867 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.438 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 4.6 mp -87.64 143.8 26.99 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -100.14 -178.72 3.92 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.19 0.596 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -60.56 -35.25 75.59 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.515 0.674 . . . . 0.0 110.116 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -129.58 126.98 39.75 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.613 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -115.92 125.35 28.73 Favored Pre-proline 0 C--N 1.279 -2.462 0 O-C-N 123.515 0.509 . . . . 0.0 110.35 -174.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 175.34 8.71 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -163.37 166.63 22.7 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 123.261 0.624 . . . . 0.0 109.586 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -99.91 28.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.4 mtm -116.24 -79.86 0.59 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 50' ' ' PHE . 35.2 t -179.18 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.349 0.565 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -77.66 164.45 25.29 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.598 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.29 141.48 36.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.451 0.569 . . . . 0.0 110.1 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 48.5 tp -110.8 125.26 53.38 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -125.42 147.09 30.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.2 p -77.91 170.2 17.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.742 0.306 . . . . 0.0 110.342 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.9 -18.7 79.4 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -74.31 -52.53 11.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.56 -23.61 63.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.472 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HA ' ' CH2' ' A' ' 109' ' ' TRP . 54.9 ttt180 -57.74 -43.97 85.74 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.041 174.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.6 mmpt? -65.07 -39.41 93.2 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.23 -54.58 45.13 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.368 0.418 . . . . 0.0 110.326 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.1 -46.51 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.461 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.26 -26.91 65.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -72.66 -25.0 61.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.033 0.444 . . . . 0.0 111.156 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.1 -1.51 57.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.305 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.06 47.78 63.32 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.542 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.4 t -73.69 112.73 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -80.27 141.19 35.76 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.739 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 78.32 15.85 1.3 Allowed 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 125.282 1.433 . . . . 0.0 112.263 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.62 113.97 19.18 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.416 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 8.4 tp10 -104.72 124.81 50.04 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.538 ' CH2' HD12 ' A' ' 129' ' ' LEU . 61.9 m95 -108.55 120.15 41.6 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.235 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -109.75 94.13 16.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.72 133.57 12.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.601 2.201 . . . . 0.0 112.532 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.79 160.08 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.625 0.77 . . . . 0.0 109.977 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -93.82 116.73 29.22 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -108.96 136.98 43.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -100.06 146.47 26.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.8 p-10 -90.12 -163.96 1.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.766 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -67.16 -32.39 73.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.139 0.975 . . . . 0.0 111.138 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -83.59 -18.5 38.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.204 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.12 20.54 20.49 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.063 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 20.0 ptmt -105.55 153.42 21.79 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -86.7 90.18 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.531 0.681 . . . . 0.0 109.24 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.26 13.23 6.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.088 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.509 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -127.78 39.72 1.87 Allowed Glycine 0 CA--C 1.552 2.361 0 C-N-CA 119.437 -1.364 . . . . 0.0 116.335 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.76 -0.58 8.7 Favored 'Trans proline' 0 C--N 1.375 1.923 0 CA-C-N 122.013 2.907 . . . . 0.0 112.624 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.54 -9.67 24.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.946 0.899 . . . . 0.0 110.662 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.509 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 16.5 m-85 -103.59 153.99 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.363 -165.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.28 142.81 35.68 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.6 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.29 122.33 26.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.538 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.4 tt -101.16 122.14 43.09 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.325 0.583 . . . . 0.0 110.007 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.36 140.02 53.17 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.393 172.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.52 141.05 29.5 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.52 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.37 173.55 6.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.08 11.51 72.85 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.987 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.02 132.99 35.08 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -137.36 170.22 16.45 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.24 113.21 1.47 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -139.38 -19.16 0.97 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.2 mt -64.17 112.86 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.279 0.561 . . . . 0.0 110.981 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.58 115.22 10.51 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.084 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.6 mtt -99.07 6.17 46.69 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.181 0.515 . . . . 0.0 110.594 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -84.7 -46.28 11.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -102.72 -11.96 18.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.283 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 m -90.76 148.21 22.71 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.833 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -135.0 112.75 10.85 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -158.17 173.17 17.11 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.19 138.16 53.07 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.052 0.541 . . . . 0.0 109.708 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.9 mmt -87.16 108.06 18.74 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -175.51 63.74 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 154' ' ' GLN . 22.9 m -102.82 -56.31 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.074 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 75.6 mt -134.58 -57.16 0.84 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.07 -173.69 2.31 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.902 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -95.07 4.83 53.28 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -103.59 16.52 26.23 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 149' ' ' SER . 21.9 mm-40 -133.34 125.01 28.24 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.255 -174.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 76.0 mt -84.47 119.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 123.365 0.416 . . . . 0.0 110.212 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -98.82 -62.68 0.85 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.246 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.76 133.1 42.74 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.32 -34.73 5.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.672 0.749 . . . . 0.0 109.892 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.97 117.0 18.58 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -98.32 146.8 25.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.24 146.66 52.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.86 0.838 . . . . 0.0 112.012 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.5 p-10 -90.08 8.92 30.25 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.3 p -69.38 -6.27 28.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.343 172.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -60.96 -39.97 91.58 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 124.623 1.169 . . . . 0.0 109.662 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -31.98 6.65 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.263 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.56 141.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 62.9 mmt-85 -60.61 118.34 33.52 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 123.28 0.363 . . . . 0.0 110.132 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -5.37 11.25 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.977 3.118 . . . . 0.0 115.012 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.07 -9.71 58.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.431 0.158 . . . . 0.0 111.377 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.14 114.06 13.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -80.6 -8.69 59.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.415 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.0 ttt -152.64 118.75 5.49 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.422 ' HE2' ' OD1' ' A' ' 164' ' ' ASP . 35.9 p90 -148.48 -179.47 6.98 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.861 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -143.88 147.32 33.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 44.4 m -80.61 151.49 29.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 124.22 0.95 . . . . 0.0 111.19 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.1 p -81.42 -50.28 9.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -85.52 30.27 0.64 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.547 ' N ' HH21 ' A' ' 181' ' ' ARG . 0.3 OUTLIER -160.27 147.24 15.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.169 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 48' ' ' TRP . 8.7 mmp_? -91.18 -39.0 12.36 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -14.72 17.68 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.122 0.264 . . . . 0.0 110.785 -170.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.403 HD12 HG13 ' A' ' 26' ' ' VAL . 28.3 tp -70.03 100.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.243 1.02 . . . . 0.0 109.813 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.45 122.95 67.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.6 mt -107.39 130.02 54.85 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.182 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 174' ' ' MET . 46.5 pt -118.24 149.77 20.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.361 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -82.27 152.97 26.11 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.469 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 10.4 pt-20 -49.04 -41.23 34.3 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.419 0.688 . . . . 0.0 112.338 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -53.12 -40.86 64.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.628 1.571 . . . . 0.0 112.462 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.17 -49.3 62.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.891 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 25.5 p80 -71.42 -24.55 62.06 Favored 'General case' 0 C--O 1.198 -1.641 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.067 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.34 80.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.001 0.52 . . . . 0.0 110.604 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 196' ' ' GLN . . . -69.22 -33.2 72.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.188 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 16.6 m-85 -73.35 -32.83 64.75 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.879 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 59.2 mm-40 -63.24 -42.96 99.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 193' ' ' ALA . 12.9 pt20 -77.55 -24.69 49.8 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.159 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 -27.3 43.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.233 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.1 42.79 75.26 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.663 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.61 165.19 24.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.611 0.364 . . . . 0.0 110.995 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.9 p -39.14 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -173.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.97 141.19 9.18 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.391 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.31 165.21 28.06 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 40.8 ttpt -157.29 121.84 4.38 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 25' ' ' PHE . 26.8 m -125.29 146.96 30.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.448 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -125.11 142.44 51.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.112 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.86 114.65 2.18 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.16 -35.03 61.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.81 94.55 2.77 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.812 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.72 35.12 7.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.19 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -67.77 97.49 0.64 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.14 0.495 . . . . 0.0 110.583 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.06 132.24 51.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.01 -25.44 0.25 Allowed Glycine 0 N--CA 1.479 1.55 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 165.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.85 127.13 32.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 117.777 0.788 . . . . 0.0 112.618 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.6 131.19 37.69 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.611 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 C--N 1.308 -1.227 0 O-C-N 124.026 0.829 . . . . 0.0 109.728 -178.238 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG11 ' HD3' ' A' ' 187' ' ' ARG . 58.0 t . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -94.01 152.81 18.54 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.298 0.57 . . . . 0.0 111.635 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 140.73 43.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.523 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -124.0 151.08 44.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.467 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.26 118.04 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -92.18 117.99 30.4 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -136.47 139.81 42.62 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 83' ' ' PRO . 97.1 t -89.54 120.86 38.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 120.723 0.297 . . . . 0.0 110.422 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.454 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 49.6 ttp -82.44 86.42 6.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.0 0.905 . . . . 0.0 110.224 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . -144.79 112.76 6.37 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -119.47 -58.7 1.89 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.398 -173.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.94 -21.52 43.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . . . -67.02 -35.76 80.63 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 95.92 158.02 32.02 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 114.064 -1.426 . . . . 0.0 114.501 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 46.4 m-85 -96.57 166.06 11.86 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 84' ' ' ASN . 21.9 mt -78.09 101.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 101.501 -3.518 . . . . 0.0 101.501 163.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -65.64 -44.29 86.86 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.055 0.847 . . . . 0.0 111.892 -167.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -132.44 176.03 8.77 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.72 119.55 71.86 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.622 0.769 . . . . 0.0 112.725 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.76 167.75 24.85 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.759 2.306 . . . . 0.0 113.02 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -42.47 114.54 0.59 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.138 1.775 . . . . 0.0 113.421 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.61 79.23 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.551 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 39.6 m -85.54 139.62 35.81 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.63 165.96 23.67 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 123.79 2.993 . . . . 0.0 111.554 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.7 p -49.15 146.33 3.65 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -37.83 -56.73 1.07 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.114 2.565 . . . . 0.0 113.595 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -86.23 -22.06 27.09 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.825 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 47.0 tptt -86.61 -12.24 49.14 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.398 -169.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.475 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 53.0 m-85 -44.05 -49.54 8.74 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.646 0.591 . . . . 0.0 112.571 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.279 30.8 m-70 -127.92 31.68 5.07 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.1 tm-20 -92.84 100.71 13.13 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.36 -10.25 3.76 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 174.76 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.354 2.077 . . . . 0.0 113.295 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 t -96.37 158.48 15.42 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.484 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.5 -13.33 40.51 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.845 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.07 -26.55 49.82 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.74 -20.17 25.12 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -116.51 -22.07 8.89 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.583 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -100.17 138.51 20.27 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.29 123.06 10.15 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.175 1.917 . . . . 0.0 112.581 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.41 114.85 29.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.26 18.28 59.34 Favored Glycine 0 C--N 1.311 -0.843 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.4 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -88.25 -161.84 37.52 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.178 -0.534 . . . . 0.0 111.985 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -129.14 131.75 47.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.38 170.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 t -147.11 147.13 30.27 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.4 110.25 2.2 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.838 171.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.412 -2.363 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.975 -179.926 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.9 0.381 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -90.94 -154.25 0.34 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.606 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -86.2 -177.44 6.26 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.054 1.342 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.15 150.45 23.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.855 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 20.8 m-85 -114.14 -166.68 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.69 -40.94 94.07 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.773 0.715 . . . . 0.0 111.844 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -118.58 147.71 43.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.608 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 24.8 mm-40 -132.54 126.77 20.29 Favored Pre-proline 0 C--O 1.249 1.039 0 C-N-CA 123.069 0.548 . . . . 0.0 110.361 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 63.4 Cg_endo -92.53 178.56 1.39 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.575 2.183 . . . . 0.0 112.503 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.5 p30 -163.94 173.74 12.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.62 -9.49 10.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.336 1.065 . . . . 0.0 109.619 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -95.25 -178.1 4.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.501 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 5.7 p -93.02 39.17 1.04 Allowed 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.9 159.56 34.54 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.433 ' HB2' ' NH2' ' A' ' 176' ' ' ARG . 53.6 tp -124.19 141.53 51.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.15 118.33 36.46 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.44 144.28 29.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 p -75.08 167.37 22.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.08 -20.46 79.68 Favored Glycine 0 C--N 1.31 -0.868 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -70.79 -57.64 4.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -25.61 67.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.265 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 50.9 ttt180 -54.94 -51.1 67.16 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 124.02 0.928 . . . . 0.0 110.171 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -69.27 -25.32 64.2 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.749 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.26 -49.55 77.42 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.897 0.379 . . . . 0.0 110.189 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.1 -37.06 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.526 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 61.2 mt-10 -67.37 -33.34 75.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.205 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.0 m -65.74 -33.84 76.81 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.028 0.531 . . . . 0.0 111.548 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.38 -6.8 58.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.244 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.32 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.85 109.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.541 0.686 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.9 m -80.3 154.85 27.57 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 80.31 14.21 0.84 Allowed 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.76 114.11 27.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.5 tp10 -112.91 138.93 49.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -119.75 116.31 25.67 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -172.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.7 mt -109.11 99.46 35.89 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.27 145.16 23.9 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.448 2.099 . . . . 0.0 112.584 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.4 m -149.57 166.3 3.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 123.633 0.773 . . . . 0.0 109.226 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.05 28.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 126' ' ' TYR . 32.3 mt -113.07 132.46 61.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -98.08 147.55 24.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.13 -160.66 0.43 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.477 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 67.0 m80 -74.63 -22.73 58.77 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 122.265 -0.272 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -87.56 -18.8 28.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.449 0.468 . . . . 0.0 110.194 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.65 36.92 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.033 173.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -101.8 148.49 25.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.634 0.717 . . . . 0.0 110.563 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.16 89.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.468 0.651 . . . . 0.0 110.493 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.4 m -115.6 13.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.433 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.19 49.96 0.9 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 119.97 -1.109 . . . . 0.0 115.245 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.49 -8.28 9.58 Favored 'Trans proline' 0 C--N 1.376 2.025 0 CA-C-N 121.335 2.568 . . . . 0.0 111.458 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -92.06 -14.29 29.53 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.41 1.484 . . . . 0.0 110.788 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.43 ' HB2' HD12 ' A' ' 114' ' ' ILE . 4.3 m-85 -91.03 150.89 21.25 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.883 0.849 . . . . 0.0 112.958 -169.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.46 143.52 39.68 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.438 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.23 117.95 20.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.27 127.59 37.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.92 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.5 m-80 -110.42 127.54 55.15 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.655 -177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.33 125.59 47.98 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.31 172.9 6.55 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 -7.91 81.07 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.82 129.56 34.83 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.85 0.833 . . . . 0.0 109.153 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -148.56 170.11 18.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -46.4 108.82 0.15 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.988 0.805 . . . . 0.0 110.127 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -126.34 -47.21 1.6 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -165.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.437 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 26.2 mt -61.69 118.82 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 119.353 0.979 . . . . 0.0 112.611 -172.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.76 127.92 34.31 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.713 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.4 mtt -94.46 -0.41 54.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.32 -50.63 5.55 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.559 0.695 . . . . 0.0 110.12 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -93.75 -9.36 37.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.216 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -108.14 140.5 41.25 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -120.73 100.51 7.15 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -145.74 165.03 30.0 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.703 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -120.82 147.72 44.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.167 0.917 . . . . 0.0 109.611 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 53.0 mtt -100.47 154.18 18.75 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.291 36.3 t70 90.76 84.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.844 2.457 . . . . 0.0 112.108 -176.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.2 t -99.49 -36.62 9.49 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.611 -1.631 . . . . 0.0 107.621 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.9 mt -136.65 -54.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 12.7 pt-20 -137.32 -179.82 5.96 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.583 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -48.19 -49.48 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.302 1.841 . . . . 0.0 114.634 -171.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.526 ' HB2' HH21 ' A' ' 181' ' ' ARG . 7.7 p-10 -90.09 10.93 22.4 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -102.42 116.57 32.9 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.554 ' H ' ' HG2' ' A' ' 180' ' ' GLU . 70.2 mt -74.31 129.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -108.5 -60.14 0.54 Allowed Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.988 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -92.83 119.15 31.87 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.0 109.91 27.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.03 -34.31 16.85 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.75 138.95 20.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.86 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.8 114.85 15.84 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.78 147.64 25.83 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 140.42 57.33 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.816 0.817 . . . . 0.0 112.916 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 20.4 p-10 -94.65 16.14 16.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.286 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 168' ' ' ILE . 18.2 p -67.01 -5.77 14.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.034 175.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.8 m -64.65 -33.43 75.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.323 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -32.95 6.34 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.249 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 165' ' ' THR . 66.7 mt -92.45 122.23 43.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -56.47 127.82 72.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 118.023 0.374 . . . . 0.0 111.504 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.06 -5.36 6.22 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.601 2.867 . . . . 0.0 115.427 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -80.24 -9.21 59.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.062 0.392 . . . . 0.0 111.13 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 127.2 31.82 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.112 0.482 . . . . 0.0 110.098 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.51 -36.75 76.76 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.036 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' MET . . . . . 0.487 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.5 ttt -148.29 132.03 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.3 -179.79 7.85 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.507 0.504 . . . . 0.0 109.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.433 ' NH2' ' HB2' ' A' ' 89' ' ' LEU . 14.6 ttm180 -136.12 139.56 43.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 183' ' ' LEU . 63.9 m -74.63 139.44 43.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 O-C-N 124.062 0.851 . . . . 0.0 110.105 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 p -82.7 -12.75 57.35 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.437 ' HG3' ' HB ' ' A' ' 138' ' ' ILE . 72.8 mmtt -90.24 -5.0 56.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.866 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -151.32 142.77 23.49 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.526 HH21 ' HB2' ' A' ' 153' ' ' ASP . 17.5 mmt180 -89.35 -30.41 18.42 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -170.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -86.39 -25.35 25.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.093 0.473 . . . . 0.0 110.561 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.0 tt -75.18 102.54 5.01 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.812 -172.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.89 142.2 19.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.2 mt -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.376 0.608 . . . . 0.0 111.1 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.487 HG22 ' HG3' ' A' ' 174' ' ' MET . 44.9 pt -124.72 157.7 32.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.652 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.47 ' HD3' HG11 ' A' ' 22' ' ' VAL . 97.0 mtt180 -80.25 159.63 25.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.496 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 7.5 pt-20 -52.82 -37.56 60.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.729 0.812 . . . . 0.0 110.799 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.43 -42.93 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.282 1.833 . . . . 0.0 111.629 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.67 -45.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.771 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 16.3 p80 -69.6 -30.56 68.34 Favored 'General case' 0 C--O 1.2 -1.538 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.426 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -61.35 -32.03 71.91 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.301 0.572 . . . . 0.0 111.044 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.19 61.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.4 m-85 -74.52 -33.91 62.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.956 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 42.2 mt-10 -63.03 -48.89 76.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.149 0.58 . . . . 0.0 110.585 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.43 -18.57 63.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.926 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.59 -22.26 22.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.673 0.273 . . . . 0.0 111.294 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.25 46.12 66.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.58 158.72 20.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 38.4 p -106.31 139.69 40.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 108.29 56.41 0.58 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.732 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 46.1 m-85 -135.36 142.16 45.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 118.62 1.21 . . . . 0.0 112.464 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 21.1 tptm -146.24 122.77 11.07 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.47 137.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.416 0.627 . . . . 0.0 111.999 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.1 m-85 -129.0 143.68 50.95 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.276 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.7 66.81 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -69.86 100.32 1.53 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.069 0.461 . . . . 0.0 110.556 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.07 28.03 38.71 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.566 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -54.85 102.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.604 1.161 . . . . 0.0 110.893 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -103.88 111.53 24.11 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.22 1.98 23.45 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 165.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 58.3 mt -95.06 131.57 40.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 118.452 1.126 . . . . 0.0 110.103 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -90.26 132.49 35.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.58 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.8 pt? . . . . . 0 C--N 1.305 -1.369 0 O-C-N 123.717 0.635 . . . . 0.0 111.904 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 84.3 t . . . . . 0 N--CA 1.436 -1.135 0 CA-C-O 120.997 0.427 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.37 151.49 49.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.587 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -111.22 134.54 52.73 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.028 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.3 144.09 44.27 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.151 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.1 119.16 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -91.55 124.89 36.06 Favored 'General case' 0 N--CA 1.422 -1.838 0 O-C-N 123.809 0.693 . . . . 0.0 109.454 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -150.3 159.28 44.56 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.424 HG13 ' CA ' ' A' ' 201' ' ' GLY . 91.3 t -101.69 129.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.8 ptp -69.85 160.91 30.92 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.84 0.712 . . . . 0.0 111.139 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 70.76 118.96 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 124.996 1.435 . . . . 0.0 112.214 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 10.3 pt-20 -70.82 -20.12 62.6 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.008 0.909 . . . . 0.0 109.524 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.75 -16.29 62.75 Favored 'General case' 0 C--O 1.206 -1.21 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.972 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.57 -30.0 62.67 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.551 0.74 . . . . 0.0 112.63 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 75' ' ' ASN . . . 105.56 79.0 1.24 Allowed Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 119.412 -1.375 . . . . 0.0 112.043 177.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 93.4 m-85 -69.66 151.9 45.33 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.473 HG12 ' CE2' ' A' ' 68' ' ' PHE . 28.7 mt -73.91 101.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 166.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.19 -41.64 75.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.863 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.22 160.27 43.92 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -51.16 136.72 29.1 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 33.3 Cg_endo -78.52 166.84 23.54 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.208 2.605 . . . . 0.0 111.606 173.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -53.94 117.02 2.87 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.54 1.136 . . . . 0.0 113.274 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.31 10.37 64.05 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 58.2 p -86.01 148.37 47.81 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 23.8 Cg_exo -69.66 165.67 30.08 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.508 2.805 . . . . 0.0 110.212 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -59.88 155.6 16.09 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -39.93 -54.86 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 127.556 2.343 . . . . 0.0 114.015 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 181' ' ' ARG . 34.6 p-90 -86.51 -20.9 27.35 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.379 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -86.43 -12.64 48.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.483 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.518 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 52.4 m-85 -46.04 -34.27 3.99 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 88' ' ' ASN . 40.2 m-70 -129.82 15.54 5.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.31 101.82 14.07 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.072 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.12 -9.99 2.75 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.64 172.9 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.63 1.715 . . . . 0.0 111.466 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 t -98.33 157.05 16.43 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.21 -16.73 48.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -23.67 58.78 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -86.86 -22.12 25.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 45' ' ' PRO . 10.0 m-20 -115.83 -22.87 8.88 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -96.85 135.62 22.04 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 124.05 11.73 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.917 2.411 . . . . 0.0 112.176 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.61 125.6 50.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.94 23.01 62.51 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.756 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.501 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -103.97 -157.05 24.18 Favored Glycine 0 C--O 1.25 1.131 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.154 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.4 130.86 46.53 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 33.1 m -126.19 166.5 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 19.9 m -149.17 149.91 31.79 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 37' ' ' ILE . 11.1 m-30 -71.92 117.03 13.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.432 -1.341 0 CA-C-O 121.221 0.534 . . . . 0.0 112.228 -176.307 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 78.7 m-20 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.079 0.466 . . . . 0.0 112.213 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.7 mmm-85 -79.23 -173.93 3.89 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 121.901 0.858 . . . . 0.0 112.044 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -81.24 -171.96 3.53 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.146 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.36 150.69 21.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.649 0.738 . . . . 0.0 111.859 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.92 -161.19 0.75 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.869 1.268 . . . . 0.0 107.783 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -75.08 -34.62 61.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 118.762 0.71 . . . . 0.0 111.127 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.25 134.35 55.26 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 33.4 tp60 -119.31 127.55 26.41 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.45 -179.79 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.042 2.495 . . . . 0.0 113.577 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.425 HD22 HD12 ' A' ' 37' ' ' ILE . 25.1 p30 -163.57 178.84 7.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.292 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.2 mt -103.85 34.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.5 mtp -129.56 -155.92 0.73 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 40.0 p -119.73 -11.06 9.44 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.473 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 25.9 p-10 -88.19 159.36 18.19 Favored 'General case' 0 C--O 1.201 -1.448 0 O-C-N 121.669 -0.644 . . . . 0.0 110.838 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.75 135.11 54.98 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 61.1 tp -100.13 120.66 40.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.12 139.07 48.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.506 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.4 p -73.98 164.34 26.75 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.64 -21.65 77.84 Favored Glycine 0 C--N 1.327 0.074 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -75.4 -48.35 23.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.18 73.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.249 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 73.1 ttt180 -56.17 -44.16 79.08 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.382 1.073 . . . . 0.0 110.277 174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -46.68 83.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 124.071 0.857 . . . . 0.0 110.407 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.71 -55.24 31.93 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.312 1.008 . . . . 0.0 111.234 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.13 -40.27 80.55 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 C-N-CA 123.692 0.797 . . . . 0.0 111.637 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 81.5 mt-10 -68.69 -35.12 76.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -69.46 -30.47 68.38 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.17 -17.1 57.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.44 20.9 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.698 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.8 113.73 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.9 t -82.6 153.6 25.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 73.58 16.85 3.86 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 124.684 1.194 . . . . 0.0 112.227 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.47 113.5 26.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -105.38 143.45 33.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.459 ' CH2' HD12 ' A' ' 129' ' ' LEU . 58.9 m95 -117.35 119.78 36.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -174.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.1 mt -111.82 96.04 31.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.84 134.44 14.84 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.75 2.3 . . . . 0.0 113.031 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 64' ' ' GLY . 8.0 m -150.2 172.59 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.223 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.96 116.18 28.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -97.45 121.05 47.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.406 0.622 . . . . 0.0 111.145 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HG2' HG22 ' A' ' 121' ' ' VAL . 94.4 mttt -96.28 133.82 40.16 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.4 p-10 -78.22 -160.31 0.2 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.258 0.551 . . . . 0.0 111.205 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -61.28 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.261 1.024 . . . . 0.0 110.765 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -84.66 -19.56 32.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.323 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.7 21.86 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.24 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.633 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.3 ptmt -102.99 142.31 34.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.504 HG22 ' HG2' ' A' ' 115' ' ' LYS . 24.3 t -83.7 84.31 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.526 0.679 . . . . 0.0 110.213 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.46 0.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.312 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.89 58.77 0.7 Allowed Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.52 -11.38 8.22 Favored 'Trans proline' 0 C--N 1.367 1.5 0 CA-C-N 120.623 2.211 . . . . 0.0 111.631 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.71 -5.28 39.12 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 124.837 1.255 . . . . 0.0 109.762 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.614 ' HB2' HD13 ' A' ' 114' ' ' ILE . 1.8 m-85 -93.14 152.23 19.37 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.608 -172.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.15 146.64 40.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.123 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.27 118.81 25.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.305 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.459 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.5 tt -91.65 128.68 37.57 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.11 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 121.09 34.37 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.153 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.423 ' H ' ' CE1' ' A' ' 51' ' ' HIS . 2.8 mm? -79.58 128.47 33.43 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.422 173.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -102.98 174.95 5.64 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 125.573 1.795 . . . . 0.0 107.625 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.6 20.55 63.7 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.542 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.59 131.95 36.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.84 158.1 43.92 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.71 106.83 0.39 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.265 0.939 . . . . 0.0 111.399 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.68 -18.44 7.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.99 113.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.029 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.57 127.77 33.91 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.688 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.4 ttm -117.93 7.61 12.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.25 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 10.2 pt-20 -95.34 -34.93 11.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.057 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.436 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 21.8 mmt85 -94.31 -31.48 14.04 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.6 m -75.71 158.51 32.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.748 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -137.09 105.52 5.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.04 165.63 33.52 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.771 0.319 . . . . 0.0 111.753 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 19.1 mm-40 -118.18 134.29 55.14 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' MET . . . . . 0.477 ' SD ' HG12 ' A' ' 155' ' ' ILE . 11.5 mmt -74.01 156.38 37.59 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.145 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.336 16.3 t70 100.41 99.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 172.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 m -100.49 -55.78 2.51 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 165.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.1 -42.94 2.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.795 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 5.4 pt-20 -142.99 -178.59 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -46.37 -49.39 17.93 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 125.87 1.668 . . . . 0.0 115.164 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.4 27.58 1.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.814 1.293 . . . . 0.0 112.318 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -123.71 115.78 21.98 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 104.654 -2.351 . . . . 0.0 104.654 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.477 HG12 ' SD ' ' A' ' 147' ' ' MET . 57.1 mt -84.63 124.92 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 118.388 0.54 . . . . 0.0 110.775 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.93 -66.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.131 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 7.7 t30 -93.0 119.5 32.32 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.3 mt -125.12 125.12 68.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -103.86 -34.21 8.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.372 0.606 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.07 137.07 14.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -127.18 119.3 26.11 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.71 147.21 24.59 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.65 145.91 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.559 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 30.6 p-10 -89.42 4.54 48.72 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.156 0.983 . . . . 0.0 110.63 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -66.1 -6.48 13.32 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.374 1.07 . . . . 0.0 109.997 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -59.3 -40.98 87.9 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.66 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.77 -32.85 6.28 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.172 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 137' ' ' ALA . 81.0 mt -81.23 141.99 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.402 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 51.7 mtm180 -55.47 114.61 7.58 Favored Pre-proline 0 N--CA 1.45 -0.446 0 O-C-N 123.409 0.443 . . . . 0.0 110.763 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.45 -19.3 67.04 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 123.261 2.641 . . . . 0.0 113.867 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 6.3 p-10 -73.59 -11.72 60.52 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.903 0.481 . . . . 0.0 112.074 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.41 48.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 123.654 0.597 . . . . 0.0 110.67 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.5 -38.56 14.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.9 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.7 ttt -141.47 125.27 16.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.46 -177.96 6.69 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.012 0.925 . . . . 0.0 108.64 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.447 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -142.65 151.63 41.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 118.444 0.565 . . . . 0.0 111.76 -177.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.591 ' SG ' HD22 ' A' ' 183' ' ' LEU . 67.2 m -82.86 129.98 35.07 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 124.157 0.911 . . . . 0.0 109.479 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.5 p -64.06 -51.07 65.82 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.31 22.91 2.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.32 139.68 39.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 48' ' ' TRP . 16.2 mmt180 -91.28 -27.29 18.52 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.924 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.69 -0.4 20.12 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.329 -172.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.591 HD22 ' SG ' ' A' ' 177' ' ' CYS . 1.8 tt -95.11 103.66 15.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.562 0.696 . . . . 0.0 109.315 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.2 mt -111.84 140.47 31.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.4 HD12 ' OD2' ' A' ' 164' ' ' ASP . 53.0 mt -116.78 137.24 52.34 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 118.584 0.629 . . . . 0.0 112.412 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.0 pt -129.36 151.8 36.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.653 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -80.29 163.44 23.95 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.739 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.471 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 0.2 OUTLIER -55.36 -42.08 73.41 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.493 0.717 . . . . 0.0 110.534 176.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -50.49 -39.72 49.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.872 1.669 . . . . 0.0 112.135 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.24 -46.88 76.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.922 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.501 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 14.8 p80 -77.2 -21.94 53.13 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.089 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.67 80.07 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.523 0.678 . . . . 0.0 110.38 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.47 73.97 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.093 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.71 -32.48 67.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.0 mm-40 -57.1 -49.63 75.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -81.51 -7.02 59.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.88 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.57 -27.28 18.29 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 122.097 -0.377 . . . . 0.0 110.167 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 66.98 43.31 91.56 Favored Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 155.72 21.2 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.0 p -106.15 139.37 40.77 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.424 ' CA ' HG13 ' A' ' 29' ' ' VAL . . . 106.44 56.6 0.64 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.634 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -126.95 147.61 50.09 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 121.206 0.527 . . . . 0.0 111.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -156.85 121.76 4.56 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.6 139.53 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.728 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 97.3 m-85 -128.55 151.33 49.57 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 210' ' ' TRP . 20.3 mm-40 -64.66 121.28 14.12 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.27 45.74 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.21 90.12 2.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.347 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.39 32.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.95 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 206' ' ' GLU . 19.6 t90 -58.77 105.35 0.3 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.851 0.861 . . . . 0.0 110.618 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.84 105.55 15.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.8 -24.42 0.3 Allowed Glycine 0 N--CA 1.474 1.172 0 N-CA-C 119.177 2.431 . . . . 0.0 119.177 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.87 115.34 3.33 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.117 0.958 . . . . 0.0 110.567 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.52 125.6 28.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.583 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.103 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tmm? . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.98 46.01 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.112 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 m -124.92 6.56 8.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.591 0.196 . . . . 0.0 110.737 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t 60.82 -149.22 0.42 Allowed 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -112.8 102.8 10.8 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.447 ' O ' ' HD2' ' A' ' 8' ' ' HIS . 34.2 t-80 -77.73 128.35 33.91 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -71.37 100.89 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.075 0.464 . . . . 0.0 111.137 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.447 ' HD2' ' O ' ' A' ' 6' ' ' HIS . 1.9 p80 -160.98 163.22 31.9 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -99.62 -173.52 2.48 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -116.14 33.32 5.59 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.431 ' HB3' ' CD ' ' A' ' 206' ' ' GLU . 48.9 m 71.75 -162.81 0.13 Allowed 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.771 -168.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 m -139.34 -62.31 0.53 Allowed 'General case' 0 C--O 1.246 0.891 0 CA-C-N 120.077 1.308 . . . . 0.0 112.063 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.44 29.55 65.85 Favored Glycine 0 CA--C 1.486 -1.726 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.4 mt -105.11 127.33 52.84 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.442 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 86.1 t -83.09 -52.33 0.64 Allowed Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.815 170.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 8.9 Cg_endo -90.52 103.62 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 121.904 1.736 . . . . 0.0 112.129 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -156.97 -45.83 0.07 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.22 -61.88 0.19 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.654 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -98.75 134.76 41.19 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 122.686 -0.302 . . . . 0.0 110.338 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.254 0.3 OUTLIER 71.25 151.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.708 2.403 . . . . 0.0 113.485 -178.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ttp -112.14 -39.08 4.56 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.44 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.898 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -96.91 148.02 23.37 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.46 137.07 47.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.612 0.72 . . . . 0.0 111.828 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.71 151.35 49.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.621 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG13 HD12 ' A' ' 183' ' ' LEU . 80.8 t -81.6 130.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 172.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -91.73 122.11 33.98 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.712 0.768 . . . . 0.0 110.81 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -138.57 152.48 48.21 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.02 127.51 56.77 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.556 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 12.0 tmm? -85.78 84.42 7.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.56 112.47 3.72 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.528 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.39 -45.92 3.98 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.258 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.97 -12.26 59.92 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.02 120.72 2.11 Favored Glycine 0 N--CA 1.409 -3.119 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.659 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -70.76 152.13 44.12 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mt -78.49 101.4 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -72.73 -42.28 64.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.189 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.526 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 41.1 ttmt -133.01 141.78 48.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.32 132.37 95.32 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 55.6 Cg_endo -74.73 167.55 26.85 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.891 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -54.5 124.64 16.77 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 112.727 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.99 68.51 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.287 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -85.65 133.26 42.2 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.47 165.53 32.44 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.294 2.663 . . . . 0.0 109.948 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 p -51.92 149.46 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.23 -50.45 3.61 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 128.243 2.617 . . . . 0.0 113.684 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -85.89 -25.89 25.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.966 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -80.57 -15.38 56.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.649 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -44.83 -47.55 11.01 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.634 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 2.8 m-70 -127.01 30.12 5.5 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.76 -1.213 . . . . 0.0 109.869 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HA ' HH21 ' A' ' 176' ' ' ARG . 2.1 tm-20 -92.88 101.99 14.36 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -9.23 0.31 Allowed Glycine 0 CA--C 1.54 1.603 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.23 168.2 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 118.779 1.289 . . . . 0.0 112.801 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 t -97.09 154.48 17.31 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.5 mt -102.38 10.64 38.93 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.441 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.36 -29.55 70.54 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.726 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.9 -13.73 38.41 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -114.98 -21.97 9.8 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.29 134.81 20.36 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.87 127.47 25.26 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.278 2.652 . . . . 0.0 113.268 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.53 115.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.24 22.91 50.38 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.971 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -102.56 -167.32 26.47 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.01 141.85 49.34 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 117.511 0.656 . . . . 0.0 109.265 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 31.1 m -133.71 165.92 30.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.0 t -153.07 153.85 33.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.183 0.516 . . . . 0.0 111.211 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.95 117.93 19.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.889 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.526 ' OG ' ' HB3' ' A' ' 39' ' ' LYS . 12.8 p -75.41 138.88 41.98 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -82.23 82.24 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.028 0.918 . . . . 0.0 111.618 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -86.1 -32.02 21.58 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -117.21 131.78 23.84 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.56 -31.55 50.3 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.195 2.597 . . . . 0.0 114.756 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.88 -158.32 0.65 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.862 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . 0.27 90.6 m-20 85.52 142.84 0.06 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -88.61 -154.88 0.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.954 1.301 . . . . 0.0 111.336 -169.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.67 -167.46 1.63 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.937 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -87.31 150.69 23.69 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.372 0.669 . . . . 0.0 112.089 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -105.83 -159.55 0.71 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -71.37 -42.18 68.77 Favored 'General case' 0 CA--C 1.48 -1.749 0 CA-C-N 119.086 0.857 . . . . 0.0 110.624 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -120.83 135.69 55.1 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 35.5 tp60 -116.4 117.99 37.91 Favored Pre-proline 0 C--N 1.28 -2.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.59 162.62 27.34 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.939 2.426 . . . . 0.0 112.058 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -163.81 174.32 11.71 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.181 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.25 -6.47 10.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.444 0.64 . . . . 0.0 110.311 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -96.55 -174.78 3.13 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.847 -0.533 . . . . 0.0 111.273 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -96.41 43.88 1.07 Allowed 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.214 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -138.33 151.33 47.45 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.01 138.85 54.58 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 51.7 tp -105.96 129.61 54.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.184 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.08 140.36 49.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.054 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -70.82 167.3 19.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.063 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.47 -37.67 92.86 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.502 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -72.25 -37.43 69.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.35 -30.52 62.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.351 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.406 ' HG3' ' CE3' ' A' ' 109' ' ' TRP . 49.3 ttp180 -58.41 -48.71 79.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.099 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 97' ' ' LYS . 10.2 tmtt? -62.43 -37.44 85.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.936 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.79 -53.21 59.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 120.583 0.23 . . . . 0.0 111.105 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.2 -41.5 87.01 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.17 -31.14 71.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.313 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -71.42 -22.08 61.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.54 -19.81 32.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.96 0.41 . . . . 0.0 110.551 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.06 48.05 7.19 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.269 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.1 t -78.97 114.57 19.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.4 t -80.03 158.24 26.55 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.137 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 78.5 19.19 0.95 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.316 1.01 . . . . 0.0 110.406 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.03 134.03 50.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.498 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.9 tp10 -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE3' ' HG3' ' A' ' 96' ' ' ARG . 52.2 m95 -117.0 118.62 32.92 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 123.459 0.475 . . . . 0.0 110.082 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.12 102.49 43.52 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.99 129.98 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.744 2.296 . . . . 0.0 113.683 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' GLY . 12.1 m -142.87 172.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.359 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.72 116.23 29.53 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.529 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.4 mp -101.59 124.93 55.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.468 0.651 . . . . 0.0 110.966 -176.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 87.3 mttt -97.35 132.14 43.36 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.6 -161.56 0.24 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -62.6 -31.57 72.42 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.44 -4.27 55.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.739 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.74 14.75 79.22 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.709 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 20.1 pttp -104.84 140.06 38.68 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.534 0.333 . . . . 0.0 110.247 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.23 107.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.43 -0.29 6.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.417 0.627 . . . . 0.0 110.905 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.87 75.95 0.34 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.45 -27.68 2.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.093 1.862 . . . . 0.0 113.773 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -118.53 23.38 11.55 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.813 1.292 . . . . 0.0 109.285 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.529 ' HB2' HD13 ' A' ' 114' ' ' ILE . 2.9 m-85 -88.66 144.86 26.01 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.528 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.77 46.43 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.758 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.7 126.88 32.32 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.534 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 tt -90.54 125.28 35.56 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.846 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.634 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 14.8 m120 -107.15 137.03 45.98 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.955 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.21 120.58 42.96 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.9 172.96 6.52 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 124.029 0.83 . . . . 0.0 110.649 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 22.78 64.24 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.54 131.19 37.87 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -147.88 151.61 36.18 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -52.89 115.19 1.71 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.966 0.791 . . . . 0.0 112.09 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -131.93 -26.36 1.97 Allowed 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -167.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 17.7 mt -62.36 125.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.72 125.74 26.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 23.0 ttt -118.83 1.88 11.57 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.737 0.78 . . . . 0.0 109.718 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.4 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 11.2 pt-20 -99.57 -32.56 11.04 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.73 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.4 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 68.0 mtt85 -108.02 -10.87 15.41 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.182 0.593 . . . . 0.0 110.552 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.5 m -93.84 110.6 22.25 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.362 0.601 . . . . 0.0 110.603 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -78.61 100.72 7.09 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.379 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.49 145.46 27.93 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.239 0.543 . . . . 0.0 111.904 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -101.3 127.97 47.67 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 71.8 mtp -100.73 154.56 18.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 24.0 t70 90.71 85.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 127.269 2.228 . . . . 0.0 114.1 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.7 m -100.43 -26.77 13.76 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.322 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -145.99 -48.05 0.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 14.3 pt-20 -139.75 177.79 7.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.16 -38.58 80.09 Favored 'General case' 0 C--O 1.214 -0.782 0 O-C-N 124.292 0.995 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 25.7 m-20 -85.97 26.11 1.04 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -123.46 113.31 18.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.0 mt -87.03 132.29 32.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 124.238 1.015 . . . . 0.0 109.946 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.05 -72.51 0.95 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.478 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -90.76 133.11 35.42 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.65 124.51 59.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.84 -34.55 8.49 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.04 136.87 20.55 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.85 123.73 29.67 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.84 143.2 32.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.67 139.64 57.07 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.767 0.794 . . . . 0.0 112.96 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.58 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.7 p-10 -94.33 15.55 17.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.112 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.7 p -67.45 -5.22 13.88 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.892 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.1 m -61.57 -38.14 86.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.959 0.903 . . . . 0.0 110.673 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.406 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.63 -30.5 7.08 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.788 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 137' ' ' ALA . 73.8 mt -85.82 139.2 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -54.79 117.96 15.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 O-C-N 123.189 0.306 . . . . 0.0 111.243 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.16 -13.18 33.97 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.419 2.746 . . . . 0.0 114.037 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.84 -12.73 60.22 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.76 129.06 38.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.075 0.464 . . . . 0.0 109.83 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -83.63 -17.0 43.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.794 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.424 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.0 ttt -154.38 128.16 8.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -153.36 178.52 9.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 178' ' ' THR . 1.6 ppt_? -128.47 142.43 51.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.414 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 58.2 m -86.52 140.48 29.87 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 123.832 0.708 . . . . 0.0 109.483 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 176' ' ' ARG . 19.3 p -68.75 -44.56 73.5 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.745 2.868 . . . . 0.0 118.745 -168.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -89.19 23.7 2.38 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.544 0.611 . . . . 0.0 112.333 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 9.0 tp10 -154.94 135.6 13.53 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.418 HH21 ' CD ' ' A' ' 151' ' ' GLU . 69.8 mtt180 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.9 mtm-85 -83.81 -7.37 59.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.767 -167.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 180' ' ' GLU . 26.2 tp -82.42 100.63 10.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.819 0.818 . . . . 0.0 110.973 -174.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.1 mt -117.84 124.38 72.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 207' ' ' ALA . 43.4 mt -103.94 134.71 46.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.523 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.0 pt -123.68 157.74 29.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.597 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -86.06 162.43 18.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.62 -44.63 26.95 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.199 1.399 . . . . 0.0 111.996 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.22 -43.56 70.94 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.439 1.096 . . . . 0.0 111.301 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.31 -53.19 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.178 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 13.7 p80 -75.31 -26.54 58.76 Favored 'General case' 0 C--O 1.195 -1.804 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.714 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.99 83.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 0.0 110.351 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.77 72.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.552 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.457 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 21.0 m-85 -73.57 -36.43 65.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.247 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -56.92 -50.75 71.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 121.625 0.726 . . . . 0.0 109.218 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.91 -26.67 61.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.21 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.53 -27.47 62.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.425 0.155 . . . . 0.0 111.046 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.9 47.51 13.85 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.05 165.87 18.2 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.8 p -42.15 -72.83 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -165.96 144.43 9.19 Favored Glycine 0 CA--C 1.488 -1.637 0 C-N-CA 118.998 -1.572 . . . . 0.0 113.118 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 194' ' ' PHE . 74.5 m-85 -137.37 152.78 50.05 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 22.4 tptm -132.21 121.84 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 24.7 m -116.43 139.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.563 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -121.68 151.44 40.47 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.431 ' CD ' ' HB3' ' A' ' 11' ' ' SER . 49.6 mt-10 -75.62 133.39 40.9 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.207 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.405 ' HB2' HD22 ' A' ' 185' ' ' LEU . . . -80.13 -38.34 31.73 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.936 0.874 . . . . 0.0 108.642 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.74 104.8 13.26 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.004 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.55 35.33 47.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.523 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.439 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 8.7 t90 -54.31 102.18 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.082 1.353 . . . . 0.0 111.217 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.55 109.89 21.74 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.73 2.94 31.82 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 167.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.439 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 82.7 mt -94.14 145.37 24.74 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 117.902 0.851 . . . . 0.0 109.738 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.2 0.524 . . . . 0.0 111.459 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.997 178.42 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.506 -0.729 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.49 142.55 8.94 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.112 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.9 t -73.73 -42.4 61.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 m -110.08 105.37 14.45 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -77.57 -40.76 41.24 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -165.47 94.09 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.555 1.142 . . . . 0.0 109.308 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -167.0 -40.11 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.228 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 68.68 112.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.614 1.166 . . . . 0.0 110.232 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -84.56 152.85 23.61 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 76.89 25.47 0.84 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.233 0.958 . . . . 0.0 110.91 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 m -74.03 -51.74 14.9 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m 61.97 173.21 0.13 Allowed 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.857 1.263 . . . . 0.0 113.565 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.66 85.18 1.16 Allowed Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.89 71.41 10.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.896 0.855 . . . . 0.0 110.557 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.69 134.25 24.87 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.11 107.28 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.484 2.123 . . . . 0.0 111.091 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -152.09 123.62 7.83 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.22 -25.39 1.57 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.653 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -60.97 -43.59 98.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 117.073 0.437 . . . . 0.0 111.785 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -145.95 101.31 3.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.319 0.58 . . . . 0.0 109.573 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -98.94 160.44 14.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.455 HG11 ' NE ' ' A' ' 187' ' ' ARG . 45.0 t -94.96 119.06 42.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 118.75 0.704 . . . . 0.0 110.469 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -87.01 155.8 20.01 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.317 0.579 . . . . 0.0 112.3 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -112.06 138.45 48.7 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.158 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.85 150.92 49.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.46 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.8 130.0 36.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -95.72 128.86 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.512 0.507 . . . . 0.0 111.141 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -150.12 149.58 30.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.94 115.56 41.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.657 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 57.0 ttp -85.28 101.61 12.67 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 173.56 177.19 0.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.144 1.778 . . . . 0.0 107.56 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.17 -36.21 1.53 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 122.04 0.924 . . . . 0.0 110.147 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -89.64 -0.85 57.79 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.962 1.305 . . . . 0.0 111.46 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.18 58.5 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.57 82.69 1.14 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.253 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -95.01 164.61 12.82 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.31 102.21 13.41 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' OE1' ' HB3' ' A' ' 72' ' ' TYR . 2.2 mm-40 -61.87 -55.42 29.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.917 -172.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -137.03 176.47 8.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 46' ' ' THR . 7.8 mp -55.37 125.74 60.08 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HB3' ' HB ' ' A' ' 66' ' ' VAL . 16.4 Cg_exo -71.44 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 123.031 2.487 . . . . 0.0 111.344 169.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -55.8 117.16 3.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.889 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 9.11 83.52 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.281 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m -85.79 139.32 35.22 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -67.59 166.28 24.52 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.686 2.924 . . . . 0.0 112.619 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.406 ' HA ' HD21 ' A' ' 40' ' ' LEU . 5.3 p -53.23 152.01 4.77 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.09 -58.74 2.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 127.534 2.333 . . . . 0.0 113.975 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -80.55 -25.39 38.62 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.431 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 45.1 tptt -80.52 -16.77 53.43 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -172.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -45.51 -43.37 11.69 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.462 ' HB3' ' HG3' ' A' ' 176' ' ' ARG . 55.9 m170 -126.98 24.16 6.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.978 -1.076 . . . . 0.0 111.097 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -93.45 102.7 14.93 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.063 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.29 -8.95 0.59 Allowed Glycine 0 CA--C 1.538 1.495 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.99 171.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 118.499 1.149 . . . . 0.0 113.648 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -98.55 137.93 36.49 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.56 -0.78 48.4 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.07 -23.22 67.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.021 0.438 . . . . 0.0 111.381 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -88.74 -27.88 20.88 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -112.69 -15.53 12.97 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -110.21 135.75 20.55 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.95 123.94 13.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.635 2.223 . . . . 0.0 113.36 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.4 t -95.02 107.68 19.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.47 23.54 28.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.15 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.22 -153.85 25.24 Favored Glycine 0 C--O 1.24 0.507 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.46 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -131.81 132.2 43.53 Favored 'General case' 0 C--O 1.248 0.981 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 41' ' ' PRO . 21.3 m -134.03 168.33 24.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -149.15 158.28 44.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -84.85 106.69 16.57 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 p -69.41 120.89 15.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.568 0.699 . . . . 0.0 109.409 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -74.45 106.51 6.09 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.161 -173.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -104.05 -38.03 7.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.881 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.434 ' HB3' ' OE1' ' A' ' 38' ' ' GLU . 72.7 t80 -111.46 131.61 22.22 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.68 154.02 23.42 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.447 2.098 . . . . 0.0 114.36 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 79.42 2.0 2.27 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.152 1.381 . . . . 0.0 114.556 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -73.52 137.42 44.4 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -90.68 -151.36 0.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -165.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -84.88 -171.19 3.5 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.645 1.578 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.488 HD13 HG23 ' A' ' 122' ' ' VAL . 8.6 mp -100.12 150.21 22.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.171 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.505 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 18.3 m-85 -125.4 -165.74 1.45 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.208 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -52.49 -51.59 58.64 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 123.499 0.719 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -116.2 142.89 46.22 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.918 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 24.6 mm-40 -121.34 111.89 33.24 Favored Pre-proline 0 C--N 1.285 -2.224 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.025 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 167.3 27.68 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.458 2.106 . . . . 0.0 111.35 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -142.69 156.39 45.03 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.4 mt -91.12 -19.48 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -99.02 -179.07 4.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 33.5 t -97.82 66.1 1.88 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.712 -1.195 . . . . 0.0 114.057 -174.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -140.13 121.05 14.54 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.491 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 138.12 31.71 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.354 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 64.9 tp -111.57 127.12 55.63 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.79 141.24 45.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.53 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -78.95 170.2 17.05 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.74 -16.37 79.23 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -69.71 -58.62 3.69 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -25.59 63.33 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.101 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -60.22 -40.89 91.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.509 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.545 ' HA ' ' CE ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.29 -29.5 65.13 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.508 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.82 -57.84 10.98 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.49 -42.74 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.427 0.691 . . . . 0.0 112.562 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.12 -27.48 62.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 p -78.3 -13.0 60.04 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.497 0.665 . . . . 0.0 111.39 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -88.73 -25.57 22.24 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.592 173.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.28 48.36 8.28 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.38 107.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.582 0.706 . . . . 0.0 111.671 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -66.92 137.3 56.45 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.151 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 79.94 11.55 1.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.493 1.917 . . . . 0.0 113.667 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.75 114.32 26.04 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -107.5 144.63 34.19 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.429 ' CH2' HD12 ' A' ' 129' ' ' LEU . 67.0 m95 -116.46 121.43 41.82 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 123.586 0.554 . . . . 0.0 110.238 -174.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.57 96.51 43.87 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.38 139.75 16.72 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.549 2.166 . . . . 0.0 112.868 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.14 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.319 0.648 . . . . 0.0 109.804 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.18 116.55 28.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 126' ' ' TYR . 54.9 mt -110.54 131.14 62.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.613 0.72 . . . . 0.0 112.865 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.488 ' HG2' HG22 ' A' ' 121' ' ' VAL . 93.0 mttt -104.76 148.75 26.27 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.571 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -89.32 -160.69 0.7 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.316 0.579 . . . . 0.0 111.241 -174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -63.85 -34.3 77.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.62 1.168 . . . . 0.0 110.507 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.53 -19.42 29.51 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.66 19.7 24.12 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.571 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 52.2 pttt -99.29 146.35 26.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.488 HG22 ' HG2' ' A' ' 115' ' ' LYS . 17.6 t -82.71 81.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.681 0.753 . . . . 0.0 110.148 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 HD13 ' A' ' 78' ' ' LEU . 10.1 m -105.4 8.19 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.429 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.78 50.76 0.88 Allowed Glycine 0 CA--C 1.542 1.757 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.73 -6.76 9.7 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 121.097 2.449 . . . . 0.0 112.285 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -103.11 -0.99 29.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.438 ' HB2' HD12 ' A' ' 114' ' ' ILE . 2.7 m-85 -98.0 147.87 24.06 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 122.002 0.906 . . . . 0.0 112.86 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.28 139.5 42.72 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.702 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -79.67 124.3 28.44 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.046 0.451 . . . . 0.0 110.111 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.429 HD12 ' CH2' ' A' ' 109' ' ' TRP . 8.0 tt -96.86 125.98 41.68 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.759 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -122.88 134.62 54.37 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.848 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.78 31.94 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.719 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.07 174.12 6.39 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 124.87 1.356 . . . . 0.0 109.016 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.78 28.9 25.12 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.592 -0.814 . . . . 0.0 115.114 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.407 ' HB3' ' NH2' ' A' ' 176' ' ' ARG . . . -112.89 131.79 55.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.151 -1.019 . . . . 0.0 110.984 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.78 111.66 6.13 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.724 -1.125 . . . . 0.0 107.99 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.0 t70 71.21 -52.34 0.69 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 125.978 1.711 . . . . 0.0 112.253 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.36 -100.58 0.06 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 125.961 1.704 . . . . 0.0 114.484 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 179' ' ' LYS . 46.8 mt -64.12 125.08 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 O-C-N 123.686 0.616 . . . . 0.0 110.405 -172.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 100.64 1.94 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.538 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 21.6 ttt -75.81 -12.75 60.23 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.353 -171.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.53 -39.89 67.19 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -101.21 4.55 42.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.347 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.538 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 77.7 p -92.54 115.65 28.29 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.767 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -92.53 104.53 16.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.32 164.02 32.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.529 0.681 . . . . 0.0 112.532 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.87 117.95 31.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 26.3 ttt -100.28 107.48 19.3 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.883 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.6 t70 170.41 89.33 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.909 1.683 . . . . 0.0 108.589 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB3' ' HA2' ' A' ' 156' ' ' GLY . 7.8 p -101.07 -56.88 2.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.294 0.568 . . . . 0.0 110.358 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.17 -59.94 1.9 Allowed 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.54 -177.07 3.21 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.537 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 152' ' ' LYS . 1.2 tpmt? -76.01 -26.51 56.75 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.224 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.46 11.4 14.78 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.613 1.196 . . . . 0.0 110.025 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -124.68 127.84 47.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 48.5 mt -84.79 143.84 10.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 149' ' ' SER . . . -119.42 -70.44 0.33 Allowed Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.425 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.37 118.93 28.34 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 59.1 mt -118.29 132.23 68.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -106.67 -42.29 5.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -154.65 110.62 3.19 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.64 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -88.15 124.71 34.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.75 24.42 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.74 146.46 52.34 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -96.06 -9.15 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -68.0 -6.02 20.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.567 1.147 . . . . 0.0 111.035 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.9 m -65.39 -38.19 89.25 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -110.52 -30.98 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.373 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.83 151.52 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.491 ' HD3' ' OD2' ' A' ' 171' ' ' ASP . 55.5 mtt180 -62.44 126.65 88.56 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 122.267 0.227 . . . . 0.0 111.471 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.86 -10.12 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.139 1.892 . . . . 0.0 110.816 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' A' ' 169' ' ' ARG . 4.3 p-10 -85.21 2.14 45.1 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.091 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.99 134.73 33.88 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.52 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 67.8 mttm -84.01 -27.44 28.38 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.507 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.0 ttt -150.76 128.05 11.31 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.56 -179.19 7.03 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 123.559 0.537 . . . . 0.0 110.004 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -136.12 154.7 50.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 63.4 m -87.48 143.82 27.03 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.206 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.5 p -82.91 -9.61 59.22 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.447 ' HB2' HD12 ' A' ' 138' ' ' ILE . 58.9 mttp -105.87 23.74 13.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.72 -0.613 . . . . 0.0 111.853 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 183' ' ' LEU . 7.4 tp10 175.05 134.16 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 17.1 mmt180 -89.53 -31.05 17.8 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.495 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -77.85 -20.13 53.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.269 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 180' ' ' GLU . 20.3 tp -83.85 100.35 10.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.067 0.937 . . . . 0.0 110.64 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.3 mt -116.46 119.41 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 55.2 mt -104.89 136.04 45.12 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.608 0.718 . . . . 0.0 111.723 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.6 pt -119.3 153.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.417 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 10.6 mtp180 -86.06 161.3 19.0 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.498 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.7 pt-20 -55.42 -40.02 70.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.7 -26.34 66.97 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.465 0.706 . . . . 0.0 111.829 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.2 t -71.31 -51.01 37.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.797 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.548 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 19.3 p80 -73.17 -21.91 60.6 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.089 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.9 76.82 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.063 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.24 75.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.511 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.7 m-85 -71.18 -33.35 69.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.272 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 62.9 mm-40 -59.6 -47.93 83.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.491 0.663 . . . . 0.0 109.811 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -78.03 -12.76 60.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.516 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.06 -28.42 20.14 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.083 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.39 47.7 87.61 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.443 ' HB2' ' CE1' ' A' ' 202' ' ' PHE . 66.5 mt -77.9 164.18 25.37 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.5 p -41.41 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.45 135.06 6.81 Favored Glycine 0 CA--C 1.493 -1.322 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.809 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 199' ' ' LEU . 70.5 m-85 -146.37 161.94 39.28 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 58.1 tptt -153.59 122.26 6.34 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 18.0 m -112.66 134.46 55.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.054 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 73.4 m-85 -118.26 140.05 50.39 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.95 115.51 9.26 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.08 -35.05 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.382 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.97 92.67 0.52 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.062 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.99 35.6 17.97 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.399 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.405 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 8.3 t90 -53.12 115.01 1.66 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.802 0.841 . . . . 0.0 110.061 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.23 99.78 11.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.47 -1.59 9.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 117.832 1.893 . . . . 0.0 117.832 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.405 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 88.0 mt -94.56 143.2 26.62 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 118.029 0.914 . . . . 0.0 112.327 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.48 132.36 52.59 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.488 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 2.5 pt? . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.047 0.842 . . . . 0.0 112.387 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.89 153.7 6.51 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m 65.79 98.48 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.468 1.107 . . . . 0.0 112.084 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -59.31 -42.91 92.49 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 112.01 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -71.91 131.54 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -58.65 -46.78 86.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -152.45 156.76 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.414 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.424 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 22.5 m80 -77.05 107.83 9.69 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.685 0.616 . . . . 0.0 110.475 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -126.39 7.54 7.05 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -114.06 13.76 18.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.306 1.05 . . . . 0.0 108.594 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 8' ' ' HIS . 48.9 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.393 0.616 . . . . 0.0 111.116 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -102.57 150.35 23.5 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.309 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.35 104.02 3.09 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.52 156.78 36.5 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.3 t -65.3 121.21 73.41 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.506 ' O ' ' HD2' ' A' ' 17' ' ' ARG . 30.4 Cg_endo -64.77 95.29 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.324 2.682 . . . . 0.0 114.811 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 4.5 mpt_? -136.2 86.53 2.23 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.029 1.332 . . . . 0.0 108.146 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.61 -83.37 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.357 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.849 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m 71.58 -56.28 0.64 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.713 1.605 . . . . 0.0 109.515 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.98 92.48 2.4 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -86.9 114.48 23.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.39 115.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -80.55 152.95 28.36 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -167.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.28 141.1 48.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.972 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.7 141.0 52.24 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 62.0 t -72.73 120.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.3 115.11 27.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.857 0.723 . . . . 0.0 110.7 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -140.3 120.16 13.51 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.9 t -72.66 129.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.461 ' HB3' ' HG3' ' A' ' 203' ' ' LYS 0.268 20.8 ptt? -102.01 66.68 1.04 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.73 1.252 . . . . 0.0 112.619 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.46 110.72 12.1 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -106.66 -17.24 14.29 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 122.19 0.995 . . . . 0.0 108.721 -171.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -86.97 -25.85 24.12 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.698 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.32 80.68 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.89 137.41 3.36 Favored Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.216 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -65.9 156.63 32.86 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.38 102.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -51.73 -52.19 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.832 1.332 . . . . 0.0 112.205 -169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -139.69 172.03 13.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 46' ' ' THR . 8.9 mp -55.46 124.63 56.33 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 18.8 Cg_endo -75.09 166.77 28.41 Favored 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 122.664 2.243 . . . . 0.0 112.198 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.15 121.4 6.74 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 125.109 1.364 . . . . 0.0 112.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.09 0.2 68.4 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.649 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.7 m -85.88 137.87 35.47 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.93 166.49 23.2 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 123.416 2.744 . . . . 0.0 109.795 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.473 ' HA ' HD21 ' A' ' 40' ' ' LEU . 18.0 p -48.22 153.01 0.75 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' OD1' ' HG3' ' A' ' 86' ' ' MET . 16.2 m-20 -37.68 -57.03 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 C-N-CA 126.863 2.065 . . . . 0.0 114.955 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -80.47 -30.33 37.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.419 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.72 -11.58 59.84 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.725 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 27.8 m-85 -45.84 -46.01 15.36 Favored 'General case' 0 C--O 1.209 -1.048 0 O-C-N 123.559 0.537 . . . . 0.0 111.347 174.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 17.4 m170 -129.41 17.0 5.98 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.19 101.34 13.41 Favored 'General case' 0 N--CA 1.425 -1.688 0 C-N-CA 117.76 -1.576 . . . . 0.0 108.373 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.03 -9.17 55.05 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.59 173.77 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 119.814 1.807 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -98.88 157.15 16.5 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.38 5.95 49.02 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.36 68.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.972 0.415 . . . . 0.0 111.792 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -88.37 -32.57 18.31 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.1 -22.61 15.13 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -102.53 136.97 19.26 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.37 123.86 13.95 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.063 2.509 . . . . 0.0 112.571 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.63 115.98 40.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.76 23.65 45.31 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.445 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -103.41 -159.33 25.01 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 121.453 -0.403 . . . . 0.0 112.315 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -133.31 135.68 44.99 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 27.2 m -133.41 172.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 t -155.64 154.47 31.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.52 119.84 16.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -73.07 137.45 45.29 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 123.719 0.637 . . . . 0.0 109.671 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -85.02 73.9 10.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -90.88 -22.38 20.96 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 172.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -147.24 98.59 3.99 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 112.839 -1.982 . . . . 0.0 105.781 170.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.58 -27.59 6.09 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.519 2.146 . . . . 0.0 114.827 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.92 86.4 7.32 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -171.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -153.99 -176.24 5.76 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 125.041 1.337 . . . . 0.0 108.344 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -98.68 -159.37 0.74 Allowed 'General case' 0 C--O 1.262 1.716 0 CA-C-O 121.361 0.6 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.39 -167.59 1.88 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.614 1.566 . . . . 0.0 112.42 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.79 147.39 25.18 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.573 0.749 . . . . 0.0 111.76 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.87 -171.52 1.86 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.17 0.988 . . . . 0.0 109.416 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.04 -46.09 71.79 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.546 0.688 . . . . 0.0 110.517 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.0 131.14 53.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 48.0 tp60 -111.44 116.21 50.99 Favored Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 121.053 0.454 . . . . 0.0 109.96 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.12 164.91 21.92 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.82 2.347 . . . . 0.0 112.413 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -157.36 173.61 16.67 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.417 HG22 HH21 ' A' ' 181' ' ' ARG . 16.0 mt -90.37 3.02 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 121.608 0.718 . . . . 0.0 110.33 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.47 ' HG3' ' OD1' ' A' ' 47' ' ' ASP . 4.1 mpp? -104.98 -175.7 2.87 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.88 -0.513 . . . . 0.0 110.321 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 22.6 t -92.58 16.41 12.12 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 120.989 0.423 . . . . 0.0 112.065 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -115.67 151.1 35.67 Favored 'General case' 0 C--O 1.205 -1.238 0 O-C-N 121.082 -1.012 . . . . 0.0 109.321 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.9 139.86 50.13 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 119.009 -1.077 . . . . 0.0 110.803 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 55.1 tp -109.1 126.39 53.14 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 129' ' ' LEU . 47.6 t -126.38 140.97 47.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.6 p -73.4 162.49 29.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.09 -31.92 82.39 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.211 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -72.34 -36.12 68.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.794 0.331 . . . . 0.0 110.753 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.26 -27.62 56.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -60.26 -39.32 86.37 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.112 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.7 mmtp -60.09 -44.18 94.99 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.15 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.63 -51.7 68.81 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.745 0.653 . . . . 0.0 110.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.93 -44.07 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.031 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.98 -20.35 60.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.8 t -72.06 -32.08 66.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.92 -2.07 57.91 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.396 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.69 47.86 82.65 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.555 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -75.24 110.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -75.84 151.79 37.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.188 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 79.58 12.77 1.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.231 1.413 . . . . 0.0 111.972 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.8 tp10 -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -113.27 126.14 55.07 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.51 99.75 42.28 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.33 125.47 6.38 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.501 2.134 . . . . 0.0 112.93 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 64' ' ' GLY . 12.6 m -143.07 170.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -104.93 116.84 32.65 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.1 mp -103.99 133.55 47.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.424 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.641 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -97.34 144.36 27.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -85.53 -163.8 0.91 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.107 0.48 . . . . 0.0 111.515 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -67.16 -29.64 69.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.235 0.614 . . . . 0.0 110.503 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -87.56 -5.49 58.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.65 18.86 64.97 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 114.402 0.521 . . . . 0.0 114.402 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -105.27 152.67 22.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 117.417 0.609 . . . . 0.0 110.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.12 85.71 2.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.405 0.621 . . . . 0.0 109.894 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.412 ' C ' ' HD3' ' A' ' 124' ' ' PRO . 11.6 m -110.13 6.67 8.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.497 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -125.37 59.17 0.65 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.679 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 10.6 Cg_endo -85.26 -19.68 3.63 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.41 2.073 . . . . 0.0 113.152 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.0 6.8 21.26 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.017 0.527 . . . . 0.0 110.688 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.497 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 1.5 m-85 -88.29 145.28 25.94 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.221 0.534 . . . . 0.0 110.158 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.38 144.29 48.12 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.408 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.99 128.27 34.32 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 91' ' ' VAL . 1.3 tt -97.68 126.93 43.28 Favored 'General case' 0 C--O 1.268 2.06 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 25.7 m-80 -111.13 127.22 55.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.757 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.96 122.6 38.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.85 174.42 5.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 124.148 0.905 . . . . 0.0 109.478 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.39 26.19 28.65 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.99 41.22 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.037 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.88 170.14 18.3 Favored 'General case' 0 C--N 1.263 -3.169 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.57 107.99 0.23 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.908 1.231 . . . . 0.0 111.995 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -80.48 -71.19 0.47 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.034 -1.894 . . . . 0.0 115.686 -163.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.21 124.67 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 O-C-N 123.804 0.69 . . . . 0.0 111.669 -170.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 141' ' ' GLU . 11.8 t70 -82.67 128.16 34.09 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.62 -22.91 32.08 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.437 ' HG2' ' OD2' ' A' ' 139' ' ' ASP . 11.1 pt-20 -95.37 -27.29 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.421 0.555 . . . . 0.0 111.157 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -86.81 -5.76 59.01 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.488 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -121.12 168.45 11.54 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -137.2 106.78 6.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -159.67 164.4 34.05 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.649 0.261 . . . . 0.0 111.148 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.89 129.75 51.49 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 62.2 mtt -92.26 107.63 19.35 Favored 'General case' 0 C--O 1.201 -1.455 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.202 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 165.45 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.026 1.73 . . . . 0.0 111.028 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.6 p -100.93 -56.47 2.31 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.848 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.9 mt -110.14 -31.84 7.21 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.553 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.79 -174.84 1.94 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 147' ' ' MET . 39.4 ttpt -63.02 -43.71 97.96 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.821 0.737 . . . . 0.0 112.852 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.26 26.01 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.152 0.977 . . . . 0.0 112.358 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -139.12 114.25 9.52 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.3 mt -85.03 144.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.12 -77.6 0.77 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -78.79 118.85 21.24 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 39.8 mt -126.34 116.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -100.79 -39.03 8.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.309 0.576 . . . . 0.0 109.769 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.18 128.88 24.67 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.72 111.18 17.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 147.18 24.11 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.75 129.45 39.84 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.189 0.931 . . . . 0.0 110.585 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.421 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.0 p-10 -84.68 11.6 8.68 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 124.413 1.085 . . . . 0.0 110.775 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.0 p -71.69 -4.94 30.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.139 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -73.76 -34.7 64.83 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.498 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.65 -33.62 8.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.719 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.8 mt -91.47 153.52 3.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.0 124.33 73.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 118.074 0.397 . . . . 0.0 111.037 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.43 -5.34 15.75 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.6 2.867 . . . . 0.0 113.908 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.68 -0.28 51.8 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.93 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.25 120.71 14.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.107 0.479 . . . . 0.0 110.457 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -73.99 -28.64 61.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.03 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.421 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.4 ttt -147.68 125.66 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -152.56 175.55 12.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 51' ' ' HIS . 0.2 OUTLIER -152.07 162.23 41.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.37 160.69 20.6 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.3 p -82.24 -49.29 10.25 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 124.134 0.974 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.75 4.68 31.66 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.31 138.08 47.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' SER . 11.4 mtm180 -90.14 -30.16 17.82 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.818 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.0 -28.07 13.95 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.2 tp -71.05 100.63 2.05 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-O 122.133 0.968 . . . . 0.0 112.76 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.23 132.87 64.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.94 122.25 43.74 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.604 0.716 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 191' ' ' HIS . 34.2 pt -112.08 151.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -85.08 159.99 20.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.439 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 11.3 pt-20 -54.44 -39.77 67.72 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -73.13 -27.89 61.94 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.105 0.562 . . . . 0.0 111.454 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.47 -47.42 72.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.631 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.7 p80 -71.21 -26.05 62.77 Favored 'General case' 0 C--O 1.196 -1.748 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.742 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.91 71.24 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.492 0.495 . . . . 0.0 110.7 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.55 -39.25 74.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.99 -32.41 70.6 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 65.6 mm-40 -58.25 -53.5 57.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.679 0.791 . . . . 0.0 109.678 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.52 -23.5 58.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.785 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.75 60.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.261 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.12 47.85 10.56 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.962 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.9 mt -80.32 161.78 24.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.6 p -38.8 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.87 128.81 1.53 Allowed Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.91 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -136.17 150.85 49.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 30' ' ' MET . 53.7 mtmt -106.99 128.45 54.36 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 15.6 m -118.84 129.24 75.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 123.797 0.686 . . . . 0.0 109.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.2 m-85 -118.44 154.52 32.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.17 116.06 12.15 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.98 -36.98 67.2 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.428 0.455 . . . . 0.0 111.646 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.28 102.07 1.02 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.18 60.32 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.657 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -57.45 100.62 0.05 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.974 1.31 . . . . 0.0 111.888 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.0 133.96 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -26.56 0.29 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 118.809 2.283 . . . . 0.0 118.809 167.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.47 134.12 45.17 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 118.313 1.057 . . . . 0.0 112.141 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -86.81 131.57 34.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.2 pt? . . . . . 0 C--N 1.299 -1.589 0 O-C-N 123.336 0.398 . . . . 0.0 110.563 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.38 175.25 45.59 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.351 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -86.09 28.57 0.8 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 123.7 0.8 . . . . 0.0 112.823 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -63.19 -42.51 99.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -85.47 97.15 9.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 168.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -68.18 -36.11 79.08 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.728 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -146.15 99.41 3.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -149.84 -70.27 0.19 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -141.63 65.08 1.39 Allowed 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 167.36 125.38 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 t 63.94 36.83 9.84 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -70.63 -19.65 62.8 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.816 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.57 -102.14 1.03 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.55 35.71 20.06 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.858 0.863 . . . . 0.0 110.029 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.15 -45.51 93.86 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.19 97.57 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 120.894 1.355 . . . . 0.0 110.868 172.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -99.59 -20.68 16.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.86 -137.78 48.34 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.837 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 m -103.23 118.82 37.65 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -80.33 88.44 5.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.667 0.746 . . . . 0.0 109.394 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -110.89 165.22 12.03 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.288 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.84 109.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.301 1.048 . . . . 0.0 112.883 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 157.53 26.33 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.059 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -107.58 137.77 45.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.673 0.749 . . . . 0.0 113.002 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -126.66 151.15 48.45 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.788 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -84.2 126.46 40.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -98.8 129.44 45.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.131 0.491 . . . . 0.0 112.323 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 203' ' ' LYS . 81.7 tttt -150.5 163.95 37.15 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.448 ' N ' ' HG2' ' A' ' 28' ' ' LYS . 48.2 t -103.77 131.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.465 ' HB3' ' HB2' ' A' ' 203' ' ' LYS . 14.1 ptp -91.01 97.29 11.09 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 167.82 134.88 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 125.099 1.36 . . . . 0.0 109.467 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.17 -17.83 31.8 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 9.6 mm-40 -88.75 0.2 56.71 Favored 'General case' 0 C--O 1.199 -1.604 0 C-N-CA 125.341 1.456 . . . . 0.0 111.851 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -69.9 -12.53 61.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.383 -0.823 . . . . 0.0 112.779 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.28 1.18 Allowed Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.832 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -89.27 145.46 25.37 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.1 mt -78.16 101.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -61.64 -41.22 97.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.177 0.923 . . . . 0.0 112.001 -169.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -141.79 170.56 15.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mp -52.88 123.51 32.65 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 125.108 1.363 . . . . 0.0 113.457 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -72.41 166.54 29.49 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.539 2.16 . . . . 0.0 111.776 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.77 115.83 1.84 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.57 6.59 58.39 Favored Glycine 0 C--O 1.225 -0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.653 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 33.4 m -85.95 140.98 35.2 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 44' ' ' SER . 1.5 Cg_endo -76.28 166.27 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.36 2.706 . . . . 0.0 110.158 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -49.49 151.73 1.52 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -40.66 -53.44 2.77 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 127.281 2.232 . . . . 0.0 114.521 -173.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -83.25 -29.18 28.65 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.743 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -81.09 -12.06 59.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.062 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 16.0 m-85 -43.89 -49.03 8.49 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.511 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 42.6 m80 -129.38 27.21 5.33 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.247 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.99 102.04 14.38 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.84 -9.93 35.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.01 161.76 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.986 1.393 . . . . 0.0 112.032 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -98.68 159.5 14.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.08 12.94 26.41 Favored 'General case' 0 C--O 1.206 -1.184 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.78 75.33 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 121.953 0.882 . . . . 0.0 111.17 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -89.52 -27.92 19.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.171 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.68 -22.23 19.54 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -114.21 144.74 32.25 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 123.16 12.26 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.774 2.316 . . . . 0.0 112.95 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -97.88 116.27 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.5 23.34 58.58 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.829 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -98.43 -160.22 30.1 Favored Glycine 0 C--O 1.245 0.814 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.814 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 46.6 mt-10 -127.48 130.08 48.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.462 0.305 . . . . 0.0 110.184 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.3 m -132.75 166.69 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 23.5 t -143.1 149.36 38.04 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.85 114.69 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.7 p -65.68 132.65 49.3 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -85.83 58.12 4.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.22 0.533 . . . . 0.0 112.388 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -76.39 -28.82 56.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.003 0.906 . . . . 0.0 108.677 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -114.44 106.27 52.76 Favored Pre-proline 0 N--CA 1.417 -2.113 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -48.26 -69.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.045 3.164 . . . . 0.0 115.513 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.81 103.05 14.94 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.4 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 29.9 t-20 -139.43 155.33 47.67 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 5.9 mmp_? -78.96 -165.48 0.75 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 122.031 0.92 . . . . 0.0 113.369 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.405 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.3 p-10 -93.7 -162.91 0.98 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.796 1.639 . . . . 0.0 110.372 -175.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.1 mp -91.73 135.98 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.727 0.298 . . . . 0.0 111.703 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 1.4 m-30 -99.36 -105.49 0.21 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.708 0.403 . . . . 0.0 110.542 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -117.0 -47.67 2.68 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.31 129.54 53.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 124.996 1.318 . . . . 0.0 107.616 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 15.8 mm100 -105.88 116.35 59.89 Favored Pre-proline 0 C--N 1.295 -1.786 0 O-C-N 123.436 0.46 . . . . 0.0 112.053 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.19 168.11 13.55 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.79 2.327 . . . . 0.0 111.36 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -163.66 -178.55 5.84 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.51 -13.47 9.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.19 178.45 5.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.209 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' HG3' ' A' ' 181' ' ' ARG . 3.7 m -90.48 46.67 1.36 Allowed 'General case' 0 C--O 1.251 1.182 0 CA-C-O 121.22 0.533 . . . . 0.0 110.41 -176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -136.73 145.26 44.44 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.7 tp -122.79 141.37 51.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.262 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 56.6 tp -113.7 125.91 54.65 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 129' ' ' LEU . 50.1 t -126.63 142.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -72.99 164.1 27.18 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -71.68 -18.51 77.35 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -65.1 -58.3 6.39 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.14 60.39 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.049 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 47.7 ttt180 -57.25 -47.9 80.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.927 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 1.2 mmmp? -61.88 -38.74 89.42 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 109.859 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.28 -53.53 56.2 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.601 0.563 . . . . 0.0 110.746 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.03 -41.85 87.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 123.716 0.806 . . . . 0.0 111.506 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 49.4 mt-10 -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.0 m -64.32 -30.58 71.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.145 0.497 . . . . 0.0 111.599 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.467 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.8 mp -84.44 -10.1 57.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.985 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.05 43.03 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.455 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.5 t -77.73 100.62 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 m -76.95 156.35 32.05 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.842 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 80.81 13.84 0.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.652 1.581 . . . . 0.0 110.838 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.59 122.69 47.19 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.021 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -115.81 144.68 43.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -114.66 122.25 45.88 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.173 0.589 . . . . 0.0 110.466 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HG ' HD21 ' A' ' 130' ' ' ASN . 78.6 mt -115.27 98.81 51.39 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.88 138.71 13.34 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.421 2.081 . . . . 0.0 113.185 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 64' ' ' GLY . 6.9 m -145.89 173.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.496 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.49 116.91 33.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 173.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 23.0 mt -111.34 134.19 54.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.315 0.579 . . . . 0.0 112.248 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.2 mptp? -98.11 148.38 23.6 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 5.9 p-10 -92.91 -160.49 0.76 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 71.8 m80 -71.84 -18.96 62.04 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.944 0.498 . . . . 0.0 111.554 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.8 -19.41 24.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.17 51.63 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.242 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.3 ptmt -98.32 138.61 35.32 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 91.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.148 0.499 . . . . 0.0 109.758 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.439 HG23 HD13 ' A' ' 78' ' ' LEU . 11.9 m -115.98 12.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.012 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.419 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -123.91 65.42 0.53 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.523 173.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 8.3 Cg_endo -85.37 -23.58 2.26 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.494 2.129 . . . . 0.0 113.224 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.55 4.08 21.84 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.441 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.419 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 6.9 m-85 -84.74 140.8 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.554 0.692 . . . . 0.0 110.972 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -129.85 141.44 50.82 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.928 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -79.8 127.26 32.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 91' ' ' VAL . 4.4 tt -93.41 124.79 37.64 Favored 'General case' 0 C--O 1.282 2.81 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.511 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 36.7 m-80 -104.58 128.84 52.69 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.106 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 114.37 27.66 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.4 169.63 9.93 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.133 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.09 22.52 78.79 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.915 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.7 131.67 34.39 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.21 169.26 18.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -58.15 105.71 0.3 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -127.52 -33.68 2.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 24.3 mt -59.36 119.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.037 -173.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.58 128.15 35.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.423 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 64.1 mtp -109.66 -25.64 10.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.931 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.51 -29.67 18.79 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.868 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -96.17 -11.59 25.93 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.522 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 m -104.56 149.74 25.23 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -114.34 104.83 12.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.423 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 4.3 p90 -154.19 150.95 28.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.399 0.619 . . . . 0.0 112.364 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 51.7 mm-40 -108.92 139.66 43.47 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.234 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 90.7 mtp -100.84 155.23 18.05 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.161 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 151' ' ' GLU . 16.7 t70 85.85 78.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.916 1.686 . . . . 0.0 113.766 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.601 ' OG ' ' HA3' ' A' ' 156' ' ' GLY . 49.9 m -103.19 -57.21 2.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.174 166.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.7 mt -94.02 -45.21 7.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 2.3 pp20? -147.01 171.78 14.73 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.567 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -54.75 -44.98 74.09 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.458 1.103 . . . . 0.0 113.548 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.554 ' HB3' HH12 ' A' ' 181' ' ' ARG . 7.0 t70 -92.38 15.1 14.66 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.011 0.91 . . . . 0.0 110.496 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 9.8 mm-40 -102.38 119.37 38.7 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 124.121 0.969 . . . . 0.0 110.308 175.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 50.7 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.601 ' HA3' ' OG ' ' A' ' 149' ' ' SER . . . -115.52 -65.05 0.39 Allowed Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.5 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 6.4 t30 -84.86 119.08 24.93 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 52.2 mt -128.12 127.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.47 -29.37 8.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.919 0.39 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.08 130.08 16.33 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.07 118.9 24.3 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.76 139.59 38.14 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.5 mt -57.77 145.42 34.84 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 138' ' ' ILE . 15.1 p-10 -94.61 15.1 18.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.683 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.55 -5.21 18.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.596 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -61.4 -35.72 78.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.212 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.79 -31.82 6.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.252 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 137' ' ' ALA . 78.3 mt -90.02 154.13 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -50.15 122.92 15.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 123.91 0.884 . . . . 0.0 112.708 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.4 -6.0 17.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.025 1.816 . . . . 0.0 110.512 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.493 ' HA ' ' NH2' ' A' ' 187' ' ' ARG . 5.8 p-10 -99.67 6.3 45.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.092 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -85.62 132.03 34.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.466 ' HG2' ' HD2' ' A' ' 187' ' ' ARG . 76.7 mttt -84.93 -16.51 40.79 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.138 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 185' ' ' LEU . 26.4 ttt -159.77 127.72 4.82 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.37 164.3 38.39 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 142.43 34.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.512 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 38.6 m -93.01 120.47 33.34 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -53.45 -46.46 69.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.476 ' HB2' HD12 ' A' ' 138' ' ' ILE . 41.2 mttp -79.2 24.32 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.21 158.33 44.02 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.554 HH12 ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -91.27 -51.54 5.25 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.762 174.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.433 ' HD3' ' OE2' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -92.54 -13.41 29.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.239 -167.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.512 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 37.3 tp -77.78 101.16 6.58 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 122.017 0.913 . . . . 0.0 111.841 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.5 mt -120.87 121.36 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 174' ' ' MET . 66.7 mt -97.15 133.59 41.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 120.933 0.397 . . . . 0.0 110.66 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.449 HG22 ' HG3' ' A' ' 174' ' ' MET . 42.7 pt -120.97 158.02 23.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.282 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.493 ' NH2' ' HA ' ' A' ' 171' ' ' ASP . 93.7 mtt180 -83.14 162.53 21.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.789 0.804 . . . . 0.0 111.068 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -55.56 -47.4 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.268 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.16 -26.94 69.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.115 0.259 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.467 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 61.9 t -65.21 -54.35 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.743 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -74.89 -26.43 59.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.232 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.35 -34.14 77.62 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.446 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.19 -37.34 78.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.231 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -69.65 -38.06 76.97 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.823 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -65.12 -40.79 95.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -77.04 -25.64 52.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.419 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.41 -27.49 46.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 121.176 0.513 . . . . 0.0 109.912 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.54 47.5 4.84 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.066 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.99 165.32 19.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.98 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -161.07 125.26 1.42 Allowed Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.361 -1.399 . . . . 0.0 112.347 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -120.66 145.34 47.54 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 30' ' ' MET . 50.2 tptt -105.18 121.37 43.68 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.88 129.72 71.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.342 0.591 . . . . 0.0 111.185 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -111.29 141.18 45.16 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.04 106.17 1.0 Allowed 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.82 74.47 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.163 0.506 . . . . 0.0 111.451 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -77.35 89.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.317 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.6 35.13 6.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.438 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.413 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 16.1 t90 -63.82 99.16 0.22 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.668 0.747 . . . . 0.0 111.802 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.16 130.5 51.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.36 -26.51 0.27 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 165.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.413 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 86.4 mt -76.26 141.3 41.74 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.384 1.092 . . . . 0.0 111.451 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.23 130.32 38.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.673 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HB2' ' CH2' ' A' ' 210' ' ' TRP . 36.7 tp . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.04 -148.85 20.54 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -91.73 16.23 11.15 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.867 0.841 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 124.654 1.182 . . . . 0.0 112.449 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -76.07 39.9 0.19 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -103.67 117.64 34.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.282 33.2 m170 -96.61 72.31 2.68 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -164.59 146.23 8.26 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.716 2.407 . . . . 0.0 105.625 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -138.54 133.97 33.28 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -81.75 82.46 7.44 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t 74.13 -56.35 0.64 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.178 1.791 . . . . 0.0 112.562 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.252 54.8 p 58.76 97.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.66 125.51 39.43 Favored Glycine 0 C--O 1.249 1.04 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.507 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.0 mt -104.12 151.59 23.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t -126.14 93.43 43.56 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -88.49 -20.77 1.6 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 122.479 2.12 . . . . 0.0 111.327 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -117.36 119.39 34.96 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.166 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.21 -107.94 0.37 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.1 m -127.2 20.07 6.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -131.55 119.93 22.19 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.282 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 88.4 mtp -113.21 160.91 17.78 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.3 115.4 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -118.22 145.26 45.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.203 0.525 . . . . 0.0 110.341 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -114.2 132.63 56.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.647 -172.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 78.8 m-85 -116.62 141.63 47.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 17.2 t -78.32 121.79 31.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -96.24 129.86 43.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -173.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -150.47 153.92 36.76 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.8 t -87.82 145.61 7.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.55 140.98 31.04 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.187 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 88.91 128.48 0.03 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.742 2.017 . . . . 0.0 112.472 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 33.0 tt0 -73.21 -26.38 61.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.938 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 -0.25 43.82 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.069 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -77.05 11.64 1.73 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.17 65.88 0.95 Allowed Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.352 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 10.4 m-85 -79.79 142.01 35.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.032 0.444 . . . . 0.0 110.415 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.431 HD12 HD22 ' A' ' 84' ' ' ASN . 23.0 mt -89.41 104.66 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 170.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 40.7 mm-40 -61.85 -57.23 12.61 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.083 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -117.49 176.47 5.15 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.04 132.17 88.55 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.15 166.49 29.44 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.271 1.981 . . . . 0.0 112.124 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -52.46 124.71 14.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.86 1.264 . . . . 0.0 112.476 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.44 81.75 Favored Glycine 0 CA--C 1.516 0.133 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.093 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 50.8 m -85.83 139.46 35.15 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.71 165.77 24.47 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.295 2.663 . . . . 0.0 110.878 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 p -54.17 150.59 8.13 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.55 ' HB3' ' NH1' ' A' ' 181' ' ' ARG . 3.8 m-20 -41.34 -59.18 1.63 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.707 2.003 . . . . 0.0 114.786 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -79.11 -30.53 43.82 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.853 0.359 . . . . 0.0 111.705 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 17.8 tppt? -79.01 -11.93 60.02 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.637 -173.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' O ' HD11 ' A' ' 56' ' ' LEU . 8.5 m-85 -44.72 -44.54 9.27 Favored 'General case' 0 C--O 1.194 -1.84 0 C-N-CA 123.517 0.727 . . . . 0.0 112.205 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.44 ' CG ' ' HD2' ' A' ' 176' ' ' ARG . 65.5 m80 -129.4 21.57 5.62 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.48 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 49' ' ' LYS . 1.8 tm-20 -91.91 101.32 13.89 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.29 -5.83 4.83 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.38 164.32 21.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -97.97 142.86 29.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.555 HD13 ' ND2' ' A' ' 130' ' ' ASN . 4.4 mp -99.28 -4.94 30.7 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.639 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.12 -21.59 66.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.116 0.484 . . . . 0.0 111.822 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.31 -21.13 24.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -116.86 -22.98 8.27 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -94.35 139.13 22.32 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.06 123.22 11.83 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.558 2.172 . . . . 0.0 112.812 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 HD22 ' A' ' 110' ' ' LEU . 30.1 t -100.07 107.55 21.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 23.56 30.24 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.434 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -96.85 -157.75 31.17 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.813 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.75 132.75 46.67 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.12 170.68 19.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -145.39 152.56 40.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.847 -0.533 . . . . 0.0 111.264 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -77.24 107.4 9.61 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -58.79 130.12 45.38 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.231 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -86.6 70.26 10.41 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 25.0 t-20 -79.6 -38.11 34.69 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -119.44 90.77 43.18 Favored Pre-proline 0 N--CA 1.425 -1.708 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.11 -20.07 63.21 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.225 2.617 . . . . 0.0 114.111 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.33 9.67 19.73 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 13.3 t-20 -74.52 139.15 43.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -77.28 -165.46 0.59 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.687 0.755 . . . . 0.0 112.839 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -84.6 -165.28 1.13 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.238 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 122' ' ' VAL . 8.1 mp -90.48 150.37 21.83 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.767 0.794 . . . . 0.0 113.114 -173.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 29.4 m-85 -121.85 -149.24 0.42 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.741 2.017 . . . . 0.0 106.977 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -81.14 -31.91 33.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.878 0.763 . . . . 0.0 110.929 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.433 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 59.0 m-85 -134.97 148.19 49.93 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 11.0 mm100 -121.82 120.98 28.33 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 93.5 Cg_endo -87.1 170.62 7.01 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.26 1.973 . . . . 0.0 110.474 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.431 HD22 HD12 ' A' ' 37' ' ' ILE . 33.8 p30 -155.9 179.19 9.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.993 -0.442 . . . . 0.0 110.984 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.5 mt -86.97 -22.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -86.25 -92.3 0.09 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -168.68 -40.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -67.43 117.1 8.95 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 120.956 0.408 . . . . 0.0 112.035 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.2 tp -87.43 133.75 33.69 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.462 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 40.9 tp -105.33 121.32 43.63 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.768 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.33 137.07 56.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 p -76.49 172.73 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.433 0.293 . . . . 0.0 110.904 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.37 -20.48 79.33 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -65.59 -58.29 6.11 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.22 -28.93 64.56 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.562 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 100' ' ' GLU . 54.6 ttt180 -57.9 -43.69 86.31 Favored 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.356 0.41 . . . . 0.0 110.108 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -67.26 -28.32 67.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.82 -54.02 22.31 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.39 -46.26 92.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 C-N-CA 123.744 0.818 . . . . 0.0 112.039 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 96' ' ' ARG . 50.2 mt-10 -62.07 -31.84 72.31 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.423 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -78.33 -11.27 59.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.24 -13.94 51.27 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.679 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.78 33.89 26.17 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.72 101.21 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.989 0.899 . . . . 0.0 109.853 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.0 m -86.76 150.3 24.26 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 80.51 10.05 1.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.606 1.162 . . . . 0.0 111.348 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.05 26.18 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.661 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.4 tp10 -94.62 144.83 25.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -125.88 108.66 11.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.413 HD22 HG22 ' A' ' 62' ' ' VAL . 72.3 mt -109.32 95.63 19.21 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.35 140.83 12.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.775 2.317 . . . . 0.0 113.37 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.5 m -147.62 169.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.961 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.95 116.82 29.4 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.1 mt -113.97 128.45 70.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.184 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.37 146.1 24.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 8.8 p-10 -84.83 -160.51 0.49 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 122.48 0.312 . . . . 0.0 110.436 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.501 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 56.8 m80 -73.69 -19.55 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.562 0.345 . . . . 0.0 110.452 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -93.19 -20.06 20.83 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.068 0.461 . . . . 0.0 110.22 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.04 22.1 12.57 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.12 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.424 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 61.0 pttt -105.15 146.82 28.69 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.92 89.94 2.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 121.638 0.732 . . . . 0.0 110.146 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 78' ' ' LEU . 6.3 m -114.12 10.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.088 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.36 42.35 1.37 Allowed Glycine 0 CA--C 1.549 2.159 0 C-N-CA 119.304 -1.426 . . . . 0.0 116.496 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.0 -1.69 9.99 Favored 'Trans proline' 0 C--N 1.376 1.981 0 CA-C-N 122.049 2.924 . . . . 0.0 112.107 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.9 -7.31 37.09 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 125.139 1.375 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -98.92 144.04 28.55 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.374 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.92 143.51 50.18 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.299 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.7 119.85 24.36 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 3.9 tt -91.85 125.01 36.4 Favored 'General case' 0 C--O 1.281 2.737 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.255 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.555 ' ND2' HD13 ' A' ' 56' ' ' LEU . 17.3 m120 -123.83 141.64 51.85 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.785 -1.552 . . . . 0.0 107.393 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.401 HD23 ' HE ' ' A' ' 176' ' ' ARG . 3.3 mm? -103.29 132.94 49.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.479 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.45 170.47 8.38 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.63 16.96 67.07 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 132.11 43.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.45 169.09 18.62 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.41 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 10.9 t70 -73.01 108.59 5.99 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.155 -174.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -132.18 -12.83 3.17 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -167.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 177' ' ' CYS . 23.2 mt -65.5 120.04 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.37 115.0 6.52 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.0 ttt -95.37 -7.79 37.51 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.378 0.609 . . . . 0.0 110.169 -172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.33 -49.81 6.15 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.182 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -87.08 -16.25 36.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.167 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 104.7 16.65 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.768 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.428 ' H ' ' HB3' ' A' ' 160' ' ' ALA . 11.6 mm-40 -71.41 103.7 2.99 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.949 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.85 161.6 42.4 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.97 129.79 51.51 Favored 'General case' 0 N--CA 1.402 -2.854 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.795 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 56.0 mtt -92.66 108.21 19.8 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -151.51 -25.27 0.2 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -167.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 53.6 m -70.59 -56.38 6.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.16 -35.52 4.67 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.677 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -164.18 -174.39 3.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 147' ' ' MET . 10.2 tmtt? -65.04 -33.64 76.52 Favored 'General case' 0 C--O 1.196 -1.737 0 O-C-N 123.84 0.713 . . . . 0.0 111.022 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.26 23.72 4.27 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.331 0.586 . . . . 0.0 111.904 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.453 ' HA ' ' NE2' ' A' ' 154' ' ' GLN . 17.1 mm-40 -125.62 114.28 18.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.452 0.644 . . . . 0.0 111.197 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 56.9 mt -84.86 134.13 27.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.856 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -110.34 -70.88 0.64 Allowed Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -84.22 127.4 33.92 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.81 127.65 66.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -112.87 -24.16 9.71 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.1 0.476 . . . . 0.0 110.905 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 144' ' ' GLU . . . -151.54 136.22 17.1 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -131.25 108.27 9.56 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.35 138.0 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.1 mt -54.37 140.23 34.34 Favored 'General case' 0 C--O 1.253 1.251 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.563 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.1 p-10 -87.99 6.28 36.67 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.226 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -68.27 -6.14 22.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.878 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.0 m -61.03 -40.82 95.05 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 124.614 1.166 . . . . 0.0 110.046 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.53 -32.21 6.54 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.384 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.515 HG13 ' CB ' ' A' ' 137' ' ' ALA . 83.3 mt -82.94 147.24 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.406 ' HD2' ' OD2' ' A' ' 171' ' ' ASP . 9.3 mmt85 -54.03 118.13 14.8 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 122.908 0.483 . . . . 0.0 112.041 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 14.5 Cg_exo -70.64 -11.89 30.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.409 2.072 . . . . 0.0 111.653 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.406 ' OD2' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -88.97 0.47 56.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.475 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.04 127.65 33.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -76.34 -22.53 54.8 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.434 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.7 ttt -155.77 122.45 5.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -148.51 -179.23 6.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.44 ' HD2' ' CG ' ' A' ' 51' ' ' HIS . 12.2 ptp180 -151.43 164.73 36.1 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.49 ' HB3' HD11 ' A' ' 138' ' ' ILE . 61.6 m -86.5 152.32 22.75 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 124.206 0.941 . . . . 0.0 112.082 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 136' ' ' ASP . 3.7 p -82.12 -50.77 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.411 ' HB2' HD12 ' A' ' 138' ' ' ILE . 48.9 mmtm -85.19 2.62 42.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.66 104.04 5.0 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.55 ' NH1' ' HB3' ' A' ' 47' ' ' ASP . 27.7 ptt180 -68.0 -27.12 66.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.004 -170.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.454 ' O ' HG13 ' A' ' 184' ' ' ILE . 17.9 mtm-85 -88.85 -33.55 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.064 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.475 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.9 tt -62.34 105.75 0.66 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.448 1.099 . . . . 0.0 111.24 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 182' ' ' ARG . 67.1 mt -110.6 130.46 63.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 45.0 mt -107.78 121.86 45.59 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.397 0.618 . . . . 0.0 110.564 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.5 pt -111.36 143.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.27 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -77.11 154.71 33.0 Favored 'General case' 0 C--O 1.259 1.57 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 2.8 pm0 -55.16 -39.4 69.45 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.474 0.71 . . . . 0.0 112.357 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -54.01 -43.42 70.06 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.463 1.505 . . . . 0.0 111.718 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.7 -48.32 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.435 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.572 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 20.7 p80 -72.21 -25.25 61.58 Favored 'General case' 0 C--O 1.196 -1.743 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.108 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.0 73.09 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.452 0.47 . . . . 0.0 110.526 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.19 -35.62 71.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.2 m-85 -68.6 -35.69 77.68 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.693 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -59.1 -51.54 69.6 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.812 0.695 . . . . 0.0 110.219 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.07 -16.51 59.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.071 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.85 -27.34 36.45 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.02 47.94 17.35 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.516 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.12 165.0 25.16 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.417 -0.113 . . . . 0.0 111.041 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.4 p -43.37 -77.03 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -171.0 138.4 4.92 Favored Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.719 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.433 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 35.2 m-85 -136.36 153.46 51.12 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -112.86 122.02 46.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.97 129.32 68.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.214 0.53 . . . . 0.0 109.642 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 60.0 m-85 -114.1 137.39 51.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.75 109.53 3.88 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.04 -33.11 57.36 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.495 0.497 . . . . 0.0 112.088 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.41 92.52 1.08 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.296 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.52 35.05 14.71 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 16.3 t90 -67.51 101.03 0.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.923 0.889 . . . . 0.0 112.164 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -104.35 152.03 22.75 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.94 -25.67 0.3 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 166.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.437 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 86.4 mt -94.68 145.72 24.65 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 117.956 0.878 . . . . 0.0 112.659 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.4 132.85 52.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 215' ' ' LEU . 2.5 pt? . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.16 53.28 0.33 Allowed Glycine 0 C--N 1.301 -1.38 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.3 m -54.93 -41.58 71.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.819 1.248 . . . . 0.0 112.74 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 t -95.33 -20.2 19.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.916 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -64.71 -45.86 84.78 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.702 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -94.83 102.16 14.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.145 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -143.33 110.86 5.85 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.22 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -85.8 -29.15 24.02 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 170.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -167.73 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.497 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -124.77 -79.52 0.61 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 p -78.94 -28.07 43.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.132 0.491 . . . . 0.0 110.19 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m 73.34 -45.94 0.63 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.223 1.809 . . . . 0.0 113.977 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.8 83.84 1.27 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.52 128.62 47.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.721 0.296 . . . . 0.0 110.262 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.78 116.11 65.55 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.37 28.02 0.59 Allowed 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.95 2.433 . . . . 0.0 112.327 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 68.61 -70.12 0.14 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.913 1.685 . . . . 0.0 110.769 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.82 -156.17 27.85 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -131.31 130.41 42.71 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -122.68 95.91 4.82 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.241 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -84.17 157.91 21.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 187' ' ' ARG . 41.5 t -81.83 110.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' OE2' ' A' ' 208' ' ' GLU . 20.8 ptmt -79.44 156.06 28.04 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.2 0.524 . . . . 0.0 111.699 -175.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -109.68 141.29 42.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.738 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -124.22 146.0 49.0 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.022 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.79 117.82 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -105.7 123.11 47.4 Favored 'General case' 0 C--N 1.282 -2.358 0 O-C-N 123.638 0.586 . . . . 0.0 110.506 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -139.32 139.43 37.28 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.8 t -86.6 110.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.74 98.7 9.5 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 119.509 -0.876 . . . . 0.0 108.906 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.63 110.84 5.76 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.43 -35.12 8.9 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.919 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.24 -23.93 57.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.124 0.487 . . . . 0.0 110.462 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . . . -79.73 -28.06 40.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.71 156.06 22.02 Favored Glycine 0 N--CA 1.413 -2.892 0 CA-C-N 113.635 -1.621 . . . . 0.0 114.381 174.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 71.7 m-85 -87.1 156.13 19.84 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.822 -1.189 . . . . 0.0 108.119 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.448 HG12 ' CE2' ' A' ' 68' ' ' PHE . 22.4 mt -79.52 101.85 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -57.9 -45.16 86.86 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -131.82 176.19 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.62 119.58 74.87 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 124.004 0.815 . . . . 0.0 110.981 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -66.94 166.75 21.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.671 2.248 . . . . 0.0 111.946 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -49.97 117.51 2.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.226 1.011 . . . . 0.0 113.697 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.36 66.21 Favored Glycine 0 C--O 1.206 -1.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.731 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.4 m -86.44 137.49 34.42 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.81 166.67 26.89 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 124.062 3.174 . . . . 0.0 111.154 169.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 p -53.47 150.69 6.4 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.39 -57.21 1.44 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 128.25 2.62 . . . . 0.0 114.522 -174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -85.86 -21.02 28.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.703 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -79.1 -20.03 49.71 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.625 0.37 . . . . 0.0 111.926 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.518 ' HA ' HD21 ' A' ' 56' ' ' LEU . 57.9 m-85 -45.11 -33.24 2.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 4.5 m-70 -129.11 16.07 6.19 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 120.577 -1.327 . . . . 0.0 109.95 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 101.28 13.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.378 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.55 -9.38 1.28 Allowed Glycine 0 CA--C 1.549 2.181 0 N-CA-C 118.066 1.986 . . . . 0.0 118.066 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.128 1.964 . . . . 0.0 112.152 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.2 t -97.45 150.01 21.52 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 50' ' ' PHE . 77.4 mt -86.25 -3.14 58.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.514 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.48 66.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.48 -20.52 25.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -114.62 -22.89 9.53 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -108.11 136.54 19.78 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.61 123.09 11.45 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.69 2.26 . . . . 0.0 112.183 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.02 116.78 34.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.64 21.39 58.11 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -99.2 -162.94 29.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.382 -177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -116.85 137.85 51.92 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.22 172.78 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -148.96 155.61 41.08 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.448 ' CE2' HG12 ' A' ' 37' ' ' ILE . 7.8 m-85 -75.02 104.83 5.75 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p -81.7 117.29 21.92 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -85.54 119.62 26.09 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.735 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -71.49 -37.94 71.22 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -177.05 -48.37 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.451 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.18 135.48 34.61 Favored 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.825 1.683 . . . . 0.0 112.249 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.52 149.26 40.91 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -154.51 -171.4 3.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.781 0.432 . . . . 0.0 111.35 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -81.13 -161.48 0.41 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.95 0.9 . . . . 0.0 111.872 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.443 ' HB2' HG21 ' A' ' 122' ' ' VAL . 2.6 p-10 -81.95 -168.24 1.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.191 0.996 . . . . 0.0 112.615 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD13 HG23 ' A' ' 122' ' ' VAL . 5.2 mp -87.8 142.61 27.68 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.765 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 21.8 m-85 -107.76 -167.57 1.27 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.78 -42.85 89.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.37 138.18 53.88 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 16.2 mm100 -119.25 131.5 24.34 Favored Pre-proline 0 C--O 1.261 1.679 0 O-C-N 123.531 0.519 . . . . 0.0 110.471 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.67 177.68 2.15 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.141 2.561 . . . . 0.0 111.967 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 26.6 p30 -163.49 179.11 7.5 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.91 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.1 mm -91.93 3.22 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 CA-C-O 122.542 1.163 . . . . 0.0 108.701 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -109.98 -102.37 0.39 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.238 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 64.7 p -173.51 -14.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.557 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -69.63 116.75 10.39 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.44 132.02 34.61 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.101 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 34.3 tp -104.28 119.55 39.21 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.628 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.42 136.98 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.503 -173.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -71.38 172.04 10.13 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.276 0.63 . . . . 0.0 111.649 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 97' ' ' LYS . . . -68.03 -34.02 80.56 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -64.52 -55.56 19.8 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.509 0.723 . . . . 0.0 110.085 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.51 69.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.464 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 58.7 ttt180 -58.39 -48.36 80.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.979 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 7.6 mtpm? -62.18 -32.36 72.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.796 0.685 . . . . 0.0 112.047 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.84 -53.06 61.96 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.982 0.42 . . . . 0.0 110.349 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.44 -36.32 75.78 Favored 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.921 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 51.6 mt-10 -68.87 -38.66 79.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.124 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.3 m -70.53 -28.7 65.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.965 0.412 . . . . 0.0 111.764 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.35 -14.98 57.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.647 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.52 48.42 68.46 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 173' ' ' LYS . 94.9 t -67.93 109.06 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.66 0.743 . . . . 0.0 111.421 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -64.33 136.64 57.34 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 75.67 7.87 3.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.118 1.367 . . . . 0.0 114.391 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.21 114.12 26.56 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 9.1 tp10 -103.39 146.58 28.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -114.15 120.94 42.24 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.607 0.567 . . . . 0.0 110.631 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.62 97.28 50.68 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.51 140.78 17.23 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.872 2.381 . . . . 0.0 112.9 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.8 m -148.66 167.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.528 0.731 . . . . 0.0 110.005 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.48 116.61 30.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 33.9 mt -112.92 132.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.172 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -92.86 134.91 34.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -80.0 -160.81 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.407 ' HE1' ' O ' ' A' ' 34' ' ' ALA . 58.8 m80 -68.56 -26.89 65.63 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.898 -0.501 . . . . 0.0 110.922 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.39 -19.19 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.327 0.651 . . . . 0.0 110.907 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.12 14.06 27.35 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.518 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -101.85 139.76 37.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.355 0.578 . . . . 0.0 110.289 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 58.7 t -83.0 84.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.312 1.053 . . . . 0.0 110.539 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.458 HG23 HD13 ' A' ' 78' ' ' LEU . 17.3 m -111.21 16.83 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.474 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.447 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -130.84 45.4 1.14 Allowed Glycine 0 CA--C 1.547 2.089 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.828 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.07 -5.05 9.63 Favored 'Trans proline' 0 C--N 1.383 2.342 0 CA-C-N 121.416 2.608 . . . . 0.0 112.506 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -108.47 0.03 20.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.807 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.458 ' HB3' HD11 ' A' ' 90' ' ' LEU . 6.8 m-85 -92.16 134.84 34.48 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.239 -174.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.69 142.36 51.45 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.975 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -83.87 112.47 20.15 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.6 tt -88.35 129.95 35.26 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.57 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -123.88 141.03 52.4 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.525 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.24 131.85 51.11 Favored 'General case' 0 CA--C 1.486 -1.511 0 O-C-N 123.799 0.687 . . . . 0.0 110.356 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.34 173.08 6.48 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 124.719 1.262 . . . . 0.0 108.361 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.54 13.63 64.98 Favored Glycine 0 C--N 1.305 -1.145 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.725 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.82 130.07 45.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.28 107.94 3.83 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.291 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.74 -46.59 0.63 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 125.854 1.661 . . . . 0.0 112.682 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.458 ' C ' ' HB2' ' A' ' 164' ' ' ASP . . . 65.34 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 126.558 1.943 . . . . 0.0 115.912 171.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.1 mm -55.23 124.29 7.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.274 1.03 . . . . 0.0 111.083 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.62 95.26 3.33 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.3 ttm -76.74 -4.14 41.79 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.996 -170.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.74 -50.22 9.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.494 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -99.68 1.36 43.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.988 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.5 p -94.32 119.06 32.53 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.28 100.9 12.87 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -155.27 161.65 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.306 0.574 . . . . 0.0 112.511 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -118.28 145.58 44.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.748 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 59.2 mtt -100.7 155.67 17.77 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.343 33.7 t70 93.07 86.4 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.23 2.212 . . . . 0.0 115.952 174.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.7 m -101.48 -37.38 8.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.41 168.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.0 mt -135.23 -45.27 0.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.111 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.447 ' CD ' HH22 ' A' ' 181' ' ' ARG . 40.0 mt-10 -139.65 177.24 8.08 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.552 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -31.25 71.76 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -96.51 24.01 6.3 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.481 1.134 . . . . 0.0 110.074 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.465 HE22 ' HG2' ' A' ' 181' ' ' ARG . 21.3 mm-40 -114.66 115.19 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.5 mt -78.32 139.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 -84.85 1.75 Allowed Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -82.31 121.38 26.6 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.33 109.86 26.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.19 -43.67 12.81 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.85 110.66 4.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -85.33 121.22 27.75 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -93.99 132.0 38.89 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.82 136.05 51.47 Favored 'General case' 0 C--O 1.257 1.487 0 O-C-N 124.185 0.928 . . . . 0.0 111.708 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.458 ' HB2' ' C ' ' A' ' 137' ' ' ALA . 21.5 p-10 -87.22 1.62 52.55 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.988 -175.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.1 p -68.27 -4.53 14.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.031 1.333 . . . . 0.0 111.203 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.2 m -67.61 -34.37 76.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.264 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.13 -31.69 6.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.403 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.3 mt -91.89 141.68 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.448 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 48.3 mtp180 -53.96 121.5 29.68 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 123.415 0.686 . . . . 0.0 111.435 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.17 -6.85 18.29 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.876 2.384 . . . . 0.0 112.603 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.05 -10.0 55.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.291 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.47 120.3 15.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 104' ' ' VAL . 98.8 mttt -71.98 -30.79 65.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.998 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.546 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.9 ttt -153.35 129.59 10.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.24 -178.92 7.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 22.9 ttp180 -138.53 142.08 39.31 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.78 144.6 52.63 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.6 p -81.07 -35.88 31.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.47 -7.39 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.06 117.85 13.2 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 176' ' ' ARG . 6.2 ptp180 -76.48 -24.76 53.82 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.303 -173.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -89.77 -15.72 31.8 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.77 99.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.685 -174.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.42 123.08 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -107.64 124.45 50.0 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.845 0.831 . . . . 0.0 111.251 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.546 HG22 ' HG3' ' A' ' 174' ' ' MET . 36.3 pt -116.07 155.27 17.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.987 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 22' ' ' VAL . 47.8 mtm180 -85.98 158.59 19.84 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.5 pt-20 -47.82 -42.46 26.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.35 1.06 . . . . 0.0 113.097 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.92 -40.47 69.91 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 125.445 1.498 . . . . 0.0 112.291 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.45 -46.97 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.563 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 33.1 p80 -71.01 -31.74 68.33 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.02 70.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.0 -34.77 61.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.13 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.7 m-85 -73.21 -35.52 66.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.008 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 47.7 mt-10 -60.75 -53.38 58.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.523 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.65 -24.17 66.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.56 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -79.76 -27.41 40.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.344 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.47 36.61 43.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.82 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.32 157.11 32.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.4 p -102.03 137.11 40.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.55 71.35 0.92 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.369 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 55.5 m-85 -141.96 149.54 40.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 118.175 0.988 . . . . 0.0 112.795 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -161.71 121.51 2.53 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.07 156.14 38.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -140.72 161.89 36.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 123.558 0.743 . . . . 0.0 109.934 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.04 117.69 20.33 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -26.98 62.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.576 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.472 ' OE2' ' HE3' ' A' ' 23' ' ' LYS . 35.3 mt-10 -67.58 97.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.304 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 70.65 35.65 67.26 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.741 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.6 t90 -52.92 102.71 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.969 0.908 . . . . 0.0 110.304 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.24 113.14 26.48 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.02 -25.02 0.25 Allowed Glycine 0 CA--C 1.539 1.575 0 N-CA-C 119.999 2.76 . . . . 0.0 119.999 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.13 114.93 21.0 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 119.019 1.41 . . . . 0.0 110.74 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.99 132.36 42.32 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.482 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.241 174.875 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.76 81.22 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -76.79 -10.87 59.68 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.887 0.475 . . . . 0.0 111.498 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -65.44 109.27 2.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 69.3 10.86 7.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.014 0.926 . . . . 0.0 113.025 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -122.15 79.43 1.59 Allowed 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -114.13 161.11 18.18 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -78.55 77.52 5.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.735 0.779 . . . . 0.0 108.954 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -147.03 97.45 2.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.685 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -141.87 155.68 45.53 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 m -90.88 -21.31 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m 70.19 -49.48 0.64 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.637 1.575 . . . . 0.0 114.677 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.16 101.1 2.47 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -136.05 108.18 7.22 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 123.038 0.535 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.14 119.27 76.51 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 172.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.24 -28.15 64.15 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.232 1.955 . . . . 0.0 112.908 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -131.39 83.37 2.1 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.394 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 90.01 1.65 Allowed Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.124 -2.391 . . . . 0.0 107.124 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.5 m -139.6 94.13 2.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 65.44 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.82 134.07 36.56 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 169.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 t -81.13 120.28 32.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.929 0.395 . . . . 0.0 110.33 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -98.2 127.9 44.38 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.41 141.89 44.37 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.429 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -124.47 143.49 50.62 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.5 111.14 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -92.06 132.39 36.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.409 0.624 . . . . 0.0 110.952 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HE2' ' OXT' ' A' ' 215' ' ' LEU . 0.4 OUTLIER -148.77 156.45 42.37 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 103.193 -2.892 . . . . 0.0 103.193 177.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -94.64 131.38 41.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.9 ptp -70.2 173.57 6.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.833 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 77.44 112.42 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.273 1.829 . . . . 0.0 112.375 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.91 -16.83 34.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.624 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -13.62 43.16 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB1' HE22 ' A' ' 82' ' ' GLN . . . -68.93 -35.76 77.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 90.65 145.45 13.95 Favored Glycine 0 N--CA 1.401 -3.684 0 CA-C-N 113.775 -1.557 . . . . 0.0 114.754 171.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.446 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 21.9 m-85 -95.92 166.08 11.96 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 113.436 -1.382 . . . . 0.0 107.863 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.1 mt -78.3 101.34 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 162.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -62.59 -51.66 66.45 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 124.504 1.127 . . . . 0.0 112.234 -169.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.6 176.14 8.7 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 46' ' ' THR . 9.6 mp -60.68 126.94 86.3 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 36.7 Cg_endo -73.68 167.7 26.62 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.079 2.519 . . . . 0.0 112.284 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.6 112.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 124.28 1.032 . . . . 0.0 112.712 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.68 66.98 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 115.691 1.037 . . . . 0.0 115.691 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 81.1 p -85.94 146.94 44.38 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 118.204 1.002 . . . . 0.0 113.213 -176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.38 166.36 15.28 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.913 3.075 . . . . 0.0 111.741 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.44 ' HA ' HD21 ' A' ' 40' ' ' LEU . 35.9 p -56.85 155.16 8.23 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.39 -56.06 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 127.925 2.49 . . . . 0.0 112.915 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -85.86 -19.67 30.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.495 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -84.17 -17.14 40.97 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 30.3 m-85 -45.18 -40.53 7.27 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 12.4 m170 -128.98 20.71 5.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 111.396 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.95 102.57 14.93 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.49 -2.93 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.464 1.345 . . . . 0.0 116.464 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.83 160.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.097 0.949 . . . . 0.0 113.219 -173.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -98.12 134.53 41.06 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.67 -10.78 55.32 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.84 63.03 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.13 -17.88 28.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.58 -21.24 9.25 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 58.4 t80 -105.92 138.8 19.75 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 123.29 11.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.029 1.82 . . . . 0.0 112.572 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.46 122.69 44.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.57 75.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.63 -165.92 29.5 Favored Glycine 0 CA--C 1.502 -0.736 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.319 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mt-10 -117.93 130.09 56.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 35.6 m -126.78 160.93 34.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 p -142.33 150.02 40.23 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.959 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -75.27 107.33 7.3 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.2 p -49.29 131.03 20.12 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 124.881 1.363 . . . . 0.0 112.792 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -81.64 50.9 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.15 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -76.83 -24.6 52.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -134.17 91.4 23.52 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.296 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.53 145.85 38.27 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.849 2.366 . . . . 0.0 111.089 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.9 t70 70.14 15.59 7.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.482 1.134 . . . . 0.0 110.656 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 61.5 t30 -77.03 152.13 35.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.272 20.4 mmt180 -69.17 -174.17 0.61 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 -164.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.47 -172.75 4.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.861 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.71 150.7 22.48 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.389 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -114.63 -159.89 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.441 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.31 -37.42 85.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.481 0.582 . . . . 0.0 111.099 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -126.36 157.14 39.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.412 HE22 ' HB1' ' A' ' 34' ' ' ALA . 34.9 tp60 -141.53 136.41 15.55 Favored Pre-proline 0 C--O 1.26 1.636 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.87 178.12 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.441 2.094 . . . . 0.0 113.441 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.9 p30 -160.98 173.98 14.47 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.2 mm -90.54 -14.59 8.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.907 0.86 . . . . 0.0 109.849 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -94.67 -151.75 0.33 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.372 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 2.1 m -102.58 0.91 34.12 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.481 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 4.0 p-10 -92.62 167.31 12.0 Favored 'General case' 0 C--O 1.201 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 112.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.71 141.64 51.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 126' ' ' TYR . 40.4 tp -112.66 126.4 55.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.72 141.45 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -79.53 172.57 13.61 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.353 0.261 . . . . 0.0 110.61 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.93 93.41 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -64.08 -47.22 80.91 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 122.762 0.425 . . . . 0.0 112.003 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.36 -28.74 66.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -56.99 -47.56 80.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.944 0.497 . . . . 0.0 110.442 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.8 -28.75 68.63 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.795 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.51 -54.19 46.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.33 -43.88 87.17 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.53 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -66.12 -35.01 79.35 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -68.24 -21.75 64.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.024 0.44 . . . . 0.0 111.441 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.497 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -86.29 -2.8 58.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.811 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.44 37.17 85.4 Favored Glycine 0 N--CA 1.438 -1.18 0 O-C-N 123.952 0.782 . . . . 0.0 112.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.17 116.67 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.375 0.607 . . . . 0.0 109.628 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -88.01 157.77 18.81 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.205 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 78.0 15.48 1.46 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.903 0.881 . . . . 0.0 112.243 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.18 114.98 29.44 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 7.1 tp10 -105.73 140.77 38.27 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.43 ' CH2' HD12 ' A' ' 129' ' ' LEU . 43.8 m95 -116.87 121.94 42.93 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.804 0.842 . . . . 0.0 109.7 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -113.43 109.13 51.47 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.597 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.48 137.1 16.24 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 122.54 2.16 . . . . 0.0 113.407 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 172.27 2.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.401 1.08 . . . . 0.0 109.586 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.502 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -103.16 116.51 32.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 126' ' ' TYR . 22.1 mt -107.53 142.69 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.186 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -118.38 135.35 54.38 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.623 1.169 . . . . 0.0 108.128 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.9 p30 -86.19 -162.29 0.73 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.1 m80 -74.4 -12.61 60.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.384 1.074 . . . . 0.0 111.815 -174.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.51 -19.48 29.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.07 1.29 63.04 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.174 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -89.65 154.77 19.71 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.748 -0.266 . . . . 0.0 110.412 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.57 126.17 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 116' ' ' ASP . 11.3 p -129.81 -32.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.921 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.95 73.14 0.47 Allowed Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.491 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.08 -0.99 9.76 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 CA-C-N 119.673 1.736 . . . . 0.0 109.746 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.61 -12.19 17.92 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.203 1.401 . . . . 0.0 111.158 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.471 ' HB2' HD12 ' A' ' 114' ' ' ILE . 10.0 m-85 -92.57 149.26 21.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.539 0.685 . . . . 0.0 112.528 -172.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.39 143.02 49.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.368 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.23 120.38 27.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.564 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.0 tt -91.61 131.83 36.75 Favored 'General case' 0 C--O 1.259 1.573 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.405 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.567 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 7.9 p30 -124.42 140.96 52.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.217 174.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.43 141.05 32.72 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.573 0.546 . . . . 0.0 110.462 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.5 173.02 6.67 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 124.656 1.222 . . . . 0.0 108.412 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.72 17.18 73.6 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 132.89 33.97 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.295 0.569 . . . . 0.0 109.779 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -137.07 168.98 18.55 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.9 103.1 0.14 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.716 1.143 . . . . 0.0 111.27 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -88.66 -54.9 3.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.026 -1.897 . . . . 0.0 115.497 -163.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 179' ' ' LYS . 45.9 mt -51.22 113.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 124.366 1.041 . . . . 0.0 113.758 -169.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -70.93 107.07 3.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.517 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 46.7 mtt -91.3 8.84 34.05 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -85.84 -50.39 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -93.21 -4.9 51.17 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.484 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 61.0 p -91.74 151.02 20.82 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.995 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.58 97.81 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -147.78 163.42 36.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.16 140.79 49.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.506 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.16 155.65 20.66 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.998 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.321 34.6 t70 96.0 95.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.455 2.302 . . . . 0.0 115.783 174.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.0 m -100.57 -56.16 2.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 167.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -128.33 -41.05 1.58 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.063 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 47.8 mt-10 -125.83 -179.08 4.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.058 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -71.71 -44.23 64.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 124.201 0.938 . . . . 0.0 111.07 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -82.91 26.01 0.63 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.894 0.854 . . . . 0.0 112.241 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -113.21 122.05 46.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.28 116.17 21.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -84.02 -61.55 1.83 Allowed Glycine 0 CA--C 1.493 -1.315 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -111.02 132.86 53.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.2 mp -119.8 113.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -89.34 -39.19 13.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.614 -0.835 . . . . 0.0 109.994 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.19 117.4 3.5 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.173 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.36 145.08 26.48 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.95 146.02 47.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HG ' ' OE2' ' A' ' 208' ' ' GLU . 93.8 mt -53.78 136.55 39.83 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.512 1.133 . . . . 0.0 112.559 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.618 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 41.0 p-10 -96.5 10.44 38.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.166 -177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.2 p -68.19 -5.16 16.65 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.938 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.8 m -61.14 -40.53 94.17 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.147 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.52 -33.68 6.31 Favored 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.255 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.26 151.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -44.41 117.61 2.97 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.046 0.938 . . . . 0.0 110.934 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.34 -16.04 39.04 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.461 2.107 . . . . 0.0 111.856 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.62 11.43 31.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.496 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.04 143.38 39.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -95.99 -28.95 14.41 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.444 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -143.75 124.57 14.24 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.35 178.23 10.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.61 163.25 40.31 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.138 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.456 ' SG ' HD22 ' A' ' 183' ' ' LEU . 71.2 m -83.3 149.93 26.46 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.125 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.5 p -81.44 -51.51 8.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.408 ' HB2' HD12 ' A' ' 138' ' ' ILE . 83.7 mttt -89.5 20.65 3.8 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 8.4 tp10 -145.92 134.32 21.9 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 171.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' SER . 15.3 mmt180 -89.96 -33.16 16.49 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 123.821 0.701 . . . . 0.0 112.386 -168.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -91.67 -12.11 35.03 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.971 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.456 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.5 tt -86.68 109.13 18.99 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.433 0.635 . . . . 0.0 110.401 -173.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.19 129.06 75.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.7 121.54 43.8 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.801 0.81 . . . . 0.0 111.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 48.7 pt -111.29 147.77 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.007 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.35 150.11 38.51 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.15 -39.2 27.99 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.52 -30.28 69.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 111.73 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.497 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.7 t -66.4 -49.48 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.999 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.568 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 17.1 p80 -70.87 -29.73 65.92 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.085 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -59.35 -34.84 72.86 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.37 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.38 61.65 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 19.2 m-30 -68.98 -34.55 75.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.696 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 39.5 mt-10 -65.48 -49.11 70.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.493 0.717 . . . . 0.0 111.146 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -69.92 -29.89 67.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.48 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 109.897 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 78.72 45.22 9.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.661 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.9 mt -81.4 154.14 26.58 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 27.5 p -101.45 129.82 47.56 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.69 71.71 0.75 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.756 -0.657 . . . . 0.0 114.582 172.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 14.9 m-85 -124.7 145.77 49.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.061 0.93 . . . . 0.0 112.666 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -144.0 121.94 12.04 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.03 128.9 69.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 69.2 m-85 -120.46 137.97 54.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.06 111.03 3.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.22 86.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.526 0.516 . . . . 0.0 112.175 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.462 ' OE2' ' HG ' ' A' ' 163' ' ' LEU . 30.1 mm-40 -68.07 100.61 1.02 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.345 0.593 . . . . 0.0 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.56 32.85 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.066 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.66 104.64 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.967 . . . . 0.0 110.129 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.91 103.78 13.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -173.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -7.41 2.96 Favored Glycine 0 N--CA 1.471 1.005 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.14 117.46 23.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.548 1.174 . . . . 0.0 110.552 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.99 125.79 29.78 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.3 pt? . . . . . 0 C--N 1.31 -1.112 0 O-C-N 124.263 0.977 . . . . 0.0 112.313 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 C--O 1.243 0.719 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.12 101.89 0.23 Allowed Glycine 0 C--O 1.239 0.406 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.426 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 p -110.93 177.92 4.51 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -110.74 30.6 6.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.596 0.712 . . . . 0.0 110.543 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -71.76 -16.95 62.21 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -70.64 -29.6 66.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.2 m80 59.8 41.54 17.99 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.305 1.042 . . . . 0.0 112.674 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -81.37 65.92 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.158 0.98 . . . . 0.0 109.581 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -133.85 0.21 3.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.228 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.21 127.43 21.11 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -176.56 107.65 0.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.7 t -111.65 -48.71 3.05 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.83 -76.23 0.81 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt 66.86 -69.96 0.12 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.225 1.41 . . . . 0.0 113.95 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.91 115.75 65.41 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.03 -56.97 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.217 1.944 . . . . 0.0 111.228 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -130.19 -55.78 1.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.56 -166.75 20.98 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -108.67 13.51 25.09 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.765 0.793 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -82.07 0.77 38.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.788 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.3 ttp -48.54 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.746 1.219 . . . . 0.0 114.001 -169.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.96 118.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' OE2' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -112.04 155.8 23.22 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -114.57 142.78 45.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.253 0.549 . . . . 0.0 111.128 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 83.9 m-85 -125.11 147.38 49.04 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.772 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 85.9 t -80.74 123.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -91.94 133.67 35.48 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.502 0.668 . . . . 0.0 110.733 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -150.18 151.35 32.94 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.22 121.35 45.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 26.9 ttt -79.23 81.29 5.51 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.299 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 178.74 111.72 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 124.734 1.271 . . . . 0.0 108.41 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.47 -23.54 25.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 47.0 mt-10 -82.54 -4.11 57.06 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.055 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -62.39 -35.33 78.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 97.0 92.62 1.87 Allowed Glycine 0 N--CA 1.397 -3.96 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.755 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.09 141.01 57.74 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -70.85 101.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 169.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' OE2' ' HD2' ' A' ' 73' ' ' PRO . 26.5 mt-10 -78.2 -33.99 49.72 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.274 0.559 . . . . 0.0 111.411 -170.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -122.41 161.77 22.86 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.9 124.97 91.91 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 122.618 0.367 . . . . 0.0 111.874 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.74 168.98 21.56 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.075 2.516 . . . . 0.0 111.417 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -39.8 118.85 0.91 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.234 1.413 . . . . 0.0 113.303 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 13.53 83.15 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 48.8 m -85.51 138.52 35.97 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 44' ' ' SER . 15.8 Cg_exo -67.57 166.71 23.04 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.513 3.475 . . . . 0.0 111.037 173.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -60.01 145.92 44.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -38.09 -53.78 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 127.171 2.188 . . . . 0.0 114.121 -174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.437 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 56.5 p-90 -85.77 -23.18 27.37 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.582 -173.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 48.6 tptt -86.93 -11.77 49.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.979 -171.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 88' ' ' ASN . 20.9 m-85 -43.28 -51.46 6.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.079 0.862 . . . . 0.0 112.743 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.493 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.0 m-70 -128.43 32.45 4.85 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.339 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.2 tm-20 -92.38 101.24 13.71 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.67 -10.65 12.18 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.6 169.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.944 1.872 . . . . 0.0 114.108 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -98.28 160.16 14.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.362 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.441 HD22 ' HG2' ' A' ' 45' ' ' PRO . 81.9 mt -112.76 14.42 19.94 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.3 -22.9 64.7 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.683 0.754 . . . . 0.0 110.434 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -88.95 -20.8 24.03 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.555 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.6 -22.95 12.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.58 140.78 23.51 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 122.41 9.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.914 1.743 . . . . 0.0 112.095 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.443 HG22 HD22 ' A' ' 110' ' ' LEU . 47.9 t -96.72 123.7 49.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.14 24.32 52.36 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.707 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -107.09 -168.3 22.22 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.406 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.7 mt-10 -123.56 128.25 49.46 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.36 174.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 p -146.39 151.98 38.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.05 113.97 8.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 p -64.8 118.83 9.56 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-O 122.013 0.911 . . . . 0.0 111.551 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -85.59 74.44 10.29 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 2.6 t30 -74.56 -39.74 62.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.561 ' HB3' ' HD3' ' A' ' 73' ' ' PRO 0.257 41.2 t80 -159.71 -63.68 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.953 171.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 72' ' ' TYR . 12.5 Cg_exo -73.45 121.59 7.26 Favored 'Trans proline' 0 C--N 1.373 1.832 0 CA-C-N 121.302 1.501 . . . . 0.0 109.7 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.78 -41.85 64.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.256 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 9.3 m120 65.3 -162.12 0.26 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HG2' ' HB3' ' A' ' 33' ' ' GLU . 16.6 mmt180 -90.26 -164.32 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.849 0.833 . . . . 0.0 112.075 -174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.5 -170.43 2.94 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 125.614 1.566 . . . . 0.0 110.392 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -88.17 149.54 23.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.296 0.57 . . . . 0.0 111.621 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -120.9 -165.31 1.2 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -66.09 -44.08 85.41 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.924 0.784 . . . . 0.0 111.24 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -113.53 142.25 46.17 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.853 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 15.2 mm100 -128.4 128.62 23.62 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.592 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 82' ' ' GLN . 57.1 Cg_endo -91.42 175.6 2.26 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.892 2.395 . . . . 0.0 113.108 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -163.54 172.16 14.8 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.099 0.959 . . . . 0.0 108.419 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.94 -16.94 9.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.975 0.893 . . . . 0.0 109.723 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -85.48 -164.04 0.95 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.811 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.424 ' CB ' HH21 ' A' ' 176' ' ' ARG . 26.4 p -122.08 54.1 1.19 Allowed 'General case' 0 C--O 1.252 1.205 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 2.6 t30 -137.39 153.42 50.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -109.66 141.96 41.5 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.7 tp -108.33 125.9 52.23 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 129' ' ' LEU . 47.1 t -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.625 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.5 p -74.48 172.44 11.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.634 0.774 . . . . 0.0 110.626 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.07 -37.65 94.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.556 -0.354 . . . . 0.0 112.655 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -61.39 -52.63 63.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.783 0.801 . . . . 0.0 109.71 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.35 -32.76 73.92 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.42 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.34 -39.97 84.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.233 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 8.9 mmpt? -64.69 -38.73 91.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.672 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.22 -52.99 62.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.054 0.454 . . . . 0.0 110.296 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.4 mt -61.54 -43.55 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.109 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.39 -41.34 85.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -70.29 -25.28 63.26 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.35 -21.23 59.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.91 47.82 6.06 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.9 t -74.02 101.24 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.616 0.722 . . . . 0.0 109.588 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 m -70.05 147.1 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.965 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 79.45 9.14 1.65 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.362 1.065 . . . . 0.0 111.999 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.58 114.71 29.16 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 8.7 tp10 -111.75 146.85 36.84 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -116.6 120.91 40.18 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.039 0.136 . . . . 0.0 111.092 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.443 HD22 HG22 ' A' ' 62' ' ' VAL . 50.7 mt -106.2 101.98 37.55 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 173.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.17 132.4 12.61 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.666 2.244 . . . . 0.0 112.814 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 64' ' ' GLY . 5.0 m -144.64 170.27 7.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.581 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.79 116.55 32.8 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.8 mt -109.82 133.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.496 0.665 . . . . 0.0 112.409 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HG2' HG22 ' A' ' 121' ' ' VAL . 66.1 mttt -95.6 143.67 26.7 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 174.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.522 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -83.22 -160.7 0.44 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.461 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 35.5 m80 -70.15 -30.87 68.14 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.768 0.827 . . . . 0.0 110.137 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -81.78 -19.98 40.12 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.7 14.88 33.29 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.119 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 17.9 ptpt -95.36 140.51 30.13 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.46 HG22 ' HG2' ' A' ' 115' ' ' LYS . 48.7 t -77.94 89.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.571 0.701 . . . . 0.0 110.024 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.38 11.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.614 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -126.1 54.43 0.76 Allowed Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.669 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.71 -17.44 5.04 Favored 'Trans proline' 0 C--N 1.368 1.594 0 CA-C-N 120.629 2.215 . . . . 0.0 112.342 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.71 7.65 44.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.199 0.523 . . . . 0.0 110.346 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.416 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 5.8 m-85 -95.1 144.32 25.84 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 121.515 0.674 . . . . 0.0 110.601 -177.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -133.58 141.63 47.77 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.023 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.413 ' HB3' ' ND2' ' A' ' 88' ' ' ASN . 55.5 m-85 -80.75 119.76 23.76 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 91' ' ' VAL . 3.9 tt -86.45 121.25 28.74 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 12.3 m120 -97.91 125.81 43.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.08 121.71 42.29 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.401 0.438 . . . . 0.0 110.02 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.66 172.9 6.55 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.855 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 20.29 65.33 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.278 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.03 40.61 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.61 169.32 17.86 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -53.71 104.96 0.11 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -131.58 -27.34 1.94 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 -164.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 179' ' ' LYS . 24.3 mt -63.01 122.86 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.533 1.06 . . . . 0.0 110.874 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.43 107.74 7.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.787 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -77.32 -9.44 58.83 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -70.33 -50.06 43.0 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.436 0.636 . . . . 0.0 109.759 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.69 -2.5 35.21 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.307 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.8 p -99.88 142.38 31.43 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.489 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 14.7 mm-40 -122.61 107.5 12.04 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -161.71 161.28 29.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.747 0.308 . . . . 0.0 111.681 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 59.5 mm-40 -125.46 142.07 51.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 58.7 mtt -100.43 108.32 20.28 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.67 7.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.7 p -72.67 -56.67 4.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.204 -0.599 . . . . 0.0 112.051 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -117.82 -39.23 3.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.687 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 153' ' ' ASP . 10.4 pt-20 -158.24 -176.34 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -68.93 -13.3 62.35 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -114.6 23.24 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.215 0.531 . . . . 0.0 112.15 -179.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 180' ' ' GLU . 21.8 mm-40 -129.37 120.81 26.2 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 72.1 mt -72.91 133.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.061 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -115.79 -70.6 0.47 Allowed Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 8.2 t30 -79.17 122.14 25.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.2 mt -126.91 106.85 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 33.9 t70 -90.25 -44.74 9.52 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.791 0.805 . . . . 0.0 109.088 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.66 110.88 3.92 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.797 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.32 125.64 39.09 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.66 146.87 27.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.0 140.02 57.7 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.867 0.842 . . . . 0.0 112.484 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.4 p-10 -94.46 6.64 48.17 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.46 -5.5 19.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.632 1.173 . . . . 0.0 109.866 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -62.0 -39.49 92.39 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.651 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.24 -31.84 6.72 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.697 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 64.5 mt -83.16 150.62 4.18 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -60.95 120.19 51.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 118.208 0.458 . . . . 0.0 109.96 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.97 -16.35 45.12 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.405 2.07 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.56 -6.15 58.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.19 127.35 32.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.12 -33.36 71.74 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.547 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.7 ttt -151.1 130.08 12.55 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -153.79 -178.72 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.136 0.574 . . . . 0.0 109.585 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.424 HH21 ' CB ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -136.76 145.68 44.89 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.52 152.63 40.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.835 0.709 . . . . 0.0 110.374 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -81.94 -45.36 15.51 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.4 mmpt? -73.45 -20.01 60.81 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.553 -173.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.405 ' HG2' ' CG1' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.68 134.8 52.75 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 175.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.437 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 52.1 mmt-85 -89.59 -36.59 15.22 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -85.77 -19.83 30.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.173 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.9 100.64 2.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.962 0.887 . . . . 0.0 110.914 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.75 124.95 62.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 57.7 mt -112.14 133.67 54.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.45 0.643 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.547 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.4 pt -121.87 159.48 24.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.176 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -86.15 161.43 18.86 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.775 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -49.0 -47.71 44.19 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.994 1.718 . . . . 0.0 109.717 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.12 -45.75 22.59 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.997 2.119 . . . . 0.0 113.525 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -46.42 75.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.605 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 11.5 p80 -77.35 -21.6 53.08 Favored 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.006 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.86 81.63 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.31 -40.82 94.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.71 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 191' ' ' HIS . 22.7 m-85 -65.91 -37.62 86.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.09 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.7 mm-40 -55.36 -51.51 66.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.651 0.78 . . . . 0.0 109.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.62 -10.65 59.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.504 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.01 -27.88 20.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.48 62.91 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.946 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 61.0 mt -84.5 160.28 20.55 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.1 p -94.65 121.75 36.53 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 105.3 63.82 0.64 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.796 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 46.2 m-85 -127.14 135.06 50.18 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 117.938 0.869 . . . . 0.0 112.782 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 50.9 tptt -144.02 121.54 11.75 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.2 m -126.11 129.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.5 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.42 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 72.0 m-85 -110.62 165.02 12.15 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -68.64 122.96 19.61 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.37 -35.64 35.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 23' ' ' LYS . 14.7 mt-10 -75.14 97.85 3.56 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.447 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.06 35.37 34.8 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.678 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.523 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 9.9 t90 -55.21 106.61 0.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.131 0.972 . . . . 0.0 109.712 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -103.23 99.02 8.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.55 15.22 68.18 Favored Glycine 0 N--CA 1.47 0.965 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.523 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 95.5 mt -93.97 156.38 16.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.167 0.984 . . . . 0.0 110.991 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.81 131.64 48.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.065 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.051 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.99 -19.06 7.88 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.631 -1.271 . . . . 0.0 114.67 -174.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -84.96 -7.71 59.04 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.898 0.849 . . . . 0.0 112.549 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 m -121.72 169.15 11.02 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -88.32 124.37 33.83 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -72.89 113.24 9.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -64.13 149.26 48.07 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.992 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -102.66 131.74 49.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -68.35 132.68 47.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -50.56 105.86 0.11 Allowed 'General case' 0 C--N 1.345 0.41 0 O-C-N 124.304 1.002 . . . . 0.0 109.105 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 t -81.94 136.43 35.3 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.026 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 m -82.83 89.49 6.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.04 87.18 0.45 Allowed Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.44 67.87 2.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 122.114 0.959 . . . . 0.0 112.014 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 40.7 t -93.79 -48.14 0.28 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.643 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 16.9 Cg_exo -69.53 110.39 2.5 Favored 'Trans proline' 0 C--N 1.396 3.072 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -78.86 119.14 21.62 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.886 0.85 . . . . 0.0 113.161 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.87 71.06 0.23 Allowed Glycine 0 N--CA 1.418 -2.554 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.181 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -65.42 -39.31 91.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -104.99 105.38 15.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.92 108.35 12.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.275 0.56 . . . . 0.0 111.049 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.77 145.78 18.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -107.2 144.78 33.47 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.694 0.283 . . . . 0.0 110.398 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -116.56 139.75 50.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.671 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.97 136.42 54.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 37.9 t -72.97 107.73 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -99.76 134.2 42.99 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.525 0.679 . . . . 0.0 112.453 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -151.1 165.36 34.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.97 141.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.71 82.76 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 162.27 137.1 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 127.637 2.375 . . . . 0.0 107.655 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -80.48 -29.29 37.39 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.011 0.91 . . . . 0.0 109.185 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 11.4 pt-20 -83.17 0.73 43.95 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.578 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -66.75 -20.69 66.01 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.895 0.379 . . . . 0.0 110.441 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 66.86 0.29 Allowed Glycine 1 N--CA 1.393 -4.208 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.574 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 19.1 m-85 -70.83 133.06 46.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.856 172.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.49 101.9 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 171.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -59.16 -41.77 89.14 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.681 -171.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -148.0 173.39 12.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 46' ' ' THR . 5.8 mp -60.62 124.61 79.7 Favored Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 124.269 1.027 . . . . 0.0 113.333 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 167.76 25.65 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.803 2.335 . . . . 0.0 112.275 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -45.92 113.76 0.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.898 1.679 . . . . 0.0 112.761 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.61 7.72 87.06 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.522 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.33 132.18 45.87 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 117.21 0.505 . . . . 0.0 111.814 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' HG2' HD22 ' A' ' 56' ' ' LEU . 31.1 Cg_exo -61.42 165.64 12.76 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.693 2.929 . . . . 0.0 111.958 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.516 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.9 p -52.94 150.14 5.78 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -39.35 -54.91 1.82 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 127.991 2.516 . . . . 0.0 113.708 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.45 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 53.7 p-90 -83.52 -24.3 31.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.151 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HE3' HD12 ' A' ' 54' ' ' ILE . 51.5 tptt -85.41 -12.82 51.11 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.524 -172.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -45.11 -43.94 10.13 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -128.96 25.24 5.6 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -92.96 100.9 13.26 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 118.113 -1.435 . . . . 0.0 107.422 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.11 -9.58 3.92 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.475 HD12 ' HE3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -134.0 172.09 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 120.452 2.126 . . . . 0.0 113.752 -175.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.7 t -98.06 150.48 21.36 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.011 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.48 HD22 ' HG2' ' A' ' 45' ' ' PRO . 43.7 mt -98.33 -4.36 35.14 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.02 47.23 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -89.14 -22.41 22.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -101.2 -22.17 14.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -96.31 140.81 22.4 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.38 122.59 10.08 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.932 1.754 . . . . 0.0 110.913 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -101.45 119.3 49.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.05 16.86 66.39 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.436 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -96.29 -150.26 26.69 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.84 133.54 44.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.96 167.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -145.74 154.07 41.66 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.156 -0.34 . . . . 0.0 110.448 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 115.59 15.53 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 170.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.7 p -55.02 152.27 7.85 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.268 0.98 . . . . 0.0 112.755 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -81.95 19.38 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.297 1.039 . . . . 0.0 110.41 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.3 -37.74 81.48 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -134.83 103.8 10.86 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.85 171.19 14.6 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.343 2.029 . . . . 0.0 111.466 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t0 56.01 81.4 0.12 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.957 1.703 . . . . 0.0 111.536 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 48.6 t-20 -157.75 159.64 37.02 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 33' ' ' GLU . 10.6 mmt180 -83.51 -165.37 1.09 Allowed 'General case' 0 C--O 1.262 1.762 0 CA-C-O 122.013 0.911 . . . . 0.0 112.844 -168.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.27 -160.83 0.73 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.637 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 mp -92.89 138.75 31.21 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.114 0.483 . . . . 0.0 111.768 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 2.4 m-30 -108.23 -155.93 0.57 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.957 1.703 . . . . 0.0 108.432 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -64.21 -49.54 71.57 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.515 0.674 . . . . 0.0 110.381 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.15 139.3 53.48 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.825 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 14.3 mm100 -107.39 119.0 52.16 Favored Pre-proline 0 N--CA 1.431 -1.387 0 O-C-N 123.745 0.653 . . . . 0.0 111.309 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 90.6 Cg_endo -84.08 168.12 12.17 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 122.713 2.275 . . . . 0.0 111.259 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -159.35 169.79 23.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.18 -7.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 124.103 0.877 . . . . 0.0 110.286 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -98.99 -168.56 1.64 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.333 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 p -101.97 21.95 13.86 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -173.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -116.43 162.97 16.74 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.541 -0.724 . . . . 0.0 109.316 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.3 tp -123.49 141.7 51.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.968 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 54.1 tp -114.47 127.14 55.66 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 129' ' ' LEU . 47.0 t -126.92 144.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.76 -172.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -76.55 168.77 19.48 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.58 0.352 . . . . 0.0 110.173 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.83 -36.08 90.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -65.2 -45.27 85.48 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -30.38 64.3 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.387 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -58.78 -45.09 90.59 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -57.48 -42.16 82.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.057 0.848 . . . . 0.0 110.617 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.72 -54.26 48.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.354 0.409 . . . . 0.0 110.887 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.14 -41.4 86.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 C-N-CA 123.513 0.725 . . . . 0.0 111.818 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.99 -34.29 75.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.626 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -68.01 -27.55 66.65 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.966 0.412 . . . . 0.0 111.027 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.2 -7.34 59.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.608 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.84 42.73 98.35 Favored Glycine 0 N--CA 1.441 -0.98 0 O-C-N 123.563 0.539 . . . . 0.0 112.321 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -72.07 112.61 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -79.86 155.37 27.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 75.69 15.17 2.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.96 1.304 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.3 113.85 25.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.2 tp10 -109.35 138.7 45.32 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.483 ' CZ3' ' HG ' ' A' ' 129' ' ' LEU . 59.7 m95 -119.6 114.5 22.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.4 mt -110.73 96.59 29.21 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.76 146.23 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.336 2.024 . . . . 0.0 112.239 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 64' ' ' GLY . 2.5 m -149.73 169.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.714 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -90.74 115.35 27.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 126' ' ' TYR . 31.2 mt -108.49 126.55 65.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.49 0.662 . . . . 0.0 112.029 -173.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.64 ' HG2' HG22 ' A' ' 121' ' ' VAL . 90.5 mttt -99.49 136.15 39.85 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.665 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.8 p-10 -81.1 -160.47 0.33 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.866 0.365 . . . . 0.0 110.817 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.665 0.786 . . . . 0.0 110.028 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -79.88 -19.83 47.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.515 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.26 38.17 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.725 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.665 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.9 ptmt -93.92 133.48 37.3 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 115' ' ' LYS . 23.0 t -77.35 93.11 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.132 0.491 . . . . 0.0 109.738 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.408 HG23 HD13 ' A' ' 78' ' ' LEU . 18.9 m -120.31 11.89 6.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.547 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.27 51.8 0.82 Allowed Glycine 0 C--O 1.201 -1.943 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.393 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 90.6 Cg_endo -84.34 -1.97 9.87 Favored 'Trans proline' 0 C--N 1.368 1.584 0 CA-C-N 121.542 2.671 . . . . 0.0 112.209 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -113.54 7.26 17.37 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.591 1.186 . . . . 0.0 109.124 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.429 ' HB2' HD12 ' A' ' 114' ' ' ILE . 3.6 m-85 -93.98 137.31 33.32 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.842 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.8 139.94 53.08 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.693 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -79.45 115.41 19.06 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.483 ' HG ' ' CZ3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -87.28 119.9 28.01 Favored 'General case' 0 C--O 1.274 2.369 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -176.081 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.539 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -101.67 122.07 43.2 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 129' ' ' LEU . 3.5 mm? -96.51 113.25 24.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.14 173.42 7.03 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 124.21 0.944 . . . . 0.0 109.5 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.27 63.86 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.113 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.65 130.94 34.61 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -148.09 100.26 3.15 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.081 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.472 ' O ' ' HE2' ' A' ' 179' ' ' LYS . 16.9 t70 72.41 -48.53 0.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.138 1.775 . . . . 0.0 111.614 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 67.49 -95.82 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 179' ' ' LYS . 28.6 mt -65.15 123.19 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -166.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.1 129.18 37.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.335 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 51.5 ttm -107.43 1.01 23.28 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.487 0.661 . . . . 0.0 110.932 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.3 -49.21 7.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.684 0.754 . . . . 0.0 110.93 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -99.4 10.91 40.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.242 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.7 p -114.44 162.58 16.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -160.27 160.33 32.46 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.407 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -123.53 132.99 54.05 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.82 0.848 . . . . 0.0 109.525 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 57.5 mtt -92.64 126.3 37.66 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.927 0.491 . . . . 0.0 109.986 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -164.36 -26.23 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -168.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HA2' ' A' ' 156' ' ' GLY . 50.0 m -56.59 -55.9 28.16 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 90.6 mt -135.96 -80.71 0.41 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.035 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.95 178.02 5.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -60.33 -34.24 73.54 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-O 120.98 0.419 . . . . 0.0 110.236 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.64 26.54 1.99 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.83 0.824 . . . . 0.0 111.503 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 149' ' ' SER . 38.7 mm-40 -116.99 115.04 24.67 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.747 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 51.5 mt -81.12 121.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.018 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.488 ' HA2' ' OG ' ' A' ' 149' ' ' SER . . . -88.47 -45.31 5.0 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.92 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -124.08 125.41 44.46 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mp -116.89 122.34 69.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -99.34 -51.18 3.87 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.55 0.69 . . . . 0.0 109.886 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.49 110.52 5.94 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.7 124.13 33.81 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -95.23 146.47 24.31 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.02 141.47 58.76 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.864 0.84 . . . . 0.0 112.59 -173.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -85.9 -2.04 57.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.279 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.7 p -68.89 -5.72 22.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.642 1.177 . . . . 0.0 110.01 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.8 m -65.15 -35.08 79.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.19 -30.51 7.43 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.36 144.99 7.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -59.2 120.9 51.67 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.13 0.572 . . . . 0.0 110.817 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 -5.78 16.89 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.426 2.751 . . . . 0.0 114.269 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.91 -3.38 57.37 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.134 -0.354 . . . . 0.0 110.811 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.65 137.39 38.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -90.93 -25.18 19.91 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 91.4 mtp -140.84 131.05 24.89 Favored 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -153.43 153.29 32.23 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.477 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.716 ' CZ ' HG23 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -113.03 143.88 43.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.425 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 39.9 m -88.13 131.98 34.5 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.4 0.438 . . . . 0.0 110.302 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.2 p -81.97 -9.35 59.6 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.5 mmtt -99.04 0.61 44.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.372 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -157.01 143.46 18.2 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.45 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 19.6 mmt180 -90.28 -25.89 20.3 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.615 0.245 . . . . 0.0 111.488 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 182' ' ' ARG . 54.3 mtt180 -78.19 -38.06 44.22 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.425 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 18.9 tp -69.62 100.7 1.5 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 123.247 1.499 . . . . 0.0 113.94 -168.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.716 HG23 ' CZ ' ' A' ' 176' ' ' ARG . 19.8 mt -113.53 116.1 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 112.296 -2.229 . . . . 0.0 106.597 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.25 131.93 54.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 121.833 0.825 . . . . 0.0 113.001 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.99 155.89 24.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.305 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -80.14 156.77 26.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.74 -37.32 70.85 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -57.17 -37.72 72.54 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.94 0.896 . . . . 0.0 111.062 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.33 -51.19 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.938 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.8 p80 -72.47 -26.7 61.9 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.24 -35.68 77.91 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.136 0.494 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.45 -33.78 69.66 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -71.22 -33.03 69.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.097 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 54.1 mm-40 -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.07 -7.43 58.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.007 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.95 24.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 77.99 47.42 8.5 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.779 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.52 165.48 18.02 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.283 20.0 p -67.34 -87.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -169.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.68 124.93 2.01 Favored Glycine 0 CA--C 1.492 -1.384 0 C-N-CA 119.443 -1.36 . . . . 0.0 112.676 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.35 162.82 29.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -108.84 138.51 45.06 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.47 129.35 35.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 124.662 1.226 . . . . 0.0 109.278 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.423 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 74.0 m-85 -125.4 143.12 51.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 115.52 9.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.58 75.82 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.89 96.8 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.987 0.804 . . . . 0.0 109.505 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.79 32.19 41.66 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.982 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -57.73 112.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.559 0.744 . . . . 0.0 110.061 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -102.15 74.99 1.47 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.6 14.57 65.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 116.924 1.53 . . . . 0.0 116.924 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.53 114.76 16.69 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 118.585 1.193 . . . . 0.0 110.341 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -68.37 133.01 48.05 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.191 0.996 . . . . 0.0 110.388 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 5.5 mp . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.92 31.49 8.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.64 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -144.16 101.9 3.79 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.5 t -134.82 153.3 52.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.139 0.495 . . . . 0.0 109.831 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -137.5 88.65 2.36 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.94 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -106.55 -3.4 20.83 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.249 0.547 . . . . 0.0 110.167 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -95.63 87.43 4.71 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.136 0.493 . . . . 0.0 110.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -120.19 82.38 1.89 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -125.68 110.58 13.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -99.79 107.3 19.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.631 0.729 . . . . 0.0 111.327 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 p -95.2 44.28 1.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 123.993 0.917 . . . . 0.0 109.313 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 m 68.39 85.25 0.14 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.444 1.098 . . . . 0.0 109.733 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.97 101.84 2.41 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -78.08 -40.44 38.46 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.914 0.387 . . . . 0.0 110.045 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.479 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 60.2 t -77.52 -56.64 1.14 Allowed Pre-proline 0 CA--C 1.56 1.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.83 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 33.2 Cg_endo -93.96 49.31 0.31 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.888 1.726 . . . . 0.0 111.221 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -67.31 115.61 7.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.151 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.15 -83.97 1.64 Allowed Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.5 p -171.91 154.25 3.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -85.78 130.48 34.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -73.27 105.07 4.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.1 130.12 36.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.103 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.478 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.6 ptmt -96.45 139.07 33.09 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.21 0.529 . . . . 0.0 109.84 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -121.03 142.66 49.6 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.737 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 64.8 m-85 -119.84 143.43 47.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.667 0.746 . . . . 0.0 112.926 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.27 112.92 16.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -94.68 127.64 40.8 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HG2' ' HD2' ' A' ' 203' ' ' LYS . 22.4 tptm -150.2 139.35 21.17 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 t -88.55 142.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.4 mtt -86.4 75.88 9.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.469 0.652 . . . . 0.0 109.819 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.16 112.47 2.04 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -128.72 -50.88 1.25 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.172 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -1.4 57.1 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.27 1.033 . . . . 0.0 108.621 170.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 79' ' ' TYR . . . -106.14 27.67 8.41 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.263 2.225 . . . . 0.0 110.507 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.585 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 124.45 68.63 0.2 Allowed Glycine 0 N--CA 1.421 -2.352 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -94.66 131.66 40.21 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 166.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -83.01 106.92 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 101.814 -3.402 . . . . 0.0 101.814 162.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -76.87 -50.49 13.25 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.282 0.563 . . . . 0.0 111.126 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -116.08 166.25 12.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.672 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.15 134.61 94.86 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 123.682 0.614 . . . . 0.0 111.641 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.91 162.64 41.94 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.675 2.25 . . . . 0.0 112.282 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -64.24 119.16 9.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.95 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.5 3.58 66.69 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.546 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 m -85.61 146.41 44.04 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.21 166.79 17.98 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 0.0 111.504 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.9 p -59.59 161.29 6.16 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.91 -52.17 35.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.204 1.402 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.403 ' CH2' ' HE2' ' A' ' 49' ' ' LYS . 9.0 p-90 -72.12 -32.96 67.45 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HE2' ' CH2' ' A' ' 48' ' ' TRP . 4.8 mptp? -65.67 -23.65 66.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.543 ' HA ' HD21 ' A' ' 56' ' ' LEU . 72.4 m-85 -60.66 -21.36 62.72 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.029 0.442 . . . . 0.0 111.548 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 11.6 m80 -127.15 -10.38 5.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.33 102.3 14.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.129 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 178' ' ' THR . . . 57.43 -10.97 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 N-CA-C 121.867 3.507 . . . . 0.0 121.867 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 173.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.651 2.726 . . . . 0.0 112.667 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -91.2 142.8 27.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 50' ' ' PHE . 62.3 mt -91.66 -4.68 54.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.125 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.65 -33.79 71.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.87 -5.3 58.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -111.89 -21.33 11.66 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -102.0 137.31 19.46 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.76 123.74 12.49 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.815 2.343 . . . . 0.0 112.347 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.5 114.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 17.13 57.2 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.23 -157.39 25.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.061 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.8 mt-10 -129.63 137.08 50.47 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.2 m -133.82 173.75 14.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 t -144.24 153.41 42.03 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.697 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -69.01 150.18 47.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 p -72.15 130.35 40.65 Favored 'General case' 0 C--N 1.276 -2.602 0 O-C-N 123.671 0.607 . . . . 0.0 109.6 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -85.83 73.72 10.31 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -105.09 -38.51 6.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -128.88 100.53 20.99 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.33 -18.36 49.98 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.425 2.75 . . . . 0.0 113.986 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.47 5.75 43.92 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 120.997 0.427 . . . . 0.0 112.092 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -77.51 127.21 32.14 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -66.75 -168.77 0.07 Allowed 'General case' 0 C--O 1.256 1.411 0 CA-C-O 123.018 1.39 . . . . 0.0 114.695 -167.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -70.69 -168.5 0.26 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 112.351 -2.204 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -110.5 151.97 26.93 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CE1' ' HB1' ' A' ' 34' ' ' ALA . 23.0 m-85 -109.7 -154.38 0.53 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.929 0.891 . . . . 0.0 109.093 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.46 -47.1 74.21 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.086 0.469 . . . . 0.0 111.62 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.21 140.49 51.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.585 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 21.8 tp60 -124.7 120.97 25.71 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.738 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -88.85 -174.46 1.02 Allowed 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.396 2.064 . . . . 0.0 111.553 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -163.67 177.92 8.34 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.87 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.48 -13.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 123.641 0.588 . . . . 0.0 109.426 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.99 -70.72 0.52 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 181' ' ' ARG . 22.8 t -179.81 -53.73 0.01 OUTLIER 'General case' 0 C--N 1.362 1.116 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.41 -167.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.63 166.39 12.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.4 132.17 56.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 56.6 tp -104.77 132.42 51.04 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.6 136.86 58.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 O-C-N 122.408 -0.183 . . . . 0.0 110.718 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.8 p -76.32 170.07 17.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.853 0.461 . . . . 0.0 109.87 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.0 81.05 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.54 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -64.44 -53.39 49.18 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.152 0.501 . . . . 0.0 110.21 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -30.58 70.39 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.129 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.32 -44.1 97.28 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.587 0.755 . . . . 0.0 110.321 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -62.39 -39.46 93.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.934 0.771 . . . . 0.0 109.897 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 102' ' ' LEU . 4.1 mm? -57.62 -59.73 4.75 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.429 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -55.84 -41.34 66.13 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 123.234 0.614 . . . . 0.0 112.578 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.55 -42.52 78.29 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 p -71.49 -27.38 63.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 98' ' ' LEU . 9.5 mp -67.58 -25.4 65.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.863 0.363 . . . . 0.0 111.567 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.03 42.41 5.98 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.17 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.3 t -81.93 101.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 m -74.87 146.99 41.45 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.609 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 80.02 12.27 1.07 Allowed 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.28 1.432 . . . . 0.0 112.56 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.48 113.89 21.54 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.02 131.48 51.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.48 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 53.2 m95 -111.37 123.13 49.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.454 -174.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.2 mt -108.92 95.11 16.19 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.8 132.98 8.97 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -150.3 167.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.98 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.635 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.92 116.71 33.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 24.4 mt -106.24 136.28 41.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.784 -172.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HG2' HG22 ' A' ' 121' ' ' VAL . 63.1 mttp -95.46 146.76 24.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.59 -160.35 0.72 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -70.58 -23.16 62.54 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.377 1.071 . . . . 0.0 110.385 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -92.98 -19.71 21.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.838 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.57 12.97 33.84 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.094 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -99.42 151.16 21.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 117.691 0.745 . . . . 0.0 109.348 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 115' ' ' LYS . 30.6 t -84.73 81.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.666 0.746 . . . . 0.0 110.244 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.7 m -104.45 11.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.086 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -127.39 48.11 0.99 Allowed Glycine 0 N--CA 1.422 -2.25 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.312 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 95.5 Cg_endo -84.95 -2.52 9.63 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 121.405 2.602 . . . . 0.0 111.634 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -114.12 14.27 18.23 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.819 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.451 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 19.6 m-85 -112.8 138.24 49.92 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 111.646 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.96 138.82 52.19 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.965 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.89 125.44 29.72 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.48 HD12 ' CZ3' ' A' ' 109' ' ' TRP . 6.4 tt -102.09 125.95 48.91 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.798 0.809 . . . . 0.0 110.354 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.19 140.55 52.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.317 170.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 176' ' ' ARG . 2.8 mm? -95.79 143.64 26.85 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.204 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.64 173.29 6.37 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 122.992 0.517 . . . . 0.0 109.897 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.25 7.52 84.92 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.39 132.35 40.53 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.63 0.728 . . . . 0.0 110.464 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -132.66 170.45 15.2 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -47.85 107.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.191 0.932 . . . . 0.0 111.391 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.692 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -94.29 -55.58 3.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -163.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.58 117.97 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.126 0.891 . . . . 0.0 112.886 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -67.0 109.84 3.13 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.57 -1.92 58.26 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 12.9 pt-20 -100.05 -30.26 12.06 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.032 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 59.9 mtt85 -102.18 -12.65 17.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 m -97.75 131.44 44.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.872 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -109.42 115.29 29.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.75 174.52 14.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.011 0.434 . . . . 0.0 111.492 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -129.46 128.62 43.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 91.2 mtp -100.79 155.13 18.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.261 19.4 t70 88.71 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.121 2.169 . . . . 0.0 113.076 177.027 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.0 p -101.57 -57.47 2.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.232 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -112.91 -24.4 9.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.784 0.802 . . . . 0.0 109.284 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 32.5 mt-10 -151.95 175.96 11.97 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 126.401 1.88 . . . . 0.0 106.47 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.577 ' N ' ' HE2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -70.53 -38.32 74.22 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -98.79 26.53 5.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.114 1.435 . . . . 0.0 110.607 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.655 ' NE2' ' HD3' ' A' ' 181' ' ' ARG . 9.7 mm-40 -108.2 121.46 44.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.093 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.46 132.59 31.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -97.8 -55.98 1.11 Allowed Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.887 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -112.12 133.3 54.35 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.724 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.47 123.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.4 -39.27 9.27 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.977 0.417 . . . . 0.0 110.447 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.91 117.04 6.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.625 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.98 123.14 45.37 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.36 142.46 30.81 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.87 133.68 56.24 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 122.456 1.122 . . . . 0.0 113.001 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.692 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 18.7 p-10 -88.43 6.22 38.59 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.096 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.2 p -68.9 -4.67 17.35 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.215 1.406 . . . . 0.0 109.979 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.9 m -68.56 -40.68 80.52 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.935 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -103.6 -33.25 9.06 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.196 -0.315 . . . . 0.0 110.864 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.8 146.01 6.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.468 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 1.6 mpp_? -64.85 125.79 89.7 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -4.77 9.86 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.976 3.117 . . . . 0.0 114.658 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 3.9 p30 -83.56 -10.68 58.13 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.244 -0.285 . . . . 0.0 111.177 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.53 138.74 53.56 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.284 0.564 . . . . 0.0 111.076 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.97 -30.0 24.61 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.214 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.1 ttt -148.99 130.42 14.77 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.68 178.45 8.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.296 0.373 . . . . 0.0 110.609 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.563 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 ppt_? -148.54 138.26 22.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 59.6 m -78.17 153.37 32.11 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.973 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 51' ' ' HIS . 7.3 p -81.52 -50.38 9.46 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -97.81 30.13 3.12 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -155.64 127.17 7.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.655 ' HD3' ' NE2' ' A' ' 154' ' ' GLN . 1.8 mpt_? -81.0 -40.99 23.41 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.043 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -86.51 -7.12 58.65 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.175 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.8 tp -88.2 104.2 16.49 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 122.094 0.95 . . . . 0.0 111.902 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.71 123.18 69.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.22 128.85 51.99 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.343 0.592 . . . . 0.0 110.54 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 45.8 pt -112.0 148.86 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.736 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -80.73 156.18 26.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.56 -38.22 43.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.955 0.902 . . . . 0.0 112.487 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.63 -39.79 85.5 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.112 1.365 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.45 -51.34 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.737 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.575 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 18.3 p80 -68.92 -27.86 66.14 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.387 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.41 -32.18 72.12 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.562 0.539 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.9 59.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.201 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -71.72 -32.12 67.42 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.218 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 70.2 mm-40 -55.68 -53.85 51.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.815 0.846 . . . . 0.0 109.149 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -76.88 -20.72 55.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.246 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.81 -27.98 44.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.61 0.243 . . . . 0.0 110.66 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.04 47.76 12.72 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.225 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.78 165.3 23.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.75 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -159.83 132.76 3.08 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.67 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.84 165.31 25.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.4 ' HD2' ' HG2' ' A' ' 28' ' ' LYS . 16.9 ptpt -128.47 131.81 48.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 173.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.59 130.25 71.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.009 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -113.04 153.16 28.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.64 112.02 9.34 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.9 -36.96 84.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 123.829 0.705 . . . . 0.0 112.068 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.63 94.92 1.04 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.51 35.19 14.52 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.622 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -58.64 100.63 0.07 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.513 0.725 . . . . 0.0 111.492 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -104.39 126.54 51.58 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.39 -26.49 0.21 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 120.298 2.879 . . . . 0.0 120.298 163.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.22 115.15 24.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 118.899 1.349 . . . . 0.0 111.602 -172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -82.69 134.66 35.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.753 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.794 1.638 . . . . 0.0 111.577 171.071 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.26 93.33 1.27 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -85.96 -51.87 6.08 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t -163.1 100.49 0.97 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 110.818 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -115.14 -33.6 5.31 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -129.1 140.53 51.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -103.57 156.39 17.81 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.673 0.273 . . . . 0.0 110.512 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -78.69 133.9 37.16 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.0 t60 72.4 106.85 0.07 Allowed 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 125.078 1.351 . . . . 0.0 110.525 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.292 3.0 p-80 80.29 121.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.388 2.275 . . . . 0.0 113.042 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 m -94.01 -37.64 11.55 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -93.34 127.09 38.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.86 -5.66 47.24 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.479 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.75 110.28 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.68 105.96 30.15 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.31 -71.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.912 1.742 . . . . 0.0 114.726 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 60.62 75.79 0.39 Allowed 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.526 1.13 . . . . 0.0 109.355 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.99 71.37 0.9 Allowed Glycine 0 C--N 1.306 -1.094 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.184 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m 73.13 -33.58 0.27 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.741 1.617 . . . . 0.0 113.979 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 m80 63.59 -108.29 0.22 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 86.3 mmm 59.35 22.33 10.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.002 0.906 . . . . 0.0 111.108 -171.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.5 110.48 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.0 155.57 37.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.043 0.449 . . . . 0.0 112.111 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.35 138.33 46.89 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.929 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 204' ' ' VAL . 65.1 m-85 -125.76 147.52 49.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.31 0.576 . . . . 0.0 112.156 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.1 t -78.3 124.85 37.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -96.43 135.24 38.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.601 0.715 . . . . 0.0 112.154 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -149.78 162.95 39.27 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 81' ' ' PHE . 21.8 t -104.59 143.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.4 ttm -96.55 80.55 3.13 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.47 114.75 4.16 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.018 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.43 -33.67 2.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.86 -0.53 57.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.37 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.98 -31.96 20.32 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 172.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.6 161.1 33.43 Favored Glycine 1 N--CA 1.383 -4.862 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.902 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 47.9 m-85 -95.97 164.14 12.84 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.06 101.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -54.0 -51.18 64.79 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 125.131 1.519 . . . . 0.0 113.174 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -146.81 153.61 40.39 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 40' ' ' LEU . 6.6 mp -48.98 121.16 10.18 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.016 1.326 . . . . 0.0 113.593 -175.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 67' ' ' SER . 31.1 Cg_endo -75.59 167.03 27.34 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.472 2.115 . . . . 0.0 111.161 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -54.66 128.82 34.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.539 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.26 3.57 81.94 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.585 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m -85.47 128.93 57.21 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.73 165.7 3.39 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.616 3.544 . . . . 0.0 112.799 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 p -54.2 147.08 13.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 50' ' ' PHE . 4.0 m-20 -38.19 -56.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 127.059 2.143 . . . . 0.0 114.32 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.434 ' HB2' ' HD2' ' A' ' 181' ' ' ARG . 23.9 p-90 -85.88 -16.08 39.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.835 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -86.66 -13.19 46.26 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.019 -171.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HD2' ' O ' ' A' ' 47' ' ' ASP . 65.9 m-85 -48.66 -27.64 2.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 130' ' ' ASN . 46.8 m170 -127.84 1.24 6.02 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.582 -0.699 . . . . 0.0 111.319 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.84 102.15 14.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.587 -167.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.14 -9.84 0.98 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.18 164.81 30.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 119.516 1.658 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -91.38 143.7 26.35 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.8 0.12 56.82 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.206 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.56 -37.97 52.16 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -90.38 -15.39 31.13 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 178.534 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.49 -23.1 12.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.631 -0.668 . . . . 0.0 112.66 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -97.46 134.71 22.27 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.8 122.09 9.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.462 1.441 . . . . 0.0 110.805 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.12 127.59 54.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.49 66.91 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -101.3 -167.44 27.81 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.613 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.2 mt-10 -116.96 137.75 52.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.48 163.1 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 41' ' ' PRO . 28.7 t -146.29 148.16 32.14 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.046 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.59 116.59 9.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -68.94 151.32 46.69 Favored 'General case' 0 N--CA 1.411 -2.407 0 O-C-N 124.026 0.829 . . . . 0.0 111.71 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -83.61 58.84 4.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.251 1.024 . . . . 0.0 109.823 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -95.2 -29.53 14.48 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.017 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -131.37 106.11 14.62 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.85 142.63 32.04 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.567 2.178 . . . . 0.0 112.434 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.81 88.79 0.1 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.062 1.345 . . . . 0.0 112.387 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.443 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 19.7 t-20 -152.52 154.91 36.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 77' ' ' ASN . 6.0 mmp_? -84.19 -162.2 0.63 Allowed 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.4 p-10 -86.41 -170.16 2.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.873 1.269 . . . . 0.0 113.143 -176.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 5.1 mp -87.89 144.51 26.54 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.367 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -103.82 -175.9 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -57.58 -41.28 80.81 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.591 0.71 . . . . 0.0 112.18 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.421 ' O ' HG11 ' A' ' 29' ' ' VAL . 95.8 m-85 -118.36 134.91 54.66 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 172.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -121.77 129.5 25.15 Favored Pre-proline 0 C--N 1.283 -2.307 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.182 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.22 171.72 13.57 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.463 2.108 . . . . 0.0 111.734 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.1 p30 -160.08 173.65 15.49 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -96.7 14.89 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-O 123.109 1.433 . . . . 0.0 109.184 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -121.3 -176.09 3.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.722 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 m -98.09 46.9 1.0 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -127.63 162.02 27.49 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.539 -0.726 . . . . 0.0 109.603 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.8 tp -122.99 129.86 52.06 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.2 tp -102.27 123.79 46.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.61 138.05 54.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 122.791 0.436 . . . . 0.0 110.014 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -76.99 174.0 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.639 0.376 . . . . 0.0 111.119 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.61 -37.25 67.95 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.396 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.96 -35.0 66.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.103 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.38 -34.38 70.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 100' ' ' GLU . 64.8 ttt180 -57.84 -46.24 85.05 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.02 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -55.17 -38.4 68.26 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.28 -51.21 69.86 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.53 -41.66 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.069 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 mm-40 -69.19 -36.79 77.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.222 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -74.9 -29.6 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.26 -19.66 56.23 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.245 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.45 48.71 5.2 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.804 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 174' ' ' MET . 97.2 t -82.69 101.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.0 m -77.04 150.44 35.76 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.332 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.1 9.2 1.4 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.391 1.476 . . . . 0.0 113.3 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.49 113.8 25.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.447 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 9.1 tp10 -99.41 139.82 34.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.467 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 57.0 m95 -116.96 121.74 42.27 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -116.41 93.31 39.49 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.1 139.82 21.91 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.858 2.372 . . . . 0.0 113.894 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 64' ' ' GLY . 4.3 m -150.75 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 124.52 1.128 . . . . 0.0 109.522 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -96.95 116.21 28.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -108.36 130.17 61.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.423 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 121' ' ' VAL . 57.8 mttm -96.7 135.27 38.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -169.82 2.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.983 0.356 . . . . 0.0 110.528 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 63.2 m80 -59.59 -31.15 69.2 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.022 0.929 . . . . 0.0 111.147 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -87.52 -3.01 59.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.46 64.47 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -105.34 147.73 27.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 118.461 1.13 . . . . 0.0 110.553 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 115' ' ' LYS . 45.9 t -81.65 90.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.715 0.769 . . . . 0.0 110.34 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.9 6.22 7.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.076 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.06 45.28 1.17 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 119.309 -1.424 . . . . 0.0 116.072 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 78.3 Cg_endo -84.04 -1.44 9.9 Favored 'Trans proline' 0 C--N 1.381 2.251 0 CA-C-N 122.222 3.011 . . . . 0.0 111.02 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.64 -9.22 41.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -98.43 149.55 22.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.637 0.732 . . . . 0.0 112.707 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.0 140.18 45.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.472 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.23 122.89 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.467 HD12 ' CZ3' ' A' ' 109' ' ' TRP . 6.9 tt -99.71 128.55 45.81 Favored 'General case' 0 C--O 1.275 2.434 0 CA-C-O 121.819 0.819 . . . . 0.0 110.914 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.19 140.65 52.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.611 174.135 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.7 140.09 36.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.99 173.76 6.59 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.183 0.927 . . . . 0.0 109.39 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.88 22.13 50.59 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.134 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.43 132.96 45.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.416 0.627 . . . . 0.0 111.164 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -132.72 150.64 52.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -50.13 105.43 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.139 0.971 . . . . 0.0 113.453 -170.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -117.14 -34.1 4.47 Favored 'General case' 0 N--CA 1.398 -3.068 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -167.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 179' ' ' LYS . 41.2 mt -54.62 112.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.517 0.675 . . . . 0.0 111.67 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.85 128.88 36.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.668 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.4 mtt -101.79 4.62 40.61 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.505 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 11.4 pt-20 -88.93 -30.09 19.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.797 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.505 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 3.1 mmp_? -109.55 -28.07 9.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.875 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -83.09 138.68 33.6 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.661 0.743 . . . . 0.0 112.471 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.97 113.87 17.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -153.67 163.17 40.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.199 0.312 . . . . 0.0 111.244 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.66 139.15 52.39 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.299 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 60.2 mtt -100.63 108.57 20.5 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -173.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.7 t70 169.4 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.423 1.889 . . . . 0.0 108.198 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 34.8 t -99.0 -57.17 2.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.418 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 80.0 mt -107.58 -51.98 2.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 -165.97 2.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.571 175.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 147' ' ' MET . 53.8 pttt -59.68 -27.77 66.7 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.11 12.53 35.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.716 0.77 . . . . 0.0 111.892 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 26.0 mm-40 -111.96 116.09 30.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.51 131.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -109.22 -72.25 0.73 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -82.91 127.19 33.29 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.98 121.55 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.06 -39.3 13.75 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.98 134.35 16.2 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.59 120.76 37.64 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.14 146.79 26.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.95 135.18 57.16 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.828 0.705 . . . . 0.0 111.255 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.595 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 13.0 p-10 -92.76 14.04 18.43 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.279 1.038 . . . . 0.0 111.082 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 p -68.56 -5.14 18.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.755 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.4 m -62.8 -35.51 80.11 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 124.187 0.995 . . . . 0.0 110.457 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.42 -31.15 6.9 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.104 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.523 HG13 ' HB2' ' A' ' 137' ' ' ALA . 85.7 mt -90.64 154.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.457 ' HD2' ' OD1' ' A' ' 171' ' ' ASP . 8.3 mmt180 -45.07 119.38 4.01 Favored Pre-proline 0 C--O 1.225 -0.23 0 C-N-CA 123.466 0.706 . . . . 0.0 112.542 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.05 -16.54 25.46 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.093 1.862 . . . . 0.0 111.109 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.457 ' OD1' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -98.06 9.69 42.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.537 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.76 142.55 58.39 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.181 0.515 . . . . 0.0 109.834 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.06 -36.07 15.11 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.971 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.445 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.6 ttt -153.19 118.9 5.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -140.33 -179.7 6.15 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.74 145.01 50.66 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 39.5 m -82.47 147.95 28.42 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 40.6 p -80.54 -45.66 17.07 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.452 ' HB2' HD12 ' A' ' 138' ' ' ILE . 65.6 mttp -79.62 17.62 0.87 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.5 150.18 34.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.434 ' HD2' ' HB2' ' A' ' 48' ' ' TRP . 4.9 mmp_? -91.95 -43.59 9.37 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.875 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -83.66 -33.84 25.15 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.394 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.88 102.3 0.19 Allowed 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.416 1.072 . . . . 0.0 113.187 -170.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 51' ' ' HIS . 87.1 mt -112.88 126.83 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.18 176.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.98 122.94 46.26 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.445 HG22 ' HG3' ' A' ' 174' ' ' MET . 49.2 pt -111.66 151.08 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -86.72 163.11 17.51 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.547 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 15.0 tp10 -50.44 -48.38 56.42 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.187 1.395 . . . . 0.0 111.872 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -63.98 -31.17 72.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.329 0.652 . . . . 0.0 111.558 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.83 -48.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.75 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.571 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 24.9 p80 -71.52 -33.04 68.85 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.699 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.09 72.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.554 0.534 . . . . 0.0 110.457 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.15 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.616 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.77 -40.57 75.98 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.442 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 37.8 mt-10 -62.08 -47.55 84.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.149 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -71.87 -19.27 61.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.24 47.14 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.656 0.265 . . . . 0.0 111.033 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.91 47.74 5.46 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.304 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.6 mt -89.63 165.83 13.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -50.27 -91.11 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.66 143.42 11.44 Favored Glycine 0 CA--C 1.497 -1.086 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.935 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.79 165.73 24.61 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -133.06 128.59 36.57 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 170.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 15.6 m -132.53 129.92 59.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 123.687 0.617 . . . . 0.0 110.092 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.08 147.05 49.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.63 114.76 3.17 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.019 0.824 . . . . 0.0 109.68 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.57 61.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.104 0.253 . . . . 0.0 111.618 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.64 98.69 1.54 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.27 35.73 16.81 Favored Glycine 0 N--CA 1.422 -2.284 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.594 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -52.74 106.3 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.694 0.759 . . . . 0.0 110.045 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.72 99.65 10.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.837 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.93 -23.16 0.31 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 119.022 2.369 . . . . 0.0 119.022 167.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 69.6 mt -68.11 147.08 52.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.31 134.6 50.15 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 215' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 125.674 1.59 . . . . 0.0 112.426 -174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 C--O 1.236 0.388 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.63 100.24 2.04 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 m -87.62 -75.3 0.41 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.659 0.23 . . . . 0.0 110.608 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -78.9 -48.89 13.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 120.84 0.352 . . . . 0.0 110.152 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.306 13.0 p80 -94.02 46.71 1.18 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.406 1.098 . . . . 0.0 112.466 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -77.12 -20.8 55.14 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -119.6 114.23 21.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.269 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 178.15 -61.83 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -143.86 79.09 1.61 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.47 0.652 . . . . 0.0 109.25 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -137.27 77.04 1.62 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 m -135.51 96.67 3.5 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 p -83.68 174.21 10.69 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.684 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.77 -120.83 0.8 Allowed Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp 56.1 43.86 26.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.665 0.745 . . . . 0.0 110.254 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -89.12 118.01 68.78 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.406 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.11 108.72 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.968 2.445 . . . . 0.0 109.352 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -153.33 138.49 17.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.837 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 168.04 11.25 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -71.08 -47.83 56.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -138.88 97.0 3.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -73.37 138.39 45.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.432 HG13 ' HG2' ' A' ' 188' ' ' GLU . 52.4 t -93.71 109.74 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 7.7 ptpp? -81.17 147.84 29.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.444 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -109.17 133.15 53.39 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.629 -174.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 76.3 m-85 -118.79 145.09 45.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.656 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 58.5 t -75.99 124.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -97.81 124.37 42.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.428 0.455 . . . . 0.0 111.591 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -137.46 147.44 45.31 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.7 133.73 40.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.5 ttt -91.19 82.18 5.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.783 0.801 . . . . 0.0 110.01 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.58 116.88 5.68 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.207 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.49 -36.54 2.07 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -83.25 -23.3 32.78 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.133 0.973 . . . . 0.0 109.982 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . . . -67.22 -34.49 77.59 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 154.12 30.79 Favored Glycine 1 N--CA 1.392 -4.259 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.909 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.13 166.95 11.5 Favored 'General case' 0 C--N 1.254 -3.571 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' ' 41' ' ' PRO . 44.6 mt -75.74 101.73 2.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 165.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -63.36 -45.64 90.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.676 -1.602 . . . . 0.0 112.659 -167.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.38 177.08 7.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.041 0.536 . . . . 0.0 110.163 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.38 122.82 84.74 Favored Pre-proline 0 C--N 1.32 -0.687 0 O-C-N 123.808 0.692 . . . . 0.0 112.604 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' ' 37' ' ' ILE . 14.1 Cg_exo -69.82 166.7 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.776 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -48.92 113.51 0.8 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.95 1.3 . . . . 0.0 113.395 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.78 72.88 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.975 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.13 143.31 39.41 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.52 165.86 16.84 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.931 3.087 . . . . 0.0 111.503 172.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.1 p -62.09 155.82 23.16 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 86' ' ' MET . 4.2 m-20 -46.07 -52.71 11.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.096 1.358 . . . . 0.0 113.027 -175.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 30.7 p-90 -73.35 -23.72 60.25 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -74.53 -23.68 58.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.41 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 96.1 m-85 -58.79 -24.9 62.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.628 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 9.0 m80 -114.61 2.29 14.49 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.79 100.65 12.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.468 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.97 -11.79 0.01 OUTLIER Glycine 0 CA--C 1.555 2.542 0 N-CA-C 121.238 3.255 . . . . 0.0 121.238 166.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.06 166.04 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 121.15 2.475 . . . . 0.0 112.191 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB2' ' HG ' ' A' ' 132' ' ' LEU . 32.5 t -84.54 153.73 23.09 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.56 11.6 39.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -170.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.55 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -13.24 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.925 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.32 -22.8 13.29 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.479 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -109.51 137.37 20.3 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.88 122.62 10.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.14 1.893 . . . . 0.0 111.979 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.49 115.64 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.34 55.66 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -100.8 -156.28 27.39 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 33.9 mt-10 -128.83 133.31 47.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 122.468 -0.431 . . . . 0.0 110.894 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 18.8 m -131.81 166.61 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.461 ' OG ' ' HE2' ' A' ' 115' ' ' LYS . 20.0 m -145.62 156.52 43.72 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 5.9 m-85 -74.84 105.8 6.07 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.938 0.774 . . . . 0.0 109.805 175.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p -84.15 131.33 34.78 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.02 143.24 28.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.937 -172.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -97.07 -39.32 9.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 80.7 t80 -176.66 -54.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.1 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 72' ' ' TYR . 12.1 Cg_exo -72.94 114.16 3.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 121.496 1.464 . . . . 0.0 111.644 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -90.72 88.77 7.22 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -90.04 -172.58 3.55 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.644 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -82.69 -161.81 0.52 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.4 -176.22 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.659 1.184 . . . . 0.0 112.59 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 122' ' ' VAL . 8.4 mp -94.04 150.99 19.85 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 34' ' ' ALA . 20.9 m-85 -110.06 -154.7 0.54 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.761 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -71.11 -38.34 72.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.156 0.503 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.54 138.98 52.52 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 18.2 tp60 -122.53 114.08 30.33 Favored Pre-proline 0 N--CA 1.414 -2.231 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.5 159.33 28.93 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 122.171 1.914 . . . . 0.0 111.356 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.47 171.8 8.82 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.5 mm -88.71 -18.34 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.475 ' HG3' ' OD2' ' A' ' 47' ' ' ASP . 4.7 mpp? -80.74 -95.91 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.151 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 43.2 t -175.89 34.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.485 1.136 . . . . 0.0 110.048 -174.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -136.86 154.33 50.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.714 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.81 139.9 48.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 59.3 tp -112.18 130.02 56.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.16 135.95 61.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.257 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.8 p -71.51 169.63 15.04 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 96' ' ' ARG . . . -63.89 -39.94 97.85 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.149 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -75.74 -32.7 60.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.058 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.48 -28.19 63.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.876 0.37 . . . . 0.0 110.048 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 109' ' ' TRP . 69.1 mtp180 -58.81 -43.12 90.49 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.854 172.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.9 mmpt? -61.47 -35.31 77.27 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 123.527 0.517 . . . . 0.0 111.359 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.85 -58.29 7.92 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.884 0.373 . . . . 0.0 110.115 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.16 -44.25 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.042 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.22 -37.42 87.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.0 p -75.65 -27.4 58.36 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.018 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.3 -24.38 61.32 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.738 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.11 48.45 6.92 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.8 104.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-O 121.818 0.818 . . . . 0.0 110.944 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m -55.31 123.87 15.22 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.799 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 78.21 15.08 1.41 Allowed 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.521 1.528 . . . . 0.0 113.835 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.2 114.24 21.67 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.5 tp10 -105.84 144.92 31.9 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.237 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.527 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 64.9 m95 -116.3 119.66 36.44 Favored 'General case' 0 N--CA 1.425 -1.702 0 O-C-N 124.363 1.04 . . . . 0.0 109.009 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 66.3 mt -110.92 93.36 17.11 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.46 139.49 10.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.647 2.231 . . . . 0.0 112.73 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' GLY . 4.1 m -147.5 173.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 108.777 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -99.66 116.16 31.11 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 172.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 29.9 mt -108.44 132.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.2 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 mppt? -101.12 132.3 46.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.54 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.8 p-10 -82.19 -160.37 0.37 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.54 0.736 . . . . 0.0 112.524 -172.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -67.55 -32.77 73.77 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.746 0.818 . . . . 0.0 110.391 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -77.11 -21.21 54.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.52 36.91 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.109 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.62 157.66 16.31 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.47 103.44 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 116' ' ' ASP . 12.9 p -103.38 -29.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.901 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -127.98 76.52 0.4 Allowed Glycine 0 N--CA 1.407 -3.292 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.869 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.72 -23.03 7.3 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 CA-C-N 119.478 1.639 . . . . 0.0 112.651 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -116.96 4.16 12.82 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.652 0.739 . . . . 0.0 111.049 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -72.33 142.05 48.82 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.81 49.56 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.649 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -81.45 127.93 33.33 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.495 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 6.8 tt -103.85 126.28 50.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.568 0.699 . . . . 0.0 110.417 -176.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.79 141.74 51.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.203 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 176' ' ' ARG . 2.9 mm? -99.79 129.22 45.87 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.999 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 55' ' ' SER . 7.4 mp -87.62 173.1 9.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.344 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.9 78.61 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.305 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.27 131.94 47.04 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.11 0.481 . . . . 0.0 109.85 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.48 170.71 15.21 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.597 ' OD2' ' HE2' ' A' ' 179' ' ' LYS . 23.6 t70 -56.04 104.96 0.16 Allowed 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.164 0.915 . . . . 0.0 110.712 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -125.03 -36.13 2.58 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 -166.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 179' ' ' LYS . 31.6 mt -63.2 116.13 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.199 0.909 . . . . 0.0 111.123 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.11 128.95 36.03 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.998 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.0 ttm -105.21 1.42 28.19 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 121.061 0.457 . . . . 0.0 111.93 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.24 -50.64 5.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.987 0.899 . . . . 0.0 109.778 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -82.26 -4.9 58.03 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.37 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 p -106.2 162.97 13.18 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.183 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -126.75 93.71 3.85 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -150.94 161.97 41.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 9.0 mm-40 -121.98 141.62 51.14 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.358 1.463 . . . . 0.0 108.252 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 81.8 mtp -100.84 107.57 19.14 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.61 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 t -69.6 -55.76 9.2 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.793 -0.567 . . . . 0.0 112.03 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.1 mt -136.56 -62.24 0.66 Allowed 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -116.82 170.36 8.67 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 111.8 -2.455 . . . . 0.0 105.796 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 147' ' ' MET . 0.0 OUTLIER -61.03 -39.6 90.4 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 124.09 0.956 . . . . 0.0 109.502 -176.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.89 -10.31 59.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.862 1.265 . . . . 0.0 111.683 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -102.01 115.5 30.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 46.3 mt -72.07 130.62 35.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.904 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -105.3 -75.57 1.01 Allowed Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.021 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 5.6 t30 -82.97 120.43 25.7 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.11 113.1 34.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.32 -29.82 15.45 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.98 2.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.185 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.11 121.87 33.27 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.02 140.65 30.46 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.96 140.34 58.85 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 124.258 0.974 . . . . 0.0 113.605 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.479 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.9 p-10 -93.46 6.51 47.93 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.254 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.0 p -67.44 -4.8 12.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.909 1.283 . . . . 0.0 110.401 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.1 m -63.85 -38.33 90.69 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.702 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.57 -31.37 6.8 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.875 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 78.5 mt -89.37 139.06 18.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 30.1 mmt180 -59.92 122.61 67.06 Favored Pre-proline 0 C--N 1.316 -0.858 0 O-C-N 123.489 0.493 . . . . 0.0 109.94 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 6.6 Cg_exo -69.46 -7.97 22.37 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.486 2.124 . . . . 0.0 113.265 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.36 1.86 56.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.364 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.16 125.42 26.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 17.7 tttt -72.31 -27.18 62.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.372 0.606 . . . . 0.0 112.066 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.509 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.5 ttt -154.16 131.43 11.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -141.6 171.19 14.41 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.102 0.477 . . . . 0.0 111.475 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.628 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.3 OUTLIER -136.69 126.83 26.21 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.715 -176.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 25.6 m -74.54 142.91 44.7 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.635 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.7 p -81.51 -39.52 24.59 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.597 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 69.2 mmtt -74.43 11.2 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -174.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.94 140.69 4.64 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 7.1 mmt180 -90.18 -31.66 16.95 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -83.95 -28.96 27.44 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.61 111.0 5.13 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.305 1.05 . . . . 0.0 113.237 -173.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.57 129.73 74.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.91 129.85 56.79 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.382 0.611 . . . . 0.0 111.288 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 174' ' ' MET . 45.4 pt -116.1 157.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.017 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.471 ' CD ' ' HA ' ' A' ' 173' ' ' LYS . 48.2 mtp180 -85.85 162.33 18.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.509 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.8 pt-20 -57.44 -36.22 71.11 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.452 ' OD2' ' HE2' ' A' ' 173' ' ' LYS . 5.1 p-10 -64.33 -32.38 73.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.43 0.456 . . . . 0.0 111.615 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 -48.9 79.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.637 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.505 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 17.8 p80 -73.62 -25.46 60.32 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.749 -1.181 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.03 74.1 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.414 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.12 -36.08 69.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -70.43 -33.25 71.12 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.3 mm-40 -58.51 -45.61 88.42 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.707 0.765 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -85.81 -12.42 50.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.225 -175.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -85.42 -27.92 25.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.88 48.37 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.09 165.34 19.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.8 p -41.49 -62.5 0.86 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -173.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.42 140.35 5.17 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 118.431 -1.842 . . . . 0.0 113.21 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -142.31 161.91 36.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.9 mmpt? -139.16 122.05 16.61 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.1 m -124.19 142.35 41.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.45 142.25 50.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.04 108.83 3.23 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.31 -30.42 66.22 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.432 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.67 92.11 1.15 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.88 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.17 31.12 26.44 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.588 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -58.19 101.62 0.08 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 110.967 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -104.01 120.95 42.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.67 -25.43 1.43 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 118.684 2.234 . . . . 0.0 118.684 168.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.53 143.67 36.35 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.619 1.209 . . . . 0.0 112.923 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.63 134.57 49.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.532 ' H ' HD12 ' A' ' 215' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.478 0.971 0 O-C-N 124.259 0.974 . . . . 0.0 110.67 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.9 49.25 0.79 Allowed Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -81.6 125.66 30.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.006 -0.597 . . . . 0.0 109.504 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -132.12 145.93 51.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -71.93 114.31 9.89 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -78.96 112.67 16.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.799 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -80.04 -26.39 39.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.838 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -89.73 9.7 26.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.589 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.91 103.54 16.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -140.4 113.59 8.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 m -84.95 -73.66 0.43 Allowed 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.2 t 178.34 160.62 0.59 Allowed 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.95 70.43 2.54 Favored Glycine 0 C--N 1.317 -0.501 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.26 87.49 7.39 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.542 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.57 130.9 14.72 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.56 91.1 0.59 Allowed 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 122.118 1.879 . . . . 0.0 111.155 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.04 -64.61 1.28 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.244 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.88 -113.51 4.79 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -173.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -118.44 124.09 46.8 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -136.77 131.21 33.08 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -86.1 111.49 20.38 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.36 139.08 37.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -87.61 134.4 33.64 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.885 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -109.67 145.23 36.87 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.199 0.523 . . . . 0.0 111.33 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -128.53 150.84 50.0 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.425 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 61.7 t -80.99 126.31 39.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -95.0 117.42 30.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.458 0.474 . . . . 0.0 110.719 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HG3' ' C ' ' A' ' 215' ' ' LEU . 1.2 tmtp? -135.68 139.28 43.57 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.64 122.98 49.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.6 ptp -76.07 84.58 2.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.976 0.893 . . . . 0.0 111.438 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . -145.17 112.38 6.08 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.274 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 38.2 mt-10 -131.18 -37.19 1.27 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -84.41 -31.48 24.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.016 176.216 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.595 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . . . -72.16 -35.21 68.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 167.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.46 26.97 Favored Glycine 0 N--CA 1.42 -2.421 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.478 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 32' ' ' GLU . 88.7 m-85 -90.68 166.94 12.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.439 HG12 ' CE1' ' A' ' 68' ' ' PHE . 49.5 mt -78.24 100.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 161.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 71' ' ' ASN . 63.7 mm-40 -59.0 -63.66 1.22 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.483 -171.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -125.22 175.42 7.43 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.717 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -59.81 123.7 72.92 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.26 0.975 . . . . 0.0 112.838 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -65.06 166.86 17.44 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.897 2.398 . . . . 0.0 112.878 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' VAL . 6.9 t30 -53.88 114.43 1.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.352 1.061 . . . . 0.0 112.419 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.71 12.31 62.66 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.128 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.6 m -86.38 139.71 34.01 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 167.24 24.93 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.096 3.197 . . . . 0.0 111.449 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -51.96 149.05 5.29 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.42 -49.56 7.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.661 2.384 . . . . 0.0 114.141 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -86.15 -30.05 22.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.863 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 21.1 tptm -80.28 -12.47 59.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.629 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 51.9 m-85 -48.54 -33.71 10.08 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.648 0.593 . . . . 0.0 112.23 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -128.36 9.46 6.11 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 49' ' ' LYS . 4.3 mm-40 -87.92 102.66 14.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.37 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.65 -8.96 0.17 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.91 171.29 14.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 119.181 1.491 . . . . 0.0 112.828 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -98.5 150.54 21.57 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.79 14.53 31.36 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.498 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.78 -32.39 60.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -88.82 -24.14 22.66 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.3 -22.04 14.21 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -110.79 138.38 21.07 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.75 123.4 12.59 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.291 1.994 . . . . 0.0 111.967 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.71 113.67 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 16.37 60.33 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.99 -149.56 20.35 Favored Glycine 0 C--O 1.241 0.556 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.909 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.4 mt-10 -132.68 138.53 47.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.098 0.475 . . . . 0.0 110.51 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 42' ' ' ASN . 29.6 m -131.15 174.51 12.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 p -147.31 152.72 38.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 116' ' ' ASP . 21.2 m-85 -79.36 123.63 27.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 p -56.17 135.17 53.28 Favored 'General case' 0 C--O 1.266 1.942 0 O-C-N 124.339 1.024 . . . . 0.0 109.835 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.39 66.64 3.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.211 1.005 . . . . 0.0 112.114 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 10.6 t30 -95.34 -30.31 13.99 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.537 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -143.78 89.82 7.2 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.655 172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.06 6.01 5.93 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.991 2.461 . . . . 0.0 111.134 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.82 -4.22 37.24 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.247 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -82.07 162.9 22.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -85.83 -154.62 0.21 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 121.578 0.704 . . . . 0.0 112.023 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.17 -169.54 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.585 1.554 . . . . 0.0 112.355 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -94.11 150.73 20.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.96 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -102.35 -163.07 0.97 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.727 1.211 . . . . 0.0 109.244 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -68.75 -30.12 68.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.506 0.67 . . . . 0.0 109.604 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.402 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 64.8 m-85 -134.85 148.39 50.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.851 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 15.3 tp60 -129.93 126.55 22.52 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.0 175.26 5.04 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.315 2.01 . . . . 0.0 111.117 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.42 ' HB2' ' H ' ' A' ' 86' ' ' MET . 0.3 OUTLIER -140.19 -178.4 5.45 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.02 -19.98 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.42 ' H ' ' HB2' ' A' ' 84' ' ' ASN . 3.2 mpp? -84.66 -92.39 0.08 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.397 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 60.2 p -174.11 -29.06 0.01 OUTLIER 'General case' 0 C--N 1.369 1.421 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -70.96 115.53 10.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.022 0.915 . . . . 0.0 111.985 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.33 126.66 33.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.671 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 38.6 tp -93.54 122.4 35.94 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.414 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -71.88 156.4 39.32 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -60.16 -34.61 84.88 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.994 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -68.92 -41.78 77.7 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 120.838 0.351 . . . . 0.0 111.203 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.77 -28.92 61.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.958 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -59.9 -42.44 93.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.944 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 10.0 mmpt? -64.42 -32.56 74.23 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.21 -55.43 33.86 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 120.68 0.276 . . . . 0.0 110.385 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.73 -41.11 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.592 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -70.79 -27.18 63.71 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.8 m -71.92 -27.09 62.59 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.516 0.674 . . . . 0.0 110.557 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.8 -9.93 59.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.077 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.74 47.94 58.43 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.16 103.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.782 0.801 . . . . 0.0 110.094 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 m -77.26 146.82 36.67 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.838 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 80.39 1.18 1.93 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 126.008 1.723 . . . . 0.0 113.001 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.62 23.28 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.8 tp10 -99.13 142.74 30.23 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -117.86 113.49 21.84 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.986 0.804 . . . . 0.0 108.887 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.34 100.98 32.62 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.3 134.56 9.1 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.718 2.279 . . . . 0.0 112.846 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -149.88 174.63 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -108.85 116.94 32.94 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -96.43 133.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.832 -174.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' HG2' HG22 ' A' ' 121' ' ' VAL . 61.8 mttm -92.9 129.5 38.8 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 41.8 p-10 -76.17 -163.92 0.34 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.51 -24.94 67.26 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.523 0.729 . . . . 0.0 110.679 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.16 -19.96 24.84 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.038 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 11.85 41.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.093 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -101.28 142.66 32.37 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.427 -0.455 . . . . 0.0 110.462 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 115' ' ' LYS . 13.7 t -78.9 88.56 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.2 m -110.59 1.38 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.774 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.94 64.5 0.54 Allowed Glycine 0 C--O 1.203 -1.806 0 C-N-CA 119.406 -1.378 . . . . 0.0 113.244 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 8.5 Cg_endo -84.0 -19.72 4.7 Favored 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 120.375 2.087 . . . . 0.0 112.61 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -103.65 7.76 37.45 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.218 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.462 ' HB2' HD13 ' A' ' 114' ' ' ILE . 7.9 m-85 -96.34 143.41 27.42 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.136 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.34 147.65 52.4 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.71 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.4 123.53 33.04 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 5.0 tt -91.11 128.14 36.81 Favored 'General case' 0 C--O 1.263 1.793 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -120.74 140.91 51.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.68 119.3 38.56 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.17 173.04 6.55 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.714 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.87 27.47 72.23 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.168 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.08 131.72 44.91 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.14 159.91 34.52 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 105.304 -2.109 . . . . 0.0 105.304 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.407 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 13.2 t70 -66.67 112.5 4.21 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.268 0.556 . . . . 0.0 111.344 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -129.83 -14.26 4.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 177' ' ' CYS . 32.4 mt -61.29 117.61 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.305 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -63.84 129.12 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.764 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 65.6 mtt -116.34 5.9 13.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.868 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.5 -50.21 5.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.07 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -98.53 -31.51 11.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.373 0.606 . . . . 0.0 109.998 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 m -73.54 128.49 35.63 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 159' ' ' ASP . 42.7 mt-10 -107.87 112.36 24.95 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -162.01 165.39 27.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.193 0.308 . . . . 0.0 111.085 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -127.3 146.17 50.54 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 124.583 1.177 . . . . 0.0 107.946 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.485 ' SD ' HG12 ' A' ' 155' ' ' ILE . 23.1 mmt -100.44 106.7 18.3 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.028 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.6 t70 170.3 76.39 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.384 1.074 . . . . 0.0 111.184 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 154' ' ' GLN . 5.7 p -101.53 -49.13 4.11 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.9 mt -131.57 -58.83 0.98 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.08 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 154' ' ' GLN . 6.5 mm-40 -114.43 -179.26 3.58 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.345 -174.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.536 ' H ' ' HD3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -67.52 -33.99 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.377 174.15 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 9.1 p-10 -98.73 25.09 6.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 109.539 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.495 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 24.8 mm-40 -126.14 115.44 19.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.485 HG12 ' SD ' ' A' ' 147' ' ' MET . 23.6 mt -79.36 141.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -113.95 -73.44 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.78 121.15 26.06 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.3 mt -126.94 119.33 52.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 15.1 m-20 -97.45 -42.28 7.8 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.576 0.703 . . . . 0.0 109.312 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.66 140.19 25.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.64 117.05 20.54 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.24 147.6 25.56 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 144.28 56.01 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.498 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.7 p-10 -93.99 10.69 32.47 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.126 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.4 p -69.69 -4.96 21.9 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.966 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.8 m -60.82 -39.21 88.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 124.297 1.039 . . . . 0.0 109.879 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.435 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.32 -31.84 6.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.322 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' ' 137' ' ' ALA . 70.2 mt -89.45 146.09 6.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.484 ' HD3' ' OD1' ' A' ' 171' ' ' ASP . 44.8 mtt180 -46.56 125.12 7.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 124.645 1.178 . . . . 0.0 113.401 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.46 -5.54 14.22 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.302 2.001 . . . . 0.0 109.93 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.484 ' OD1' ' HD3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.97 -8.54 57.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.875 175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.84 136.13 50.39 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.469 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 87.5 mttt -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.406 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.9 ttt -148.9 127.05 12.06 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -150.91 -178.66 6.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.91 148.77 40.96 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.538 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.45 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 34.9 m -84.97 121.85 28.37 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 124.326 1.016 . . . . 0.0 109.136 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.443 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 19.5 p -55.99 -50.3 71.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -169.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -82.47 9.74 8.6 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -173.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -137.99 113.29 9.37 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.495 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 11.2 ptp180 -57.53 -39.17 76.02 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -83.4 -30.58 27.24 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.731 0.812 . . . . 0.0 111.791 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.45 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 22.2 tp -63.79 101.32 0.35 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.03 126.15 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.647 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.63 133.81 51.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.432 0.634 . . . . 0.0 110.634 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.418 HG22 ' HG3' ' A' ' 174' ' ' MET . 44.4 pt -116.47 154.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.439 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.49 ' HD3' ' OD2' ' A' ' 189' ' ' ASP . 76.3 mtt180 -79.5 163.39 24.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.816 173.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 13.3 pt-20 -58.75 -36.67 74.74 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.721 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' A' ' 187' ' ' ARG . 23.3 m-20 -54.99 -45.08 75.0 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.26 1.024 . . . . 0.0 110.087 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.4 t -64.38 -50.32 76.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.754 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.555 ' CD2' ' HA ' ' A' ' 188' ' ' GLU . 21.5 p80 -70.75 -29.86 66.21 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.595 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.71 80.81 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 122.549 0.34 . . . . 0.0 110.491 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.7 80.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.45 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.64 -33.1 64.37 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.6 mm-40 -60.03 -47.06 87.39 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.23 -21.22 54.13 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.194 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.06 -27.15 59.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.728 0.299 . . . . 0.0 110.648 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.63 39.62 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.878 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.9 mt -82.04 166.0 20.15 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.7 p -53.35 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -152.51 130.75 3.15 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.316 -1.421 . . . . 0.0 112.899 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.402 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 66.2 m-85 -124.26 157.63 34.41 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . 0.3 OUTLIER -126.38 120.59 30.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.94 139.32 44.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.343 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.531 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 75.2 m-85 -118.59 143.17 46.97 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.96 102.95 4.97 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.69 97.26 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 123.987 0.804 . . . . 0.0 112.182 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.12 87.02 3.59 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 98.85 35.4 4.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -68.54 100.31 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.831 0.452 . . . . 0.0 110.576 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -103.74 133.97 47.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.52 -25.58 0.28 Allowed Glycine 0 N--CA 1.478 1.485 0 N-CA-C 119.344 2.498 . . . . 0.0 119.344 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.45 146.64 24.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 118.647 1.224 . . . . 0.0 113.937 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.28 133.08 41.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.531 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 1.7 pt? . . . . . 0 C--N 1.314 -0.936 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.397 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.33 -74.37 1.24 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 t -92.36 158.86 15.86 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 m 67.34 98.32 0.05 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.777 1.631 . . . . 0.0 112.2 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -102.15 -27.89 12.63 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.1 m80 68.55 158.23 0.15 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.27 1.428 . . . . 0.0 113.346 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -140.44 110.18 6.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -83.9 -39.44 19.82 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.42 -173.02 3.16 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.688 0.795 . . . . 0.0 109.793 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -137.99 160.05 40.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -68.75 129.34 39.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -119.76 139.35 52.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.94 -40.65 5.82 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -87.19 79.03 8.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.612 0.72 . . . . 0.0 111.183 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.25 114.96 45.43 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -66.25 88.46 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.293 1.995 . . . . 0.0 114.449 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -147.82 153.39 39.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.63 76.7 0.55 Allowed Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.089 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -121.8 100.43 6.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.764 0.316 . . . . 0.0 111.481 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 177.9 -49.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.718 1.607 . . . . 0.0 108.748 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 tmt? 177.15 142.09 0.08 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.53 113.62 38.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.64 155.99 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 169.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.36 151.21 30.03 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.297 0.57 . . . . 0.0 111.466 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -127.93 144.36 51.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 79.1 t -76.8 118.02 22.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -97.94 126.1 43.18 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.536 0.684 . . . . 0.0 110.935 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -143.51 155.03 44.22 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.2 t -106.39 128.44 60.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.8 ptp -79.73 85.45 5.42 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.931 0.872 . . . . 0.0 110.248 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.54 113.39 4.46 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.684 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -118.5 -58.15 2.0 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.688 174.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.99 -7.12 56.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.96 11.16 23.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.652 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 105.39 102.67 2.81 Favored Glycine 0 N--CA 1.406 -3.358 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 23.3 m-85 -97.22 166.19 11.69 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 162.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 84' ' ' ASN . 45.5 mt -93.94 101.4 12.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 161.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 3.1 mm-40 -60.46 -50.25 74.33 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 124.523 1.139 . . . . 0.0 110.507 -172.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.13 156.24 44.75 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.494 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 40' ' ' LEU . 5.8 mp -56.44 129.08 75.07 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 126.062 1.745 . . . . 0.0 114.16 -173.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.15 167.33 27.15 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 123.022 2.482 . . . . 0.0 111.456 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.78 123.89 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -10.97 52.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.297 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 m -86.92 126.98 61.45 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.05 165.07 31.41 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.6 2.867 . . . . 0.0 111.027 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 p -48.23 149.4 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 -172.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -40.01 -54.19 2.27 Favored 'General case' 0 N--CA 1.507 2.421 0 C-N-CA 126.594 1.958 . . . . 0.0 113.141 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -82.3 -24.87 34.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.411 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 49.7 tptt -85.0 -14.73 46.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.434 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 28.9 m-85 -44.44 -45.76 9.25 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.824 0.703 . . . . 0.0 112.823 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.467 ' HB3' ' NH1' ' A' ' 176' ' ' ARG 0.334 35.9 m-70 -129.64 24.94 5.4 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -83.1 101.09 10.93 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.96 4.91 1.84 Allowed Glycine 0 CA--C 1.553 2.449 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.03 164.16 28.26 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 CA-C-N 119.118 1.459 . . . . 0.0 113.987 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.4 t -98.85 141.42 31.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 50' ' ' PHE . 82.7 mt -90.16 -2.04 58.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.112 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.01 68.95 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -89.66 -22.66 22.16 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -107.29 -24.06 12.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -101.69 132.56 21.57 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 122.72 9.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.96 1.774 . . . . 0.0 110.857 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -98.8 136.56 29.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 17.86 79.77 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -98.32 -163.0 30.62 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -126.31 132.82 51.55 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.38 167.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 32.7 t -154.55 153.51 31.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -97.06 110.48 23.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.2 p -71.65 153.12 42.3 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.49 0.493 . . . . 0.0 110.728 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -81.7 110.25 16.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.554 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 21.7 t-20 -97.63 -38.64 9.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 163.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -106.19 111.74 64.23 Favored Pre-proline 0 N--CA 1.421 -1.908 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.85 -58.23 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 123.58 2.853 . . . . 0.0 114.612 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.33 84.3 3.44 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.558 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -117.37 146.18 43.57 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -90.37 -168.69 2.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -73.65 178.62 4.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 114.061 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.37 152.28 22.03 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.141 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -122.23 -161.56 0.94 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -58.56 -32.83 69.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.425 0.631 . . . . 0.0 111.95 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.87 147.82 52.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.474 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 6.8 tp60 -133.4 111.51 12.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 84.0 Cg_endo -81.81 -179.43 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.793 2.328 . . . . 0.0 111.639 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 3.7 p30 -164.21 179.18 7.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.141 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.6 mt -93.47 9.08 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 122.25 1.024 . . . . 0.0 109.018 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.411 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 29.6 mtm -115.42 -159.14 0.7 Allowed 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.418 -171.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 50' ' ' PHE . 1.5 m -117.91 35.34 4.76 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.782 0.719 . . . . 0.0 112.177 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -133.31 158.07 43.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.608 -0.682 . . . . 0.0 109.828 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.8 tp -122.69 141.9 51.26 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 52.4 tp -110.83 129.32 55.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 129' ' ' LEU . 45.3 t -129.11 141.34 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.806 0.691 . . . . 0.0 110.385 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.4 p -76.14 168.39 20.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.366 0.666 . . . . 0.0 111.402 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.54 98.78 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.441 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.21 -37.99 66.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.057 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.82 -32.88 71.54 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.986 0.422 . . . . 0.0 109.906 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -57.57 -45.43 85.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.774 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 73.1 mmtt -64.82 -28.89 69.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.13 -54.84 27.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.74 -43.29 91.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 111.263 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -65.95 -41.17 91.6 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.2 p -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.57 -13.24 59.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.467 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.42 47.34 10.64 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.167 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.74 104.31 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.7 t -72.59 159.83 33.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.948 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 77.87 13.78 1.69 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 124.442 1.097 . . . . 0.0 111.157 173.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.35 114.43 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.605 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -106.55 139.18 41.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -114.77 115.64 27.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 123.853 0.721 . . . . 0.0 109.108 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.8 mt -111.83 96.9 35.47 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.18 143.13 12.51 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.488 2.126 . . . . 0.0 113.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 64' ' ' GLY . 5.3 m -149.3 168.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.833 1.253 . . . . 0.0 108.842 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -92.37 116.08 28.65 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 126' ' ' TYR . 38.4 mt -107.89 127.46 63.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.759 0.79 . . . . 0.0 112.236 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 67' ' ' SER . 85.3 mttt -101.48 131.51 47.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.4 p-10 -76.37 -160.49 0.15 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.29 0.567 . . . . 0.0 111.401 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.057 0.543 . . . . 0.0 110.353 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.59 -20.4 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.73 0.643 . . . . 0.0 109.73 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.55 12.65 40.6 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.235 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.2 ptpt -95.81 145.02 25.68 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 115' ' ' LYS . 21.2 t -81.99 82.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.584 0.707 . . . . 0.0 110.046 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 m -106.18 4.34 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.364 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.77 61.84 0.65 Allowed Glycine 0 C--O 1.204 -1.73 0 C-N-CA 120.545 -0.835 . . . . 0.0 113.025 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 79.9 Cg_endo -83.93 -18.87 5.16 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 120.449 2.125 . . . . 0.0 113.652 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.75 20.84 13.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.439 1.114 . . . . 0.0 110.457 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 114' ' ' ILE . 2.0 m-85 -92.11 133.48 35.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.41 139.18 52.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.497 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -80.04 119.22 22.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.293 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 91' ' ' VAL . 2.0 tt -86.65 128.3 34.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.9 m-80 -114.28 125.58 54.05 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -99.6 118.07 35.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.55 172.96 6.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.698 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.85 7.85 86.7 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.84 132.28 43.58 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.34 169.67 17.35 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.46 108.86 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.93 0.769 . . . . 0.0 109.366 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 168' ' ' ILE . . . -135.49 -30.77 0.99 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -167.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 179' ' ' LYS . 52.5 mt -64.41 114.99 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.087 -176.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.36 115.38 5.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.446 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 mmt -77.67 -1.94 33.53 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.23 -50.82 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.38 -30.91 29.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.1 m -92.74 104.22 16.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.67 117.3 34.52 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -158.39 157.96 33.31 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.82 127.16 51.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 66.1 mtp -102.59 106.94 17.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.7 t70 177.57 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.623 1.169 . . . . 0.0 112.319 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 -30.99 11.95 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.5 mt -139.21 -58.4 0.59 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.19 -167.14 2.48 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.186 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 7.9 mmpt? -66.84 -18.44 65.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -172.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.539 ' HB2' HH21 ' A' ' 181' ' ' ARG . 1.4 p30 -87.0 -2.24 58.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.677 0.671 . . . . 0.0 111.146 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -107.61 125.88 51.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.35 -177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 73.7 mt -82.73 115.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.07 -56.52 1.59 Allowed Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.674 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.67 121.87 46.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.67 126.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -102.3 -43.33 5.73 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.302 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.26 142.21 26.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.68 119.9 23.08 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -109.28 147.53 32.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.65 131.0 49.53 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.251 0.969 . . . . 0.0 112.353 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.41 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 26.4 p-10 -96.52 16.6 18.28 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.035 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -68.52 -6.19 23.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.74 1.216 . . . . 0.0 110.908 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.0 m -63.95 -40.45 96.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.292 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.54 -31.8 6.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.494 HG13 ' CB ' ' A' ' 137' ' ' ALA . 61.2 mt -83.57 138.93 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.446 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 48.6 mtm180 -58.65 119.49 37.24 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 14.0 Cg_exo -68.61 -4.68 13.59 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.485 2.79 . . . . 0.0 112.908 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 1.7 p-10 -79.44 -14.61 58.81 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.15 116.16 12.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.79 -19.73 60.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.494 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.5 ttt -146.73 123.59 11.3 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.52 -179.01 6.56 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.467 ' NH1' ' HB3' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -148.73 146.49 28.11 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.439 ' HB3' HD11 ' A' ' 138' ' ' ILE . 66.8 m -75.74 150.06 37.9 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.439 1.087 . . . . 0.0 112.736 -173.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -82.11 -24.79 34.94 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.517 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.9 mmtt -85.75 -4.56 59.2 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.126 -176.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.82 151.25 33.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.539 HH21 ' HB2' ' A' ' 153' ' ' ASP . 3.0 mmt180 -90.65 -39.86 12.23 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 123.793 0.837 . . . . 0.0 111.018 -171.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.415 ' HE ' ' HB2' ' A' ' 182' ' ' ARG . 57.1 mtm180 -84.62 -19.29 33.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.557 -174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.76 100.95 5.63 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.6 mt -110.63 135.07 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.76 122.56 44.81 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.441 0.638 . . . . 0.0 109.94 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.494 HG22 ' HG3' ' A' ' 174' ' ' MET . 38.9 pt -112.8 162.72 10.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.839 0.828 . . . . 0.0 111.467 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.563 ' HB3' HG23 ' A' ' 190' ' ' VAL . 6.2 tpp180 -78.8 143.67 35.84 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.472 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 6.5 pt-20 -54.53 -40.94 69.14 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.394 0.616 . . . . 0.0 111.873 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.87 -33.92 76.29 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 124.436 1.094 . . . . 0.0 112.01 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.563 HG23 ' HB3' ' A' ' 187' ' ' ARG . 87.0 t -68.24 -44.74 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.392 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.461 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 26.7 p80 -73.13 -22.8 60.46 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.211 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.61 72.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -73.48 -32.49 64.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.24 -36.81 74.73 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.69 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 72.3 mm-40 -56.26 -53.7 54.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.485 0.714 . . . . 0.0 110.715 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -73.23 -12.37 60.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.219 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.28 -27.52 24.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.889 0.376 . . . . 0.0 110.07 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.03 47.87 22.6 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.945 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 71.4 mt -82.66 157.25 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.255 5.2 p -41.95 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.72 125.66 2.26 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.431 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 70.2 m-85 -120.8 156.33 32.13 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.336 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -129.99 120.63 25.07 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 16.2 m -133.88 142.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.262 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.39 155.46 49.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.195 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -65.18 129.55 40.11 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.461 0.476 . . . . 0.0 110.526 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -85.41 -40.5 16.38 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.297 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.84 101.02 3.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.496 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.78 29.88 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.522 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.13 108.78 0.64 Allowed 'General case' 0 CA--C 1.574 1.878 0 C-N-CA 124.171 0.988 . . . . 0.0 110.137 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -102.02 102.43 12.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 73.96 -22.16 1.23 Allowed Glycine 0 N--CA 1.475 1.252 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 167.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.37 148.8 46.64 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.494 0.647 . . . . 0.0 111.245 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -108.55 132.87 53.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 O-C-N 124.318 1.011 . . . . 0.0 113.123 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.94 40.57 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.666 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 m -96.59 92.29 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.186 0.517 . . . . 0.0 109.715 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.7 t -150.73 138.98 20.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -88.69 121.22 30.84 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -84.2 89.88 7.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.076 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -157.64 105.22 2.02 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 124.935 1.294 . . . . 0.0 108.844 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.49 98.76 4.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 m80 80.12 109.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.792 1.637 . . . . 0.0 111.765 -170.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -72.86 -24.44 60.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.1 m -60.84 109.0 0.94 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.122 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 t -145.39 109.28 4.78 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.31 130.12 6.95 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.406 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -121.53 102.35 8.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.9 t -92.0 111.23 48.9 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.39 153.74 35.55 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.89 2.394 . . . . 0.0 112.769 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.04 116.56 11.31 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.13 92.63 1.59 Allowed Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.948 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 m -82.13 85.27 6.81 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -88.25 -30.05 19.97 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.607 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.278 26.0 ptt? 51.49 80.1 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.42 1.488 . . . . 0.0 111.482 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.96 119.49 11.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.065 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HG2' ' OE2' ' A' ' 188' ' ' GLU . 7.8 ptpp? -93.88 141.9 27.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.891 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -109.45 138.58 45.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -124.4 142.73 51.07 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.712 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -80.1 116.35 24.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -92.23 125.56 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.48 0.657 . . . . 0.0 111.795 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 0.0 OUTLIER -141.05 165.13 28.4 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.343 1.457 . . . . 0.0 107.11 175.581 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.47 144.49 20.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttm -91.06 85.87 6.06 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.38 133.66 13.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.153 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.511 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -123.25 -64.07 1.2 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -84.8 -21.47 29.9 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.559 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.54 25.61 1.21 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.005 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' HA3' HE21 ' A' ' 82' ' ' GLN . . . 123.77 60.7 0.19 Allowed Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 118.58 -1.772 . . . . 0.0 117.376 173.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 3.2 m-85 -92.3 127.96 37.97 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.563 0.681 . . . . 0.0 110.458 166.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -87.71 103.37 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.17 -50.95 19.76 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.275 0.56 . . . . 0.0 111.887 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -115.04 169.42 9.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.586 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 5.3 mp -71.55 133.89 84.61 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 123.141 0.577 . . . . 0.0 112.132 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.07 168.4 24.84 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.321 2.681 . . . . 0.0 113.355 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -48.32 115.72 1.31 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.441 1.497 . . . . 0.0 112.665 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.3 14.36 71.63 Favored Glycine 0 C--O 1.208 -1.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.0 m -84.54 145.13 44.14 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 118.124 0.962 . . . . 0.0 111.74 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.24 165.53 21.83 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.387 2.725 . . . . 0.0 111.119 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.4 p -58.35 153.19 16.02 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -46.19 -58.3 3.77 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.311 1.444 . . . . 0.0 112.99 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 13.1 p-90 -71.2 -23.01 61.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.007 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HE3' HD12 ' A' ' 54' ' ' ILE . 43.0 tptt -77.3 -21.85 52.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.187 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 70.6 m-85 -52.83 -26.51 14.75 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.249 0.547 . . . . 0.0 112.379 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -120.26 -0.16 10.5 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 3.6 tm-20 -94.27 101.3 13.27 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.027 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -10.51 0.01 OUTLIER Glycine 0 CA--C 1.559 2.815 0 N-CA-C 120.711 3.044 . . . . 0.0 120.711 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.424 HD12 ' HE3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -130.1 174.58 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.066 2.433 . . . . 0.0 114.04 -173.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -88.05 148.29 24.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.251 -1.34 . . . . 0.0 107.776 171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.0 mt -98.29 -1.73 41.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.588 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.62 68.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.166 0.508 . . . . 0.0 112.324 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.1 -14.95 52.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.742 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.95 -22.52 9.54 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -101.07 139.05 20.17 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.29 122.94 9.46 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.123 1.882 . . . . 0.0 112.632 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.71 122.88 43.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.48 62.51 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.5 -168.03 27.66 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.5 131.14 55.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.99 165.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -139.42 141.72 37.5 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 23.1 m-85 -69.52 122.89 19.94 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 123.857 0.723 . . . . 0.0 109.092 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 p -69.9 118.53 12.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.28 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 73' ' ' PRO . 88.1 tttt -86.15 93.2 8.97 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 170.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -91.06 -37.69 13.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' HB3' ' HD3' ' A' ' 73' ' ' PRO 0.258 76.5 t80 -131.62 -70.76 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 175.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 72' ' ' TYR . 30.9 Cg_endo -90.18 170.33 4.04 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 CA-C-N 121.128 1.439 . . . . 0.0 112.246 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.46 80.24 9.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 8.7 t-20 -70.36 153.23 43.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.06 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -94.02 -148.58 0.27 Allowed 'General case' 0 C--O 1.256 1.44 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.95 -167.8 0.32 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.162 2.185 . . . . 0.0 114.525 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.02 149.94 27.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.171 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -114.04 -169.15 1.46 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.169 0.988 . . . . 0.0 109.006 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 94' ' ' ARG . 48.6 m-20 -65.84 -34.24 77.7 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.748 0.785 . . . . 0.0 110.274 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.444 ' CD1' ' HE1' ' A' ' 202' ' ' PHE . 57.1 m-85 -134.18 153.74 51.66 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.488 HE21 ' HA3' ' A' ' 35' ' ' GLY . 56.0 mt-30 -134.42 134.76 22.8 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.512 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.07 -179.26 1.74 Allowed 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.811 2.341 . . . . 0.0 111.36 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -163.48 171.52 15.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -101.12 21.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.88 1.324 . . . . 0.0 108.294 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 40' ' ' LEU . 63.4 mtm -102.31 -93.71 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.102 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.466 ' HB2' ' CB ' ' A' ' 50' ' ' PHE . 17.9 m -167.17 -33.3 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.85 174.66 7.84 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.3 tp -116.13 142.1 47.27 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.804 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.86 127.45 55.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.55 142.38 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.05 0.54 . . . . 0.0 110.169 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 p -83.8 168.91 15.72 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -66.04 -32.3 82.03 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.837 -0.22 . . . . 0.0 113.093 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.403 ' HD2' ' OD1' ' A' ' 80' ' ' ASP . 5.9 ptp180 -67.12 -41.15 86.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.528 0.68 . . . . 0.0 110.372 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.9 -24.3 52.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.112 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -61.4 -42.08 98.17 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.2 mmtp -60.94 -39.35 89.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.41 ' O ' HD13 ' A' ' 102' ' ' LEU . 4.5 mm? -59.95 -55.8 29.64 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.393 0.433 . . . . 0.0 110.26 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.75 -45.35 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 112.075 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.33 -36.37 83.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -70.86 -22.03 62.35 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 98' ' ' LEU . 10.5 mp -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.672 0.272 . . . . 0.0 110.949 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 47.18 13.62 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.8 t -79.74 100.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-O 121.427 0.632 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 m -80.88 154.26 27.16 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 84.5 m-20 80.63 15.21 0.7 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.62 1.568 . . . . 0.0 110.964 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.94 114.17 28.23 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.418 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 7.7 tp10 -104.34 133.1 49.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.415 ' CH2' HD12 ' A' ' 129' ' ' LEU . 68.5 m95 -109.21 123.55 49.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.278 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -111.4 93.49 19.2 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 135.1 15.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.698 2.266 . . . . 0.0 112.416 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.09 167.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.42 115.98 28.57 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 126' ' ' TYR . 32.8 mt -106.84 128.16 61.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HG2' HG22 ' A' ' 121' ' ' VAL . 84.0 mttt -97.25 142.06 29.6 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 9.1 p-10 -80.68 -162.35 0.46 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.861 0.362 . . . . 0.0 110.937 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.41 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 69.6 m80 -75.44 -9.44 58.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.522 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -109.34 2.01 20.43 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.807 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.3 7.14 80.26 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.55 139.06 32.36 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 118.602 1.201 . . . . 0.0 110.477 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 115' ' ' LYS . 21.2 t -76.95 90.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.497 0.665 . . . . 0.0 109.803 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.66 8.55 5.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.714 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.84 45.06 1.15 Allowed Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.847 -1.168 . . . . 0.0 114.76 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -83.32 -0.37 9.85 Favored 'Trans proline' 0 C--N 1.368 1.585 0 CA-C-N 121.278 2.539 . . . . 0.0 111.924 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -92.88 -12.18 31.64 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.832 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 114' ' ' ILE . 3.2 m-85 -92.24 147.2 23.11 Favored 'General case' 0 C--O 1.255 1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.343 -173.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.66 137.93 47.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.386 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -81.27 125.64 30.58 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.415 HD12 ' CH2' ' A' ' 109' ' ' TRP . 7.3 tt -99.75 125.13 45.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.41 0.624 . . . . 0.0 110.365 -176.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.2 141.37 52.14 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.622 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.718 ' HB2' ' HD2' ' A' ' 176' ' ' ARG . 3.0 mm? -98.92 144.28 28.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 108' ' ' GLU . 3.2 mm? -101.85 174.72 5.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.29 1.436 . . . . 0.0 109.388 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.81 17.24 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.39 132.1 42.26 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 122.12 0.962 . . . . 0.0 113.341 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.0 165.5 30.56 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 168.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -53.57 101.9 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.228 1.376 . . . . 0.0 111.89 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -78.93 -66.59 0.85 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.161 -164.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 179' ' ' LYS . 60.3 mt -59.1 126.83 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 O-C-N 123.955 0.785 . . . . 0.0 112.251 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -69.1 122.77 19.44 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 tpt -90.51 -16.33 29.08 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.14 -35.61 9.95 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -91.69 -6.2 52.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.092 0.472 . . . . 0.0 111.265 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.2 p -89.41 143.81 26.54 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.71 103.4 7.8 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -151.24 168.03 26.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.391 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -116.78 144.03 44.96 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 124.317 1.047 . . . . 0.0 110.239 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.42 155.22 20.11 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 35.9 t70 91.94 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.067 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.5 m -101.06 -22.98 14.58 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 166.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 99.5 mt -160.87 -47.84 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.926 1.691 . . . . 0.0 107.245 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 42.7 mt-10 -131.97 179.61 5.98 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.093 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -72.0 -24.4 61.56 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 123.675 0.609 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -98.25 25.27 6.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.287 1.042 . . . . 0.0 109.946 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -122.29 116.2 23.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.452 HG21 HG12 ' A' ' 158' ' ' ILE . 59.3 mt -84.86 120.8 36.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 123.131 0.27 . . . . 0.0 110.45 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -83.13 -48.25 5.47 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.305 -175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -134.09 139.24 45.82 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 155' ' ' ILE . 45.3 mt -125.05 134.06 67.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -103.24 -42.33 5.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.15 114.88 8.99 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 158' ' ' ILE . 3.2 tm? -99.08 119.89 38.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 129.69 35.97 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.87 137.81 56.31 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 124.27 0.981 . . . . 0.0 112.62 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.666 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.9 p-10 -88.23 -0.2 56.83 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.708 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -67.1 -6.13 16.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.893 1.277 . . . . 0.0 109.967 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -64.05 -35.79 81.87 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.376 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.64 -33.26 6.18 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.82 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.12 154.33 5.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -67.45 117.12 44.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.3 -13.25 35.51 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.808 2.339 . . . . 0.0 112.462 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.99 -2.51 58.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.711 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 130.52 40.6 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.532 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 15.4 tppt? -68.68 -33.94 74.83 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.054 0.454 . . . . 0.0 111.395 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.493 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.2 ttt -149.25 135.4 19.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -151.62 -178.19 6.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.138 0.575 . . . . 0.0 110.18 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.718 ' HD2' ' HB2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -151.91 142.96 23.16 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.341 -176.194 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' A' ' 183' ' ' LEU . 83.8 m -69.61 146.23 51.88 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.335 0.397 . . . . 0.0 111.751 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.7 p -81.54 -48.68 11.5 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.404 ' HB2' HD12 ' A' ' 138' ' ' ILE . 60.3 mttm -72.23 -20.76 61.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.728 0.411 . . . . 0.0 111.563 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.48 133.67 55.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.457 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 10.7 mmt180 -90.58 -34.95 15.3 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.856 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -87.76 -20.92 25.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.376 0.608 . . . . 0.0 110.648 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.553 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.3 tt -84.13 114.07 21.51 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.5 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 71.2 mt -120.91 132.37 70.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 59.6 mt -111.17 124.18 51.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.319 1.056 . . . . 0.0 113.263 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.493 HG22 ' HG3' ' A' ' 174' ' ' MET . 48.1 pt -112.68 154.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.966 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 17.3 mtp180 -83.63 162.26 20.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.446 ' OE2' ' HG2' ' A' ' 23' ' ' LYS . 7.8 pt-20 -51.74 -35.51 43.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.15 0.58 . . . . 0.0 111.824 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -46.19 -51.08 14.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.441 1.896 . . . . 0.0 111.335 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.57 -53.43 42.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.595 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 12.8 p80 -72.23 -25.4 61.62 Favored 'General case' 0 C--O 1.194 -1.816 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.334 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -34.72 73.64 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.855 0.359 . . . . 0.0 110.628 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.12 73.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.176 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -70.52 -32.91 70.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.171 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 53.6 mm-40 -59.12 -49.82 76.42 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-O 121.62 0.724 . . . . 0.0 109.136 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.38 -22.41 54.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.964 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.17 58.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.214 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.09 46.52 50.76 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.87 164.85 24.13 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.663 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 4.5 p -43.37 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.66 136.15 5.14 Favored Glycine 0 CA--C 1.493 -1.311 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.099 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.444 ' HE1' ' CD1' ' A' ' 81' ' ' PHE . 60.6 m-85 -135.68 162.62 32.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.73 122.12 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.64 133.48 66.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.079 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.406 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 72.3 m-85 -126.51 132.52 51.36 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.48 115.02 6.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.13 65.08 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 124.021 0.826 . . . . 0.0 112.217 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.73 90.73 1.08 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.512 0.673 . . . . 0.0 110.258 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 81.19 35.1 24.7 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.553 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 19.8 t90 -59.87 98.63 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.7 0.8 . . . . 0.0 110.206 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -103.98 132.31 50.35 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.81 -9.09 2.06 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 165.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.553 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 95.4 mt -94.83 135.73 35.98 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 118.382 1.091 . . . . 0.0 112.819 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.15 133.04 36.15 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 28' ' ' LYS 0.27 0.9 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.05 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptm . . . . . 0 C--O 1.241 0.653 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.19 -40.87 1.48 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -88.99 138.67 31.19 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 m 72.69 99.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.415 1.486 . . . . 0.0 110.864 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -100.2 162.19 13.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.8 t60 65.01 -78.8 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.965 1.306 . . . . 0.0 110.95 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.8 t60 166.98 84.84 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -123.52 96.8 5.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -173.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.471 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 53.0 t-80 -121.56 -92.05 0.55 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m170 175.37 127.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.995 2.118 . . . . 0.0 106.789 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 t 58.6 38.0 25.28 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.712 1.258 . . . . 0.0 109.082 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 9' ' ' HIS . 15.4 m -95.59 82.37 3.63 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.344 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.95 58.76 9.87 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.635 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -93.24 102.26 14.54 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.65 -0.324 . . . . 0.0 110.914 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.89 88.95 17.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 171' ' ' ASP . 4.0 Cg_exo -80.83 120.96 3.96 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.627 2.218 . . . . 0.0 111.834 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.92 96.28 7.63 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.202 0.525 . . . . 0.0 111.376 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.25 85.38 0.39 Allowed Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 p -76.63 -15.13 59.9 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.594 0.758 . . . . 0.0 112.253 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -168.28 -178.43 3.61 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -60.33 110.26 1.2 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.913 0.758 . . . . 0.0 110.258 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 67.3 t -84.79 122.22 37.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.628 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -103.28 150.72 23.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.177 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -125.85 155.93 40.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 60.8 m-85 -138.06 142.47 40.3 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.357 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 20.6 t -81.91 121.32 35.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.5 131.48 37.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -150.73 164.68 35.57 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.7 t -99.66 128.33 51.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.58 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 27.3 ttt -88.32 100.36 12.95 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.095 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 166.7 142.96 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 126.203 1.801 . . . . 0.0 108.719 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -94.53 -31.5 13.88 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 30.7 mt-10 -84.44 -0.26 52.18 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.003 -175.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -78.15 0.46 24.83 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.22 103.43 1.05 Allowed Glycine 0 N--CA 1.402 -3.628 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -95.58 147.04 23.99 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 39' ' ' LYS . 12.6 mt -85.07 101.31 9.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 102.864 -3.013 . . . . 0.0 102.864 166.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.72 -37.99 64.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.765 -172.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' O ' HG22 ' A' ' 37' ' ' ILE . 35.4 mmtp -114.46 176.47 5.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.554 ' HG ' ' SD ' ' A' ' 86' ' ' MET . 4.6 mp -83.94 129.26 59.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 9.8 Cg_endo -66.53 166.43 21.91 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.581 2.187 . . . . 0.0 112.892 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.87 127.1 30.38 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 124.065 0.946 . . . . 0.0 112.031 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.67 1.25 89.16 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 116.158 -0.474 . . . . 0.0 113.54 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.2 m -85.55 136.57 37.09 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.29 166.74 24.29 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.306 3.337 . . . . 0.0 112.096 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -50.88 148.88 3.8 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -45.9 -56.0 5.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.657 1.983 . . . . 0.0 113.448 -174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 17.2 p-90 -75.48 -26.53 58.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.343 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -78.7 -21.02 48.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.243 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HA ' HD21 ' A' ' 56' ' ' LEU . 33.1 m-85 -45.76 -38.92 7.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 1.3 m-70 -128.44 22.1 6.04 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.574 -0.704 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 1.2 tm-20 -93.99 100.85 12.91 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.898 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.24 -3.51 0.07 OUTLIER Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 52' ' ' GLU . 2.4 pp -123.0 173.7 8.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -171.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -98.31 135.88 39.28 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.103 170.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 50' ' ' PHE . 91.7 mt -84.11 -1.72 55.46 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -24.84 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 111.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -88.08 -22.82 23.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -116.31 -21.88 9.09 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -103.48 138.15 19.45 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.77 123.22 12.24 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.656 2.237 . . . . 0.0 112.682 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.06 114.73 33.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.31 19.46 45.64 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.396 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -95.62 -166.54 34.91 Favored Glycine 0 C--N 1.307 -1.062 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.198 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.83 128.56 42.54 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 34.9 m -126.94 169.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -148.19 162.55 39.22 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.907 -0.496 . . . . 0.0 110.177 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 19.8 m-85 -75.98 163.97 26.63 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.25 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 13.2 p -92.47 137.04 32.7 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.555 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -86.05 51.53 2.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.703 -0.623 . . . . 0.0 110.934 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.31 -37.92 51.67 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -131.01 90.27 39.89 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.12 -30.96 73.26 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.864 3.043 . . . . 0.0 114.122 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.43 -6.65 51.13 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.087 0.47 . . . . 0.0 112.249 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.568 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 8.0 t-20 -71.52 145.5 49.1 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 34.2 mtp180 -78.47 -172.51 2.92 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -79.86 -165.73 0.87 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.46 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HA ' HE21 ' A' ' 82' ' ' GLN . 4.6 mp -87.74 150.58 23.5 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.277 0.561 . . . . 0.0 111.758 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 5.5 m-85 -114.79 -163.58 0.88 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.51 -44.2 93.19 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.481 0.658 . . . . 0.0 110.725 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.84 151.65 41.48 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.515 -1.22 . . . . 0.0 107.881 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 78' ' ' LEU . 3.8 mm-40 -121.81 114.93 30.94 Favored Pre-proline 0 C--N 1.289 -2.036 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.51 168.08 7.35 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.548 2.832 . . . . 0.0 112.322 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -163.89 174.92 10.91 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 121.997 -0.44 . . . . 0.0 110.864 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.55 7.34 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.204 0 CA-C-O 123.103 1.43 . . . . 0.0 109.098 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.554 ' SD ' ' HG ' ' A' ' 40' ' ' LEU . 50.6 mtm -104.58 -164.19 1.03 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 m -121.4 53.68 1.16 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.813 -0.555 . . . . 0.0 110.991 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -136.84 155.11 50.21 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.7 tp -119.5 141.19 49.41 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.264 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 126' ' ' TYR . 58.2 tp -117.16 130.17 56.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.84 139.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 122.56 0.344 . . . . 0.0 110.084 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.2 p -76.27 174.56 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.33 0.252 . . . . 0.0 110.691 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.95 -38.81 59.93 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -69.01 -38.57 79.33 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.08 0.467 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.4 63.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -62.15 -39.94 94.3 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.738 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -55.37 -40.36 71.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.812 0.695 . . . . 0.0 112.412 178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 197' ' ' ALA . 4.0 mm? -60.14 -52.78 63.86 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.186 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.5 -45.03 99.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 C-N-CA 123.295 0.638 . . . . 0.0 112.2 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.4 -37.8 88.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -68.71 -22.14 64.37 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.211 0.529 . . . . 0.0 111.295 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.58 -8.55 58.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.806 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.28 44.5 74.83 Favored Glycine 0 CA--C 1.495 -1.195 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.115 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 173' ' ' LYS . 81.6 t -73.88 104.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.504 0.668 . . . . 0.0 110.403 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 m -79.27 150.62 31.49 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 79.53 1.43 2.23 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.564 . . . . 0.0 112.878 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.51 114.74 25.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.2 tp10 -99.49 137.73 37.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CH2' HD12 ' A' ' 129' ' ' LEU . 66.9 m95 -115.6 121.51 42.83 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.079 0.862 . . . . 0.0 109.209 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.67 98.31 49.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.26 124.9 6.14 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.497 2.131 . . . . 0.0 114.023 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 64' ' ' GLY . 16.1 m -139.74 172.24 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.9 116.69 33.36 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -100.54 130.16 50.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 121' ' ' VAL . 89.7 mttt -103.74 139.45 38.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.503 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 32.8 p-10 -83.91 -159.94 0.41 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 60.0 m80 -67.99 -14.87 63.31 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.079 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -19.48 16.53 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.2 20.18 21.35 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.703 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.439 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.4 ptpt -95.79 147.86 23.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 115' ' ' LYS . 16.1 t -82.2 84.5 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.417 HG23 HD13 ' A' ' 78' ' ' LEU . 6.6 m -111.84 12.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.105 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.51 51.81 0.85 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.35 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -84.72 -14.66 6.35 Favored 'Trans proline' 0 C--N 1.375 1.967 0 CA-C-N 120.795 2.298 . . . . 0.0 112.885 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -97.12 7.73 46.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.359 0.599 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.509 ' HB2' HD13 ' A' ' 114' ' ' ILE . 3.9 m-85 -102.02 148.35 25.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.569 0.699 . . . . 0.0 112.272 -170.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.6 142.63 41.26 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.608 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -82.47 131.05 35.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.452 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.452 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.9 tt -105.19 126.11 51.73 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.816 0.817 . . . . 0.0 110.091 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.402 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -125.39 141.2 52.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.051 174.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.59 141.78 30.21 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -123.6 174.47 7.41 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.318 1.047 . . . . 0.0 108.685 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 14.61 81.26 Favored Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.714 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.66 132.86 43.72 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.75 105.16 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 119.106 0.866 . . . . 0.0 112.015 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.23 -35.26 3.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 179' ' ' LYS . 57.0 mt -64.72 115.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.841 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.11 111.95 4.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.406 ' HA ' ' HG ' ' A' ' 143' ' ' SER . 15.2 ttt -97.89 17.65 17.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.774 0.797 . . . . 0.0 110.23 -174.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.55 -50.09 4.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.076 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 142' ' ' ARG . 2.7 mmp_? -97.12 11.43 36.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.191 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 140' ' ' MET . 50.0 p -104.88 154.38 20.14 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.154 175.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 75.2 mm-40 -133.81 117.37 16.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -166.0 172.34 11.56 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.58 0.55 . . . . 0.0 111.196 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.84 133.21 49.37 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 38.7 mtt -101.34 108.66 20.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.5 t70 172.78 73.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.705 2.002 . . . . 0.0 108.868 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 22.8 t -101.15 -49.45 4.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.05 -67.09 0.76 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 154' ' ' GLN . 3.0 pp20? -109.07 -176.19 2.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 174.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 147' ' ' MET . 11.0 mmpt? -66.78 -30.88 71.2 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -171.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' HB3' HH12 ' A' ' 181' ' ' ARG . 21.1 t70 -104.85 26.27 9.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.673 1.225 . . . . 0.0 109.429 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.545 ' HG2' ' OE2' ' A' ' 151' ' ' GLU . 15.3 mm-40 -106.8 123.55 48.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.194 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.6 124.33 39.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.824 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -103.35 -66.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.634 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -94.85 135.37 36.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.5 mt -131.9 145.14 35.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 13.2 t70 -110.44 -51.96 2.82 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 172.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.87 118.85 7.65 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.573 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.27 121.6 35.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.87 132.4 37.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -54.98 137.26 46.47 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.552 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.2 p-10 -92.69 -0.28 57.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.978 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.9 p -68.22 -6.16 22.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.07 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.6 m -63.84 -39.43 94.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.687 173.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -110.8 -31.31 7.23 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 119.701 -0.799 . . . . 0.0 112.288 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 137' ' ' ALA . 52.7 mt -89.03 150.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.492 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 27.7 mtp180 -57.92 122.37 57.09 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 122.535 0.334 . . . . 0.0 111.832 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.22 -5.76 17.72 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 123.419 2.746 . . . . 0.0 112.311 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 8.3 p-10 -96.47 -7.99 33.34 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.712 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.36 132.85 47.78 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.475 ' HB2' HG22 ' A' ' 104' ' ' VAL . 75.1 mmtt -73.75 -40.24 63.66 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.206 -174.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.45 ' HB3' HG11 ' A' ' 104' ' ' VAL . 27.0 ttt -142.85 123.98 14.51 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -146.39 -178.33 6.09 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.481 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.405 ' CD ' ' HB3' ' A' ' 51' ' ' HIS . 8.9 ttp180 -146.62 142.32 27.8 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.536 ' SG ' HD22 ' A' ' 183' ' ' LEU . 65.3 m -70.69 145.7 50.39 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 124.161 0.913 . . . . 0.0 111.607 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.8 p -82.21 -18.92 40.91 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.495 ' HB2' HD12 ' A' ' 138' ' ' ILE . 19.3 mtpp -108.96 20.79 18.02 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.749 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 9.5 tp10 -172.6 116.63 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.464 ' HD2' ' NE2' ' A' ' 154' ' ' GLN 0.275 0.0 OUTLIER -89.29 -11.19 44.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -173.012 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -90.56 -25.9 19.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 180' ' ' GLU . 3.3 tt -77.74 100.85 6.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.3 mt -108.08 120.56 59.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 30.7 mt -93.05 125.5 37.67 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 121.706 0.765 . . . . 0.0 111.615 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.8 pt -110.85 139.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.883 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -81.38 162.4 23.39 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 22' ' ' VAL . 7.1 pt-20 -43.68 -44.24 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.463 1.105 . . . . 0.0 112.546 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -56.33 -44.83 80.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.64 1.576 . . . . 0.0 110.725 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.33 -48.05 82.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 9.3 p80 -74.02 -29.26 61.84 Favored 'General case' 0 C--O 1.197 -1.672 0 C-N-CA 118.061 -1.456 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.0 77.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.18 83.38 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.174 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -72.11 -34.81 68.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.211 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 56.5 mm-40 -62.33 -47.24 85.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.322 0.582 . . . . 0.0 109.555 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -75.06 -15.89 60.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.565 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -83.75 -27.12 29.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.782 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 72.61 47.65 26.34 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.462 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.74 164.58 25.12 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -46.46 -76.54 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 116.933 2.198 . . . . 0.0 116.933 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.66 130.79 1.91 Allowed Glycine 0 CA--C 1.498 -0.978 0 C-N-CA 119.029 -1.557 . . . . 0.0 113.213 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -129.19 159.37 36.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 122.418 0.287 . . . . 0.0 110.273 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 77.4 tttt -120.78 121.67 38.69 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.2 130.43 72.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.118 0.485 . . . . 0.0 111.058 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 85.0 m-85 -107.04 138.97 42.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.72 115.97 9.57 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.62 -45.37 37.76 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.591 0.557 . . . . 0.0 112.285 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.19 95.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.988 0.805 . . . . 0.0 109.547 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.63 35.65 28.21 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.882 -1.152 . . . . 0.0 111.922 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.469 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 9.3 t90 -46.06 107.12 0.09 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.528 1.131 . . . . 0.0 110.368 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -82.78 71.53 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.11 15.16 67.12 Favored Glycine 0 C--N 1.31 -0.9 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 167.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 92.1 mt -89.89 146.35 24.48 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 118.365 1.082 . . . . 0.0 109.875 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.1 134.09 35.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.244 0.778 0 O-C-N 124.335 1.022 . . . . 0.0 108.894 174.187 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.22 45.83 0.03 OUTLIER Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 108.196 -1.961 . . . . 0.0 108.196 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -103.55 13.67 32.88 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.885 -0.658 . . . . 0.0 111.662 -171.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -99.44 89.55 4.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.589 0.709 . . . . 0.0 111.407 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -107.79 -24.45 11.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.19 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -76.26 -26.13 55.65 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.918 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -81.16 84.47 6.54 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -177.42 -49.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.7 t60 67.18 -58.82 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.836 2.054 . . . . 0.0 113.606 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -76.7 82.79 3.33 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.938 0.495 . . . . 0.0 110.026 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -127.07 94.56 4.05 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -158.32 -36.35 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.049 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.46 -117.08 1.73 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 61.08 82.66 0.16 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.532 1.133 . . . . 0.0 112.021 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.5 t -111.11 106.36 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.82 95.49 0.24 Allowed 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.067 2.511 . . . . 0.0 113.393 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.37 84.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.998 1.319 . . . . 0.0 108.254 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.64 141.98 15.88 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.689 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 m -83.47 95.6 8.32 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -116.1 130.14 56.66 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.031 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.2 ttm -69.7 118.68 12.87 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.89 109.52 26.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 21.4 ptmt -93.15 154.43 18.08 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.34 135.46 50.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.368 0.604 . . . . 0.0 111.764 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -122.19 143.92 49.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.31 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.69 121.64 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -97.78 114.03 25.95 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 111.038 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -135.26 150.86 50.14 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.42 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.54 84.67 7.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.09 113.69 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.96 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 34.1 tt0 -112.94 -66.97 1.03 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -0.91 55.89 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.05 0.929 . . . . 0.0 109.5 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 79' ' ' TYR . . . -94.81 25.41 4.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 119.42 39.21 0.68 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 168.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.635 ' CD1' ' HA ' ' A' ' 32' ' ' GLU . 11.3 m-85 -69.22 128.36 36.36 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 120.233 2.017 . . . . 0.0 112.889 170.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.517 HG12 ' CE2' ' A' ' 68' ' ' PHE . 9.4 mt -84.37 101.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.47 -59.62 3.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.924 0.869 . . . . 0.0 109.366 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 13.7 mptt -108.7 162.26 14.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.285 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 5.8 mp -70.31 139.75 87.29 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 124.639 1.212 . . . . 0.0 114.054 -171.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 11.3 Cg_exo -74.8 166.43 29.3 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.449 2.766 . . . . 0.0 111.345 171.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -53.15 122.27 9.12 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.324 1.049 . . . . 0.0 112.856 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.01 7.22 70.69 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 114.734 0.654 . . . . 0.0 114.734 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 27.0 m -85.33 142.79 38.24 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HG2' HD22 ' A' ' 56' ' ' LEU . 1.6 Cg_endo -75.51 166.08 29.3 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.848 3.032 . . . . 0.0 111.139 172.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -52.92 148.85 7.08 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.37 -52.55 4.53 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 127.243 2.217 . . . . 0.0 114.894 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -85.68 -30.08 23.46 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.747 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 52.6 tptt -81.16 -12.21 59.26 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.387 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 88' ' ' ASN . 40.7 m-85 -44.29 -50.31 9.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.688 0.617 . . . . 0.0 111.952 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.482 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.3 m-70 -128.91 32.33 4.78 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.58 -0.848 . . . . 0.0 113.257 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 7.8 tm-20 -92.45 101.37 13.82 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.52 -8.83 17.47 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.01 170.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.0 t -98.89 158.2 15.8 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.054 -1.884 . . . . 0.0 106.876 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.475 HD22 ' HG2' ' A' ' 45' ' ' PRO . 97.3 mt -113.07 15.5 19.53 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.91 67.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.068 0.461 . . . . 0.0 110.916 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -88.23 -21.85 24.29 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.453 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.19 -22.6 12.03 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.83 140.09 21.27 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.32 123.8 12.75 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.914 2.409 . . . . 0.0 112.73 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG22 HD22 ' A' ' 110' ' ' LEU . 22.4 t -100.89 117.09 45.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.91 14.99 61.92 Favored Glycine 0 C--N 1.318 -0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.55 -167.26 36.61 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.664 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.76 128.86 50.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 23.6 m -127.92 173.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 33.2 t -153.98 149.21 26.99 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 37' ' ' ILE . 1.1 m-30 -76.76 128.86 35.42 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 167.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 71' ' ' ASN . 15.0 p -74.67 168.71 19.28 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.625 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -80.93 47.97 1.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 123.501 1.619 . . . . 0.0 109.355 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.473 ' ND2' ' H ' ' A' ' 39' ' ' LYS . 20.1 p30 -71.41 -34.1 70.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.589 -2.096 . . . . 0.0 110.597 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -125.19 109.94 26.9 Favored Pre-proline 0 N--CA 1.417 -2.099 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 124.11 13.67 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.759 2.306 . . . . 0.0 113.662 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.19 15.48 9.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.111 1.364 . . . . 0.0 113.464 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -66.86 134.59 52.38 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.32 -175.58 1.6 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.45 -176.22 3.6 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.915 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD13 HG23 ' A' ' 122' ' ' VAL . 7.4 mp -98.0 151.84 19.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -167.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.493 ' CE2' ' HB1' ' A' ' 34' ' ' ALA . 5.9 m-85 -111.4 -163.35 0.84 Allowed 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.87 -45.06 96.06 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 119.308 0.958 . . . . 0.0 110.611 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.13 145.31 47.95 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.539 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 27.8 tp60 -124.74 120.93 25.67 Favored Pre-proline 0 N--CA 1.416 -2.15 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.874 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.97 166.93 9.75 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 122.846 2.364 . . . . 0.0 112.326 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -157.58 168.98 25.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.501 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -90.0 0.52 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 122.759 1.266 . . . . 0.0 108.544 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.51 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 37.9 mtm -94.47 -147.33 0.26 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 36.8 p -144.99 27.26 1.31 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . 61.0 t30 -114.51 118.33 33.47 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.13 141.36 30.26 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.751 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 47.1 tp -108.75 123.05 48.41 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 129' ' ' LEU . 59.2 t -128.52 139.13 52.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.483 -173.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.1 p -78.89 175.33 10.62 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.972 0.509 . . . . 0.0 110.967 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.59 73.17 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 94' ' ' ARG . 8.6 ptt180 -61.66 -47.73 84.04 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.524 0.729 . . . . 0.0 111.324 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -31.47 68.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.08 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -60.1 -42.74 95.35 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.736 0.414 . . . . 0.0 110.28 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -56.51 -45.5 81.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 124.221 0.951 . . . . 0.0 110.496 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 197' ' ' ALA . 4.6 mm? -58.8 -52.89 63.77 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.471 0.482 . . . . 0.0 111.797 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.9 mt -58.93 -44.47 90.96 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 C-N-CA 123.46 0.704 . . . . 0.0 111.776 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.21 -25.77 61.78 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.0 m -70.33 -26.35 63.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.34 -21.4 33.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.7 48.0 7.49 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.62 109.96 4.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.24 0.543 . . . . 0.0 110.019 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 m -75.36 146.96 40.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.678 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.07 12.05 1.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.504 1.522 . . . . 0.0 112.873 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.43 113.93 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.2 tp10 -111.0 141.87 43.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -116.26 119.19 34.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.501 ' HG ' HD21 ' A' ' 130' ' ' ASN . 68.8 mt -109.33 100.71 42.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.42 139.53 18.52 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.58 2.186 . . . . 0.0 113.418 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -148.22 162.26 6.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 124.552 1.141 . . . . 0.0 108.774 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.21 123.59 42.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -120.1 135.71 59.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -169.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.5 mptp? -98.09 150.63 21.23 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.613 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.3 p-10 -91.53 -163.05 0.98 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.903 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -66.02 -36.96 84.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 0.0 109.73 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.13 -19.25 47.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.32 14.69 29.77 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.722 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.613 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 17.2 ptpt -97.44 145.96 25.68 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.8 t -81.43 90.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.504 HG23 HD13 ' A' ' 78' ' ' LEU . 3.9 m -114.97 13.78 8.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.813 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.472 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -135.54 46.9 1.01 Allowed Glycine 0 CA--C 1.545 1.947 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.879 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.09 -13.99 7.47 Favored 'Trans proline' 0 C--N 1.379 2.166 0 CA-C-N 121.565 2.682 . . . . 0.0 111.426 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.1 -4.13 43.4 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.784 1.634 . . . . 0.0 110.438 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.472 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 5.5 m-85 -98.89 149.51 22.85 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.66 -171.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.5 147.54 43.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.208 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -85.13 128.7 34.76 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.926 0.393 . . . . 0.0 110.55 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.472 HD12 HG21 ' A' ' 91' ' ' VAL . 4.5 tt -92.67 125.62 37.38 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.852 -176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.501 HD21 ' HG ' ' A' ' 110' ' ' LEU . 35.7 m-80 -101.03 132.4 46.47 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.337 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.91 114.47 28.77 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.25 172.6 7.69 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.855 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.68 16.86 80.4 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.8 132.72 34.52 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.13 169.22 19.16 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.24 112.06 4.93 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -134.11 -17.71 2.09 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -165.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.7 mt -63.32 122.48 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 118.969 0.804 . . . . 0.0 111.023 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.49 128.14 35.52 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.189 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.425 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 63.2 mtt -119.53 10.35 11.78 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.709 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.66 -38.63 8.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.892 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -113.99 3.7 15.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 16.8 p -90.77 155.84 18.5 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 120.682 0.277 . . . . 0.0 111.396 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.443 ' CB ' ' HB2' ' A' ' 159' ' ' ASP . 64.6 mm-40 -122.04 106.04 10.84 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.425 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 6.2 p90 -164.35 162.87 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.96 0.409 . . . . 0.0 111.938 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.61 125.79 47.54 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 85.8 mtp -91.05 153.46 20.1 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.307 17.9 t70 88.57 82.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.663 1.585 . . . . 0.0 113.152 -177.243 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.416 ' HB3' ' CA ' ' A' ' 156' ' ' GLY . 11.7 p -100.83 -56.08 2.42 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.123 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.0 mt -99.8 -45.3 5.78 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 11.9 pt-20 -155.46 176.11 13.01 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.97 -21.59 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 119.689 1.132 . . . . 0.0 113.691 -170.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.46 12.35 10.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.101 0.953 . . . . 0.0 110.534 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.538 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 22.8 mm-40 -125.38 115.82 20.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.65 147.13 5.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 149' ' ' SER . . . -110.77 -78.69 0.98 Allowed Glycine 0 CA--C 1.491 -1.431 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.698 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.28 123.01 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 44.0 mt -128.59 106.98 15.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 144' ' ' GLU . 20.2 m-20 -86.63 -34.73 19.72 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.04 110.61 2.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.293 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -84.26 124.01 30.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 143' ' ' SER . . . -99.37 147.04 25.65 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.62 139.44 55.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.117 0.886 . . . . 0.0 113.375 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.567 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.0 p-10 -93.61 3.51 55.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.06 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.9 p -66.22 -3.94 6.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.737 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -64.0 -39.95 95.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 123.534 0.733 . . . . 0.0 109.959 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -108.14 -32.82 7.36 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 118.601 -1.24 . . . . 0.0 111.269 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.422 HG13 ' CB ' ' A' ' 137' ' ' ALA . 74.0 mt -85.81 149.95 4.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.428 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 69.3 mtp180 -51.73 127.4 33.93 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.02 0.528 . . . . 0.0 112.01 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.93 -13.67 23.97 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.393 2.062 . . . . 0.0 111.33 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 7.9 p-10 -96.59 7.27 46.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.325 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 151.01 44.14 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.868 0.842 . . . . 0.0 109.78 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -102.19 -30.44 11.12 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.479 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.4 ttt -160.65 128.33 4.42 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -153.75 -179.2 7.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.128 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -137.05 139.24 41.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 60.4 m -72.75 146.64 46.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.767 0.667 . . . . 0.0 110.17 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.9 p -73.05 -50.42 23.09 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.51 15.45 17.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.79 110.13 6.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.538 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 13.2 ptt180 -76.85 -22.36 53.63 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.807 -170.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -86.82 -16.63 35.61 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.289 -0.257 . . . . 0.0 110.948 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.6 tp -87.06 99.76 12.15 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.802 0.81 . . . . 0.0 111.484 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.23 123.78 59.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.16 133.18 52.78 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.041 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' A' ' 174' ' ' MET . 41.1 pt -121.58 158.61 24.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.989 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.617 ' HD3' ' OD1' ' A' ' 189' ' ' ASP . 9.1 ptp180 -85.07 162.06 19.45 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.504 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.9 pt-20 -54.13 -39.85 66.85 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.617 ' OD1' ' HD3' ' A' ' 187' ' ' ARG . 7.5 m-20 -52.53 -42.21 64.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.21 1.004 . . . . 0.0 111.304 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.04 -50.34 77.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.684 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.576 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 21.9 p80 -71.67 -31.06 66.39 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.525 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.97 73.31 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 111.025 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.43 -36.8 68.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.733 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -69.0 -35.57 76.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.345 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 18.8 mm-40 -55.65 -49.15 73.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -79.79 -22.8 42.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.295 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -75.32 -27.89 59.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.658 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 80.55 42.44 10.18 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.46 166.53 18.25 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 17.1 p -57.75 -164.1 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.71 134.83 12.88 Favored Glycine 0 CA--C 1.49 -1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 113.427 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -129.47 159.59 35.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -117.49 120.86 39.4 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.89 135.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -128.89 147.62 50.84 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.03 107.82 7.35 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.81 -33.95 77.21 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.684 0.793 . . . . 0.0 111.929 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.82 100.54 0.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.854 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 73.9 30.03 62.09 Favored Glycine 0 C--O 1.219 -0.824 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.424 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.65 104.58 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.182 0.993 . . . . 0.0 110.911 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.88 126.91 51.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.46 -25.58 0.27 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 119.362 2.505 . . . . 0.0 119.362 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 142.28 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -172.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.5 131.43 34.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.171 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 215' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.314 -0.935 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.481 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.3 -165.7 48.89 Favored Glycine 0 C--O 1.253 1.309 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.8 m -91.75 91.62 8.04 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.501 0.667 . . . . 0.0 109.453 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -152.93 148.68 27.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -74.26 -57.51 3.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -152.61 -64.75 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -93.16 -20.5 20.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 84.1 t60 64.91 11.81 7.3 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.818 0.847 . . . . 0.0 111.718 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . 0.383 28.6 m80 -92.23 75.54 5.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -173.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -141.65 38.13 1.66 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 m -48.15 138.92 8.92 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.385 2.274 . . . . 0.0 114.698 -172.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 m -136.51 -156.0 0.67 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.54 93.27 0.2 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.86 95.53 10.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.8 t -113.18 109.18 52.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.34 97.74 1.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 121.92 1.747 . . . . 0.0 109.263 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -78.98 132.68 36.76 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.521 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.61 -66.32 2.91 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 p -67.31 -70.48 0.25 Allowed 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 123.74 0.816 . . . . 0.0 111.681 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 73.1 -35.82 0.34 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.45 1.5 . . . . 0.0 113.435 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.2 ttp 65.9 79.88 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.36 137.72 21.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.911 -173.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 7.4 ptpp? -108.11 146.06 33.2 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -118.88 143.96 46.67 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.038 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB3' ' HB ' ' A' ' 204' ' ' VAL . 97.6 m-85 -126.87 151.3 48.57 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 -176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 HD12 ' A' ' 183' ' ' LEU . 14.0 t -85.89 129.9 37.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -95.92 135.3 37.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -150.61 158.79 44.56 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.23 131.11 60.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.485 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 13.4 tmm? -103.54 105.87 16.23 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.521 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 161.53 123.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.085 2.154 . . . . 0.0 108.662 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -86.84 -23.28 25.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.54 -13.94 62.31 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.394 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -73.32 -32.53 64.64 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 77.82 1.08 Allowed Glycine 1 N--CA 1.391 -4.3 0 C-N-CA 118.943 -1.599 . . . . 0.0 114.127 177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -63.71 136.02 57.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 68' ' ' PHE . 29.8 mt -68.36 104.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 40.1 mm-40 -54.29 -70.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.2 1.562 . . . . 0.0 111.283 -173.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 176.5 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.427 0.691 . . . . 0.0 110.022 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.8 mp -72.14 130.92 85.77 Favored Pre-proline 0 C--O 1.252 1.22 0 O-C-N 123.93 0.769 . . . . 0.0 111.044 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 1.1 Cg_endo -78.62 167.4 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.912 2.408 . . . . 0.0 111.658 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.03 129.33 41.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.686 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.76 0.72 90.34 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.712 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 m -84.97 137.39 37.71 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 117.172 0.486 . . . . 0.0 110.183 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.31 165.55 10.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.306 2.67 . . . . 0.0 112.238 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -55.66 155.09 6.03 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -45.28 -51.47 10.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.232 1.413 . . . . 0.0 111.595 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.611 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 27.1 p-90 -85.94 -16.48 38.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.042 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . 0.423 54.4 mttt -86.75 -11.24 51.66 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.607 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 45.3 m-85 -49.87 -34.1 19.07 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 123.705 0.628 . . . . 0.0 111.944 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -128.04 20.33 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.579 -0.701 . . . . 0.0 112.616 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 0.9 OUTLIER -93.03 101.17 13.49 Favored 'General case' 0 C--O 1.2 -1.525 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.179 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.16 -10.98 0.01 OUTLIER Glycine 0 CA--C 1.556 2.612 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 168.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.52 173.84 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 121.12 2.46 . . . . 0.0 112.277 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -85.93 141.97 29.17 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.8 mt -87.79 -2.78 58.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.495 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.38 66.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.227 0.537 . . . . 0.0 111.904 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -87.63 -39.18 15.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.138 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.93 -21.33 18.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -99.06 141.48 22.95 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.01 122.8 9.69 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.053 1.835 . . . . 0.0 111.898 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.36 110.18 23.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.26 21.17 39.17 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.45 -153.55 30.33 Favored Glycine 0 C--O 1.252 1.262 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 35.4 mt-10 -141.61 139.1 33.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 28.9 m -133.73 166.44 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 m -144.09 150.31 37.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 120.771 0.32 . . . . 0.0 111.248 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' HG12 ' A' ' 37' ' ' ILE . 13.1 m-85 -80.52 120.58 24.68 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 38' ' ' GLU . 14.1 p -61.32 139.87 58.09 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.697 0.623 . . . . 0.0 109.918 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.14 43.17 0.77 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.617 0.723 . . . . 0.0 112.537 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -70.07 -30.18 67.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.854 0.835 . . . . 0.0 110.067 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CD1' ' HB2' ' A' ' 75' ' ' ASN . 2.7 t80 -106.92 113.15 62.94 Favored Pre-proline 0 N--CA 1.423 -1.775 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.98 -58.58 0.87 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.17 2.58 . . . . 0.0 113.202 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -112.91 92.28 3.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.79 0.805 . . . . 0.0 110.293 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 72' ' ' TYR . 36.2 t-20 -133.1 151.31 52.02 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.42 -165.89 1.41 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -164.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.22 -172.94 4.25 Favored 'General case' 0 C--O 1.194 -1.867 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.438 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 4.6 mp -87.64 143.8 26.99 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -100.14 -178.72 3.92 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.19 0.596 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -60.56 -35.25 75.59 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.515 0.674 . . . . 0.0 110.116 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -129.58 126.98 39.75 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.613 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -115.92 125.35 28.73 Favored Pre-proline 0 C--N 1.279 -2.462 0 O-C-N 123.515 0.509 . . . . 0.0 110.35 -174.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 175.34 8.71 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -163.37 166.63 22.7 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 123.261 0.624 . . . . 0.0 109.586 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -99.91 28.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.4 mtm -116.24 -79.86 0.59 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 50' ' ' PHE . 35.2 t -179.18 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.349 0.565 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -77.66 164.45 25.29 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.598 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.29 141.48 36.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.451 0.569 . . . . 0.0 110.1 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 48.5 tp -110.8 125.26 53.38 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -125.42 147.09 30.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.2 p -77.91 170.2 17.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.742 0.306 . . . . 0.0 110.342 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.9 -18.7 79.4 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -74.31 -52.53 11.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.56 -23.61 63.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.472 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HA ' ' CH2' ' A' ' 109' ' ' TRP . 54.9 ttt180 -57.74 -43.97 85.74 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.041 174.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.6 mmpt? -65.07 -39.41 93.2 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.23 -54.58 45.13 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.368 0.418 . . . . 0.0 110.326 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.1 -46.51 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.461 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.26 -26.91 65.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -72.66 -25.0 61.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.033 0.444 . . . . 0.0 111.156 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.1 -1.51 57.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.305 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.06 47.78 63.32 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.542 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.4 t -73.69 112.73 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -80.27 141.19 35.76 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.739 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 78.32 15.85 1.3 Allowed 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 125.282 1.433 . . . . 0.0 112.263 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.62 113.97 19.18 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.416 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 8.4 tp10 -104.72 124.81 50.04 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.538 ' CH2' HD12 ' A' ' 129' ' ' LEU . 61.9 m95 -108.55 120.15 41.6 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.235 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -109.75 94.13 16.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.72 133.57 12.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.601 2.201 . . . . 0.0 112.532 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.79 160.08 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.625 0.77 . . . . 0.0 109.977 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -93.82 116.73 29.22 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -108.96 136.98 43.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -100.06 146.47 26.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.8 p-10 -90.12 -163.96 1.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.766 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -67.16 -32.39 73.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.139 0.975 . . . . 0.0 111.138 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -83.59 -18.5 38.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.204 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.12 20.54 20.49 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.063 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 20.0 ptmt -105.55 153.42 21.79 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -86.7 90.18 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.531 0.681 . . . . 0.0 109.24 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.26 13.23 6.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.088 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.509 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -127.78 39.72 1.87 Allowed Glycine 0 CA--C 1.552 2.361 0 C-N-CA 119.437 -1.364 . . . . 0.0 116.335 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.76 -0.58 8.7 Favored 'Trans proline' 0 C--N 1.375 1.923 0 CA-C-N 122.013 2.907 . . . . 0.0 112.624 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.54 -9.67 24.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.946 0.899 . . . . 0.0 110.662 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.509 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 16.5 m-85 -103.59 153.99 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.363 -165.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.28 142.81 35.68 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.6 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.29 122.33 26.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.538 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.4 tt -101.16 122.14 43.09 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.325 0.583 . . . . 0.0 110.007 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.36 140.02 53.17 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.393 172.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.52 141.05 29.5 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.52 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.37 173.55 6.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.08 11.51 72.85 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.987 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.02 132.99 35.08 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -137.36 170.22 16.45 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.24 113.21 1.47 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -139.38 -19.16 0.97 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.2 mt -64.17 112.86 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.279 0.561 . . . . 0.0 110.981 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.58 115.22 10.51 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.084 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.6 mtt -99.07 6.17 46.69 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.181 0.515 . . . . 0.0 110.594 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -84.7 -46.28 11.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -102.72 -11.96 18.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.283 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 m -90.76 148.21 22.71 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.833 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -135.0 112.75 10.85 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -158.17 173.17 17.11 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.19 138.16 53.07 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.052 0.541 . . . . 0.0 109.708 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.9 mmt -87.16 108.06 18.74 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -175.51 63.74 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 154' ' ' GLN . 22.9 m -102.82 -56.31 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.074 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 75.6 mt -134.58 -57.16 0.84 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.07 -173.69 2.31 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.902 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -95.07 4.83 53.28 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -103.59 16.52 26.23 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 149' ' ' SER . 21.9 mm-40 -133.34 125.01 28.24 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.255 -174.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 76.0 mt -84.47 119.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 123.365 0.416 . . . . 0.0 110.212 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -98.82 -62.68 0.85 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.246 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.76 133.1 42.74 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.32 -34.73 5.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.672 0.749 . . . . 0.0 109.892 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.97 117.0 18.58 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -98.32 146.8 25.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.24 146.66 52.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.86 0.838 . . . . 0.0 112.012 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.5 p-10 -90.08 8.92 30.25 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.3 p -69.38 -6.27 28.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.343 172.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -60.96 -39.97 91.58 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 124.623 1.169 . . . . 0.0 109.662 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -31.98 6.65 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.263 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.56 141.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 62.9 mmt-85 -60.61 118.34 33.52 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 123.28 0.363 . . . . 0.0 110.132 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -5.37 11.25 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.977 3.118 . . . . 0.0 115.012 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.07 -9.71 58.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.431 0.158 . . . . 0.0 111.377 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.14 114.06 13.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -80.6 -8.69 59.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.415 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.0 ttt -152.64 118.75 5.49 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.422 ' HE2' ' OD1' ' A' ' 164' ' ' ASP . 35.9 p90 -148.48 -179.47 6.98 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.861 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -143.88 147.32 33.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 44.4 m -80.61 151.49 29.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 124.22 0.95 . . . . 0.0 111.19 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.1 p -81.42 -50.28 9.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -85.52 30.27 0.64 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.547 ' N ' HH21 ' A' ' 181' ' ' ARG . 0.3 OUTLIER -160.27 147.24 15.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.169 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 48' ' ' TRP . 8.7 mmp_? -91.18 -39.0 12.36 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -14.72 17.68 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.122 0.264 . . . . 0.0 110.785 -170.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.403 HD12 HG13 ' A' ' 26' ' ' VAL . 28.3 tp -70.03 100.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.243 1.02 . . . . 0.0 109.813 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.45 122.95 67.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.6 mt -107.39 130.02 54.85 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.182 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 174' ' ' MET . 46.5 pt -118.24 149.77 20.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.361 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -82.27 152.97 26.11 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.469 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 10.4 pt-20 -49.04 -41.23 34.3 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.419 0.688 . . . . 0.0 112.338 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -53.12 -40.86 64.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.628 1.571 . . . . 0.0 112.462 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.17 -49.3 62.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.891 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 25.5 p80 -71.42 -24.55 62.06 Favored 'General case' 0 C--O 1.198 -1.641 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.067 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.34 80.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.001 0.52 . . . . 0.0 110.604 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 196' ' ' GLN . . . -69.22 -33.2 72.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.188 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 16.6 m-85 -73.35 -32.83 64.75 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.879 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 59.2 mm-40 -63.24 -42.96 99.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 193' ' ' ALA . 12.9 pt20 -77.55 -24.69 49.8 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.159 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 -27.3 43.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.233 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.1 42.79 75.26 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.663 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.61 165.19 24.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.611 0.364 . . . . 0.0 110.995 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.9 p -39.14 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -173.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.97 141.19 9.18 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.391 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.31 165.21 28.06 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 40.8 ttpt -157.29 121.84 4.38 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 25' ' ' PHE . 26.8 m -125.29 146.96 30.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.448 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -125.11 142.44 51.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.112 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.86 114.65 2.18 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.16 -35.03 61.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.81 94.55 2.77 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.812 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.72 35.12 7.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.19 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -67.77 97.49 0.64 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.14 0.495 . . . . 0.0 110.583 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.06 132.24 51.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.01 -25.44 0.25 Allowed Glycine 0 N--CA 1.479 1.55 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 165.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.85 127.13 32.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 117.777 0.788 . . . . 0.0 112.618 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.6 131.19 37.69 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.611 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 C--N 1.308 -1.227 0 O-C-N 124.026 0.829 . . . . 0.0 109.728 -178.238 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 C--O 1.218 -0.558 0 N-CA-C 110.685 -0.117 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.16 14.86 9.46 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 119.649 -1.262 . . . . 0.0 114.092 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -98.99 96.95 8.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -101.16 149.91 23.49 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -79.37 79.92 5.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.879 0.847 . . . . 0.0 110.591 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -90.42 135.03 33.94 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.205 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -126.81 103.82 7.72 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.628 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -78.55 -24.01 45.86 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.352 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -147.01 -86.12 0.1 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.634 168.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 50.45 65.02 1.57 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.345 1.458 . . . . 0.0 110.606 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.6 t -109.09 -162.97 0.84 Allowed 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.771 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.8 m 66.08 29.07 10.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.201 1.0 . . . . 0.0 111.029 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.85 73.08 0.63 Allowed Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -92.99 165.02 13.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.116 0.484 . . . . 0.0 111.262 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.67 91.46 25.48 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.44 117.51 5.16 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.104 1.869 . . . . 0.0 110.923 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -106.91 122.86 47.26 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.846 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.78 -53.07 3.29 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.0 m 64.11 160.08 0.1 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -179.09 174.24 1.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.6 ptm -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.528 1.058 . . . . 0.0 109.529 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG11 ' HD3' ' A' ' 187' ' ' ARG . 58.0 t -85.11 120.77 36.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.309 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -94.01 152.81 18.54 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.298 0.57 . . . . 0.0 111.635 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 140.73 43.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.523 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -124.0 151.08 44.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.467 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.26 118.04 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -92.18 117.99 30.4 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -136.47 139.81 42.62 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 83' ' ' PRO . 97.1 t -89.54 120.86 38.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 120.723 0.297 . . . . 0.0 110.422 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.454 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 49.6 ttp -82.44 86.42 6.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.0 0.905 . . . . 0.0 110.224 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . -144.79 112.76 6.37 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -119.47 -58.7 1.89 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.398 -173.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.94 -21.52 43.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . . . -67.02 -35.76 80.63 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 95.92 158.02 32.02 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 114.064 -1.426 . . . . 0.0 114.501 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 46.4 m-85 -96.57 166.06 11.86 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 84' ' ' ASN . 21.9 mt -78.09 101.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 101.501 -3.518 . . . . 0.0 101.501 163.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -65.64 -44.29 86.86 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.055 0.847 . . . . 0.0 111.892 -167.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -132.44 176.03 8.77 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.72 119.55 71.86 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.622 0.769 . . . . 0.0 112.725 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.76 167.75 24.85 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.759 2.306 . . . . 0.0 113.02 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -42.47 114.54 0.59 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.138 1.775 . . . . 0.0 113.421 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.61 79.23 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.551 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 39.6 m -85.54 139.62 35.81 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.63 165.96 23.67 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 123.79 2.993 . . . . 0.0 111.554 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.7 p -49.15 146.33 3.65 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -37.83 -56.73 1.07 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.114 2.565 . . . . 0.0 113.595 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -86.23 -22.06 27.09 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.825 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 47.0 tptt -86.61 -12.24 49.14 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.398 -169.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.475 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 53.0 m-85 -44.05 -49.54 8.74 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.646 0.591 . . . . 0.0 112.571 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.279 30.8 m-70 -127.92 31.68 5.07 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.1 tm-20 -92.84 100.71 13.13 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.36 -10.25 3.76 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 174.76 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.354 2.077 . . . . 0.0 113.295 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 t -96.37 158.48 15.42 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.484 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.5 -13.33 40.51 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.845 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.07 -26.55 49.82 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.74 -20.17 25.12 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -116.51 -22.07 8.89 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.583 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -100.17 138.51 20.27 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.29 123.06 10.15 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.175 1.917 . . . . 0.0 112.581 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.41 114.85 29.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.26 18.28 59.34 Favored Glycine 0 C--N 1.311 -0.843 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.4 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -88.25 -161.84 37.52 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.178 -0.534 . . . . 0.0 111.985 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -129.14 131.75 47.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.38 170.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 t -147.11 147.13 30.27 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.4 110.25 2.2 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.838 171.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 p -62.31 123.86 19.35 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.975 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -85.63 81.26 8.72 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.47 -39.14 91.63 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.143 0.497 . . . . 0.0 110.827 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -170.84 -53.35 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.396 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.39 118.57 5.76 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 120.898 1.065 . . . . 0.0 111.494 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.47 99.75 8.93 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.6 178.49 4.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.674 -174.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -90.94 -154.25 0.34 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.606 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -86.2 -177.44 6.26 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.054 1.342 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.15 150.45 23.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.855 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 20.8 m-85 -114.14 -166.68 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.69 -40.94 94.07 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.773 0.715 . . . . 0.0 111.844 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -118.58 147.71 43.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.608 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 24.8 mm-40 -132.54 126.77 20.29 Favored Pre-proline 0 C--O 1.249 1.039 0 C-N-CA 123.069 0.548 . . . . 0.0 110.361 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 63.4 Cg_endo -92.53 178.56 1.39 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.575 2.183 . . . . 0.0 112.503 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.5 p30 -163.94 173.74 12.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.62 -9.49 10.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.336 1.065 . . . . 0.0 109.619 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -95.25 -178.1 4.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.501 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 5.7 p -93.02 39.17 1.04 Allowed 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.9 159.56 34.54 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.433 ' HB2' ' NH2' ' A' ' 176' ' ' ARG . 53.6 tp -124.19 141.53 51.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.15 118.33 36.46 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.44 144.28 29.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 p -75.08 167.37 22.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.08 -20.46 79.68 Favored Glycine 0 C--N 1.31 -0.868 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -70.79 -57.64 4.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -25.61 67.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.265 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 50.9 ttt180 -54.94 -51.1 67.16 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 124.02 0.928 . . . . 0.0 110.171 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -69.27 -25.32 64.2 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.749 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.26 -49.55 77.42 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.897 0.379 . . . . 0.0 110.189 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.1 -37.06 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.526 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 61.2 mt-10 -67.37 -33.34 75.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.205 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.0 m -65.74 -33.84 76.81 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.028 0.531 . . . . 0.0 111.548 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.38 -6.8 58.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.244 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.32 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.85 109.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.541 0.686 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.9 m -80.3 154.85 27.57 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 80.31 14.21 0.84 Allowed 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.76 114.11 27.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.5 tp10 -112.91 138.93 49.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -119.75 116.31 25.67 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -172.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.7 mt -109.11 99.46 35.89 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.27 145.16 23.9 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.448 2.099 . . . . 0.0 112.584 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.4 m -149.57 166.3 3.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 123.633 0.773 . . . . 0.0 109.226 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.05 28.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 126' ' ' TYR . 32.3 mt -113.07 132.46 61.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -98.08 147.55 24.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.13 -160.66 0.43 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.477 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 67.0 m80 -74.63 -22.73 58.77 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 122.265 -0.272 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -87.56 -18.8 28.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.449 0.468 . . . . 0.0 110.194 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.65 36.92 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.033 173.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -101.8 148.49 25.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.634 0.717 . . . . 0.0 110.563 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.16 89.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.468 0.651 . . . . 0.0 110.493 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.4 m -115.6 13.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.433 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.19 49.96 0.9 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 119.97 -1.109 . . . . 0.0 115.245 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.49 -8.28 9.58 Favored 'Trans proline' 0 C--N 1.376 2.025 0 CA-C-N 121.335 2.568 . . . . 0.0 111.458 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -92.06 -14.29 29.53 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.41 1.484 . . . . 0.0 110.788 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.43 ' HB2' HD12 ' A' ' 114' ' ' ILE . 4.3 m-85 -91.03 150.89 21.25 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.883 0.849 . . . . 0.0 112.958 -169.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.46 143.52 39.68 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.438 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.23 117.95 20.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.27 127.59 37.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.92 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.5 m-80 -110.42 127.54 55.15 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.655 -177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.33 125.59 47.98 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.31 172.9 6.55 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 -7.91 81.07 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.82 129.56 34.83 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.85 0.833 . . . . 0.0 109.153 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -148.56 170.11 18.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -46.4 108.82 0.15 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.988 0.805 . . . . 0.0 110.127 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -126.34 -47.21 1.6 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -165.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.437 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 26.2 mt -61.69 118.82 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 119.353 0.979 . . . . 0.0 112.611 -172.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.76 127.92 34.31 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.713 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.4 mtt -94.46 -0.41 54.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.32 -50.63 5.55 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.559 0.695 . . . . 0.0 110.12 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -93.75 -9.36 37.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.216 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -108.14 140.5 41.25 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -120.73 100.51 7.15 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -145.74 165.03 30.0 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.703 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -120.82 147.72 44.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.167 0.917 . . . . 0.0 109.611 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 53.0 mtt -100.47 154.18 18.75 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.291 36.3 t70 90.76 84.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.844 2.457 . . . . 0.0 112.108 -176.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.2 t -99.49 -36.62 9.49 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.611 -1.631 . . . . 0.0 107.621 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.9 mt -136.65 -54.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 12.7 pt-20 -137.32 -179.82 5.96 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.583 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -48.19 -49.48 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.302 1.841 . . . . 0.0 114.634 -171.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.526 ' HB2' HH21 ' A' ' 181' ' ' ARG . 7.7 p-10 -90.09 10.93 22.4 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -102.42 116.57 32.9 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.554 ' H ' ' HG2' ' A' ' 180' ' ' GLU . 70.2 mt -74.31 129.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -108.5 -60.14 0.54 Allowed Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.988 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -92.83 119.15 31.87 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.0 109.91 27.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.03 -34.31 16.85 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.75 138.95 20.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.86 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.8 114.85 15.84 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.78 147.64 25.83 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 140.42 57.33 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.816 0.817 . . . . 0.0 112.916 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 20.4 p-10 -94.65 16.14 16.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.286 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 168' ' ' ILE . 18.2 p -67.01 -5.77 14.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.034 175.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.8 m -64.65 -33.43 75.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.323 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -32.95 6.34 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.249 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 165' ' ' THR . 66.7 mt -92.45 122.23 43.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -56.47 127.82 72.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 118.023 0.374 . . . . 0.0 111.504 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.06 -5.36 6.22 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.601 2.867 . . . . 0.0 115.427 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -80.24 -9.21 59.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.062 0.392 . . . . 0.0 111.13 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 127.2 31.82 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.112 0.482 . . . . 0.0 110.098 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.51 -36.75 76.76 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.036 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' MET . . . . . 0.487 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.5 ttt -148.29 132.03 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.3 -179.79 7.85 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.507 0.504 . . . . 0.0 109.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.433 ' NH2' ' HB2' ' A' ' 89' ' ' LEU . 14.6 ttm180 -136.12 139.56 43.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 183' ' ' LEU . 63.9 m -74.63 139.44 43.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 O-C-N 124.062 0.851 . . . . 0.0 110.105 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 p -82.7 -12.75 57.35 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.437 ' HG3' ' HB ' ' A' ' 138' ' ' ILE . 72.8 mmtt -90.24 -5.0 56.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.866 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -151.32 142.77 23.49 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.526 HH21 ' HB2' ' A' ' 153' ' ' ASP . 17.5 mmt180 -89.35 -30.41 18.42 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -170.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -86.39 -25.35 25.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.093 0.473 . . . . 0.0 110.561 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.0 tt -75.18 102.54 5.01 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.812 -172.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.89 142.2 19.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.2 mt -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.376 0.608 . . . . 0.0 111.1 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.487 HG22 ' HG3' ' A' ' 174' ' ' MET . 44.9 pt -124.72 157.7 32.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.652 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.47 ' HD3' HG11 ' A' ' 22' ' ' VAL . 97.0 mtt180 -80.25 159.63 25.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.496 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 7.5 pt-20 -52.82 -37.56 60.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.729 0.812 . . . . 0.0 110.799 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.43 -42.93 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.282 1.833 . . . . 0.0 111.629 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.67 -45.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.771 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 16.3 p80 -69.6 -30.56 68.34 Favored 'General case' 0 C--O 1.2 -1.538 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.426 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -61.35 -32.03 71.91 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.301 0.572 . . . . 0.0 111.044 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.19 61.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.4 m-85 -74.52 -33.91 62.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.956 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 42.2 mt-10 -63.03 -48.89 76.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.149 0.58 . . . . 0.0 110.585 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.43 -18.57 63.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.926 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.59 -22.26 22.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.673 0.273 . . . . 0.0 111.294 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.25 46.12 66.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.58 158.72 20.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 38.4 p -106.31 139.69 40.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 108.29 56.41 0.58 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.732 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 46.1 m-85 -135.36 142.16 45.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 118.62 1.21 . . . . 0.0 112.464 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 21.1 tptm -146.24 122.77 11.07 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.47 137.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.416 0.627 . . . . 0.0 111.999 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.1 m-85 -129.0 143.68 50.95 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.276 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.7 66.81 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -69.86 100.32 1.53 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.069 0.461 . . . . 0.0 110.556 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.07 28.03 38.71 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.566 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -54.85 102.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.604 1.161 . . . . 0.0 110.893 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -103.88 111.53 24.11 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.22 1.98 23.45 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 165.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 58.3 mt -95.06 131.57 40.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 118.452 1.126 . . . . 0.0 110.103 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -90.26 132.49 35.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.58 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.8 pt? . . . . . 0 C--N 1.305 -1.369 0 O-C-N 123.717 0.635 . . . . 0.0 111.904 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.78 -80.68 0.64 Allowed Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 p 57.19 179.06 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.344 1.457 . . . . 0.0 114.167 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -82.02 93.46 6.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -98.18 76.95 2.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.442 0.639 . . . . 0.0 109.59 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -166.97 34.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -81.78 74.85 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.903 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -61.67 162.4 8.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.34 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -100.78 133.76 44.77 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -87.2 135.96 33.11 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t 73.65 140.29 0.06 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.794 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -64.8 -32.22 73.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.911 -176.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.47 20.36 76.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.2 mt -128.36 128.05 43.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.09 117.73 36.66 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.15 98.52 0.54 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.826 1.684 . . . . 0.0 110.388 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -76.87 -46.21 25.42 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.821 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.26 148.12 19.35 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -83.3 84.51 7.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.814 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -83.47 114.66 21.63 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.5 mmt -70.54 -27.28 64.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -171.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 84.3 t -81.77 115.93 25.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.093 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.37 151.49 49.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.587 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -111.22 134.54 52.73 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.028 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.3 144.09 44.27 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.151 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.1 119.16 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -91.55 124.89 36.06 Favored 'General case' 0 N--CA 1.422 -1.838 0 O-C-N 123.809 0.693 . . . . 0.0 109.454 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -150.3 159.28 44.56 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.424 HG13 ' CA ' ' A' ' 201' ' ' GLY . 91.3 t -101.69 129.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.8 ptp -69.85 160.91 30.92 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.84 0.712 . . . . 0.0 111.139 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 70.76 118.96 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 124.996 1.435 . . . . 0.0 112.214 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 10.3 pt-20 -70.82 -20.12 62.6 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.008 0.909 . . . . 0.0 109.524 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.75 -16.29 62.75 Favored 'General case' 0 C--O 1.206 -1.21 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.972 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.57 -30.0 62.67 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.551 0.74 . . . . 0.0 112.63 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 75' ' ' ASN . . . 105.56 79.0 1.24 Allowed Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 119.412 -1.375 . . . . 0.0 112.043 177.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 93.4 m-85 -69.66 151.9 45.33 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.473 HG12 ' CE2' ' A' ' 68' ' ' PHE . 28.7 mt -73.91 101.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 166.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' CB ' ' HB3' ' A' ' 71' ' ' ASN . 58.1 mm-40 -56.19 -41.64 75.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.863 -171.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.22 160.27 43.92 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -51.16 136.72 29.1 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 33.3 Cg_endo -78.52 166.84 23.54 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.208 2.605 . . . . 0.0 111.606 173.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -53.94 117.02 2.87 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.54 1.136 . . . . 0.0 113.274 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.31 10.37 64.05 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 58.2 p -86.01 148.37 47.81 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 23.8 Cg_exo -69.66 165.67 30.08 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.508 2.805 . . . . 0.0 110.212 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -59.88 155.6 16.09 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -39.93 -54.86 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 127.556 2.343 . . . . 0.0 114.015 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 181' ' ' ARG . 34.6 p-90 -86.51 -20.9 27.35 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.379 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -86.43 -12.64 48.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.483 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.518 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 52.4 m-85 -46.04 -34.27 3.99 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 88' ' ' ASN . 40.2 m-70 -129.82 15.54 5.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.31 101.82 14.07 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.072 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.12 -9.99 2.75 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.64 172.9 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.63 1.715 . . . . 0.0 111.466 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 t -98.33 157.05 16.43 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.21 -16.73 48.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -23.67 58.78 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -86.86 -22.12 25.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 45' ' ' PRO . 10.0 m-20 -115.83 -22.87 8.88 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -96.85 135.62 22.04 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 124.05 11.73 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.917 2.411 . . . . 0.0 112.176 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.61 125.6 50.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.94 23.01 62.51 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.756 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.501 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -103.97 -157.05 24.18 Favored Glycine 0 C--O 1.25 1.131 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.154 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.4 130.86 46.53 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 33.1 m -126.19 166.5 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 19.9 m -149.17 149.91 31.79 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 37' ' ' ILE . 11.1 m-30 -71.92 117.03 13.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -63.89 147.37 52.08 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.221 0.534 . . . . 0.0 112.228 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -69.59 76.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.562 1.173 . . . . 0.0 113.649 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.404 ' HB3' ' CB ' ' A' ' 38' ' ' GLU . 29.2 t-20 -106.78 -37.32 6.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.812 -1.54 . . . . 0.0 106.878 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -142.75 124.64 8.69 Favored Pre-proline 0 N--CA 1.435 -1.181 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.964 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.79 15.64 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.86 2.374 . . . . 0.0 109.339 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.05 -164.87 1.12 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.673 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 78.7 m-20 73.78 167.0 0.3 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.953 1.301 . . . . 0.0 112.213 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.7 mmm-85 -79.23 -173.93 3.89 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 121.901 0.858 . . . . 0.0 112.044 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -81.24 -171.96 3.53 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.146 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.36 150.69 21.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.649 0.738 . . . . 0.0 111.859 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.92 -161.19 0.75 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.869 1.268 . . . . 0.0 107.783 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -75.08 -34.62 61.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 118.762 0.71 . . . . 0.0 111.127 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.25 134.35 55.26 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 33.4 tp60 -119.31 127.55 26.41 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.45 -179.79 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.042 2.495 . . . . 0.0 113.577 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.425 HD22 HD12 ' A' ' 37' ' ' ILE . 25.1 p30 -163.57 178.84 7.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.292 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.2 mt -103.85 34.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.5 mtp -129.56 -155.92 0.73 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 40.0 p -119.73 -11.06 9.44 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.473 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 25.9 p-10 -88.19 159.36 18.19 Favored 'General case' 0 C--O 1.201 -1.448 0 O-C-N 121.669 -0.644 . . . . 0.0 110.838 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.75 135.11 54.98 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 61.1 tp -100.13 120.66 40.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.12 139.07 48.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.506 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.4 p -73.98 164.34 26.75 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.64 -21.65 77.84 Favored Glycine 0 C--N 1.327 0.074 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -75.4 -48.35 23.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.18 73.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.249 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 73.1 ttt180 -56.17 -44.16 79.08 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.382 1.073 . . . . 0.0 110.277 174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -46.68 83.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 124.071 0.857 . . . . 0.0 110.407 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.71 -55.24 31.93 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.312 1.008 . . . . 0.0 111.234 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.13 -40.27 80.55 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 C-N-CA 123.692 0.797 . . . . 0.0 111.637 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 81.5 mt-10 -68.69 -35.12 76.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -69.46 -30.47 68.38 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.17 -17.1 57.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.44 20.9 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.698 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.8 113.73 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.9 t -82.6 153.6 25.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 73.58 16.85 3.86 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 124.684 1.194 . . . . 0.0 112.227 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.47 113.5 26.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -105.38 143.45 33.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.459 ' CH2' HD12 ' A' ' 129' ' ' LEU . 58.9 m95 -117.35 119.78 36.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -174.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.1 mt -111.82 96.04 31.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.84 134.44 14.84 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.75 2.3 . . . . 0.0 113.031 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 64' ' ' GLY . 8.0 m -150.2 172.59 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.223 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.96 116.18 28.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -97.45 121.05 47.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.406 0.622 . . . . 0.0 111.145 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HG2' HG22 ' A' ' 121' ' ' VAL . 94.4 mttt -96.28 133.82 40.16 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.4 p-10 -78.22 -160.31 0.2 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.258 0.551 . . . . 0.0 111.205 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -61.28 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.261 1.024 . . . . 0.0 110.765 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -84.66 -19.56 32.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.323 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.7 21.86 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.24 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.633 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.3 ptmt -102.99 142.31 34.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.504 HG22 ' HG2' ' A' ' 115' ' ' LYS . 24.3 t -83.7 84.31 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.526 0.679 . . . . 0.0 110.213 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.46 0.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.312 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.89 58.77 0.7 Allowed Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.52 -11.38 8.22 Favored 'Trans proline' 0 C--N 1.367 1.5 0 CA-C-N 120.623 2.211 . . . . 0.0 111.631 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.71 -5.28 39.12 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 124.837 1.255 . . . . 0.0 109.762 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.614 ' HB2' HD13 ' A' ' 114' ' ' ILE . 1.8 m-85 -93.14 152.23 19.37 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.608 -172.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.15 146.64 40.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.123 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.27 118.81 25.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.305 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.459 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.5 tt -91.65 128.68 37.57 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.11 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 121.09 34.37 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.153 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.423 ' H ' ' CE1' ' A' ' 51' ' ' HIS . 2.8 mm? -79.58 128.47 33.43 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.422 173.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -102.98 174.95 5.64 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 125.573 1.795 . . . . 0.0 107.625 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.6 20.55 63.7 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.542 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.59 131.95 36.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.84 158.1 43.92 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.71 106.83 0.39 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.265 0.939 . . . . 0.0 111.399 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.68 -18.44 7.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.99 113.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.029 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.57 127.77 33.91 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.688 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.4 ttm -117.93 7.61 12.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.25 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 10.2 pt-20 -95.34 -34.93 11.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.057 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.436 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 21.8 mmt85 -94.31 -31.48 14.04 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.6 m -75.71 158.51 32.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.748 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -137.09 105.52 5.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.04 165.63 33.52 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.771 0.319 . . . . 0.0 111.753 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 19.1 mm-40 -118.18 134.29 55.14 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' MET . . . . . 0.477 ' SD ' HG12 ' A' ' 155' ' ' ILE . 11.5 mmt -74.01 156.38 37.59 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.145 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.336 16.3 t70 100.41 99.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 172.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 m -100.49 -55.78 2.51 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 165.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.1 -42.94 2.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.795 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 5.4 pt-20 -142.99 -178.59 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -46.37 -49.39 17.93 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 125.87 1.668 . . . . 0.0 115.164 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.4 27.58 1.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.814 1.293 . . . . 0.0 112.318 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -123.71 115.78 21.98 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 104.654 -2.351 . . . . 0.0 104.654 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.477 HG12 ' SD ' ' A' ' 147' ' ' MET . 57.1 mt -84.63 124.92 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 118.388 0.54 . . . . 0.0 110.775 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.93 -66.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.131 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 7.7 t30 -93.0 119.5 32.32 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.3 mt -125.12 125.12 68.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -103.86 -34.21 8.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.372 0.606 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.07 137.07 14.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -127.18 119.3 26.11 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.71 147.21 24.59 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.65 145.91 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.559 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 30.6 p-10 -89.42 4.54 48.72 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.156 0.983 . . . . 0.0 110.63 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -66.1 -6.48 13.32 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.374 1.07 . . . . 0.0 109.997 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -59.3 -40.98 87.9 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.66 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.77 -32.85 6.28 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.172 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 137' ' ' ALA . 81.0 mt -81.23 141.99 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.402 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 51.7 mtm180 -55.47 114.61 7.58 Favored Pre-proline 0 N--CA 1.45 -0.446 0 O-C-N 123.409 0.443 . . . . 0.0 110.763 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.45 -19.3 67.04 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 123.261 2.641 . . . . 0.0 113.867 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 6.3 p-10 -73.59 -11.72 60.52 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.903 0.481 . . . . 0.0 112.074 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.41 48.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 123.654 0.597 . . . . 0.0 110.67 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.5 -38.56 14.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.9 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.7 ttt -141.47 125.27 16.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.46 -177.96 6.69 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.012 0.925 . . . . 0.0 108.64 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.447 ' O ' ' HD3' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -142.65 151.63 41.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 118.444 0.565 . . . . 0.0 111.76 -177.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.591 ' SG ' HD22 ' A' ' 183' ' ' LEU . 67.2 m -82.86 129.98 35.07 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 124.157 0.911 . . . . 0.0 109.479 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.5 p -64.06 -51.07 65.82 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.31 22.91 2.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.32 139.68 39.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 48' ' ' TRP . 16.2 mmt180 -91.28 -27.29 18.52 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.924 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.69 -0.4 20.12 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.329 -172.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.591 HD22 ' SG ' ' A' ' 177' ' ' CYS . 1.8 tt -95.11 103.66 15.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.562 0.696 . . . . 0.0 109.315 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.2 mt -111.84 140.47 31.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.4 HD12 ' OD2' ' A' ' 164' ' ' ASP . 53.0 mt -116.78 137.24 52.34 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 118.584 0.629 . . . . 0.0 112.412 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.0 pt -129.36 151.8 36.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.653 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -80.29 163.44 23.95 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.739 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.471 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 0.2 OUTLIER -55.36 -42.08 73.41 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.493 0.717 . . . . 0.0 110.534 176.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -50.49 -39.72 49.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.872 1.669 . . . . 0.0 112.135 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.24 -46.88 76.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.922 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.501 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 14.8 p80 -77.2 -21.94 53.13 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.089 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.67 80.07 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.523 0.678 . . . . 0.0 110.38 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.47 73.97 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.093 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.71 -32.48 67.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.0 mm-40 -57.1 -49.63 75.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -81.51 -7.02 59.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.88 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.57 -27.28 18.29 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 122.097 -0.377 . . . . 0.0 110.167 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 66.98 43.31 91.56 Favored Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 155.72 21.2 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.0 p -106.15 139.37 40.77 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.424 ' CA ' HG13 ' A' ' 29' ' ' VAL . . . 106.44 56.6 0.64 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.634 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -126.95 147.61 50.09 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 121.206 0.527 . . . . 0.0 111.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -156.85 121.76 4.56 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.6 139.53 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.728 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 97.3 m-85 -128.55 151.33 49.57 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 210' ' ' TRP . 20.3 mm-40 -64.66 121.28 14.12 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.27 45.74 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.21 90.12 2.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.347 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.39 32.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.95 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 206' ' ' GLU . 19.6 t90 -58.77 105.35 0.3 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.851 0.861 . . . . 0.0 110.618 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.84 105.55 15.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.8 -24.42 0.3 Allowed Glycine 0 N--CA 1.474 1.172 0 N-CA-C 119.177 2.431 . . . . 0.0 119.177 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.87 115.34 3.33 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.117 0.958 . . . . 0.0 110.567 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.52 125.6 28.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.583 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.103 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -96.91 148.02 23.37 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.46 137.07 47.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.612 0.72 . . . . 0.0 111.828 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.71 151.35 49.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.621 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG13 HD12 ' A' ' 183' ' ' LEU . 80.8 t -81.6 130.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 172.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -91.73 122.11 33.98 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.712 0.768 . . . . 0.0 110.81 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -138.57 152.48 48.21 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.02 127.51 56.77 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.556 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 12.0 tmm? -85.78 84.42 7.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.56 112.47 3.72 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.528 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.39 -45.92 3.98 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.258 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.97 -12.26 59.92 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.02 120.72 2.11 Favored Glycine 0 N--CA 1.409 -3.119 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.659 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -70.76 152.13 44.12 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mt -78.49 101.4 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -72.73 -42.28 64.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.189 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.526 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 41.1 ttmt -133.01 141.78 48.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.32 132.37 95.32 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 55.6 Cg_endo -74.73 167.55 26.85 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.891 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -54.5 124.64 16.77 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 112.727 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.99 68.51 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.287 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -85.65 133.26 42.2 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.47 165.53 32.44 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.294 2.663 . . . . 0.0 109.948 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 p -51.92 149.46 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.23 -50.45 3.61 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 128.243 2.617 . . . . 0.0 113.684 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -85.89 -25.89 25.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.966 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -80.57 -15.38 56.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.649 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -44.83 -47.55 11.01 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.634 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 2.8 m-70 -127.01 30.12 5.5 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.76 -1.213 . . . . 0.0 109.869 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HA ' HH21 ' A' ' 176' ' ' ARG . 2.1 tm-20 -92.88 101.99 14.36 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -9.23 0.31 Allowed Glycine 0 CA--C 1.54 1.603 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.23 168.2 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 118.779 1.289 . . . . 0.0 112.801 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 t -97.09 154.48 17.31 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.5 mt -102.38 10.64 38.93 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.441 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.36 -29.55 70.54 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.726 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.9 -13.73 38.41 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -114.98 -21.97 9.8 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.29 134.81 20.36 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.87 127.47 25.26 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.278 2.652 . . . . 0.0 113.268 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.53 115.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.24 22.91 50.38 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.971 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -102.56 -167.32 26.47 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.01 141.85 49.34 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 117.511 0.656 . . . . 0.0 109.265 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 31.1 m -133.71 165.92 30.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.0 t -153.07 153.85 33.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.183 0.516 . . . . 0.0 111.211 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.95 117.93 19.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.889 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.526 ' OG ' ' HB3' ' A' ' 39' ' ' LYS . 12.8 p . . . . . 0 N--CA 1.417 -2.102 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . 0.27 90.6 m-20 . . . . . 0 C--O 1.24 0.564 0 CA-C-O 122.048 0.927 . . . . 0.0 112.872 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -88.61 -154.88 0.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.954 1.301 . . . . 0.0 111.336 -169.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.67 -167.46 1.63 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.937 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -87.31 150.69 23.69 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.372 0.669 . . . . 0.0 112.089 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -105.83 -159.55 0.71 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -71.37 -42.18 68.77 Favored 'General case' 0 CA--C 1.48 -1.749 0 CA-C-N 119.086 0.857 . . . . 0.0 110.624 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -120.83 135.69 55.1 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 35.5 tp60 -116.4 117.99 37.91 Favored Pre-proline 0 C--N 1.28 -2.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.59 162.62 27.34 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.939 2.426 . . . . 0.0 112.058 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -163.81 174.32 11.71 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.181 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.25 -6.47 10.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.444 0.64 . . . . 0.0 110.311 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -96.55 -174.78 3.13 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.847 -0.533 . . . . 0.0 111.273 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -96.41 43.88 1.07 Allowed 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.214 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -138.33 151.33 47.45 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.01 138.85 54.58 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 51.7 tp -105.96 129.61 54.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.184 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.08 140.36 49.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.054 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -70.82 167.3 19.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.063 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.47 -37.67 92.86 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.502 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -72.25 -37.43 69.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.35 -30.52 62.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.351 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.406 ' HG3' ' CE3' ' A' ' 109' ' ' TRP . 49.3 ttp180 -58.41 -48.71 79.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.099 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 10.2 tmtt? -62.43 -37.44 85.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.936 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.79 -53.21 59.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 120.583 0.23 . . . . 0.0 111.105 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.2 -41.5 87.01 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.17 -31.14 71.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.313 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -71.42 -22.08 61.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.54 -19.81 32.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.96 0.41 . . . . 0.0 110.551 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.06 48.05 7.19 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.269 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.1 t -78.97 114.57 19.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.4 t -80.03 158.24 26.55 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.137 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 78.5 19.19 0.95 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.316 1.01 . . . . 0.0 110.406 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.03 134.03 50.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.498 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.9 tp10 -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE3' ' HG3' ' A' ' 96' ' ' ARG . 52.2 m95 -117.0 118.62 32.92 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 123.459 0.475 . . . . 0.0 110.082 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HG ' HD21 ' A' ' 130' ' ' ASN . 83.7 mt -107.12 102.49 43.52 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.99 129.98 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.744 2.296 . . . . 0.0 113.683 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' GLY . 12.1 m -142.87 172.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.359 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.72 116.23 29.53 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.529 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.4 mp -101.59 124.93 55.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.468 0.651 . . . . 0.0 110.966 -176.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 87.3 mttt -97.35 132.14 43.36 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.6 -161.56 0.24 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -62.6 -31.57 72.42 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.44 -4.27 55.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.739 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.74 14.75 79.22 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.709 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 20.1 pttp -104.84 140.06 38.68 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.534 0.333 . . . . 0.0 110.247 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.23 107.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.43 -0.29 6.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.417 0.627 . . . . 0.0 110.905 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.87 75.95 0.34 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.45 -27.68 2.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.093 1.862 . . . . 0.0 113.773 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -118.53 23.38 11.55 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.813 1.292 . . . . 0.0 109.285 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.529 ' HB2' HD13 ' A' ' 114' ' ' ILE . 2.9 m-85 -88.66 144.86 26.01 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.528 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.77 46.43 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.758 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.7 126.88 32.32 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.534 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 tt -90.54 125.28 35.56 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.846 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.634 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 28.2 m-80 -107.15 137.03 45.98 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.955 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.21 120.58 42.96 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.9 172.96 6.52 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 124.029 0.83 . . . . 0.0 110.649 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 22.78 64.24 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.54 131.19 37.87 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -147.88 151.61 36.18 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -52.89 115.19 1.71 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.966 0.791 . . . . 0.0 112.09 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -131.93 -26.36 1.97 Allowed 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -167.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 17.7 mt -62.36 125.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.72 125.74 26.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 23.0 ttt -118.83 1.88 11.57 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.737 0.78 . . . . 0.0 109.718 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.4 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 11.2 pt-20 -99.57 -32.56 11.04 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.73 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.4 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 68.0 mtt85 -108.02 -10.87 15.41 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.182 0.593 . . . . 0.0 110.552 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.5 m -93.84 110.6 22.25 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.362 0.601 . . . . 0.0 110.603 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -78.61 100.72 7.09 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.379 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.49 145.46 27.93 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.239 0.543 . . . . 0.0 111.904 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -101.3 127.97 47.67 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 71.8 mtp -100.73 154.56 18.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 24.0 t70 90.71 85.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 127.269 2.228 . . . . 0.0 114.1 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.7 m -100.43 -26.77 13.76 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.322 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -145.99 -48.05 0.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 14.3 pt-20 -139.75 177.79 7.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.16 -38.58 80.09 Favored 'General case' 0 C--O 1.214 -0.782 0 O-C-N 124.292 0.995 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 25.7 m-20 -85.97 26.11 1.04 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -123.46 113.31 18.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.0 mt -87.03 132.29 32.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 124.238 1.015 . . . . 0.0 109.946 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.05 -72.51 0.95 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.478 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -90.76 133.11 35.42 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.65 124.51 59.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.84 -34.55 8.49 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.04 136.87 20.55 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.85 123.73 29.67 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.84 143.2 32.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.67 139.64 57.07 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.767 0.794 . . . . 0.0 112.96 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.58 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.7 p-10 -94.33 15.55 17.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.112 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.7 p -67.45 -5.22 13.88 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.892 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.1 m -61.57 -38.14 86.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.959 0.903 . . . . 0.0 110.673 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.406 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.63 -30.5 7.08 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.788 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 137' ' ' ALA . 73.8 mt -85.82 139.2 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -54.79 117.96 15.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 O-C-N 123.189 0.306 . . . . 0.0 111.243 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.16 -13.18 33.97 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.419 2.746 . . . . 0.0 114.037 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.84 -12.73 60.22 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.76 129.06 38.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.075 0.464 . . . . 0.0 109.83 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -83.63 -17.0 43.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.794 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.424 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.0 ttt -154.38 128.16 8.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -153.36 178.52 9.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 178' ' ' THR . 1.6 ppt_? -128.47 142.43 51.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.414 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 58.2 m -86.52 140.48 29.87 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 123.832 0.708 . . . . 0.0 109.483 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 176' ' ' ARG . 19.3 p -68.75 -44.56 73.5 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.745 2.868 . . . . 0.0 118.745 -168.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -89.19 23.7 2.38 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.544 0.611 . . . . 0.0 112.333 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 9.0 tp10 -154.94 135.6 13.53 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.418 HH21 ' CD ' ' A' ' 151' ' ' GLU . 69.8 mtt180 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.9 mtm-85 -83.81 -7.37 59.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.767 -167.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 180' ' ' GLU . 26.2 tp -82.42 100.63 10.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.819 0.818 . . . . 0.0 110.973 -174.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.1 mt -117.84 124.38 72.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 207' ' ' ALA . 43.4 mt -103.94 134.71 46.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.523 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.0 pt -123.68 157.74 29.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.597 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -86.06 162.43 18.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.62 -44.63 26.95 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.199 1.399 . . . . 0.0 111.996 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.22 -43.56 70.94 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.439 1.096 . . . . 0.0 111.301 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.31 -53.19 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.178 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 13.7 p80 -75.31 -26.54 58.76 Favored 'General case' 0 C--O 1.195 -1.804 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.714 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.99 83.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 0.0 110.351 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.77 72.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.552 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.457 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 21.0 m-85 -73.57 -36.43 65.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.247 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -56.92 -50.75 71.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 121.625 0.726 . . . . 0.0 109.218 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.91 -26.67 61.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.21 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.53 -27.47 62.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.425 0.155 . . . . 0.0 111.046 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.9 47.51 13.85 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.05 165.87 18.2 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.8 p -42.15 -72.83 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -165.96 144.43 9.19 Favored Glycine 0 CA--C 1.488 -1.637 0 C-N-CA 118.998 -1.572 . . . . 0.0 113.118 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 194' ' ' PHE . 74.5 m-85 -137.37 152.78 50.05 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 22.4 tptm -132.21 121.84 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 24.7 m -116.43 139.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.563 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -121.68 151.44 40.47 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.62 133.39 40.9 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.207 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.405 ' HB2' HD22 ' A' ' 185' ' ' LEU . . . -80.13 -38.34 31.73 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.936 0.874 . . . . 0.0 108.642 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.74 104.8 13.26 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.004 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.55 35.33 47.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.523 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.439 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 8.7 t90 -54.31 102.18 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.082 1.353 . . . . 0.0 111.217 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.55 109.89 21.74 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.73 2.94 31.82 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 167.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.439 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 82.7 mt -94.14 145.37 24.74 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 117.902 0.851 . . . . 0.0 109.738 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.2 0.524 . . . . 0.0 111.459 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.997 178.42 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.455 HG11 ' NE ' ' A' ' 187' ' ' ARG . 45.0 t . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -87.01 155.8 20.01 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.317 0.579 . . . . 0.0 112.3 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -112.06 138.45 48.7 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.158 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.85 150.92 49.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.46 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.8 130.0 36.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -95.72 128.86 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.512 0.507 . . . . 0.0 111.141 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -150.12 149.58 30.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.94 115.56 41.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.657 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 57.0 ttp -85.28 101.61 12.67 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 173.56 177.19 0.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.144 1.778 . . . . 0.0 107.56 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.17 -36.21 1.53 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 122.04 0.924 . . . . 0.0 110.147 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -89.64 -0.85 57.79 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.962 1.305 . . . . 0.0 111.46 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.18 58.5 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.57 82.69 1.14 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.253 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -95.01 164.61 12.82 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.31 102.21 13.41 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.87 -55.42 29.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.917 -172.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -137.03 176.47 8.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 46' ' ' THR . 7.8 mp -55.37 125.74 60.08 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HB3' ' HB ' ' A' ' 66' ' ' VAL . 16.4 Cg_exo -71.44 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 123.031 2.487 . . . . 0.0 111.344 169.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -55.8 117.16 3.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.889 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 9.11 83.52 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.281 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m -85.79 139.32 35.22 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -67.59 166.28 24.52 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.686 2.924 . . . . 0.0 112.619 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.406 ' HA ' HD21 ' A' ' 40' ' ' LEU . 5.3 p -53.23 152.01 4.77 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.09 -58.74 2.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 127.534 2.333 . . . . 0.0 113.975 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -80.55 -25.39 38.62 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.431 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 45.1 tptt -80.52 -16.77 53.43 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -172.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -45.51 -43.37 11.69 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.462 ' HB3' ' HG3' ' A' ' 176' ' ' ARG . 55.9 m170 -126.98 24.16 6.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.978 -1.076 . . . . 0.0 111.097 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -93.45 102.7 14.93 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.063 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.29 -8.95 0.59 Allowed Glycine 0 CA--C 1.538 1.495 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.99 171.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 118.499 1.149 . . . . 0.0 113.648 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -98.55 137.93 36.49 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.56 -0.78 48.4 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.07 -23.22 67.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.021 0.438 . . . . 0.0 111.381 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -88.74 -27.88 20.88 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -112.69 -15.53 12.97 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -110.21 135.75 20.55 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.95 123.94 13.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.635 2.223 . . . . 0.0 113.36 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.4 t -95.02 107.68 19.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.47 23.54 28.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.15 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.22 -153.85 25.24 Favored Glycine 0 C--O 1.24 0.507 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.46 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -131.81 132.2 43.53 Favored 'General case' 0 C--O 1.248 0.981 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 41' ' ' PRO . 21.3 m -134.03 168.33 24.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -149.15 158.28 44.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -84.85 106.69 16.57 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 121.568 0.699 . . . . 0.0 109.409 178.405 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 . . . . . 0 C--O 1.246 0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -90.68 -151.36 0.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -165.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -84.88 -171.19 3.5 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.645 1.578 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.488 HD13 HG23 ' A' ' 122' ' ' VAL . 8.6 mp -100.12 150.21 22.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.171 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.505 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 18.3 m-85 -125.4 -165.74 1.45 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.208 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -52.49 -51.59 58.64 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 123.499 0.719 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -116.2 142.89 46.22 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.918 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 24.6 mm-40 -121.34 111.89 33.24 Favored Pre-proline 0 C--N 1.285 -2.224 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.025 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 167.3 27.68 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.458 2.106 . . . . 0.0 111.35 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -142.69 156.39 45.03 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.4 mt -91.12 -19.48 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -99.02 -179.07 4.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 33.5 t -97.82 66.1 1.88 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.712 -1.195 . . . . 0.0 114.057 -174.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -140.13 121.05 14.54 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.491 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 138.12 31.71 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.354 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 64.9 tp -111.57 127.12 55.63 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.79 141.24 45.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.53 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -78.95 170.2 17.05 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.74 -16.37 79.23 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -69.71 -58.62 3.69 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -25.59 63.33 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.101 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -60.22 -40.89 91.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.509 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.545 ' CE ' ' HA ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.29 -29.5 65.13 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.508 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.82 -57.84 10.98 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.49 -42.74 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.427 0.691 . . . . 0.0 112.562 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.12 -27.48 62.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 p -78.3 -13.0 60.04 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.497 0.665 . . . . 0.0 111.39 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -88.73 -25.57 22.24 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.592 173.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.28 48.36 8.28 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.38 107.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.582 0.706 . . . . 0.0 111.671 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -66.92 137.3 56.45 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.151 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 79.94 11.55 1.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.493 1.917 . . . . 0.0 113.667 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.75 114.32 26.04 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -107.5 144.63 34.19 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.429 ' CH2' HD12 ' A' ' 129' ' ' LEU . 67.0 m95 -116.46 121.43 41.82 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 123.586 0.554 . . . . 0.0 110.238 -174.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.57 96.51 43.87 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.38 139.75 16.72 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.549 2.166 . . . . 0.0 112.868 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.14 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.319 0.648 . . . . 0.0 109.804 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.18 116.55 28.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 126' ' ' TYR . 54.9 mt -110.54 131.14 62.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.613 0.72 . . . . 0.0 112.865 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.488 ' HG2' HG22 ' A' ' 121' ' ' VAL . 93.0 mttt -104.76 148.75 26.27 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.571 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -89.32 -160.69 0.7 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.316 0.579 . . . . 0.0 111.241 -174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -63.85 -34.3 77.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.62 1.168 . . . . 0.0 110.507 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.53 -19.42 29.51 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.66 19.7 24.12 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.571 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 52.2 pttt -99.29 146.35 26.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.488 HG22 ' HG2' ' A' ' 115' ' ' LYS . 17.6 t -82.71 81.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.681 0.753 . . . . 0.0 110.148 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 HD13 ' A' ' 78' ' ' LEU . 10.1 m -105.4 8.19 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.429 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.78 50.76 0.88 Allowed Glycine 0 CA--C 1.542 1.757 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.73 -6.76 9.7 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 121.097 2.449 . . . . 0.0 112.285 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -103.11 -0.99 29.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.438 ' HB2' HD12 ' A' ' 114' ' ' ILE . 2.7 m-85 -98.0 147.87 24.06 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 122.002 0.906 . . . . 0.0 112.86 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.28 139.5 42.72 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.702 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -79.67 124.3 28.44 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.046 0.451 . . . . 0.0 110.111 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.429 HD12 ' CH2' ' A' ' 109' ' ' TRP . 8.0 tt -96.86 125.98 41.68 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.759 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -122.88 134.62 54.37 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.848 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.78 31.94 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.719 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.07 174.12 6.39 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 124.87 1.356 . . . . 0.0 109.016 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.78 28.9 25.12 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.592 -0.814 . . . . 0.0 115.114 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.407 ' HB3' ' NH2' ' A' ' 176' ' ' ARG . . . -112.89 131.79 55.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.151 -1.019 . . . . 0.0 110.984 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.78 111.66 6.13 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.724 -1.125 . . . . 0.0 107.99 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.0 t70 71.21 -52.34 0.69 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 125.978 1.711 . . . . 0.0 112.253 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.36 -100.58 0.06 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 125.961 1.704 . . . . 0.0 114.484 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 179' ' ' LYS . 46.8 mt -64.12 125.08 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 O-C-N 123.686 0.616 . . . . 0.0 110.405 -172.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 100.64 1.94 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.538 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 21.6 ttt -75.81 -12.75 60.23 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.353 -171.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.53 -39.89 67.19 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -101.21 4.55 42.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.347 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.538 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 77.7 p -92.54 115.65 28.29 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.767 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -92.53 104.53 16.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.32 164.02 32.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.529 0.681 . . . . 0.0 112.532 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.87 117.95 31.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 26.3 ttt -100.28 107.48 19.3 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.883 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.6 t70 170.41 89.33 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.909 1.683 . . . . 0.0 108.589 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB3' ' HA2' ' A' ' 156' ' ' GLY . 7.8 p -101.07 -56.88 2.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.294 0.568 . . . . 0.0 110.358 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.17 -59.94 1.9 Allowed 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.54 -177.07 3.21 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.537 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 152' ' ' LYS . 1.2 tpmt? -76.01 -26.51 56.75 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.224 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.46 11.4 14.78 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.613 1.196 . . . . 0.0 110.025 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -124.68 127.84 47.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 48.5 mt -84.79 143.84 10.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 149' ' ' SER . . . -119.42 -70.44 0.33 Allowed Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.425 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.37 118.93 28.34 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 59.1 mt -118.29 132.23 68.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -106.67 -42.29 5.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -154.65 110.62 3.19 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.64 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -88.15 124.71 34.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.75 24.42 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.74 146.46 52.34 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -96.06 -9.15 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -68.0 -6.02 20.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.567 1.147 . . . . 0.0 111.035 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.9 m -65.39 -38.19 89.25 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -110.52 -30.98 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.373 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.83 151.52 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.491 ' HD3' ' OD2' ' A' ' 171' ' ' ASP . 55.5 mtt180 -62.44 126.65 88.56 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 122.267 0.227 . . . . 0.0 111.471 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.86 -10.12 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.139 1.892 . . . . 0.0 110.816 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' A' ' 169' ' ' ARG . 4.3 p-10 -85.21 2.14 45.1 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.091 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.99 134.73 33.88 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.52 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 67.8 mttm -84.01 -27.44 28.38 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.507 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.0 ttt -150.76 128.05 11.31 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.56 -179.19 7.03 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 123.559 0.537 . . . . 0.0 110.004 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -136.12 154.7 50.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 63.4 m -87.48 143.82 27.03 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.206 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.5 p -82.91 -9.61 59.22 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.447 ' HB2' HD12 ' A' ' 138' ' ' ILE . 58.9 mttp -105.87 23.74 13.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.72 -0.613 . . . . 0.0 111.853 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 183' ' ' LEU . 7.4 tp10 175.05 134.16 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 17.1 mmt180 -89.53 -31.05 17.8 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.495 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -77.85 -20.13 53.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.269 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 180' ' ' GLU . 20.3 tp -83.85 100.35 10.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.067 0.937 . . . . 0.0 110.64 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.3 mt -116.46 119.41 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 55.2 mt -104.89 136.04 45.12 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.608 0.718 . . . . 0.0 111.723 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.6 pt -119.3 153.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.417 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 10.6 mtp180 -86.06 161.3 19.0 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.498 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.7 pt-20 -55.42 -40.02 70.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.7 -26.34 66.97 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.465 0.706 . . . . 0.0 111.829 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.2 t -71.31 -51.01 37.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.797 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.548 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 19.3 p80 -73.17 -21.91 60.6 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.089 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.9 76.82 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.063 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.24 75.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.511 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.7 m-85 -71.18 -33.35 69.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.272 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 62.9 mm-40 -59.6 -47.93 83.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.491 0.663 . . . . 0.0 109.811 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -78.03 -12.76 60.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.516 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.06 -28.42 20.14 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.083 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.39 47.7 87.61 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.443 ' HB2' ' CE1' ' A' ' 202' ' ' PHE . 66.5 mt -77.9 164.18 25.37 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.5 p -41.41 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.45 135.06 6.81 Favored Glycine 0 CA--C 1.493 -1.322 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.809 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 199' ' ' LEU . 70.5 m-85 -146.37 161.94 39.28 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 58.1 tptt -153.59 122.26 6.34 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 18.0 m -112.66 134.46 55.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.054 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 73.4 m-85 -118.26 140.05 50.39 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.95 115.51 9.26 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.08 -35.05 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.382 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.97 92.67 0.52 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.062 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.99 35.6 17.97 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.399 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.405 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 8.3 t90 -53.12 115.01 1.66 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.802 0.841 . . . . 0.0 110.061 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.23 99.78 11.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.47 -1.59 9.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 117.832 1.893 . . . . 0.0 117.832 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.405 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 88.0 mt -94.56 143.2 26.62 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 118.029 0.914 . . . . 0.0 112.327 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.48 132.36 52.59 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.488 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 2.5 pt? . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.047 0.842 . . . . 0.0 112.387 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.22 -0.499 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -80.55 152.95 28.36 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -167.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.28 141.1 48.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.972 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.7 141.0 52.24 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 62.0 t -72.73 120.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.3 115.11 27.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.857 0.723 . . . . 0.0 110.7 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -140.3 120.16 13.51 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.9 t -72.66 129.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.461 ' HB3' ' HG3' ' A' ' 203' ' ' LYS 0.268 20.8 ptt? -102.01 66.68 1.04 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.73 1.252 . . . . 0.0 112.619 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.46 110.72 12.1 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -106.66 -17.24 14.29 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 122.19 0.995 . . . . 0.0 108.721 -171.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -86.97 -25.85 24.12 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.698 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.32 80.68 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.89 137.41 3.36 Favored Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.216 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -65.9 156.63 32.86 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.38 102.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -51.73 -52.19 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.832 1.332 . . . . 0.0 112.205 -169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -139.69 172.03 13.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 46' ' ' THR . 8.9 mp -55.46 124.63 56.33 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 18.8 Cg_endo -75.09 166.77 28.41 Favored 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 122.664 2.243 . . . . 0.0 112.198 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.15 121.4 6.74 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 125.109 1.364 . . . . 0.0 112.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.09 0.2 68.4 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.649 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.7 m -85.88 137.87 35.47 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.93 166.49 23.2 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 123.416 2.744 . . . . 0.0 109.795 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.473 ' HA ' HD21 ' A' ' 40' ' ' LEU . 18.0 p -48.22 153.01 0.75 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' OD1' ' HG3' ' A' ' 86' ' ' MET . 16.2 m-20 -37.68 -57.03 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 C-N-CA 126.863 2.065 . . . . 0.0 114.955 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -80.47 -30.33 37.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.419 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.72 -11.58 59.84 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.725 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 27.8 m-85 -45.84 -46.01 15.36 Favored 'General case' 0 C--O 1.209 -1.048 0 O-C-N 123.559 0.537 . . . . 0.0 111.347 174.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 17.4 m170 -129.41 17.0 5.98 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.19 101.34 13.41 Favored 'General case' 0 N--CA 1.425 -1.688 0 C-N-CA 117.76 -1.576 . . . . 0.0 108.373 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.03 -9.17 55.05 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.59 173.77 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 119.814 1.807 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -98.88 157.15 16.5 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.38 5.95 49.02 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.36 68.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.972 0.415 . . . . 0.0 111.792 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -88.37 -32.57 18.31 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.1 -22.61 15.13 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -102.53 136.97 19.26 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.37 123.86 13.95 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.063 2.509 . . . . 0.0 112.571 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.63 115.98 40.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.76 23.65 45.31 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.445 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -103.41 -159.33 25.01 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 121.453 -0.403 . . . . 0.0 112.315 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -133.31 135.68 44.99 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 27.2 m -133.41 172.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 t -155.64 154.47 31.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.52 119.84 16.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.424 -1.738 0 O-C-N 123.719 0.637 . . . . 0.0 109.671 177.002 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 . . . . . 0 CA--C 1.499 -1.017 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -98.68 -159.37 0.74 Allowed 'General case' 0 C--O 1.262 1.716 0 CA-C-O 121.361 0.6 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.39 -167.59 1.88 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.614 1.566 . . . . 0.0 112.42 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.79 147.39 25.18 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.573 0.749 . . . . 0.0 111.76 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.87 -171.52 1.86 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.17 0.988 . . . . 0.0 109.416 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.04 -46.09 71.79 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.546 0.688 . . . . 0.0 110.517 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.0 131.14 53.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 48.0 tp60 -111.44 116.21 50.99 Favored Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 121.053 0.454 . . . . 0.0 109.96 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.12 164.91 21.92 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.82 2.347 . . . . 0.0 112.413 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -157.36 173.61 16.67 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.417 HG22 HH21 ' A' ' 181' ' ' ARG . 16.0 mt -90.37 3.02 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 121.608 0.718 . . . . 0.0 110.33 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.47 ' HG3' ' OD1' ' A' ' 47' ' ' ASP . 4.1 mpp? -104.98 -175.7 2.87 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.88 -0.513 . . . . 0.0 110.321 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 22.6 t -92.58 16.41 12.12 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 120.989 0.423 . . . . 0.0 112.065 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -115.67 151.1 35.67 Favored 'General case' 0 C--O 1.205 -1.238 0 O-C-N 121.082 -1.012 . . . . 0.0 109.321 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.9 139.86 50.13 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 119.009 -1.077 . . . . 0.0 110.803 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 55.1 tp -109.1 126.39 53.14 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 129' ' ' LEU . 47.6 t -126.38 140.97 47.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.6 p -73.4 162.49 29.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.09 -31.92 82.39 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.211 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -72.34 -36.12 68.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.794 0.331 . . . . 0.0 110.753 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.26 -27.62 56.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -60.26 -39.32 86.37 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.112 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.7 mmtp -60.09 -44.18 94.99 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.15 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.63 -51.7 68.81 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.745 0.653 . . . . 0.0 110.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.93 -44.07 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.031 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.98 -20.35 60.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.8 t -72.06 -32.08 66.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.92 -2.07 57.91 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.396 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.69 47.86 82.65 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.555 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -75.24 110.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -75.84 151.79 37.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.188 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 79.58 12.77 1.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.231 1.413 . . . . 0.0 111.972 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.8 tp10 -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -113.27 126.14 55.07 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.51 99.75 42.28 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.33 125.47 6.38 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.501 2.134 . . . . 0.0 112.93 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 64' ' ' GLY . 12.6 m -143.07 170.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -104.93 116.84 32.65 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.1 mp -103.99 133.55 47.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.424 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.641 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -97.34 144.36 27.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -85.53 -163.8 0.91 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.107 0.48 . . . . 0.0 111.515 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -67.16 -29.64 69.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.235 0.614 . . . . 0.0 110.503 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -87.56 -5.49 58.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.65 18.86 64.97 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 114.402 0.521 . . . . 0.0 114.402 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -105.27 152.67 22.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 117.417 0.609 . . . . 0.0 110.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.12 85.71 2.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.405 0.621 . . . . 0.0 109.894 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.412 ' C ' ' HD3' ' A' ' 124' ' ' PRO . 11.6 m -110.13 6.67 8.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.497 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -125.37 59.17 0.65 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.679 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 10.6 Cg_endo -85.26 -19.68 3.63 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.41 2.073 . . . . 0.0 113.152 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.0 6.8 21.26 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.017 0.527 . . . . 0.0 110.688 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.497 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 1.5 m-85 -88.29 145.28 25.94 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.221 0.534 . . . . 0.0 110.158 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.38 144.29 48.12 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.408 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.99 128.27 34.32 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 91' ' ' VAL . 1.3 tt -97.68 126.93 43.28 Favored 'General case' 0 C--O 1.268 2.06 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 25.7 m-80 -111.13 127.22 55.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.757 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.96 122.6 38.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.85 174.42 5.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 124.148 0.905 . . . . 0.0 109.478 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.39 26.19 28.65 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.99 41.22 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.037 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.88 170.14 18.3 Favored 'General case' 0 C--N 1.263 -3.169 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.57 107.99 0.23 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.908 1.231 . . . . 0.0 111.995 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -80.48 -71.19 0.47 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.034 -1.894 . . . . 0.0 115.686 -163.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.21 124.67 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 O-C-N 123.804 0.69 . . . . 0.0 111.669 -170.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 141' ' ' GLU . 11.8 t70 -82.67 128.16 34.09 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.62 -22.91 32.08 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.437 ' HG2' ' OD2' ' A' ' 139' ' ' ASP . 11.1 pt-20 -95.37 -27.29 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.421 0.555 . . . . 0.0 111.157 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -86.81 -5.76 59.01 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.488 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -121.12 168.45 11.54 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -137.2 106.78 6.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -159.67 164.4 34.05 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.649 0.261 . . . . 0.0 111.148 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.89 129.75 51.49 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 62.2 mtt -92.26 107.63 19.35 Favored 'General case' 0 C--O 1.201 -1.455 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.202 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 165.45 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.026 1.73 . . . . 0.0 111.028 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.6 p -100.93 -56.47 2.31 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.848 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.9 mt -110.14 -31.84 7.21 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.553 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.79 -174.84 1.94 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 147' ' ' MET . 39.4 ttpt -63.02 -43.71 97.96 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.821 0.737 . . . . 0.0 112.852 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.26 26.01 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.152 0.977 . . . . 0.0 112.358 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -139.12 114.25 9.52 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.3 mt -85.03 144.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.12 -77.6 0.77 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -78.79 118.85 21.24 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 39.8 mt -126.34 116.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -100.79 -39.03 8.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.309 0.576 . . . . 0.0 109.769 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.18 128.88 24.67 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.72 111.18 17.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 147.18 24.11 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.75 129.45 39.84 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.189 0.931 . . . . 0.0 110.585 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.421 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.0 p-10 -84.68 11.6 8.68 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 124.413 1.085 . . . . 0.0 110.775 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.0 p -71.69 -4.94 30.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.139 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -73.76 -34.7 64.83 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.498 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.65 -33.62 8.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.719 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.8 mt -91.47 153.52 3.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.0 124.33 73.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 118.074 0.397 . . . . 0.0 111.037 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.43 -5.34 15.75 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.6 2.867 . . . . 0.0 113.908 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.68 -0.28 51.8 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.93 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.25 120.71 14.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.107 0.479 . . . . 0.0 110.457 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -73.99 -28.64 61.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.03 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.421 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.4 ttt -147.68 125.66 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -152.56 175.55 12.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 51' ' ' HIS . 0.2 OUTLIER -152.07 162.23 41.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.37 160.69 20.6 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.3 p -82.24 -49.29 10.25 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 124.134 0.974 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.75 4.68 31.66 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.31 138.08 47.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' SER . 11.4 mtm180 -90.14 -30.16 17.82 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.818 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.0 -28.07 13.95 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.2 tp -71.05 100.63 2.05 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-O 122.133 0.968 . . . . 0.0 112.76 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.23 132.87 64.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.94 122.25 43.74 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.604 0.716 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 191' ' ' HIS . 34.2 pt -112.08 151.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -85.08 159.99 20.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.439 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 11.3 pt-20 -54.44 -39.77 67.72 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -73.13 -27.89 61.94 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.105 0.562 . . . . 0.0 111.454 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.47 -47.42 72.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.631 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.7 p80 -71.21 -26.05 62.77 Favored 'General case' 0 C--O 1.196 -1.748 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.742 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.91 71.24 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.492 0.495 . . . . 0.0 110.7 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.55 -39.25 74.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.99 -32.41 70.6 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 65.6 mm-40 -58.25 -53.5 57.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.679 0.791 . . . . 0.0 109.678 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.52 -23.5 58.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.785 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.75 60.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.261 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.12 47.85 10.56 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.962 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.9 mt -80.32 161.78 24.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.6 p -38.8 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.87 128.81 1.53 Allowed Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.91 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -136.17 150.85 49.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 30' ' ' MET . 53.7 mtmt -106.99 128.45 54.36 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 15.6 m -118.84 129.24 75.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 123.797 0.686 . . . . 0.0 109.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.2 m-85 -118.44 154.52 32.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.17 116.06 12.15 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.98 -36.98 67.2 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.428 0.455 . . . . 0.0 111.646 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.28 102.07 1.02 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.18 60.32 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.657 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -57.45 100.62 0.05 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.974 1.31 . . . . 0.0 111.888 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.0 133.96 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -26.56 0.29 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 118.809 2.283 . . . . 0.0 118.809 167.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.47 134.12 45.17 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 118.313 1.057 . . . . 0.0 112.141 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -86.81 131.57 34.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.2 pt? . . . . . 0 C--N 1.299 -1.589 0 O-C-N 123.336 0.398 . . . . 0.0 110.563 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.433 -1.29 0 CA-C-O 122.301 1.048 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 157.53 26.33 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.059 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -107.58 137.77 45.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.673 0.749 . . . . 0.0 113.002 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -126.66 151.15 48.45 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.788 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -84.2 126.46 40.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -98.8 129.44 45.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.131 0.491 . . . . 0.0 112.323 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 203' ' ' LYS . 81.7 tttt -150.5 163.95 37.15 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.448 ' N ' ' HG2' ' A' ' 28' ' ' LYS . 48.2 t -103.77 131.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.465 ' HB3' ' HB2' ' A' ' 203' ' ' LYS . 14.1 ptp -91.01 97.29 11.09 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 167.82 134.88 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 125.099 1.36 . . . . 0.0 109.467 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.17 -17.83 31.8 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 9.6 mm-40 -88.75 0.2 56.71 Favored 'General case' 0 C--O 1.199 -1.604 0 C-N-CA 125.341 1.456 . . . . 0.0 111.851 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -69.9 -12.53 61.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.383 -0.823 . . . . 0.0 112.779 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.28 1.18 Allowed Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.832 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -89.27 145.46 25.37 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.1 mt -78.16 101.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -61.64 -41.22 97.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.177 0.923 . . . . 0.0 112.001 -169.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -141.79 170.56 15.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mp -52.88 123.51 32.65 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 125.108 1.363 . . . . 0.0 113.457 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -72.41 166.54 29.49 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.539 2.16 . . . . 0.0 111.776 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.77 115.83 1.84 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.57 6.59 58.39 Favored Glycine 0 C--O 1.225 -0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.653 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 33.4 m -85.95 140.98 35.2 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 44' ' ' SER . 1.5 Cg_endo -76.28 166.27 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.36 2.706 . . . . 0.0 110.158 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -49.49 151.73 1.52 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -40.66 -53.44 2.77 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 127.281 2.232 . . . . 0.0 114.521 -173.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -83.25 -29.18 28.65 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.743 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -81.09 -12.06 59.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.062 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 16.0 m-85 -43.89 -49.03 8.49 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.511 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 42.6 m80 -129.38 27.21 5.33 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.247 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.99 102.04 14.38 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.84 -9.93 35.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.01 161.76 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.986 1.393 . . . . 0.0 112.032 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -98.68 159.5 14.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.08 12.94 26.41 Favored 'General case' 0 C--O 1.206 -1.184 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.78 75.33 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 121.953 0.882 . . . . 0.0 111.17 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -89.52 -27.92 19.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.171 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.68 -22.23 19.54 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -114.21 144.74 32.25 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 123.16 12.26 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.774 2.316 . . . . 0.0 112.95 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -97.88 116.27 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.5 23.34 58.58 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.829 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -98.43 -160.22 30.1 Favored Glycine 0 C--O 1.245 0.814 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.814 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 46.6 mt-10 -127.48 130.08 48.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.462 0.305 . . . . 0.0 110.184 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.3 m -132.75 166.69 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 23.5 t -143.1 149.36 38.04 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.85 114.69 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.7 p . . . . . 0 C--N 1.296 -1.726 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 29.9 t-20 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 5.9 mmp_? -78.96 -165.48 0.75 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 122.031 0.92 . . . . 0.0 113.369 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.405 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.3 p-10 -93.7 -162.91 0.98 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.796 1.639 . . . . 0.0 110.372 -175.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.1 mp -91.73 135.98 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.727 0.298 . . . . 0.0 111.703 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 1.4 m-30 -99.36 -105.49 0.21 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.708 0.403 . . . . 0.0 110.542 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -117.0 -47.67 2.68 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.31 129.54 53.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 124.996 1.318 . . . . 0.0 107.616 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 15.8 mm100 -105.88 116.35 59.89 Favored Pre-proline 0 C--N 1.295 -1.786 0 O-C-N 123.436 0.46 . . . . 0.0 112.053 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.19 168.11 13.55 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.79 2.327 . . . . 0.0 111.36 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -163.66 -178.55 5.84 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.51 -13.47 9.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.19 178.45 5.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.209 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' HG3' ' A' ' 181' ' ' ARG . 3.7 m -90.48 46.67 1.36 Allowed 'General case' 0 C--O 1.251 1.182 0 CA-C-O 121.22 0.533 . . . . 0.0 110.41 -176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -136.73 145.26 44.44 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.7 tp -122.79 141.37 51.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.262 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 56.6 tp -113.7 125.91 54.65 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 129' ' ' LEU . 50.1 t -126.63 142.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -72.99 164.1 27.18 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -71.68 -18.51 77.35 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -65.1 -58.3 6.39 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.14 60.39 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.049 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 47.7 ttt180 -57.25 -47.9 80.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.927 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 1.2 mmmp? -61.88 -38.74 89.42 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 109.859 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.28 -53.53 56.2 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.601 0.563 . . . . 0.0 110.746 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.03 -41.85 87.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 123.716 0.806 . . . . 0.0 111.506 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 49.4 mt-10 -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.0 m -64.32 -30.58 71.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.145 0.497 . . . . 0.0 111.599 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.467 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.8 mp -84.44 -10.1 57.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.985 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.05 43.03 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.455 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.5 t -77.73 100.62 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 m -76.95 156.35 32.05 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.842 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 80.81 13.84 0.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.652 1.581 . . . . 0.0 110.838 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.59 122.69 47.19 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.021 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -115.81 144.68 43.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -114.66 122.25 45.88 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.173 0.589 . . . . 0.0 110.466 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HG ' HD21 ' A' ' 130' ' ' ASN . 78.6 mt -115.27 98.81 51.39 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.88 138.71 13.34 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.421 2.081 . . . . 0.0 113.185 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 64' ' ' GLY . 6.9 m -145.89 173.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.496 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.49 116.91 33.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 173.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 23.0 mt -111.34 134.19 54.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.315 0.579 . . . . 0.0 112.248 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.2 mptp? -98.11 148.38 23.6 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 5.9 p-10 -92.91 -160.49 0.76 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 71.8 m80 -71.84 -18.96 62.04 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.944 0.498 . . . . 0.0 111.554 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.8 -19.41 24.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.17 51.63 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.242 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.3 ptmt -98.32 138.61 35.32 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 91.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.148 0.499 . . . . 0.0 109.758 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.439 HG23 HD13 ' A' ' 78' ' ' LEU . 11.9 m -115.98 12.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.012 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.419 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -123.91 65.42 0.53 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.523 173.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 8.3 Cg_endo -85.37 -23.58 2.26 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.494 2.129 . . . . 0.0 113.224 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.55 4.08 21.84 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.441 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.419 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 6.9 m-85 -84.74 140.8 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.554 0.692 . . . . 0.0 110.972 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -129.85 141.44 50.82 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.928 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -79.8 127.26 32.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 91' ' ' VAL . 4.4 tt -93.41 124.79 37.64 Favored 'General case' 0 C--O 1.282 2.81 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.511 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 36.7 m-80 -104.58 128.84 52.69 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.106 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 114.37 27.66 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.4 169.63 9.93 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.133 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.09 22.52 78.79 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.915 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.7 131.67 34.39 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.21 169.26 18.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -58.15 105.71 0.3 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -127.52 -33.68 2.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 24.3 mt -59.36 119.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.037 -173.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.58 128.15 35.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.423 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 64.1 mtp -109.66 -25.64 10.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.931 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.51 -29.67 18.79 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.868 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -96.17 -11.59 25.93 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.522 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 m -104.56 149.74 25.23 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -114.34 104.83 12.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.423 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 4.3 p90 -154.19 150.95 28.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.399 0.619 . . . . 0.0 112.364 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 51.7 mm-40 -108.92 139.66 43.47 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.234 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 90.7 mtp -100.84 155.23 18.05 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.161 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 151' ' ' GLU . 16.7 t70 85.85 78.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.916 1.686 . . . . 0.0 113.766 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.601 ' OG ' ' HA3' ' A' ' 156' ' ' GLY . 49.9 m -103.19 -57.21 2.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.174 166.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.7 mt -94.02 -45.21 7.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 2.3 pp20? -147.01 171.78 14.73 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.567 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -54.75 -44.98 74.09 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.458 1.103 . . . . 0.0 113.548 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.554 ' HB3' HH12 ' A' ' 181' ' ' ARG . 7.0 t70 -92.38 15.1 14.66 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.011 0.91 . . . . 0.0 110.496 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 9.8 mm-40 -102.38 119.37 38.7 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 124.121 0.969 . . . . 0.0 110.308 175.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 50.7 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.601 ' HA3' ' OG ' ' A' ' 149' ' ' SER . . . -115.52 -65.05 0.39 Allowed Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.5 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 6.4 t30 -84.86 119.08 24.93 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 52.2 mt -128.12 127.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.47 -29.37 8.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.919 0.39 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.08 130.08 16.33 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.07 118.9 24.3 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.76 139.59 38.14 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.5 mt -57.77 145.42 34.84 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 138' ' ' ILE . 15.1 p-10 -94.61 15.1 18.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.683 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.55 -5.21 18.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.596 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -61.4 -35.72 78.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.212 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.79 -31.82 6.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.252 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 137' ' ' ALA . 78.3 mt -90.02 154.13 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -50.15 122.92 15.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 123.91 0.884 . . . . 0.0 112.708 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.4 -6.0 17.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.025 1.816 . . . . 0.0 110.512 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.493 ' HA ' ' NH2' ' A' ' 187' ' ' ARG . 5.8 p-10 -99.67 6.3 45.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.092 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -85.62 132.03 34.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.466 ' HG2' ' HD2' ' A' ' 187' ' ' ARG . 76.7 mttt -84.93 -16.51 40.79 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.138 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 185' ' ' LEU . 26.4 ttt -159.77 127.72 4.82 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.37 164.3 38.39 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 142.43 34.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.512 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 38.6 m -93.01 120.47 33.34 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -53.45 -46.46 69.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.476 ' HB2' HD12 ' A' ' 138' ' ' ILE . 41.2 mttp -79.2 24.32 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.21 158.33 44.02 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.554 HH12 ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -91.27 -51.54 5.25 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.762 174.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.433 ' HD3' ' OE2' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -92.54 -13.41 29.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.239 -167.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.512 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 37.3 tp -77.78 101.16 6.58 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 122.017 0.913 . . . . 0.0 111.841 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.5 mt -120.87 121.36 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 174' ' ' MET . 66.7 mt -97.15 133.59 41.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 120.933 0.397 . . . . 0.0 110.66 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.449 HG22 ' HG3' ' A' ' 174' ' ' MET . 42.7 pt -120.97 158.02 23.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.282 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.493 ' NH2' ' HA ' ' A' ' 171' ' ' ASP . 93.7 mtt180 -83.14 162.53 21.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.789 0.804 . . . . 0.0 111.068 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -55.56 -47.4 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.268 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.16 -26.94 69.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.115 0.259 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.467 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 61.9 t -65.21 -54.35 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.743 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -74.89 -26.43 59.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.232 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.35 -34.14 77.62 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.446 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.19 -37.34 78.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.231 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -69.65 -38.06 76.97 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.823 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -65.12 -40.79 95.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -77.04 -25.64 52.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.419 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.41 -27.49 46.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 121.176 0.513 . . . . 0.0 109.912 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.54 47.5 4.84 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.066 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.99 165.32 19.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.98 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -161.07 125.26 1.42 Allowed Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.361 -1.399 . . . . 0.0 112.347 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -120.66 145.34 47.54 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 30' ' ' MET . 50.2 tptt -105.18 121.37 43.68 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.88 129.72 71.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.342 0.591 . . . . 0.0 111.185 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -111.29 141.18 45.16 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.04 106.17 1.0 Allowed 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.82 74.47 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.163 0.506 . . . . 0.0 111.451 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -77.35 89.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.317 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.6 35.13 6.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.438 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.413 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 16.1 t90 -63.82 99.16 0.22 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.668 0.747 . . . . 0.0 111.802 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.16 130.5 51.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.36 -26.51 0.27 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 165.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.413 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 86.4 mt -76.26 141.3 41.74 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.384 1.092 . . . . 0.0 111.451 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.23 130.32 38.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.673 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HB2' ' CH2' ' A' ' 210' ' ' TRP . 36.7 tp . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -118.22 145.26 45.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.203 0.525 . . . . 0.0 110.341 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -114.2 132.63 56.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.647 -172.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 78.8 m-85 -116.62 141.63 47.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 17.2 t -78.32 121.79 31.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -96.24 129.86 43.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -173.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -150.47 153.92 36.76 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.8 t -87.82 145.61 7.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.55 140.98 31.04 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.187 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 88.91 128.48 0.03 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.742 2.017 . . . . 0.0 112.472 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 33.0 tt0 -73.21 -26.38 61.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.938 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 -0.25 43.82 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.069 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -77.05 11.64 1.73 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.17 65.88 0.95 Allowed Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.352 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 10.4 m-85 -79.79 142.01 35.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.032 0.444 . . . . 0.0 110.415 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.431 HD12 HD22 ' A' ' 84' ' ' ASN . 23.0 mt -89.41 104.66 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 170.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -61.85 -57.23 12.61 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.083 -172.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -117.49 176.47 5.15 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.04 132.17 88.55 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.15 166.49 29.44 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.271 1.981 . . . . 0.0 112.124 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -52.46 124.71 14.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.86 1.264 . . . . 0.0 112.476 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.44 81.75 Favored Glycine 0 CA--C 1.516 0.133 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.093 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 50.8 m -85.83 139.46 35.15 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.71 165.77 24.47 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.295 2.663 . . . . 0.0 110.878 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 p -54.17 150.59 8.13 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.55 ' HB3' ' NH1' ' A' ' 181' ' ' ARG . 3.8 m-20 -41.34 -59.18 1.63 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.707 2.003 . . . . 0.0 114.786 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -79.11 -30.53 43.82 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.853 0.359 . . . . 0.0 111.705 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 17.8 tppt? -79.01 -11.93 60.02 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.637 -173.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' O ' HD11 ' A' ' 56' ' ' LEU . 8.5 m-85 -44.72 -44.54 9.27 Favored 'General case' 0 C--O 1.194 -1.84 0 C-N-CA 123.517 0.727 . . . . 0.0 112.205 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.44 ' CG ' ' HD2' ' A' ' 176' ' ' ARG . 65.5 m80 -129.4 21.57 5.62 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.48 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 49' ' ' LYS . 1.8 tm-20 -91.91 101.32 13.89 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.29 -5.83 4.83 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.38 164.32 21.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -97.97 142.86 29.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' ' 50' ' ' PHE . 4.4 mp -99.28 -4.94 30.7 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.639 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.12 -21.59 66.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.116 0.484 . . . . 0.0 111.822 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.31 -21.13 24.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -116.86 -22.98 8.27 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -94.35 139.13 22.32 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.06 123.22 11.83 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.558 2.172 . . . . 0.0 112.812 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 HD22 ' A' ' 110' ' ' LEU . 30.1 t -100.07 107.55 21.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 23.56 30.24 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.434 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -96.85 -157.75 31.17 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.813 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.75 132.75 46.67 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.12 170.68 19.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -145.39 152.56 40.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.847 -0.533 . . . . 0.0 111.264 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -77.24 107.4 9.61 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p . . . . . 0 C--N 1.294 -1.837 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.231 177.381 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 13.3 t-20 . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -77.28 -165.46 0.59 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.687 0.755 . . . . 0.0 112.839 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.6 -165.28 1.13 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.238 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 122' ' ' VAL . 8.1 mp -90.48 150.37 21.83 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.767 0.794 . . . . 0.0 113.114 -173.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 29.4 m-85 -121.85 -149.24 0.42 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.741 2.017 . . . . 0.0 106.977 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -81.14 -31.91 33.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.878 0.763 . . . . 0.0 110.929 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.433 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 59.0 m-85 -134.97 148.19 49.93 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 11.0 mm100 -121.82 120.98 28.33 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 93.5 Cg_endo -87.1 170.62 7.01 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.26 1.973 . . . . 0.0 110.474 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.431 HD22 HD12 ' A' ' 37' ' ' ILE . 33.8 p30 -155.9 179.19 9.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.993 -0.442 . . . . 0.0 110.984 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.5 mt -86.97 -22.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -86.25 -92.3 0.09 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -168.68 -40.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -67.43 117.1 8.95 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 120.956 0.408 . . . . 0.0 112.035 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.2 tp -87.43 133.75 33.69 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.462 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 40.9 tp -105.33 121.32 43.63 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.768 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.33 137.07 56.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 p -76.49 172.73 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.433 0.293 . . . . 0.0 110.904 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.37 -20.48 79.33 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -65.59 -58.29 6.11 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.22 -28.93 64.56 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.562 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 100' ' ' GLU . 54.6 ttt180 -57.9 -43.69 86.31 Favored 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.356 0.41 . . . . 0.0 110.108 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -67.26 -28.32 67.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.82 -54.02 22.31 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.39 -46.26 92.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 C-N-CA 123.744 0.818 . . . . 0.0 112.039 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 96' ' ' ARG . 50.2 mt-10 -62.07 -31.84 72.31 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.423 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -78.33 -11.27 59.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.24 -13.94 51.27 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.679 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.78 33.89 26.17 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.72 101.21 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.989 0.899 . . . . 0.0 109.853 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.0 m -86.76 150.3 24.26 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 80.51 10.05 1.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.606 1.162 . . . . 0.0 111.348 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.05 26.18 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.661 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.4 tp10 -94.62 144.83 25.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -125.88 108.66 11.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.413 HD22 HG22 ' A' ' 62' ' ' VAL . 72.3 mt -109.32 95.63 19.21 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.35 140.83 12.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.775 2.317 . . . . 0.0 113.37 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.5 m -147.62 169.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.961 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.95 116.82 29.4 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.1 mt -113.97 128.45 70.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.184 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.37 146.1 24.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 8.8 p-10 -84.83 -160.51 0.49 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 122.48 0.312 . . . . 0.0 110.436 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.501 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 56.8 m80 -73.69 -19.55 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.562 0.345 . . . . 0.0 110.452 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -93.19 -20.06 20.83 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.068 0.461 . . . . 0.0 110.22 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.04 22.1 12.57 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.12 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.424 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 61.0 pttt -105.15 146.82 28.69 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.92 89.94 2.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 121.638 0.732 . . . . 0.0 110.146 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 78' ' ' LEU . 6.3 m -114.12 10.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.088 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.36 42.35 1.37 Allowed Glycine 0 CA--C 1.549 2.159 0 C-N-CA 119.304 -1.426 . . . . 0.0 116.496 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.0 -1.69 9.99 Favored 'Trans proline' 0 C--N 1.376 1.981 0 CA-C-N 122.049 2.924 . . . . 0.0 112.107 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.9 -7.31 37.09 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 125.139 1.375 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -98.92 144.04 28.55 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.374 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.92 143.51 50.18 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.299 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.7 119.85 24.36 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 3.9 tt -91.85 125.01 36.4 Favored 'General case' 0 C--O 1.281 2.737 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.255 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.404 ' OD1' HD13 ' A' ' 56' ' ' LEU . 26.9 m-80 -123.83 141.64 51.85 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.785 -1.552 . . . . 0.0 107.393 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.401 HD23 ' HE ' ' A' ' 176' ' ' ARG . 3.3 mm? -103.29 132.94 49.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.479 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.45 170.47 8.38 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.63 16.96 67.07 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 132.11 43.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.45 169.09 18.62 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.41 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 10.9 t70 -73.01 108.59 5.99 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.155 -174.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -132.18 -12.83 3.17 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -167.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 177' ' ' CYS . 23.2 mt -65.5 120.04 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.37 115.0 6.52 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.0 ttt -95.37 -7.79 37.51 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.378 0.609 . . . . 0.0 110.169 -172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.33 -49.81 6.15 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.182 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -87.08 -16.25 36.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.167 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 104.7 16.65 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.768 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.428 ' H ' ' HB3' ' A' ' 160' ' ' ALA . 11.6 mm-40 -71.41 103.7 2.99 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.949 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.85 161.6 42.4 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.97 129.79 51.51 Favored 'General case' 0 N--CA 1.402 -2.854 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.795 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 56.0 mtt -92.66 108.21 19.8 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -151.51 -25.27 0.2 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -167.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 53.6 m -70.59 -56.38 6.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.16 -35.52 4.67 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.677 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -164.18 -174.39 3.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 147' ' ' MET . 10.2 tmtt? -65.04 -33.64 76.52 Favored 'General case' 0 C--O 1.196 -1.737 0 O-C-N 123.84 0.713 . . . . 0.0 111.022 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.26 23.72 4.27 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.331 0.586 . . . . 0.0 111.904 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.453 ' HA ' ' NE2' ' A' ' 154' ' ' GLN . 17.1 mm-40 -125.62 114.28 18.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.452 0.644 . . . . 0.0 111.197 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 56.9 mt -84.86 134.13 27.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.856 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -110.34 -70.88 0.64 Allowed Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -84.22 127.4 33.92 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.81 127.65 66.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -112.87 -24.16 9.71 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.1 0.476 . . . . 0.0 110.905 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 144' ' ' GLU . . . -151.54 136.22 17.1 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -131.25 108.27 9.56 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.35 138.0 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.1 mt -54.37 140.23 34.34 Favored 'General case' 0 C--O 1.253 1.251 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.563 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.1 p-10 -87.99 6.28 36.67 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.226 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -68.27 -6.14 22.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.878 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.0 m -61.03 -40.82 95.05 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 124.614 1.166 . . . . 0.0 110.046 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.53 -32.21 6.54 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.384 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.515 HG13 ' CB ' ' A' ' 137' ' ' ALA . 83.3 mt -82.94 147.24 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.406 ' HD2' ' OD2' ' A' ' 171' ' ' ASP . 9.3 mmt85 -54.03 118.13 14.8 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 122.908 0.483 . . . . 0.0 112.041 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 14.5 Cg_exo -70.64 -11.89 30.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.409 2.072 . . . . 0.0 111.653 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.406 ' OD2' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -88.97 0.47 56.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.475 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.04 127.65 33.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -76.34 -22.53 54.8 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.434 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.7 ttt -155.77 122.45 5.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -148.51 -179.23 6.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.44 ' HD2' ' CG ' ' A' ' 51' ' ' HIS . 12.2 ptp180 -151.43 164.73 36.1 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.49 ' HB3' HD11 ' A' ' 138' ' ' ILE . 61.6 m -86.5 152.32 22.75 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 124.206 0.941 . . . . 0.0 112.082 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 136' ' ' ASP . 3.7 p -82.12 -50.77 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.411 ' HB2' HD12 ' A' ' 138' ' ' ILE . 48.9 mmtm -85.19 2.62 42.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.66 104.04 5.0 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.55 ' NH1' ' HB3' ' A' ' 47' ' ' ASP . 27.7 ptt180 -68.0 -27.12 66.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.004 -170.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.454 ' O ' HG13 ' A' ' 184' ' ' ILE . 17.9 mtm-85 -88.85 -33.55 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.064 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.475 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.9 tt -62.34 105.75 0.66 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.448 1.099 . . . . 0.0 111.24 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 182' ' ' ARG . 67.1 mt -110.6 130.46 63.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 45.0 mt -107.78 121.86 45.59 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.397 0.618 . . . . 0.0 110.564 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.5 pt -111.36 143.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.27 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -77.11 154.71 33.0 Favored 'General case' 0 C--O 1.259 1.57 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 2.8 pm0 -55.16 -39.4 69.45 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.474 0.71 . . . . 0.0 112.357 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -54.01 -43.42 70.06 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.463 1.505 . . . . 0.0 111.718 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.7 -48.32 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.435 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.572 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 20.7 p80 -72.21 -25.25 61.58 Favored 'General case' 0 C--O 1.196 -1.743 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.108 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.0 73.09 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.452 0.47 . . . . 0.0 110.526 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.19 -35.62 71.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.2 m-85 -68.6 -35.69 77.68 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.693 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -59.1 -51.54 69.6 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.812 0.695 . . . . 0.0 110.219 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.07 -16.51 59.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.071 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.85 -27.34 36.45 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.02 47.94 17.35 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.516 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.12 165.0 25.16 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.417 -0.113 . . . . 0.0 111.041 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.4 p -43.37 -77.03 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -171.0 138.4 4.92 Favored Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.719 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.433 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 35.2 m-85 -136.36 153.46 51.12 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -112.86 122.02 46.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.97 129.32 68.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.214 0.53 . . . . 0.0 109.642 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 60.0 m-85 -114.1 137.39 51.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.75 109.53 3.88 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.04 -33.11 57.36 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.495 0.497 . . . . 0.0 112.088 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.41 92.52 1.08 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.296 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.52 35.05 14.71 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 16.3 t90 -67.51 101.03 0.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.923 0.889 . . . . 0.0 112.164 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -104.35 152.03 22.75 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.94 -25.67 0.3 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 166.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.437 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 86.4 mt -94.68 145.72 24.65 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 117.956 0.878 . . . . 0.0 112.659 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.4 132.85 52.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 215' ' ' LEU . 2.5 pt? . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 187' ' ' ARG . 41.5 t . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' OE2' ' A' ' 208' ' ' GLU . 20.8 ptmt -79.44 156.06 28.04 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.2 0.524 . . . . 0.0 111.699 -175.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -109.68 141.29 42.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.738 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -124.22 146.0 49.0 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.022 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.79 117.82 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -105.7 123.11 47.4 Favored 'General case' 0 C--N 1.282 -2.358 0 O-C-N 123.638 0.586 . . . . 0.0 110.506 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -139.32 139.43 37.28 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.8 t -86.6 110.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.74 98.7 9.5 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 119.509 -0.876 . . . . 0.0 108.906 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.63 110.84 5.76 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.43 -35.12 8.9 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.919 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.24 -23.93 57.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.124 0.487 . . . . 0.0 110.462 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . . . -79.73 -28.06 40.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.71 156.06 22.02 Favored Glycine 0 N--CA 1.413 -2.892 0 CA-C-N 113.635 -1.621 . . . . 0.0 114.381 174.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 71.7 m-85 -87.1 156.13 19.84 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.822 -1.189 . . . . 0.0 108.119 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.448 HG12 ' CE2' ' A' ' 68' ' ' PHE . 22.4 mt -79.52 101.85 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -57.9 -45.16 86.86 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -131.82 176.19 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.62 119.58 74.87 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 124.004 0.815 . . . . 0.0 110.981 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -66.94 166.75 21.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.671 2.248 . . . . 0.0 111.946 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -49.97 117.51 2.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.226 1.011 . . . . 0.0 113.697 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.36 66.21 Favored Glycine 0 C--O 1.206 -1.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.731 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.4 m -86.44 137.49 34.42 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.81 166.67 26.89 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 124.062 3.174 . . . . 0.0 111.154 169.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 p -53.47 150.69 6.4 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.39 -57.21 1.44 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 128.25 2.62 . . . . 0.0 114.522 -174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -85.86 -21.02 28.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.703 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -79.1 -20.03 49.71 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.625 0.37 . . . . 0.0 111.926 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.518 ' HA ' HD21 ' A' ' 56' ' ' LEU . 57.9 m-85 -45.11 -33.24 2.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 4.5 m-70 -129.11 16.07 6.19 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 120.577 -1.327 . . . . 0.0 109.95 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 101.28 13.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.378 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.55 -9.38 1.28 Allowed Glycine 0 CA--C 1.549 2.181 0 N-CA-C 118.066 1.986 . . . . 0.0 118.066 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.128 1.964 . . . . 0.0 112.152 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.2 t -97.45 150.01 21.52 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 50' ' ' PHE . 77.4 mt -86.25 -3.14 58.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.514 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.48 66.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.48 -20.52 25.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -114.62 -22.89 9.53 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -108.11 136.54 19.78 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.61 123.09 11.45 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.69 2.26 . . . . 0.0 112.183 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.02 116.78 34.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.64 21.39 58.11 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -99.2 -162.94 29.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.382 -177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -116.85 137.85 51.92 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.22 172.78 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -148.96 155.61 41.08 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.448 ' CE2' HG12 ' A' ' 37' ' ' ILE . 7.8 m-85 -75.02 104.83 5.75 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.12 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -81.13 -161.48 0.41 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.95 0.9 . . . . 0.0 111.872 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.443 ' HB2' HG21 ' A' ' 122' ' ' VAL . 2.6 p-10 -81.95 -168.24 1.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.191 0.996 . . . . 0.0 112.615 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD13 HG23 ' A' ' 122' ' ' VAL . 5.2 mp -87.8 142.61 27.68 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.765 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 21.8 m-85 -107.76 -167.57 1.27 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.78 -42.85 89.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.37 138.18 53.88 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 16.2 mm100 -119.25 131.5 24.34 Favored Pre-proline 0 C--O 1.261 1.679 0 O-C-N 123.531 0.519 . . . . 0.0 110.471 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.67 177.68 2.15 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.141 2.561 . . . . 0.0 111.967 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 26.6 p30 -163.49 179.11 7.5 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.91 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.1 mm -91.93 3.22 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 CA-C-O 122.542 1.163 . . . . 0.0 108.701 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -109.98 -102.37 0.39 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.238 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 64.7 p -173.51 -14.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.557 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -69.63 116.75 10.39 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.44 132.02 34.61 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.101 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 34.3 tp -104.28 119.55 39.21 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.628 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.42 136.98 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.503 -173.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -71.38 172.04 10.13 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.276 0.63 . . . . 0.0 111.649 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 97' ' ' LYS . . . -68.03 -34.02 80.56 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -64.52 -55.56 19.8 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.509 0.723 . . . . 0.0 110.085 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.51 69.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.464 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 58.7 ttt180 -58.39 -48.36 80.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.979 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 7.6 mtpm? -62.18 -32.36 72.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.796 0.685 . . . . 0.0 112.047 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.84 -53.06 61.96 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.982 0.42 . . . . 0.0 110.349 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.44 -36.32 75.78 Favored 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.921 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 51.6 mt-10 -68.87 -38.66 79.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.124 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.3 m -70.53 -28.7 65.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.965 0.412 . . . . 0.0 111.764 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.35 -14.98 57.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.647 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.52 48.42 68.46 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 173' ' ' LYS . 94.9 t -67.93 109.06 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.66 0.743 . . . . 0.0 111.421 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -64.33 136.64 57.34 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 75.67 7.87 3.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.118 1.367 . . . . 0.0 114.391 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.21 114.12 26.56 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 9.1 tp10 -103.39 146.58 28.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -114.15 120.94 42.24 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.607 0.567 . . . . 0.0 110.631 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.62 97.28 50.68 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.51 140.78 17.23 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.872 2.381 . . . . 0.0 112.9 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.8 m -148.66 167.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.528 0.731 . . . . 0.0 110.005 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.48 116.61 30.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 33.9 mt -112.92 132.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.172 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -92.86 134.91 34.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -80.0 -160.81 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.407 ' HE1' ' O ' ' A' ' 34' ' ' ALA . 58.8 m80 -68.56 -26.89 65.63 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.898 -0.501 . . . . 0.0 110.922 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.39 -19.19 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.327 0.651 . . . . 0.0 110.907 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.12 14.06 27.35 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.518 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -101.85 139.76 37.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.355 0.578 . . . . 0.0 110.289 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 58.7 t -83.0 84.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.312 1.053 . . . . 0.0 110.539 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.458 HG23 HD13 ' A' ' 78' ' ' LEU . 17.3 m -111.21 16.83 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.474 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.447 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -130.84 45.4 1.14 Allowed Glycine 0 CA--C 1.547 2.089 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.828 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.07 -5.05 9.63 Favored 'Trans proline' 0 C--N 1.383 2.342 0 CA-C-N 121.416 2.608 . . . . 0.0 112.506 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -108.47 0.03 20.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.807 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.458 ' HB3' HD11 ' A' ' 90' ' ' LEU . 6.8 m-85 -92.16 134.84 34.48 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.239 -174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.69 142.36 51.45 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.975 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -83.87 112.47 20.15 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.6 tt -88.35 129.95 35.26 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.57 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -123.88 141.03 52.4 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.525 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.24 131.85 51.11 Favored 'General case' 0 CA--C 1.486 -1.511 0 O-C-N 123.799 0.687 . . . . 0.0 110.356 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.34 173.08 6.48 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 124.719 1.262 . . . . 0.0 108.361 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.54 13.63 64.98 Favored Glycine 0 C--N 1.305 -1.145 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.725 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.82 130.07 45.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.28 107.94 3.83 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.291 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.74 -46.59 0.63 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 125.854 1.661 . . . . 0.0 112.682 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.458 ' C ' ' HB2' ' A' ' 164' ' ' ASP . . . 65.34 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 126.558 1.943 . . . . 0.0 115.912 171.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.1 mm -55.23 124.29 7.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.274 1.03 . . . . 0.0 111.083 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.62 95.26 3.33 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.3 ttm -76.74 -4.14 41.79 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.996 -170.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.74 -50.22 9.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.494 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -99.68 1.36 43.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.988 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.5 p -94.32 119.06 32.53 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.28 100.9 12.87 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -155.27 161.65 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.306 0.574 . . . . 0.0 112.511 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -118.28 145.58 44.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.748 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 59.2 mtt -100.7 155.67 17.77 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.343 33.7 t70 93.07 86.4 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.23 2.212 . . . . 0.0 115.952 174.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.7 m -101.48 -37.38 8.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.41 168.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.0 mt -135.23 -45.27 0.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.111 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.447 ' CD ' HH22 ' A' ' 181' ' ' ARG . 40.0 mt-10 -139.65 177.24 8.08 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.552 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -31.25 71.76 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -96.51 24.01 6.3 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.481 1.134 . . . . 0.0 110.074 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.465 HE22 ' HG2' ' A' ' 181' ' ' ARG . 21.3 mm-40 -114.66 115.19 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.5 mt -78.32 139.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 -84.85 1.75 Allowed Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -82.31 121.38 26.6 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.33 109.86 26.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.19 -43.67 12.81 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.85 110.66 4.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -85.33 121.22 27.75 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -93.99 132.0 38.89 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.82 136.05 51.47 Favored 'General case' 0 C--O 1.257 1.487 0 O-C-N 124.185 0.928 . . . . 0.0 111.708 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.458 ' HB2' ' C ' ' A' ' 137' ' ' ALA . 21.5 p-10 -87.22 1.62 52.55 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.988 -175.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.1 p -68.27 -4.53 14.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.031 1.333 . . . . 0.0 111.203 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.2 m -67.61 -34.37 76.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.264 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.13 -31.69 6.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.403 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.3 mt -91.89 141.68 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.448 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 48.3 mtp180 -53.96 121.5 29.68 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 123.415 0.686 . . . . 0.0 111.435 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.17 -6.85 18.29 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.876 2.384 . . . . 0.0 112.603 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.05 -10.0 55.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.291 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.47 120.3 15.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 104' ' ' VAL . 98.8 mttt -71.98 -30.79 65.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.998 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.546 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.9 ttt -153.35 129.59 10.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.24 -178.92 7.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 22.9 ttp180 -138.53 142.08 39.31 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.78 144.6 52.63 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.6 p -81.07 -35.88 31.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.47 -7.39 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.06 117.85 13.2 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 176' ' ' ARG . 6.2 ptp180 -76.48 -24.76 53.82 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.303 -173.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -89.77 -15.72 31.8 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.77 99.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.685 -174.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.42 123.08 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -107.64 124.45 50.0 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.845 0.831 . . . . 0.0 111.251 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.546 HG22 ' HG3' ' A' ' 174' ' ' MET . 36.3 pt -116.07 155.27 17.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.987 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 22' ' ' VAL . 47.8 mtm180 -85.98 158.59 19.84 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.5 pt-20 -47.82 -42.46 26.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.35 1.06 . . . . 0.0 113.097 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.92 -40.47 69.91 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 125.445 1.498 . . . . 0.0 112.291 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.45 -46.97 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.563 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 33.1 p80 -71.01 -31.74 68.33 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.02 70.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.0 -34.77 61.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.13 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.7 m-85 -73.21 -35.52 66.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.008 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 47.7 mt-10 -60.75 -53.38 58.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.523 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.65 -24.17 66.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.56 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -79.76 -27.41 40.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.344 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.47 36.61 43.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.82 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.32 157.11 32.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.4 p -102.03 137.11 40.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.55 71.35 0.92 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.369 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 55.5 m-85 -141.96 149.54 40.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 118.175 0.988 . . . . 0.0 112.795 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -161.71 121.51 2.53 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.07 156.14 38.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -140.72 161.89 36.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 123.558 0.743 . . . . 0.0 109.934 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.04 117.69 20.33 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -26.98 62.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.576 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.472 ' OE2' ' HE3' ' A' ' 23' ' ' LYS . 35.3 mt-10 -67.58 97.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.304 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 70.65 35.65 67.26 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.741 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.6 t90 -52.92 102.71 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.969 0.908 . . . . 0.0 110.304 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.24 113.14 26.48 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.02 -25.02 0.25 Allowed Glycine 0 CA--C 1.539 1.575 0 N-CA-C 119.999 2.76 . . . . 0.0 119.999 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.13 114.93 21.0 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 119.019 1.41 . . . . 0.0 110.74 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.99 132.36 42.32 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.482 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.241 174.875 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 C--O 1.237 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -98.2 127.9 44.38 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.41 141.89 44.37 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.429 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -124.47 143.49 50.62 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.5 111.14 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -92.06 132.39 36.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.409 0.624 . . . . 0.0 110.952 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HE2' ' OXT' ' A' ' 215' ' ' LEU . 0.4 OUTLIER -148.77 156.45 42.37 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 103.193 -2.892 . . . . 0.0 103.193 177.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -94.64 131.38 41.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.9 ptp -70.2 173.57 6.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.833 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 77.44 112.42 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.273 1.829 . . . . 0.0 112.375 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.91 -16.83 34.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.624 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -13.62 43.16 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB1' HE22 ' A' ' 82' ' ' GLN . . . -68.93 -35.76 77.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 90.65 145.45 13.95 Favored Glycine 0 N--CA 1.401 -3.684 0 CA-C-N 113.775 -1.557 . . . . 0.0 114.754 171.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.446 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 21.9 m-85 -95.92 166.08 11.96 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 113.436 -1.382 . . . . 0.0 107.863 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.1 mt -78.3 101.34 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 162.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -62.59 -51.66 66.45 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 124.504 1.127 . . . . 0.0 112.234 -169.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.6 176.14 8.7 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 46' ' ' THR . 9.6 mp -60.68 126.94 86.3 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 36.7 Cg_endo -73.68 167.7 26.62 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.079 2.519 . . . . 0.0 112.284 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.6 112.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 124.28 1.032 . . . . 0.0 112.712 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.68 66.98 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 115.691 1.037 . . . . 0.0 115.691 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 81.1 p -85.94 146.94 44.38 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 118.204 1.002 . . . . 0.0 113.213 -176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.38 166.36 15.28 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.913 3.075 . . . . 0.0 111.741 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.44 ' HA ' HD21 ' A' ' 40' ' ' LEU . 35.9 p -56.85 155.16 8.23 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.39 -56.06 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 127.925 2.49 . . . . 0.0 112.915 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -85.86 -19.67 30.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.495 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -84.17 -17.14 40.97 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 30.3 m-85 -45.18 -40.53 7.27 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 12.4 m170 -128.98 20.71 5.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 111.396 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.95 102.57 14.93 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.49 -2.93 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.464 1.345 . . . . 0.0 116.464 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.83 160.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.097 0.949 . . . . 0.0 113.219 -173.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -98.12 134.53 41.06 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.67 -10.78 55.32 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.84 63.03 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.13 -17.88 28.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.58 -21.24 9.25 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 58.4 t80 -105.92 138.8 19.75 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 123.29 11.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.029 1.82 . . . . 0.0 112.572 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.46 122.69 44.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.57 75.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.63 -165.92 29.5 Favored Glycine 0 CA--C 1.502 -0.736 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.319 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mt-10 -117.93 130.09 56.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 35.6 m -126.78 160.93 34.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 p -142.33 150.02 40.23 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.959 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -75.27 107.33 7.3 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--N 1.296 -1.758 0 O-C-N 124.881 1.363 . . . . 0.0 112.792 178.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 61.5 t30 . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.272 20.4 mmt180 -69.17 -174.17 0.61 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 -164.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.47 -172.75 4.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.861 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.71 150.7 22.48 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.389 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -114.63 -159.89 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.441 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.31 -37.42 85.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.481 0.582 . . . . 0.0 111.099 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -126.36 157.14 39.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.412 HE22 ' HB1' ' A' ' 34' ' ' ALA . 34.9 tp60 -141.53 136.41 15.55 Favored Pre-proline 0 C--O 1.26 1.636 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.87 178.12 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.441 2.094 . . . . 0.0 113.441 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.9 p30 -160.98 173.98 14.47 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.2 mm -90.54 -14.59 8.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.907 0.86 . . . . 0.0 109.849 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -94.67 -151.75 0.33 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.372 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 2.1 m -102.58 0.91 34.12 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.481 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 4.0 p-10 -92.62 167.31 12.0 Favored 'General case' 0 C--O 1.201 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 112.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.71 141.64 51.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 126' ' ' TYR . 40.4 tp -112.66 126.4 55.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.72 141.45 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -79.53 172.57 13.61 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.353 0.261 . . . . 0.0 110.61 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.93 93.41 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -64.08 -47.22 80.91 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 122.762 0.425 . . . . 0.0 112.003 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.36 -28.74 66.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -56.99 -47.56 80.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.944 0.497 . . . . 0.0 110.442 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.8 -28.75 68.63 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.795 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.51 -54.19 46.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.33 -43.88 87.17 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.53 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -66.12 -35.01 79.35 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -68.24 -21.75 64.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.024 0.44 . . . . 0.0 111.441 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.497 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -86.29 -2.8 58.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.811 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.44 37.17 85.4 Favored Glycine 0 N--CA 1.438 -1.18 0 O-C-N 123.952 0.782 . . . . 0.0 112.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.17 116.67 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.375 0.607 . . . . 0.0 109.628 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -88.01 157.77 18.81 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.205 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 78.0 15.48 1.46 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.903 0.881 . . . . 0.0 112.243 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.18 114.98 29.44 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 7.1 tp10 -105.73 140.77 38.27 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.43 ' CH2' HD12 ' A' ' 129' ' ' LEU . 43.8 m95 -116.87 121.94 42.93 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.804 0.842 . . . . 0.0 109.7 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -113.43 109.13 51.47 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.597 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.48 137.1 16.24 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 122.54 2.16 . . . . 0.0 113.407 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 172.27 2.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.401 1.08 . . . . 0.0 109.586 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.502 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -103.16 116.51 32.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 126' ' ' TYR . 22.1 mt -107.53 142.69 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.186 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -118.38 135.35 54.38 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.623 1.169 . . . . 0.0 108.128 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.9 p30 -86.19 -162.29 0.73 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.1 m80 -74.4 -12.61 60.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.384 1.074 . . . . 0.0 111.815 -174.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.51 -19.48 29.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.07 1.29 63.04 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.174 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -89.65 154.77 19.71 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.748 -0.266 . . . . 0.0 110.412 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.57 126.17 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 116' ' ' ASP . 11.3 p -129.81 -32.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.921 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.95 73.14 0.47 Allowed Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.491 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.08 -0.99 9.76 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 CA-C-N 119.673 1.736 . . . . 0.0 109.746 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.61 -12.19 17.92 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.203 1.401 . . . . 0.0 111.158 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.471 ' HB2' HD12 ' A' ' 114' ' ' ILE . 10.0 m-85 -92.57 149.26 21.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.539 0.685 . . . . 0.0 112.528 -172.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.39 143.02 49.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.368 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.23 120.38 27.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.564 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.0 tt -91.61 131.83 36.75 Favored 'General case' 0 C--O 1.259 1.573 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.405 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.567 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 7.9 p30 -124.42 140.96 52.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.217 174.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.43 141.05 32.72 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.573 0.546 . . . . 0.0 110.462 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.5 173.02 6.67 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 124.656 1.222 . . . . 0.0 108.412 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.72 17.18 73.6 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 132.89 33.97 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.295 0.569 . . . . 0.0 109.779 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -137.07 168.98 18.55 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.9 103.1 0.14 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.716 1.143 . . . . 0.0 111.27 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -88.66 -54.9 3.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.026 -1.897 . . . . 0.0 115.497 -163.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 179' ' ' LYS . 45.9 mt -51.22 113.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 124.366 1.041 . . . . 0.0 113.758 -169.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -70.93 107.07 3.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.517 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 46.7 mtt -91.3 8.84 34.05 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -85.84 -50.39 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -93.21 -4.9 51.17 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.484 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 61.0 p -91.74 151.02 20.82 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.995 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.58 97.81 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -147.78 163.42 36.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.16 140.79 49.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.506 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.16 155.65 20.66 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.998 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.321 34.6 t70 96.0 95.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.455 2.302 . . . . 0.0 115.783 174.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.0 m -100.57 -56.16 2.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 167.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -128.33 -41.05 1.58 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.063 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 47.8 mt-10 -125.83 -179.08 4.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.058 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -71.71 -44.23 64.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 124.201 0.938 . . . . 0.0 111.07 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -82.91 26.01 0.63 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.894 0.854 . . . . 0.0 112.241 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -113.21 122.05 46.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.28 116.17 21.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -84.02 -61.55 1.83 Allowed Glycine 0 CA--C 1.493 -1.315 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -111.02 132.86 53.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.2 mp -119.8 113.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -89.34 -39.19 13.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.614 -0.835 . . . . 0.0 109.994 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.19 117.4 3.5 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.173 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.36 145.08 26.48 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.95 146.02 47.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HG ' ' OE2' ' A' ' 208' ' ' GLU . 93.8 mt -53.78 136.55 39.83 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.512 1.133 . . . . 0.0 112.559 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.618 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 41.0 p-10 -96.5 10.44 38.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.166 -177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.2 p -68.19 -5.16 16.65 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.938 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.8 m -61.14 -40.53 94.17 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.147 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.52 -33.68 6.31 Favored 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.255 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.26 151.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -44.41 117.61 2.97 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.046 0.938 . . . . 0.0 110.934 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.34 -16.04 39.04 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.461 2.107 . . . . 0.0 111.856 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.62 11.43 31.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.496 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.04 143.38 39.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -95.99 -28.95 14.41 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.444 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -143.75 124.57 14.24 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.35 178.23 10.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.61 163.25 40.31 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.138 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.456 ' SG ' HD22 ' A' ' 183' ' ' LEU . 71.2 m -83.3 149.93 26.46 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.125 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.5 p -81.44 -51.51 8.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.408 ' HB2' HD12 ' A' ' 138' ' ' ILE . 83.7 mttt -89.5 20.65 3.8 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 8.4 tp10 -145.92 134.32 21.9 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 171.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' SER . 15.3 mmt180 -89.96 -33.16 16.49 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 123.821 0.701 . . . . 0.0 112.386 -168.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -91.67 -12.11 35.03 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.971 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.456 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.5 tt -86.68 109.13 18.99 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.433 0.635 . . . . 0.0 110.401 -173.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.19 129.06 75.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.7 121.54 43.8 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.801 0.81 . . . . 0.0 111.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 48.7 pt -111.29 147.77 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.007 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.35 150.11 38.51 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.15 -39.2 27.99 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.52 -30.28 69.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 111.73 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.497 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.7 t -66.4 -49.48 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.999 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.568 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 17.1 p80 -70.87 -29.73 65.92 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.085 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -59.35 -34.84 72.86 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.37 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.38 61.65 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 19.2 m-30 -68.98 -34.55 75.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.696 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 39.5 mt-10 -65.48 -49.11 70.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.493 0.717 . . . . 0.0 111.146 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -69.92 -29.89 67.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.48 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 109.897 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 78.72 45.22 9.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.661 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.9 mt -81.4 154.14 26.58 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 27.5 p -101.45 129.82 47.56 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.69 71.71 0.75 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.756 -0.657 . . . . 0.0 114.582 172.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 14.9 m-85 -124.7 145.77 49.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.061 0.93 . . . . 0.0 112.666 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -144.0 121.94 12.04 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.03 128.9 69.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 69.2 m-85 -120.46 137.97 54.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.06 111.03 3.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.22 86.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.526 0.516 . . . . 0.0 112.175 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.462 ' OE2' ' HG ' ' A' ' 163' ' ' LEU . 30.1 mm-40 -68.07 100.61 1.02 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.345 0.593 . . . . 0.0 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.56 32.85 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.066 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.66 104.64 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.967 . . . . 0.0 110.129 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.91 103.78 13.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -173.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -7.41 2.96 Favored Glycine 0 N--CA 1.471 1.005 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.14 117.46 23.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.548 1.174 . . . . 0.0 110.552 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.99 125.79 29.78 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.3 pt? . . . . . 0 C--N 1.31 -1.112 0 O-C-N 124.263 0.977 . . . . 0.0 112.313 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.409 -2.517 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' OE2' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -112.04 155.8 23.22 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -114.57 142.78 45.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.253 0.549 . . . . 0.0 111.128 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 83.9 m-85 -125.11 147.38 49.04 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.772 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 85.9 t -80.74 123.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -91.94 133.67 35.48 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.502 0.668 . . . . 0.0 110.733 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -150.18 151.35 32.94 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.22 121.35 45.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 26.9 ttt -79.23 81.29 5.51 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.299 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 178.74 111.72 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 124.734 1.271 . . . . 0.0 108.41 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.47 -23.54 25.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 47.0 mt-10 -82.54 -4.11 57.06 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.055 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -62.39 -35.33 78.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 97.0 92.62 1.87 Allowed Glycine 0 N--CA 1.397 -3.96 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.755 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.09 141.01 57.74 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -70.85 101.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 169.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -78.2 -33.99 49.72 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.274 0.559 . . . . 0.0 111.411 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -122.41 161.77 22.86 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.9 124.97 91.91 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 122.618 0.367 . . . . 0.0 111.874 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.74 168.98 21.56 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.075 2.516 . . . . 0.0 111.417 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -39.8 118.85 0.91 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.234 1.413 . . . . 0.0 113.303 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 13.53 83.15 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 48.8 m -85.51 138.52 35.97 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 44' ' ' SER . 15.8 Cg_exo -67.57 166.71 23.04 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.513 3.475 . . . . 0.0 111.037 173.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -60.01 145.92 44.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -38.09 -53.78 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 127.171 2.188 . . . . 0.0 114.121 -174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.437 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 56.5 p-90 -85.77 -23.18 27.37 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.582 -173.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 48.6 tptt -86.93 -11.77 49.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.979 -171.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 88' ' ' ASN . 20.9 m-85 -43.28 -51.46 6.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.079 0.862 . . . . 0.0 112.743 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.493 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.0 m-70 -128.43 32.45 4.85 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.339 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.2 tm-20 -92.38 101.24 13.71 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.67 -10.65 12.18 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.6 169.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.944 1.872 . . . . 0.0 114.108 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -98.28 160.16 14.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.362 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.441 HD22 ' HG2' ' A' ' 45' ' ' PRO . 81.9 mt -112.76 14.42 19.94 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.3 -22.9 64.7 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.683 0.754 . . . . 0.0 110.434 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -88.95 -20.8 24.03 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.555 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.6 -22.95 12.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.58 140.78 23.51 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 122.41 9.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.914 1.743 . . . . 0.0 112.095 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.443 HG22 HD22 ' A' ' 110' ' ' LEU . 47.9 t -96.72 123.7 49.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.14 24.32 52.36 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.707 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -107.09 -168.3 22.22 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.406 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.7 mt-10 -123.56 128.25 49.46 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.36 174.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 p -146.39 151.98 38.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.05 113.97 8.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.409 -2.515 0 CA-C-O 122.013 0.911 . . . . 0.0 111.551 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 83.8 m-20 . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HG2' ' HB3' ' A' ' 33' ' ' GLU . 16.6 mmt180 -90.26 -164.32 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.849 0.833 . . . . 0.0 112.075 -174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.5 -170.43 2.94 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 125.614 1.566 . . . . 0.0 110.392 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -88.17 149.54 23.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.296 0.57 . . . . 0.0 111.621 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -120.9 -165.31 1.2 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -66.09 -44.08 85.41 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.924 0.784 . . . . 0.0 111.24 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -113.53 142.25 46.17 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.853 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.431 HE22 ' HB1' ' A' ' 34' ' ' ALA . 23.7 mm-40 -128.4 128.62 23.62 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.592 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 82' ' ' GLN . 57.1 Cg_endo -91.42 175.6 2.26 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.892 2.395 . . . . 0.0 113.108 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -163.54 172.16 14.8 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.099 0.959 . . . . 0.0 108.419 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.94 -16.94 9.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.975 0.893 . . . . 0.0 109.723 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -85.48 -164.04 0.95 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.811 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.424 ' CB ' HH21 ' A' ' 176' ' ' ARG . 26.4 p -122.08 54.1 1.19 Allowed 'General case' 0 C--O 1.252 1.205 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 2.6 t30 -137.39 153.42 50.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -109.66 141.96 41.5 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.7 tp -108.33 125.9 52.23 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 129' ' ' LEU . 47.1 t -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.625 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.5 p -74.48 172.44 11.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.634 0.774 . . . . 0.0 110.626 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.07 -37.65 94.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.556 -0.354 . . . . 0.0 112.655 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -61.39 -52.63 63.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.783 0.801 . . . . 0.0 109.71 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.35 -32.76 73.92 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.42 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.34 -39.97 84.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.233 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 8.9 mmpt? -64.69 -38.73 91.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.672 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.22 -52.99 62.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.054 0.454 . . . . 0.0 110.296 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.4 mt -61.54 -43.55 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.109 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.39 -41.34 85.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -70.29 -25.28 63.26 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.35 -21.23 59.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.91 47.82 6.06 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.9 t -74.02 101.24 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.616 0.722 . . . . 0.0 109.588 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 m -70.05 147.1 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.965 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 79.45 9.14 1.65 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.362 1.065 . . . . 0.0 111.999 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.58 114.71 29.16 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 8.7 tp10 -111.75 146.85 36.84 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -116.6 120.91 40.18 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.039 0.136 . . . . 0.0 111.092 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.443 HD22 HG22 ' A' ' 62' ' ' VAL . 50.7 mt -106.2 101.98 37.55 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 173.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.17 132.4 12.61 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.666 2.244 . . . . 0.0 112.814 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 64' ' ' GLY . 5.0 m -144.64 170.27 7.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.581 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.79 116.55 32.8 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.8 mt -109.82 133.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.496 0.665 . . . . 0.0 112.409 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HG2' HG22 ' A' ' 121' ' ' VAL . 66.1 mttt -95.6 143.67 26.7 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 174.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.522 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -83.22 -160.7 0.44 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.461 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 35.5 m80 -70.15 -30.87 68.14 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.768 0.827 . . . . 0.0 110.137 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -81.78 -19.98 40.12 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.7 14.88 33.29 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.119 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 17.9 ptpt -95.36 140.51 30.13 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.46 HG22 ' HG2' ' A' ' 115' ' ' LYS . 48.7 t -77.94 89.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.571 0.701 . . . . 0.0 110.024 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.38 11.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.614 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -126.1 54.43 0.76 Allowed Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.669 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.71 -17.44 5.04 Favored 'Trans proline' 0 C--N 1.368 1.594 0 CA-C-N 120.629 2.215 . . . . 0.0 112.342 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.71 7.65 44.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.199 0.523 . . . . 0.0 110.346 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.416 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 5.8 m-85 -95.1 144.32 25.84 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 121.515 0.674 . . . . 0.0 110.601 -177.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -133.58 141.63 47.77 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.023 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.413 ' HB3' ' ND2' ' A' ' 88' ' ' ASN . 55.5 m-85 -80.75 119.76 23.76 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 91' ' ' VAL . 3.9 tt -86.45 121.25 28.74 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 91.8 m-20 -97.91 125.81 43.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.08 121.71 42.29 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.401 0.438 . . . . 0.0 110.02 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.66 172.9 6.55 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.855 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 20.29 65.33 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.278 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.03 40.61 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.61 169.32 17.86 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -53.71 104.96 0.11 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -131.58 -27.34 1.94 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 -164.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 179' ' ' LYS . 24.3 mt -63.01 122.86 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.533 1.06 . . . . 0.0 110.874 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.43 107.74 7.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.787 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -77.32 -9.44 58.83 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -70.33 -50.06 43.0 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.436 0.636 . . . . 0.0 109.759 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.69 -2.5 35.21 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.307 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.8 p -99.88 142.38 31.43 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.489 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 14.7 mm-40 -122.61 107.5 12.04 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -161.71 161.28 29.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.747 0.308 . . . . 0.0 111.681 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 59.5 mm-40 -125.46 142.07 51.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 58.7 mtt -100.43 108.32 20.28 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.67 7.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.7 p -72.67 -56.67 4.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.204 -0.599 . . . . 0.0 112.051 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -117.82 -39.23 3.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.687 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 153' ' ' ASP . 10.4 pt-20 -158.24 -176.34 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -68.93 -13.3 62.35 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -114.6 23.24 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.215 0.531 . . . . 0.0 112.15 -179.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.438 HE21 ' HA ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -129.37 120.81 26.2 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 72.1 mt -72.91 133.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.061 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -115.79 -70.6 0.47 Allowed Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 8.2 t30 -79.17 122.14 25.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.2 mt -126.91 106.85 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 33.9 t70 -90.25 -44.74 9.52 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.791 0.805 . . . . 0.0 109.088 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.66 110.88 3.92 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.797 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.32 125.64 39.09 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.66 146.87 27.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.0 140.02 57.7 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.867 0.842 . . . . 0.0 112.484 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.4 p-10 -94.46 6.64 48.17 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.46 -5.5 19.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.632 1.173 . . . . 0.0 109.866 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -62.0 -39.49 92.39 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.651 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.24 -31.84 6.72 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.697 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 64.5 mt -83.16 150.62 4.18 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -60.95 120.19 51.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 118.208 0.458 . . . . 0.0 109.96 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.97 -16.35 45.12 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.405 2.07 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.56 -6.15 58.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.19 127.35 32.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.12 -33.36 71.74 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.547 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.7 ttt -151.1 130.08 12.55 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -153.79 -178.72 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.136 0.574 . . . . 0.0 109.585 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.424 HH21 ' CB ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -136.76 145.68 44.89 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.52 152.63 40.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.835 0.709 . . . . 0.0 110.374 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -81.94 -45.36 15.51 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.4 mmpt? -73.45 -20.01 60.81 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.553 -173.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.405 ' HG2' ' CG1' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.68 134.8 52.75 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 175.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.437 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 52.1 mmt-85 -89.59 -36.59 15.22 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -85.77 -19.83 30.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.173 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.9 100.64 2.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.962 0.887 . . . . 0.0 110.914 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.75 124.95 62.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 57.7 mt -112.14 133.67 54.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.45 0.643 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.547 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.4 pt -121.87 159.48 24.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.176 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -86.15 161.43 18.86 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.775 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -49.0 -47.71 44.19 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.994 1.718 . . . . 0.0 109.717 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.12 -45.75 22.59 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.997 2.119 . . . . 0.0 113.525 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -46.42 75.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.605 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 11.5 p80 -77.35 -21.6 53.08 Favored 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.006 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.86 81.63 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.31 -40.82 94.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.71 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 191' ' ' HIS . 22.7 m-85 -65.91 -37.62 86.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.09 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.7 mm-40 -55.36 -51.51 66.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.651 0.78 . . . . 0.0 109.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.62 -10.65 59.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.504 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.01 -27.88 20.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.48 62.91 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.946 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 61.0 mt -84.5 160.28 20.55 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.1 p -94.65 121.75 36.53 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 105.3 63.82 0.64 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.796 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 46.2 m-85 -127.14 135.06 50.18 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 117.938 0.869 . . . . 0.0 112.782 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 50.9 tptt -144.02 121.54 11.75 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.2 m -126.11 129.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.5 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.42 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 72.0 m-85 -110.62 165.02 12.15 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -68.64 122.96 19.61 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.37 -35.64 35.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 23' ' ' LYS . 14.7 mt-10 -75.14 97.85 3.56 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.447 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.06 35.37 34.8 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.678 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.523 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 9.9 t90 -55.21 106.61 0.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.131 0.972 . . . . 0.0 109.712 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -103.23 99.02 8.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.55 15.22 68.18 Favored Glycine 0 N--CA 1.47 0.965 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.523 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 95.5 mt -93.97 156.38 16.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.167 0.984 . . . . 0.0 110.991 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.81 131.64 48.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.065 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.051 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -107.2 144.78 33.47 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.694 0.283 . . . . 0.0 110.398 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -116.56 139.75 50.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.671 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.97 136.42 54.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 37.9 t -72.97 107.73 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -99.76 134.2 42.99 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.525 0.679 . . . . 0.0 112.453 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -151.1 165.36 34.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.97 141.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.71 82.76 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 162.27 137.1 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 127.637 2.375 . . . . 0.0 107.655 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -80.48 -29.29 37.39 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.011 0.91 . . . . 0.0 109.185 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 11.4 pt-20 -83.17 0.73 43.95 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.578 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -66.75 -20.69 66.01 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.895 0.379 . . . . 0.0 110.441 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 66.86 0.29 Allowed Glycine 1 N--CA 1.393 -4.208 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.574 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 19.1 m-85 -70.83 133.06 46.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.856 172.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.49 101.9 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 171.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -59.16 -41.77 89.14 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.681 -171.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -148.0 173.39 12.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 46' ' ' THR . 5.8 mp -60.62 124.61 79.7 Favored Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 124.269 1.027 . . . . 0.0 113.333 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 167.76 25.65 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.803 2.335 . . . . 0.0 112.275 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -45.92 113.76 0.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.898 1.679 . . . . 0.0 112.761 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.61 7.72 87.06 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.522 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.33 132.18 45.87 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 117.21 0.505 . . . . 0.0 111.814 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.48 ' HG2' HD22 ' A' ' 56' ' ' LEU . 31.1 Cg_exo -61.42 165.64 12.76 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.693 2.929 . . . . 0.0 111.958 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.516 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.9 p -52.94 150.14 5.78 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -39.35 -54.91 1.82 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 127.991 2.516 . . . . 0.0 113.708 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.45 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 53.7 p-90 -83.52 -24.3 31.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.151 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HE3' HD12 ' A' ' 54' ' ' ILE . 51.5 tptt -85.41 -12.82 51.11 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.524 -172.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -45.11 -43.94 10.13 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -128.96 25.24 5.6 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -92.96 100.9 13.26 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 118.113 -1.435 . . . . 0.0 107.422 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.11 -9.58 3.92 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.475 HD12 ' HE3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -134.0 172.09 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 120.452 2.126 . . . . 0.0 113.752 -175.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.7 t -98.06 150.48 21.36 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.011 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.48 HD22 ' HG2' ' A' ' 45' ' ' PRO . 43.7 mt -98.33 -4.36 35.14 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.02 47.23 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -89.14 -22.41 22.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -101.2 -22.17 14.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -96.31 140.81 22.4 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.38 122.59 10.08 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.932 1.754 . . . . 0.0 110.913 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -101.45 119.3 49.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.05 16.86 66.39 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.436 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -96.29 -150.26 26.69 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.84 133.54 44.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.96 167.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -145.74 154.07 41.66 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.156 -0.34 . . . . 0.0 110.448 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 115.59 15.53 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 170.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--N 1.303 -1.429 0 O-C-N 124.268 0.98 . . . . 0.0 112.755 -176.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 48.6 t-20 . . . . . 0 N--CA 1.443 -0.786 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 33' ' ' GLU . 10.6 mmt180 -83.51 -165.37 1.09 Allowed 'General case' 0 C--O 1.262 1.762 0 CA-C-O 122.013 0.911 . . . . 0.0 112.844 -168.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.27 -160.83 0.73 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.637 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 mp -92.89 138.75 31.21 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.114 0.483 . . . . 0.0 111.768 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 2.4 m-30 -108.23 -155.93 0.57 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.957 1.703 . . . . 0.0 108.432 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -64.21 -49.54 71.57 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.515 0.674 . . . . 0.0 110.381 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.15 139.3 53.48 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.825 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 14.3 mm100 -107.39 119.0 52.16 Favored Pre-proline 0 N--CA 1.431 -1.387 0 O-C-N 123.745 0.653 . . . . 0.0 111.309 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 90.6 Cg_endo -84.08 168.12 12.17 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 122.713 2.275 . . . . 0.0 111.259 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -159.35 169.79 23.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.18 -7.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 124.103 0.877 . . . . 0.0 110.286 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -98.99 -168.56 1.64 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.333 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 p -101.97 21.95 13.86 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -173.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -116.43 162.97 16.74 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.541 -0.724 . . . . 0.0 109.316 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.3 tp -123.49 141.7 51.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.968 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 54.1 tp -114.47 127.14 55.66 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 129' ' ' LEU . 47.0 t -126.92 144.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.76 -172.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -76.55 168.77 19.48 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.58 0.352 . . . . 0.0 110.173 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.83 -36.08 90.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -65.2 -45.27 85.48 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -30.38 64.3 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.387 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -58.78 -45.09 90.59 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -57.48 -42.16 82.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.057 0.848 . . . . 0.0 110.617 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.72 -54.26 48.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.354 0.409 . . . . 0.0 110.887 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.14 -41.4 86.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 C-N-CA 123.513 0.725 . . . . 0.0 111.818 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.99 -34.29 75.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.626 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -68.01 -27.55 66.65 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.966 0.412 . . . . 0.0 111.027 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.2 -7.34 59.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.608 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.84 42.73 98.35 Favored Glycine 0 N--CA 1.441 -0.98 0 O-C-N 123.563 0.539 . . . . 0.0 112.321 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -72.07 112.61 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -79.86 155.37 27.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 75.69 15.17 2.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.96 1.304 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.3 113.85 25.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.2 tp10 -109.35 138.7 45.32 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.483 ' CZ3' ' HG ' ' A' ' 129' ' ' LEU . 59.7 m95 -119.6 114.5 22.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.4 mt -110.73 96.59 29.21 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.76 146.23 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.336 2.024 . . . . 0.0 112.239 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 64' ' ' GLY . 2.5 m -149.73 169.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.714 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -90.74 115.35 27.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 126' ' ' TYR . 31.2 mt -108.49 126.55 65.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.49 0.662 . . . . 0.0 112.029 -173.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.64 ' HG2' HG22 ' A' ' 121' ' ' VAL . 90.5 mttt -99.49 136.15 39.85 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.665 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.8 p-10 -81.1 -160.47 0.33 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.866 0.365 . . . . 0.0 110.817 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.665 0.786 . . . . 0.0 110.028 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -79.88 -19.83 47.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.515 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.26 38.17 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.725 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.665 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.9 ptmt -93.92 133.48 37.3 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 115' ' ' LYS . 23.0 t -77.35 93.11 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.132 0.491 . . . . 0.0 109.738 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.408 HG23 HD13 ' A' ' 78' ' ' LEU . 18.9 m -120.31 11.89 6.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.547 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.27 51.8 0.82 Allowed Glycine 0 C--O 1.201 -1.943 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.393 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 90.6 Cg_endo -84.34 -1.97 9.87 Favored 'Trans proline' 0 C--N 1.368 1.584 0 CA-C-N 121.542 2.671 . . . . 0.0 112.209 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -113.54 7.26 17.37 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.591 1.186 . . . . 0.0 109.124 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.429 ' HB2' HD12 ' A' ' 114' ' ' ILE . 3.6 m-85 -93.98 137.31 33.32 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.842 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.8 139.94 53.08 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.693 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -79.45 115.41 19.06 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.483 ' HG ' ' CZ3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -87.28 119.9 28.01 Favored 'General case' 0 C--O 1.274 2.369 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -176.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.539 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -101.67 122.07 43.2 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 129' ' ' LEU . 3.5 mm? -96.51 113.25 24.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.14 173.42 7.03 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 124.21 0.944 . . . . 0.0 109.5 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.27 63.86 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.113 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.65 130.94 34.61 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -148.09 100.26 3.15 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.081 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.472 ' O ' ' HE2' ' A' ' 179' ' ' LYS . 16.9 t70 72.41 -48.53 0.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.138 1.775 . . . . 0.0 111.614 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 67.49 -95.82 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 179' ' ' LYS . 28.6 mt -65.15 123.19 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -166.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.1 129.18 37.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.335 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 51.5 ttm -107.43 1.01 23.28 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.487 0.661 . . . . 0.0 110.932 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.3 -49.21 7.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.684 0.754 . . . . 0.0 110.93 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -99.4 10.91 40.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.242 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.7 p -114.44 162.58 16.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -160.27 160.33 32.46 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.407 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -123.53 132.99 54.05 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.82 0.848 . . . . 0.0 109.525 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 57.5 mtt -92.64 126.3 37.66 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.927 0.491 . . . . 0.0 109.986 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -164.36 -26.23 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -168.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HA2' ' A' ' 156' ' ' GLY . 50.0 m -56.59 -55.9 28.16 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 90.6 mt -135.96 -80.71 0.41 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.035 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.95 178.02 5.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -60.33 -34.24 73.54 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-O 120.98 0.419 . . . . 0.0 110.236 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.64 26.54 1.99 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.83 0.824 . . . . 0.0 111.503 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 149' ' ' SER . 38.7 mm-40 -116.99 115.04 24.67 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.747 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 51.5 mt -81.12 121.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.018 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.488 ' HA2' ' OG ' ' A' ' 149' ' ' SER . . . -88.47 -45.31 5.0 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.92 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -124.08 125.41 44.46 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mp -116.89 122.34 69.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -99.34 -51.18 3.87 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.55 0.69 . . . . 0.0 109.886 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.49 110.52 5.94 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.7 124.13 33.81 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -95.23 146.47 24.31 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.02 141.47 58.76 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.864 0.84 . . . . 0.0 112.59 -173.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -85.9 -2.04 57.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.279 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.7 p -68.89 -5.72 22.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.642 1.177 . . . . 0.0 110.01 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.8 m -65.15 -35.08 79.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.19 -30.51 7.43 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.36 144.99 7.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -59.2 120.9 51.67 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.13 0.572 . . . . 0.0 110.817 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 -5.78 16.89 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.426 2.751 . . . . 0.0 114.269 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.91 -3.38 57.37 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.134 -0.354 . . . . 0.0 110.811 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.65 137.39 38.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -90.93 -25.18 19.91 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 91.4 mtp -140.84 131.05 24.89 Favored 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -153.43 153.29 32.23 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.477 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.716 ' CZ ' HG23 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -113.03 143.88 43.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.425 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 39.9 m -88.13 131.98 34.5 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.4 0.438 . . . . 0.0 110.302 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.2 p -81.97 -9.35 59.6 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.5 mmtt -99.04 0.61 44.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.372 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -157.01 143.46 18.2 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.45 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 19.6 mmt180 -90.28 -25.89 20.3 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.615 0.245 . . . . 0.0 111.488 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 182' ' ' ARG . 54.3 mtt180 -78.19 -38.06 44.22 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.425 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 18.9 tp -69.62 100.7 1.5 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 123.247 1.499 . . . . 0.0 113.94 -168.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.716 HG23 ' CZ ' ' A' ' 176' ' ' ARG . 19.8 mt -113.53 116.1 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 112.296 -2.229 . . . . 0.0 106.597 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.25 131.93 54.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 121.833 0.825 . . . . 0.0 113.001 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.99 155.89 24.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.305 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -80.14 156.77 26.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.74 -37.32 70.85 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -57.17 -37.72 72.54 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.94 0.896 . . . . 0.0 111.062 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.33 -51.19 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.938 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.8 p80 -72.47 -26.7 61.9 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.24 -35.68 77.91 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.136 0.494 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.45 -33.78 69.66 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -71.22 -33.03 69.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.097 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 54.1 mm-40 -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.07 -7.43 58.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.007 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.95 24.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 77.99 47.42 8.5 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.779 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.52 165.48 18.02 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.283 20.0 p -67.34 -87.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -169.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.68 124.93 2.01 Favored Glycine 0 CA--C 1.492 -1.384 0 C-N-CA 119.443 -1.36 . . . . 0.0 112.676 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.35 162.82 29.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -108.84 138.51 45.06 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.47 129.35 35.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 124.662 1.226 . . . . 0.0 109.278 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.423 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 74.0 m-85 -125.4 143.12 51.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 115.52 9.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.58 75.82 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.89 96.8 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.987 0.804 . . . . 0.0 109.505 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.79 32.19 41.66 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.982 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -57.73 112.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.559 0.744 . . . . 0.0 110.061 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -102.15 74.99 1.47 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.6 14.57 65.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 116.924 1.53 . . . . 0.0 116.924 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.53 114.76 16.69 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 118.585 1.193 . . . . 0.0 110.341 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -68.37 133.01 48.05 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.191 0.996 . . . . 0.0 110.388 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 5.5 mp . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.865 0.364 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.478 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.6 ptmt -96.45 139.07 33.09 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.21 0.529 . . . . 0.0 109.84 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -121.03 142.66 49.6 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.737 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 64.8 m-85 -119.84 143.43 47.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.667 0.746 . . . . 0.0 112.926 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.27 112.92 16.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -94.68 127.64 40.8 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HG2' ' HD2' ' A' ' 203' ' ' LYS . 22.4 tptm -150.2 139.35 21.17 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 t -88.55 142.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.4 mtt -86.4 75.88 9.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.469 0.652 . . . . 0.0 109.819 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.16 112.47 2.04 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -128.72 -50.88 1.25 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.172 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -1.4 57.1 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.27 1.033 . . . . 0.0 108.621 170.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 79' ' ' TYR . . . -106.14 27.67 8.41 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.263 2.225 . . . . 0.0 110.507 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.585 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 124.45 68.63 0.2 Allowed Glycine 0 N--CA 1.421 -2.352 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -94.66 131.66 40.21 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 166.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -83.01 106.92 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 101.814 -3.402 . . . . 0.0 101.814 162.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -76.87 -50.49 13.25 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.282 0.563 . . . . 0.0 111.126 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -116.08 166.25 12.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.672 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.15 134.61 94.86 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 123.682 0.614 . . . . 0.0 111.641 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.91 162.64 41.94 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.675 2.25 . . . . 0.0 112.282 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -64.24 119.16 9.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.95 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.5 3.58 66.69 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.546 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 m -85.61 146.41 44.04 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.21 166.79 17.98 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 0.0 111.504 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.9 p -59.59 161.29 6.16 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.91 -52.17 35.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.204 1.402 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.403 ' CH2' ' HE2' ' A' ' 49' ' ' LYS . 9.0 p-90 -72.12 -32.96 67.45 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HE2' ' CH2' ' A' ' 48' ' ' TRP . 4.8 mptp? -65.67 -23.65 66.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.543 ' HA ' HD21 ' A' ' 56' ' ' LEU . 72.4 m-85 -60.66 -21.36 62.72 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.029 0.442 . . . . 0.0 111.548 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 11.6 m80 -127.15 -10.38 5.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.33 102.3 14.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.129 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 178' ' ' THR . . . 57.43 -10.97 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 N-CA-C 121.867 3.507 . . . . 0.0 121.867 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 173.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.651 2.726 . . . . 0.0 112.667 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -91.2 142.8 27.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 50' ' ' PHE . 62.3 mt -91.66 -4.68 54.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.125 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.65 -33.79 71.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.87 -5.3 58.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -111.89 -21.33 11.66 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -102.0 137.31 19.46 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.76 123.74 12.49 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.815 2.343 . . . . 0.0 112.347 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.5 114.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 17.13 57.2 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.23 -157.39 25.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.061 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.8 mt-10 -129.63 137.08 50.47 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.2 m -133.82 173.75 14.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 t -144.24 153.41 42.03 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.697 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -69.01 150.18 47.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--N 1.276 -2.602 0 O-C-N 123.671 0.607 . . . . 0.0 109.6 177.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -66.75 -168.77 0.07 Allowed 'General case' 0 C--O 1.256 1.411 0 CA-C-O 123.018 1.39 . . . . 0.0 114.695 -167.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -70.69 -168.5 0.26 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 112.351 -2.204 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -110.5 151.97 26.93 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CE1' ' HB1' ' A' ' 34' ' ' ALA . 23.0 m-85 -109.7 -154.38 0.53 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.929 0.891 . . . . 0.0 109.093 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.46 -47.1 74.21 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.086 0.469 . . . . 0.0 111.62 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.21 140.49 51.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.585 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 21.8 tp60 -124.7 120.97 25.71 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.738 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -88.85 -174.46 1.02 Allowed 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.396 2.064 . . . . 0.0 111.553 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -163.67 177.92 8.34 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.87 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.48 -13.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 123.641 0.588 . . . . 0.0 109.426 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.99 -70.72 0.52 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 181' ' ' ARG . 22.8 t -179.81 -53.73 0.01 OUTLIER 'General case' 0 C--N 1.362 1.116 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.41 -167.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.63 166.39 12.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.4 132.17 56.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 56.6 tp -104.77 132.42 51.04 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.6 136.86 58.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 O-C-N 122.408 -0.183 . . . . 0.0 110.718 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.8 p -76.32 170.07 17.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.853 0.461 . . . . 0.0 109.87 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.0 81.05 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.54 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -64.44 -53.39 49.18 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.152 0.501 . . . . 0.0 110.21 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -30.58 70.39 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.129 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.32 -44.1 97.28 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.587 0.755 . . . . 0.0 110.321 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -62.39 -39.46 93.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.934 0.771 . . . . 0.0 109.897 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 102' ' ' LEU . 4.1 mm? -57.62 -59.73 4.75 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.429 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -55.84 -41.34 66.13 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 123.234 0.614 . . . . 0.0 112.578 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.55 -42.52 78.29 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 p -71.49 -27.38 63.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 98' ' ' LEU . 9.5 mp -67.58 -25.4 65.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.863 0.363 . . . . 0.0 111.567 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.03 42.41 5.98 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.17 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.3 t -81.93 101.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 m -74.87 146.99 41.45 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.609 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 80.02 12.27 1.07 Allowed 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.28 1.432 . . . . 0.0 112.56 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.48 113.89 21.54 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.02 131.48 51.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.48 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 53.2 m95 -111.37 123.13 49.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.454 -174.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.2 mt -108.92 95.11 16.19 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.8 132.98 8.97 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -150.3 167.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.98 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.635 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.92 116.71 33.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 24.4 mt -106.24 136.28 41.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.784 -172.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HG2' HG22 ' A' ' 121' ' ' VAL . 63.1 mttp -95.46 146.76 24.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.59 -160.35 0.72 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -70.58 -23.16 62.54 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.377 1.071 . . . . 0.0 110.385 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -92.98 -19.71 21.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.838 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.57 12.97 33.84 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.094 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -99.42 151.16 21.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 117.691 0.745 . . . . 0.0 109.348 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 115' ' ' LYS . 30.6 t -84.73 81.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.666 0.746 . . . . 0.0 110.244 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.7 m -104.45 11.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.086 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -127.39 48.11 0.99 Allowed Glycine 0 N--CA 1.422 -2.25 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.312 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 95.5 Cg_endo -84.95 -2.52 9.63 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 121.405 2.602 . . . . 0.0 111.634 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -114.12 14.27 18.23 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.819 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.451 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 19.6 m-85 -112.8 138.24 49.92 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 111.646 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.96 138.82 52.19 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.965 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.89 125.44 29.72 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.48 HD12 ' CZ3' ' A' ' 109' ' ' TRP . 6.4 tt -102.09 125.95 48.91 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.798 0.809 . . . . 0.0 110.354 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.19 140.55 52.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.317 170.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 176' ' ' ARG . 2.8 mm? -95.79 143.64 26.85 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.204 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.64 173.29 6.37 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 122.992 0.517 . . . . 0.0 109.897 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.25 7.52 84.92 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.39 132.35 40.53 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.63 0.728 . . . . 0.0 110.464 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -132.66 170.45 15.2 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -47.85 107.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.191 0.932 . . . . 0.0 111.391 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.692 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -94.29 -55.58 3.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -163.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.58 117.97 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.126 0.891 . . . . 0.0 112.886 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -67.0 109.84 3.13 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.57 -1.92 58.26 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 12.9 pt-20 -100.05 -30.26 12.06 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.032 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 59.9 mtt85 -102.18 -12.65 17.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 m -97.75 131.44 44.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.872 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -109.42 115.29 29.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.75 174.52 14.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.011 0.434 . . . . 0.0 111.492 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -129.46 128.62 43.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 91.2 mtp -100.79 155.13 18.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.261 19.4 t70 88.71 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.121 2.169 . . . . 0.0 113.076 177.027 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.0 p -101.57 -57.47 2.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.232 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -112.91 -24.4 9.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.784 0.802 . . . . 0.0 109.284 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 32.5 mt-10 -151.95 175.96 11.97 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 126.401 1.88 . . . . 0.0 106.47 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.577 ' HE2' ' N ' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -70.53 -38.32 74.22 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -98.79 26.53 5.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.114 1.435 . . . . 0.0 110.607 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.655 ' NE2' ' HD3' ' A' ' 181' ' ' ARG . 9.7 mm-40 -108.2 121.46 44.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.093 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.46 132.59 31.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -97.8 -55.98 1.11 Allowed Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.887 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -112.12 133.3 54.35 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.724 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.47 123.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.4 -39.27 9.27 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.977 0.417 . . . . 0.0 110.447 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.91 117.04 6.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.625 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.98 123.14 45.37 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.36 142.46 30.81 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.87 133.68 56.24 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 122.456 1.122 . . . . 0.0 113.001 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.692 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 18.7 p-10 -88.43 6.22 38.59 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.096 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.2 p -68.9 -4.67 17.35 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.215 1.406 . . . . 0.0 109.979 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.9 m -68.56 -40.68 80.52 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.935 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -103.6 -33.25 9.06 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.196 -0.315 . . . . 0.0 110.864 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.8 146.01 6.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.468 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 1.6 mpp_? -64.85 125.79 89.7 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -4.77 9.86 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.976 3.117 . . . . 0.0 114.658 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 3.9 p30 -83.56 -10.68 58.13 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.244 -0.285 . . . . 0.0 111.177 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.53 138.74 53.56 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.284 0.564 . . . . 0.0 111.076 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.97 -30.0 24.61 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.214 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.1 ttt -148.99 130.42 14.77 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.68 178.45 8.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.296 0.373 . . . . 0.0 110.609 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.563 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 ppt_? -148.54 138.26 22.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 59.6 m -78.17 153.37 32.11 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.973 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 51' ' ' HIS . 7.3 p -81.52 -50.38 9.46 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -97.81 30.13 3.12 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -155.64 127.17 7.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.655 ' HD3' ' NE2' ' A' ' 154' ' ' GLN . 1.8 mpt_? -81.0 -40.99 23.41 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.043 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -86.51 -7.12 58.65 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.175 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.8 tp -88.2 104.2 16.49 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 122.094 0.95 . . . . 0.0 111.902 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.71 123.18 69.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.22 128.85 51.99 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.343 0.592 . . . . 0.0 110.54 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 45.8 pt -112.0 148.86 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.736 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -80.73 156.18 26.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.56 -38.22 43.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.955 0.902 . . . . 0.0 112.487 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.63 -39.79 85.5 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.112 1.365 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.45 -51.34 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.737 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.575 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 18.3 p80 -68.92 -27.86 66.14 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.387 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.41 -32.18 72.12 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.562 0.539 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.9 59.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.201 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -71.72 -32.12 67.42 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.218 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 70.2 mm-40 -55.68 -53.85 51.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.815 0.846 . . . . 0.0 109.149 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -76.88 -20.72 55.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.246 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.81 -27.98 44.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.61 0.243 . . . . 0.0 110.66 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.04 47.76 12.72 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.225 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.78 165.3 23.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.75 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -159.83 132.76 3.08 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.67 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.84 165.31 25.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.4 ' HD2' ' HG2' ' A' ' 28' ' ' LYS . 16.9 ptpt -128.47 131.81 48.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 173.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.59 130.25 71.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.009 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -113.04 153.16 28.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.64 112.02 9.34 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.9 -36.96 84.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 123.829 0.705 . . . . 0.0 112.068 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.63 94.92 1.04 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.51 35.19 14.52 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.622 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -58.64 100.63 0.07 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.513 0.725 . . . . 0.0 111.492 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -104.39 126.54 51.58 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.39 -26.49 0.21 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 120.298 2.879 . . . . 0.0 120.298 163.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.22 115.15 24.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 118.899 1.349 . . . . 0.0 111.602 -172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -82.69 134.66 35.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.753 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.794 1.638 . . . . 0.0 111.577 171.071 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.0 155.57 37.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.043 0.449 . . . . 0.0 112.111 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.35 138.33 46.89 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.929 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 204' ' ' VAL . 65.1 m-85 -125.76 147.52 49.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.31 0.576 . . . . 0.0 112.156 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.1 t -78.3 124.85 37.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -96.43 135.24 38.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.601 0.715 . . . . 0.0 112.154 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -149.78 162.95 39.27 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 81' ' ' PHE . 21.8 t -104.59 143.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.4 ttm -96.55 80.55 3.13 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.47 114.75 4.16 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.018 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.43 -33.67 2.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.86 -0.53 57.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.37 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.98 -31.96 20.32 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 172.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.6 161.1 33.43 Favored Glycine 1 N--CA 1.383 -4.862 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.902 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 47.9 m-85 -95.97 164.14 12.84 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.06 101.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -54.0 -51.18 64.79 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 125.131 1.519 . . . . 0.0 113.174 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -146.81 153.61 40.39 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 40' ' ' LEU . 6.6 mp -48.98 121.16 10.18 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.016 1.326 . . . . 0.0 113.593 -175.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 67' ' ' SER . 31.1 Cg_endo -75.59 167.03 27.34 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.472 2.115 . . . . 0.0 111.161 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -54.66 128.82 34.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.539 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.26 3.57 81.94 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.585 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m -85.47 128.93 57.21 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.73 165.7 3.39 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.616 3.544 . . . . 0.0 112.799 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 p -54.2 147.08 13.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 50' ' ' PHE . 4.0 m-20 -38.19 -56.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 127.059 2.143 . . . . 0.0 114.32 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.434 ' HB2' ' HD2' ' A' ' 181' ' ' ARG . 23.9 p-90 -85.88 -16.08 39.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.835 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -86.66 -13.19 46.26 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.019 -171.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HD2' ' O ' ' A' ' 47' ' ' ASP . 65.9 m-85 -48.66 -27.64 2.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 130' ' ' ASN . 46.8 m170 -127.84 1.24 6.02 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.582 -0.699 . . . . 0.0 111.319 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.84 102.15 14.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.587 -167.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.14 -9.84 0.98 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.18 164.81 30.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 119.516 1.658 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -91.38 143.7 26.35 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.8 0.12 56.82 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.206 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.56 -37.97 52.16 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -90.38 -15.39 31.13 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 178.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.49 -23.1 12.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.631 -0.668 . . . . 0.0 112.66 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -97.46 134.71 22.27 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.8 122.09 9.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.462 1.441 . . . . 0.0 110.805 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.12 127.59 54.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.49 66.91 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -101.3 -167.44 27.81 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.613 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.2 mt-10 -116.96 137.75 52.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.48 163.1 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 41' ' ' PRO . 28.7 t -146.29 148.16 32.14 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.046 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.59 116.59 9.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.411 -2.407 0 O-C-N 124.026 0.829 . . . . 0.0 111.71 -176.568 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.443 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 19.7 t-20 . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 77' ' ' ASN . 6.0 mmp_? -84.19 -162.2 0.63 Allowed 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.4 p-10 -86.41 -170.16 2.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.873 1.269 . . . . 0.0 113.143 -176.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 5.1 mp -87.89 144.51 26.54 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.367 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -103.82 -175.9 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -57.58 -41.28 80.81 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.591 0.71 . . . . 0.0 112.18 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.421 ' O ' HG11 ' A' ' 29' ' ' VAL . 95.8 m-85 -118.36 134.91 54.66 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 172.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -121.77 129.5 25.15 Favored Pre-proline 0 C--N 1.283 -2.307 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.182 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.22 171.72 13.57 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.463 2.108 . . . . 0.0 111.734 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.1 p30 -160.08 173.65 15.49 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -96.7 14.89 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-O 123.109 1.433 . . . . 0.0 109.184 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -121.3 -176.09 3.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.722 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 m -98.09 46.9 1.0 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -127.63 162.02 27.49 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.539 -0.726 . . . . 0.0 109.603 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.8 tp -122.99 129.86 52.06 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.2 tp -102.27 123.79 46.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.61 138.05 54.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 122.791 0.436 . . . . 0.0 110.014 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -76.99 174.0 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.639 0.376 . . . . 0.0 111.119 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.61 -37.25 67.95 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.396 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.96 -35.0 66.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.103 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.38 -34.38 70.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 100' ' ' GLU . 64.8 ttt180 -57.84 -46.24 85.05 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.02 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -55.17 -38.4 68.26 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.28 -51.21 69.86 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.53 -41.66 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.069 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 mm-40 -69.19 -36.79 77.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.222 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -74.9 -29.6 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.26 -19.66 56.23 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.245 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.45 48.71 5.2 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.804 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 174' ' ' MET . 97.2 t -82.69 101.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.0 m -77.04 150.44 35.76 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.332 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.1 9.2 1.4 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.391 1.476 . . . . 0.0 113.3 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.49 113.8 25.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.447 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 9.1 tp10 -99.41 139.82 34.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.467 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 57.0 m95 -116.96 121.74 42.27 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -116.41 93.31 39.49 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.1 139.82 21.91 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.858 2.372 . . . . 0.0 113.894 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 64' ' ' GLY . 4.3 m -150.75 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 124.52 1.128 . . . . 0.0 109.522 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -96.95 116.21 28.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -108.36 130.17 61.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.423 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 121' ' ' VAL . 57.8 mttm -96.7 135.27 38.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -169.82 2.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.983 0.356 . . . . 0.0 110.528 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 63.2 m80 -59.59 -31.15 69.2 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.022 0.929 . . . . 0.0 111.147 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -87.52 -3.01 59.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.46 64.47 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -105.34 147.73 27.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 118.461 1.13 . . . . 0.0 110.553 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 115' ' ' LYS . 45.9 t -81.65 90.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.715 0.769 . . . . 0.0 110.34 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.9 6.22 7.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.076 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.06 45.28 1.17 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 119.309 -1.424 . . . . 0.0 116.072 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 78.3 Cg_endo -84.04 -1.44 9.9 Favored 'Trans proline' 0 C--N 1.381 2.251 0 CA-C-N 122.222 3.011 . . . . 0.0 111.02 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.64 -9.22 41.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -98.43 149.55 22.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.637 0.732 . . . . 0.0 112.707 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.0 140.18 45.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.472 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.23 122.89 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.467 HD12 ' CZ3' ' A' ' 109' ' ' TRP . 6.9 tt -99.71 128.55 45.81 Favored 'General case' 0 C--O 1.275 2.434 0 CA-C-O 121.819 0.819 . . . . 0.0 110.914 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.19 140.65 52.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.611 174.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.7 140.09 36.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.99 173.76 6.59 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.183 0.927 . . . . 0.0 109.39 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.88 22.13 50.59 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.134 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.43 132.96 45.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.416 0.627 . . . . 0.0 111.164 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -132.72 150.64 52.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -50.13 105.43 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.139 0.971 . . . . 0.0 113.453 -170.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -117.14 -34.1 4.47 Favored 'General case' 0 N--CA 1.398 -3.068 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -167.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 179' ' ' LYS . 41.2 mt -54.62 112.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.517 0.675 . . . . 0.0 111.67 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.85 128.88 36.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.668 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.4 mtt -101.79 4.62 40.61 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.505 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 11.4 pt-20 -88.93 -30.09 19.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.797 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.505 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 3.1 mmp_? -109.55 -28.07 9.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.875 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -83.09 138.68 33.6 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.661 0.743 . . . . 0.0 112.471 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.97 113.87 17.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -153.67 163.17 40.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.199 0.312 . . . . 0.0 111.244 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.66 139.15 52.39 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.299 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 60.2 mtt -100.63 108.57 20.5 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -173.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.7 t70 169.4 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.423 1.889 . . . . 0.0 108.198 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 34.8 t -99.0 -57.17 2.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.418 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 80.0 mt -107.58 -51.98 2.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 -165.97 2.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.571 175.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 147' ' ' MET . 53.8 pttt -59.68 -27.77 66.7 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.11 12.53 35.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.716 0.77 . . . . 0.0 111.892 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 26.0 mm-40 -111.96 116.09 30.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.51 131.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -109.22 -72.25 0.73 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -82.91 127.19 33.29 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.98 121.55 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.06 -39.3 13.75 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.98 134.35 16.2 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.59 120.76 37.64 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.14 146.79 26.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.95 135.18 57.16 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.828 0.705 . . . . 0.0 111.255 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.595 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 13.0 p-10 -92.76 14.04 18.43 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.279 1.038 . . . . 0.0 111.082 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 p -68.56 -5.14 18.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.755 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.4 m -62.8 -35.51 80.11 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 124.187 0.995 . . . . 0.0 110.457 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.42 -31.15 6.9 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.104 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.523 HG13 ' HB2' ' A' ' 137' ' ' ALA . 85.7 mt -90.64 154.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.457 ' HD2' ' OD1' ' A' ' 171' ' ' ASP . 8.3 mmt180 -45.07 119.38 4.01 Favored Pre-proline 0 C--O 1.225 -0.23 0 C-N-CA 123.466 0.706 . . . . 0.0 112.542 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.05 -16.54 25.46 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.093 1.862 . . . . 0.0 111.109 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.457 ' OD1' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -98.06 9.69 42.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.537 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.76 142.55 58.39 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.181 0.515 . . . . 0.0 109.834 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.06 -36.07 15.11 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.971 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.445 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.6 ttt -153.19 118.9 5.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -140.33 -179.7 6.15 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.74 145.01 50.66 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 39.5 m -82.47 147.95 28.42 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 40.6 p -80.54 -45.66 17.07 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.452 ' HB2' HD12 ' A' ' 138' ' ' ILE . 65.6 mttp -79.62 17.62 0.87 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.5 150.18 34.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.434 ' HD2' ' HB2' ' A' ' 48' ' ' TRP . 4.9 mmp_? -91.95 -43.59 9.37 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.875 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -83.66 -33.84 25.15 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.394 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.88 102.3 0.19 Allowed 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.416 1.072 . . . . 0.0 113.187 -170.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 51' ' ' HIS . 87.1 mt -112.88 126.83 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.18 176.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.98 122.94 46.26 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.445 HG22 ' HG3' ' A' ' 174' ' ' MET . 49.2 pt -111.66 151.08 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -86.72 163.11 17.51 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.547 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 15.0 tp10 -50.44 -48.38 56.42 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.187 1.395 . . . . 0.0 111.872 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -63.98 -31.17 72.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.329 0.652 . . . . 0.0 111.558 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.83 -48.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.75 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.571 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 24.9 p80 -71.52 -33.04 68.85 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.699 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.09 72.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.554 0.534 . . . . 0.0 110.457 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.15 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.616 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.77 -40.57 75.98 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.442 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 37.8 mt-10 -62.08 -47.55 84.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.149 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.87 -19.27 61.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.24 47.14 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.656 0.265 . . . . 0.0 111.033 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.91 47.74 5.46 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.304 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.6 mt -89.63 165.83 13.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -50.27 -91.11 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.66 143.42 11.44 Favored Glycine 0 CA--C 1.497 -1.086 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.935 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.79 165.73 24.61 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -133.06 128.59 36.57 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 170.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 15.6 m -132.53 129.92 59.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 123.687 0.617 . . . . 0.0 110.092 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.08 147.05 49.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.63 114.76 3.17 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.019 0.824 . . . . 0.0 109.68 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.57 61.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.104 0.253 . . . . 0.0 111.618 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.64 98.69 1.54 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.27 35.73 16.81 Favored Glycine 0 N--CA 1.422 -2.284 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.594 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -52.74 106.3 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.694 0.759 . . . . 0.0 110.045 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.72 99.65 10.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.837 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.93 -23.16 0.31 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 119.022 2.369 . . . . 0.0 119.022 167.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 69.6 mt -68.11 147.08 52.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.31 134.6 50.15 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 215' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 125.674 1.59 . . . . 0.0 112.426 -174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.432 HG13 ' HG2' ' A' ' 188' ' ' GLU . 52.4 t . . . . . 0 N--CA 1.419 -1.977 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 7.7 ptpp? -81.17 147.84 29.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.444 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -109.17 133.15 53.39 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.629 -174.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 76.3 m-85 -118.79 145.09 45.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.656 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 58.5 t -75.99 124.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -97.81 124.37 42.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.428 0.455 . . . . 0.0 111.591 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -137.46 147.44 45.31 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.7 133.73 40.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.5 ttt -91.19 82.18 5.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.783 0.801 . . . . 0.0 110.01 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.58 116.88 5.68 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.207 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.49 -36.54 2.07 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -83.25 -23.3 32.78 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.133 0.973 . . . . 0.0 109.982 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . . . -67.22 -34.49 77.59 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 154.12 30.79 Favored Glycine 1 N--CA 1.392 -4.259 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.909 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.13 166.95 11.5 Favored 'General case' 0 C--N 1.254 -3.571 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' ' 41' ' ' PRO . 44.6 mt -75.74 101.73 2.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 165.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -63.36 -45.64 90.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.676 -1.602 . . . . 0.0 112.659 -167.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.38 177.08 7.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.041 0.536 . . . . 0.0 110.163 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.38 122.82 84.74 Favored Pre-proline 0 C--N 1.32 -0.687 0 O-C-N 123.808 0.692 . . . . 0.0 112.604 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' ' 37' ' ' ILE . 14.1 Cg_exo -69.82 166.7 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.776 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -48.92 113.51 0.8 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.95 1.3 . . . . 0.0 113.395 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.78 72.88 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.975 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.13 143.31 39.41 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.52 165.86 16.84 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.931 3.087 . . . . 0.0 111.503 172.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.1 p -62.09 155.82 23.16 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 86' ' ' MET . 4.2 m-20 -46.07 -52.71 11.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.096 1.358 . . . . 0.0 113.027 -175.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 30.7 p-90 -73.35 -23.72 60.25 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -74.53 -23.68 58.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.41 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 96.1 m-85 -58.79 -24.9 62.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.628 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 9.0 m80 -114.61 2.29 14.49 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.79 100.65 12.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.468 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.97 -11.79 0.01 OUTLIER Glycine 0 CA--C 1.555 2.542 0 N-CA-C 121.238 3.255 . . . . 0.0 121.238 166.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.06 166.04 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 121.15 2.475 . . . . 0.0 112.191 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB2' ' HG ' ' A' ' 132' ' ' LEU . 32.5 t -84.54 153.73 23.09 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.56 11.6 39.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -170.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.55 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -13.24 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.925 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.32 -22.8 13.29 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.479 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -109.51 137.37 20.3 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.88 122.62 10.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.14 1.893 . . . . 0.0 111.979 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.49 115.64 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.34 55.66 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -100.8 -156.28 27.39 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 33.9 mt-10 -128.83 133.31 47.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 122.468 -0.431 . . . . 0.0 110.894 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 18.8 m -131.81 166.61 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.461 ' OG ' ' HE2' ' A' ' 115' ' ' LYS . 20.0 m -145.62 156.52 43.72 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 5.9 m-85 -74.84 105.8 6.07 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.938 0.774 . . . . 0.0 109.805 175.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.41 -2.44 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -82.69 -161.81 0.52 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.4 -176.22 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.659 1.184 . . . . 0.0 112.59 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 122' ' ' VAL . 8.4 mp -94.04 150.99 19.85 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 34' ' ' ALA . 20.9 m-85 -110.06 -154.7 0.54 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.761 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -71.11 -38.34 72.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.156 0.503 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.54 138.98 52.52 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 18.2 tp60 -122.53 114.08 30.33 Favored Pre-proline 0 N--CA 1.414 -2.231 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.5 159.33 28.93 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 122.171 1.914 . . . . 0.0 111.356 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.47 171.8 8.82 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.5 mm -88.71 -18.34 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.475 ' HG3' ' OD2' ' A' ' 47' ' ' ASP . 4.7 mpp? -80.74 -95.91 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.151 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 43.2 t -175.89 34.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.485 1.136 . . . . 0.0 110.048 -174.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -136.86 154.33 50.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.714 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.81 139.9 48.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 59.3 tp -112.18 130.02 56.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.16 135.95 61.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.257 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.8 p -71.51 169.63 15.04 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 96' ' ' ARG . . . -63.89 -39.94 97.85 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.149 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -75.74 -32.7 60.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.058 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.48 -28.19 63.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.876 0.37 . . . . 0.0 110.048 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 109' ' ' TRP . 69.1 mtp180 -58.81 -43.12 90.49 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.854 172.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.9 mmpt? -61.47 -35.31 77.27 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 123.527 0.517 . . . . 0.0 111.359 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.85 -58.29 7.92 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.884 0.373 . . . . 0.0 110.115 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.16 -44.25 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.042 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.22 -37.42 87.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.0 p -75.65 -27.4 58.36 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.018 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.3 -24.38 61.32 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.738 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.11 48.45 6.92 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.8 104.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-O 121.818 0.818 . . . . 0.0 110.944 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m -55.31 123.87 15.22 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.799 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 78.21 15.08 1.41 Allowed 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.521 1.528 . . . . 0.0 113.835 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.2 114.24 21.67 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.5 tp10 -105.84 144.92 31.9 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.237 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.527 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 64.9 m95 -116.3 119.66 36.44 Favored 'General case' 0 N--CA 1.425 -1.702 0 O-C-N 124.363 1.04 . . . . 0.0 109.009 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 66.3 mt -110.92 93.36 17.11 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.46 139.49 10.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.647 2.231 . . . . 0.0 112.73 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' GLY . 4.1 m -147.5 173.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 108.777 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -99.66 116.16 31.11 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 172.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 29.9 mt -108.44 132.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.2 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 mppt? -101.12 132.3 46.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.54 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.8 p-10 -82.19 -160.37 0.37 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.54 0.736 . . . . 0.0 112.524 -172.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -67.55 -32.77 73.77 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.746 0.818 . . . . 0.0 110.391 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -77.11 -21.21 54.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.52 36.91 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.109 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.62 157.66 16.31 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.47 103.44 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 116' ' ' ASP . 12.9 p -103.38 -29.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.901 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -127.98 76.52 0.4 Allowed Glycine 0 N--CA 1.407 -3.292 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.869 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.72 -23.03 7.3 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 CA-C-N 119.478 1.639 . . . . 0.0 112.651 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -116.96 4.16 12.82 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.652 0.739 . . . . 0.0 111.049 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -72.33 142.05 48.82 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.81 49.56 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.649 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -81.45 127.93 33.33 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.495 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 6.8 tt -103.85 126.28 50.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.568 0.699 . . . . 0.0 110.417 -176.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.79 141.74 51.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.203 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 176' ' ' ARG . 2.9 mm? -99.79 129.22 45.87 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.999 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 55' ' ' SER . 7.4 mp -87.62 173.1 9.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.344 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.9 78.61 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.305 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.27 131.94 47.04 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.11 0.481 . . . . 0.0 109.85 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.48 170.71 15.21 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.597 ' OD2' ' HE2' ' A' ' 179' ' ' LYS . 23.6 t70 -56.04 104.96 0.16 Allowed 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.164 0.915 . . . . 0.0 110.712 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -125.03 -36.13 2.58 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 -166.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 179' ' ' LYS . 31.6 mt -63.2 116.13 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.199 0.909 . . . . 0.0 111.123 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.11 128.95 36.03 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.998 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.0 ttm -105.21 1.42 28.19 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 121.061 0.457 . . . . 0.0 111.93 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.24 -50.64 5.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.987 0.899 . . . . 0.0 109.778 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -82.26 -4.9 58.03 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.37 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 p -106.2 162.97 13.18 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.183 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -126.75 93.71 3.85 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -150.94 161.97 41.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 9.0 mm-40 -121.98 141.62 51.14 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.358 1.463 . . . . 0.0 108.252 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 81.8 mtp -100.84 107.57 19.14 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.61 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 t -69.6 -55.76 9.2 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.793 -0.567 . . . . 0.0 112.03 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.1 mt -136.56 -62.24 0.66 Allowed 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -116.82 170.36 8.67 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 111.8 -2.455 . . . . 0.0 105.796 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 147' ' ' MET . 0.0 OUTLIER -61.03 -39.6 90.4 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 124.09 0.956 . . . . 0.0 109.502 -176.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.89 -10.31 59.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.862 1.265 . . . . 0.0 111.683 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -102.01 115.5 30.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 46.3 mt -72.07 130.62 35.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.904 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -105.3 -75.57 1.01 Allowed Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.021 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 5.6 t30 -82.97 120.43 25.7 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.11 113.1 34.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.32 -29.82 15.45 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.98 2.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.185 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.11 121.87 33.27 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.02 140.65 30.46 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.96 140.34 58.85 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 124.258 0.974 . . . . 0.0 113.605 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.479 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.9 p-10 -93.46 6.51 47.93 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.254 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.0 p -67.44 -4.8 12.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.909 1.283 . . . . 0.0 110.401 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.1 m -63.85 -38.33 90.69 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.702 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.57 -31.37 6.8 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.875 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 78.5 mt -89.37 139.06 18.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 30.1 mmt180 -59.92 122.61 67.06 Favored Pre-proline 0 C--N 1.316 -0.858 0 O-C-N 123.489 0.493 . . . . 0.0 109.94 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 6.6 Cg_exo -69.46 -7.97 22.37 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.486 2.124 . . . . 0.0 113.265 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.36 1.86 56.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.364 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.16 125.42 26.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 17.7 tttt -72.31 -27.18 62.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.372 0.606 . . . . 0.0 112.066 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.509 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.5 ttt -154.16 131.43 11.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -141.6 171.19 14.41 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.102 0.477 . . . . 0.0 111.475 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.628 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.3 OUTLIER -136.69 126.83 26.21 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.715 -176.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 25.6 m -74.54 142.91 44.7 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.635 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.7 p -81.51 -39.52 24.59 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.597 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 69.2 mmtt -74.43 11.2 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -174.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.94 140.69 4.64 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 7.1 mmt180 -90.18 -31.66 16.95 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -83.95 -28.96 27.44 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.61 111.0 5.13 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.305 1.05 . . . . 0.0 113.237 -173.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.57 129.73 74.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.91 129.85 56.79 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.382 0.611 . . . . 0.0 111.288 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 174' ' ' MET . 45.4 pt -116.1 157.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.017 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.471 ' CD ' ' HA ' ' A' ' 173' ' ' LYS . 48.2 mtp180 -85.85 162.33 18.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.509 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.8 pt-20 -57.44 -36.22 71.11 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.452 ' OD2' ' HE2' ' A' ' 173' ' ' LYS . 5.1 p-10 -64.33 -32.38 73.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.43 0.456 . . . . 0.0 111.615 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 -48.9 79.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.637 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.505 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 17.8 p80 -73.62 -25.46 60.32 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.749 -1.181 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.03 74.1 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.414 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.12 -36.08 69.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -70.43 -33.25 71.12 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.3 mm-40 -58.51 -45.61 88.42 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.707 0.765 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -85.81 -12.42 50.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.225 -175.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -85.42 -27.92 25.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.88 48.37 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.09 165.34 19.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.8 p -41.49 -62.5 0.86 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -173.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.42 140.35 5.17 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 118.431 -1.842 . . . . 0.0 113.21 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -142.31 161.91 36.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.9 mmpt? -139.16 122.05 16.61 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.1 m -124.19 142.35 41.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.45 142.25 50.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.04 108.83 3.23 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.31 -30.42 66.22 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.432 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.67 92.11 1.15 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.88 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.17 31.12 26.44 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.588 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -58.19 101.62 0.08 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 110.967 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -104.01 120.95 42.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.67 -25.43 1.43 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 118.684 2.234 . . . . 0.0 118.684 168.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.53 143.67 36.35 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.619 1.209 . . . . 0.0 112.923 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.63 134.57 49.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.532 ' H ' HD12 ' A' ' 215' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.478 0.971 0 O-C-N 124.259 0.974 . . . . 0.0 110.67 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -87.61 134.4 33.64 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.885 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -109.67 145.23 36.87 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.199 0.523 . . . . 0.0 111.33 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -128.53 150.84 50.0 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.425 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 61.7 t -80.99 126.31 39.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -95.0 117.42 30.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.458 0.474 . . . . 0.0 110.719 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HG3' ' C ' ' A' ' 215' ' ' LEU . 1.2 tmtp? -135.68 139.28 43.57 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.64 122.98 49.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.6 ptp -76.07 84.58 2.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.976 0.893 . . . . 0.0 111.438 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . -145.17 112.38 6.08 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.274 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 38.2 mt-10 -131.18 -37.19 1.27 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -84.41 -31.48 24.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.016 176.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.595 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . . . -72.16 -35.21 68.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 167.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.46 26.97 Favored Glycine 0 N--CA 1.42 -2.421 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.478 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 32' ' ' GLU . 88.7 m-85 -90.68 166.94 12.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.439 HG12 ' CE1' ' A' ' 68' ' ' PHE . 49.5 mt -78.24 100.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 161.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -59.0 -63.66 1.22 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.483 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -125.22 175.42 7.43 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.717 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -59.81 123.7 72.92 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.26 0.975 . . . . 0.0 112.838 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -65.06 166.86 17.44 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.897 2.398 . . . . 0.0 112.878 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' VAL . 6.9 t30 -53.88 114.43 1.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.352 1.061 . . . . 0.0 112.419 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.71 12.31 62.66 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.128 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.6 m -86.38 139.71 34.01 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 167.24 24.93 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.096 3.197 . . . . 0.0 111.449 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -51.96 149.05 5.29 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.42 -49.56 7.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.661 2.384 . . . . 0.0 114.141 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -86.15 -30.05 22.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.863 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 21.1 tptm -80.28 -12.47 59.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.629 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 51.9 m-85 -48.54 -33.71 10.08 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.648 0.593 . . . . 0.0 112.23 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -128.36 9.46 6.11 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 49' ' ' LYS . 4.3 mm-40 -87.92 102.66 14.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.37 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.65 -8.96 0.17 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.91 171.29 14.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 119.181 1.491 . . . . 0.0 112.828 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -98.5 150.54 21.57 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.79 14.53 31.36 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.498 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.78 -32.39 60.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -88.82 -24.14 22.66 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.3 -22.04 14.21 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -110.79 138.38 21.07 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.75 123.4 12.59 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.291 1.994 . . . . 0.0 111.967 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.71 113.67 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 16.37 60.33 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.99 -149.56 20.35 Favored Glycine 0 C--O 1.241 0.556 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.909 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.4 mt-10 -132.68 138.53 47.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.098 0.475 . . . . 0.0 110.51 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 42' ' ' ASN . 29.6 m -131.15 174.51 12.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 p -147.31 152.72 38.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 116' ' ' ASP . 21.2 m-85 -79.36 123.63 27.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.266 1.942 0 O-C-N 124.339 1.024 . . . . 0.0 109.835 174.412 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 CA--C 1.508 -0.653 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -85.83 -154.62 0.21 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 121.578 0.704 . . . . 0.0 112.023 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.17 -169.54 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.585 1.554 . . . . 0.0 112.355 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -94.11 150.73 20.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.96 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -102.35 -163.07 0.97 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.727 1.211 . . . . 0.0 109.244 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -68.75 -30.12 68.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.506 0.67 . . . . 0.0 109.604 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.402 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 64.8 m-85 -134.85 148.39 50.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.851 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 15.3 tp60 -129.93 126.55 22.52 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.0 175.26 5.04 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.315 2.01 . . . . 0.0 111.117 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.42 ' HB2' ' H ' ' A' ' 86' ' ' MET . 0.3 OUTLIER -140.19 -178.4 5.45 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.02 -19.98 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.42 ' H ' ' HB2' ' A' ' 84' ' ' ASN . 3.2 mpp? -84.66 -92.39 0.08 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.397 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 60.2 p -174.11 -29.06 0.01 OUTLIER 'General case' 0 C--N 1.369 1.421 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -70.96 115.53 10.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.022 0.915 . . . . 0.0 111.985 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.33 126.66 33.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.671 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 38.6 tp -93.54 122.4 35.94 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.414 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -71.88 156.4 39.32 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -60.16 -34.61 84.88 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.994 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -68.92 -41.78 77.7 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 120.838 0.351 . . . . 0.0 111.203 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.77 -28.92 61.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.958 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -59.9 -42.44 93.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.944 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 10.0 mmpt? -64.42 -32.56 74.23 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.21 -55.43 33.86 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 120.68 0.276 . . . . 0.0 110.385 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.73 -41.11 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.592 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -70.79 -27.18 63.71 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.8 m -71.92 -27.09 62.59 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.516 0.674 . . . . 0.0 110.557 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.8 -9.93 59.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.077 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.74 47.94 58.43 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.16 103.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.782 0.801 . . . . 0.0 110.094 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 m -77.26 146.82 36.67 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.838 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 80.39 1.18 1.93 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 126.008 1.723 . . . . 0.0 113.001 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.62 23.28 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.8 tp10 -99.13 142.74 30.23 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -117.86 113.49 21.84 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.986 0.804 . . . . 0.0 108.887 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.34 100.98 32.62 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.3 134.56 9.1 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.718 2.279 . . . . 0.0 112.846 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -149.88 174.63 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -108.85 116.94 32.94 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -96.43 133.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.832 -174.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' HG2' HG22 ' A' ' 121' ' ' VAL . 61.8 mttm -92.9 129.5 38.8 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 41.8 p-10 -76.17 -163.92 0.34 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.51 -24.94 67.26 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.523 0.729 . . . . 0.0 110.679 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.16 -19.96 24.84 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.038 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 11.85 41.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.093 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -101.28 142.66 32.37 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.427 -0.455 . . . . 0.0 110.462 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 115' ' ' LYS . 13.7 t -78.9 88.56 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.2 m -110.59 1.38 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.774 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.94 64.5 0.54 Allowed Glycine 0 C--O 1.203 -1.806 0 C-N-CA 119.406 -1.378 . . . . 0.0 113.244 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 8.5 Cg_endo -84.0 -19.72 4.7 Favored 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 120.375 2.087 . . . . 0.0 112.61 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -103.65 7.76 37.45 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.218 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.462 ' HB2' HD13 ' A' ' 114' ' ' ILE . 7.9 m-85 -96.34 143.41 27.42 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.136 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.34 147.65 52.4 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.71 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.4 123.53 33.04 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 5.0 tt -91.11 128.14 36.81 Favored 'General case' 0 C--O 1.263 1.793 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -120.74 140.91 51.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.68 119.3 38.56 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.17 173.04 6.55 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.714 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.87 27.47 72.23 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.168 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.08 131.72 44.91 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.14 159.91 34.52 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 105.304 -2.109 . . . . 0.0 105.304 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.407 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 13.2 t70 -66.67 112.5 4.21 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.268 0.556 . . . . 0.0 111.344 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -129.83 -14.26 4.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 177' ' ' CYS . 32.4 mt -61.29 117.61 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.305 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -63.84 129.12 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.764 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 65.6 mtt -116.34 5.9 13.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.868 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.5 -50.21 5.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.07 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -98.53 -31.51 11.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.373 0.606 . . . . 0.0 109.998 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 m -73.54 128.49 35.63 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 159' ' ' ASP . 42.7 mt-10 -107.87 112.36 24.95 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -162.01 165.39 27.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.193 0.308 . . . . 0.0 111.085 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -127.3 146.17 50.54 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 124.583 1.177 . . . . 0.0 107.946 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.485 ' SD ' HG12 ' A' ' 155' ' ' ILE . 23.1 mmt -100.44 106.7 18.3 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.028 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.6 t70 170.3 76.39 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.384 1.074 . . . . 0.0 111.184 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 154' ' ' GLN . 5.7 p -101.53 -49.13 4.11 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.9 mt -131.57 -58.83 0.98 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.08 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 154' ' ' GLN . 6.5 mm-40 -114.43 -179.26 3.58 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.345 -174.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -67.52 -33.99 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.377 174.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 9.1 p-10 -98.73 25.09 6.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 109.539 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.495 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 24.8 mm-40 -126.14 115.44 19.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.485 HG12 ' SD ' ' A' ' 147' ' ' MET . 23.6 mt -79.36 141.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -113.95 -73.44 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.78 121.15 26.06 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.3 mt -126.94 119.33 52.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 15.1 m-20 -97.45 -42.28 7.8 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.576 0.703 . . . . 0.0 109.312 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.66 140.19 25.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.64 117.05 20.54 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.24 147.6 25.56 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 144.28 56.01 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.498 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.7 p-10 -93.99 10.69 32.47 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.126 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.4 p -69.69 -4.96 21.9 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.966 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.8 m -60.82 -39.21 88.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 124.297 1.039 . . . . 0.0 109.879 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.435 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.32 -31.84 6.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.322 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' ' 137' ' ' ALA . 70.2 mt -89.45 146.09 6.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.484 ' HD3' ' OD1' ' A' ' 171' ' ' ASP . 44.8 mtt180 -46.56 125.12 7.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 124.645 1.178 . . . . 0.0 113.401 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.46 -5.54 14.22 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.302 2.001 . . . . 0.0 109.93 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.484 ' OD1' ' HD3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.97 -8.54 57.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.875 175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.84 136.13 50.39 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.469 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 87.5 mttt -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.406 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.9 ttt -148.9 127.05 12.06 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -150.91 -178.66 6.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.91 148.77 40.96 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.538 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.45 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 34.9 m -84.97 121.85 28.37 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 124.326 1.016 . . . . 0.0 109.136 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.443 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 19.5 p -55.99 -50.3 71.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -169.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -82.47 9.74 8.6 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -173.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -137.99 113.29 9.37 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.495 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 11.2 ptp180 -57.53 -39.17 76.02 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -83.4 -30.58 27.24 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.731 0.812 . . . . 0.0 111.791 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.45 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 22.2 tp -63.79 101.32 0.35 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.03 126.15 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.647 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.63 133.81 51.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.432 0.634 . . . . 0.0 110.634 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.418 HG22 ' HG3' ' A' ' 174' ' ' MET . 44.4 pt -116.47 154.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.439 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.49 ' HD3' ' OD2' ' A' ' 189' ' ' ASP . 76.3 mtt180 -79.5 163.39 24.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.816 173.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 13.3 pt-20 -58.75 -36.67 74.74 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.721 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' A' ' 187' ' ' ARG . 23.3 m-20 -54.99 -45.08 75.0 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.26 1.024 . . . . 0.0 110.087 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.4 t -64.38 -50.32 76.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.754 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.555 ' CD2' ' HA ' ' A' ' 188' ' ' GLU . 21.5 p80 -70.75 -29.86 66.21 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.595 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.71 80.81 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 122.549 0.34 . . . . 0.0 110.491 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.7 80.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.45 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.64 -33.1 64.37 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.6 mm-40 -60.03 -47.06 87.39 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.23 -21.22 54.13 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.194 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.06 -27.15 59.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.728 0.299 . . . . 0.0 110.648 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.63 39.62 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.878 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.9 mt -82.04 166.0 20.15 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.7 p -53.35 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -152.51 130.75 3.15 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.316 -1.421 . . . . 0.0 112.899 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.402 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 66.2 m-85 -124.26 157.63 34.41 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . 0.3 OUTLIER -126.38 120.59 30.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.94 139.32 44.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.343 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.531 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 75.2 m-85 -118.59 143.17 46.97 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.96 102.95 4.97 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.69 97.26 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 123.987 0.804 . . . . 0.0 112.182 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.12 87.02 3.59 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 98.85 35.4 4.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -68.54 100.31 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.831 0.452 . . . . 0.0 110.576 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -103.74 133.97 47.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.52 -25.58 0.28 Allowed Glycine 0 N--CA 1.478 1.485 0 N-CA-C 119.344 2.498 . . . . 0.0 119.344 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.45 146.64 24.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 118.647 1.224 . . . . 0.0 113.937 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.28 133.08 41.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.531 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 1.7 pt? . . . . . 0 C--N 1.314 -0.936 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.397 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--O 1.249 1.04 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' NZ ' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.64 155.99 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 169.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.36 151.21 30.03 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.297 0.57 . . . . 0.0 111.466 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -127.93 144.36 51.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 79.1 t -76.8 118.02 22.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -97.94 126.1 43.18 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.536 0.684 . . . . 0.0 110.935 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -143.51 155.03 44.22 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.2 t -106.39 128.44 60.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.8 ptp -79.73 85.45 5.42 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.931 0.872 . . . . 0.0 110.248 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.54 113.39 4.46 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.684 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -118.5 -58.15 2.0 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.688 174.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.99 -7.12 56.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.96 11.16 23.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.652 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 105.39 102.67 2.81 Favored Glycine 0 N--CA 1.406 -3.358 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 23.3 m-85 -97.22 166.19 11.69 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 162.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 84' ' ' ASN . 45.5 mt -93.94 101.4 12.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 161.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -60.46 -50.25 74.33 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 124.523 1.139 . . . . 0.0 110.507 -172.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.13 156.24 44.75 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.494 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 40' ' ' LEU . 5.8 mp -56.44 129.08 75.07 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 126.062 1.745 . . . . 0.0 114.16 -173.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.15 167.33 27.15 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 123.022 2.482 . . . . 0.0 111.456 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.78 123.89 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -10.97 52.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.297 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 m -86.92 126.98 61.45 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.05 165.07 31.41 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.6 2.867 . . . . 0.0 111.027 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 p -48.23 149.4 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 -172.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -40.01 -54.19 2.27 Favored 'General case' 0 N--CA 1.507 2.421 0 C-N-CA 126.594 1.958 . . . . 0.0 113.141 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -82.3 -24.87 34.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.411 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 49.7 tptt -85.0 -14.73 46.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.434 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 28.9 m-85 -44.44 -45.76 9.25 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.824 0.703 . . . . 0.0 112.823 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.467 ' HB3' ' NH1' ' A' ' 176' ' ' ARG 0.334 35.9 m-70 -129.64 24.94 5.4 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -83.1 101.09 10.93 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.96 4.91 1.84 Allowed Glycine 0 CA--C 1.553 2.449 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.03 164.16 28.26 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 CA-C-N 119.118 1.459 . . . . 0.0 113.987 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.4 t -98.85 141.42 31.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 50' ' ' PHE . 82.7 mt -90.16 -2.04 58.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.112 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.01 68.95 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -89.66 -22.66 22.16 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -107.29 -24.06 12.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -101.69 132.56 21.57 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 122.72 9.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.96 1.774 . . . . 0.0 110.857 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -98.8 136.56 29.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 17.86 79.77 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -98.32 -163.0 30.62 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -126.31 132.82 51.55 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.38 167.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 32.7 t -154.55 153.51 31.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -97.06 110.48 23.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.2 p . . . . . 0 C--N 1.316 -0.86 0 O-C-N 123.49 0.493 . . . . 0.0 110.728 -179.188 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -90.37 -168.69 2.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -73.65 178.62 4.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 114.061 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.37 152.28 22.03 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.141 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -122.23 -161.56 0.94 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -58.56 -32.83 69.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.425 0.631 . . . . 0.0 111.95 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.87 147.82 52.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.474 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -133.4 111.51 12.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 84.0 Cg_endo -81.81 -179.43 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.793 2.328 . . . . 0.0 111.639 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 3.7 p30 -164.21 179.18 7.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.141 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.6 mt -93.47 9.08 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 122.25 1.024 . . . . 0.0 109.018 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.411 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 29.6 mtm -115.42 -159.14 0.7 Allowed 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.418 -171.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 50' ' ' PHE . 1.5 m -117.91 35.34 4.76 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.782 0.719 . . . . 0.0 112.177 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -133.31 158.07 43.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.608 -0.682 . . . . 0.0 109.828 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.8 tp -122.69 141.9 51.26 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 52.4 tp -110.83 129.32 55.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 129' ' ' LEU . 45.3 t -129.11 141.34 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.806 0.691 . . . . 0.0 110.385 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.4 p -76.14 168.39 20.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.366 0.666 . . . . 0.0 111.402 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.54 98.78 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.441 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.21 -37.99 66.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.057 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.82 -32.88 71.54 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.986 0.422 . . . . 0.0 109.906 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -57.57 -45.43 85.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.774 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 73.1 mmtt -64.82 -28.89 69.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.13 -54.84 27.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.74 -43.29 91.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 111.263 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -65.95 -41.17 91.6 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.2 p -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.57 -13.24 59.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.467 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.42 47.34 10.64 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.167 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.74 104.31 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.7 t -72.59 159.83 33.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.948 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 77.87 13.78 1.69 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 124.442 1.097 . . . . 0.0 111.157 173.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.35 114.43 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.605 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -106.55 139.18 41.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -114.77 115.64 27.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 123.853 0.721 . . . . 0.0 109.108 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.8 mt -111.83 96.9 35.47 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.18 143.13 12.51 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.488 2.126 . . . . 0.0 113.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 64' ' ' GLY . 5.3 m -149.3 168.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.833 1.253 . . . . 0.0 108.842 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -92.37 116.08 28.65 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 126' ' ' TYR . 38.4 mt -107.89 127.46 63.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.759 0.79 . . . . 0.0 112.236 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 67' ' ' SER . 85.3 mttt -101.48 131.51 47.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.4 p-10 -76.37 -160.49 0.15 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.29 0.567 . . . . 0.0 111.401 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.057 0.543 . . . . 0.0 110.353 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.59 -20.4 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.73 0.643 . . . . 0.0 109.73 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.55 12.65 40.6 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.235 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.2 ptpt -95.81 145.02 25.68 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 115' ' ' LYS . 21.2 t -81.99 82.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.584 0.707 . . . . 0.0 110.046 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 m -106.18 4.34 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.364 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.77 61.84 0.65 Allowed Glycine 0 C--O 1.204 -1.73 0 C-N-CA 120.545 -0.835 . . . . 0.0 113.025 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 79.9 Cg_endo -83.93 -18.87 5.16 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 120.449 2.125 . . . . 0.0 113.652 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.75 20.84 13.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.439 1.114 . . . . 0.0 110.457 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 114' ' ' ILE . 2.0 m-85 -92.11 133.48 35.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.41 139.18 52.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.497 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -80.04 119.22 22.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.293 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 91' ' ' VAL . 2.0 tt -86.65 128.3 34.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.9 m-80 -114.28 125.58 54.05 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -99.6 118.07 35.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.55 172.96 6.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.698 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.85 7.85 86.7 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.84 132.28 43.58 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.34 169.67 17.35 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.46 108.86 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.93 0.769 . . . . 0.0 109.366 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 168' ' ' ILE . . . -135.49 -30.77 0.99 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -167.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 179' ' ' LYS . 52.5 mt -64.41 114.99 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.087 -176.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.36 115.38 5.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.446 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 mmt -77.67 -1.94 33.53 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.23 -50.82 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.38 -30.91 29.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.1 m -92.74 104.22 16.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.67 117.3 34.52 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -158.39 157.96 33.31 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.82 127.16 51.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 66.1 mtp -102.59 106.94 17.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.7 t70 177.57 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.623 1.169 . . . . 0.0 112.319 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 -30.99 11.95 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.5 mt -139.21 -58.4 0.59 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.19 -167.14 2.48 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.186 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 7.9 mmpt? -66.84 -18.44 65.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -172.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.539 ' HB2' HH21 ' A' ' 181' ' ' ARG . 1.4 p30 -87.0 -2.24 58.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.677 0.671 . . . . 0.0 111.146 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.42 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 29.2 mm-40 -107.61 125.88 51.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.35 -177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 73.7 mt -82.73 115.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.07 -56.52 1.59 Allowed Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.674 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.67 121.87 46.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.67 126.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -102.3 -43.33 5.73 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.302 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.26 142.21 26.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.68 119.9 23.08 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -109.28 147.53 32.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.65 131.0 49.53 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.251 0.969 . . . . 0.0 112.353 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.41 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 26.4 p-10 -96.52 16.6 18.28 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.035 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -68.52 -6.19 23.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.74 1.216 . . . . 0.0 110.908 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.0 m -63.95 -40.45 96.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.292 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.54 -31.8 6.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.494 HG13 ' CB ' ' A' ' 137' ' ' ALA . 61.2 mt -83.57 138.93 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.446 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 48.6 mtm180 -58.65 119.49 37.24 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 14.0 Cg_exo -68.61 -4.68 13.59 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.485 2.79 . . . . 0.0 112.908 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 1.7 p-10 -79.44 -14.61 58.81 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.15 116.16 12.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.79 -19.73 60.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.494 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.5 ttt -146.73 123.59 11.3 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.52 -179.01 6.56 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.467 ' NH1' ' HB3' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -148.73 146.49 28.11 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.439 ' HB3' HD11 ' A' ' 138' ' ' ILE . 66.8 m -75.74 150.06 37.9 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.439 1.087 . . . . 0.0 112.736 -173.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -82.11 -24.79 34.94 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.517 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.9 mmtt -85.75 -4.56 59.2 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.126 -176.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.82 151.25 33.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.539 HH21 ' HB2' ' A' ' 153' ' ' ASP . 3.0 mmt180 -90.65 -39.86 12.23 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 123.793 0.837 . . . . 0.0 111.018 -171.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.415 ' HE ' ' HB2' ' A' ' 182' ' ' ARG . 57.1 mtm180 -84.62 -19.29 33.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.557 -174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.76 100.95 5.63 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.6 mt -110.63 135.07 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.76 122.56 44.81 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.441 0.638 . . . . 0.0 109.94 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.494 HG22 ' HG3' ' A' ' 174' ' ' MET . 38.9 pt -112.8 162.72 10.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.839 0.828 . . . . 0.0 111.467 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.563 ' HB3' HG23 ' A' ' 190' ' ' VAL . 6.2 tpp180 -78.8 143.67 35.84 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.472 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 6.5 pt-20 -54.53 -40.94 69.14 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.394 0.616 . . . . 0.0 111.873 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.87 -33.92 76.29 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 124.436 1.094 . . . . 0.0 112.01 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.563 HG23 ' HB3' ' A' ' 187' ' ' ARG . 87.0 t -68.24 -44.74 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.392 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.461 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 26.7 p80 -73.13 -22.8 60.46 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.211 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.61 72.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -73.48 -32.49 64.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.24 -36.81 74.73 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.69 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 72.3 mm-40 -56.26 -53.7 54.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.485 0.714 . . . . 0.0 110.715 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -73.23 -12.37 60.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.219 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.28 -27.52 24.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.889 0.376 . . . . 0.0 110.07 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.03 47.87 22.6 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.945 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 71.4 mt -82.66 157.25 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.255 5.2 p -41.95 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.72 125.66 2.26 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.431 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 70.2 m-85 -120.8 156.33 32.13 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.336 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -129.99 120.63 25.07 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 16.2 m -133.88 142.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.262 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.39 155.46 49.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.195 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -65.18 129.55 40.11 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.461 0.476 . . . . 0.0 110.526 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -85.41 -40.5 16.38 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.297 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.84 101.02 3.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.496 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.78 29.88 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.522 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.13 108.78 0.64 Allowed 'General case' 0 CA--C 1.574 1.878 0 C-N-CA 124.171 0.988 . . . . 0.0 110.137 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -102.02 102.43 12.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 73.96 -22.16 1.23 Allowed Glycine 0 N--CA 1.475 1.252 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 167.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.37 148.8 46.64 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.494 0.647 . . . . 0.0 111.245 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -108.55 132.87 53.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 O-C-N 124.318 1.011 . . . . 0.0 113.123 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HG2' ' OE2' ' A' ' 188' ' ' GLU . 7.8 ptpp? -93.88 141.9 27.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.891 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -109.45 138.58 45.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -124.4 142.73 51.07 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.712 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -80.1 116.35 24.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -92.23 125.56 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.48 0.657 . . . . 0.0 111.795 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 0.0 OUTLIER -141.05 165.13 28.4 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.343 1.457 . . . . 0.0 107.11 175.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.47 144.49 20.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttm -91.06 85.87 6.06 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.38 133.66 13.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.153 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.511 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -123.25 -64.07 1.2 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -84.8 -21.47 29.9 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.559 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.54 25.61 1.21 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.005 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' HA3' HE21 ' A' ' 82' ' ' GLN . . . 123.77 60.7 0.19 Allowed Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 118.58 -1.772 . . . . 0.0 117.376 173.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 3.2 m-85 -92.3 127.96 37.97 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.563 0.681 . . . . 0.0 110.458 166.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -87.71 103.37 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.17 -50.95 19.76 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.275 0.56 . . . . 0.0 111.887 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -115.04 169.42 9.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.586 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 5.3 mp -71.55 133.89 84.61 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 123.141 0.577 . . . . 0.0 112.132 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.07 168.4 24.84 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.321 2.681 . . . . 0.0 113.355 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -48.32 115.72 1.31 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.441 1.497 . . . . 0.0 112.665 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.3 14.36 71.63 Favored Glycine 0 C--O 1.208 -1.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.0 m -84.54 145.13 44.14 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 118.124 0.962 . . . . 0.0 111.74 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.24 165.53 21.83 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.387 2.725 . . . . 0.0 111.119 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.4 p -58.35 153.19 16.02 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -46.19 -58.3 3.77 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.311 1.444 . . . . 0.0 112.99 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 13.1 p-90 -71.2 -23.01 61.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.007 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HE3' HD12 ' A' ' 54' ' ' ILE . 43.0 tptt -77.3 -21.85 52.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.187 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 70.6 m-85 -52.83 -26.51 14.75 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.249 0.547 . . . . 0.0 112.379 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -120.26 -0.16 10.5 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 3.6 tm-20 -94.27 101.3 13.27 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.027 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -10.51 0.01 OUTLIER Glycine 0 CA--C 1.559 2.815 0 N-CA-C 120.711 3.044 . . . . 0.0 120.711 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.424 HD12 ' HE3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -130.1 174.58 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.066 2.433 . . . . 0.0 114.04 -173.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -88.05 148.29 24.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.251 -1.34 . . . . 0.0 107.776 171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.0 mt -98.29 -1.73 41.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.588 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.62 68.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.166 0.508 . . . . 0.0 112.324 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.1 -14.95 52.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.742 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.95 -22.52 9.54 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -101.07 139.05 20.17 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.29 122.94 9.46 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.123 1.882 . . . . 0.0 112.632 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.71 122.88 43.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.48 62.51 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.5 -168.03 27.66 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.5 131.14 55.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.99 165.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -139.42 141.72 37.5 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 23.1 m-85 -69.52 122.89 19.94 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 123.857 0.723 . . . . 0.0 109.092 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.404 -2.771 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.28 -177.84 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 8.7 t-20 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -94.02 -148.58 0.27 Allowed 'General case' 0 C--O 1.256 1.44 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.95 -167.8 0.32 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.162 2.185 . . . . 0.0 114.525 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.02 149.94 27.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.171 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -114.04 -169.15 1.46 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.169 0.988 . . . . 0.0 109.006 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 94' ' ' ARG . 48.6 m-20 -65.84 -34.24 77.7 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.748 0.785 . . . . 0.0 110.274 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.444 ' CD1' ' HE1' ' A' ' 202' ' ' PHE . 57.1 m-85 -134.18 153.74 51.66 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.488 HE21 ' HA3' ' A' ' 35' ' ' GLY . 56.0 mt-30 -134.42 134.76 22.8 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.512 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.07 -179.26 1.74 Allowed 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.811 2.341 . . . . 0.0 111.36 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -163.48 171.52 15.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -101.12 21.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.88 1.324 . . . . 0.0 108.294 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 40' ' ' LEU . 63.4 mtm -102.31 -93.71 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.102 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.466 ' HB2' ' CB ' ' A' ' 50' ' ' PHE . 17.9 m -167.17 -33.3 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.85 174.66 7.84 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.3 tp -116.13 142.1 47.27 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.804 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.86 127.45 55.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.55 142.38 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.05 0.54 . . . . 0.0 110.169 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 p -83.8 168.91 15.72 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -66.04 -32.3 82.03 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.837 -0.22 . . . . 0.0 113.093 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.403 ' HD2' ' OD1' ' A' ' 80' ' ' ASP . 5.9 ptp180 -67.12 -41.15 86.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.528 0.68 . . . . 0.0 110.372 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.9 -24.3 52.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.112 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -61.4 -42.08 98.17 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.2 mmtp -60.94 -39.35 89.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.41 ' O ' HD13 ' A' ' 102' ' ' LEU . 4.5 mm? -59.95 -55.8 29.64 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.393 0.433 . . . . 0.0 110.26 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.75 -45.35 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 112.075 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.33 -36.37 83.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -70.86 -22.03 62.35 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 98' ' ' LEU . 10.5 mp -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.672 0.272 . . . . 0.0 110.949 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 47.18 13.62 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.8 t -79.74 100.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-O 121.427 0.632 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 m -80.88 154.26 27.16 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 84.5 m-20 80.63 15.21 0.7 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.62 1.568 . . . . 0.0 110.964 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.94 114.17 28.23 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.418 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 7.7 tp10 -104.34 133.1 49.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.415 ' CH2' HD12 ' A' ' 129' ' ' LEU . 68.5 m95 -109.21 123.55 49.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.278 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -111.4 93.49 19.2 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 135.1 15.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.698 2.266 . . . . 0.0 112.416 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.09 167.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.42 115.98 28.57 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 126' ' ' TYR . 32.8 mt -106.84 128.16 61.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HG2' HG22 ' A' ' 121' ' ' VAL . 84.0 mttt -97.25 142.06 29.6 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 9.1 p-10 -80.68 -162.35 0.46 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.861 0.362 . . . . 0.0 110.937 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.41 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 69.6 m80 -75.44 -9.44 58.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.522 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -109.34 2.01 20.43 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.807 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.3 7.14 80.26 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.55 139.06 32.36 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 118.602 1.201 . . . . 0.0 110.477 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 115' ' ' LYS . 21.2 t -76.95 90.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.497 0.665 . . . . 0.0 109.803 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.66 8.55 5.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.714 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.84 45.06 1.15 Allowed Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.847 -1.168 . . . . 0.0 114.76 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -83.32 -0.37 9.85 Favored 'Trans proline' 0 C--N 1.368 1.585 0 CA-C-N 121.278 2.539 . . . . 0.0 111.924 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -92.88 -12.18 31.64 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.832 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 114' ' ' ILE . 3.2 m-85 -92.24 147.2 23.11 Favored 'General case' 0 C--O 1.255 1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.343 -173.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.66 137.93 47.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.386 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -81.27 125.64 30.58 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.415 HD12 ' CH2' ' A' ' 109' ' ' TRP . 7.3 tt -99.75 125.13 45.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.41 0.624 . . . . 0.0 110.365 -176.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.2 141.37 52.14 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.622 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.718 ' HB2' ' HD2' ' A' ' 176' ' ' ARG . 3.0 mm? -98.92 144.28 28.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 108' ' ' GLU . 3.2 mm? -101.85 174.72 5.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.29 1.436 . . . . 0.0 109.388 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.81 17.24 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.39 132.1 42.26 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 122.12 0.962 . . . . 0.0 113.341 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.0 165.5 30.56 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 168.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -53.57 101.9 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.228 1.376 . . . . 0.0 111.89 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -78.93 -66.59 0.85 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.161 -164.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 179' ' ' LYS . 60.3 mt -59.1 126.83 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 O-C-N 123.955 0.785 . . . . 0.0 112.251 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -69.1 122.77 19.44 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 tpt -90.51 -16.33 29.08 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.14 -35.61 9.95 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -91.69 -6.2 52.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.092 0.472 . . . . 0.0 111.265 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.2 p -89.41 143.81 26.54 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.71 103.4 7.8 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -151.24 168.03 26.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.391 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -116.78 144.03 44.96 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 124.317 1.047 . . . . 0.0 110.239 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.42 155.22 20.11 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 35.9 t70 91.94 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.067 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.5 m -101.06 -22.98 14.58 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 166.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 99.5 mt -160.87 -47.84 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.926 1.691 . . . . 0.0 107.245 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 42.7 mt-10 -131.97 179.61 5.98 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.093 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -72.0 -24.4 61.56 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 123.675 0.609 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -98.25 25.27 6.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.287 1.042 . . . . 0.0 109.946 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -122.29 116.2 23.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.452 HG21 HG12 ' A' ' 158' ' ' ILE . 59.3 mt -84.86 120.8 36.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 123.131 0.27 . . . . 0.0 110.45 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -83.13 -48.25 5.47 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.305 -175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -134.09 139.24 45.82 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 155' ' ' ILE . 45.3 mt -125.05 134.06 67.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -103.24 -42.33 5.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.15 114.88 8.99 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 158' ' ' ILE . 3.2 tm? -99.08 119.89 38.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 129.69 35.97 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.87 137.81 56.31 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 124.27 0.981 . . . . 0.0 112.62 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.666 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.9 p-10 -88.23 -0.2 56.83 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.708 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -67.1 -6.13 16.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.893 1.277 . . . . 0.0 109.967 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -64.05 -35.79 81.87 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.376 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.64 -33.26 6.18 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.82 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.12 154.33 5.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -67.45 117.12 44.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.3 -13.25 35.51 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.808 2.339 . . . . 0.0 112.462 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.99 -2.51 58.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.711 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 130.52 40.6 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.532 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 15.4 tppt? -68.68 -33.94 74.83 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.054 0.454 . . . . 0.0 111.395 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.493 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.2 ttt -149.25 135.4 19.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -151.62 -178.19 6.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.138 0.575 . . . . 0.0 110.18 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.718 ' HD2' ' HB2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -151.91 142.96 23.16 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.341 -176.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' A' ' 183' ' ' LEU . 83.8 m -69.61 146.23 51.88 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.335 0.397 . . . . 0.0 111.751 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.7 p -81.54 -48.68 11.5 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.404 ' HB2' HD12 ' A' ' 138' ' ' ILE . 60.3 mttm -72.23 -20.76 61.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.728 0.411 . . . . 0.0 111.563 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.48 133.67 55.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.457 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 10.7 mmt180 -90.58 -34.95 15.3 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.856 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -87.76 -20.92 25.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.376 0.608 . . . . 0.0 110.648 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.553 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.3 tt -84.13 114.07 21.51 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.5 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 71.2 mt -120.91 132.37 70.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 59.6 mt -111.17 124.18 51.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.319 1.056 . . . . 0.0 113.263 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.493 HG22 ' HG3' ' A' ' 174' ' ' MET . 48.1 pt -112.68 154.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.966 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 17.3 mtp180 -83.63 162.26 20.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.446 ' OE2' ' HG2' ' A' ' 23' ' ' LYS . 7.8 pt-20 -51.74 -35.51 43.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.15 0.58 . . . . 0.0 111.824 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -46.19 -51.08 14.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.441 1.896 . . . . 0.0 111.335 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.57 -53.43 42.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.595 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 12.8 p80 -72.23 -25.4 61.62 Favored 'General case' 0 C--O 1.194 -1.816 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.334 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -34.72 73.64 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.855 0.359 . . . . 0.0 110.628 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.12 73.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.176 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -70.52 -32.91 70.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.171 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 53.6 mm-40 -59.12 -49.82 76.42 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-O 121.62 0.724 . . . . 0.0 109.136 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.38 -22.41 54.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.964 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.17 58.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.214 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.09 46.52 50.76 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.87 164.85 24.13 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.663 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 4.5 p -43.37 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.66 136.15 5.14 Favored Glycine 0 CA--C 1.493 -1.311 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.099 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.444 ' HE1' ' CD1' ' A' ' 81' ' ' PHE . 60.6 m-85 -135.68 162.62 32.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.73 122.12 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.64 133.48 66.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.079 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.406 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 72.3 m-85 -126.51 132.52 51.36 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.48 115.02 6.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.13 65.08 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 124.021 0.826 . . . . 0.0 112.217 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.73 90.73 1.08 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.512 0.673 . . . . 0.0 110.258 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 81.19 35.1 24.7 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.553 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 19.8 t90 -59.87 98.63 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.7 0.8 . . . . 0.0 110.206 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -103.98 132.31 50.35 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.81 -9.09 2.06 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 165.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.553 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 95.4 mt -94.83 135.73 35.98 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 118.382 1.091 . . . . 0.0 112.819 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.15 133.04 36.15 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 28' ' ' LYS 0.27 0.9 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 67.3 t . . . . . 0 C--O 1.243 0.713 0 CA-C-O 120.683 0.278 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -103.28 150.72 23.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.177 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -125.85 155.93 40.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 60.8 m-85 -138.06 142.47 40.3 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.357 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 20.6 t -81.91 121.32 35.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.5 131.48 37.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -150.73 164.68 35.57 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.7 t -99.66 128.33 51.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.58 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 27.3 ttt -88.32 100.36 12.95 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.095 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 166.7 142.96 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 126.203 1.801 . . . . 0.0 108.719 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -94.53 -31.5 13.88 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 30.7 mt-10 -84.44 -0.26 52.18 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.003 -175.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -78.15 0.46 24.83 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.22 103.43 1.05 Allowed Glycine 0 N--CA 1.402 -3.628 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -95.58 147.04 23.99 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 39' ' ' LYS . 12.6 mt -85.07 101.31 9.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 102.864 -3.013 . . . . 0.0 102.864 166.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.72 -37.99 64.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.765 -172.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.482 ' O ' HG22 ' A' ' 37' ' ' ILE . 35.4 mmtp -114.46 176.47 5.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.554 ' HG ' ' SD ' ' A' ' 86' ' ' MET . 4.6 mp -83.94 129.26 59.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 9.8 Cg_endo -66.53 166.43 21.91 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.581 2.187 . . . . 0.0 112.892 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.87 127.1 30.38 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 124.065 0.946 . . . . 0.0 112.031 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.67 1.25 89.16 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 116.158 -0.474 . . . . 0.0 113.54 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.2 m -85.55 136.57 37.09 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.29 166.74 24.29 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.306 3.337 . . . . 0.0 112.096 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -50.88 148.88 3.8 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -45.9 -56.0 5.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.657 1.983 . . . . 0.0 113.448 -174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 17.2 p-90 -75.48 -26.53 58.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.343 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -78.7 -21.02 48.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.243 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HA ' HD21 ' A' ' 56' ' ' LEU . 33.1 m-85 -45.76 -38.92 7.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 1.3 m-70 -128.44 22.1 6.04 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.574 -0.704 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 1.2 tm-20 -93.99 100.85 12.91 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.898 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.24 -3.51 0.07 OUTLIER Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 52' ' ' GLU . 2.4 pp -123.0 173.7 8.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -171.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -98.31 135.88 39.28 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.103 170.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 50' ' ' PHE . 91.7 mt -84.11 -1.72 55.46 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -24.84 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 111.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -88.08 -22.82 23.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -116.31 -21.88 9.09 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -103.48 138.15 19.45 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.77 123.22 12.24 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.656 2.237 . . . . 0.0 112.682 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.06 114.73 33.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.31 19.46 45.64 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.396 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -95.62 -166.54 34.91 Favored Glycine 0 C--N 1.307 -1.062 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.198 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.83 128.56 42.54 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 34.9 m -126.94 169.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -148.19 162.55 39.22 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.907 -0.496 . . . . 0.0 110.177 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 19.8 m-85 -75.98 163.97 26.63 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.25 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 13.2 p . . . . . 0 N--CA 1.402 -2.86 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.555 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.568 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 8.0 t-20 . . . . . 0 C--O 1.244 0.78 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 34.2 mtp180 -78.47 -172.51 2.92 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.86 -165.73 0.87 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.46 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HA ' HE21 ' A' ' 82' ' ' GLN . 4.6 mp -87.74 150.58 23.5 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.277 0.561 . . . . 0.0 111.758 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 5.5 m-85 -114.79 -163.58 0.88 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.51 -44.2 93.19 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.481 0.658 . . . . 0.0 110.725 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.84 151.65 41.48 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.515 -1.22 . . . . 0.0 107.881 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 78' ' ' LEU . 3.8 mm-40 -121.81 114.93 30.94 Favored Pre-proline 0 C--N 1.289 -2.036 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.51 168.08 7.35 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.548 2.832 . . . . 0.0 112.322 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -163.89 174.92 10.91 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 121.997 -0.44 . . . . 0.0 110.864 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.55 7.34 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.204 0 CA-C-O 123.103 1.43 . . . . 0.0 109.098 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.554 ' SD ' ' HG ' ' A' ' 40' ' ' LEU . 50.6 mtm -104.58 -164.19 1.03 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 m -121.4 53.68 1.16 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.813 -0.555 . . . . 0.0 110.991 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -136.84 155.11 50.21 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.7 tp -119.5 141.19 49.41 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.264 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 126' ' ' TYR . 58.2 tp -117.16 130.17 56.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.84 139.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 122.56 0.344 . . . . 0.0 110.084 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.2 p -76.27 174.56 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.33 0.252 . . . . 0.0 110.691 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.95 -38.81 59.93 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -69.01 -38.57 79.33 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.08 0.467 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.4 63.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -62.15 -39.94 94.3 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.738 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -55.37 -40.36 71.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.812 0.695 . . . . 0.0 112.412 178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 197' ' ' ALA . 4.0 mm? -60.14 -52.78 63.86 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.186 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.5 -45.03 99.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 C-N-CA 123.295 0.638 . . . . 0.0 112.2 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.4 -37.8 88.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -68.71 -22.14 64.37 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.211 0.529 . . . . 0.0 111.295 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.58 -8.55 58.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.806 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.28 44.5 74.83 Favored Glycine 0 CA--C 1.495 -1.195 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.115 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 173' ' ' LYS . 81.6 t -73.88 104.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.504 0.668 . . . . 0.0 110.403 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 m -79.27 150.62 31.49 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 79.53 1.43 2.23 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.564 . . . . 0.0 112.878 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.51 114.74 25.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.2 tp10 -99.49 137.73 37.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CH2' HD12 ' A' ' 129' ' ' LEU . 66.9 m95 -115.6 121.51 42.83 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.079 0.862 . . . . 0.0 109.209 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.67 98.31 49.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.26 124.9 6.14 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.497 2.131 . . . . 0.0 114.023 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 64' ' ' GLY . 16.1 m -139.74 172.24 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.9 116.69 33.36 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -100.54 130.16 50.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 121' ' ' VAL . 89.7 mttt -103.74 139.45 38.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.503 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 32.8 p-10 -83.91 -159.94 0.41 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 60.0 m80 -67.99 -14.87 63.31 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.079 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -19.48 16.53 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.2 20.18 21.35 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.703 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.439 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.4 ptpt -95.79 147.86 23.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 115' ' ' LYS . 16.1 t -82.2 84.5 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.417 HG23 HD13 ' A' ' 78' ' ' LEU . 6.6 m -111.84 12.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.105 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.51 51.81 0.85 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.35 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -84.72 -14.66 6.35 Favored 'Trans proline' 0 C--N 1.375 1.967 0 CA-C-N 120.795 2.298 . . . . 0.0 112.885 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -97.12 7.73 46.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.359 0.599 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.509 ' HB2' HD13 ' A' ' 114' ' ' ILE . 3.9 m-85 -102.02 148.35 25.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.569 0.699 . . . . 0.0 112.272 -170.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.6 142.63 41.26 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.608 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -82.47 131.05 35.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.452 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.452 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.9 tt -105.19 126.11 51.73 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.816 0.817 . . . . 0.0 110.091 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.402 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -125.39 141.2 52.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.051 174.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.59 141.78 30.21 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -123.6 174.47 7.41 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.318 1.047 . . . . 0.0 108.685 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 14.61 81.26 Favored Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.714 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.66 132.86 43.72 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.75 105.16 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 119.106 0.866 . . . . 0.0 112.015 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.23 -35.26 3.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 179' ' ' LYS . 57.0 mt -64.72 115.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.841 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.11 111.95 4.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.406 ' HA ' ' HG ' ' A' ' 143' ' ' SER . 15.2 ttt -97.89 17.65 17.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.774 0.797 . . . . 0.0 110.23 -174.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.55 -50.09 4.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.076 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 142' ' ' ARG . 2.7 mmp_? -97.12 11.43 36.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.191 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 140' ' ' MET . 50.0 p -104.88 154.38 20.14 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.154 175.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 75.2 mm-40 -133.81 117.37 16.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -166.0 172.34 11.56 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.58 0.55 . . . . 0.0 111.196 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.84 133.21 49.37 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 38.7 mtt -101.34 108.66 20.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.5 t70 172.78 73.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.705 2.002 . . . . 0.0 108.868 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 22.8 t -101.15 -49.45 4.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.05 -67.09 0.76 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 154' ' ' GLN . 3.0 pp20? -109.07 -176.19 2.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 174.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 147' ' ' MET . 11.0 mmpt? -66.78 -30.88 71.2 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -171.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.428 ' HB3' HH12 ' A' ' 181' ' ' ARG . 21.1 t70 -104.85 26.27 9.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.673 1.225 . . . . 0.0 109.429 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.545 ' HG2' ' OE2' ' A' ' 151' ' ' GLU . 15.3 mm-40 -106.8 123.55 48.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.194 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.6 124.33 39.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.824 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -103.35 -66.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.634 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -94.85 135.37 36.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.5 mt -131.9 145.14 35.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 13.2 t70 -110.44 -51.96 2.82 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 172.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.87 118.85 7.65 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.573 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.27 121.6 35.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.87 132.4 37.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -54.98 137.26 46.47 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.552 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.2 p-10 -92.69 -0.28 57.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.978 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.9 p -68.22 -6.16 22.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.07 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.6 m -63.84 -39.43 94.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.687 173.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -110.8 -31.31 7.23 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 119.701 -0.799 . . . . 0.0 112.288 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 137' ' ' ALA . 52.7 mt -89.03 150.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.492 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 27.7 mtp180 -57.92 122.37 57.09 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 122.535 0.334 . . . . 0.0 111.832 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.22 -5.76 17.72 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 123.419 2.746 . . . . 0.0 112.311 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 8.3 p-10 -96.47 -7.99 33.34 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.712 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.36 132.85 47.78 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.475 ' HB2' HG22 ' A' ' 104' ' ' VAL . 75.1 mmtt -73.75 -40.24 63.66 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.206 -174.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.45 ' HB3' HG11 ' A' ' 104' ' ' VAL . 27.0 ttt -142.85 123.98 14.51 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -146.39 -178.33 6.09 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.481 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.405 ' CD ' ' HB3' ' A' ' 51' ' ' HIS . 8.9 ttp180 -146.62 142.32 27.8 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.536 ' SG ' HD22 ' A' ' 183' ' ' LEU . 65.3 m -70.69 145.7 50.39 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 124.161 0.913 . . . . 0.0 111.607 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.8 p -82.21 -18.92 40.91 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.495 ' HB2' HD12 ' A' ' 138' ' ' ILE . 19.3 mtpp -108.96 20.79 18.02 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.749 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 9.5 tp10 -172.6 116.63 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.464 ' HD2' ' NE2' ' A' ' 154' ' ' GLN 0.275 0.0 OUTLIER -89.29 -11.19 44.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -173.012 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -90.56 -25.9 19.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 180' ' ' GLU . 3.3 tt -77.74 100.85 6.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.3 mt -108.08 120.56 59.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 30.7 mt -93.05 125.5 37.67 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 121.706 0.765 . . . . 0.0 111.615 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.8 pt -110.85 139.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.883 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -81.38 162.4 23.39 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 22' ' ' VAL . 7.1 pt-20 -43.68 -44.24 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.463 1.105 . . . . 0.0 112.546 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -56.33 -44.83 80.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.64 1.576 . . . . 0.0 110.725 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.33 -48.05 82.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 9.3 p80 -74.02 -29.26 61.84 Favored 'General case' 0 C--O 1.197 -1.672 0 C-N-CA 118.061 -1.456 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.0 77.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.18 83.38 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.174 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -72.11 -34.81 68.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.211 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 56.5 mm-40 -62.33 -47.24 85.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.322 0.582 . . . . 0.0 109.555 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -75.06 -15.89 60.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.565 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -83.75 -27.12 29.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.782 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 72.61 47.65 26.34 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.462 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.74 164.58 25.12 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -46.46 -76.54 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 116.933 2.198 . . . . 0.0 116.933 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.66 130.79 1.91 Allowed Glycine 0 CA--C 1.498 -0.978 0 C-N-CA 119.029 -1.557 . . . . 0.0 113.213 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -129.19 159.37 36.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 122.418 0.287 . . . . 0.0 110.273 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 77.4 tttt -120.78 121.67 38.69 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.2 130.43 72.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.118 0.485 . . . . 0.0 111.058 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 85.0 m-85 -107.04 138.97 42.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.72 115.97 9.57 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.62 -45.37 37.76 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.591 0.557 . . . . 0.0 112.285 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.19 95.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.988 0.805 . . . . 0.0 109.547 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.63 35.65 28.21 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.882 -1.152 . . . . 0.0 111.922 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.469 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 9.3 t90 -46.06 107.12 0.09 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.528 1.131 . . . . 0.0 110.368 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -82.78 71.53 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.11 15.16 67.12 Favored Glycine 0 C--N 1.31 -0.9 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 167.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 92.1 mt -89.89 146.35 24.48 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 118.365 1.082 . . . . 0.0 109.875 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.1 134.09 35.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.244 0.778 0 O-C-N 124.335 1.022 . . . . 0.0 108.894 174.187 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 21.4 ptmt -93.15 154.43 18.08 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.34 135.46 50.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.368 0.604 . . . . 0.0 111.764 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -122.19 143.92 49.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.31 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.69 121.64 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -97.78 114.03 25.95 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 111.038 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -135.26 150.86 50.14 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.42 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.54 84.67 7.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.09 113.69 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.96 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 34.1 tt0 -112.94 -66.97 1.03 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -0.91 55.89 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.05 0.929 . . . . 0.0 109.5 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 79' ' ' TYR . . . -94.81 25.41 4.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 119.42 39.21 0.68 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 168.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.635 ' CD1' ' HA ' ' A' ' 32' ' ' GLU . 11.3 m-85 -69.22 128.36 36.36 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 120.233 2.017 . . . . 0.0 112.889 170.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.517 HG12 ' CE2' ' A' ' 68' ' ' PHE . 9.4 mt -84.37 101.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.47 -59.62 3.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.924 0.869 . . . . 0.0 109.366 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.423 ' O ' HG22 ' A' ' 37' ' ' ILE . 13.7 mptt -108.7 162.26 14.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.285 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 5.8 mp -70.31 139.75 87.29 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 124.639 1.212 . . . . 0.0 114.054 -171.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 11.3 Cg_exo -74.8 166.43 29.3 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.449 2.766 . . . . 0.0 111.345 171.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -53.15 122.27 9.12 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.324 1.049 . . . . 0.0 112.856 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.01 7.22 70.69 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 114.734 0.654 . . . . 0.0 114.734 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 27.0 m -85.33 142.79 38.24 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HG2' HD22 ' A' ' 56' ' ' LEU . 1.6 Cg_endo -75.51 166.08 29.3 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.848 3.032 . . . . 0.0 111.139 172.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -52.92 148.85 7.08 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.37 -52.55 4.53 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 127.243 2.217 . . . . 0.0 114.894 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -85.68 -30.08 23.46 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.747 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 52.6 tptt -81.16 -12.21 59.26 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.387 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 88' ' ' ASN . 40.7 m-85 -44.29 -50.31 9.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.688 0.617 . . . . 0.0 111.952 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.482 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.3 m-70 -128.91 32.33 4.78 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.58 -0.848 . . . . 0.0 113.257 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 7.8 tm-20 -92.45 101.37 13.82 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.52 -8.83 17.47 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.01 170.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.0 t -98.89 158.2 15.8 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.054 -1.884 . . . . 0.0 106.876 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.475 HD22 ' HG2' ' A' ' 45' ' ' PRO . 97.3 mt -113.07 15.5 19.53 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.91 67.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.068 0.461 . . . . 0.0 110.916 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -88.23 -21.85 24.29 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.453 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.19 -22.6 12.03 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.83 140.09 21.27 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.32 123.8 12.75 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.914 2.409 . . . . 0.0 112.73 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.451 HG22 HD22 ' A' ' 110' ' ' LEU . 22.4 t -100.89 117.09 45.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.91 14.99 61.92 Favored Glycine 0 C--N 1.318 -0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.55 -167.26 36.61 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.664 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.76 128.86 50.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 23.6 m -127.92 173.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 33.2 t -153.98 149.21 26.99 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 37' ' ' ILE . 1.1 m-30 -76.76 128.86 35.42 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 167.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 p . . . . . 0 C--N 1.288 -2.079 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.625 177.977 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 . . . . . 0 C--O 1.241 0.639 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.32 -175.58 1.6 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.45 -176.22 3.6 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.915 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD13 HG23 ' A' ' 122' ' ' VAL . 7.4 mp -98.0 151.84 19.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -167.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.493 ' CE2' ' HB1' ' A' ' 34' ' ' ALA . 5.9 m-85 -111.4 -163.35 0.84 Allowed 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.87 -45.06 96.06 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 119.308 0.958 . . . . 0.0 110.611 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.13 145.31 47.95 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.539 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 27.8 tp60 -124.74 120.93 25.67 Favored Pre-proline 0 N--CA 1.416 -2.15 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.874 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.97 166.93 9.75 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 122.846 2.364 . . . . 0.0 112.326 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -157.58 168.98 25.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.501 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -90.0 0.52 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 122.759 1.266 . . . . 0.0 108.544 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.51 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 37.9 mtm -94.47 -147.33 0.26 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 36.8 p -144.99 27.26 1.31 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . 61.0 t30 -114.51 118.33 33.47 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.13 141.36 30.26 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.751 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 47.1 tp -108.75 123.05 48.41 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 129' ' ' LEU . 59.2 t -128.52 139.13 52.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.483 -173.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.1 p -78.89 175.33 10.62 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.972 0.509 . . . . 0.0 110.967 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.59 73.17 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 94' ' ' ARG . 8.6 ptt180 -61.66 -47.73 84.04 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.524 0.729 . . . . 0.0 111.324 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -31.47 68.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.08 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -60.1 -42.74 95.35 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.736 0.414 . . . . 0.0 110.28 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -56.51 -45.5 81.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 124.221 0.951 . . . . 0.0 110.496 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 197' ' ' ALA . 4.6 mm? -58.8 -52.89 63.77 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.471 0.482 . . . . 0.0 111.797 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.9 mt -58.93 -44.47 90.96 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 C-N-CA 123.46 0.704 . . . . 0.0 111.776 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.21 -25.77 61.78 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.0 m -70.33 -26.35 63.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.34 -21.4 33.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.7 48.0 7.49 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.62 109.96 4.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.24 0.543 . . . . 0.0 110.019 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 m -75.36 146.96 40.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.678 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.07 12.05 1.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.504 1.522 . . . . 0.0 112.873 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.43 113.93 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.2 tp10 -111.0 141.87 43.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -116.26 119.19 34.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.501 ' HG ' HD21 ' A' ' 130' ' ' ASN . 68.8 mt -109.33 100.71 42.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.42 139.53 18.52 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.58 2.186 . . . . 0.0 113.418 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -148.22 162.26 6.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 124.552 1.141 . . . . 0.0 108.774 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.21 123.59 42.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -120.1 135.71 59.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -169.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.5 mptp? -98.09 150.63 21.23 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.613 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.3 p-10 -91.53 -163.05 0.98 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.903 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -66.02 -36.96 84.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 0.0 109.73 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.13 -19.25 47.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.32 14.69 29.77 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.722 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.613 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 17.2 ptpt -97.44 145.96 25.68 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.8 t -81.43 90.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.504 HG23 HD13 ' A' ' 78' ' ' LEU . 3.9 m -114.97 13.78 8.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.813 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.472 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -135.54 46.9 1.01 Allowed Glycine 0 CA--C 1.545 1.947 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.879 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.09 -13.99 7.47 Favored 'Trans proline' 0 C--N 1.379 2.166 0 CA-C-N 121.565 2.682 . . . . 0.0 111.426 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.1 -4.13 43.4 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.784 1.634 . . . . 0.0 110.438 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.472 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 5.5 m-85 -98.89 149.51 22.85 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.66 -171.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.5 147.54 43.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.208 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -85.13 128.7 34.76 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.926 0.393 . . . . 0.0 110.55 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.472 HD12 HG21 ' A' ' 91' ' ' VAL . 4.5 tt -92.67 125.62 37.38 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.852 -176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.501 HD21 ' HG ' ' A' ' 110' ' ' LEU . 35.7 m-80 -101.03 132.4 46.47 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.337 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.91 114.47 28.77 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.25 172.6 7.69 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.855 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.68 16.86 80.4 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.8 132.72 34.52 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.13 169.22 19.16 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.24 112.06 4.93 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -134.11 -17.71 2.09 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -165.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.7 mt -63.32 122.48 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 118.969 0.804 . . . . 0.0 111.023 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.49 128.14 35.52 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.189 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.425 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 63.2 mtt -119.53 10.35 11.78 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.709 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.66 -38.63 8.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.892 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -113.99 3.7 15.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 16.8 p -90.77 155.84 18.5 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 120.682 0.277 . . . . 0.0 111.396 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.443 ' CB ' ' HB2' ' A' ' 159' ' ' ASP . 64.6 mm-40 -122.04 106.04 10.84 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.425 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 6.2 p90 -164.35 162.87 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.96 0.409 . . . . 0.0 111.938 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.61 125.79 47.54 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 85.8 mtp -91.05 153.46 20.1 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.307 17.9 t70 88.57 82.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.663 1.585 . . . . 0.0 113.152 -177.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.416 ' HB3' ' CA ' ' A' ' 156' ' ' GLY . 11.7 p -100.83 -56.08 2.42 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.123 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.0 mt -99.8 -45.3 5.78 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 11.9 pt-20 -155.46 176.11 13.01 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.97 -21.59 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 119.689 1.132 . . . . 0.0 113.691 -170.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.46 12.35 10.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.101 0.953 . . . . 0.0 110.534 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.538 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 22.8 mm-40 -125.38 115.82 20.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.65 147.13 5.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 149' ' ' SER . . . -110.77 -78.69 0.98 Allowed Glycine 0 CA--C 1.491 -1.431 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.698 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.28 123.01 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 44.0 mt -128.59 106.98 15.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 144' ' ' GLU . 20.2 m-20 -86.63 -34.73 19.72 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.04 110.61 2.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.293 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -84.26 124.01 30.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 143' ' ' SER . . . -99.37 147.04 25.65 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.62 139.44 55.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.117 0.886 . . . . 0.0 113.375 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.567 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.0 p-10 -93.61 3.51 55.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.06 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.9 p -66.22 -3.94 6.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.737 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -64.0 -39.95 95.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 123.534 0.733 . . . . 0.0 109.959 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -108.14 -32.82 7.36 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 118.601 -1.24 . . . . 0.0 111.269 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.422 HG13 ' CB ' ' A' ' 137' ' ' ALA . 74.0 mt -85.81 149.95 4.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.428 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 69.3 mtp180 -51.73 127.4 33.93 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.02 0.528 . . . . 0.0 112.01 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.93 -13.67 23.97 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.393 2.062 . . . . 0.0 111.33 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 7.9 p-10 -96.59 7.27 46.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.325 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 151.01 44.14 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.868 0.842 . . . . 0.0 109.78 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -102.19 -30.44 11.12 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.479 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.4 ttt -160.65 128.33 4.42 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -153.75 -179.2 7.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.128 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -137.05 139.24 41.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 60.4 m -72.75 146.64 46.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.767 0.667 . . . . 0.0 110.17 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.9 p -73.05 -50.42 23.09 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.51 15.45 17.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.79 110.13 6.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.538 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 13.2 ptt180 -76.85 -22.36 53.63 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.807 -170.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -86.82 -16.63 35.61 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.289 -0.257 . . . . 0.0 110.948 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.6 tp -87.06 99.76 12.15 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.802 0.81 . . . . 0.0 111.484 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.23 123.78 59.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.16 133.18 52.78 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.041 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' A' ' 174' ' ' MET . 41.1 pt -121.58 158.61 24.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.989 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.617 ' HD3' ' OD1' ' A' ' 189' ' ' ASP . 9.1 ptp180 -85.07 162.06 19.45 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.504 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.9 pt-20 -54.13 -39.85 66.85 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.617 ' OD1' ' HD3' ' A' ' 187' ' ' ARG . 7.5 m-20 -52.53 -42.21 64.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.21 1.004 . . . . 0.0 111.304 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.04 -50.34 77.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.684 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.576 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 21.9 p80 -71.67 -31.06 66.39 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.525 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.97 73.31 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 111.025 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.43 -36.8 68.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.733 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -69.0 -35.57 76.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.345 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 18.8 mm-40 -55.65 -49.15 73.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -79.79 -22.8 42.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.295 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -75.32 -27.89 59.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.658 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 80.55 42.44 10.18 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.46 166.53 18.25 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 17.1 p -57.75 -164.1 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.71 134.83 12.88 Favored Glycine 0 CA--C 1.49 -1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 113.427 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -129.47 159.59 35.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -117.49 120.86 39.4 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.89 135.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -128.89 147.62 50.84 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.03 107.82 7.35 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.81 -33.95 77.21 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.684 0.793 . . . . 0.0 111.929 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.82 100.54 0.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.854 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 73.9 30.03 62.09 Favored Glycine 0 C--O 1.219 -0.824 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.424 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.65 104.58 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.182 0.993 . . . . 0.0 110.911 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.88 126.91 51.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.46 -25.58 0.27 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 119.362 2.505 . . . . 0.0 119.362 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 142.28 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -172.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.5 131.43 34.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.171 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 215' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.314 -0.935 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.481 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 120.709 0.29 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 7.4 ptpp? -108.11 146.06 33.2 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -118.88 143.96 46.67 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.038 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB3' ' HB ' ' A' ' 204' ' ' VAL . 97.6 m-85 -126.87 151.3 48.57 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 -176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 HD12 ' A' ' 183' ' ' LEU . 14.0 t -85.89 129.9 37.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -95.92 135.3 37.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -150.61 158.79 44.56 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.23 131.11 60.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.485 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 13.4 tmm? -103.54 105.87 16.23 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.521 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 161.53 123.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.085 2.154 . . . . 0.0 108.662 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -86.84 -23.28 25.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.54 -13.94 62.31 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.394 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -73.32 -32.53 64.64 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 77.82 1.08 Allowed Glycine 1 N--CA 1.391 -4.3 0 C-N-CA 118.943 -1.599 . . . . 0.0 114.127 177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -63.71 136.02 57.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 68' ' ' PHE . 29.8 mt -68.36 104.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 40.1 mm-40 -54.29 -70.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.2 1.562 . . . . 0.0 111.283 -173.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 176.5 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.427 0.691 . . . . 0.0 110.022 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.8 mp -72.14 130.92 85.77 Favored Pre-proline 0 C--O 1.252 1.22 0 O-C-N 123.93 0.769 . . . . 0.0 111.044 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 1.1 Cg_endo -78.62 167.4 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.912 2.408 . . . . 0.0 111.658 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.03 129.33 41.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.686 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.76 0.72 90.34 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.712 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 m -84.97 137.39 37.71 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 117.172 0.486 . . . . 0.0 110.183 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.31 165.55 10.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.306 2.67 . . . . 0.0 112.238 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -55.66 155.09 6.03 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -45.28 -51.47 10.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.232 1.413 . . . . 0.0 111.595 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.611 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 27.1 p-90 -85.94 -16.48 38.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.042 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . 0.423 54.4 mttt -86.75 -11.24 51.66 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.607 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 45.3 m-85 -49.87 -34.1 19.07 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 123.705 0.628 . . . . 0.0 111.944 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -128.04 20.33 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.579 -0.701 . . . . 0.0 112.616 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 0.9 OUTLIER -93.03 101.17 13.49 Favored 'General case' 0 C--O 1.2 -1.525 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.179 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.16 -10.98 0.01 OUTLIER Glycine 0 CA--C 1.556 2.612 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 168.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.52 173.84 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 121.12 2.46 . . . . 0.0 112.277 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -85.93 141.97 29.17 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.8 mt -87.79 -2.78 58.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.495 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.38 66.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.227 0.537 . . . . 0.0 111.904 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -87.63 -39.18 15.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.138 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.93 -21.33 18.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -99.06 141.48 22.95 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.01 122.8 9.69 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.053 1.835 . . . . 0.0 111.898 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.36 110.18 23.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.26 21.17 39.17 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.45 -153.55 30.33 Favored Glycine 0 C--O 1.252 1.262 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 35.4 mt-10 -141.61 139.1 33.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 28.9 m -133.73 166.44 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 m -144.09 150.31 37.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 120.771 0.32 . . . . 0.0 111.248 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' HG12 ' A' ' 37' ' ' ILE . 13.1 m-85 -80.52 120.58 24.68 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 38' ' ' GLU . 14.1 p . . . . . 0 C--N 1.294 -1.815 0 O-C-N 123.697 0.623 . . . . 0.0 109.918 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.42 -165.89 1.41 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -164.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.22 -172.94 4.25 Favored 'General case' 0 C--O 1.194 -1.867 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.438 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 4.6 mp -87.64 143.8 26.99 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -100.14 -178.72 3.92 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.19 0.596 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -60.56 -35.25 75.59 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.515 0.674 . . . . 0.0 110.116 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -129.58 126.98 39.75 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.613 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -115.92 125.35 28.73 Favored Pre-proline 0 C--N 1.279 -2.462 0 O-C-N 123.515 0.509 . . . . 0.0 110.35 -174.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 175.34 8.71 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -163.37 166.63 22.7 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 123.261 0.624 . . . . 0.0 109.586 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -99.91 28.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.4 mtm -116.24 -79.86 0.59 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 50' ' ' PHE . 35.2 t -179.18 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.349 0.565 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -77.66 164.45 25.29 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.598 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.29 141.48 36.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.451 0.569 . . . . 0.0 110.1 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 48.5 tp -110.8 125.26 53.38 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -125.42 147.09 30.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.2 p -77.91 170.2 17.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.742 0.306 . . . . 0.0 110.342 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.9 -18.7 79.4 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -74.31 -52.53 11.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.56 -23.61 63.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.472 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HA ' ' CH2' ' A' ' 109' ' ' TRP . 54.9 ttt180 -57.74 -43.97 85.74 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.041 174.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.6 mmpt? -65.07 -39.41 93.2 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.23 -54.58 45.13 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.368 0.418 . . . . 0.0 110.326 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.1 -46.51 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.461 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.26 -26.91 65.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -72.66 -25.0 61.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.033 0.444 . . . . 0.0 111.156 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.1 -1.51 57.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.305 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.06 47.78 63.32 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.542 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.4 t -73.69 112.73 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -80.27 141.19 35.76 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.739 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 78.32 15.85 1.3 Allowed 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 125.282 1.433 . . . . 0.0 112.263 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.62 113.97 19.18 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.416 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 8.4 tp10 -104.72 124.81 50.04 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.538 ' CH2' HD12 ' A' ' 129' ' ' LEU . 61.9 m95 -108.55 120.15 41.6 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.235 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -109.75 94.13 16.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.72 133.57 12.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.601 2.201 . . . . 0.0 112.532 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.79 160.08 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.625 0.77 . . . . 0.0 109.977 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -93.82 116.73 29.22 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -108.96 136.98 43.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -100.06 146.47 26.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.8 p-10 -90.12 -163.96 1.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.766 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -67.16 -32.39 73.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.139 0.975 . . . . 0.0 111.138 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -83.59 -18.5 38.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.204 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.12 20.54 20.49 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.063 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 20.0 ptmt -105.55 153.42 21.79 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -86.7 90.18 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.531 0.681 . . . . 0.0 109.24 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.26 13.23 6.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.088 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.509 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -127.78 39.72 1.87 Allowed Glycine 0 CA--C 1.552 2.361 0 C-N-CA 119.437 -1.364 . . . . 0.0 116.335 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.76 -0.58 8.7 Favored 'Trans proline' 0 C--N 1.375 1.923 0 CA-C-N 122.013 2.907 . . . . 0.0 112.624 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.54 -9.67 24.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.946 0.899 . . . . 0.0 110.662 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.509 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 16.5 m-85 -103.59 153.99 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.363 -165.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.28 142.81 35.68 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.6 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.29 122.33 26.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.538 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.4 tt -101.16 122.14 43.09 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.325 0.583 . . . . 0.0 110.007 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.36 140.02 53.17 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.393 172.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.52 141.05 29.5 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.52 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.37 173.55 6.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.08 11.51 72.85 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.987 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.02 132.99 35.08 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -137.36 170.22 16.45 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.24 113.21 1.47 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -139.38 -19.16 0.97 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.2 mt -64.17 112.86 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.279 0.561 . . . . 0.0 110.981 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.58 115.22 10.51 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.084 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.6 mtt -99.07 6.17 46.69 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.181 0.515 . . . . 0.0 110.594 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -84.7 -46.28 11.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -102.72 -11.96 18.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.283 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 m -90.76 148.21 22.71 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.833 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -135.0 112.75 10.85 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -158.17 173.17 17.11 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.19 138.16 53.07 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.052 0.541 . . . . 0.0 109.708 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.9 mmt -87.16 108.06 18.74 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -175.51 63.74 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 154' ' ' GLN . 22.9 m -102.82 -56.31 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.074 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 75.6 mt -134.58 -57.16 0.84 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.07 -173.69 2.31 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.902 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -95.07 4.83 53.28 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -103.59 16.52 26.23 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.553 HE22 ' HB2' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -133.34 125.01 28.24 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.255 -174.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 76.0 mt -84.47 119.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 123.365 0.416 . . . . 0.0 110.212 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -98.82 -62.68 0.85 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.246 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.76 133.1 42.74 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.32 -34.73 5.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.672 0.749 . . . . 0.0 109.892 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.97 117.0 18.58 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -98.32 146.8 25.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.24 146.66 52.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.86 0.838 . . . . 0.0 112.012 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.5 p-10 -90.08 8.92 30.25 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.3 p -69.38 -6.27 28.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.343 172.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -60.96 -39.97 91.58 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 124.623 1.169 . . . . 0.0 109.662 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -31.98 6.65 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.263 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.56 141.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 62.9 mmt-85 -60.61 118.34 33.52 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 123.28 0.363 . . . . 0.0 110.132 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -5.37 11.25 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.977 3.118 . . . . 0.0 115.012 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.07 -9.71 58.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.431 0.158 . . . . 0.0 111.377 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.14 114.06 13.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -80.6 -8.69 59.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.415 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.0 ttt -152.64 118.75 5.49 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.422 ' HE2' ' OD1' ' A' ' 164' ' ' ASP . 35.9 p90 -148.48 -179.47 6.98 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.861 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -143.88 147.32 33.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 44.4 m -80.61 151.49 29.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 124.22 0.95 . . . . 0.0 111.19 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.1 p -81.42 -50.28 9.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -85.52 30.27 0.64 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.547 ' N ' HH21 ' A' ' 181' ' ' ARG . 0.3 OUTLIER -160.27 147.24 15.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 48' ' ' TRP . 8.7 mmp_? -91.18 -39.0 12.36 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -14.72 17.68 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.122 0.264 . . . . 0.0 110.785 -170.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.403 HD12 HG13 ' A' ' 26' ' ' VAL . 28.3 tp -70.03 100.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.243 1.02 . . . . 0.0 109.813 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.45 122.95 67.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.6 mt -107.39 130.02 54.85 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.182 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 174' ' ' MET . 46.5 pt -118.24 149.77 20.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.361 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -82.27 152.97 26.11 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.469 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 10.4 pt-20 -49.04 -41.23 34.3 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.419 0.688 . . . . 0.0 112.338 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -53.12 -40.86 64.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.628 1.571 . . . . 0.0 112.462 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.17 -49.3 62.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.891 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 25.5 p80 -71.42 -24.55 62.06 Favored 'General case' 0 C--O 1.198 -1.641 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.067 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.34 80.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.001 0.52 . . . . 0.0 110.604 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 196' ' ' GLN . . . -69.22 -33.2 72.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.188 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 16.6 m-85 -73.35 -32.83 64.75 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.879 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 59.2 mm-40 -63.24 -42.96 99.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 193' ' ' ALA . 2.8 pt20 -77.55 -24.69 49.8 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.159 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 -27.3 43.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.233 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.1 42.79 75.26 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.663 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.61 165.19 24.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.611 0.364 . . . . 0.0 110.995 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.9 p -39.14 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -173.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.97 141.19 9.18 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.391 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.31 165.21 28.06 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 40.8 ttpt -157.29 121.84 4.38 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 25' ' ' PHE . 26.8 m -125.29 146.96 30.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.448 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -125.11 142.44 51.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.112 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.86 114.65 2.18 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.16 -35.03 61.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.81 94.55 2.77 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.812 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.72 35.12 7.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.19 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -67.77 97.49 0.64 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.14 0.495 . . . . 0.0 110.583 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.06 132.24 51.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.01 -25.44 0.25 Allowed Glycine 0 N--CA 1.479 1.55 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 165.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.85 127.13 32.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 117.777 0.788 . . . . 0.0 112.618 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.6 131.19 37.69 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.611 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 C--N 1.308 -1.227 0 O-C-N 124.026 0.829 . . . . 0.0 109.728 -178.238 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG11 ' HD3' ' A' ' 187' ' ' ARG . 58.0 t . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -94.01 152.81 18.54 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.298 0.57 . . . . 0.0 111.635 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 140.73 43.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.523 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -124.0 151.08 44.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.467 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.26 118.04 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -92.18 117.99 30.4 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -136.47 139.81 42.62 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 83' ' ' PRO . 97.1 t -89.54 120.86 38.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 120.723 0.297 . . . . 0.0 110.422 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.454 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 49.6 ttp -82.44 86.42 6.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.0 0.905 . . . . 0.0 110.224 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . -144.79 112.76 6.37 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -119.47 -58.7 1.89 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.398 -173.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.94 -21.52 43.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . . . -67.02 -35.76 80.63 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 95.92 158.02 32.02 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 114.064 -1.426 . . . . 0.0 114.501 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 46.4 m-85 -96.57 166.06 11.86 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 84' ' ' ASN . 21.9 mt -78.09 101.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 101.501 -3.518 . . . . 0.0 101.501 163.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -65.64 -44.29 86.86 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.055 0.847 . . . . 0.0 111.892 -167.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -132.44 176.03 8.77 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.72 119.55 71.86 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.622 0.769 . . . . 0.0 112.725 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.76 167.75 24.85 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.759 2.306 . . . . 0.0 113.02 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -42.47 114.54 0.59 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.138 1.775 . . . . 0.0 113.421 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.61 79.23 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.551 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 39.6 m -85.54 139.62 35.81 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.63 165.96 23.67 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 123.79 2.993 . . . . 0.0 111.554 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.7 p -49.15 146.33 3.65 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -37.83 -56.73 1.07 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.114 2.565 . . . . 0.0 113.595 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -86.23 -22.06 27.09 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.825 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 47.0 tptt -86.61 -12.24 49.14 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.398 -169.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.475 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 53.0 m-85 -44.05 -49.54 8.74 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.646 0.591 . . . . 0.0 112.571 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.279 30.8 m-70 -127.92 31.68 5.07 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.1 tm-20 -92.84 100.71 13.13 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.36 -10.25 3.76 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 174.76 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.354 2.077 . . . . 0.0 113.295 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 t -96.37 158.48 15.42 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.484 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.5 -13.33 40.51 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.845 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.07 -26.55 49.82 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.74 -20.17 25.12 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -116.51 -22.07 8.89 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.583 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -100.17 138.51 20.27 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.29 123.06 10.15 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.175 1.917 . . . . 0.0 112.581 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.41 114.85 29.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.26 18.28 59.34 Favored Glycine 0 C--N 1.311 -0.843 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.4 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -88.25 -161.84 37.52 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.178 -0.534 . . . . 0.0 111.985 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -129.14 131.75 47.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.38 170.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 t -147.11 147.13 30.27 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.4 110.25 2.2 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.838 171.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.412 -2.363 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.975 -179.926 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 120.9 0.381 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -90.94 -154.25 0.34 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.606 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -86.2 -177.44 6.26 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.054 1.342 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.15 150.45 23.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.855 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 20.8 m-85 -114.14 -166.68 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.69 -40.94 94.07 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.773 0.715 . . . . 0.0 111.844 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -118.58 147.71 43.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.608 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 24.8 mm-40 -132.54 126.77 20.29 Favored Pre-proline 0 C--O 1.249 1.039 0 C-N-CA 123.069 0.548 . . . . 0.0 110.361 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 63.4 Cg_endo -92.53 178.56 1.39 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.575 2.183 . . . . 0.0 112.503 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.5 p30 -163.94 173.74 12.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.62 -9.49 10.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.336 1.065 . . . . 0.0 109.619 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -95.25 -178.1 4.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.501 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 5.7 p -93.02 39.17 1.04 Allowed 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.9 159.56 34.54 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.433 ' HB2' ' NH2' ' A' ' 176' ' ' ARG . 53.6 tp -124.19 141.53 51.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.15 118.33 36.46 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.44 144.28 29.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 p -75.08 167.37 22.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.08 -20.46 79.68 Favored Glycine 0 C--N 1.31 -0.868 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -70.79 -57.64 4.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -25.61 67.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.265 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 50.9 ttt180 -54.94 -51.1 67.16 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 124.02 0.928 . . . . 0.0 110.171 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -69.27 -25.32 64.2 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.749 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.26 -49.55 77.42 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.897 0.379 . . . . 0.0 110.189 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.1 -37.06 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.526 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 61.2 mt-10 -67.37 -33.34 75.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.205 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.0 m -65.74 -33.84 76.81 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.028 0.531 . . . . 0.0 111.548 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.38 -6.8 58.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.244 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.32 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.85 109.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.541 0.686 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.9 m -80.3 154.85 27.57 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 80.31 14.21 0.84 Allowed 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.76 114.11 27.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.5 tp10 -112.91 138.93 49.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -119.75 116.31 25.67 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -172.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.7 mt -109.11 99.46 35.89 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.27 145.16 23.9 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.448 2.099 . . . . 0.0 112.584 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.4 m -149.57 166.3 3.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 123.633 0.773 . . . . 0.0 109.226 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.05 28.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 126' ' ' TYR . 32.3 mt -113.07 132.46 61.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -98.08 147.55 24.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.13 -160.66 0.43 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.477 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 67.0 m80 -74.63 -22.73 58.77 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 122.265 -0.272 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -87.56 -18.8 28.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.449 0.468 . . . . 0.0 110.194 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.65 36.92 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.033 173.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -101.8 148.49 25.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.634 0.717 . . . . 0.0 110.563 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.16 89.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.468 0.651 . . . . 0.0 110.493 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.4 m -115.6 13.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.433 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.19 49.96 0.9 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 119.97 -1.109 . . . . 0.0 115.245 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.49 -8.28 9.58 Favored 'Trans proline' 0 C--N 1.376 2.025 0 CA-C-N 121.335 2.568 . . . . 0.0 111.458 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -92.06 -14.29 29.53 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.41 1.484 . . . . 0.0 110.788 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.43 ' HB2' HD12 ' A' ' 114' ' ' ILE . 4.3 m-85 -91.03 150.89 21.25 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.883 0.849 . . . . 0.0 112.958 -169.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.46 143.52 39.68 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.438 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.23 117.95 20.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.27 127.59 37.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.92 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.5 m-80 -110.42 127.54 55.15 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.655 -177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.33 125.59 47.98 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.31 172.9 6.55 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 -7.91 81.07 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.82 129.56 34.83 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.85 0.833 . . . . 0.0 109.153 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -148.56 170.11 18.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -46.4 108.82 0.15 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.988 0.805 . . . . 0.0 110.127 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -126.34 -47.21 1.6 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -165.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.437 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 26.2 mt -61.69 118.82 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 119.353 0.979 . . . . 0.0 112.611 -172.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.76 127.92 34.31 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.713 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.4 mtt -94.46 -0.41 54.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.32 -50.63 5.55 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.559 0.695 . . . . 0.0 110.12 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -93.75 -9.36 37.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.216 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -108.14 140.5 41.25 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -120.73 100.51 7.15 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -145.74 165.03 30.0 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.703 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -120.82 147.72 44.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.167 0.917 . . . . 0.0 109.611 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 53.0 mtt -100.47 154.18 18.75 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.291 36.3 t70 90.76 84.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.844 2.457 . . . . 0.0 112.108 -176.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.2 t -99.49 -36.62 9.49 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.611 -1.631 . . . . 0.0 107.621 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.9 mt -136.65 -54.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 12.7 pt-20 -137.32 -179.82 5.96 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.583 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -48.19 -49.48 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.302 1.841 . . . . 0.0 114.634 -171.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.526 ' HB2' HH21 ' A' ' 181' ' ' ARG . 7.7 p-10 -90.09 10.93 22.4 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -102.42 116.57 32.9 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.554 ' H ' ' HG2' ' A' ' 180' ' ' GLU . 70.2 mt -74.31 129.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -108.5 -60.14 0.54 Allowed Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.988 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -92.83 119.15 31.87 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.0 109.91 27.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.03 -34.31 16.85 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.75 138.95 20.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.86 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.8 114.85 15.84 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.78 147.64 25.83 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 140.42 57.33 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.816 0.817 . . . . 0.0 112.916 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 20.4 p-10 -94.65 16.14 16.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.286 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 168' ' ' ILE . 18.2 p -67.01 -5.77 14.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.034 175.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.8 m -64.65 -33.43 75.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.323 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -32.95 6.34 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.249 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 165' ' ' THR . 66.7 mt -92.45 122.23 43.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -56.47 127.82 72.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 118.023 0.374 . . . . 0.0 111.504 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.06 -5.36 6.22 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.601 2.867 . . . . 0.0 115.427 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -80.24 -9.21 59.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.062 0.392 . . . . 0.0 111.13 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 127.2 31.82 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.112 0.482 . . . . 0.0 110.098 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.51 -36.75 76.76 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.036 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . 0.487 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.5 ttt -148.29 132.03 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.3 -179.79 7.85 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.507 0.504 . . . . 0.0 109.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.433 ' NH2' ' HB2' ' A' ' 89' ' ' LEU . 14.6 ttm180 -136.12 139.56 43.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 183' ' ' LEU . 63.9 m -74.63 139.44 43.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 O-C-N 124.062 0.851 . . . . 0.0 110.105 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 p -82.7 -12.75 57.35 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.437 ' HG3' ' HB ' ' A' ' 138' ' ' ILE . 72.8 mmtt -90.24 -5.0 56.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.866 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -151.32 142.77 23.49 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.526 HH21 ' HB2' ' A' ' 153' ' ' ASP . 17.5 mmt180 -89.35 -30.41 18.42 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -170.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -86.39 -25.35 25.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.093 0.473 . . . . 0.0 110.561 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.0 tt -75.18 102.54 5.01 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.812 -172.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.89 142.2 19.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.2 mt -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.376 0.608 . . . . 0.0 111.1 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.487 HG22 ' HG3' ' A' ' 174' ' ' MET . 44.9 pt -124.72 157.7 32.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.652 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.47 ' HD3' HG11 ' A' ' 22' ' ' VAL . 97.0 mtt180 -80.25 159.63 25.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.496 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 7.5 pt-20 -52.82 -37.56 60.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.729 0.812 . . . . 0.0 110.799 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.43 -42.93 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.282 1.833 . . . . 0.0 111.629 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.67 -45.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.771 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 16.3 p80 -69.6 -30.56 68.34 Favored 'General case' 0 C--O 1.2 -1.538 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.426 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -61.35 -32.03 71.91 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.301 0.572 . . . . 0.0 111.044 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.19 61.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.4 m-85 -74.52 -33.91 62.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.956 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 42.2 mt-10 -63.03 -48.89 76.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.149 0.58 . . . . 0.0 110.585 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.43 -18.57 63.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.926 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.59 -22.26 22.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.673 0.273 . . . . 0.0 111.294 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.25 46.12 66.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.58 158.72 20.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 38.4 p -106.31 139.69 40.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 108.29 56.41 0.58 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.732 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 46.1 m-85 -135.36 142.16 45.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 118.62 1.21 . . . . 0.0 112.464 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 21.1 tptm -146.24 122.77 11.07 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.47 137.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.416 0.627 . . . . 0.0 111.999 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.1 m-85 -129.0 143.68 50.95 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.276 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.7 66.81 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -69.86 100.32 1.53 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.069 0.461 . . . . 0.0 110.556 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.07 28.03 38.71 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.566 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -54.85 102.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.604 1.161 . . . . 0.0 110.893 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -103.88 111.53 24.11 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.22 1.98 23.45 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 165.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 58.3 mt -95.06 131.57 40.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 118.452 1.126 . . . . 0.0 110.103 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -90.26 132.49 35.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.58 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.8 pt? . . . . . 0 C--N 1.305 -1.369 0 O-C-N 123.717 0.635 . . . . 0.0 111.904 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 84.3 t . . . . . 0 N--CA 1.436 -1.135 0 CA-C-O 120.997 0.427 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.37 151.49 49.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.587 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -111.22 134.54 52.73 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.028 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.3 144.09 44.27 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.151 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.1 119.16 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -91.55 124.89 36.06 Favored 'General case' 0 N--CA 1.422 -1.838 0 O-C-N 123.809 0.693 . . . . 0.0 109.454 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -150.3 159.28 44.56 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.424 HG13 ' CA ' ' A' ' 201' ' ' GLY . 91.3 t -101.69 129.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.8 ptp -69.85 160.91 30.92 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.84 0.712 . . . . 0.0 111.139 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 70.76 118.96 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 124.996 1.435 . . . . 0.0 112.214 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 10.3 pt-20 -70.82 -20.12 62.6 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.008 0.909 . . . . 0.0 109.524 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.75 -16.29 62.75 Favored 'General case' 0 C--O 1.206 -1.21 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.972 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.57 -30.0 62.67 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.551 0.74 . . . . 0.0 112.63 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 75' ' ' ASN . . . 105.56 79.0 1.24 Allowed Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 119.412 -1.375 . . . . 0.0 112.043 177.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 93.4 m-85 -69.66 151.9 45.33 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.473 HG12 ' CE2' ' A' ' 68' ' ' PHE . 28.7 mt -73.91 101.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 166.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -56.19 -41.64 75.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.863 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.22 160.27 43.92 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -51.16 136.72 29.1 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 33.3 Cg_endo -78.52 166.84 23.54 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.208 2.605 . . . . 0.0 111.606 173.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -53.94 117.02 2.87 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.54 1.136 . . . . 0.0 113.274 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.31 10.37 64.05 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 58.2 p -86.01 148.37 47.81 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 23.8 Cg_exo -69.66 165.67 30.08 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.508 2.805 . . . . 0.0 110.212 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -59.88 155.6 16.09 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -39.93 -54.86 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 127.556 2.343 . . . . 0.0 114.015 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 181' ' ' ARG . 34.6 p-90 -86.51 -20.9 27.35 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.379 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -86.43 -12.64 48.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.483 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.518 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 52.4 m-85 -46.04 -34.27 3.99 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 88' ' ' ASN . 40.2 m-70 -129.82 15.54 5.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.31 101.82 14.07 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.072 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.12 -9.99 2.75 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.64 172.9 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.63 1.715 . . . . 0.0 111.466 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 t -98.33 157.05 16.43 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.21 -16.73 48.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -23.67 58.78 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -86.86 -22.12 25.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 45' ' ' PRO . 10.0 m-20 -115.83 -22.87 8.88 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -96.85 135.62 22.04 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 124.05 11.73 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.917 2.411 . . . . 0.0 112.176 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.61 125.6 50.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.94 23.01 62.51 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.756 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.501 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -103.97 -157.05 24.18 Favored Glycine 0 C--O 1.25 1.131 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.154 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.4 130.86 46.53 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 33.1 m -126.19 166.5 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 19.9 m -149.17 149.91 31.79 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 37' ' ' ILE . 11.1 m-30 -71.92 117.03 13.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.432 -1.341 0 CA-C-O 121.221 0.534 . . . . 0.0 112.228 -176.307 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 78.7 m-20 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.079 0.466 . . . . 0.0 112.213 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.7 mmm-85 -79.23 -173.93 3.89 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 121.901 0.858 . . . . 0.0 112.044 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -81.24 -171.96 3.53 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.146 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.36 150.69 21.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.649 0.738 . . . . 0.0 111.859 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.92 -161.19 0.75 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.869 1.268 . . . . 0.0 107.783 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -75.08 -34.62 61.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 118.762 0.71 . . . . 0.0 111.127 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.25 134.35 55.26 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 33.4 tp60 -119.31 127.55 26.41 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.45 -179.79 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.042 2.495 . . . . 0.0 113.577 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.425 HD22 HD12 ' A' ' 37' ' ' ILE . 25.1 p30 -163.57 178.84 7.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.292 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.2 mt -103.85 34.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.5 mtp -129.56 -155.92 0.73 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 40.0 p -119.73 -11.06 9.44 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.473 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 25.9 p-10 -88.19 159.36 18.19 Favored 'General case' 0 C--O 1.201 -1.448 0 O-C-N 121.669 -0.644 . . . . 0.0 110.838 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.75 135.11 54.98 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 61.1 tp -100.13 120.66 40.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.12 139.07 48.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.506 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.4 p -73.98 164.34 26.75 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.64 -21.65 77.84 Favored Glycine 0 C--N 1.327 0.074 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -75.4 -48.35 23.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.18 73.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.249 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 73.1 ttt180 -56.17 -44.16 79.08 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.382 1.073 . . . . 0.0 110.277 174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -46.68 83.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 124.071 0.857 . . . . 0.0 110.407 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.71 -55.24 31.93 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.312 1.008 . . . . 0.0 111.234 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.13 -40.27 80.55 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 C-N-CA 123.692 0.797 . . . . 0.0 111.637 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 81.5 mt-10 -68.69 -35.12 76.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -69.46 -30.47 68.38 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.17 -17.1 57.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.44 20.9 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.698 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.8 113.73 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.9 t -82.6 153.6 25.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 73.58 16.85 3.86 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 124.684 1.194 . . . . 0.0 112.227 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.47 113.5 26.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -105.38 143.45 33.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.459 ' CH2' HD12 ' A' ' 129' ' ' LEU . 58.9 m95 -117.35 119.78 36.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -174.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.1 mt -111.82 96.04 31.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.84 134.44 14.84 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.75 2.3 . . . . 0.0 113.031 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 64' ' ' GLY . 8.0 m -150.2 172.59 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.223 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.96 116.18 28.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -97.45 121.05 47.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.406 0.622 . . . . 0.0 111.145 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HG2' HG22 ' A' ' 121' ' ' VAL . 94.4 mttt -96.28 133.82 40.16 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.4 p-10 -78.22 -160.31 0.2 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.258 0.551 . . . . 0.0 111.205 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -61.28 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.261 1.024 . . . . 0.0 110.765 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -84.66 -19.56 32.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.323 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.7 21.86 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.24 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.633 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.3 ptmt -102.99 142.31 34.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.504 HG22 ' HG2' ' A' ' 115' ' ' LYS . 24.3 t -83.7 84.31 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.526 0.679 . . . . 0.0 110.213 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.46 0.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.312 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.89 58.77 0.7 Allowed Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.52 -11.38 8.22 Favored 'Trans proline' 0 C--N 1.367 1.5 0 CA-C-N 120.623 2.211 . . . . 0.0 111.631 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.71 -5.28 39.12 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 124.837 1.255 . . . . 0.0 109.762 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.614 ' HB2' HD13 ' A' ' 114' ' ' ILE . 1.8 m-85 -93.14 152.23 19.37 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.608 -172.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.15 146.64 40.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.123 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.27 118.81 25.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.305 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.459 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.5 tt -91.65 128.68 37.57 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.11 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 121.09 34.37 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.153 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.423 ' H ' ' CE1' ' A' ' 51' ' ' HIS . 2.8 mm? -79.58 128.47 33.43 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.422 173.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -102.98 174.95 5.64 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 125.573 1.795 . . . . 0.0 107.625 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.6 20.55 63.7 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.542 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.59 131.95 36.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.84 158.1 43.92 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.71 106.83 0.39 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.265 0.939 . . . . 0.0 111.399 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.68 -18.44 7.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.99 113.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.029 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.57 127.77 33.91 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.688 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.4 ttm -117.93 7.61 12.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.25 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 10.2 pt-20 -95.34 -34.93 11.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.057 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.436 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 21.8 mmt85 -94.31 -31.48 14.04 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.6 m -75.71 158.51 32.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.748 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -137.09 105.52 5.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.04 165.63 33.52 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.771 0.319 . . . . 0.0 111.753 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 19.1 mm-40 -118.18 134.29 55.14 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' MET . . . . . 0.477 ' SD ' HG12 ' A' ' 155' ' ' ILE . 11.5 mmt -74.01 156.38 37.59 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.145 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.336 16.3 t70 100.41 99.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 172.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 m -100.49 -55.78 2.51 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 165.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.1 -42.94 2.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.795 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 5.4 pt-20 -142.99 -178.59 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -46.37 -49.39 17.93 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 125.87 1.668 . . . . 0.0 115.164 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.4 27.58 1.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.814 1.293 . . . . 0.0 112.318 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -123.71 115.78 21.98 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 104.654 -2.351 . . . . 0.0 104.654 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.477 HG12 ' SD ' ' A' ' 147' ' ' MET . 57.1 mt -84.63 124.92 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 118.388 0.54 . . . . 0.0 110.775 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.93 -66.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.131 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 7.7 t30 -93.0 119.5 32.32 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.3 mt -125.12 125.12 68.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -103.86 -34.21 8.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.372 0.606 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.07 137.07 14.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -127.18 119.3 26.11 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.71 147.21 24.59 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.65 145.91 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.559 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 30.6 p-10 -89.42 4.54 48.72 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.156 0.983 . . . . 0.0 110.63 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -66.1 -6.48 13.32 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.374 1.07 . . . . 0.0 109.997 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -59.3 -40.98 87.9 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.66 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.77 -32.85 6.28 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.172 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 137' ' ' ALA . 81.0 mt -81.23 141.99 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.402 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 51.7 mtm180 -55.47 114.61 7.58 Favored Pre-proline 0 N--CA 1.45 -0.446 0 O-C-N 123.409 0.443 . . . . 0.0 110.763 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.45 -19.3 67.04 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 123.261 2.641 . . . . 0.0 113.867 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 6.3 p-10 -73.59 -11.72 60.52 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.903 0.481 . . . . 0.0 112.074 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.41 48.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 123.654 0.597 . . . . 0.0 110.67 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.5 -38.56 14.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.9 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.7 ttt -141.47 125.27 16.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.46 -177.96 6.69 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.012 0.925 . . . . 0.0 108.64 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -142.65 151.63 41.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 118.444 0.565 . . . . 0.0 111.76 -177.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.591 ' SG ' HD22 ' A' ' 183' ' ' LEU . 67.2 m -82.86 129.98 35.07 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 124.157 0.911 . . . . 0.0 109.479 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.5 p -64.06 -51.07 65.82 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.31 22.91 2.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.32 139.68 39.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 48' ' ' TRP . 16.2 mmt180 -91.28 -27.29 18.52 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.924 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.69 -0.4 20.12 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.329 -172.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.591 HD22 ' SG ' ' A' ' 177' ' ' CYS . 1.8 tt -95.11 103.66 15.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.562 0.696 . . . . 0.0 109.315 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.2 mt -111.84 140.47 31.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.4 HD12 ' OD2' ' A' ' 164' ' ' ASP . 53.0 mt -116.78 137.24 52.34 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 118.584 0.629 . . . . 0.0 112.412 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.0 pt -129.36 151.8 36.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.653 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -80.29 163.44 23.95 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.739 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.471 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 0.2 OUTLIER -55.36 -42.08 73.41 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.493 0.717 . . . . 0.0 110.534 176.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -50.49 -39.72 49.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.872 1.669 . . . . 0.0 112.135 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.24 -46.88 76.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.922 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.501 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 14.8 p80 -77.2 -21.94 53.13 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.089 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.67 80.07 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.523 0.678 . . . . 0.0 110.38 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.47 73.97 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.093 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.71 -32.48 67.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.0 mm-40 -57.1 -49.63 75.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -81.51 -7.02 59.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.88 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.57 -27.28 18.29 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 122.097 -0.377 . . . . 0.0 110.167 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 66.98 43.31 91.56 Favored Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 155.72 21.2 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.0 p -106.15 139.37 40.77 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.424 ' CA ' HG13 ' A' ' 29' ' ' VAL . . . 106.44 56.6 0.64 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.634 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -126.95 147.61 50.09 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 121.206 0.527 . . . . 0.0 111.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -156.85 121.76 4.56 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.6 139.53 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.728 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 97.3 m-85 -128.55 151.33 49.57 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 210' ' ' TRP . 20.3 mm-40 -64.66 121.28 14.12 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.27 45.74 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.21 90.12 2.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.347 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.39 32.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.95 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 206' ' ' GLU . 19.6 t90 -58.77 105.35 0.3 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.851 0.861 . . . . 0.0 110.618 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.84 105.55 15.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.8 -24.42 0.3 Allowed Glycine 0 N--CA 1.474 1.172 0 N-CA-C 119.177 2.431 . . . . 0.0 119.177 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.87 115.34 3.33 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.117 0.958 . . . . 0.0 110.567 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.52 125.6 28.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.583 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.103 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tmm? . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.98 46.01 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.112 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 m -124.92 6.56 8.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.591 0.196 . . . . 0.0 110.737 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t 60.82 -149.22 0.42 Allowed 'General case' 0 C--O 1.246 0.874 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -112.8 102.8 10.8 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.447 ' O ' ' HD2' ' A' ' 8' ' ' HIS . 34.2 t-80 -77.73 128.35 33.91 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -71.37 100.89 2.26 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.075 0.464 . . . . 0.0 111.137 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.447 ' HD2' ' O ' ' A' ' 6' ' ' HIS . 1.9 p80 -160.98 163.22 31.9 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -99.62 -173.52 2.48 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -116.14 33.32 5.59 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.431 ' HB3' ' CD ' ' A' ' 206' ' ' GLU . 48.9 m 71.75 -162.81 0.13 Allowed 'General case' 0 CA--C 1.573 1.86 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.771 -168.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 m -139.34 -62.31 0.53 Allowed 'General case' 0 C--O 1.246 0.891 0 CA-C-N 120.077 1.308 . . . . 0.0 112.063 -175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.44 29.55 65.85 Favored Glycine 0 CA--C 1.486 -1.726 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.4 mt -105.11 127.33 52.84 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.442 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 86.1 t -83.09 -52.33 0.64 Allowed Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.815 170.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 8.9 Cg_endo -90.52 103.62 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 121.904 1.736 . . . . 0.0 112.129 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -156.97 -45.83 0.07 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.22 -61.88 0.19 Allowed Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.654 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.5 t -98.75 134.76 41.19 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 122.686 -0.302 . . . . 0.0 110.338 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.254 0.3 OUTLIER 71.25 151.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.708 2.403 . . . . 0.0 113.485 -178.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ttp -112.14 -39.08 4.56 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.91 119.44 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.898 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -96.91 148.02 23.37 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.027 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.46 137.07 47.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.612 0.72 . . . . 0.0 111.828 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -127.71 151.35 49.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.621 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG13 HD12 ' A' ' 183' ' ' LEU . 80.8 t -81.6 130.72 35.35 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 172.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -91.73 122.11 33.98 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.712 0.768 . . . . 0.0 110.81 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -138.57 152.48 48.21 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.02 127.51 56.77 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.556 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 12.0 tmm? -85.78 84.42 7.57 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.56 112.47 3.72 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.528 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.39 -45.92 3.98 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.258 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.97 -12.26 59.92 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.969 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.56 -30.92 68.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.02 120.72 2.11 Favored Glycine 0 N--CA 1.409 -3.119 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.659 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -70.76 152.13 44.12 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 29.0 mt -78.49 101.4 4.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 170.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -72.73 -42.28 64.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.189 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.526 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 41.1 ttmt -133.01 141.78 48.46 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -172.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -64.32 132.37 95.32 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -171.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 55.6 Cg_endo -74.73 167.55 26.85 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.446 2.764 . . . . 0.0 112.891 175.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -54.5 124.64 16.77 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 112.727 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.51 3.99 68.51 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.287 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.1 m -85.65 133.26 42.2 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.47 165.53 32.44 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.294 2.663 . . . . 0.0 109.948 172.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 p -51.92 149.46 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.23 -50.45 3.61 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 128.243 2.617 . . . . 0.0 113.684 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -85.89 -25.89 25.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.966 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -80.57 -15.38 56.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.649 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -44.83 -47.55 11.01 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.634 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 2.8 m-70 -127.01 30.12 5.5 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.76 -1.213 . . . . 0.0 109.869 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HA ' HH21 ' A' ' 176' ' ' ARG . 2.1 tm-20 -92.88 101.99 14.36 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -9.23 0.31 Allowed Glycine 0 CA--C 1.54 1.603 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.23 168.2 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 118.779 1.289 . . . . 0.0 112.801 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.0 t -97.09 154.48 17.31 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.5 mt -102.38 10.64 38.93 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.441 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.36 -29.55 70.54 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.726 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.9 -13.73 38.41 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 176.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -114.98 -21.97 9.8 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -109.29 134.81 20.36 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.87 127.47 25.26 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.278 2.652 . . . . 0.0 113.268 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -98.53 115.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.24 22.91 50.38 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.971 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -102.56 -167.32 26.47 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.01 141.85 49.34 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 117.511 0.656 . . . . 0.0 109.265 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 31.1 m -133.71 165.92 30.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.0 t -153.07 153.85 33.68 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.183 0.516 . . . . 0.0 111.211 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.95 117.93 19.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.889 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.526 ' OG ' ' HB3' ' A' ' 39' ' ' LYS . 12.8 p -75.41 138.88 41.98 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -82.23 82.24 7.82 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.028 0.918 . . . . 0.0 111.618 -177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -86.1 -32.02 21.58 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -117.21 131.78 23.84 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.56 -31.55 50.3 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 123.195 2.597 . . . . 0.0 114.756 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -96.88 -158.32 0.65 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.862 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . 0.27 90.6 m-20 85.52 142.84 0.06 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.872 1.669 . . . . 0.0 112.872 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -88.61 -154.88 0.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.954 1.301 . . . . 0.0 111.336 -169.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.67 -167.46 1.63 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.937 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -87.31 150.69 23.69 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.372 0.669 . . . . 0.0 112.089 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -105.83 -159.55 0.71 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -71.37 -42.18 68.77 Favored 'General case' 0 CA--C 1.48 -1.749 0 CA-C-N 119.086 0.857 . . . . 0.0 110.624 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -120.83 135.69 55.1 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 35.5 tp60 -116.4 117.99 37.91 Favored Pre-proline 0 C--N 1.28 -2.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.59 162.62 27.34 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.939 2.426 . . . . 0.0 112.058 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -163.81 174.32 11.71 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.181 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.9 mt -93.25 -6.47 10.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.444 0.64 . . . . 0.0 110.311 -174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -96.55 -174.78 3.13 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.847 -0.533 . . . . 0.0 111.273 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.0 t -96.41 43.88 1.07 Allowed 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.214 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -138.33 151.33 47.45 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -123.01 138.85 54.58 Favored 'General case' 0 C--O 1.207 -1.136 0 CA-C-N 119.384 0.993 . . . . 0.0 110.189 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 51.7 tp -105.96 129.61 54.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.184 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.08 140.36 49.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.054 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.2 p -70.82 167.3 19.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.063 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.47 -37.67 92.86 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.502 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -72.25 -37.43 69.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.35 -30.52 62.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.034 0.445 . . . . 0.0 110.351 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.406 ' HG3' ' CE3' ' A' ' 109' ' ' TRP . 49.3 ttp180 -58.41 -48.71 79.79 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.099 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 97' ' ' LYS . 10.2 tmtt? -62.43 -37.44 85.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.936 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.79 -53.21 59.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 120.583 0.23 . . . . 0.0 111.105 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.2 -41.5 87.01 Favored 'Isoleucine or valine' 0 C--O 1.25 1.097 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.17 -31.14 71.35 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.313 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -71.42 -22.08 61.9 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -84.54 -19.81 32.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.96 0.41 . . . . 0.0 110.551 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.06 48.05 7.19 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.269 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.1 t -78.97 114.57 19.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.4 t -80.03 158.24 26.55 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.137 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 78.5 19.19 0.95 Allowed 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.316 1.01 . . . . 0.0 110.406 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.03 134.03 50.79 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.498 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.9 tp10 -130.12 142.17 50.62 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.406 ' CE3' ' HG3' ' A' ' 96' ' ' ARG . 52.2 m95 -117.0 118.62 32.92 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 123.459 0.475 . . . . 0.0 110.082 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HG ' HD21 ' A' ' 130' ' ' ASN . 83.7 mt -107.12 102.49 43.52 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.99 129.98 5.54 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.744 2.296 . . . . 0.0 113.683 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' GLY . 12.1 m -142.87 172.86 7.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.359 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.72 116.23 29.53 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.529 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.4 mp -101.59 124.93 55.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.468 0.651 . . . . 0.0 110.966 -176.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 87.3 mttt -97.35 132.14 43.36 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.6 -161.56 0.24 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.862 0.363 . . . . 0.0 111.285 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -62.6 -31.57 72.42 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.44 -4.27 55.35 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.739 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.74 14.75 79.22 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.709 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 20.1 pttp -104.84 140.06 38.68 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 122.534 0.333 . . . . 0.0 110.247 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.23 107.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.8 m -122.43 -0.29 6.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.417 0.627 . . . . 0.0 110.905 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -121.87 75.95 0.34 Allowed Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 175.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -82.45 -27.68 2.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.093 1.862 . . . . 0.0 113.773 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -118.53 23.38 11.55 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.813 1.292 . . . . 0.0 109.285 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.529 ' HB2' HD13 ' A' ' 114' ' ' ILE . 2.9 m-85 -88.66 144.86 26.01 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.528 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.77 46.43 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.758 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.7 126.88 32.32 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.534 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 tt -90.54 125.28 35.56 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.846 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.634 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 28.2 m-80 -107.15 137.03 45.98 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.955 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.21 120.58 42.96 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.9 172.96 6.52 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 124.029 0.83 . . . . 0.0 110.649 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 22.78 64.24 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -92.54 131.19 37.87 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -147.88 151.61 36.18 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -52.89 115.19 1.71 Allowed 'General case' 0 N--CA 1.481 1.075 0 O-C-N 123.966 0.791 . . . . 0.0 112.09 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -131.93 -26.36 1.97 Allowed 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -167.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 17.7 mt -62.36 125.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.72 125.74 26.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 23.0 ttt -118.83 1.88 11.57 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.737 0.78 . . . . 0.0 109.718 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.4 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 11.2 pt-20 -99.57 -32.56 11.04 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.73 -175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.4 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 68.0 mtt85 -108.02 -10.87 15.41 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.182 0.593 . . . . 0.0 110.552 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.5 m -93.84 110.6 22.25 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.362 0.601 . . . . 0.0 110.603 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -78.61 100.72 7.09 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.379 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.49 145.46 27.93 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.239 0.543 . . . . 0.0 111.904 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -101.3 127.97 47.67 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 71.8 mtp -100.73 154.56 18.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.165 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 24.0 t70 90.71 85.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 127.269 2.228 . . . . 0.0 114.1 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 35.7 m -100.43 -26.77 13.76 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.322 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -145.99 -48.05 0.21 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 14.3 pt-20 -139.75 177.79 7.7 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -59.16 -38.58 80.09 Favored 'General case' 0 C--O 1.214 -0.782 0 O-C-N 124.292 0.995 . . . . 0.0 111.102 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 25.7 m-20 -85.97 26.11 1.04 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -123.46 113.31 18.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.0 mt -87.03 132.29 32.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 124.238 1.015 . . . . 0.0 109.946 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.05 -72.51 0.95 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.478 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -90.76 133.11 35.42 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.588 -0.153 . . . . 0.0 110.588 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.65 124.51 59.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.84 -34.55 8.49 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -149.04 136.87 20.55 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.85 123.73 29.67 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.84 143.2 32.77 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.67 139.64 57.07 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.767 0.794 . . . . 0.0 112.96 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.58 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.7 p-10 -94.33 15.55 17.27 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.112 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.7 p -67.45 -5.22 13.88 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.892 175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.1 m -61.57 -38.14 86.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.959 0.903 . . . . 0.0 110.673 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.406 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.63 -30.5 7.08 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.788 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 137' ' ' ALA . 73.8 mt -85.82 139.2 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -54.79 117.96 15.56 Favored Pre-proline 0 N--CA 1.45 -0.43 0 O-C-N 123.189 0.306 . . . . 0.0 111.243 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.16 -13.18 33.97 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 123.419 2.746 . . . . 0.0 114.037 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -75.84 -12.73 60.22 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.76 129.06 38.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.075 0.464 . . . . 0.0 109.83 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -83.63 -17.0 43.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.794 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.424 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.0 ttt -154.38 128.16 8.75 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -153.36 178.52 9.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 178' ' ' THR . 1.6 ppt_? -128.47 142.43 51.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.414 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 58.2 m -86.52 140.48 29.87 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 123.832 0.708 . . . . 0.0 109.483 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 176' ' ' ARG . 19.3 p -68.75 -44.56 73.5 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.745 2.868 . . . . 0.0 118.745 -168.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -89.19 23.7 2.38 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.544 0.611 . . . . 0.0 112.333 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 9.0 tp10 -154.94 135.6 13.53 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.418 HH21 ' CD ' ' A' ' 151' ' ' GLU . 69.8 mtt180 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.971 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 36.9 mtm-85 -83.81 -7.37 59.47 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.767 -167.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 180' ' ' GLU . 26.2 tp -82.42 100.63 10.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.819 0.818 . . . . 0.0 110.973 -174.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.1 mt -117.84 124.38 72.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 207' ' ' ALA . 43.4 mt -103.94 134.71 46.76 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.523 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.424 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.0 pt -123.68 157.74 29.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.597 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -86.06 162.43 18.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.993 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -47.62 -44.63 26.95 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 125.199 1.399 . . . . 0.0 111.996 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.22 -43.56 70.94 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.439 1.096 . . . . 0.0 111.301 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.8 t -61.31 -53.19 52.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.178 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 13.7 p80 -75.31 -26.54 58.76 Favored 'General case' 0 C--O 1.195 -1.804 0 C-N-CA 118.611 -1.235 . . . . 0.0 110.714 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.99 83.62 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.03 0.443 . . . . 0.0 110.351 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -68.71 -32.77 72.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.552 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.457 ' HB3' ' CE2' ' A' ' 202' ' ' PHE . 21.0 m-85 -73.57 -36.43 65.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.247 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -56.92 -50.75 71.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 121.625 0.726 . . . . 0.0 109.218 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.91 -26.67 61.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.21 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.53 -27.47 62.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.425 0.155 . . . . 0.0 111.046 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.9 47.51 13.85 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.05 165.87 18.2 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.8 p -42.15 -72.83 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -165.96 144.43 9.19 Favored Glycine 0 CA--C 1.488 -1.637 0 C-N-CA 118.998 -1.572 . . . . 0.0 113.118 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 194' ' ' PHE . 74.5 m-85 -137.37 152.78 50.05 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 22.4 tptm -132.21 121.84 24.3 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 24.7 m -116.43 139.55 42.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.563 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -121.68 151.44 40.47 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.431 ' CD ' ' HB3' ' A' ' 11' ' ' SER . 49.6 mt-10 -75.62 133.39 40.9 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.207 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.405 ' HB2' HD22 ' A' ' 185' ' ' LEU . . . -80.13 -38.34 31.73 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.936 0.874 . . . . 0.0 108.642 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -82.74 104.8 13.26 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.004 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 75.55 35.33 47.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.369 -0.92 . . . . 0.0 113.523 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.439 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 8.7 t90 -54.31 102.18 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 125.082 1.353 . . . . 0.0 111.217 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -103.55 109.89 21.74 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.73 2.94 31.82 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 167.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.439 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 82.7 mt -94.14 145.37 24.74 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 117.902 0.851 . . . . 0.0 109.738 -176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.5 125.35 51.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.2 0.524 . . . . 0.0 111.459 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 47.6 tp . . . . . 0 C--N 1.31 -1.142 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.997 178.42 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.506 -0.729 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.49 142.55 8.94 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.112 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.9 t -73.73 -42.4 61.21 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 m -110.08 105.37 14.45 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -77.57 -40.76 41.24 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -165.47 94.09 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.555 1.142 . . . . 0.0 109.308 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -167.0 -40.11 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.228 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 68.68 112.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.614 1.166 . . . . 0.0 110.232 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -84.56 152.85 23.61 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 76.89 25.47 0.84 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.233 0.958 . . . . 0.0 110.91 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 m -74.03 -51.74 14.9 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m 61.97 173.21 0.13 Allowed 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.857 1.263 . . . . 0.0 113.565 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.66 85.18 1.16 Allowed Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.89 71.41 10.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.896 0.855 . . . . 0.0 110.557 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.69 134.25 24.87 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.11 107.28 0.31 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.484 2.123 . . . . 0.0 111.091 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -152.09 123.62 7.83 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 147.22 -25.39 1.57 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.653 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -60.97 -43.59 98.56 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 117.073 0.437 . . . . 0.0 111.785 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -145.95 101.31 3.52 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.319 0.58 . . . . 0.0 109.573 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -98.94 160.44 14.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.455 HG11 ' NE ' ' A' ' 187' ' ' ARG . 45.0 t -94.96 119.06 42.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 118.75 0.704 . . . . 0.0 110.469 -174.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -87.01 155.8 20.01 Favored 'General case' 0 C--O 1.253 1.238 0 CA-C-O 121.317 0.579 . . . . 0.0 112.3 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -112.06 138.45 48.7 Favored 'General case' 0 C--O 1.248 1.018 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.158 -172.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.85 150.92 49.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.46 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.8 130.0 36.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -95.72 128.86 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.512 0.507 . . . . 0.0 111.141 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -150.12 149.58 30.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.94 115.56 41.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 172.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.657 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 57.0 ttp -85.28 101.61 12.67 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 173.56 177.19 0.11 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.144 1.778 . . . . 0.0 107.56 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -130.17 -36.21 1.53 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 122.04 0.924 . . . . 0.0 110.147 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -89.64 -0.85 57.79 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 124.962 1.305 . . . . 0.0 111.46 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.18 58.5 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.57 82.69 1.14 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.253 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -95.01 164.61 12.82 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.31 102.21 13.41 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 170.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' OE1' ' HB3' ' A' ' 72' ' ' TYR . 2.2 mm-40 -61.87 -55.42 29.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.917 -172.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -137.03 176.47 8.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.655 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 46' ' ' THR . 7.8 mp -55.37 125.74 60.08 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HB3' ' HB ' ' A' ' 66' ' ' VAL . 16.4 Cg_exo -71.44 166.99 27.6 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 123.031 2.487 . . . . 0.0 111.344 169.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -55.8 117.16 3.4 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.353 1.061 . . . . 0.0 112.889 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 9.11 83.52 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.281 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.7 m -85.79 139.32 35.22 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -67.59 166.28 24.52 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.686 2.924 . . . . 0.0 112.619 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.406 ' HA ' HD21 ' A' ' 40' ' ' LEU . 5.3 p -53.23 152.01 4.77 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.09 -58.74 2.32 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 127.534 2.333 . . . . 0.0 113.975 -173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -80.55 -25.39 38.62 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.431 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 45.1 tptt -80.52 -16.77 53.43 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -172.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -45.51 -43.37 11.69 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.462 ' HB3' ' HG3' ' A' ' 176' ' ' ARG . 55.9 m170 -126.98 24.16 6.46 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.978 -1.076 . . . . 0.0 111.097 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -93.45 102.7 14.93 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.063 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.29 -8.95 0.59 Allowed Glycine 0 CA--C 1.538 1.495 0 N-CA-C 118.07 1.988 . . . . 0.0 118.07 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.3 pp -120.99 171.17 10.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 118.499 1.149 . . . . 0.0 113.648 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 t -98.55 137.93 36.49 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.56 -0.78 48.4 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.07 -23.22 67.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.021 0.438 . . . . 0.0 111.381 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -88.74 -27.88 20.88 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -112.69 -15.53 12.97 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -110.21 135.75 20.55 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.95 123.94 13.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.635 2.223 . . . . 0.0 113.36 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.4 t -95.02 107.68 19.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.47 23.54 28.58 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.15 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.22 -153.85 25.24 Favored Glycine 0 C--O 1.24 0.507 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.46 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -131.81 132.2 43.53 Favored 'General case' 0 C--O 1.248 0.981 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 41' ' ' PRO . 21.3 m -134.03 168.33 24.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -149.15 158.28 44.05 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -84.85 106.69 16.57 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 p -69.41 120.89 15.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.568 0.699 . . . . 0.0 109.409 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -74.45 106.51 6.09 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.161 -173.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -104.05 -38.03 7.12 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.881 173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.434 ' HB3' ' OE1' ' A' ' 38' ' ' GLU . 72.7 t80 -111.46 131.61 22.22 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.68 154.02 23.42 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.447 2.098 . . . . 0.0 114.36 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 79.42 2.0 2.27 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.152 1.381 . . . . 0.0 114.556 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -73.52 137.42 44.4 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -90.68 -151.36 0.25 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -165.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -84.88 -171.19 3.5 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.645 1.578 . . . . 0.0 111.921 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.488 HD13 HG23 ' A' ' 122' ' ' VAL . 8.6 mp -100.12 150.21 22.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.171 -174.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.505 ' H ' ' NE2' ' A' ' 82' ' ' GLN . 18.3 m-85 -125.4 -165.74 1.45 Allowed 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 124.413 1.085 . . . . 0.0 109.208 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -52.49 -51.59 58.64 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 123.499 0.719 . . . . 0.0 111.724 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -116.2 142.89 46.22 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.918 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 24.6 mm-40 -121.34 111.89 33.24 Favored Pre-proline 0 C--N 1.285 -2.224 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.025 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.29 167.3 27.68 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.458 2.106 . . . . 0.0 111.35 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -142.69 156.39 45.03 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.4 mt -91.12 -19.48 7.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -99.02 -179.07 4.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 33.5 t -97.82 66.1 1.88 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.712 -1.195 . . . . 0.0 114.057 -174.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -140.13 121.05 14.54 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.491 169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 138.12 31.71 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.354 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 64.9 tp -111.57 127.12 55.63 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.79 141.24 45.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.53 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -78.95 170.2 17.05 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.74 -16.37 79.23 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -69.71 -58.62 3.69 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -25.59 63.33 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.101 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -60.22 -40.89 91.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.509 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.545 ' CE ' ' HA ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -71.29 -29.5 65.13 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.508 -176.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.82 -57.84 10.98 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 170.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.49 -42.74 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 C-N-CA 123.427 0.691 . . . . 0.0 112.562 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -72.12 -27.48 62.66 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 p -78.3 -13.0 60.04 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.497 0.665 . . . . 0.0 111.39 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -88.73 -25.57 22.24 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.592 173.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.28 48.36 8.28 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.38 107.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.582 0.706 . . . . 0.0 111.671 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.3 m -66.92 137.3 56.45 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.151 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 79.94 11.55 1.17 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.493 1.917 . . . . 0.0 113.667 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.75 114.32 26.04 Favored 'General case' 0 C--O 1.25 1.118 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -107.5 144.63 34.19 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.429 ' CH2' HD12 ' A' ' 129' ' ' LEU . 67.0 m95 -116.46 121.43 41.82 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 123.586 0.554 . . . . 0.0 110.238 -174.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.2 mt -114.57 96.51 43.87 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.38 139.75 16.72 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.549 2.166 . . . . 0.0 112.868 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 m -151.14 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.319 0.648 . . . . 0.0 109.804 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -91.18 116.55 28.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 126' ' ' TYR . 54.9 mt -110.54 131.14 62.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.613 0.72 . . . . 0.0 112.865 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.488 ' HG2' HG22 ' A' ' 121' ' ' VAL . 93.0 mttt -104.76 148.75 26.27 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.571 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -89.32 -160.69 0.7 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.316 0.579 . . . . 0.0 111.241 -174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -63.85 -34.3 77.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.62 1.168 . . . . 0.0 110.507 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.53 -19.42 29.51 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.893 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.66 19.7 24.12 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.571 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 52.2 pttt -99.29 146.35 26.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.488 HG22 ' HG2' ' A' ' 115' ' ' LYS . 17.6 t -82.71 81.33 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.681 0.753 . . . . 0.0 110.148 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 HD13 ' A' ' 78' ' ' LEU . 10.1 m -105.4 8.19 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.429 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.78 50.76 0.88 Allowed Glycine 0 CA--C 1.542 1.757 0 C-N-CA 119.842 -1.17 . . . . 0.0 114.896 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.73 -6.76 9.7 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 121.097 2.449 . . . . 0.0 112.285 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -103.11 -0.99 29.84 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.618 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.438 ' HB2' HD12 ' A' ' 114' ' ' ILE . 2.7 m-85 -98.0 147.87 24.06 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 122.002 0.906 . . . . 0.0 112.86 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -136.28 139.5 42.72 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.702 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -79.67 124.3 28.44 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.046 0.451 . . . . 0.0 110.111 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.429 HD12 ' CH2' ' A' ' 109' ' ' TRP . 8.0 tt -96.86 125.98 41.68 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.759 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -122.88 134.62 54.37 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.848 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.4 138.78 31.94 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.719 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -118.07 174.12 6.39 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 124.87 1.356 . . . . 0.0 109.016 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.78 28.9 25.12 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.592 -0.814 . . . . 0.0 115.114 170.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.407 ' HB3' ' NH2' ' A' ' 176' ' ' ARG . . . -112.89 131.79 55.58 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 119.151 -1.019 . . . . 0.0 110.984 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.78 111.66 6.13 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.724 -1.125 . . . . 0.0 107.99 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.0 t70 71.21 -52.34 0.69 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 125.978 1.711 . . . . 0.0 112.253 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 66.36 -100.58 0.06 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 125.961 1.704 . . . . 0.0 114.484 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 179' ' ' LYS . 46.8 mt -64.12 125.08 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 O-C-N 123.686 0.616 . . . . 0.0 110.405 -172.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 100.64 1.94 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.538 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 21.6 ttt -75.81 -12.75 60.23 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.353 -171.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.53 -39.89 67.19 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -101.21 4.55 42.0 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.347 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.538 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 77.7 p -92.54 115.65 28.29 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.767 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -92.53 104.53 16.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.32 164.02 32.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.529 0.681 . . . . 0.0 112.532 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.87 117.95 31.13 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 26.3 ttt -100.28 107.48 19.3 Favored 'General case' 0 N--CA 1.394 -3.229 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.883 -171.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 18.6 t70 170.41 89.33 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.909 1.683 . . . . 0.0 108.589 172.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.437 ' HB3' ' HA2' ' A' ' 156' ' ' GLY . 7.8 p -101.07 -56.88 2.21 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.294 0.568 . . . . 0.0 110.358 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.17 -59.94 1.9 Allowed 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.54 -177.07 3.21 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.537 177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 152' ' ' LYS . 1.2 tpmt? -76.01 -26.51 56.75 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.224 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.46 11.4 14.78 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.613 1.196 . . . . 0.0 110.025 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -124.68 127.84 47.9 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 48.5 mt -84.79 143.84 10.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 149' ' ' SER . . . -119.42 -70.44 0.33 Allowed Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.425 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -88.37 118.93 28.34 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 59.1 mt -118.29 132.23 68.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -106.67 -42.29 5.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -154.65 110.62 3.19 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.64 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -88.15 124.71 34.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.19 146.75 24.42 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 73.9 mt -62.74 146.46 52.34 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -96.06 -9.15 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.803 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -68.0 -6.02 20.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.567 1.147 . . . . 0.0 111.035 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.9 m -65.39 -38.19 89.25 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -110.52 -30.98 7.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.373 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.83 151.52 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.491 ' HD3' ' OD2' ' A' ' 171' ' ' ASP . 55.5 mtt180 -62.44 126.65 88.56 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 122.267 0.227 . . . . 0.0 111.471 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.86 -10.12 21.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.139 1.892 . . . . 0.0 110.816 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' A' ' 169' ' ' ARG . 4.3 p-10 -85.21 2.14 45.1 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.091 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.99 134.73 33.88 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.52 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 67.8 mttm -84.01 -27.44 28.38 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.507 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.0 ttt -150.76 128.05 11.31 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -150.56 -179.19 7.03 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 123.559 0.537 . . . . 0.0 110.004 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -136.12 154.7 50.91 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 63.4 m -87.48 143.82 27.03 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 120.907 0.384 . . . . 0.0 110.206 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.5 p -82.91 -9.61 59.22 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.447 ' HB2' HD12 ' A' ' 138' ' ' ILE . 58.9 mttp -105.87 23.74 13.46 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.72 -0.613 . . . . 0.0 111.853 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 183' ' ' LEU . 7.4 tp10 175.05 134.16 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -176.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.58 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 17.1 mmt180 -89.53 -31.05 17.8 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.495 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -77.85 -20.13 53.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.269 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.438 ' H ' ' HG3' ' A' ' 180' ' ' GLU . 20.3 tp -83.85 100.35 10.92 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.067 0.937 . . . . 0.0 110.64 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.3 mt -116.46 119.41 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 55.2 mt -104.89 136.04 45.12 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.608 0.718 . . . . 0.0 111.723 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.6 pt -119.3 153.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.417 176.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 10.6 mtp180 -86.06 161.3 19.0 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.879 174.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.498 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.7 pt-20 -55.42 -40.02 70.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.7 -26.34 66.97 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.465 0.706 . . . . 0.0 111.829 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.2 t -71.31 -51.01 37.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.797 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.548 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 19.3 p80 -73.17 -21.91 60.6 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.089 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.9 76.82 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.179 0.514 . . . . 0.0 110.063 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.24 75.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.511 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.7 m-85 -71.18 -33.35 69.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.272 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 62.9 mm-40 -59.6 -47.93 83.65 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.491 0.663 . . . . 0.0 109.811 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -78.03 -12.76 60.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.516 -176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.06 -28.42 20.14 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.083 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 62.39 47.7 87.61 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.443 ' HB2' ' CE1' ' A' ' 202' ' ' PHE . 66.5 mt -77.9 164.18 25.37 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.5 p -41.41 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -171.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.45 135.06 6.81 Favored Glycine 0 CA--C 1.493 -1.322 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.809 -175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 199' ' ' LEU . 70.5 m-85 -146.37 161.94 39.28 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 58.1 tptt -153.59 122.26 6.34 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 18.0 m -112.66 134.46 55.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.054 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 73.4 m-85 -118.26 140.05 50.39 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.95 115.51 9.26 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.08 -35.05 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.382 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.97 92.67 0.52 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.062 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.99 35.6 17.97 Favored Glycine 0 N--CA 1.437 -1.295 0 C-N-CA 120.11 -1.043 . . . . 0.0 111.399 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.405 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 8.3 t90 -53.12 115.01 1.66 Allowed 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 123.802 0.841 . . . . 0.0 110.061 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.23 99.78 11.04 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.47 -1.59 9.11 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 117.832 1.893 . . . . 0.0 117.832 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.405 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 88.0 mt -94.56 143.2 26.62 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 118.029 0.914 . . . . 0.0 112.327 -175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -106.48 132.36 52.59 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.488 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 2.5 pt? . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.047 0.842 . . . . 0.0 112.387 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.89 153.7 6.51 Favored Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m 65.79 98.48 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.468 1.107 . . . . 0.0 112.084 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -59.31 -42.91 92.49 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.819 0.848 . . . . 0.0 112.01 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -71.91 131.54 43.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -58.65 -46.78 86.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 -172.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -152.45 156.76 40.09 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.414 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.424 ' HB3' ' OG ' ' A' ' 11' ' ' SER . 22.5 m80 -77.05 107.83 9.69 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 123.685 0.616 . . . . 0.0 110.475 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -126.39 7.54 7.05 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -114.06 13.76 18.21 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.306 1.05 . . . . 0.0 108.594 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 8' ' ' HIS . 48.9 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.393 0.616 . . . . 0.0 111.116 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 m -102.57 150.35 23.5 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.309 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.35 104.02 3.09 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.1 mt -74.52 156.78 36.5 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.3 t -65.3 121.21 73.41 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.506 ' O ' ' HD2' ' A' ' 17' ' ' ARG . 30.4 Cg_endo -64.77 95.29 0.23 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.324 2.682 . . . . 0.0 114.811 -175.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 4.5 mpt_? -136.2 86.53 2.23 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.029 1.332 . . . . 0.0 108.146 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.61 -83.37 0.05 OUTLIER Glycine 0 N--CA 1.421 -2.357 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.849 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m 71.58 -56.28 0.64 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.713 1.605 . . . . 0.0 109.515 -174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.98 92.48 2.4 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -86.9 114.48 23.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.39 115.31 2.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -80.55 152.95 28.36 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -167.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.28 141.1 48.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.972 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -122.7 141.0 52.24 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 62.0 t -72.73 120.89 22.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 173.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.3 115.11 27.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.857 0.723 . . . . 0.0 110.7 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -140.3 120.16 13.51 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.9 t -72.66 129.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.461 ' HB3' ' HG3' ' A' ' 203' ' ' LYS 0.268 20.8 ptt? -102.01 66.68 1.04 Allowed 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.73 1.252 . . . . 0.0 112.619 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -129.46 110.72 12.1 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -106.66 -17.24 14.29 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 122.19 0.995 . . . . 0.0 108.721 -171.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -86.97 -25.85 24.12 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.673 -1.603 . . . . 0.0 107.698 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.26 -35.32 80.68 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.89 137.41 3.36 Favored Glycine 0 N--CA 1.408 -3.198 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.216 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -65.9 156.63 32.86 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -71.38 102.26 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 165.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -51.73 -52.19 50.4 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.832 1.332 . . . . 0.0 112.205 -169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -139.69 172.03 13.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.143 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 46' ' ' THR . 8.9 mp -55.46 124.63 56.33 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -173.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 18.8 Cg_endo -75.09 166.77 28.41 Favored 'Trans proline' 0 CA--C 1.55 1.278 0 C-N-CA 122.664 2.243 . . . . 0.0 112.198 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -52.15 121.4 6.74 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 125.109 1.364 . . . . 0.0 112.847 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.09 0.2 68.4 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.649 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.7 m -85.88 137.87 35.47 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.93 166.49 23.2 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 123.416 2.744 . . . . 0.0 109.795 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.473 ' HA ' HD21 ' A' ' 40' ' ' LEU . 18.0 p -48.22 153.01 0.75 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' OD1' ' HG3' ' A' ' 86' ' ' MET . 16.2 m-20 -37.68 -57.03 1.01 Allowed 'General case' 0 N--CA 1.512 2.628 0 C-N-CA 126.863 2.065 . . . . 0.0 114.955 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -80.47 -30.33 37.45 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.419 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -79.72 -11.58 59.84 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.725 -171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 27.8 m-85 -45.84 -46.01 15.36 Favored 'General case' 0 C--O 1.209 -1.048 0 O-C-N 123.559 0.537 . . . . 0.0 111.347 174.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 176' ' ' ARG . 17.4 m170 -129.41 17.0 5.98 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.19 101.34 13.41 Favored 'General case' 0 N--CA 1.425 -1.688 0 C-N-CA 117.76 -1.576 . . . . 0.0 108.373 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.03 -9.17 55.05 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 116.807 1.483 . . . . 0.0 116.807 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.59 173.77 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 119.814 1.807 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.8 t -98.88 157.15 16.5 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.38 5.95 49.02 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.36 68.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.972 0.415 . . . . 0.0 111.792 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -88.37 -32.57 18.31 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.1 -22.61 15.13 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -102.53 136.97 19.26 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.37 123.86 13.95 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.063 2.509 . . . . 0.0 112.571 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.0 t -98.63 115.98 40.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.76 23.65 45.31 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.445 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -103.41 -159.33 25.01 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 121.453 -0.403 . . . . 0.0 112.315 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -133.31 135.68 44.99 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 27.2 m -133.41 172.56 16.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 t -155.64 154.47 31.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -71.52 119.84 16.25 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -73.07 137.45 45.29 Favored 'General case' 0 N--CA 1.424 -1.738 0 O-C-N 123.719 0.637 . . . . 0.0 109.671 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -85.02 73.9 10.6 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.568 0.699 . . . . 0.0 112.322 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -90.88 -22.38 20.96 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 172.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -147.24 98.59 3.99 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 112.839 -1.982 . . . . 0.0 105.781 170.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.58 -27.59 6.09 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.519 2.146 . . . . 0.0 114.827 -173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.92 86.4 7.32 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -171.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -153.99 -176.24 5.76 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 125.041 1.337 . . . . 0.0 108.344 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -98.68 -159.37 0.74 Allowed 'General case' 0 C--O 1.262 1.716 0 CA-C-O 121.361 0.6 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.39 -167.59 1.88 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 125.614 1.566 . . . . 0.0 112.42 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.79 147.39 25.18 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.573 0.749 . . . . 0.0 111.76 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.87 -171.52 1.86 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.17 0.988 . . . . 0.0 109.416 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -54.04 -46.09 71.79 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.546 0.688 . . . . 0.0 110.517 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.0 131.14 53.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 48.0 tp60 -111.44 116.21 50.99 Favored Pre-proline 0 N--CA 1.415 -2.225 0 CA-C-O 121.053 0.454 . . . . 0.0 109.96 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.12 164.91 21.92 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.82 2.347 . . . . 0.0 112.413 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -157.36 173.61 16.67 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.417 HG22 HH21 ' A' ' 181' ' ' ARG . 16.0 mt -90.37 3.02 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 CA-C-O 121.608 0.718 . . . . 0.0 110.33 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.47 ' HG3' ' OD1' ' A' ' 47' ' ' ASP . 4.1 mpp? -104.98 -175.7 2.87 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.88 -0.513 . . . . 0.0 110.321 -176.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 22.6 t -92.58 16.41 12.12 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 120.989 0.423 . . . . 0.0 112.065 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -115.67 151.1 35.67 Favored 'General case' 0 C--O 1.205 -1.238 0 O-C-N 121.082 -1.012 . . . . 0.0 109.321 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.9 139.86 50.13 Favored 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 119.009 -1.077 . . . . 0.0 110.803 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 55.1 tp -109.1 126.39 53.14 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG21 HD12 ' A' ' 129' ' ' LEU . 47.6 t -126.38 140.97 47.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.6 p -73.4 162.49 29.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.515 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.09 -31.92 82.39 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.339 -0.458 . . . . 0.0 112.211 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -72.34 -36.12 68.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.794 0.331 . . . . 0.0 110.753 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.26 -27.62 56.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -60.26 -39.32 86.37 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.112 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.7 mmtp -60.09 -44.18 94.99 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.15 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.63 -51.7 68.81 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.745 0.653 . . . . 0.0 110.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.93 -44.07 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.031 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -73.98 -20.35 60.37 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.8 t -72.06 -32.08 66.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -85.92 -2.07 57.91 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.396 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.69 47.86 82.65 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.555 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -75.24 110.06 9.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -75.84 151.79 37.39 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.188 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 79.58 12.77 1.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.231 1.413 . . . . 0.0 111.972 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 9.8 tp10 -106.76 129.82 54.57 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -113.27 126.14 55.07 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.2 mt -110.51 99.75 42.28 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.33 125.47 6.38 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.501 2.134 . . . . 0.0 112.93 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 64' ' ' GLY . 12.6 m -143.07 170.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -104.93 116.84 32.65 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.1 mp -103.99 133.55 47.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.424 -175.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.641 ' HE3' ' N ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -97.34 144.36 27.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -85.53 -163.8 0.91 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.107 0.48 . . . . 0.0 111.515 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -67.16 -29.64 69.4 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.235 0.614 . . . . 0.0 110.503 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -87.56 -5.49 58.74 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.442 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.65 18.86 64.97 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 114.402 0.521 . . . . 0.0 114.402 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -105.27 152.67 22.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 117.417 0.609 . . . . 0.0 110.008 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.12 85.71 2.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.405 0.621 . . . . 0.0 109.894 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.412 ' C ' ' HD3' ' A' ' 124' ' ' PRO . 11.6 m -110.13 6.67 8.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.497 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -125.37 59.17 0.65 Allowed Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.679 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 10.6 Cg_endo -85.26 -19.68 3.63 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.41 2.073 . . . . 0.0 113.152 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.0 6.8 21.26 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.017 0.527 . . . . 0.0 110.688 -176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.497 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 1.5 m-85 -88.29 145.28 25.94 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.221 0.534 . . . . 0.0 110.158 -175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -134.38 144.29 48.12 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.408 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.99 128.27 34.32 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.425 HD12 HG21 ' A' ' 91' ' ' VAL . 1.3 tt -97.68 126.93 43.28 Favored 'General case' 0 C--O 1.268 2.06 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 25.7 m-80 -111.13 127.22 55.5 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.757 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.96 122.6 38.95 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.85 174.42 5.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 124.148 0.905 . . . . 0.0 109.478 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.39 26.19 28.65 Favored Glycine 0 CA--C 1.488 -1.631 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -112.65 144.99 41.22 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.037 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.88 170.14 18.3 Favored 'General case' 0 C--N 1.263 -3.169 0 N-CA-C 102.402 -3.184 . . . . 0.0 102.402 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.57 107.99 0.23 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 119.908 1.231 . . . . 0.0 111.995 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -80.48 -71.19 0.47 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 113.034 -1.894 . . . . 0.0 115.686 -163.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.3 mt -62.21 124.67 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 O-C-N 123.804 0.69 . . . . 0.0 111.669 -170.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 141' ' ' GLU . 11.8 t70 -82.67 128.16 34.09 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.62 -22.91 32.08 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.437 ' HG2' ' OD2' ' A' ' 139' ' ' ASP . 11.1 pt-20 -95.37 -27.29 15.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 118.421 0.555 . . . . 0.0 111.157 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -86.81 -5.76 59.01 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.488 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 17.2 m -121.12 168.45 11.54 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -137.2 106.78 6.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -159.67 164.4 34.05 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.649 0.261 . . . . 0.0 111.148 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.89 129.75 51.49 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 62.2 mtt -92.26 107.63 19.35 Favored 'General case' 0 C--O 1.201 -1.455 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.202 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 165.45 70.94 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 126.026 1.73 . . . . 0.0 111.028 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.6 p -100.93 -56.47 2.31 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.345 -0.942 . . . . 0.0 108.848 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.9 mt -110.14 -31.84 7.21 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.553 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -169.79 -174.84 1.94 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 147' ' ' MET . 39.4 ttpt -63.02 -43.71 97.96 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.821 0.737 . . . . 0.0 112.852 -175.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -81.26 26.01 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.152 0.977 . . . . 0.0 112.358 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -139.12 114.25 9.52 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.3 mt -85.03 144.08 10.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.12 -77.6 0.77 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -78.79 118.85 21.24 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 39.8 mt -126.34 116.15 44.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -100.79 -39.03 8.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.309 0.576 . . . . 0.0 109.769 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.18 128.88 24.67 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.72 111.18 17.28 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 147.18 24.11 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.2 mt -64.75 129.45 39.84 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.189 0.931 . . . . 0.0 110.585 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.421 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.0 p-10 -84.68 11.6 8.68 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 124.413 1.085 . . . . 0.0 110.775 -177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 39.0 p -71.69 -4.94 30.27 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.139 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -73.76 -34.7 64.83 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.498 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -103.65 -33.62 8.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.719 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.8 mt -91.47 153.52 3.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.0 124.33 73.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 118.074 0.397 . . . . 0.0 111.037 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.43 -5.34 15.75 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.6 2.867 . . . . 0.0 113.908 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.68 -0.28 51.8 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.93 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.25 120.71 14.25 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.107 0.479 . . . . 0.0 110.457 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -73.99 -28.64 61.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.03 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.421 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.4 ttt -147.68 125.66 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -152.56 175.55 12.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 51' ' ' HIS . 0.2 OUTLIER -152.07 162.23 41.42 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.3 m -84.37 160.69 20.6 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.3 p -82.24 -49.29 10.25 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 124.134 0.974 . . . . 0.0 112.773 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.75 4.68 31.66 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.31 138.08 47.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 87' ' ' SER . 11.4 mtm180 -90.14 -30.16 17.82 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.818 -176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -98.0 -28.07 13.95 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.031 -172.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.2 tp -71.05 100.63 2.05 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-O 122.133 0.968 . . . . 0.0 112.76 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.23 132.87 64.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.4 mt -116.94 122.25 43.74 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.604 0.716 . . . . 0.0 111.07 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 191' ' ' HIS . 34.2 pt -112.08 151.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -85.08 159.99 20.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.439 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 11.3 pt-20 -54.44 -39.77 67.72 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -73.13 -27.89 61.94 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.105 0.562 . . . . 0.0 111.454 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.47 -47.42 72.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.631 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.7 p80 -71.21 -26.05 62.77 Favored 'General case' 0 C--O 1.196 -1.748 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.742 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.91 71.24 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.492 0.495 . . . . 0.0 110.7 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.55 -39.25 74.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.194 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -69.99 -32.41 70.6 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 65.6 mm-40 -58.25 -53.5 57.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.679 0.791 . . . . 0.0 109.678 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -74.52 -23.5 58.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.785 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.75 60.9 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.261 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.12 47.85 10.56 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.962 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.9 mt -80.32 161.78 24.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.6 p -38.8 -79.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -171.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.87 128.81 1.53 Allowed Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 119.4 -1.381 . . . . 0.0 112.91 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -136.17 150.85 49.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 30' ' ' MET . 53.7 mtmt -106.99 128.45 54.36 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 15.6 m -118.84 129.24 75.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 123.797 0.686 . . . . 0.0 109.994 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.2 m-85 -118.44 154.52 32.32 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -72.17 116.06 12.15 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.98 -36.98 67.2 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.428 0.455 . . . . 0.0 111.646 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.28 102.07 1.02 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.18 60.32 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 112.657 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -57.45 100.62 0.05 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.974 1.31 . . . . 0.0 111.888 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.0 133.96 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -26.56 0.29 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 118.809 2.283 . . . . 0.0 118.809 167.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.47 134.12 45.17 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 118.313 1.057 . . . . 0.0 112.141 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -86.81 131.57 34.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.2 pt? . . . . . 0 C--N 1.299 -1.589 0 O-C-N 123.336 0.398 . . . . 0.0 110.563 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 CA--C 1.508 -0.664 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.38 175.25 45.59 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.351 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -86.09 28.57 0.8 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 123.7 0.8 . . . . 0.0 112.823 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -63.19 -42.51 99.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -85.47 97.15 9.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 168.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -68.18 -36.11 79.08 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.728 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -146.15 99.41 3.24 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -149.84 -70.27 0.19 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -141.63 65.08 1.39 Allowed 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 167.36 125.38 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 t 63.94 36.83 9.84 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -70.63 -19.65 62.8 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.816 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.57 -102.14 1.03 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.55 35.71 20.06 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 123.858 0.863 . . . . 0.0 110.029 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -52.15 -45.51 93.86 Favored Pre-proline 0 CA--C 1.555 1.161 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -64.19 97.57 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 120.894 1.355 . . . . 0.0 110.868 172.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -99.59 -20.68 16.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.86 -137.78 48.34 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.837 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 m -103.23 118.82 37.65 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -80.33 88.44 5.55 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.667 0.746 . . . . 0.0 109.394 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -110.89 165.22 12.03 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.288 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.84 109.92 14.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 122.301 1.048 . . . . 0.0 112.883 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.71 157.53 26.33 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.172 -1.831 . . . . 0.0 108.059 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -107.58 137.77 45.01 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.673 0.749 . . . . 0.0 113.002 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -126.66 151.15 48.45 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.788 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -84.2 126.46 40.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -98.8 129.44 45.2 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.131 0.491 . . . . 0.0 112.323 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 203' ' ' LYS . 81.7 tttt -150.5 163.95 37.15 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.448 ' N ' ' HG2' ' A' ' 28' ' ' LYS . 48.2 t -103.77 131.63 51.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.465 ' HB3' ' HB2' ' A' ' 203' ' ' LYS . 14.1 ptp -91.01 97.29 11.09 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 167.82 134.88 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 125.099 1.36 . . . . 0.0 109.467 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -87.17 -17.83 31.8 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 9.6 mm-40 -88.75 0.2 56.71 Favored 'General case' 0 C--O 1.199 -1.604 0 C-N-CA 125.341 1.456 . . . . 0.0 111.851 177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -69.9 -12.53 61.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.383 -0.823 . . . . 0.0 112.779 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.84 93.28 1.18 Allowed Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.832 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -89.27 145.46 25.37 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.1 mt -78.16 101.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -61.64 -41.22 97.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.177 0.923 . . . . 0.0 112.001 -169.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -141.79 170.56 15.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.5 mp -52.88 123.51 32.65 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 125.108 1.363 . . . . 0.0 113.457 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -72.41 166.54 29.49 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.539 2.16 . . . . 0.0 111.776 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.77 115.83 1.84 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.57 6.59 58.39 Favored Glycine 0 C--O 1.225 -0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.653 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 33.4 m -85.95 140.98 35.2 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 44' ' ' SER . 1.5 Cg_endo -76.28 166.27 27.93 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.36 2.706 . . . . 0.0 110.158 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -49.49 151.73 1.52 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -40.66 -53.44 2.77 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 127.281 2.232 . . . . 0.0 114.521 -173.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -83.25 -29.18 28.65 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.743 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -81.09 -12.06 59.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.062 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 16.0 m-85 -43.89 -49.03 8.49 Favored 'General case' 0 C--O 1.199 -1.569 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.511 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 42.6 m80 -129.38 27.21 5.33 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.247 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.99 102.04 14.38 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.84 -9.93 35.04 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.01 161.76 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.986 1.393 . . . . 0.0 112.032 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 t -98.68 159.5 14.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -108.08 12.94 26.41 Favored 'General case' 0 C--O 1.206 -1.184 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -172.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.78 75.33 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 121.953 0.882 . . . . 0.0 111.17 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -89.52 -27.92 19.97 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.171 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.68 -22.23 19.54 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -114.21 144.74 32.25 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 123.16 12.26 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.774 2.316 . . . . 0.0 112.95 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -97.88 116.27 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.5 23.34 58.58 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.829 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -98.43 -160.22 30.1 Favored Glycine 0 C--O 1.245 0.814 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.814 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 46.6 mt-10 -127.48 130.08 48.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 122.462 0.305 . . . . 0.0 110.184 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.3 m -132.75 166.69 28.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.429 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 23.5 t -143.1 149.36 38.04 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.85 114.69 8.27 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.7 p -65.68 132.65 49.3 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -85.83 58.12 4.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.22 0.533 . . . . 0.0 112.388 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -76.39 -28.82 56.88 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.003 0.906 . . . . 0.0 108.677 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -114.44 106.27 52.76 Favored Pre-proline 0 N--CA 1.417 -2.113 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -48.26 -69.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 124.045 3.164 . . . . 0.0 115.513 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -94.81 103.05 14.94 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 119.231 -0.988 . . . . 0.0 112.4 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 29.9 t-20 -139.43 155.33 47.67 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 5.9 mmp_? -78.96 -165.48 0.75 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 122.031 0.92 . . . . 0.0 113.369 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.405 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.3 p-10 -93.7 -162.91 0.98 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 125.796 1.639 . . . . 0.0 110.372 -175.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.1 mp -91.73 135.98 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.727 0.298 . . . . 0.0 111.703 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 1.4 m-30 -99.36 -105.49 0.21 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.708 0.403 . . . . 0.0 110.542 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -117.0 -47.67 2.68 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -121.31 129.54 53.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 124.996 1.318 . . . . 0.0 107.616 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 15.8 mm100 -105.88 116.35 59.89 Favored Pre-proline 0 C--N 1.295 -1.786 0 O-C-N 123.436 0.46 . . . . 0.0 112.053 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.19 168.11 13.55 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 122.79 2.327 . . . . 0.0 111.36 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -163.66 -178.55 5.84 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.51 -13.47 9.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.19 178.45 5.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.209 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.449 ' OG ' ' HG3' ' A' ' 181' ' ' ARG . 3.7 m -90.48 46.67 1.36 Allowed 'General case' 0 C--O 1.251 1.182 0 CA-C-O 121.22 0.533 . . . . 0.0 110.41 -176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -136.73 145.26 44.44 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.7 tp -122.79 141.37 51.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.262 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 56.6 tp -113.7 125.91 54.65 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 129' ' ' LEU . 50.1 t -126.63 142.41 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -175.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -72.99 164.1 27.18 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -71.68 -18.51 77.35 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -65.1 -58.3 6.39 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.14 60.39 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.049 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 47.7 ttt180 -57.25 -47.9 80.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.927 174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 1.2 mmmp? -61.88 -38.74 89.42 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.769 0.668 . . . . 0.0 109.859 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.28 -53.53 56.2 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.601 0.563 . . . . 0.0 110.746 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.4 mt -60.03 -41.85 87.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 C-N-CA 123.716 0.806 . . . . 0.0 111.506 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 49.4 mt-10 -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.0 m -64.32 -30.58 71.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.145 0.497 . . . . 0.0 111.599 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.467 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.8 mp -84.44 -10.1 57.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.985 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.05 43.03 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.455 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.5 t -77.73 100.62 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 m -76.95 156.35 32.05 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.842 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 80.81 13.84 0.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.652 1.581 . . . . 0.0 110.838 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.59 122.69 47.19 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.021 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -115.81 144.68 43.66 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -114.66 122.25 45.88 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.173 0.589 . . . . 0.0 110.466 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.491 ' HG ' HD21 ' A' ' 130' ' ' ASN . 78.6 mt -115.27 98.81 51.39 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.88 138.71 13.34 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.421 2.081 . . . . 0.0 113.185 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 64' ' ' GLY . 6.9 m -145.89 173.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.496 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.49 116.91 33.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 173.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 23.0 mt -111.34 134.19 54.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.315 0.579 . . . . 0.0 112.248 -171.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.2 mptp? -98.11 148.38 23.6 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 5.9 p-10 -92.91 -160.49 0.76 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 71.8 m80 -71.84 -18.96 62.04 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.944 0.498 . . . . 0.0 111.554 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -89.8 -19.41 24.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.68 13.17 51.63 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.242 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.3 ptmt -98.32 138.61 35.32 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.86 91.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.148 0.499 . . . . 0.0 109.758 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.439 HG23 HD13 ' A' ' 78' ' ' LEU . 11.9 m -115.98 12.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.012 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.419 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -123.91 65.42 0.53 Allowed Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.523 173.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 122' ' ' VAL . 8.3 Cg_endo -85.37 -23.58 2.26 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.494 2.129 . . . . 0.0 113.224 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.55 4.08 21.84 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.441 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.419 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 6.9 m-85 -84.74 140.8 31.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.554 0.692 . . . . 0.0 110.972 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -129.85 141.44 50.82 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.928 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -79.8 127.26 32.0 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 91' ' ' VAL . 4.4 tt -93.41 124.79 37.64 Favored 'General case' 0 C--O 1.282 2.81 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.511 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 36.7 m-80 -104.58 128.84 52.69 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.106 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.08 114.37 27.66 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 172.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.4 169.63 9.93 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.133 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.09 22.52 78.79 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.915 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.7 131.67 34.39 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.21 169.26 18.56 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -58.15 105.71 0.3 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -127.52 -33.68 2.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -168.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.48 ' HA ' ' HB3' ' A' ' 164' ' ' ASP . 24.3 mt -59.36 119.08 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.289 0.566 . . . . 0.0 112.037 -173.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.58 128.15 35.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.423 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 64.1 mtp -109.66 -25.64 10.3 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.033 0.444 . . . . 0.0 110.931 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -89.51 -29.67 18.79 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.868 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -96.17 -11.59 25.93 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.917 0.389 . . . . 0.0 110.522 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.4 m -104.56 149.74 25.23 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -114.34 104.83 12.45 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.423 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 4.3 p90 -154.19 150.95 28.64 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.399 0.619 . . . . 0.0 112.364 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 51.7 mm-40 -108.92 139.66 43.47 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.234 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 90.7 mtp -100.84 155.23 18.05 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.161 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.562 ' HA ' ' O ' ' A' ' 151' ' ' GLU . 16.7 t70 85.85 78.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.916 1.686 . . . . 0.0 113.766 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.601 ' OG ' ' HA3' ' A' ' 156' ' ' GLY . 49.9 m -103.19 -57.21 2.08 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.174 166.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.7 mt -94.02 -45.21 7.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 2.3 pp20? -147.01 171.78 14.73 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.567 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -54.75 -44.98 74.09 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.458 1.103 . . . . 0.0 113.548 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.554 ' HB3' HH12 ' A' ' 181' ' ' ARG . 7.0 t70 -92.38 15.1 14.66 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.011 0.91 . . . . 0.0 110.496 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 151' ' ' GLU . 9.8 mm-40 -102.38 119.37 38.7 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 124.121 0.969 . . . . 0.0 110.308 175.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 50.7 mt -85.21 129.35 37.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.601 ' HA3' ' OG ' ' A' ' 149' ' ' SER . . . -115.52 -65.05 0.39 Allowed Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.5 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 6.4 t30 -84.86 119.08 24.93 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 52.2 mt -128.12 127.28 67.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.47 -29.37 8.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.919 0.39 . . . . 0.0 110.55 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.08 130.08 16.33 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.07 118.9 24.3 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.76 139.59 38.14 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.5 mt -57.77 145.42 34.84 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 138' ' ' ILE . 15.1 p-10 -94.61 15.1 18.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.683 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.55 -5.21 18.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.596 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -61.4 -35.72 78.3 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.212 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.79 -31.82 6.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.252 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 137' ' ' ALA . 78.3 mt -90.02 154.13 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -50.15 122.92 15.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 123.91 0.884 . . . . 0.0 112.708 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.4 -6.0 17.27 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.025 1.816 . . . . 0.0 110.512 174.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.493 ' HA ' ' NH2' ' A' ' 187' ' ' ARG . 5.8 p-10 -99.67 6.3 45.65 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.092 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -85.62 132.03 34.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.466 ' HG2' ' HD2' ' A' ' 187' ' ' ARG . 76.7 mttt -84.93 -16.51 40.79 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.138 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 185' ' ' LEU . 26.4 ttt -159.77 127.72 4.82 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.37 164.3 38.39 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.61 142.43 34.67 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.512 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 38.6 m -93.01 120.47 33.34 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -53.45 -46.46 69.89 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.476 ' HB2' HD12 ' A' ' 138' ' ' ILE . 41.2 mttp -79.2 24.32 0.34 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' A' ' 182' ' ' ARG . 1.4 tm-20 -148.21 158.33 44.02 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.554 HH12 ' HB3' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -91.27 -51.54 5.25 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.762 174.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.433 ' HD3' ' OE2' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -92.54 -13.41 29.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.239 -167.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.512 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 37.3 tp -77.78 101.16 6.58 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 122.017 0.913 . . . . 0.0 111.841 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 78.5 mt -120.87 121.36 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 174' ' ' MET . 66.7 mt -97.15 133.59 41.59 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 120.933 0.397 . . . . 0.0 110.66 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.449 HG22 ' HG3' ' A' ' 174' ' ' MET . 42.7 pt -120.97 158.02 23.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.282 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.493 ' NH2' ' HA ' ' A' ' 171' ' ' ASP . 93.7 mtt180 -83.14 162.53 21.27 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.789 0.804 . . . . 0.0 111.068 173.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -55.56 -47.4 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.268 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.16 -26.94 69.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.115 0.259 . . . . 0.0 111.484 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.467 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 61.9 t -65.21 -54.35 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.743 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -74.89 -26.43 59.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.232 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.35 -34.14 77.62 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.446 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.19 -37.34 78.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.231 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -69.65 -38.06 76.97 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.823 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -65.12 -40.79 95.0 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.661 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -77.04 -25.64 52.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.419 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.41 -27.49 46.7 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 121.176 0.513 . . . . 0.0 109.912 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.54 47.5 4.84 Favored Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.066 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.99 165.32 19.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.98 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -170.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -161.07 125.26 1.42 Allowed Glycine 0 CA--C 1.487 -1.673 0 C-N-CA 119.361 -1.399 . . . . 0.0 112.347 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -120.66 145.34 47.54 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 30' ' ' MET . 50.2 tptt -105.18 121.37 43.68 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.88 129.72 71.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.342 0.591 . . . . 0.0 111.185 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -111.29 141.18 45.16 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -64.04 106.17 1.0 Allowed 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.82 74.47 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.163 0.506 . . . . 0.0 111.451 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -77.35 89.25 3.76 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.317 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 94.6 35.13 6.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.438 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.413 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 16.1 t90 -63.82 99.16 0.22 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.668 0.747 . . . . 0.0 111.802 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.16 130.5 51.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.36 -26.51 0.27 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 165.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.413 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 86.4 mt -76.26 141.3 41.74 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 118.384 1.092 . . . . 0.0 111.451 -175.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.23 130.32 38.97 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.673 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HB2' ' CH2' ' A' ' 210' ' ' TRP . 36.7 tp . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.04 -148.85 20.54 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -91.73 16.23 11.15 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.867 0.841 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 124.654 1.182 . . . . 0.0 112.449 -176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -76.07 39.9 0.19 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -103.67 117.64 34.85 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . 0.282 33.2 m170 -96.61 72.31 2.68 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -164.59 146.23 8.26 Favored 'General case' 0 CA--C 1.488 -1.436 0 C-N-CA 127.716 2.407 . . . . 0.0 105.625 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -138.54 133.97 33.28 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -81.75 82.46 7.44 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t 74.13 -56.35 0.64 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.178 1.791 . . . . 0.0 112.562 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.252 54.8 p 58.76 97.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 -173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.66 125.51 39.43 Favored Glycine 0 C--O 1.249 1.04 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.507 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.0 mt -104.12 151.59 23.11 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t -126.14 93.43 43.56 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -88.49 -20.77 1.6 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 122.479 2.12 . . . . 0.0 111.327 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -117.36 119.39 34.96 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.166 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.21 -107.94 0.37 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.1 m -127.2 20.07 6.89 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -131.55 119.93 22.19 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.282 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 88.4 mtp -113.21 160.91 17.78 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 174.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.8 t -90.3 115.4 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -118.22 145.26 45.12 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.203 0.525 . . . . 0.0 110.341 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -114.2 132.63 56.04 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.647 -172.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 78.8 m-85 -116.62 141.63 47.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.585 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 17.2 t -78.32 121.79 31.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -96.24 129.86 43.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -173.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -150.47 153.92 36.76 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.8 t -87.82 145.61 7.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.1 ttm -84.55 140.98 31.04 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.187 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 88.91 128.48 0.03 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.742 2.017 . . . . 0.0 112.472 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 33.0 tt0 -73.21 -26.38 61.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.938 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 -0.25 43.82 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.069 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -77.05 11.64 1.73 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.17 65.88 0.95 Allowed Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.352 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 10.4 m-85 -79.79 142.01 35.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.032 0.444 . . . . 0.0 110.415 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.431 HD12 HD22 ' A' ' 84' ' ' ASN . 23.0 mt -89.41 104.66 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 170.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 40.7 mm-40 -61.85 -57.23 12.61 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.083 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -117.49 176.47 5.15 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.04 132.17 88.55 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.15 166.49 29.44 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.271 1.981 . . . . 0.0 112.124 174.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -52.46 124.71 14.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.86 1.264 . . . . 0.0 112.476 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.39 13.44 81.75 Favored Glycine 0 CA--C 1.516 0.133 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.093 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 50.8 m -85.83 139.46 35.15 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.71 165.77 24.47 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.295 2.663 . . . . 0.0 110.878 171.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 p -54.17 150.59 8.13 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.55 ' HB3' ' NH1' ' A' ' 181' ' ' ARG . 3.8 m-20 -41.34 -59.18 1.63 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.707 2.003 . . . . 0.0 114.786 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -79.11 -30.53 43.82 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 120.853 0.359 . . . . 0.0 111.705 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HD3' ' HB3' ' A' ' 52' ' ' GLU . 17.8 tppt? -79.01 -11.93 60.02 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.637 -173.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' O ' HD11 ' A' ' 56' ' ' LEU . 8.5 m-85 -44.72 -44.54 9.27 Favored 'General case' 0 C--O 1.194 -1.84 0 C-N-CA 123.517 0.727 . . . . 0.0 112.205 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.44 ' CG ' ' HD2' ' A' ' 176' ' ' ARG . 65.5 m80 -129.4 21.57 5.62 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.48 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 49' ' ' LYS . 1.8 tm-20 -91.91 101.32 13.89 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.29 -5.83 4.83 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.38 164.32 21.23 Favored 'Isoleucine or valine' 0 C--O 1.248 1.005 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.3 t -97.97 142.86 29.18 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' ' 50' ' ' PHE . 4.4 mp -99.28 -4.94 30.7 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.639 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.12 -21.59 66.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.116 0.484 . . . . 0.0 111.822 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.31 -21.13 24.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -116.86 -22.98 8.27 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -94.35 139.13 22.32 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.06 123.22 11.83 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.558 2.172 . . . . 0.0 112.812 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 HD22 ' A' ' 110' ' ' LEU . 30.1 t -100.07 107.55 21.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.77 23.56 30.24 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.434 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -96.85 -157.75 31.17 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.813 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.75 132.75 46.67 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.12 170.68 19.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.1 m -145.39 152.56 40.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.847 -0.533 . . . . 0.0 111.264 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -77.24 107.4 9.61 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -58.79 130.12 45.38 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.231 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -86.6 70.26 10.41 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 25.0 t-20 -79.6 -38.11 34.69 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -119.44 90.77 43.18 Favored Pre-proline 0 N--CA 1.425 -1.708 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -65.11 -20.07 63.21 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.225 2.617 . . . . 0.0 114.111 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -87.33 9.67 19.73 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 13.3 t-20 -74.52 139.15 43.61 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -77.28 -165.46 0.59 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.687 0.755 . . . . 0.0 112.839 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.6 -165.28 1.13 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.238 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 122' ' ' VAL . 8.1 mp -90.48 150.37 21.83 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.767 0.794 . . . . 0.0 113.114 -173.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 29.4 m-85 -121.85 -149.24 0.42 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 126.741 2.017 . . . . 0.0 106.977 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -81.14 -31.91 33.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.878 0.763 . . . . 0.0 110.929 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.433 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 59.0 m-85 -134.97 148.19 49.93 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 11.0 mm100 -121.82 120.98 28.33 Favored Pre-proline 0 C--O 1.245 0.859 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.507 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 93.5 Cg_endo -87.1 170.62 7.01 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.26 1.973 . . . . 0.0 110.474 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.431 HD22 HD12 ' A' ' 37' ' ' ILE . 33.8 p30 -155.9 179.19 9.45 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.993 -0.442 . . . . 0.0 110.984 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 64.5 mt -86.97 -22.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -86.25 -92.3 0.09 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -174.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -168.68 -40.66 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -67.43 117.1 8.95 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 120.956 0.408 . . . . 0.0 112.035 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.2 tp -87.43 133.75 33.69 Favored 'General case' 0 C--O 1.204 -1.323 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.462 -172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 40.9 tp -105.33 121.32 43.63 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.768 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.33 137.07 56.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.947 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 p -76.49 172.73 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 122.433 0.293 . . . . 0.0 110.904 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.37 -20.48 79.33 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -65.59 -58.29 6.11 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.22 -28.93 64.56 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.685 -1.598 . . . . 0.0 111.562 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 100' ' ' GLU . 54.6 ttt180 -57.9 -43.69 86.31 Favored 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.356 0.41 . . . . 0.0 110.108 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -67.26 -28.32 67.94 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.82 -54.02 22.31 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.39 -46.26 92.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.166 0 C-N-CA 123.744 0.818 . . . . 0.0 112.039 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 96' ' ' ARG . 50.2 mt-10 -62.07 -31.84 72.31 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.423 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.5 m -78.33 -11.27 59.93 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.24 -13.94 51.27 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.679 169.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.78 33.89 26.17 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.72 101.21 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.989 0.899 . . . . 0.0 109.853 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 21.0 m -86.76 150.3 24.26 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 80.51 10.05 1.15 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.606 1.162 . . . . 0.0 111.348 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.05 26.18 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.661 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.4 tp10 -94.62 144.83 25.27 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -125.88 108.66 11.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.413 HD22 HG22 ' A' ' 62' ' ' VAL . 72.3 mt -109.32 95.63 19.21 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.35 140.83 12.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.775 2.317 . . . . 0.0 113.37 -176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.451 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.5 m -147.62 169.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.961 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.95 116.82 29.4 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.1 mt -113.97 128.45 70.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 120.241 -0.583 . . . . 0.0 112.184 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.37 146.1 24.63 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 8.8 p-10 -84.83 -160.51 0.49 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 122.48 0.312 . . . . 0.0 110.436 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.501 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 56.8 m80 -73.69 -19.55 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.562 0.345 . . . . 0.0 110.452 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -93.19 -20.06 20.83 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.068 0.461 . . . . 0.0 110.22 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.04 22.1 12.57 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.12 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.424 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 61.0 pttt -105.15 146.82 28.69 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.92 89.94 2.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 121.638 0.732 . . . . 0.0 110.146 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 78' ' ' LEU . 6.3 m -114.12 10.16 7.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.088 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.36 42.35 1.37 Allowed Glycine 0 CA--C 1.549 2.159 0 C-N-CA 119.304 -1.426 . . . . 0.0 116.496 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.0 -1.69 9.99 Favored 'Trans proline' 0 C--N 1.376 1.981 0 CA-C-N 122.049 2.924 . . . . 0.0 112.107 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.9 -7.31 37.09 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 125.139 1.375 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -98.92 144.04 28.55 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.374 -171.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.92 143.51 50.18 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.299 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.7 119.85 24.36 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 3.9 tt -91.85 125.01 36.4 Favored 'General case' 0 C--O 1.281 2.737 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.255 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.404 ' OD1' HD13 ' A' ' 56' ' ' LEU . 26.9 m-80 -123.83 141.64 51.85 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.785 -1.552 . . . . 0.0 107.393 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.401 HD23 ' HE ' ' A' ' 176' ' ' ARG . 3.3 mm? -103.29 132.94 49.15 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.479 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.45 170.47 8.38 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.63 16.96 67.07 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.25 132.11 43.32 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.45 169.09 18.62 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.41 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 10.9 t70 -73.01 108.59 5.99 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.155 -174.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -132.18 -12.83 3.17 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -167.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 177' ' ' CYS . 23.2 mt -65.5 120.04 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.37 115.0 6.52 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.0 ttt -95.37 -7.79 37.51 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.378 0.609 . . . . 0.0 110.169 -172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.33 -49.81 6.15 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.182 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -87.08 -16.25 36.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.167 -176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.0 m -95.96 104.7 16.65 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.768 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.428 ' H ' ' HB3' ' A' ' 160' ' ' ALA . 11.6 mm-40 -71.41 103.7 2.99 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.949 176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.85 161.6 42.4 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.816 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.97 129.79 51.51 Favored 'General case' 0 N--CA 1.402 -2.854 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.795 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 56.0 mtt -92.66 108.21 19.8 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -151.51 -25.27 0.2 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -167.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 53.6 m -70.59 -56.38 6.64 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 116.746 2.128 . . . . 0.0 116.746 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.16 -35.52 4.67 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.677 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -164.18 -174.39 3.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 147' ' ' MET . 10.2 tmtt? -65.04 -33.64 76.52 Favored 'General case' 0 C--O 1.196 -1.737 0 O-C-N 123.84 0.713 . . . . 0.0 111.022 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -93.26 23.72 4.27 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.331 0.586 . . . . 0.0 111.904 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.453 ' HA ' ' NE2' ' A' ' 154' ' ' GLN . 17.1 mm-40 -125.62 114.28 18.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.452 0.644 . . . . 0.0 111.197 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 56.9 mt -84.86 134.13 27.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.856 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -110.34 -70.88 0.64 Allowed Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -84.22 127.4 33.92 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.81 127.65 66.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -112.87 -24.16 9.71 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.1 0.476 . . . . 0.0 110.905 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.428 ' HB3' ' H ' ' A' ' 144' ' ' GLU . . . -151.54 136.22 17.1 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -131.25 108.27 9.56 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.35 138.0 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.1 mt -54.37 140.23 34.34 Favored 'General case' 0 C--O 1.253 1.251 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.563 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.1 p-10 -87.99 6.28 36.67 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.226 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -68.27 -6.14 22.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.878 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.0 m -61.03 -40.82 95.05 Favored 'General case' 0 N--CA 1.422 -1.874 0 C-N-CA 124.614 1.166 . . . . 0.0 110.046 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.53 -32.21 6.54 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.384 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.515 HG13 ' CB ' ' A' ' 137' ' ' ALA . 83.3 mt -82.94 147.24 6.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.406 ' HD2' ' OD2' ' A' ' 171' ' ' ASP . 9.3 mmt85 -54.03 118.13 14.8 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 122.908 0.483 . . . . 0.0 112.041 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 14.5 Cg_exo -70.64 -11.89 30.37 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.409 2.072 . . . . 0.0 111.653 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.406 ' OD2' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -88.97 0.47 56.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.475 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.04 127.65 33.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -76.34 -22.53 54.8 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.434 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.7 ttt -155.77 122.45 5.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -148.51 -179.23 6.81 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.44 ' HD2' ' CG ' ' A' ' 51' ' ' HIS . 12.2 ptp180 -151.43 164.73 36.1 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.49 ' HB3' HD11 ' A' ' 138' ' ' ILE . 61.6 m -86.5 152.32 22.75 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 124.206 0.941 . . . . 0.0 112.082 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' A' ' 136' ' ' ASP . 3.7 p -82.12 -50.77 8.68 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.411 ' HB2' HD12 ' A' ' 138' ' ' ILE . 48.9 mmtm -85.19 2.62 42.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -175.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.66 104.04 5.0 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 168.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.55 ' NH1' ' HB3' ' A' ' 47' ' ' ASP . 27.7 ptt180 -68.0 -27.12 66.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.004 -170.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.454 ' O ' HG13 ' A' ' 184' ' ' ILE . 17.9 mtm-85 -88.85 -33.55 17.32 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.064 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.475 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.9 tt -62.34 105.75 0.66 Allowed 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 124.448 1.099 . . . . 0.0 111.24 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 182' ' ' ARG . 67.1 mt -110.6 130.46 63.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 45.0 mt -107.78 121.86 45.59 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.397 0.618 . . . . 0.0 110.564 176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.5 pt -111.36 143.6 20.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.27 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -77.11 154.71 33.0 Favored 'General case' 0 C--O 1.259 1.57 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 2.8 pm0 -55.16 -39.4 69.45 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.474 0.71 . . . . 0.0 112.357 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -54.01 -43.42 70.06 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.463 1.505 . . . . 0.0 111.718 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.7 -48.32 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.435 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.572 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 20.7 p80 -72.21 -25.25 61.58 Favored 'General case' 0 C--O 1.196 -1.743 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.108 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.0 73.09 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.452 0.47 . . . . 0.0 110.526 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.19 -35.62 71.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.707 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 20.2 m-85 -68.6 -35.69 77.68 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.693 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 60.8 mm-40 -59.1 -51.54 69.6 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.812 0.695 . . . . 0.0 110.219 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.07 -16.51 59.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.071 -176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -80.85 -27.34 36.45 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 74.02 47.94 17.35 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.516 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.12 165.0 25.16 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.417 -0.113 . . . . 0.0 111.041 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.4 p -43.37 -77.03 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 116.917 2.191 . . . . 0.0 116.917 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -171.0 138.4 4.92 Favored Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.719 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.433 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 35.2 m-85 -136.36 153.46 51.12 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -112.86 122.02 46.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.97 129.32 68.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.214 0.53 . . . . 0.0 109.642 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 60.0 m-85 -114.1 137.39 51.8 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -68.75 109.53 3.88 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -77.04 -33.11 57.36 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 123.495 0.497 . . . . 0.0 112.088 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.41 92.52 1.08 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.296 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.52 35.05 14.71 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 16.3 t90 -67.51 101.03 0.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.923 0.889 . . . . 0.0 112.164 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -104.35 152.03 22.75 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.94 -25.67 0.3 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 166.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.437 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 86.4 mt -94.68 145.72 24.65 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 117.956 0.878 . . . . 0.0 112.659 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.4 132.85 52.72 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 215' ' ' LEU . 2.5 pt? . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.16 53.28 0.33 Allowed Glycine 0 C--N 1.301 -1.38 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.3 m -54.93 -41.58 71.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.819 1.248 . . . . 0.0 112.74 -175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.438 ' HA ' ' CE1' ' A' ' 7' ' ' HIS . 20.0 t -95.33 -20.2 19.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.484 -0.486 . . . . 0.0 109.916 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -64.71 -45.86 84.78 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.702 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -94.83 102.16 14.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.145 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 4' ' ' SER . 22.6 m170 -143.33 110.86 5.85 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.22 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -85.8 -29.15 24.02 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 170.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -167.73 -77.78 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.497 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -124.77 -79.52 0.61 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 p -78.94 -28.07 43.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.132 0.491 . . . . 0.0 110.19 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m 73.34 -45.94 0.63 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.223 1.809 . . . . 0.0 113.977 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.8 83.84 1.27 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.52 128.62 47.68 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.721 0.296 . . . . 0.0 110.262 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.78 116.11 65.55 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.37 28.02 0.59 Allowed 'Trans proline' 0 C--O 1.243 0.767 0 C-N-CA 122.95 2.433 . . . . 0.0 112.327 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 68.61 -70.12 0.14 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.913 1.685 . . . . 0.0 110.769 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.82 -156.17 27.85 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -131.31 130.41 42.71 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -122.68 95.91 4.82 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.241 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -84.17 157.91 21.5 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 187' ' ' ARG . 41.5 t -81.83 110.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' OE2' ' A' ' 208' ' ' GLU . 20.8 ptmt -79.44 156.06 28.04 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.2 0.524 . . . . 0.0 111.699 -175.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -109.68 141.29 42.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.738 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -124.22 146.0 49.0 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.022 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.79 117.82 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -105.7 123.11 47.4 Favored 'General case' 0 C--N 1.282 -2.358 0 O-C-N 123.638 0.586 . . . . 0.0 110.506 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -139.32 139.43 37.28 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.8 t -86.6 110.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.74 98.7 9.5 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 119.509 -0.876 . . . . 0.0 108.906 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.63 110.84 5.76 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -102.43 -35.12 8.9 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.919 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.24 -23.93 57.59 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.124 0.487 . . . . 0.0 110.462 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . . . -79.73 -28.06 40.55 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.71 156.06 22.02 Favored Glycine 0 N--CA 1.413 -2.892 0 CA-C-N 113.635 -1.621 . . . . 0.0 114.381 174.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 71.7 m-85 -87.1 156.13 19.84 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-N 113.822 -1.189 . . . . 0.0 108.119 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.448 HG12 ' CE2' ' A' ' 68' ' ' PHE . 22.4 mt -79.52 101.85 5.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -57.9 -45.16 86.86 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -131.82 176.19 8.55 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mp -71.62 119.58 74.87 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 124.004 0.815 . . . . 0.0 110.981 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -66.94 166.75 21.69 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.671 2.248 . . . . 0.0 111.946 177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -49.97 117.51 2.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.226 1.011 . . . . 0.0 113.697 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.18 13.36 66.21 Favored Glycine 0 C--O 1.206 -1.654 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.731 175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 40.4 m -86.44 137.49 34.42 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.81 166.67 26.89 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 124.062 3.174 . . . . 0.0 111.154 169.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 p -53.47 150.69 6.4 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -39.39 -57.21 1.44 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 128.25 2.62 . . . . 0.0 114.522 -174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -85.86 -21.02 28.25 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.703 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -79.1 -20.03 49.71 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.625 0.37 . . . . 0.0 111.926 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.518 ' HA ' HD21 ' A' ' 56' ' ' LEU . 57.9 m-85 -45.11 -33.24 2.1 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 4.5 m-70 -129.11 16.07 6.19 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 120.577 -1.327 . . . . 0.0 109.95 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 101.28 13.34 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 119.561 -0.855 . . . . 0.0 109.378 -173.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.55 -9.38 1.28 Allowed Glycine 0 CA--C 1.549 2.181 0 N-CA-C 118.066 1.986 . . . . 0.0 118.066 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.68 173.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.128 1.964 . . . . 0.0 112.152 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.2 t -97.45 150.01 21.52 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 50' ' ' PHE . 77.4 mt -86.25 -3.14 58.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.514 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.48 66.76 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -88.48 -20.52 25.05 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -114.62 -22.89 9.53 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -108.11 136.54 19.78 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.61 123.09 11.45 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.69 2.26 . . . . 0.0 112.183 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.02 116.78 34.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.64 21.39 58.11 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.334 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -99.2 -162.94 29.59 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.382 -177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -116.85 137.85 51.92 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.22 172.78 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -148.96 155.61 41.08 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.448 ' CE2' HG12 ' A' ' 37' ' ' ILE . 7.8 m-85 -75.02 104.83 5.75 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p -81.7 117.29 21.92 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -85.54 119.62 26.09 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.735 -175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -71.49 -37.94 71.22 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -177.05 -48.37 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.559 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.451 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.18 135.48 34.61 Favored 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.825 1.683 . . . . 0.0 112.249 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.52 149.26 40.91 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -154.51 -171.4 3.84 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.781 0.432 . . . . 0.0 111.35 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -81.13 -161.48 0.41 Allowed 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.95 0.9 . . . . 0.0 111.872 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.443 ' HB2' HG21 ' A' ' 122' ' ' VAL . 2.6 p-10 -81.95 -168.24 1.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.191 0.996 . . . . 0.0 112.615 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD13 HG23 ' A' ' 122' ' ' VAL . 5.2 mp -87.8 142.61 27.68 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.765 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 21.8 m-85 -107.76 -167.57 1.27 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.78 -42.85 89.96 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.37 138.18 53.88 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 16.2 mm100 -119.25 131.5 24.34 Favored Pre-proline 0 C--O 1.261 1.679 0 O-C-N 123.531 0.519 . . . . 0.0 110.471 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.67 177.68 2.15 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 123.141 2.561 . . . . 0.0 111.967 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 26.6 p30 -163.49 179.11 7.5 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.91 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.1 mm -91.93 3.22 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 CA-C-O 122.542 1.163 . . . . 0.0 108.701 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -109.98 -102.37 0.39 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.238 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 64.7 p -173.51 -14.81 0.01 OUTLIER 'General case' 0 C--O 1.24 0.557 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -69.63 116.75 10.39 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.44 132.02 34.61 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.101 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 34.3 tp -104.28 119.55 39.21 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.628 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.42 136.98 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.503 -173.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -71.38 172.04 10.13 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.276 0.63 . . . . 0.0 111.649 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 97' ' ' LYS . . . -68.03 -34.02 80.56 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -64.52 -55.56 19.8 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.509 0.723 . . . . 0.0 110.085 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.3 -28.51 69.37 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.464 -177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 58.7 ttt180 -58.39 -48.36 80.88 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.979 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 93' ' ' GLY . 7.6 mtpm? -62.18 -32.36 72.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.796 0.685 . . . . 0.0 112.047 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.84 -53.06 61.96 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.982 0.42 . . . . 0.0 110.349 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.44 -36.32 75.78 Favored 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.921 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 51.6 mt-10 -68.87 -38.66 79.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.124 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 45.3 m -70.53 -28.7 65.14 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.965 0.412 . . . . 0.0 111.764 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.35 -14.98 57.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.647 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.52 48.42 68.46 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.431 ' HA ' ' HD2' ' A' ' 173' ' ' LYS . 94.9 t -67.93 109.06 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.66 0.743 . . . . 0.0 111.421 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.7 m -64.33 136.64 57.34 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.595 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 75.67 7.87 3.78 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.118 1.367 . . . . 0.0 114.391 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -91.21 114.12 26.56 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 9.1 tp10 -103.39 146.58 28.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -114.15 120.94 42.24 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.607 0.567 . . . . 0.0 110.631 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 70.3 mt -118.62 97.28 50.68 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.51 140.78 17.23 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.872 2.381 . . . . 0.0 112.9 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.8 m -148.66 167.71 3.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.528 0.731 . . . . 0.0 110.005 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.48 116.61 30.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 33.9 mt -112.92 132.22 62.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.172 -171.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -92.86 134.91 34.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -80.0 -160.81 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.407 ' HE1' ' O ' ' A' ' 34' ' ' ALA . 58.8 m80 -68.56 -26.89 65.63 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.898 -0.501 . . . . 0.0 110.922 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -90.39 -19.19 24.25 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.327 0.651 . . . . 0.0 110.907 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.12 14.06 27.35 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.518 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -101.85 139.76 37.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.355 0.578 . . . . 0.0 110.289 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 58.7 t -83.0 84.16 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 122.312 1.053 . . . . 0.0 110.539 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.458 HG23 HD13 ' A' ' 78' ' ' LEU . 17.3 m -111.21 16.83 7.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.474 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.447 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -130.84 45.4 1.14 Allowed Glycine 0 CA--C 1.547 2.089 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.828 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -85.07 -5.05 9.63 Favored 'Trans proline' 0 C--N 1.383 2.342 0 CA-C-N 121.416 2.608 . . . . 0.0 112.506 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -108.47 0.03 20.74 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.807 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.458 ' HB3' HD11 ' A' ' 90' ' ' LEU . 6.8 m-85 -92.16 134.84 34.48 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.239 -174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.69 142.36 51.45 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.975 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -83.87 112.47 20.15 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.019 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.6 tt -88.35 129.95 35.26 Favored 'General case' 0 N--CA 1.404 -2.733 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.57 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -123.88 141.03 52.4 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.525 178.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.24 131.85 51.11 Favored 'General case' 0 CA--C 1.486 -1.511 0 O-C-N 123.799 0.687 . . . . 0.0 110.356 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.34 173.08 6.48 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 124.719 1.262 . . . . 0.0 108.361 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.54 13.63 64.98 Favored Glycine 0 C--N 1.305 -1.145 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.725 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.82 130.07 45.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.28 107.94 3.83 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.291 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.7 t70 70.74 -46.59 0.63 Allowed 'General case' 0 N--CA 1.513 2.713 0 C-N-CA 125.854 1.661 . . . . 0.0 112.682 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.458 ' C ' ' HB2' ' A' ' 164' ' ' ASP . . . 65.34 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 126.558 1.943 . . . . 0.0 115.912 171.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.1 mm -55.23 124.29 7.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.274 1.03 . . . . 0.0 111.083 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.62 95.26 3.33 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 170.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 56.3 ttm -76.74 -4.14 41.79 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.996 -170.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.74 -50.22 9.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.494 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -99.68 1.36 43.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.988 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.5 p -94.32 119.06 32.53 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.28 100.9 12.87 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -155.27 161.65 41.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.306 0.574 . . . . 0.0 112.511 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -118.28 145.58 44.95 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.748 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 59.2 mtt -100.7 155.67 17.77 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.343 33.7 t70 93.07 86.4 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.23 2.212 . . . . 0.0 115.952 174.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.7 m -101.48 -37.38 8.45 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.41 168.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 79.0 mt -135.23 -45.27 0.7 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.111 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.447 ' CD ' HH22 ' A' ' 181' ' ' ARG . 40.0 mt-10 -139.65 177.24 8.08 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.552 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -31.25 71.76 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -96.51 24.01 6.3 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.481 1.134 . . . . 0.0 110.074 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.465 HE22 ' HG2' ' A' ' 181' ' ' ARG . 21.3 mm-40 -114.66 115.19 26.71 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 58.5 mt -78.32 139.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 -84.85 1.75 Allowed Glycine 0 N--CA 1.422 -2.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -82.31 121.38 26.6 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.33 109.86 26.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -86.19 -43.67 12.81 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.85 110.66 4.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.282 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -85.33 121.22 27.75 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -93.99 132.0 38.89 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.82 136.05 51.47 Favored 'General case' 0 C--O 1.257 1.487 0 O-C-N 124.185 0.928 . . . . 0.0 111.708 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.458 ' HB2' ' C ' ' A' ' 137' ' ' ALA . 21.5 p-10 -87.22 1.62 52.55 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.988 -175.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 23.1 p -68.27 -4.53 14.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.031 1.333 . . . . 0.0 111.203 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.2 m -67.61 -34.37 76.86 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.264 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.13 -31.69 6.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.403 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.3 mt -91.89 141.68 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.448 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 48.3 mtp180 -53.96 121.5 29.68 Favored Pre-proline 0 C--N 1.32 -0.691 0 C-N-CA 123.415 0.686 . . . . 0.0 111.435 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.17 -6.85 18.29 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.876 2.384 . . . . 0.0 112.603 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.448 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.05 -10.0 55.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.291 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.47 120.3 15.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.431 ' HD2' ' HA ' ' A' ' 104' ' ' VAL . 98.8 mttt -71.98 -30.79 65.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.998 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.546 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.9 ttt -153.35 129.59 10.48 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -153.24 -178.92 7.27 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 22.9 ttp180 -138.53 142.08 39.31 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 55.8 m -69.78 144.6 52.63 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.6 p -81.07 -35.88 31.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -81.47 -7.39 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -138.06 117.85 13.2 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 176' ' ' ARG . 6.2 ptp180 -76.48 -24.76 53.82 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.303 -173.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -89.77 -15.72 31.8 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.77 99.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.685 -174.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.42 123.08 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.8 mt -107.64 124.45 50.0 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.845 0.831 . . . . 0.0 111.251 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.546 HG22 ' HG3' ' A' ' 174' ' ' MET . 36.3 pt -116.07 155.27 17.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.987 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 22' ' ' VAL . 47.8 mtm180 -85.98 158.59 19.84 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 174.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 8.5 pt-20 -47.82 -42.46 26.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.35 1.06 . . . . 0.0 113.097 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.92 -40.47 69.91 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 125.445 1.498 . . . . 0.0 112.291 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.45 -46.97 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.156 -176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.563 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 33.1 p80 -71.01 -31.74 68.33 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.02 70.25 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.0 -34.77 61.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.13 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.7 m-85 -73.21 -35.52 66.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.008 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 47.7 mt-10 -60.75 -53.38 58.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.523 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.65 -24.17 66.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.56 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -79.76 -27.41 40.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.344 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.47 36.61 43.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.82 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.3 mt -76.32 157.11 32.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.4 p -102.03 137.11 40.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.55 71.35 0.92 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.369 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 55.5 m-85 -141.96 149.54 40.22 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 118.175 0.988 . . . . 0.0 112.795 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -161.71 121.51 2.53 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 170.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.07 156.14 38.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -140.72 161.89 36.72 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 123.558 0.743 . . . . 0.0 109.934 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.04 117.69 20.33 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.39 -26.98 62.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.576 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.472 ' OE2' ' HE3' ' A' ' 23' ' ' LYS . 35.3 mt-10 -67.58 97.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.304 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 70.65 35.65 67.26 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.741 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.6 t90 -52.92 102.71 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.969 0.908 . . . . 0.0 110.304 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.24 113.14 26.48 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.02 -25.02 0.25 Allowed Glycine 0 CA--C 1.539 1.575 0 N-CA-C 119.999 2.76 . . . . 0.0 119.999 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.13 114.93 21.0 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 119.019 1.41 . . . . 0.0 110.74 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.99 132.36 42.32 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.482 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.241 174.875 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 tpp . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.76 81.22 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 m -76.79 -10.87 59.68 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 122.887 0.475 . . . . 0.0 111.498 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -65.44 109.27 2.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 69.3 10.86 7.97 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.014 0.926 . . . . 0.0 113.025 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -122.15 79.43 1.59 Allowed 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -114.13 161.11 18.18 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -78.55 77.52 5.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.735 0.779 . . . . 0.0 108.954 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -147.03 97.45 2.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.685 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -141.87 155.68 45.53 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 m -90.88 -21.31 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m 70.19 -49.48 0.64 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.637 1.575 . . . . 0.0 114.677 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.16 101.1 2.47 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -136.05 108.18 7.22 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 123.038 0.535 . . . . 0.0 109.611 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.14 119.27 76.51 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 172.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.24 -28.15 64.15 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.232 1.955 . . . . 0.0 112.908 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -131.39 83.37 2.1 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.394 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.49 90.01 1.65 Allowed Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.124 -2.391 . . . . 0.0 107.124 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.5 m -139.6 94.13 2.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 65.44 112.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.82 134.07 36.56 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 169.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 t -81.13 120.28 32.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.929 0.395 . . . . 0.0 110.33 -175.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -98.2 127.9 44.38 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.73 0.776 . . . . 0.0 110.774 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -111.41 141.89 44.37 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.429 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -124.47 143.49 50.62 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.5 111.14 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -92.06 132.39 36.61 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.409 0.624 . . . . 0.0 110.952 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HE2' ' OXT' ' A' ' 215' ' ' LEU . 0.4 OUTLIER -148.77 156.45 42.37 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 103.193 -2.892 . . . . 0.0 103.193 177.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -94.64 131.38 41.62 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.9 ptp -70.2 173.57 6.53 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.833 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 77.44 112.42 0.07 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.273 1.829 . . . . 0.0 112.375 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.91 -16.83 34.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.624 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -13.62 43.16 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB1' HE22 ' A' ' 82' ' ' GLN . . . -68.93 -35.76 77.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 90.65 145.45 13.95 Favored Glycine 0 N--CA 1.401 -3.684 0 CA-C-N 113.775 -1.557 . . . . 0.0 114.754 171.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.446 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 21.9 m-85 -95.92 166.08 11.96 Favored 'General case' 0 C--N 1.27 -2.878 0 CA-C-N 113.436 -1.382 . . . . 0.0 107.863 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.1 mt -78.3 101.34 3.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 162.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -62.59 -51.66 66.45 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 124.504 1.127 . . . . 0.0 112.234 -169.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.6 176.14 8.7 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 46' ' ' THR . 9.6 mp -60.68 126.94 86.3 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 36.7 Cg_endo -73.68 167.7 26.62 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 123.079 2.519 . . . . 0.0 112.284 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -52.6 112.89 0.91 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 124.28 1.032 . . . . 0.0 112.712 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.33 3.68 66.98 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 115.691 1.037 . . . . 0.0 115.691 172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 81.1 p -85.94 146.94 44.38 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 118.204 1.002 . . . . 0.0 113.213 -176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -63.38 166.36 15.28 Favored 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 123.913 3.075 . . . . 0.0 111.741 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.44 ' HA ' HD21 ' A' ' 40' ' ' LEU . 35.9 p -56.85 155.16 8.23 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.39 -56.06 2.1 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 127.925 2.49 . . . . 0.0 112.915 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.5 p-90 -85.86 -19.67 30.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.495 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -84.17 -17.14 40.97 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.455 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 30.3 m-85 -45.18 -40.53 7.27 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 130' ' ' ASN . 12.4 m170 -128.98 20.71 5.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.233 -0.917 . . . . 0.0 111.396 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.95 102.57 14.93 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.49 -2.93 0.99 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.464 1.345 . . . . 0.0 116.464 175.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.83 160.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.097 0.949 . . . . 0.0 113.219 -173.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.4 t -98.12 134.53 41.06 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.67 -10.78 55.32 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.82 -31.84 63.03 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -89.13 -17.88 28.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.58 -21.24 9.25 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -172.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 58.4 t80 -105.92 138.8 19.75 Favored Pre-proline 0 C--N 1.29 -2.004 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 123.29 11.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.029 1.82 . . . . 0.0 112.572 -177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.46 122.69 44.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.79 15.57 75.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.63 -165.92 29.5 Favored Glycine 0 CA--C 1.502 -0.736 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.319 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 48.4 mt-10 -117.93 130.09 56.01 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 35.6 m -126.78 160.93 34.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 p -142.33 150.02 40.23 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.959 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -75.27 107.33 7.3 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.2 p -49.29 131.03 20.12 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 124.881 1.363 . . . . 0.0 112.792 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -81.64 50.9 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.15 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -76.83 -24.6 52.74 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -134.17 91.4 23.52 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.296 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.53 145.85 38.27 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.849 2.366 . . . . 0.0 111.089 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.9 t70 70.14 15.59 7.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.482 1.134 . . . . 0.0 110.656 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 117' ' ' HIS . 61.5 t30 -77.03 152.13 35.27 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.272 20.4 mmt180 -69.17 -174.17 0.61 Allowed 'General case' 0 C--O 1.257 1.478 0 N-CA-C 117.873 2.545 . . . . 0.0 117.873 -164.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.47 -172.75 4.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.861 -172.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -100.71 150.7 22.48 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.389 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -114.63 -159.89 0.71 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.441 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.31 -37.42 85.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.481 0.582 . . . . 0.0 111.099 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -126.36 157.14 39.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.412 HE22 ' HB1' ' A' ' 34' ' ' ALA . 34.9 tp60 -141.53 136.41 15.55 Favored Pre-proline 0 C--O 1.26 1.636 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -89.87 178.12 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.441 2.094 . . . . 0.0 113.441 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.9 p30 -160.98 173.98 14.47 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.2 mm -90.54 -14.59 8.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.907 0.86 . . . . 0.0 109.849 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -94.67 -151.75 0.33 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.372 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 2.1 m -102.58 0.91 34.12 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.481 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 4.0 p-10 -92.62 167.31 12.0 Favored 'General case' 0 C--O 1.201 -1.453 0 O-C-N 121.552 -0.718 . . . . 0.0 112.588 -173.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.71 141.64 51.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 126' ' ' TYR . 40.4 tp -112.66 126.4 55.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.72 141.45 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -79.53 172.57 13.61 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.353 0.261 . . . . 0.0 110.61 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.78 -38.93 93.41 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -64.08 -47.22 80.91 Favored 'General case' 0 C--O 1.249 1.06 0 C-N-CA 122.762 0.425 . . . . 0.0 112.003 177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.36 -28.74 66.47 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.986 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -56.99 -47.56 80.52 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.944 0.497 . . . . 0.0 110.442 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.8 -28.75 68.63 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.795 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.51 -54.19 46.44 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.1 mt -58.33 -43.88 87.17 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.53 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -66.12 -35.01 79.35 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -68.24 -21.75 64.81 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.024 0.44 . . . . 0.0 111.441 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.497 ' CD2' ' HA ' ' A' ' 190' ' ' VAL . 10.9 mp -86.29 -2.8 58.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.811 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.44 37.17 85.4 Favored Glycine 0 N--CA 1.438 -1.18 0 O-C-N 123.952 0.782 . . . . 0.0 112.287 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.17 116.67 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 121.375 0.607 . . . . 0.0 109.628 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -88.01 157.77 18.81 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.205 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 78.0 15.48 1.46 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.903 0.881 . . . . 0.0 112.243 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.18 114.98 29.44 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 7.1 tp10 -105.73 140.77 38.27 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.43 ' CH2' HD12 ' A' ' 129' ' ' LEU . 43.8 m95 -116.87 121.94 42.93 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 123.804 0.842 . . . . 0.0 109.7 -172.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -113.43 109.13 51.47 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.597 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.48 137.1 16.24 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 122.54 2.16 . . . . 0.0 113.407 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 172.27 2.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.401 1.08 . . . . 0.0 109.586 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.502 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -103.16 116.51 32.63 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 126' ' ' TYR . 22.1 mt -107.53 142.69 19.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.186 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -118.38 135.35 54.38 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.623 1.169 . . . . 0.0 108.128 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.9 p30 -86.19 -162.29 0.73 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.1 m80 -74.4 -12.61 60.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.384 1.074 . . . . 0.0 111.815 -174.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.51 -19.48 29.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.07 1.29 63.04 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.174 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -89.65 154.77 19.71 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.748 -0.266 . . . . 0.0 110.412 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.57 126.17 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 116' ' ' ASP . 11.3 p -129.81 -32.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.921 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.95 73.14 0.47 Allowed Glycine 0 N--CA 1.414 -2.777 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.491 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.08 -0.99 9.76 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 CA-C-N 119.673 1.736 . . . . 0.0 109.746 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.61 -12.19 17.92 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.203 1.401 . . . . 0.0 111.158 -178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.471 ' HB2' HD12 ' A' ' 114' ' ' ILE . 10.0 m-85 -92.57 149.26 21.47 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.539 0.685 . . . . 0.0 112.528 -172.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.39 143.02 49.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.368 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -86.23 120.38 27.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.564 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 7.0 tt -91.61 131.83 36.75 Favored 'General case' 0 C--O 1.259 1.573 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.405 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.567 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 7.9 p30 -124.42 140.96 52.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.217 174.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.43 141.05 32.72 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.573 0.546 . . . . 0.0 110.462 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.5 mp -114.5 173.02 6.67 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 124.656 1.222 . . . . 0.0 108.412 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.72 17.18 73.6 Favored Glycine 0 CA--C 1.5 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 132.89 33.97 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 121.295 0.569 . . . . 0.0 109.779 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -137.07 168.98 18.55 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.9 103.1 0.14 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.716 1.143 . . . . 0.0 111.27 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -88.66 -54.9 3.94 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.026 -1.897 . . . . 0.0 115.497 -163.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.408 HD12 ' HB2' ' A' ' 179' ' ' LYS . 45.9 mt -51.22 113.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 124.366 1.041 . . . . 0.0 113.758 -169.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -70.93 107.07 3.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.517 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.434 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 46.7 mtt -91.3 8.84 34.05 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -85.84 -50.39 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -93.21 -4.9 51.17 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.484 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 140' ' ' MET . 61.0 p -91.74 151.02 20.82 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.995 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -137.58 97.81 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -147.78 163.42 36.76 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -117.16 140.79 49.09 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.506 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.16 155.65 20.66 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.998 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.321 34.6 t70 96.0 95.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.455 2.302 . . . . 0.0 115.783 174.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.0 m -100.57 -56.16 2.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 167.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.0 mt -128.33 -41.05 1.58 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.063 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 47.8 mt-10 -125.83 -179.08 4.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.058 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -71.71 -44.23 64.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 124.201 0.938 . . . . 0.0 111.07 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -82.91 26.01 0.63 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.894 0.854 . . . . 0.0 112.241 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -113.21 122.05 46.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.28 116.17 21.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -84.02 -61.55 1.83 Allowed Glycine 0 CA--C 1.493 -1.315 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -111.02 132.86 53.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.2 mp -119.8 113.75 41.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -89.34 -39.19 13.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.614 -0.835 . . . . 0.0 109.994 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.19 117.4 3.5 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.173 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -97.36 145.08 26.48 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.95 146.02 47.09 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.462 ' HG ' ' OE2' ' A' ' 208' ' ' GLU . 93.8 mt -53.78 136.55 39.83 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.512 1.133 . . . . 0.0 112.559 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.618 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 41.0 p-10 -96.5 10.44 38.34 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.166 -177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.2 p -68.19 -5.16 16.65 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.938 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.8 m -61.14 -40.53 94.17 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.147 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.52 -33.68 6.31 Favored 'General case' 0 C--O 1.212 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.255 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.26 151.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -44.41 117.61 2.97 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.046 0.938 . . . . 0.0 110.934 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.34 -16.04 39.04 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.461 2.107 . . . . 0.0 111.856 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.62 11.43 31.14 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.496 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.04 143.38 39.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -95.99 -28.95 14.41 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.444 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.0 ttt -143.75 124.57 14.24 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.35 178.23 10.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.61 163.25 40.31 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.138 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.456 ' SG ' HD22 ' A' ' 183' ' ' LEU . 71.2 m -83.3 149.93 26.46 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.125 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.5 p -81.44 -51.51 8.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.408 ' HB2' HD12 ' A' ' 138' ' ' ILE . 83.7 mttt -89.5 20.65 3.8 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -171.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.433 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 8.4 tp10 -145.92 134.32 21.9 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 171.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' SER . 15.3 mmt180 -89.96 -33.16 16.49 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 123.821 0.701 . . . . 0.0 112.386 -168.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -91.67 -12.11 35.03 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.971 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.456 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.5 tt -86.68 109.13 18.99 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.433 0.635 . . . . 0.0 110.401 -173.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.7 mt -119.19 129.06 75.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.7 121.54 43.8 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.801 0.81 . . . . 0.0 111.325 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 48.7 pt -111.29 147.77 15.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.007 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.35 150.11 38.51 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -49.15 -39.2 27.99 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.52 -30.28 69.64 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 111.73 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.497 ' HA ' ' CD2' ' A' ' 102' ' ' LEU . 56.7 t -66.4 -49.48 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.999 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.568 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 17.1 p80 -70.87 -29.73 65.92 Favored 'General case' 0 C--O 1.199 -1.559 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.085 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -59.35 -34.84 72.86 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.427 0.632 . . . . 0.0 111.37 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.38 61.65 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.934 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 19.2 m-30 -68.98 -34.55 75.49 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.696 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 39.5 mt-10 -65.48 -49.11 70.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.493 0.717 . . . . 0.0 111.146 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -69.92 -29.89 67.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.376 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -74.9 -27.48 60.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.999 0.428 . . . . 0.0 109.897 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 78.72 45.22 9.58 Favored Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.661 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.9 mt -81.4 154.14 26.58 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 27.5 p -101.45 129.82 47.56 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 107.69 71.71 0.75 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.756 -0.657 . . . . 0.0 114.582 172.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 14.9 m-85 -124.7 145.77 49.5 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.061 0.93 . . . . 0.0 112.666 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -144.0 121.94 12.04 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 169.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.03 128.9 69.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 69.2 m-85 -120.46 137.97 54.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.06 111.03 3.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.72 -46.22 86.41 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.526 0.516 . . . . 0.0 112.175 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.462 ' OE2' ' HG ' ' A' ' 163' ' ' LEU . 30.1 mm-40 -68.07 100.61 1.02 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.345 0.593 . . . . 0.0 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.14 34.56 32.85 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.066 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -50.66 104.64 0.08 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.967 . . . . 0.0 110.129 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -102.91 103.78 13.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -173.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.76 -7.41 2.96 Favored Glycine 0 N--CA 1.471 1.005 0 N-CA-C 118.775 2.27 . . . . 0.0 118.775 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.14 117.46 23.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 118.548 1.174 . . . . 0.0 110.552 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.99 125.79 29.78 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.461 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.3 pt? . . . . . 0 C--N 1.31 -1.112 0 O-C-N 124.263 0.977 . . . . 0.0 112.313 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 C--O 1.243 0.719 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.12 101.89 0.23 Allowed Glycine 0 C--O 1.239 0.406 0 C-N-CA 121.367 -0.444 . . . . 0.0 112.426 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 p -110.93 177.92 4.51 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 p -110.74 30.6 6.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.596 0.712 . . . . 0.0 110.543 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -71.76 -16.95 62.21 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -70.64 -29.6 66.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.2 m80 59.8 41.54 17.99 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.305 1.042 . . . . 0.0 112.674 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -81.37 65.92 6.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.158 0.98 . . . . 0.0 109.581 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -133.85 0.21 3.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.228 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.21 127.43 21.11 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -176.56 107.65 0.07 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.7 t -111.65 -48.71 3.05 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.83 -76.23 0.81 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt 66.86 -69.96 0.12 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.225 1.41 . . . . 0.0 113.95 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.91 115.75 65.41 Favored Pre-proline 0 C--N 1.305 -1.34 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.03 -56.97 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.217 1.944 . . . . 0.0 111.228 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -130.19 -55.78 1.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.56 -166.75 20.98 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -108.67 13.51 25.09 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.765 0.793 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -82.07 0.77 38.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.788 -175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 56.3 ttp -48.54 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.746 1.219 . . . . 0.0 114.001 -169.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t -123.96 118.33 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' OE2' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -112.04 155.8 23.22 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -114.57 142.78 45.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.253 0.549 . . . . 0.0 111.128 -173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 83.9 m-85 -125.11 147.38 49.04 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.772 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 85.9 t -80.74 123.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 173.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -91.94 133.67 35.48 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.502 0.668 . . . . 0.0 110.733 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -150.18 151.35 32.94 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.22 121.35 45.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.552 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 26.9 ttt -79.23 81.29 5.51 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.299 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 178.74 111.72 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 O-C-N 124.734 1.271 . . . . 0.0 108.41 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -86.47 -23.54 25.94 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 75' ' ' ASN . 47.0 mt-10 -82.54 -4.11 57.06 Favored 'General case' 0 C--O 1.192 -1.934 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.055 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -62.39 -35.33 78.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 97.0 92.62 1.87 Allowed Glycine 0 N--CA 1.397 -3.96 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.755 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.09 141.01 57.74 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.3 mt -70.85 101.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 103.3 -2.852 . . . . 0.0 103.3 169.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' OE2' ' HD2' ' A' ' 73' ' ' PRO . 26.5 mt-10 -78.2 -33.99 49.72 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.274 0.559 . . . . 0.0 111.411 -170.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -122.41 161.77 22.86 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.9 124.97 91.91 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 122.618 0.367 . . . . 0.0 111.874 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -77.74 168.98 21.56 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 123.075 2.516 . . . . 0.0 111.417 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -39.8 118.85 0.91 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.234 1.413 . . . . 0.0 113.303 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 13.53 83.15 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 48.8 m -85.51 138.52 35.97 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 44' ' ' SER . 15.8 Cg_exo -67.57 166.71 23.04 Favored 'Trans proline' 0 C--N 1.364 1.345 0 C-N-CA 124.513 3.475 . . . . 0.0 111.037 173.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -60.01 145.92 44.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -38.09 -53.78 1.38 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 127.171 2.188 . . . . 0.0 114.121 -174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.437 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 56.5 p-90 -85.77 -23.18 27.37 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.582 -173.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 48.6 tptt -86.93 -11.77 49.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.979 -171.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 88' ' ' ASN . 20.9 m-85 -43.28 -51.46 6.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.079 0.862 . . . . 0.0 112.743 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.493 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.0 m-70 -128.43 32.45 4.85 Favored 'General case' 0 CA--C 1.466 -2.269 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.339 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.2 tm-20 -92.38 101.24 13.71 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.67 -10.65 12.18 Favored Glycine 0 CA--C 1.552 2.376 0 N-CA-C 116.798 1.479 . . . . 0.0 116.798 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.6 169.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.944 1.872 . . . . 0.0 114.108 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.5 t -98.28 160.16 14.47 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.362 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.441 HD22 ' HG2' ' A' ' 45' ' ' PRO . 81.9 mt -112.76 14.42 19.94 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -171.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.3 -22.9 64.7 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.683 0.754 . . . . 0.0 110.434 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -88.95 -20.8 24.03 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.555 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -108.6 -22.95 12.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.58 140.78 23.51 Favored Pre-proline 0 C--N 1.292 -1.923 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 122.41 9.78 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.914 1.743 . . . . 0.0 112.095 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.443 HG22 HD22 ' A' ' 110' ' ' LEU . 47.9 t -96.72 123.7 49.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.14 24.32 52.36 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.707 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -107.09 -168.3 22.22 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.406 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.7 mt-10 -123.56 128.25 49.46 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.0 m -131.36 174.78 12.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.1 p -146.39 151.98 38.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.05 113.97 8.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 p -64.8 118.83 9.56 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-O 122.013 0.911 . . . . 0.0 111.551 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -85.59 74.44 10.29 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.423 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 2.6 t30 -74.56 -39.74 62.11 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.561 ' HB3' ' HD3' ' A' ' 73' ' ' PRO 0.257 41.2 t80 -159.71 -63.68 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.01 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.953 171.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 72' ' ' TYR . 12.5 Cg_exo -73.45 121.59 7.26 Favored 'Trans proline' 0 C--N 1.373 1.832 0 CA-C-N 121.302 1.501 . . . . 0.0 109.7 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -72.78 -41.85 64.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.256 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 83.8 m-20 65.3 -162.12 0.26 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HG2' ' HB3' ' A' ' 33' ' ' GLU . 16.6 mmt180 -90.26 -164.32 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.849 0.833 . . . . 0.0 112.075 -174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.5 -170.43 2.94 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 125.614 1.566 . . . . 0.0 110.392 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp -88.17 149.54 23.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.296 0.57 . . . . 0.0 111.621 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -120.9 -165.31 1.2 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -66.09 -44.08 85.41 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 118.924 0.784 . . . . 0.0 111.24 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -113.53 142.25 46.17 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.853 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.431 HE22 ' HB1' ' A' ' 34' ' ' ALA . 23.7 mm-40 -128.4 128.62 23.62 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.592 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 82' ' ' GLN . 57.1 Cg_endo -91.42 175.6 2.26 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.892 2.395 . . . . 0.0 113.108 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -163.54 172.16 14.8 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.099 0.959 . . . . 0.0 108.419 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.2 mt -86.94 -16.94 9.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.975 0.893 . . . . 0.0 109.723 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -85.48 -164.04 0.95 Allowed 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.811 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.424 ' CB ' HH21 ' A' ' 176' ' ' ARG . 26.4 p -122.08 54.1 1.19 Allowed 'General case' 0 C--O 1.252 1.205 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . 2.6 t30 -137.39 153.42 50.19 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -109.66 141.96 41.5 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.219 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.7 tp -108.33 125.9 52.23 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 129' ' ' LEU . 47.1 t -126.81 138.51 54.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.625 -172.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.5 p -74.48 172.44 11.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.634 0.774 . . . . 0.0 110.626 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -65.07 -37.65 94.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.556 -0.354 . . . . 0.0 112.655 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -61.39 -52.63 63.8 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 121.783 0.801 . . . . 0.0 109.71 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.35 -32.76 73.92 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.42 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.34 -39.97 84.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.233 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.57 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 8.9 mmpt? -64.69 -38.73 91.98 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.672 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.22 -52.99 62.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.054 0.454 . . . . 0.0 110.296 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.4 mt -61.54 -43.55 97.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.109 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.39 -41.34 85.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -70.29 -25.28 63.26 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.35 -21.23 59.79 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.01 0.433 . . . . 0.0 111.037 173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.91 47.82 6.06 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.9 t -74.02 101.24 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.616 0.722 . . . . 0.0 109.588 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 m -70.05 147.1 50.45 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.965 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 79.45 9.14 1.65 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.362 1.065 . . . . 0.0 111.999 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.58 114.71 29.16 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 8.7 tp10 -111.75 146.85 36.84 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -116.6 120.91 40.18 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.039 0.136 . . . . 0.0 111.092 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.443 HD22 HG22 ' A' ' 62' ' ' VAL . 50.7 mt -106.2 101.98 37.55 Favored Pre-proline 0 C--N 1.311 -1.074 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 173.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.17 132.4 12.61 Favored 'Trans proline' 0 C--O 1.243 0.726 0 C-N-CA 122.666 2.244 . . . . 0.0 112.814 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 64' ' ' GLY . 5.0 m -144.64 170.27 7.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.581 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.79 116.55 32.8 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.8 mt -109.82 133.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-O 121.496 0.665 . . . . 0.0 112.409 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HG2' HG22 ' A' ' 121' ' ' VAL . 66.1 mttt -95.6 143.67 26.7 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 174.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.522 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 3.0 p-10 -83.22 -160.7 0.44 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.461 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 35.5 m80 -70.15 -30.87 68.14 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.768 0.827 . . . . 0.0 110.137 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -81.78 -19.98 40.12 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.7 14.88 33.29 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.119 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 17.9 ptpt -95.36 140.51 30.13 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.46 HG22 ' HG2' ' A' ' 115' ' ' LYS . 48.7 t -77.94 89.18 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.571 0.701 . . . . 0.0 110.024 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -116.38 11.69 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.614 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -126.1 54.43 0.76 Allowed Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.074 -1.06 . . . . 0.0 113.669 175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.71 -17.44 5.04 Favored 'Trans proline' 0 C--N 1.368 1.594 0 CA-C-N 120.629 2.215 . . . . 0.0 112.342 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.71 7.65 44.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.199 0.523 . . . . 0.0 110.346 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.416 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 5.8 m-85 -95.1 144.32 25.84 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 121.515 0.674 . . . . 0.0 110.601 -177.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -133.58 141.63 47.77 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.023 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.413 ' HB3' ' ND2' ' A' ' 88' ' ' ASN . 55.5 m-85 -80.75 119.76 23.76 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 91' ' ' VAL . 3.9 tt -86.45 121.25 28.74 Favored 'General case' 0 C--O 1.261 1.66 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 91.8 m-20 -97.91 125.81 43.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.08 121.71 42.29 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 123.401 0.438 . . . . 0.0 110.02 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.66 172.9 6.55 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.855 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.08 20.29 65.33 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.278 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -94.48 131.03 40.61 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.61 169.32 17.86 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -53.71 104.96 0.11 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -131.58 -27.34 1.94 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 118.032 2.604 . . . . 0.0 118.032 -164.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 179' ' ' LYS . 24.3 mt -63.01 122.86 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.533 1.06 . . . . 0.0 110.874 -177.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -75.43 107.74 7.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.787 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -77.32 -9.44 58.83 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -70.33 -50.06 43.0 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.436 0.636 . . . . 0.0 109.759 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.69 -2.5 35.21 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.307 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.8 p -99.88 142.38 31.43 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.489 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 14.7 mm-40 -122.61 107.5 12.04 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -161.71 161.28 29.3 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.747 0.308 . . . . 0.0 111.681 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 59.5 mm-40 -125.46 142.07 51.71 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 58.7 mtt -100.43 108.32 20.28 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.67 7.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.7 p -72.67 -56.67 4.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.204 -0.599 . . . . 0.0 112.051 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.1 mt -117.82 -39.23 3.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.687 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 153' ' ' ASP . 10.4 pt-20 -158.24 -176.34 5.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -68.93 -13.3 62.35 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -114.6 23.24 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.215 0.531 . . . . 0.0 112.15 -179.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.438 HE21 ' HA ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -129.37 120.81 26.2 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 175.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 72.1 mt -72.91 133.58 31.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.061 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -115.79 -70.6 0.47 Allowed Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 8.2 t30 -79.17 122.14 25.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 17.2 mt -126.91 106.85 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 33.9 t70 -90.25 -44.74 9.52 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.791 0.805 . . . . 0.0 109.088 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.66 110.88 3.92 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.797 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.32 125.64 39.09 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -102.66 146.87 27.55 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.0 140.02 57.7 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-O 121.867 0.842 . . . . 0.0 112.484 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.4 p-10 -94.46 6.64 48.17 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.1 p -68.46 -5.5 19.69 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.632 1.173 . . . . 0.0 109.866 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -62.0 -39.49 92.39 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.651 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.24 -31.84 6.72 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.697 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 64.5 mt -83.16 150.62 4.18 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -60.95 120.19 51.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 118.208 0.458 . . . . 0.0 109.96 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.97 -16.35 45.12 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.405 2.07 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -81.56 -6.15 58.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.031 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.19 127.35 32.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -70.12 -33.36 71.74 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.547 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.7 ttt -151.1 130.08 12.55 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -153.79 -178.72 7.23 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.136 0.574 . . . . 0.0 109.585 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.424 HH21 ' CB ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -136.76 145.68 44.89 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.52 152.63 40.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 123.835 0.709 . . . . 0.0 110.374 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -81.94 -45.36 15.51 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 138' ' ' ILE . 7.4 mmpt? -73.45 -20.01 60.81 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.553 -173.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.405 ' HG2' ' CG1' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -124.68 134.8 52.75 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 175.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.437 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 52.1 mmt-85 -89.59 -36.59 15.22 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 34.2 mtp85 -85.77 -19.83 30.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.173 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 28.0 tp -72.9 100.64 2.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 121.962 0.887 . . . . 0.0 110.914 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.3 mt -106.75 124.95 62.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 57.7 mt -112.14 133.67 54.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.45 0.643 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.547 HG22 ' HG3' ' A' ' 174' ' ' MET . 43.4 pt -121.87 159.48 24.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.176 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.8 mtm180 -86.15 161.43 18.86 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.775 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -49.0 -47.71 44.19 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.994 1.718 . . . . 0.0 109.717 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -47.12 -45.75 22.59 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.997 2.119 . . . . 0.0 113.525 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.52 -46.42 75.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.605 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 11.5 p80 -77.35 -21.6 53.08 Favored 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 118.096 -1.442 . . . . 0.0 111.006 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.86 81.63 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -65.31 -40.82 94.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.71 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 191' ' ' HIS . 22.7 m-85 -65.91 -37.62 86.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.09 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.7 mm-40 -55.36 -51.51 66.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.651 0.78 . . . . 0.0 109.444 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.62 -10.65 59.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.504 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.01 -27.88 20.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.41 47.48 62.91 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.946 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 61.0 mt -84.5 160.28 20.55 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 20.1 p -94.65 121.75 36.53 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 105.3 63.82 0.64 Allowed Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.886 -1.052 . . . . 0.0 114.796 173.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 46.2 m-85 -127.14 135.06 50.18 Favored 'General case' 0 CA--C 1.487 -1.467 0 CA-C-N 117.938 0.869 . . . . 0.0 112.782 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 50.9 tptt -144.02 121.54 11.75 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.2 m -126.11 129.43 72.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.5 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.42 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 72.0 m-85 -110.62 165.02 12.15 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -68.64 122.96 19.61 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.37 -35.64 35.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 23' ' ' LYS . 14.7 mt-10 -75.14 97.85 3.56 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.447 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.06 35.37 34.8 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.678 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.523 ' NE1' ' HB2' ' A' ' 213' ' ' LEU . 9.9 t90 -55.21 106.61 0.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.131 0.972 . . . . 0.0 109.712 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -103.23 99.02 8.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.55 15.22 68.18 Favored Glycine 0 N--CA 1.47 0.965 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.523 ' HB2' ' NE1' ' A' ' 210' ' ' TRP . 95.5 mt -93.97 156.38 16.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 118.167 0.984 . . . . 0.0 110.991 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -101.81 131.64 48.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.065 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.3 -1.544 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.051 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 111.137 0.051 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.99 -19.06 7.88 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.631 -1.271 . . . . 0.0 114.67 -174.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -84.96 -7.71 59.04 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.898 0.849 . . . . 0.0 112.549 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.2 m -121.72 169.15 11.02 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -88.32 124.37 33.83 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -72.89 113.24 9.7 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -64.13 149.26 48.07 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.992 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -102.66 131.74 49.24 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -68.35 132.68 47.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -50.56 105.86 0.11 Allowed 'General case' 0 C--N 1.345 0.41 0 O-C-N 124.304 1.002 . . . . 0.0 109.105 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 t -81.94 136.43 35.3 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.026 -169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 m -82.83 89.49 6.82 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.04 87.18 0.45 Allowed Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.44 67.87 2.04 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 122.114 0.959 . . . . 0.0 112.014 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 40.7 t -93.79 -48.14 0.28 Allowed Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.643 175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 16.9 Cg_exo -69.53 110.39 2.5 Favored 'Trans proline' 0 C--N 1.396 3.072 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -78.86 119.14 21.62 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.886 0.85 . . . . 0.0 113.161 -174.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.87 71.06 0.23 Allowed Glycine 0 N--CA 1.418 -2.554 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.181 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -65.42 -39.31 91.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -104.99 105.38 15.39 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.4 ttt -78.92 108.35 12.33 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.275 0.56 . . . . 0.0 111.049 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.77 145.78 18.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -107.2 144.78 33.47 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 120.694 0.283 . . . . 0.0 110.398 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -116.56 139.75 50.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.671 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.97 136.42 54.1 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 37.9 t -72.97 107.73 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -99.76 134.2 42.99 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.525 0.679 . . . . 0.0 112.453 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -151.1 165.36 34.07 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.97 141.54 14.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.71 82.76 3.35 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 162.27 137.1 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 127.637 2.375 . . . . 0.0 107.655 171.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 0.3 OUTLIER -80.48 -29.29 37.39 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.011 0.91 . . . . 0.0 109.185 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.426 ' HA ' ' OD1' ' A' ' 75' ' ' ASN . 11.4 pt-20 -83.17 0.73 43.95 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.578 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -66.75 -20.69 66.01 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 120.895 0.379 . . . . 0.0 110.441 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 66.86 0.29 Allowed Glycine 1 N--CA 1.393 -4.208 0 C-N-CA 119.531 -1.318 . . . . 0.0 112.574 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' PRO . 19.1 m-85 -70.83 133.06 46.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.856 172.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.49 101.9 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 171.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -59.16 -41.77 89.14 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.681 -171.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -148.0 173.39 12.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 46' ' ' THR . 5.8 mp -60.62 124.61 79.7 Favored Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 124.269 1.027 . . . . 0.0 113.333 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.76 167.76 25.65 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.803 2.335 . . . . 0.0 112.275 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -45.92 113.76 0.67 Allowed 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 125.898 1.679 . . . . 0.0 112.761 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.61 7.72 87.06 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.522 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.33 132.18 45.87 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 117.21 0.505 . . . . 0.0 111.814 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.48 ' HG2' HD22 ' A' ' 56' ' ' LEU . 31.1 Cg_exo -61.42 165.64 12.76 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 123.693 2.929 . . . . 0.0 111.958 174.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.516 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.9 p -52.94 150.14 5.78 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -39.35 -54.91 1.82 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 127.991 2.516 . . . . 0.0 113.708 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.45 ' HB2' ' NE ' ' A' ' 181' ' ' ARG . 53.7 p-90 -83.52 -24.3 31.73 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.151 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' HE3' HD12 ' A' ' 54' ' ' ILE . 51.5 tptt -85.41 -12.82 51.11 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.524 -172.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -45.11 -43.94 10.13 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -128.96 25.24 5.6 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -92.96 100.9 13.26 Favored 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 118.113 -1.435 . . . . 0.0 107.422 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.11 -9.58 3.92 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.475 HD12 ' HE3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -134.0 172.09 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 120.452 2.126 . . . . 0.0 113.752 -175.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.7 t -98.06 150.48 21.36 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.011 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.48 HD22 ' HG2' ' A' ' 45' ' ' PRO . 43.7 mt -98.33 -4.36 35.14 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.02 47.23 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -89.14 -22.41 22.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -101.2 -22.17 14.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -96.31 140.81 22.4 Favored Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.38 122.59 10.08 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.932 1.754 . . . . 0.0 110.913 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -101.45 119.3 49.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.05 16.86 66.39 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.436 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -96.29 -150.26 26.69 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.84 133.54 44.77 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.96 167.37 26.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -145.74 154.07 41.66 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.156 -0.34 . . . . 0.0 110.448 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.69 115.59 15.53 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 170.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.7 p -55.02 152.27 7.85 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 124.268 0.98 . . . . 0.0 112.755 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -81.95 19.38 1.13 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.297 1.039 . . . . 0.0 110.41 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -60.3 -37.74 81.48 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -134.83 103.8 10.86 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.85 171.19 14.6 Favored 'Trans proline' 0 N--CA 1.443 -1.5 0 C-N-CA 122.343 2.029 . . . . 0.0 111.466 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t0 56.01 81.4 0.12 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.957 1.703 . . . . 0.0 111.536 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 48.6 t-20 -157.75 159.64 37.02 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.499 -3.149 . . . . 0.0 102.499 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 33' ' ' GLU . 10.6 mmt180 -83.51 -165.37 1.09 Allowed 'General case' 0 C--O 1.262 1.762 0 CA-C-O 122.013 0.911 . . . . 0.0 112.844 -168.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.27 -160.83 0.73 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.637 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 mp -92.89 138.75 31.21 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.114 0.483 . . . . 0.0 111.768 -177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 34' ' ' ALA . 2.4 m-30 -108.23 -155.93 0.57 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.957 1.703 . . . . 0.0 108.432 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -64.21 -49.54 71.57 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.515 0.674 . . . . 0.0 110.381 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -126.15 139.3 53.48 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.825 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 90' ' ' LEU . 14.3 mm100 -107.39 119.0 52.16 Favored Pre-proline 0 N--CA 1.431 -1.387 0 O-C-N 123.745 0.653 . . . . 0.0 111.309 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 90.6 Cg_endo -84.08 168.12 12.17 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 122.713 2.275 . . . . 0.0 111.259 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -159.35 169.79 23.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.18 -7.21 10.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 124.103 0.877 . . . . 0.0 110.286 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -98.99 -168.56 1.64 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.333 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 p -101.97 21.95 13.86 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -173.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -116.43 162.97 16.74 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.541 -0.724 . . . . 0.0 109.316 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.3 tp -123.49 141.7 51.73 Favored 'General case' 0 C--O 1.217 -0.635 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.968 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 82' ' ' GLN . 54.1 tp -114.47 127.14 55.66 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 129' ' ' LEU . 47.0 t -126.92 144.28 37.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.76 -172.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -76.55 168.77 19.48 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.58 0.352 . . . . 0.0 110.173 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.83 -36.08 90.59 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -65.2 -45.27 85.48 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 120.916 0.389 . . . . 0.0 110.595 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -30.38 64.3 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.387 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -58.78 -45.09 90.59 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.892 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -57.48 -42.16 82.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.057 0.848 . . . . 0.0 110.617 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.72 -54.26 48.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.354 0.409 . . . . 0.0 110.887 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.8 mt -60.14 -41.4 86.47 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 C-N-CA 123.513 0.725 . . . . 0.0 111.818 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -68.99 -34.29 75.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.626 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -68.01 -27.55 66.65 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.966 0.412 . . . . 0.0 111.027 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.2 -7.34 59.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.608 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.84 42.73 98.35 Favored Glycine 0 N--CA 1.441 -0.98 0 O-C-N 123.563 0.539 . . . . 0.0 112.321 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.1 t -72.07 112.61 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -79.86 155.37 27.84 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 75.69 15.17 2.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.96 1.304 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.3 113.85 25.79 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.2 tp10 -109.35 138.7 45.32 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.483 ' CZ3' ' HG ' ' A' ' 129' ' ' LEU . 59.7 m95 -119.6 114.5 22.32 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.4 mt -110.73 96.59 29.21 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.76 146.23 14.77 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.336 2.024 . . . . 0.0 112.239 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 64' ' ' GLY . 2.5 m -149.73 169.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.714 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -90.74 115.35 27.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 173.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 126' ' ' TYR . 31.2 mt -108.49 126.55 65.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.49 0.662 . . . . 0.0 112.029 -173.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.64 ' HG2' HG22 ' A' ' 121' ' ' VAL . 90.5 mttt -99.49 136.15 39.85 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.665 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.8 p-10 -81.1 -160.47 0.33 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.866 0.365 . . . . 0.0 110.817 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -63.56 -36.01 82.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.665 0.786 . . . . 0.0 110.028 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -79.88 -19.83 47.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.515 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.26 38.17 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.725 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.665 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.9 ptmt -93.92 133.48 37.3 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 115' ' ' LYS . 23.0 t -77.35 93.11 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.132 0.491 . . . . 0.0 109.738 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.408 HG23 HD13 ' A' ' 78' ' ' LEU . 18.9 m -120.31 11.89 6.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.547 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -135.27 51.8 0.82 Allowed Glycine 0 C--O 1.201 -1.943 0 C-N-CA 119.357 -1.401 . . . . 0.0 115.393 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 90.6 Cg_endo -84.34 -1.97 9.87 Favored 'Trans proline' 0 C--N 1.368 1.584 0 CA-C-N 121.542 2.671 . . . . 0.0 112.209 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -113.54 7.26 17.37 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.591 1.186 . . . . 0.0 109.124 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.429 ' HB2' HD12 ' A' ' 114' ' ' ILE . 3.6 m-85 -93.98 137.31 33.32 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.842 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -125.8 139.94 53.08 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.693 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -79.45 115.41 19.06 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.483 ' HG ' ' CZ3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -87.28 119.9 28.01 Favored 'General case' 0 C--O 1.274 2.369 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -176.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.539 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 0.4 OUTLIER -101.67 122.07 43.2 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.478 HD22 HD22 ' A' ' 129' ' ' LEU . 3.5 mm? -96.51 113.25 24.8 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.14 173.42 7.03 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 124.21 0.944 . . . . 0.0 109.5 -177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.27 63.86 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.113 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.65 130.94 34.61 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -148.09 100.26 3.15 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.081 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.472 ' O ' ' HE2' ' A' ' 179' ' ' LYS . 16.9 t70 72.41 -48.53 0.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 126.138 1.775 . . . . 0.0 111.614 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 67.49 -95.82 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 179' ' ' LYS . 28.6 mt -65.15 123.19 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -166.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.1 129.18 37.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.335 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 51.5 ttm -107.43 1.01 23.28 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.487 0.661 . . . . 0.0 110.932 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.3 -49.21 7.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.684 0.754 . . . . 0.0 110.93 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -99.4 10.91 40.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.242 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.7 p -114.44 162.58 16.49 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -129.9 110.99 12.13 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -160.27 160.33 32.46 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.407 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -123.53 132.99 54.05 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.82 0.848 . . . . 0.0 109.525 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 57.5 mtt -92.64 126.3 37.66 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 122.927 0.491 . . . . 0.0 109.986 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -164.36 -26.23 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 -168.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HA2' ' A' ' 156' ' ' GLY . 50.0 m -56.59 -55.9 28.16 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -171.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 90.6 mt -135.96 -80.71 0.41 Allowed 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.035 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.95 178.02 5.89 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -60.33 -34.24 73.54 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-O 120.98 0.419 . . . . 0.0 110.236 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -90.64 26.54 1.99 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.83 0.824 . . . . 0.0 111.503 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 149' ' ' SER . 38.7 mm-40 -116.99 115.04 24.67 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.747 172.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 51.5 mt -81.12 121.61 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.018 -176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.488 ' HA2' ' OG ' ' A' ' 149' ' ' SER . . . -88.47 -45.31 5.0 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.92 -176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -124.08 125.41 44.46 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.3 mp -116.89 122.34 69.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -99.34 -51.18 3.87 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.55 0.69 . . . . 0.0 109.886 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.49 110.52 5.94 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -88.7 124.13 33.81 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -95.23 146.47 24.31 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.02 141.47 58.76 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.864 0.84 . . . . 0.0 112.59 -173.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -85.9 -2.04 57.88 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.279 -177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.7 p -68.89 -5.72 22.95 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.642 1.177 . . . . 0.0 110.01 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.8 m -65.15 -35.08 79.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 170.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.19 -30.51 7.43 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.36 144.99 7.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -59.2 120.9 51.67 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 123.13 0.572 . . . . 0.0 110.817 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.55 -5.78 16.89 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 123.426 2.751 . . . . 0.0 114.269 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.91 -3.38 57.37 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.134 -0.354 . . . . 0.0 110.811 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.65 137.39 38.51 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -90.93 -25.18 19.91 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 91.4 mtp -140.84 131.05 24.89 Favored 'General case' 0 CA--C 1.468 -2.201 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -153.43 153.29 32.23 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.477 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.716 ' CZ ' HG23 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -113.03 143.88 43.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.425 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 39.9 m -88.13 131.98 34.5 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 123.4 0.438 . . . . 0.0 110.302 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.2 p -81.97 -9.35 59.6 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.5 mmtt -99.04 0.61 44.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.372 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 182' ' ' ARG . 0.0 OUTLIER -157.01 143.46 18.2 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.45 ' NE ' ' HB2' ' A' ' 48' ' ' TRP . 19.6 mmt180 -90.28 -25.89 20.3 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 120.615 0.245 . . . . 0.0 111.488 -171.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 182' ' ' ARG . 54.3 mtt180 -78.19 -38.06 44.22 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.425 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 18.9 tp -69.62 100.7 1.5 Allowed 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 123.247 1.499 . . . . 0.0 113.94 -168.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.716 HG23 ' CZ ' ' A' ' 176' ' ' ARG . 19.8 mt -113.53 116.1 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 112.296 -2.229 . . . . 0.0 106.597 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.25 131.93 54.6 Favored 'General case' 0 C--O 1.252 1.233 0 CA-C-O 121.833 0.825 . . . . 0.0 113.001 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.99 155.89 24.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.305 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -80.14 156.77 26.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.74 -37.32 70.85 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -57.17 -37.72 72.54 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.94 0.896 . . . . 0.0 111.062 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.33 -51.19 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.938 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 22.8 p80 -72.47 -26.7 61.9 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.277 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.24 -35.68 77.91 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.136 0.494 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -71.45 -33.78 69.66 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.434 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -71.22 -33.03 69.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.097 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 54.1 mm-40 -58.7 -50.46 73.81 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -80.07 -7.43 58.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.007 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.43 -26.95 24.45 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 77.99 47.42 8.5 Favored Glycine 0 N--CA 1.434 -1.45 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.779 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 54.7 mt -84.52 165.48 18.02 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.283 20.0 p -67.34 -87.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -169.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.68 124.93 2.01 Favored Glycine 0 CA--C 1.492 -1.384 0 C-N-CA 119.443 -1.36 . . . . 0.0 112.676 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.35 162.82 29.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -108.84 138.51 45.06 Favored 'General case' 0 CA--C 1.472 -2.04 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.47 129.35 35.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 124.662 1.226 . . . . 0.0 109.278 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.423 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 74.0 m-85 -125.4 143.12 51.13 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 115.52 9.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.99 -39.58 75.82 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.358 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.89 96.8 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.987 0.804 . . . . 0.0 109.505 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.79 32.19 41.66 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.982 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -57.73 112.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.559 0.744 . . . . 0.0 110.061 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -102.15 74.99 1.47 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.6 14.57 65.06 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 116.924 1.53 . . . . 0.0 116.924 167.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.53 114.76 16.69 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 118.585 1.193 . . . . 0.0 110.341 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -68.37 133.01 48.05 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.191 0.996 . . . . 0.0 110.388 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 5.5 mp . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.92 31.49 8.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.64 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.9 m -144.16 101.9 3.79 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.5 t -134.82 153.3 52.09 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.139 0.495 . . . . 0.0 109.831 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -137.5 88.65 2.36 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.94 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -106.55 -3.4 20.83 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.249 0.547 . . . . 0.0 110.167 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -95.63 87.43 4.71 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.136 0.493 . . . . 0.0 110.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -120.19 82.38 1.89 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -125.68 110.58 13.95 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -99.79 107.3 19.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.631 0.729 . . . . 0.0 111.327 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.6 p -95.2 44.28 1.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 123.993 0.917 . . . . 0.0 109.313 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 m 68.39 85.25 0.14 Allowed 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.444 1.098 . . . . 0.0 109.733 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.97 101.84 2.41 Favored Glycine 0 N--CA 1.423 -2.217 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -78.08 -40.44 38.46 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.914 0.387 . . . . 0.0 110.045 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.479 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 60.2 t -77.52 -56.64 1.14 Allowed Pre-proline 0 CA--C 1.56 1.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.83 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 33.2 Cg_endo -93.96 49.31 0.31 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.888 1.726 . . . . 0.0 111.221 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -67.31 115.61 7.16 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.151 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.15 -83.97 1.64 Allowed Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.5 p -171.91 154.25 3.48 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -85.78 130.48 34.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -73.27 105.07 4.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.1 130.12 36.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.103 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.478 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.6 ptmt -96.45 139.07 33.09 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.21 0.529 . . . . 0.0 109.84 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -121.03 142.66 49.6 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.737 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 64.8 m-85 -119.84 143.43 47.9 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 121.667 0.746 . . . . 0.0 112.926 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.27 112.92 16.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -94.68 127.64 40.8 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' HG2' ' HD2' ' A' ' 203' ' ' LYS . 22.4 tptm -150.2 139.35 21.17 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 t -88.55 142.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.4 mtt -86.4 75.88 9.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.469 0.652 . . . . 0.0 109.819 176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.16 112.47 2.04 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -128.72 -50.88 1.25 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.172 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -1.4 57.1 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.27 1.033 . . . . 0.0 108.621 170.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 79' ' ' TYR . . . -106.14 27.67 8.41 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 127.263 2.225 . . . . 0.0 110.507 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.585 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 124.45 68.63 0.2 Allowed Glycine 0 N--CA 1.421 -2.352 0 N-CA-C 115.889 1.116 . . . . 0.0 115.889 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -94.66 131.66 40.21 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 166.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 mt -83.01 106.92 14.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 101.814 -3.402 . . . . 0.0 101.814 162.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -76.87 -50.49 13.25 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.282 0.563 . . . . 0.0 111.126 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -116.08 166.25 12.22 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.672 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.15 134.61 94.86 Favored Pre-proline 0 C--N 1.317 -0.828 0 O-C-N 123.682 0.614 . . . . 0.0 111.641 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.91 162.64 41.94 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.675 2.25 . . . . 0.0 112.282 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -64.24 119.16 9.74 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.95 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.5 3.58 66.69 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.546 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 m -85.61 146.41 44.04 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.21 166.79 17.98 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 0.0 111.504 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.9 p -59.59 161.29 6.16 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.91 -52.17 35.24 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.204 1.402 . . . . 0.0 111.366 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.403 ' CH2' ' HE2' ' A' ' 49' ' ' LYS . 9.0 p-90 -72.12 -32.96 67.45 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HE2' ' CH2' ' A' ' 48' ' ' TRP . 4.8 mptp? -65.67 -23.65 66.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.543 ' HA ' HD21 ' A' ' 56' ' ' LEU . 72.4 m-85 -60.66 -21.36 62.72 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.029 0.442 . . . . 0.0 111.548 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 11.6 m80 -127.15 -10.38 5.89 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.33 102.3 14.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.129 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' H ' HG22 ' A' ' 178' ' ' THR . . . 57.43 -10.97 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 N-CA-C 121.867 3.507 . . . . 0.0 121.867 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.29 173.03 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 121.651 2.726 . . . . 0.0 112.667 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -91.2 142.8 27.33 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 50' ' ' PHE . 62.3 mt -91.66 -4.68 54.9 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.125 -173.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.65 -33.79 71.99 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.87 -5.3 58.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -111.89 -21.33 11.66 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -102.0 137.31 19.46 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.76 123.74 12.49 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.815 2.343 . . . . 0.0 112.347 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.5 114.99 36.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 17.13 57.2 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.23 -157.39 25.01 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.061 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 40.8 mt-10 -129.63 137.08 50.47 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.808 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 33.2 m -133.82 173.75 14.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 175.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 t -144.24 153.41 42.03 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.697 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -69.01 150.18 47.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.3 p -72.15 130.35 40.65 Favored 'General case' 0 C--N 1.276 -2.602 0 O-C-N 123.671 0.607 . . . . 0.0 109.6 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -85.83 73.72 10.31 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -105.09 -38.51 6.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -128.88 100.53 20.99 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.33 -18.36 49.98 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.425 2.75 . . . . 0.0 113.986 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.47 5.75 43.92 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 120.997 0.427 . . . . 0.0 112.092 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -77.51 127.21 32.14 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -66.75 -168.77 0.07 Allowed 'General case' 0 C--O 1.256 1.411 0 CA-C-O 123.018 1.39 . . . . 0.0 114.695 -167.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -70.69 -168.5 0.26 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 112.351 -2.204 . . . . 0.0 110.873 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -110.5 151.97 26.93 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.401 ' CE1' ' HB1' ' A' ' 34' ' ' ALA . 23.0 m-85 -109.7 -154.38 0.53 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.929 0.891 . . . . 0.0 109.093 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.46 -47.1 74.21 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.086 0.469 . . . . 0.0 111.62 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -120.21 140.49 51.09 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.585 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 21.8 tp60 -124.7 120.97 25.71 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 119.714 -0.795 . . . . 0.0 110.738 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -88.85 -174.46 1.02 Allowed 'Trans proline' 0 N--CA 1.438 -1.794 0 C-N-CA 122.396 2.064 . . . . 0.0 111.553 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -163.67 177.92 8.34 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.87 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.1 mt -90.48 -13.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 123.641 0.588 . . . . 0.0 109.426 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -81.99 -70.72 0.52 Allowed 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 181' ' ' ARG . 22.8 t -179.81 -53.73 0.01 OUTLIER 'General case' 0 C--N 1.362 1.116 0 C-N-CA 119.433 -0.907 . . . . 0.0 113.41 -167.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.63 166.39 12.96 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -170.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.4 132.17 56.75 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 56.6 tp -104.77 132.42 51.04 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.6 136.86 58.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 O-C-N 122.408 -0.183 . . . . 0.0 110.718 -174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.8 p -76.32 170.07 17.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.853 0.461 . . . . 0.0 109.87 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -66.1 -32.0 81.05 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-O 120.173 -0.237 . . . . 0.0 112.54 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -64.44 -53.39 49.18 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.152 0.501 . . . . 0.0 110.21 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -30.58 70.39 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.129 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -62.32 -44.1 97.28 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 123.587 0.755 . . . . 0.0 110.321 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -62.39 -39.46 93.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.934 0.771 . . . . 0.0 109.897 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 102' ' ' LEU . 4.1 mm? -57.62 -59.73 4.75 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.429 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -55.84 -41.34 66.13 Favored 'Isoleucine or valine' 0 C--O 1.252 1.202 0 C-N-CA 123.234 0.614 . . . . 0.0 112.578 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.55 -42.52 78.29 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.7 p -71.49 -27.38 63.19 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 98' ' ' LEU . 9.5 mp -67.58 -25.4 65.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.863 0.363 . . . . 0.0 111.567 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.03 42.41 5.98 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.17 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.3 t -81.93 101.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 m -74.87 146.99 41.45 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.609 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 80.02 12.27 1.07 Allowed 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.28 1.432 . . . . 0.0 112.56 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.48 113.89 21.54 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.02 131.48 51.23 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.48 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 53.2 m95 -111.37 123.13 49.58 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.454 -174.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.2 mt -108.92 95.11 16.19 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.8 132.98 8.97 Favored 'Trans proline' 0 C--O 1.243 0.774 0 C-N-CA 122.768 2.312 . . . . 0.0 113.222 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -150.3 167.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.98 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.635 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -102.92 116.71 33.07 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 24.4 mt -106.24 136.28 41.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.784 -172.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HG2' HG22 ' A' ' 121' ' ' VAL . 63.1 mttp -95.46 146.76 24.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 172.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.59 -160.35 0.72 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.123 0.487 . . . . 0.0 111.281 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -70.58 -23.16 62.54 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.377 1.071 . . . . 0.0 110.385 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -92.98 -19.71 21.32 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.838 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.57 12.97 33.84 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.094 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -99.42 151.16 21.41 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 117.691 0.745 . . . . 0.0 109.348 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.453 HG22 ' HG2' ' A' ' 115' ' ' LYS . 30.6 t -84.73 81.85 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.666 0.746 . . . . 0.0 110.244 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.7 m -104.45 11.64 8.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.086 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.451 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -127.39 48.11 0.99 Allowed Glycine 0 N--CA 1.422 -2.25 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.312 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 95.5 Cg_endo -84.95 -2.52 9.63 Favored 'Trans proline' 0 C--N 1.387 2.568 0 CA-C-N 121.405 2.602 . . . . 0.0 111.634 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -114.12 14.27 18.23 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.819 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.451 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 19.6 m-85 -112.8 138.24 49.92 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 111.646 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.96 138.82 52.19 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.965 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.89 125.44 29.72 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.48 HD12 ' CZ3' ' A' ' 109' ' ' TRP . 6.4 tt -102.09 125.95 48.91 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.798 0.809 . . . . 0.0 110.354 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.19 140.55 52.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.317 170.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 176' ' ' ARG . 2.8 mm? -95.79 143.64 26.85 Favored 'General case' 0 CA--C 1.501 -0.907 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.204 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.64 173.29 6.37 Favored 'General case' 0 C--N 1.277 -2.555 0 C-N-CA 122.992 0.517 . . . . 0.0 109.897 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.25 7.52 84.92 Favored Glycine 0 C--N 1.312 -0.801 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -95.39 132.35 40.53 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.63 0.728 . . . . 0.0 110.464 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -132.66 170.45 15.2 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -47.85 107.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.191 0.932 . . . . 0.0 111.391 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.692 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -94.29 -55.58 3.13 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -163.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.58 117.97 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.126 0.891 . . . . 0.0 112.886 -171.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -67.0 109.84 3.13 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 58.5 mtt -87.57 -1.92 58.26 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 142' ' ' ARG . 12.9 pt-20 -100.05 -30.26 12.06 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.032 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.539 ' HG3' ' HG3' ' A' ' 141' ' ' GLU . 59.9 mtt85 -102.18 -12.65 17.88 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 m -97.75 131.44 44.27 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.872 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -109.42 115.29 29.68 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.75 174.52 14.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.011 0.434 . . . . 0.0 111.492 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -129.46 128.62 43.28 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 91.2 mtp -100.79 155.13 18.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.261 19.4 t70 88.71 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.121 2.169 . . . . 0.0 113.076 177.027 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.0 p -101.57 -57.47 2.07 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.232 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -112.91 -24.4 9.56 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.784 0.802 . . . . 0.0 109.284 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 32.5 mt-10 -151.95 175.96 11.97 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 126.401 1.88 . . . . 0.0 106.47 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.577 ' HE2' ' N ' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -70.53 -38.32 74.22 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -98.79 26.53 5.61 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.114 1.435 . . . . 0.0 110.607 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.655 ' NE2' ' HD3' ' A' ' 181' ' ' ARG . 9.7 mm-40 -108.2 121.46 44.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.093 172.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.46 132.59 31.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -97.8 -55.98 1.11 Allowed Glycine 0 CA--C 1.495 -1.213 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.887 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -112.12 133.3 54.35 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.451 -0.374 . . . . 0.0 110.724 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.47 123.76 66.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -97.4 -39.27 9.27 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.977 0.417 . . . . 0.0 110.447 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.91 117.04 6.84 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.625 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.98 123.14 45.37 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.36 142.46 30.81 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.87 133.68 56.24 Favored 'General case' 0 C--O 1.251 1.153 0 CA-C-O 122.456 1.122 . . . . 0.0 113.001 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.692 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 18.7 p-10 -88.43 6.22 38.59 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.096 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.2 p -68.9 -4.67 17.35 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.215 1.406 . . . . 0.0 109.979 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.9 m -68.56 -40.68 80.52 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.935 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -103.6 -33.25 9.06 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.196 -0.315 . . . . 0.0 110.864 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 62.1 mt -91.8 146.01 6.82 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.468 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 1.6 mpp_? -64.85 125.79 89.7 Favored Pre-proline 0 C--N 1.309 -1.168 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -4.77 9.86 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 123.976 3.117 . . . . 0.0 114.658 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 3.9 p30 -83.56 -10.68 58.13 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.244 -0.285 . . . . 0.0 111.177 177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.53 138.74 53.56 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.284 0.564 . . . . 0.0 111.076 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.97 -30.0 24.61 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.214 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 27.1 ttt -148.99 130.42 14.77 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.68 178.45 8.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 123.296 0.373 . . . . 0.0 110.609 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.563 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 ppt_? -148.54 138.26 22.15 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 59.6 m -78.17 153.37 32.11 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.973 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 51' ' ' HIS . 7.3 p -81.52 -50.38 9.46 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -97.81 30.13 3.12 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -155.64 127.17 7.29 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.655 ' HD3' ' NE2' ' A' ' 154' ' ' GLN . 1.8 mpt_? -81.0 -40.99 23.41 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.043 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -86.51 -7.12 58.65 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.175 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.8 tp -88.2 104.2 16.49 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 122.094 0.95 . . . . 0.0 111.902 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.71 123.18 69.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.22 128.85 51.99 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.343 0.592 . . . . 0.0 110.54 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 45.8 pt -112.0 148.86 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.736 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 29.6 ttt85 -80.73 156.18 26.37 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -50.56 -38.22 43.93 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.955 0.902 . . . . 0.0 112.487 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -59.63 -39.79 85.5 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.112 1.365 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.45 -51.34 47.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.737 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.575 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 18.3 p80 -68.92 -27.86 66.14 Favored 'General case' 0 C--O 1.198 -1.621 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.387 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.41 -32.18 72.12 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.562 0.539 . . . . 0.0 111.248 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -76.05 -33.9 59.6 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.201 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -71.72 -32.12 67.42 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.218 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 70.2 mm-40 -55.68 -53.85 51.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.815 0.846 . . . . 0.0 109.149 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -76.88 -20.72 55.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.246 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.81 -27.98 44.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.61 0.243 . . . . 0.0 110.66 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 75.04 47.76 12.72 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.225 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.78 165.3 23.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -45.75 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -159.83 132.76 3.08 Favored Glycine 0 CA--C 1.5 -0.903 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.67 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -135.84 165.31 25.92 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.4 ' HD2' ' HG2' ' A' ' 28' ' ' LYS . 16.9 ptpt -128.47 131.81 48.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 173.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.59 130.25 71.69 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.009 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -113.04 153.16 28.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.64 112.02 9.34 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.9 -36.96 84.84 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 123.829 0.705 . . . . 0.0 112.068 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.63 94.92 1.04 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.51 35.19 14.52 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.622 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -58.64 100.63 0.07 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.513 0.725 . . . . 0.0 111.492 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -104.39 126.54 51.58 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 67.39 -26.49 0.21 Allowed Glycine 0 N--CA 1.483 1.819 0 N-CA-C 120.298 2.879 . . . . 0.0 120.298 163.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.22 115.15 24.42 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 118.899 1.349 . . . . 0.0 111.602 -172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -82.69 134.66 35.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.753 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.794 1.638 . . . . 0.0 111.577 171.071 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.202 0.525 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.26 93.33 1.27 Allowed Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -85.96 -51.87 6.08 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.2 t -163.1 100.49 0.97 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.419 0.628 . . . . 0.0 110.818 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -115.14 -33.6 5.31 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -129.1 140.53 51.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -103.57 156.39 17.81 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.673 0.273 . . . . 0.0 110.512 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -78.69 133.9 37.16 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.0 t60 72.4 106.85 0.07 Allowed 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 125.078 1.351 . . . . 0.0 110.525 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.292 3.0 p-80 80.29 121.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 127.388 2.275 . . . . 0.0 113.042 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 m -94.01 -37.64 11.55 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.3 m -93.34 127.09 38.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.86 -5.66 47.24 Favored Glycine 0 C--N 1.314 -0.665 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.479 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.75 110.28 6.97 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.68 105.96 30.15 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.31 -71.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.912 1.742 . . . . 0.0 114.726 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 60.62 75.79 0.39 Allowed 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.526 1.13 . . . . 0.0 109.355 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.99 71.37 0.9 Allowed Glycine 0 C--N 1.306 -1.094 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.184 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m 73.13 -33.58 0.27 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.741 1.617 . . . . 0.0 113.979 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.0 m80 63.59 -108.29 0.22 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 86.3 mmm 59.35 22.33 10.71 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.002 0.906 . . . . 0.0 111.108 -171.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.5 110.48 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -75.0 155.57 37.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.043 0.449 . . . . 0.0 112.111 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -110.35 138.33 46.89 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.929 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 204' ' ' VAL . 65.1 m-85 -125.76 147.52 49.37 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.31 0.576 . . . . 0.0 112.156 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.1 t -78.3 124.85 37.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 171.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -96.43 135.24 38.57 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.601 0.715 . . . . 0.0 112.154 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -149.78 162.95 39.27 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 81' ' ' PHE . 21.8 t -104.59 143.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.4 ttm -96.55 80.55 3.13 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.47 114.75 4.16 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.018 -177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -125.43 -33.67 2.78 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.86 -0.53 57.44 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.37 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.98 -31.96 20.32 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 172.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.6 161.1 33.43 Favored Glycine 1 N--CA 1.383 -4.862 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.902 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 47.9 m-85 -95.97 164.14 12.84 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.06 101.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 102.765 -3.05 . . . . 0.0 102.765 164.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -54.0 -51.18 64.79 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 125.131 1.519 . . . . 0.0 113.174 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -146.81 153.61 40.39 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 40' ' ' LEU . 6.6 mp -48.98 121.16 10.18 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.016 1.326 . . . . 0.0 113.593 -175.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 67' ' ' SER . 31.1 Cg_endo -75.59 167.03 27.34 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.472 2.115 . . . . 0.0 111.161 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -54.66 128.82 34.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.211 0.604 . . . . 0.0 112.539 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.26 3.57 81.94 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.611 -0.722 . . . . 0.0 113.585 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m -85.47 128.93 57.21 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -55.73 165.7 3.39 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.616 3.544 . . . . 0.0 112.799 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 p -54.2 147.08 13.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 50' ' ' PHE . 4.0 m-20 -38.19 -56.81 1.15 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 127.059 2.143 . . . . 0.0 114.32 -173.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.434 ' HB2' ' HD2' ' A' ' 181' ' ' ARG . 23.9 p-90 -85.88 -16.08 39.74 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.835 -174.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -86.66 -13.19 46.26 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 120.556 -0.458 . . . . 0.0 112.019 -171.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HD2' ' O ' ' A' ' 47' ' ' ASP . 65.9 m-85 -48.66 -27.64 2.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 130' ' ' ASN . 46.8 m170 -127.84 1.24 6.02 Favored 'General case' 0 CA--C 1.493 -1.224 0 O-C-N 121.582 -0.699 . . . . 0.0 111.319 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -92.84 102.15 14.53 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.587 -167.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.14 -9.84 0.98 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.18 164.81 30.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 119.516 1.658 . . . . 0.0 110.431 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -91.38 143.7 26.35 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.8 0.12 56.82 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.206 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.56 -37.97 52.16 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -90.38 -15.39 31.13 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 178.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -107.49 -23.1 12.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.631 -0.668 . . . . 0.0 112.66 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -97.46 134.71 22.27 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.8 122.09 9.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.462 1.441 . . . . 0.0 110.805 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.12 127.59 54.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.2 16.49 66.91 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -101.3 -167.44 27.81 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.613 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.2 mt-10 -116.96 137.75 52.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.48 163.1 38.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 41' ' ' PRO . 28.7 t -146.29 148.16 32.14 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.046 -176.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -68.59 116.59 9.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -68.94 151.32 46.69 Favored 'General case' 0 N--CA 1.411 -2.407 0 O-C-N 124.026 0.829 . . . . 0.0 111.71 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -83.61 58.84 4.8 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 122.251 1.024 . . . . 0.0 109.823 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -95.2 -29.53 14.48 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.017 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -131.37 106.11 14.62 Favored Pre-proline 0 N--CA 1.432 -1.33 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.85 142.63 32.04 Favored 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.567 2.178 . . . . 0.0 112.434 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.7 t70 64.81 88.79 0.1 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.062 1.345 . . . . 0.0 112.387 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.443 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 19.7 t-20 -152.52 154.91 36.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 77' ' ' ASN . 6.0 mmp_? -84.19 -162.2 0.63 Allowed 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 3.4 p-10 -86.41 -170.16 2.96 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.873 1.269 . . . . 0.0 113.143 -176.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 5.1 mp -87.89 144.51 26.54 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.367 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -103.82 -175.9 2.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -57.58 -41.28 80.81 Favored 'General case' 0 N--CA 1.511 2.623 0 CA-C-O 121.591 0.71 . . . . 0.0 112.18 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.421 ' O ' HG11 ' A' ' 29' ' ' VAL . 95.8 m-85 -118.36 134.91 54.66 Favored 'General case' 0 C--N 1.266 -3.043 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 172.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -121.77 129.5 25.15 Favored Pre-proline 0 C--N 1.283 -2.307 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.182 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.22 171.72 13.57 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 C-N-CA 122.463 2.108 . . . . 0.0 111.734 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 36' ' ' TYR . 5.1 p30 -160.08 173.65 15.49 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.8 mt -96.7 14.89 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-O 123.109 1.433 . . . . 0.0 109.184 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -121.3 -176.09 3.21 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.722 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 m -98.09 46.9 1.0 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -127.63 162.02 27.49 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 121.539 -0.726 . . . . 0.0 109.603 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.8 tp -122.99 129.86 52.06 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 42.2 tp -102.27 123.79 46.72 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -123.61 138.05 54.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 122.791 0.436 . . . . 0.0 110.014 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -76.99 174.0 11.13 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 122.639 0.376 . . . . 0.0 111.119 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.61 -37.25 67.95 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.396 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -72.96 -35.0 66.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.103 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.38 -34.38 70.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 100' ' ' GLU . 64.8 ttt180 -57.84 -46.24 85.05 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.02 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -55.17 -38.4 68.26 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.28 -51.21 69.86 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 78.2 mt -61.53 -41.66 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.069 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 8.4 mm-40 -69.19 -36.79 77.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.222 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -74.9 -29.6 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.26 -19.66 56.23 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.245 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.45 48.71 5.2 Favored Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.804 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 174' ' ' MET . 97.2 t -82.69 101.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.0 m -77.04 150.44 35.76 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.332 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.1 9.2 1.4 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.391 1.476 . . . . 0.0 113.3 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -94.49 113.8 25.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.447 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 9.1 tp10 -99.41 139.82 34.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.467 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 57.0 m95 -116.96 121.74 42.27 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.938 0.774 . . . . 0.0 109.851 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -116.41 93.31 39.49 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.1 139.82 21.91 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.858 2.372 . . . . 0.0 113.894 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 64' ' ' GLY . 4.3 m -150.75 170.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 124.52 1.128 . . . . 0.0 109.522 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -96.95 116.21 28.79 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 174.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -108.36 130.17 61.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.423 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 121' ' ' VAL . 57.8 mttm -96.7 135.27 38.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -169.82 2.45 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.983 0.356 . . . . 0.0 110.528 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.443 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 63.2 m80 -59.59 -31.15 69.2 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.022 0.929 . . . . 0.0 111.147 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -87.52 -3.01 59.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.64 12.46 64.47 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -105.34 147.73 27.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 118.461 1.13 . . . . 0.0 110.553 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 115' ' ' LYS . 45.9 t -81.65 90.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.715 0.769 . . . . 0.0 110.34 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.9 6.22 7.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.076 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.06 45.28 1.17 Allowed Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 119.309 -1.424 . . . . 0.0 116.072 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 78.3 Cg_endo -84.04 -1.44 9.9 Favored 'Trans proline' 0 C--N 1.381 2.251 0 CA-C-N 122.222 3.011 . . . . 0.0 111.02 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -92.64 -9.22 41.75 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -98.43 149.55 22.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.637 0.732 . . . . 0.0 112.707 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -135.0 140.18 45.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.472 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -81.23 122.89 27.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.467 HD12 ' CZ3' ' A' ' 109' ' ' TRP . 6.9 tt -99.71 128.55 45.81 Favored 'General case' 0 C--O 1.275 2.434 0 CA-C-O 121.819 0.819 . . . . 0.0 110.914 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.19 140.65 52.67 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.611 174.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.7 140.09 36.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.99 173.76 6.59 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 124.183 0.927 . . . . 0.0 109.39 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.88 22.13 50.59 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.134 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -100.43 132.96 45.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.416 0.627 . . . . 0.0 111.164 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -132.72 150.64 52.13 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -50.13 105.43 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 122.139 0.971 . . . . 0.0 113.453 -170.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -117.14 -34.1 4.47 Favored 'General case' 0 N--CA 1.398 -3.068 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -167.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 179' ' ' LYS . 41.2 mt -54.62 112.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.517 0.675 . . . . 0.0 111.67 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.85 128.88 36.81 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.189 -1.823 . . . . 0.0 111.668 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.4 mtt -101.79 4.62 40.61 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.505 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 11.4 pt-20 -88.93 -30.09 19.08 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.797 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.505 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 3.1 mmp_? -109.55 -28.07 9.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.875 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.2 m -83.09 138.68 33.6 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.661 0.743 . . . . 0.0 112.471 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.97 113.87 17.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -153.67 163.17 40.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 123.199 0.312 . . . . 0.0 111.244 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.66 139.15 52.39 Favored 'General case' 0 C--O 1.253 1.255 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.299 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 60.2 mtt -100.63 108.57 20.5 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -173.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.7 t70 169.4 79.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.423 1.889 . . . . 0.0 108.198 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 34.8 t -99.0 -57.17 2.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.418 ' HB2' ' HG3' ' A' ' 154' ' ' GLN . 80.0 mt -107.58 -51.98 2.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 -165.97 2.27 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.571 175.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 147' ' ' MET . 53.8 pttt -59.68 -27.77 66.7 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.11 12.53 35.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.716 0.77 . . . . 0.0 111.892 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 149' ' ' SER . 26.0 mm-40 -111.96 116.09 30.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.51 131.32 35.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -109.22 -72.25 0.73 Allowed Glycine 0 CA--C 1.495 -1.183 0 C-N-CA 119.988 -1.101 . . . . 0.0 111.151 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -82.91 127.19 33.29 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 58.5 mt -129.98 121.55 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -89.06 -39.3 13.75 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.133 0.492 . . . . 0.0 109.728 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.98 134.35 16.2 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.59 120.76 37.64 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.14 146.79 26.41 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.95 135.18 57.16 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.828 0.705 . . . . 0.0 111.255 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.595 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 13.0 p-10 -92.76 14.04 18.43 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.279 1.038 . . . . 0.0 111.082 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.1 p -68.56 -5.14 18.11 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.755 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.4 m -62.8 -35.51 80.11 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 124.187 0.995 . . . . 0.0 110.457 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.42 -31.15 6.9 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.104 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.523 HG13 ' HB2' ' A' ' 137' ' ' ALA . 85.7 mt -90.64 154.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.457 ' HD2' ' OD1' ' A' ' 171' ' ' ASP . 8.3 mmt180 -45.07 119.38 4.01 Favored Pre-proline 0 C--O 1.225 -0.23 0 C-N-CA 123.466 0.706 . . . . 0.0 112.542 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.05 -16.54 25.46 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.093 1.862 . . . . 0.0 111.109 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.457 ' OD1' ' HD2' ' A' ' 169' ' ' ARG . 7.8 p-10 -98.06 9.69 42.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.537 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.76 142.55 58.39 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.181 0.515 . . . . 0.0 109.834 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.06 -36.07 15.11 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.971 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.445 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.6 ttt -153.19 118.9 5.32 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -140.33 -179.7 6.15 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.74 145.01 50.66 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 39.5 m -82.47 147.95 28.42 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 40.6 p -80.54 -45.66 17.07 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.452 ' HB2' HD12 ' A' ' 138' ' ' ILE . 65.6 mttp -79.62 17.62 0.87 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.5 150.18 34.06 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.434 ' HD2' ' HB2' ' A' ' 48' ' ' TRP . 4.9 mmp_? -91.95 -43.59 9.37 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.875 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 50.3 mtm180 -83.66 -33.84 25.15 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.394 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.88 102.3 0.19 Allowed 'General case' 0 C--O 1.239 0.547 0 O-C-N 124.416 1.072 . . . . 0.0 113.187 -170.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 51' ' ' HIS . 87.1 mt -112.88 126.83 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 113.291 -1.777 . . . . 0.0 107.18 176.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.98 122.94 46.26 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.445 HG22 ' HG3' ' A' ' 174' ' ' MET . 49.2 pt -111.66 151.08 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -86.72 163.11 17.51 Favored 'General case' 0 C--N 1.278 -2.506 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.547 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 15.0 tp10 -50.44 -48.38 56.42 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 125.187 1.395 . . . . 0.0 111.872 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -63.98 -31.17 72.26 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.329 0.652 . . . . 0.0 111.558 -177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.83 -48.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.75 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.571 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 24.9 p80 -71.52 -33.04 68.85 Favored 'General case' 0 C--O 1.211 -0.946 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.699 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.09 72.75 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.554 0.534 . . . . 0.0 110.457 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.15 75.11 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.616 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.77 -40.57 75.98 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.034 0.445 . . . . 0.0 110.442 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 37.8 mt-10 -62.08 -47.55 84.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.149 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -71.87 -19.27 61.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.683 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.21 -24.24 47.14 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.656 0.265 . . . . 0.0 111.033 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.91 47.74 5.46 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.304 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 42.6 mt -89.63 165.83 13.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.2 p -50.27 -91.11 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.66 143.42 11.44 Favored Glycine 0 CA--C 1.497 -1.086 0 C-N-CA 119.532 -1.318 . . . . 0.0 112.935 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.79 165.73 24.61 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -133.06 128.59 36.57 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 170.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 15.6 m -132.53 129.92 59.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 123.687 0.617 . . . . 0.0 110.092 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.08 147.05 49.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.63 114.76 3.17 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.019 0.824 . . . . 0.0 109.68 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.57 61.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.104 0.253 . . . . 0.0 111.618 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.64 98.69 1.54 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-O 121.243 0.544 . . . . 0.0 110.542 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.27 35.73 16.81 Favored Glycine 0 N--CA 1.422 -2.284 0 CA-C-O 119.179 -0.79 . . . . 0.0 111.594 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -52.74 106.3 0.15 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.694 0.759 . . . . 0.0 110.045 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -98.72 99.65 10.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.837 -171.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.93 -23.16 0.31 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 119.022 2.369 . . . . 0.0 119.022 167.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 69.6 mt -68.11 147.08 52.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -107.31 134.6 50.15 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.61 ' H ' HD12 ' A' ' 215' ' ' LEU . 4.7 mp . . . . . 0 CA--C 1.556 1.176 0 C-N-CA 125.674 1.59 . . . . 0.0 112.426 -174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 C--O 1.236 0.388 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.63 100.24 2.04 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 m -87.62 -75.3 0.41 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.659 0.23 . . . . 0.0 110.608 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -78.9 -48.89 13.77 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 120.84 0.352 . . . . 0.0 110.152 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.306 13.0 p80 -94.02 46.71 1.18 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.406 1.098 . . . . 0.0 112.466 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -77.12 -20.8 55.14 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 171.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -119.6 114.23 21.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.269 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 178.15 -61.83 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -143.86 79.09 1.61 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.47 0.652 . . . . 0.0 109.25 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -137.27 77.04 1.62 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 m -135.51 96.67 3.5 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.7 p -83.68 174.21 10.69 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.684 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.77 -120.83 0.8 Allowed Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp 56.1 43.86 26.23 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.665 0.745 . . . . 0.0 110.254 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -89.12 118.01 68.78 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.406 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.11 108.72 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.968 2.445 . . . . 0.0 109.352 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -153.33 138.49 17.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.837 -171.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.55 168.04 11.25 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -71.08 -47.83 56.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -138.88 97.0 3.22 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 170.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -73.37 138.39 45.29 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.432 HG13 ' HG2' ' A' ' 188' ' ' GLU . 52.4 t -93.71 109.74 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 7.7 ptpp? -81.17 147.84 29.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.444 -177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -109.17 133.15 53.39 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.629 -174.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' CE2' ' HG3' ' A' ' 23' ' ' LYS . 76.3 m-85 -118.79 145.09 45.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.656 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 58.5 t -75.99 124.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 172.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -97.81 124.37 42.16 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 123.428 0.455 . . . . 0.0 111.591 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -137.46 147.44 45.31 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.7 133.73 40.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.5 ttt -91.19 82.18 5.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.783 0.801 . . . . 0.0 110.01 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.58 116.88 5.68 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 113.92 -1.491 . . . . 0.0 107.207 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.49 -36.54 2.07 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -83.25 -23.3 32.78 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.133 0.973 . . . . 0.0 109.982 179.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . . . -67.22 -34.49 77.59 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.74 154.12 30.79 Favored Glycine 1 N--CA 1.392 -4.259 0 CA-C-N 113.773 -1.558 . . . . 0.0 112.909 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -96.13 166.95 11.5 Favored 'General case' 0 C--N 1.254 -3.571 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' ' 41' ' ' PRO . 44.6 mt -75.74 101.73 2.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 165.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -63.36 -45.64 90.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.676 -1.602 . . . . 0.0 112.659 -167.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.38 177.08 7.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.041 0.536 . . . . 0.0 110.163 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -67.38 122.82 84.74 Favored Pre-proline 0 C--N 1.32 -0.687 0 O-C-N 123.808 0.692 . . . . 0.0 112.604 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' ' 37' ' ' ILE . 14.1 Cg_exo -69.82 166.7 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.776 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -48.92 113.51 0.8 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.95 1.3 . . . . 0.0 113.395 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.34 13.78 72.88 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.975 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 m -85.13 143.31 39.41 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.52 165.86 16.84 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.931 3.087 . . . . 0.0 111.503 172.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.1 p -62.09 155.82 23.16 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 86' ' ' MET . 4.2 m-20 -46.07 -52.71 11.52 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.096 1.358 . . . . 0.0 113.027 -175.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 30.7 p-90 -73.35 -23.72 60.25 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -74.53 -23.68 58.84 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.41 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 96.1 m-85 -58.79 -24.9 62.54 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.628 ' CD2' ' HB2' ' A' ' 176' ' ' ARG . 9.0 m80 -114.61 2.29 14.49 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.79 100.65 12.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 118.428 -1.309 . . . . 0.0 111.468 -172.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.97 -11.79 0.01 OUTLIER Glycine 0 CA--C 1.555 2.542 0 N-CA-C 121.238 3.255 . . . . 0.0 121.238 166.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.06 166.04 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 121.15 2.475 . . . . 0.0 112.191 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.43 ' HB2' ' HG ' ' A' ' 132' ' ' LEU . 32.5 t -84.54 153.73 23.09 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.56 11.6 39.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -170.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.3 -31.55 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -13.24 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.925 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.32 -22.8 13.29 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.479 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -109.51 137.37 20.3 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.88 122.62 10.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.14 1.893 . . . . 0.0 111.979 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.0 t -97.49 115.64 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.34 55.66 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -100.8 -156.28 27.39 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 33.9 mt-10 -128.83 133.31 47.95 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 122.468 -0.431 . . . . 0.0 110.894 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 18.8 m -131.81 166.61 28.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.461 ' OG ' ' HE2' ' A' ' 115' ' ' LYS . 20.0 m -145.62 156.52 43.72 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 5.9 m-85 -74.84 105.8 6.07 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.938 0.774 . . . . 0.0 109.805 175.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.9 p -84.15 131.33 34.78 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.02 143.24 28.22 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.937 -172.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -97.07 -39.32 9.38 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 80.7 t80 -176.66 -54.07 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.1 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 72' ' ' TYR . 12.1 Cg_exo -72.94 114.16 3.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 121.496 1.464 . . . . 0.0 111.644 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -90.72 88.77 7.22 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -90.04 -172.58 3.55 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.644 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -82.69 -161.81 0.52 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -80.4 -176.22 5.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.659 1.184 . . . . 0.0 112.59 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 122' ' ' VAL . 8.4 mp -94.04 150.99 19.85 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 34' ' ' ALA . 20.9 m-85 -110.06 -154.7 0.54 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.761 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -71.11 -38.34 72.35 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.156 0.503 . . . . 0.0 111.739 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.54 138.98 52.52 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 18.2 tp60 -122.53 114.08 30.33 Favored Pre-proline 0 N--CA 1.414 -2.231 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.5 159.33 28.93 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 C-N-CA 122.171 1.914 . . . . 0.0 111.356 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.47 171.8 8.82 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.5 mm -88.71 -18.34 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.475 ' HG3' ' OD2' ' A' ' 47' ' ' ASP . 4.7 mpp? -80.74 -95.91 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.151 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 181' ' ' ARG . 43.2 t -175.89 34.97 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.485 1.136 . . . . 0.0 110.048 -174.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -136.86 154.33 50.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.714 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.3 tp -112.81 139.9 48.05 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 59.3 tp -112.18 130.02 56.05 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.16 135.95 61.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.257 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.8 p -71.51 169.63 15.04 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 96' ' ' ARG . . . -63.89 -39.94 97.85 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.149 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -75.74 -32.7 60.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.058 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.48 -28.19 63.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.876 0.37 . . . . 0.0 110.048 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.492 ' HG2' ' CZ3' ' A' ' 109' ' ' TRP . 69.1 mtp180 -58.81 -43.12 90.49 Favored 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.854 172.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.9 mmpt? -61.47 -35.31 77.27 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 123.527 0.517 . . . . 0.0 111.359 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.85 -58.29 7.92 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.884 0.373 . . . . 0.0 110.115 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.16 -44.25 94.85 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.042 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.22 -37.42 87.2 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.0 p -75.65 -27.4 58.36 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.018 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -72.3 -24.38 61.32 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.738 173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.11 48.45 6.92 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.8 t -69.8 104.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-O 121.818 0.818 . . . . 0.0 110.944 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 m -55.31 123.87 15.22 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.503 -1.68 . . . . 0.0 111.799 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 78.21 15.08 1.41 Allowed 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 125.521 1.528 . . . . 0.0 113.835 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -84.2 114.24 21.67 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.5 tp10 -105.84 144.92 31.9 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.237 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.527 ' CZ3' HD12 ' A' ' 129' ' ' LEU . 64.9 m95 -116.3 119.66 36.44 Favored 'General case' 0 N--CA 1.425 -1.702 0 O-C-N 124.363 1.04 . . . . 0.0 109.009 -176.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 66.3 mt -110.92 93.36 17.11 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.46 139.49 10.27 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.647 2.231 . . . . 0.0 112.73 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 64' ' ' GLY . 4.1 m -147.5 173.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 108.777 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -99.66 116.16 31.11 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 172.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 29.9 mt -108.44 132.21 56.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.2 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 mppt? -101.12 132.3 46.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.54 ' HB3' HG11 ' A' ' 122' ' ' VAL . 2.8 p-10 -82.19 -160.37 0.37 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.54 0.736 . . . . 0.0 112.524 -172.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -67.55 -32.77 73.77 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 123.746 0.818 . . . . 0.0 110.391 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -77.11 -21.21 54.6 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.52 36.91 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.109 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.62 157.66 16.31 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.47 103.44 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 116' ' ' ASP . 12.9 p -103.38 -29.08 2.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.901 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -127.98 76.52 0.4 Allowed Glycine 0 N--CA 1.407 -3.292 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.869 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -79.72 -23.03 7.3 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 CA-C-N 119.478 1.639 . . . . 0.0 112.651 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -116.96 4.16 12.82 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.652 0.739 . . . . 0.0 111.049 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -72.33 142.05 48.82 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.81 49.56 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.649 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -81.45 127.93 33.33 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.495 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 6.8 tt -103.85 126.28 50.87 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.568 0.699 . . . . 0.0 110.417 -176.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -125.79 141.74 51.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.203 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 176' ' ' ARG . 2.9 mm? -99.79 129.22 45.87 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.999 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 55' ' ' SER . 7.4 mp -87.62 173.1 9.25 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.344 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.12 22.9 78.61 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.305 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -101.27 131.94 47.04 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.11 0.481 . . . . 0.0 109.85 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.48 170.71 15.21 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.597 ' OD2' ' HE2' ' A' ' 179' ' ' LYS . 23.6 t70 -56.04 104.96 0.16 Allowed 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.164 0.915 . . . . 0.0 110.712 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -125.03 -36.13 2.58 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 -166.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 179' ' ' LYS . 31.6 mt -63.2 116.13 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.199 0.909 . . . . 0.0 111.123 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.11 128.95 36.03 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.998 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 47.0 ttm -105.21 1.42 28.19 Favored 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 121.061 0.457 . . . . 0.0 111.93 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.24 -50.64 5.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.987 0.899 . . . . 0.0 109.778 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -82.26 -4.9 58.03 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.37 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.8 p -106.2 162.97 13.18 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.183 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -126.75 93.71 3.85 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -150.94 161.97 41.71 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 9.0 mm-40 -121.98 141.62 51.14 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 125.358 1.463 . . . . 0.0 108.252 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 155' ' ' ILE . 81.8 mtp -100.84 107.57 19.14 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -166.61 15.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -169.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 t -69.6 -55.76 9.2 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.793 -0.567 . . . . 0.0 112.03 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 47.1 mt -136.56 -62.24 0.66 Allowed 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -116.82 170.36 8.67 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 111.8 -2.455 . . . . 0.0 105.796 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 147' ' ' MET . 0.0 OUTLIER -61.03 -39.6 90.4 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 124.09 0.956 . . . . 0.0 109.502 -176.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.89 -10.31 59.53 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.862 1.265 . . . . 0.0 111.683 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -102.01 115.5 30.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 147' ' ' MET . 46.3 mt -72.07 130.62 35.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.904 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -105.3 -75.57 1.01 Allowed Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.021 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 5.6 t30 -82.97 120.43 25.7 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.11 113.1 34.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.32 -29.82 15.45 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.79 113.98 2.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.185 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.11 121.87 33.27 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -96.02 140.65 30.46 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.96 140.34 58.85 Favored 'General case' 0 C--O 1.255 1.373 0 O-C-N 124.258 0.974 . . . . 0.0 113.605 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.479 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.9 p-10 -93.46 6.51 47.93 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.254 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.0 p -67.44 -4.8 12.27 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.909 1.283 . . . . 0.0 110.401 174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 14.1 m -63.85 -38.33 90.69 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.702 172.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.57 -31.37 6.8 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.875 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 78.5 mt -89.37 139.06 18.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 30.1 mmt180 -59.92 122.61 67.06 Favored Pre-proline 0 C--N 1.316 -0.858 0 O-C-N 123.489 0.493 . . . . 0.0 109.94 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 6.6 Cg_exo -69.46 -7.97 22.37 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.486 2.124 . . . . 0.0 113.265 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.36 1.86 56.81 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.364 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.16 125.42 26.61 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 17.7 tttt -72.31 -27.18 62.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.372 0.606 . . . . 0.0 112.066 -170.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.509 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.5 ttt -154.16 131.43 11.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -141.6 171.19 14.41 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.102 0.477 . . . . 0.0 111.475 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.628 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.3 OUTLIER -136.69 126.83 26.21 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.715 -176.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 25.6 m -74.54 142.91 44.7 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.635 -176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 36.7 p -81.51 -39.52 24.59 Favored 'General case' 0 C--O 1.203 -1.388 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.597 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 69.2 mmtt -74.43 11.2 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -174.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.94 140.69 4.64 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 87' ' ' SER . 7.1 mmt180 -90.18 -31.66 16.95 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -169.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -83.95 -28.96 27.44 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.315 0.579 . . . . 0.0 110.277 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.61 111.0 5.13 Favored 'General case' 0 C--O 1.254 1.318 0 CA-C-O 122.305 1.05 . . . . 0.0 113.237 -173.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.57 129.73 74.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.91 129.85 56.79 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.382 0.611 . . . . 0.0 111.288 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.509 HG22 ' HG3' ' A' ' 174' ' ' MET . 45.4 pt -116.1 157.74 16.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.017 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.471 ' CD ' ' HA ' ' A' ' 173' ' ' LYS . 48.2 mtp180 -85.85 162.33 18.69 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.509 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.8 pt-20 -57.44 -36.22 71.11 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.452 ' OD2' ' HE2' ' A' ' 173' ' ' LYS . 5.1 p-10 -64.33 -32.38 73.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.43 0.456 . . . . 0.0 111.615 -177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.31 -48.9 79.51 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.637 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.505 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 17.8 p80 -73.62 -25.46 60.32 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.749 -1.181 . . . . 0.0 110.488 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.03 74.1 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.414 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.12 -36.08 69.3 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -70.43 -33.25 71.12 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.3 mm-40 -58.51 -45.61 88.42 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.707 0.765 . . . . 0.0 109.41 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -85.81 -12.42 50.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.225 -175.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -85.42 -27.92 25.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.728 0.299 . . . . 0.0 110.73 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.88 48.37 27.7 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.015 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.09 165.34 19.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.8 p -41.49 -62.5 0.86 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -173.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -175.42 140.35 5.17 Favored Glycine 0 CA--C 1.499 -0.965 0 C-N-CA 118.431 -1.842 . . . . 0.0 113.21 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -142.31 161.91 36.81 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.9 mmpt? -139.16 122.05 16.61 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.1 m -124.19 142.35 41.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.45 142.25 50.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.04 108.83 3.23 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.31 -30.42 66.22 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.432 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.67 92.11 1.15 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.88 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 84.17 31.12 26.44 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.588 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.2 t90 -58.19 101.62 0.08 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 110.967 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -104.01 120.95 42.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 75.67 -25.43 1.43 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 118.684 2.234 . . . . 0.0 118.684 168.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 99.1 mt -78.53 143.67 36.35 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 118.619 1.209 . . . . 0.0 112.923 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.63 134.57 49.57 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.532 ' H ' HD12 ' A' ' 215' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.478 0.971 0 O-C-N 124.259 0.974 . . . . 0.0 110.67 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.9 49.25 0.79 Allowed Glycine 0 CA--C 1.495 -1.191 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -81.6 125.66 30.8 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 115.006 -0.597 . . . . 0.0 109.504 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -132.12 145.93 51.71 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -71.93 114.31 9.89 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -78.96 112.67 16.38 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.799 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -80.04 -26.39 39.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.838 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -89.73 9.7 26.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.589 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.91 103.54 16.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -140.4 113.59 8.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 m -84.95 -73.66 0.43 Allowed 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.2 t 178.34 160.62 0.59 Allowed 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.95 70.43 2.54 Favored Glycine 0 C--N 1.317 -0.501 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.26 87.49 7.39 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.087 0.47 . . . . 0.0 111.542 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.57 130.9 14.72 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.56 91.1 0.59 Allowed 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 122.118 1.879 . . . . 0.0 111.155 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.04 -64.61 1.28 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.244 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.88 -113.51 4.79 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -173.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -118.44 124.09 46.8 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -136.77 131.21 33.08 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -86.1 111.49 20.38 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.36 139.08 37.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -87.61 134.4 33.64 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.885 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -109.67 145.23 36.87 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.199 0.523 . . . . 0.0 111.33 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -128.53 150.84 50.0 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.425 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 61.7 t -80.99 126.31 39.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -95.0 117.42 30.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.458 0.474 . . . . 0.0 110.719 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HG3' ' C ' ' A' ' 215' ' ' LEU . 1.2 tmtp? -135.68 139.28 43.57 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.64 122.98 49.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.6 ptp -76.07 84.58 2.93 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.976 0.893 . . . . 0.0 111.438 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . -145.17 112.38 6.08 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.274 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.424 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 38.2 mt-10 -131.18 -37.19 1.27 Allowed 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -84.41 -31.48 24.65 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.016 176.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.595 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . . . -72.16 -35.21 68.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 167.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.46 26.97 Favored Glycine 0 N--CA 1.42 -2.421 0 CA-C-N 114.319 -1.31 . . . . 0.0 114.478 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 32' ' ' GLU . 88.7 m-85 -90.68 166.94 12.88 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.439 HG12 ' CE1' ' A' ' 68' ' ' PHE . 49.5 mt -78.24 100.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 161.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 71' ' ' ASN . 63.7 mm-40 -59.0 -63.66 1.22 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.828 -1.533 . . . . 0.0 111.483 -171.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -125.22 175.42 7.43 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.717 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -59.81 123.7 72.92 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 124.26 0.975 . . . . 0.0 112.838 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -65.06 166.86 17.44 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.897 2.398 . . . . 0.0 112.878 175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' HG12 ' A' ' 66' ' ' VAL . 6.9 t30 -53.88 114.43 1.57 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 124.352 1.061 . . . . 0.0 112.419 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.71 12.31 62.66 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.128 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.6 m -86.38 139.71 34.01 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 167.24 24.93 Favored 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.096 3.197 . . . . 0.0 111.449 170.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -51.96 149.05 5.29 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.42 -49.56 7.1 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 127.661 2.384 . . . . 0.0 114.141 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -86.15 -30.05 22.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.863 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 21.1 tptm -80.28 -12.47 59.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.629 -171.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 51.9 m-85 -48.54 -33.71 10.08 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 123.648 0.593 . . . . 0.0 112.23 174.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -128.36 9.46 6.11 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 49' ' ' LYS . 4.3 mm-40 -87.92 102.66 14.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.446 -0.902 . . . . 0.0 112.37 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.65 -8.96 0.17 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 pt -125.91 171.29 14.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 119.181 1.491 . . . . 0.0 112.828 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -98.5 150.54 21.57 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.79 14.53 31.36 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.498 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.78 -32.39 60.05 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -88.82 -24.14 22.66 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -102.3 -22.04 14.21 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -110.79 138.38 21.07 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.75 123.4 12.59 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.291 1.994 . . . . 0.0 111.967 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.6 t -100.71 113.67 37.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 16.37 60.33 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.99 -149.56 20.35 Favored Glycine 0 C--O 1.241 0.556 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.909 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 41.4 mt-10 -132.68 138.53 47.32 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 121.098 0.475 . . . . 0.0 110.51 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 42' ' ' ASN . 29.6 m -131.15 174.51 12.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.4 p -147.31 152.72 38.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 116' ' ' ASP . 21.2 m-85 -79.36 123.63 27.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 p -56.17 135.17 53.28 Favored 'General case' 0 C--O 1.266 1.942 0 O-C-N 124.339 1.024 . . . . 0.0 109.835 174.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -77.39 66.64 3.18 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.211 1.005 . . . . 0.0 112.114 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 10.6 t30 -95.34 -30.31 13.99 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.089 -1.414 . . . . 0.0 107.537 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -143.78 89.82 7.2 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.655 172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.06 6.01 5.93 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.991 2.461 . . . . 0.0 111.134 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.82 -4.22 37.24 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.247 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -82.07 162.9 22.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -85.83 -154.62 0.21 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 121.578 0.704 . . . . 0.0 112.023 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.17 -169.54 2.64 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.585 1.554 . . . . 0.0 112.355 -176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mp -94.11 150.73 20.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.96 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -102.35 -163.07 0.97 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.727 1.211 . . . . 0.0 109.244 178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -68.75 -30.12 68.67 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.506 0.67 . . . . 0.0 109.604 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.402 ' CD1' ' HE2' ' A' ' 202' ' ' PHE . 64.8 m-85 -134.85 148.39 50.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.596 -1.184 . . . . 0.0 107.851 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 15.3 tp60 -129.93 126.55 22.52 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.0 175.26 5.04 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.315 2.01 . . . . 0.0 111.117 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.42 ' HB2' ' H ' ' A' ' 86' ' ' MET . 0.3 OUTLIER -140.19 -178.4 5.45 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.0 mt -93.02 -19.98 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.42 ' H ' ' HB2' ' A' ' 84' ' ' ASN . 3.2 mpp? -84.66 -92.39 0.08 Allowed 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.397 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 60.2 p -174.11 -29.06 0.01 OUTLIER 'General case' 0 C--N 1.369 1.421 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -70.96 115.53 10.2 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.022 0.915 . . . . 0.0 111.985 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.33 126.66 33.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.671 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 38.6 tp -93.54 122.4 35.94 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.72 136.03 59.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.414 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -71.88 156.4 39.32 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -60.16 -34.61 84.88 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.994 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -68.92 -41.78 77.7 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 120.838 0.351 . . . . 0.0 111.203 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.77 -28.92 61.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 109.958 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -59.9 -42.44 93.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.944 175.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 10.0 mmpt? -64.42 -32.56 74.23 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.217 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.21 -55.43 33.86 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 120.68 0.276 . . . . 0.0 110.385 173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.73 -41.11 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.592 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -70.79 -27.18 63.71 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.8 m -71.92 -27.09 62.59 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.516 0.674 . . . . 0.0 110.557 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.8 -9.93 59.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.077 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.74 47.94 58.43 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.16 103.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.782 0.801 . . . . 0.0 110.094 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 m -77.26 146.82 36.67 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.838 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 80.39 1.18 1.93 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 126.008 1.723 . . . . 0.0 113.001 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.62 23.28 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.8 tp10 -99.13 142.74 30.23 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -117.86 113.49 21.84 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.986 0.804 . . . . 0.0 108.887 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -106.34 100.98 32.62 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.3 134.56 9.1 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.718 2.279 . . . . 0.0 112.846 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -149.88 174.63 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -108.85 116.94 32.94 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -96.43 133.03 39.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.832 -174.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' HG2' HG22 ' A' ' 121' ' ' VAL . 61.8 mttm -92.9 129.5 38.8 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 41.8 p-10 -76.17 -163.92 0.34 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -65.51 -24.94 67.26 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.523 0.729 . . . . 0.0 110.679 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.16 -19.96 24.84 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.038 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 11.85 41.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.093 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -101.28 142.66 32.37 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.427 -0.455 . . . . 0.0 110.462 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 115' ' ' LYS . 13.7 t -78.9 88.56 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.2 m -110.59 1.38 9.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.774 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -123.94 64.5 0.54 Allowed Glycine 0 C--O 1.203 -1.806 0 C-N-CA 119.406 -1.378 . . . . 0.0 113.244 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 8.5 Cg_endo -84.0 -19.72 4.7 Favored 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 120.375 2.087 . . . . 0.0 112.61 -178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -103.65 7.76 37.45 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.218 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.462 ' HB2' HD13 ' A' ' 114' ' ' ILE . 7.9 m-85 -96.34 143.41 27.42 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.136 -176.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.34 147.65 52.4 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.71 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.4 123.53 33.04 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 108' ' ' GLU . 5.0 tt -91.11 128.14 36.81 Favored 'General case' 0 C--O 1.263 1.793 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -120.74 140.91 51.0 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.68 119.3 38.56 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.17 173.04 6.55 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.714 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.87 27.47 72.23 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.168 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -99.08 131.72 44.91 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -129.14 159.91 34.52 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 105.304 -2.109 . . . . 0.0 105.304 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.407 ' HA ' ' OG1' ' A' ' 178' ' ' THR . 13.2 t70 -66.67 112.5 4.21 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.268 0.556 . . . . 0.0 111.344 -168.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.498 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -129.83 -14.26 4.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -168.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.404 HG12 ' HB3' ' A' ' 177' ' ' CYS . 32.4 mt -61.29 117.61 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.305 -175.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -63.84 129.12 38.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.764 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 65.6 mtt -116.34 5.9 13.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.868 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -93.5 -50.21 5.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.07 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.5 mmm-85 -98.53 -31.51 11.93 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.373 0.606 . . . . 0.0 109.998 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 m -73.54 128.49 35.63 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.244 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 159' ' ' ASP . 42.7 mt-10 -107.87 112.36 24.95 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -162.01 165.39 27.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.193 0.308 . . . . 0.0 111.085 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -127.3 146.17 50.54 Favored 'General case' 0 C--O 1.25 1.081 0 O-C-N 124.583 1.177 . . . . 0.0 107.946 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.485 ' SD ' HG12 ' A' ' 155' ' ' ILE . 23.1 mmt -100.44 106.7 18.3 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.028 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 15.6 t70 170.3 76.39 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.384 1.074 . . . . 0.0 111.184 172.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 154' ' ' GLN . 5.7 p -101.53 -49.13 4.11 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 165.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 94.9 mt -131.57 -58.83 0.98 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.08 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 154' ' ' GLN . 6.5 mm-40 -114.43 -179.26 3.58 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.345 -174.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -67.52 -33.99 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.59 -1.641 . . . . 0.0 111.377 174.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 180' ' ' GLU . 9.1 p-10 -98.73 25.09 6.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 109.539 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.495 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 24.8 mm-40 -126.14 115.44 19.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.485 HG12 ' SD ' ' A' ' 147' ' ' MET . 23.6 mt -79.36 141.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -113.95 -73.44 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -81.78 121.15 26.06 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 16.3 mt -126.94 119.33 52.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 144' ' ' GLU . 15.1 m-20 -97.45 -42.28 7.8 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.576 0.703 . . . . 0.0 109.312 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.66 140.19 25.8 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.64 117.05 20.54 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.24 147.6 25.56 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.4 144.28 56.01 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.498 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.7 p-10 -93.99 10.69 32.47 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.126 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.4 p -69.69 -4.96 21.9 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.966 174.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.8 m -60.82 -39.21 88.13 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 124.297 1.039 . . . . 0.0 109.879 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.435 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -112.32 -31.84 6.71 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.322 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' ' 137' ' ' ALA . 70.2 mt -89.45 146.09 6.61 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.484 ' HD3' ' OD1' ' A' ' 171' ' ' ASP . 44.8 mtt180 -46.56 125.12 7.76 Favored Pre-proline 0 C--N 1.313 -1.018 0 C-N-CA 124.645 1.178 . . . . 0.0 113.401 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -79.46 -5.54 14.22 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.302 2.001 . . . . 0.0 109.93 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.484 ' OD1' ' HD3' ' A' ' 169' ' ' ARG . 4.2 p30 -86.97 -8.54 57.11 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.875 175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.84 136.13 50.39 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.469 ' HA ' ' CD ' ' A' ' 187' ' ' ARG . 87.5 mttt -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.406 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.9 ttt -148.9 127.05 12.06 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -150.91 -178.66 6.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -140.91 148.77 40.96 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.538 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.45 ' SG ' ' HG ' ' A' ' 183' ' ' LEU . 34.9 m -84.97 121.85 28.37 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 124.326 1.016 . . . . 0.0 109.136 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.443 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 19.5 p -55.99 -50.3 71.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -169.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -82.47 9.74 8.6 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -173.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -137.99 113.29 9.37 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.495 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 11.2 ptp180 -57.53 -39.17 76.02 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -83.4 -30.58 27.24 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.731 0.812 . . . . 0.0 111.791 -172.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.45 ' HG ' ' SG ' ' A' ' 177' ' ' CYS . 22.2 tp -63.79 101.32 0.35 Allowed 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.03 126.15 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.647 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 52.4 mt -107.63 133.81 51.54 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.432 0.634 . . . . 0.0 110.634 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.418 HG22 ' HG3' ' A' ' 174' ' ' MET . 44.4 pt -116.47 154.86 18.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.439 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.49 ' HD3' ' OD2' ' A' ' 189' ' ' ASP . 76.3 mtt180 -79.5 163.39 24.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.816 173.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 13.3 pt-20 -58.75 -36.67 74.74 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.721 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' A' ' 187' ' ' ARG . 23.3 m-20 -54.99 -45.08 75.0 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.26 1.024 . . . . 0.0 110.087 178.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.4 t -64.38 -50.32 76.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.754 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.555 ' CD2' ' HA ' ' A' ' 188' ' ' GLU . 21.5 p80 -70.75 -29.86 66.21 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.595 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.71 80.81 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 122.549 0.34 . . . . 0.0 110.491 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.7 80.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.45 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -73.64 -33.1 64.37 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 57.6 mm-40 -60.03 -47.06 87.39 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -77.23 -21.22 54.13 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.194 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.06 -27.15 59.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.728 0.299 . . . . 0.0 110.648 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.46 46.63 39.62 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.878 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 84.9 mt -82.04 166.0 20.15 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 6.7 p -53.35 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -152.51 130.75 3.15 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.316 -1.421 . . . . 0.0 112.899 -176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.402 ' HE2' ' CD1' ' A' ' 81' ' ' PHE . 66.2 m-85 -124.26 157.63 34.41 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . 0.3 OUTLIER -126.38 120.59 30.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.94 139.32 44.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.343 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.531 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 75.2 m-85 -118.59 143.17 46.97 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.346 -1.354 . . . . 0.0 107.346 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.96 102.95 4.97 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.69 97.26 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 123.987 0.804 . . . . 0.0 112.182 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.12 87.02 3.59 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 98.85 35.4 4.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -68.54 100.31 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.831 0.452 . . . . 0.0 110.576 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -103.74 133.97 47.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.52 -25.58 0.28 Allowed Glycine 0 N--CA 1.478 1.485 0 N-CA-C 119.344 2.498 . . . . 0.0 119.344 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 90.8 mt -89.45 146.64 24.5 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 118.647 1.224 . . . . 0.0 113.937 -171.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -96.28 133.08 41.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.531 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 1.7 pt? . . . . . 0 C--N 1.314 -0.936 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.397 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.33 -74.37 1.24 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 t -92.36 158.86 15.86 Favored 'General case' 0 C--O 1.259 1.566 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 m 67.34 98.32 0.05 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.777 1.631 . . . . 0.0 112.2 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -102.15 -27.89 12.63 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.1 m80 68.55 158.23 0.15 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.27 1.428 . . . . 0.0 113.346 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -140.44 110.18 6.4 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -83.9 -39.44 19.82 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.42 -173.02 3.16 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.688 0.795 . . . . 0.0 109.793 176.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -137.99 160.05 40.37 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -68.75 129.34 39.64 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -119.76 139.35 52.44 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -89.94 -40.65 5.82 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -87.19 79.03 8.71 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.612 0.72 . . . . 0.0 111.183 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.3 t -114.25 114.96 45.43 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -66.25 88.46 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.293 1.995 . . . . 0.0 114.449 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -147.82 153.39 39.12 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.63 76.7 0.55 Allowed Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.089 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -121.8 100.43 6.99 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.764 0.316 . . . . 0.0 111.481 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 177.9 -49.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.718 1.607 . . . . 0.0 108.748 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 tmt? 177.15 142.09 0.08 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.53 113.62 38.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' NZ ' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.64 155.99 23.5 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 169.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -112.36 151.21 30.03 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.297 0.57 . . . . 0.0 111.466 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -127.93 144.36 51.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 204' ' ' VAL . 79.1 t -76.8 118.02 22.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -97.94 126.1 43.18 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.536 0.684 . . . . 0.0 110.935 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -143.51 155.03 44.22 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.2 t -106.39 128.44 60.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.8 ptp -79.73 85.45 5.42 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.931 0.872 . . . . 0.0 110.248 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -151.54 113.39 4.46 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.684 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -118.5 -58.15 2.0 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.688 174.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.99 -7.12 56.59 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.96 11.16 23.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.652 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . 105.39 102.67 2.81 Favored Glycine 0 N--CA 1.406 -3.358 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 23.3 m-85 -97.22 166.19 11.69 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 162.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 84' ' ' ASN . 45.5 mt -93.94 101.4 12.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 161.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 3.1 mm-40 -60.46 -50.25 74.33 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 124.523 1.139 . . . . 0.0 110.507 -172.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.13 156.24 44.75 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.494 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' H ' HD12 ' A' ' 40' ' ' LEU . 5.8 mp -56.44 129.08 75.07 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 126.062 1.745 . . . . 0.0 114.16 -173.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.15 167.33 27.15 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 123.022 2.482 . . . . 0.0 111.456 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -61.78 123.89 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -10.97 52.35 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.297 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 m -86.92 126.98 61.45 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -69.05 165.07 31.41 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.6 2.867 . . . . 0.0 111.027 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 p -48.23 149.4 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 -172.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -40.01 -54.19 2.27 Favored 'General case' 0 N--CA 1.507 2.421 0 C-N-CA 126.594 1.958 . . . . 0.0 113.141 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 63.1 p-90 -82.3 -24.87 34.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.411 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 49.7 tptt -85.0 -14.73 46.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.434 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 44' ' ' SER . 28.9 m-85 -44.44 -45.76 9.25 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.824 0.703 . . . . 0.0 112.823 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.467 ' HB3' ' NH1' ' A' ' 176' ' ' ARG 0.334 35.9 m-70 -129.64 24.94 5.4 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 4.2 tm-20 -83.1 101.09 10.93 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 177.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.96 4.91 1.84 Allowed Glycine 0 CA--C 1.553 2.449 0 N-CA-C 116.629 1.412 . . . . 0.0 116.629 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.03 164.16 28.26 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 CA-C-N 119.118 1.459 . . . . 0.0 113.987 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.4 t -98.85 141.42 31.65 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 50' ' ' PHE . 82.7 mt -90.16 -2.04 58.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.112 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.01 68.95 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.0 111.098 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -89.66 -22.66 22.16 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.208 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -107.29 -24.06 12.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -171.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -101.69 132.56 21.57 Favored Pre-proline 0 C--N 1.292 -1.906 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -173.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 122.72 9.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.96 1.774 . . . . 0.0 110.857 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.1 t -98.8 136.56 29.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 17.86 79.77 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -98.32 -163.0 30.62 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -126.31 132.82 51.55 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.38 167.35 26.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 32.7 t -154.55 153.51 31.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -97.06 110.48 23.01 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.2 p -71.65 153.12 42.3 Favored 'General case' 0 C--N 1.316 -0.86 0 O-C-N 123.49 0.493 . . . . 0.0 110.728 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -81.7 110.25 16.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.554 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 21.7 t-20 -97.63 -38.64 9.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 163.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -106.19 111.74 64.23 Favored Pre-proline 0 N--CA 1.421 -1.908 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.85 -58.23 1.61 Allowed 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 123.58 2.853 . . . . 0.0 114.612 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.33 84.3 3.44 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.558 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -117.37 146.18 43.57 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -90.37 -168.69 2.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -73.65 178.62 4.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 114.061 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.2 mp -88.37 152.28 22.03 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.141 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -122.23 -161.56 0.94 Allowed 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -58.56 -32.83 69.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.425 0.631 . . . . 0.0 111.95 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -131.87 147.82 52.5 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.474 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -133.4 111.51 12.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 84.0 Cg_endo -81.81 -179.43 4.82 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.793 2.328 . . . . 0.0 111.639 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 3.7 p30 -164.21 179.18 7.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.141 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.6 mt -93.47 9.08 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 122.25 1.024 . . . . 0.0 109.018 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.411 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 29.6 mtm -115.42 -159.14 0.7 Allowed 'General case' 0 CA--C 1.557 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.418 -171.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 50' ' ' PHE . 1.5 m -117.91 35.34 4.76 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.782 0.719 . . . . 0.0 112.177 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -133.31 158.07 43.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.608 -0.682 . . . . 0.0 109.828 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.8 tp -122.69 141.9 51.26 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.086 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 52.4 tp -110.83 129.32 55.89 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 129' ' ' LEU . 45.3 t -129.11 141.34 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 O-C-N 123.806 0.691 . . . . 0.0 110.385 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.4 p -76.14 168.39 20.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.366 0.666 . . . . 0.0 111.402 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.54 98.78 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.441 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.21 -37.99 66.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.057 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.82 -32.88 71.54 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.986 0.422 . . . . 0.0 109.906 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -57.57 -45.43 85.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.774 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 73.1 mmtt -64.82 -28.89 69.86 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.13 -54.84 27.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.3 mt -59.74 -43.29 91.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 111.263 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -65.95 -41.17 91.6 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.2 p -69.18 -23.44 63.92 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.57 -13.24 59.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.467 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.42 47.34 10.64 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.167 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -81.74 104.31 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.7 t -72.59 159.83 33.25 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.559 -1.201 . . . . 0.0 108.948 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 77.87 13.78 1.69 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 124.442 1.097 . . . . 0.0 111.157 173.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.35 114.43 28.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.605 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 7.4 tp10 -106.55 139.18 41.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -114.77 115.64 27.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 123.853 0.721 . . . . 0.0 109.108 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.8 mt -111.83 96.9 35.47 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -82.18 143.13 12.51 Favored 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.488 2.126 . . . . 0.0 113.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 64' ' ' GLY . 5.3 m -149.3 168.47 2.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.833 1.253 . . . . 0.0 108.842 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 124' ' ' PRO . . . -92.37 116.08 28.65 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 126' ' ' TYR . 38.4 mt -107.89 127.46 63.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-O 121.759 0.79 . . . . 0.0 112.236 -173.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 67' ' ' SER . 85.3 mttt -101.48 131.51 47.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 174.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.4 p-10 -76.37 -160.49 0.15 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.29 0.567 . . . . 0.0 111.401 -173.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -67.91 -30.99 70.46 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.057 0.543 . . . . 0.0 110.353 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -82.59 -20.4 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.73 0.643 . . . . 0.0 109.73 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.55 12.65 40.6 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.235 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.2 ptpt -95.81 145.02 25.68 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 115' ' ' LYS . 21.2 t -81.99 82.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.584 0.707 . . . . 0.0 110.046 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 m -106.18 4.34 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.364 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.77 61.84 0.65 Allowed Glycine 0 C--O 1.204 -1.73 0 C-N-CA 120.545 -0.835 . . . . 0.0 113.025 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 113' ' ' ALA . 79.9 Cg_endo -83.93 -18.87 5.16 Favored 'Trans proline' 0 C--N 1.358 1.036 0 CA-C-N 120.449 2.125 . . . . 0.0 113.652 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.75 20.84 13.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.439 1.114 . . . . 0.0 110.457 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 114' ' ' ILE . 2.0 m-85 -92.11 133.48 35.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.708 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.41 139.18 52.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.497 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -80.04 119.22 22.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.293 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 91' ' ' VAL . 2.0 tt -86.65 128.3 34.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.9 m-80 -114.28 125.58 54.05 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -99.6 118.07 35.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.55 172.96 6.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.698 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.85 7.85 86.7 Favored Glycine 0 CA--C 1.505 -0.57 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -97.84 132.28 43.58 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.34 169.67 17.35 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.46 108.86 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 123.93 0.769 . . . . 0.0 109.366 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.494 ' CB ' HG13 ' A' ' 168' ' ' ILE . . . -135.49 -30.77 0.99 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 -167.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 179' ' ' LYS . 52.5 mt -64.41 114.99 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.087 -176.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.36 115.38 5.03 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.446 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 mmt -77.67 -1.94 33.53 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -95.23 -50.82 4.87 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -82.38 -30.91 29.96 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.1 m -92.74 104.22 16.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.67 117.3 34.52 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -158.39 157.96 33.31 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.82 127.16 51.33 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 66.1 mtp -102.59 106.94 17.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.7 t70 177.57 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.623 1.169 . . . . 0.0 112.319 169.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 -30.99 11.95 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.5 mt -139.21 -58.4 0.59 Allowed 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.19 -167.14 2.48 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.186 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 7.9 mmpt? -66.84 -18.44 65.38 Favored 'General case' 0 C--O 1.205 -1.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -172.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.539 ' HB2' HH21 ' A' ' 181' ' ' ARG . 1.4 p30 -87.0 -2.24 58.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.677 0.671 . . . . 0.0 111.146 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.42 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 29.2 mm-40 -107.61 125.88 51.87 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.35 -177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 73.7 mt -82.73 115.6 25.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -92.07 -56.52 1.59 Allowed Glycine 0 CA--C 1.498 -1.019 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.674 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -111.67 121.87 46.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.67 126.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -102.3 -43.33 5.73 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.302 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.26 142.21 26.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.68 119.9 23.08 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -109.28 147.53 32.49 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.65 131.0 49.53 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 124.251 0.969 . . . . 0.0 112.353 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.41 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 26.4 p-10 -96.52 16.6 18.28 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.035 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 15.8 p -68.52 -6.19 23.8 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.74 1.216 . . . . 0.0 110.908 175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 13.0 m -63.95 -40.45 96.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.292 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -111.54 -31.8 6.89 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.494 HG13 ' CB ' ' A' ' 137' ' ' ALA . 61.2 mt -83.57 138.93 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.446 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 48.6 mtm180 -58.65 119.49 37.24 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 169' ' ' ARG . 14.0 Cg_exo -68.61 -4.68 13.59 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.485 2.79 . . . . 0.0 112.908 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 1.7 p-10 -79.44 -14.61 58.81 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.15 116.16 12.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.79 -19.73 60.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.494 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.5 ttt -146.73 123.59 11.3 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -147.52 -179.01 6.56 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.467 ' NH1' ' HB3' ' A' ' 51' ' ' HIS . 0.1 OUTLIER -148.73 146.49 28.11 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.439 ' HB3' HD11 ' A' ' 138' ' ' ILE . 66.8 m -75.74 150.06 37.9 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 124.439 1.087 . . . . 0.0 112.736 -173.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 p -82.11 -24.79 34.94 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.517 ' HB2' HD12 ' A' ' 138' ' ' ILE . 73.9 mmtt -85.75 -4.56 59.2 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.126 -176.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.82 151.25 33.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.539 HH21 ' HB2' ' A' ' 153' ' ' ASP . 3.0 mmt180 -90.65 -39.86 12.23 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 123.793 0.837 . . . . 0.0 111.018 -171.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.415 ' HE ' ' HB2' ' A' ' 182' ' ' ARG . 57.1 mtm180 -84.62 -19.29 33.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.557 -174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.76 100.95 5.63 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 72.6 mt -110.63 135.07 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 73.8 mt -116.76 122.56 44.81 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.441 0.638 . . . . 0.0 109.94 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.494 HG22 ' HG3' ' A' ' 174' ' ' MET . 38.9 pt -112.8 162.72 10.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.839 0.828 . . . . 0.0 111.467 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.563 ' HB3' HG23 ' A' ' 190' ' ' VAL . 6.2 tpp180 -78.8 143.67 35.84 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.472 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 6.5 pt-20 -54.53 -40.94 69.14 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.394 0.616 . . . . 0.0 111.873 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.87 -33.92 76.29 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 124.436 1.094 . . . . 0.0 112.01 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.563 HG23 ' HB3' ' A' ' 187' ' ' ARG . 87.0 t -68.24 -44.74 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.392 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.461 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 26.7 p80 -73.13 -22.8 60.46 Favored 'General case' 0 C--O 1.211 -0.966 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.211 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.61 72.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.29 0.567 . . . . 0.0 109.886 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -73.48 -32.49 64.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -70.24 -36.81 74.73 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.69 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 72.3 mm-40 -56.26 -53.7 54.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.485 0.714 . . . . 0.0 110.715 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -73.23 -12.37 60.84 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.219 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -86.28 -27.52 24.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.889 0.376 . . . . 0.0 110.07 176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.03 47.87 22.6 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.945 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.401 ' HB2' ' CE2' ' A' ' 202' ' ' PHE . 71.4 mt -82.66 157.25 23.45 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . 0.255 5.2 p -41.95 -82.84 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.72 125.66 2.26 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.431 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 199' ' ' LEU . 70.2 m-85 -120.8 156.33 32.13 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.336 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -129.99 120.63 25.07 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 16.2 m -133.88 142.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.262 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -133.39 155.46 49.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.195 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -65.18 129.55 40.11 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.461 0.476 . . . . 0.0 110.526 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -85.41 -40.5 16.38 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.297 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.84 101.02 3.03 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.496 -174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.78 29.88 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.522 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.6 t90 -58.13 108.78 0.64 Allowed 'General case' 0 CA--C 1.574 1.878 0 C-N-CA 124.171 0.988 . . . . 0.0 110.137 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -102.02 102.43 12.94 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 73.96 -22.16 1.23 Allowed Glycine 0 N--CA 1.475 1.252 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 167.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.5 mt -71.37 148.8 46.64 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.494 0.647 . . . . 0.0 111.245 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -108.55 132.87 53.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 O-C-N 124.318 1.011 . . . . 0.0 113.123 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.94 40.57 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.666 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 m -96.59 92.29 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.186 0.517 . . . . 0.0 109.715 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.7 t -150.73 138.98 20.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -88.69 121.22 30.84 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -84.2 89.88 7.4 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.076 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -157.64 105.22 2.02 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 124.935 1.294 . . . . 0.0 108.844 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -76.49 98.76 4.71 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 m80 80.12 109.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.792 1.637 . . . . 0.0 111.765 -170.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -72.86 -24.44 60.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.1 m -60.84 109.0 0.94 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.122 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 t -145.39 109.28 4.78 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -126.31 130.12 6.95 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.406 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -121.53 102.35 8.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.9 t -92.0 111.23 48.9 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.39 153.74 35.55 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.89 2.394 . . . . 0.0 112.769 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.04 116.56 11.31 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.13 92.63 1.59 Allowed Glycine 0 N--CA 1.421 -2.304 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.948 -177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 m -82.13 85.27 6.81 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 174.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -88.25 -30.05 19.97 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.607 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.278 26.0 ptt? 51.49 80.1 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.42 1.488 . . . . 0.0 111.482 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.96 119.49 11.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.065 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HG2' ' OE2' ' A' ' 188' ' ' GLU . 7.8 ptpp? -93.88 141.9 27.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.891 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -109.45 138.58 45.6 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -124.4 142.73 51.07 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.712 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.0 t -80.1 116.35 24.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -92.23 125.56 36.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.48 0.657 . . . . 0.0 111.795 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 0.0 OUTLIER -141.05 165.13 28.4 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.343 1.457 . . . . 0.0 107.11 175.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.47 144.49 20.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttm -91.06 85.87 6.06 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -153.38 133.66 13.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.153 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.511 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -123.25 -64.07 1.2 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 177.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -84.8 -21.47 29.9 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.849 -1.523 . . . . 0.0 108.559 178.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.54 25.61 1.21 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.005 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' HA3' HE21 ' A' ' 82' ' ' GLN . . . 123.77 60.7 0.19 Allowed Glycine 0 N--CA 1.428 -1.887 0 C-N-CA 118.58 -1.772 . . . . 0.0 117.376 173.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 3.2 m-85 -92.3 127.96 37.97 Favored 'General case' 0 CA--C 1.495 -1.148 0 CA-C-N 117.563 0.681 . . . . 0.0 110.458 166.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -87.71 103.37 13.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 169.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.17 -50.95 19.76 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.275 0.56 . . . . 0.0 111.887 -171.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -115.04 169.42 9.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.586 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 5.3 mp -71.55 133.89 84.61 Favored Pre-proline 0 C--N 1.294 -1.837 0 C-N-CA 123.141 0.577 . . . . 0.0 112.132 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.07 168.4 24.84 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.321 2.681 . . . . 0.0 113.355 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -48.32 115.72 1.31 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 125.441 1.497 . . . . 0.0 112.665 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.3 14.36 71.63 Favored Glycine 0 C--O 1.208 -1.48 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.493 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.0 m -84.54 145.13 44.14 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 118.124 0.962 . . . . 0.0 111.74 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -65.24 165.53 21.83 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.387 2.725 . . . . 0.0 111.119 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.4 p -58.35 153.19 16.02 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -46.19 -58.3 3.77 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 125.311 1.444 . . . . 0.0 112.99 -174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 181' ' ' ARG . 13.1 p-90 -71.2 -23.01 61.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.007 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HE3' HD12 ' A' ' 54' ' ' ILE . 43.0 tptt -77.3 -21.85 52.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.187 -172.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 70.6 m-85 -52.83 -26.51 14.75 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.249 0.547 . . . . 0.0 112.379 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -120.26 -0.16 10.5 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 3.6 tm-20 -94.27 101.3 13.27 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.054 -1.458 . . . . 0.0 112.027 -172.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -10.51 0.01 OUTLIER Glycine 0 CA--C 1.559 2.815 0 N-CA-C 120.711 3.044 . . . . 0.0 120.711 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.424 HD12 ' HE3' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -130.1 174.58 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 121.066 2.433 . . . . 0.0 114.04 -173.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.1 t -88.05 148.29 24.56 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.251 -1.34 . . . . 0.0 107.776 171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.0 mt -98.29 -1.73 41.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.588 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.62 68.15 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.166 0.508 . . . . 0.0 112.324 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -83.1 -14.95 52.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.742 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -114.95 -22.52 9.54 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 113.323 0.861 . . . . 0.0 113.323 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -101.07 139.05 20.17 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.29 122.94 9.46 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.123 1.882 . . . . 0.0 112.632 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.71 122.88 43.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.54 23.48 62.51 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.5 -168.03 27.66 Favored Glycine 0 CA--C 1.502 -0.738 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -119.5 131.14 55.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -126.99 165.23 25.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -139.42 141.72 37.5 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 23.1 m-85 -69.52 122.89 19.94 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 123.857 0.723 . . . . 0.0 109.092 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 p -69.9 118.53 12.87 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.28 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 73' ' ' PRO . 88.1 tttt -86.15 93.2 8.97 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 170.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -91.06 -37.69 13.26 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.235 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' HB3' ' HD3' ' A' ' 73' ' ' PRO 0.258 76.5 t80 -131.62 -70.76 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 175.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 72' ' ' TYR . 30.9 Cg_endo -90.18 170.33 4.04 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 CA-C-N 121.128 1.439 . . . . 0.0 112.246 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.46 80.24 9.29 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' HB3' ' CG ' ' A' ' 117' ' ' HIS . 8.7 t-20 -70.36 153.23 43.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.06 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -94.02 -148.58 0.27 Allowed 'General case' 0 C--O 1.256 1.44 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.95 -167.8 0.32 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.162 2.185 . . . . 0.0 114.525 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.02 149.94 27.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.171 -176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -114.04 -169.15 1.46 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.169 0.988 . . . . 0.0 109.006 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 94' ' ' ARG . 48.6 m-20 -65.84 -34.24 77.7 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.748 0.785 . . . . 0.0 110.274 -178.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.444 ' CD1' ' HE1' ' A' ' 202' ' ' PHE . 57.1 m-85 -134.18 153.74 51.66 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.488 HE21 ' HA3' ' A' ' 35' ' ' GLY . 56.0 mt-30 -134.42 134.76 22.8 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.512 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -90.07 -179.26 1.74 Allowed 'Trans proline' 0 N--CA 1.428 -2.358 0 C-N-CA 122.811 2.341 . . . . 0.0 111.36 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -163.48 171.52 15.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.3 mt -101.12 21.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.88 1.324 . . . . 0.0 108.294 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 40' ' ' LEU . 63.4 mtm -102.31 -93.71 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.102 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.466 ' HB2' ' CB ' ' A' ' 50' ' ' PHE . 17.9 m -167.17 -33.3 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -88.85 174.66 7.84 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 58.3 tp -116.13 142.1 47.27 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.804 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.2 tp -110.86 127.45 55.43 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.55 142.38 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 123.05 0.54 . . . . 0.0 110.169 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.2 p -83.8 168.91 15.72 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 97' ' ' LYS . . . -66.04 -32.3 82.03 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.837 -0.22 . . . . 0.0 113.093 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.403 ' HD2' ' OD1' ' A' ' 80' ' ' ASP . 5.9 ptp180 -67.12 -41.15 86.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.528 0.68 . . . . 0.0 110.372 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.9 -24.3 52.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.112 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -61.4 -42.08 98.17 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 93' ' ' GLY . 34.2 mmtp -60.94 -39.35 89.13 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.41 ' O ' HD13 ' A' ' 102' ' ' LEU . 4.5 mm? -59.95 -55.8 29.64 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.393 0.433 . . . . 0.0 110.26 175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.1 mt -59.75 -45.35 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 112.075 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.33 -36.37 83.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.1 m -70.86 -22.03 62.35 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 98' ' ' LEU . 10.5 mp -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.672 0.272 . . . . 0.0 110.949 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 47.18 13.62 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.8 t -79.74 100.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-O 121.427 0.632 . . . . 0.0 110.397 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 25.6 m -80.88 154.26 27.16 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 84.5 m-20 80.63 15.21 0.7 Allowed 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 125.62 1.568 . . . . 0.0 110.964 -176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.94 114.17 28.23 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.418 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 7.7 tp10 -104.34 133.1 49.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.415 ' CH2' HD12 ' A' ' 129' ' ' LEU . 68.5 m95 -109.21 123.55 49.43 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.278 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.8 mt -111.4 93.49 19.2 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.97 135.1 15.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.698 2.266 . . . . 0.0 112.416 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.09 167.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.405 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -92.42 115.98 28.57 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 126' ' ' TYR . 32.8 mt -106.84 128.16 61.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.805 0.812 . . . . 0.0 112.082 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HG2' HG22 ' A' ' 121' ' ' VAL . 84.0 mttt -97.25 142.06 29.6 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 9.1 p-10 -80.68 -162.35 0.46 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.861 0.362 . . . . 0.0 110.937 -176.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.41 ' CG ' ' HB3' ' A' ' 75' ' ' ASN . 69.6 m80 -75.44 -9.44 58.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.105 0.478 . . . . 0.0 110.522 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -109.34 2.01 20.43 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.807 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.3 7.14 80.26 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 115.688 1.035 . . . . 0.0 115.688 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -95.55 139.06 32.36 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 118.602 1.201 . . . . 0.0 110.477 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 115' ' ' LYS . 21.2 t -76.95 90.13 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.497 0.665 . . . . 0.0 109.803 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.66 8.55 5.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.714 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.84 45.06 1.15 Allowed Glycine 0 C--O 1.209 -1.441 0 C-N-CA 119.847 -1.168 . . . . 0.0 114.76 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -83.32 -0.37 9.85 Favored 'Trans proline' 0 C--N 1.368 1.585 0 CA-C-N 121.278 2.539 . . . . 0.0 111.924 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -92.88 -12.18 31.64 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.832 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 114' ' ' ILE . 3.2 m-85 -92.24 147.2 23.11 Favored 'General case' 0 C--O 1.255 1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.343 -173.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -132.66 137.93 47.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.386 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -81.27 125.64 30.58 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.415 HD12 ' CH2' ' A' ' 109' ' ' TRP . 7.3 tt -99.75 125.13 45.6 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.41 0.624 . . . . 0.0 110.365 -176.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.2 141.37 52.14 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.622 175.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.718 ' HB2' ' HD2' ' A' ' 176' ' ' ARG . 3.0 mm? -98.92 144.28 28.28 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 108' ' ' GLU . 3.2 mm? -101.85 174.72 5.82 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 125.29 1.436 . . . . 0.0 109.388 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.81 17.24 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -96.39 132.1 42.26 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-O 122.12 0.962 . . . . 0.0 113.341 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -148.0 165.5 30.56 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 168.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -53.57 101.9 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 120.228 1.376 . . . . 0.0 111.89 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -78.93 -66.59 0.85 Allowed 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.161 -164.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 179' ' ' LYS . 60.3 mt -59.1 126.83 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 O-C-N 123.955 0.785 . . . . 0.0 112.251 -172.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -69.1 122.77 19.44 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 173.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 11.4 tpt -90.51 -16.33 29.08 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -99.14 -35.61 9.95 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -172.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -91.69 -6.2 52.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.092 0.472 . . . . 0.0 111.265 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.2 p -89.41 143.81 26.54 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.71 103.4 7.8 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -151.24 168.03 26.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.391 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -116.78 144.03 44.96 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 124.317 1.047 . . . . 0.0 110.239 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.42 155.22 20.11 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.296 35.9 t70 91.94 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 169.067 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.5 m -101.06 -22.98 14.58 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 166.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 99.5 mt -160.87 -47.84 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.926 1.691 . . . . 0.0 107.245 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 42.7 mt-10 -131.97 179.61 5.98 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 114.271 -1.332 . . . . 0.0 109.093 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -72.0 -24.4 61.56 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 123.675 0.609 . . . . 0.0 112.44 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -98.25 25.27 6.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.287 1.042 . . . . 0.0 109.946 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -122.29 116.2 23.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.861 -1.904 . . . . 0.0 105.861 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.452 HG21 HG12 ' A' ' 158' ' ' ILE . 59.3 mt -84.86 120.8 36.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 123.131 0.27 . . . . 0.0 110.45 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -83.13 -48.25 5.47 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.305 -175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -134.09 139.24 45.82 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.452 HG12 HG21 ' A' ' 155' ' ' ILE . 45.3 mt -125.05 134.06 67.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 175.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -103.24 -42.33 5.78 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.15 114.88 8.99 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 158' ' ' ILE . 3.2 tm? -99.08 119.89 38.57 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -89.53 129.69 35.97 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.87 137.81 56.31 Favored 'General case' 0 C--O 1.248 1.014 0 O-C-N 124.27 0.981 . . . . 0.0 112.62 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.666 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 22.9 p-10 -88.23 -0.2 56.83 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.708 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.2 p -67.1 -6.13 16.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.893 1.277 . . . . 0.0 109.967 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.9 m -64.05 -35.79 81.87 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.376 173.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.64 -33.26 6.18 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.82 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.4 mt -78.12 154.33 5.16 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -67.45 117.12 44.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.3 -13.25 35.51 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.808 2.339 . . . . 0.0 112.462 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -87.99 -2.51 58.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.711 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.88 130.52 40.6 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.532 ' HA ' ' HD3' ' A' ' 187' ' ' ARG . 15.4 tppt? -68.68 -33.94 74.83 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.054 0.454 . . . . 0.0 111.395 -174.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.493 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.2 ttt -149.25 135.4 19.07 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -151.62 -178.19 6.55 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.138 0.575 . . . . 0.0 110.18 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.718 ' HD2' ' HB2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -151.91 142.96 23.16 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.341 -176.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' A' ' 183' ' ' LEU . 83.8 m -69.61 146.23 51.88 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.335 0.397 . . . . 0.0 111.751 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.7 p -81.54 -48.68 11.5 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.404 ' HB2' HD12 ' A' ' 138' ' ' ILE . 60.3 mttm -72.23 -20.76 61.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.728 0.411 . . . . 0.0 111.563 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.48 133.67 55.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.457 ' HB3' ' OG ' ' A' ' 87' ' ' SER . 10.7 mmt180 -90.58 -34.95 15.3 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.856 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -87.76 -20.92 25.5 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.376 0.608 . . . . 0.0 110.648 -174.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.553 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.3 tt -84.13 114.07 21.51 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.5 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 71.2 mt -120.91 132.37 70.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 59.6 mt -111.17 124.18 51.68 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.319 1.056 . . . . 0.0 113.263 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.493 HG22 ' HG3' ' A' ' 174' ' ' MET . 48.1 pt -112.68 154.63 14.09 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.966 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' A' ' 173' ' ' LYS . 17.3 mtp180 -83.63 162.26 20.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.446 ' OE2' ' HG2' ' A' ' 23' ' ' LYS . 7.8 pt-20 -51.74 -35.51 43.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.15 0.58 . . . . 0.0 111.824 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -46.19 -51.08 14.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.441 1.896 . . . . 0.0 111.335 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.57 -53.43 42.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.595 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.584 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 12.8 p80 -72.23 -25.4 61.62 Favored 'General case' 0 C--O 1.194 -1.816 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.334 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.95 -34.72 73.64 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 120.855 0.359 . . . . 0.0 110.628 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.12 73.99 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.176 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -70.52 -32.91 70.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.171 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 53.6 mm-40 -59.12 -49.82 76.42 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-O 121.62 0.724 . . . . 0.0 109.136 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -76.38 -22.41 54.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.964 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.48 -27.17 58.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.214 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.09 46.52 50.76 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.87 164.85 24.13 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.663 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 4.5 p -43.37 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -153.66 136.15 5.14 Favored Glycine 0 CA--C 1.493 -1.311 0 C-N-CA 119.062 -1.542 . . . . 0.0 113.099 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.444 ' HE1' ' CD1' ' A' ' 81' ' ' PHE . 60.6 m-85 -135.68 162.62 32.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.73 122.12 26.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.64 133.48 66.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.079 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.406 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 72.3 m-85 -126.51 132.52 51.36 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.48 115.02 6.63 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.13 65.08 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 124.021 0.826 . . . . 0.0 112.217 -175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.73 90.73 1.08 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.512 0.673 . . . . 0.0 110.258 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 81.19 35.1 24.7 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.553 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 19.8 t90 -59.87 98.63 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.7 0.8 . . . . 0.0 110.206 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -103.98 132.31 50.35 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.81 -9.09 2.06 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 118.594 2.197 . . . . 0.0 118.594 165.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.553 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 95.4 mt -94.83 135.73 35.98 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 118.382 1.091 . . . . 0.0 112.819 -176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -92.15 133.04 36.15 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 28' ' ' LYS 0.27 0.9 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -177.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptm . . . . . 0 C--O 1.241 0.653 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.19 -40.87 1.48 Allowed Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 t -88.99 138.67 31.19 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 m 72.69 99.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.415 1.486 . . . . 0.0 110.864 -177.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -100.2 162.19 13.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.8 t60 65.01 -78.8 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.965 1.306 . . . . 0.0 110.95 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.8 t60 166.98 84.84 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -123.52 96.8 5.12 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -173.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.471 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 53.0 t-80 -121.56 -92.05 0.55 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.7 m170 175.37 127.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.995 2.118 . . . . 0.0 106.789 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 t 58.6 38.0 25.28 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 124.712 1.258 . . . . 0.0 109.082 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 9' ' ' HIS . 15.4 m -95.59 82.37 3.63 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.344 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.95 58.76 9.87 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.635 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -93.24 102.26 14.54 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.65 -0.324 . . . . 0.0 110.914 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.89 88.95 17.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' A' ' 171' ' ' ASP . 4.0 Cg_exo -80.83 120.96 3.96 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.627 2.218 . . . . 0.0 111.834 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.92 96.28 7.63 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.202 0.525 . . . . 0.0 111.376 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -120.25 85.38 0.39 Allowed Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 p -76.63 -15.13 59.9 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.594 0.758 . . . . 0.0 112.253 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -168.28 -178.43 3.61 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -60.33 110.26 1.2 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.913 0.758 . . . . 0.0 110.258 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.492 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 67.3 t -84.79 122.22 37.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.628 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 25' ' ' PHE . 20.7 ptmt -103.28 150.72 23.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.177 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -125.85 155.93 40.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 23' ' ' LYS . 60.8 m-85 -138.06 142.47 40.3 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.357 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 205' ' ' TYR . 20.6 t -81.91 121.32 35.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 173.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -92.5 131.48 37.6 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -150.73 164.68 35.57 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.7 t -99.66 128.33 51.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.58 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 27.3 ttt -88.32 100.36 12.95 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.095 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 166.7 142.96 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 126.203 1.801 . . . . 0.0 108.719 172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -94.53 -31.5 13.88 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 30.7 mt-10 -84.44 -0.26 52.18 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 113.783 -1.553 . . . . 0.0 112.003 -175.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -78.15 0.46 24.83 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.22 103.43 1.05 Allowed Glycine 0 N--CA 1.402 -3.628 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -95.58 147.04 23.99 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 39' ' ' LYS . 12.6 mt -85.07 101.31 9.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 N-CA-C 102.864 -3.013 . . . . 0.0 102.864 166.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -73.72 -37.99 64.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.765 -172.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' O ' HG22 ' A' ' 37' ' ' ILE . 35.4 mmtp -114.46 176.47 5.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.554 ' HG ' ' SD ' ' A' ' 86' ' ' MET . 4.6 mp -83.94 129.26 59.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 9.8 Cg_endo -66.53 166.43 21.91 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.581 2.187 . . . . 0.0 112.892 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -57.87 127.1 30.38 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 124.065 0.946 . . . . 0.0 112.031 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.67 1.25 89.16 Favored Glycine 0 C--O 1.221 -0.675 0 CA-C-N 116.158 -0.474 . . . . 0.0 113.54 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.2 m -85.55 136.57 37.09 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -68.29 166.74 24.29 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.306 3.337 . . . . 0.0 112.096 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -50.88 148.88 3.8 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -45.9 -56.0 5.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.657 1.983 . . . . 0.0 113.448 -174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 17.2 p-90 -75.48 -26.53 58.27 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.343 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -78.7 -21.02 48.8 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.243 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.565 ' HA ' HD21 ' A' ' 56' ' ' LEU . 33.1 m-85 -45.76 -38.92 7.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 1.3 m-70 -128.44 22.1 6.04 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.574 -0.704 . . . . 0.0 111.128 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 1.2 tm-20 -93.99 100.85 12.91 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.268 -1.373 . . . . 0.0 109.898 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.24 -3.51 0.07 OUTLIER Glycine 0 CA--C 1.553 2.429 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 52' ' ' GLU . 2.4 pp -123.0 173.7 8.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -171.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.4 t -98.31 135.88 39.28 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.103 170.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 50' ' ' PHE . 91.7 mt -84.11 -1.72 55.46 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -24.84 66.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 111.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -88.08 -22.82 23.95 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -116.31 -21.88 9.09 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -103.48 138.15 19.45 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.77 123.22 12.24 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.656 2.237 . . . . 0.0 112.682 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.06 114.73 33.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.31 19.46 45.64 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.396 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -95.62 -166.54 34.91 Favored Glycine 0 C--N 1.307 -1.062 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.198 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.83 128.56 42.54 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 34.9 m -126.94 169.57 18.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -148.19 162.55 39.22 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.907 -0.496 . . . . 0.0 110.177 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 19.8 m-85 -75.98 163.97 26.63 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.25 174.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 13.2 p -92.47 137.04 32.7 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.555 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -86.05 51.53 2.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.703 -0.623 . . . . 0.0 110.934 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.31 -37.92 51.67 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -131.01 90.27 39.89 Favored Pre-proline 0 N--CA 1.427 -1.582 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.12 -30.96 73.26 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.864 3.043 . . . . 0.0 114.122 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.43 -6.65 51.13 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.087 0.47 . . . . 0.0 112.249 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.568 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 8.0 t-20 -71.52 145.5 49.1 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 34.2 mtp180 -78.47 -172.51 2.92 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.86 -165.73 0.87 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.46 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HA ' HE21 ' A' ' 82' ' ' GLN . 4.6 mp -87.74 150.58 23.5 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.277 0.561 . . . . 0.0 111.758 -176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE2' ' HA ' ' A' ' 34' ' ' ALA . 5.5 m-85 -114.79 -163.58 0.88 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.51 -44.2 93.19 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.481 0.658 . . . . 0.0 110.725 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.84 151.65 41.48 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.515 -1.22 . . . . 0.0 107.881 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.488 HE21 ' HA ' ' A' ' 78' ' ' LEU . 3.8 mm-40 -121.81 114.93 30.94 Favored Pre-proline 0 C--N 1.289 -2.036 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -87.51 168.08 7.35 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.548 2.832 . . . . 0.0 112.322 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -163.89 174.92 10.91 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 121.997 -0.44 . . . . 0.0 110.864 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.8 mt -94.55 7.34 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.204 0 CA-C-O 123.103 1.43 . . . . 0.0 109.098 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.554 ' SD ' ' HG ' ' A' ' 40' ' ' LEU . 50.6 mtm -104.58 -164.19 1.03 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 m -121.4 53.68 1.16 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.813 -0.555 . . . . 0.0 110.991 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -136.84 155.11 50.21 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.7 tp -119.5 141.19 49.41 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.264 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 126' ' ' TYR . 58.2 tp -117.16 130.17 56.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.84 139.81 50.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 122.56 0.344 . . . . 0.0 110.084 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.2 p -76.27 174.56 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 122.33 0.252 . . . . 0.0 110.691 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.95 -38.81 59.93 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -69.01 -38.57 79.33 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.08 0.467 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.4 63.97 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -62.15 -39.94 94.3 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.738 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -55.37 -40.36 71.23 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.812 0.695 . . . . 0.0 112.412 178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 197' ' ' ALA . 4.0 mm? -60.14 -52.78 63.86 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.186 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.5 -45.03 99.79 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 C-N-CA 123.295 0.638 . . . . 0.0 112.2 -177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.4 -37.8 88.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.6 m -68.71 -22.14 64.37 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.211 0.529 . . . . 0.0 111.295 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.1 mp -85.58 -8.55 58.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.806 176.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.28 44.5 74.83 Favored Glycine 0 CA--C 1.495 -1.195 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.115 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 173' ' ' LYS . 81.6 t -73.88 104.0 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.504 0.668 . . . . 0.0 110.403 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 m -79.27 150.62 31.49 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 79.53 1.43 2.23 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.609 1.564 . . . . 0.0 112.878 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.51 114.74 25.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' LEU . 8.2 tp10 -99.49 137.73 37.57 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.452 ' CH2' HD12 ' A' ' 129' ' ' LEU . 66.9 m95 -115.6 121.51 42.83 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 124.079 0.862 . . . . 0.0 109.209 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.4 mt -114.67 98.31 49.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -79.26 124.9 6.14 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.497 2.131 . . . . 0.0 114.023 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 64' ' ' GLY . 16.1 m -139.74 172.24 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.9 116.69 33.36 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -100.54 130.16 50.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.354 0.597 . . . . 0.0 110.084 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 121' ' ' VAL . 89.7 mttt -103.74 139.45 38.96 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.503 ' HA ' ' CD1' ' A' ' 68' ' ' PHE . 32.8 p-10 -83.91 -159.94 0.41 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 75' ' ' ASN . 60.0 m80 -67.99 -14.87 63.31 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.079 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -19.48 16.53 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.2 20.18 21.35 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.703 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.439 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 18.4 ptpt -95.79 147.86 23.19 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 115' ' ' LYS . 16.1 t -82.2 84.5 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.541 0.686 . . . . 0.0 109.554 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.417 HG23 HD13 ' A' ' 78' ' ' LEU . 6.6 m -111.84 12.26 8.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.105 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.51 51.81 0.85 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.35 173.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -84.72 -14.66 6.35 Favored 'Trans proline' 0 C--N 1.375 1.967 0 CA-C-N 120.795 2.298 . . . . 0.0 112.885 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -97.12 7.73 46.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.359 0.599 . . . . 0.0 110.071 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.509 ' HB2' HD13 ' A' ' 114' ' ' ILE . 3.9 m-85 -102.02 148.35 25.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.569 0.699 . . . . 0.0 112.272 -170.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -137.6 142.63 41.26 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.608 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -82.47 131.05 35.22 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.452 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.452 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.9 tt -105.19 126.11 51.73 Favored 'General case' 0 C--O 1.267 2.016 0 CA-C-O 121.816 0.817 . . . . 0.0 110.091 -176.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.402 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -125.39 141.2 52.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.051 174.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.59 141.78 30.21 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 mp -123.6 174.47 7.41 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 124.318 1.047 . . . . 0.0 108.685 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 14.61 81.26 Favored Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.714 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.66 132.86 43.72 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.18 168.44 12.42 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -48.75 105.16 0.07 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 119.106 0.866 . . . . 0.0 112.015 -174.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.23 -35.26 3.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -168.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 179' ' ' LYS . 57.0 mt -64.72 115.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.841 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.11 111.95 4.78 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.406 ' HA ' ' HG ' ' A' ' 143' ' ' SER . 15.2 ttt -97.89 17.65 17.69 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.774 0.797 . . . . 0.0 110.23 -174.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.55 -50.09 4.19 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.076 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 142' ' ' ARG . 2.7 mmp_? -97.12 11.43 36.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.191 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 140' ' ' MET . 50.0 p -104.88 154.38 20.14 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.154 175.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 159' ' ' ASP . 75.2 mm-40 -133.81 117.37 16.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 176.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -166.0 172.34 11.56 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 123.58 0.55 . . . . 0.0 111.196 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -127.84 133.21 49.37 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 152' ' ' LYS . 38.7 mtt -101.34 108.66 20.34 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.5 t70 172.78 73.97 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.705 2.002 . . . . 0.0 108.868 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.456 ' HB3' ' HB3' ' A' ' 154' ' ' GLN . 22.8 t -101.15 -49.45 4.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 86.2 mt -130.05 -67.09 0.76 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 154' ' ' GLN . 3.0 pp20? -109.07 -176.19 2.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.978 174.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 147' ' ' MET . 11.0 mmpt? -66.78 -30.88 71.2 Favored 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -171.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' HB3' HH12 ' A' ' 181' ' ' ARG . 21.1 t70 -104.85 26.27 9.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.673 1.225 . . . . 0.0 109.429 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.545 ' HG2' ' OE2' ' A' ' 151' ' ' GLU . 15.3 mm-40 -106.8 123.55 48.32 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.194 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 51.6 mt -82.6 124.33 39.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.031 0.443 . . . . 0.0 111.824 -173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -103.35 -66.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.634 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -94.85 135.37 36.43 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 21.5 mt -131.9 145.14 35.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 144' ' ' GLU . 13.2 t70 -110.44 -51.96 2.82 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 172.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.87 118.85 7.65 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.337 -1.301 . . . . 0.0 109.573 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -94.27 121.6 35.96 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.87 132.4 37.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.1 mt -54.98 137.26 46.47 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.552 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 19.2 p-10 -92.69 -0.28 57.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.971 -1.468 . . . . 0.0 109.978 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.9 p -68.22 -6.16 22.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.07 174.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.6 m -63.84 -39.43 94.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.687 173.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -110.8 -31.31 7.23 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 119.701 -0.799 . . . . 0.0 112.288 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 137' ' ' ALA . 52.7 mt -89.03 150.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.492 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 27.7 mtp180 -57.92 122.37 57.09 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 122.535 0.334 . . . . 0.0 111.832 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.22 -5.76 17.72 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 123.419 2.746 . . . . 0.0 112.311 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 8.3 p-10 -96.47 -7.99 33.34 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.712 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.36 132.85 47.78 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.475 ' HB2' HG22 ' A' ' 104' ' ' VAL . 75.1 mmtt -73.75 -40.24 63.66 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.206 -174.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.45 ' HB3' HG11 ' A' ' 104' ' ' VAL . 27.0 ttt -142.85 123.98 14.51 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -146.39 -178.33 6.09 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.481 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.405 ' CD ' ' HB3' ' A' ' 51' ' ' HIS . 8.9 ttp180 -146.62 142.32 27.8 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.536 ' SG ' HD22 ' A' ' 183' ' ' LEU . 65.3 m -70.69 145.7 50.39 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 124.161 0.913 . . . . 0.0 111.607 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.8 p -82.21 -18.92 40.91 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.495 ' HB2' HD12 ' A' ' 138' ' ' ILE . 19.3 mtpp -108.96 20.79 18.02 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.749 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 183' ' ' LEU . 9.5 tp10 -172.6 116.63 0.32 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.464 ' HD2' ' NE2' ' A' ' 154' ' ' GLN 0.275 0.0 OUTLIER -89.29 -11.19 44.19 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -173.012 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -90.56 -25.9 19.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 180' ' ' GLU . 3.3 tt -77.74 100.85 6.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.3 mt -108.08 120.56 59.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 30.7 mt -93.05 125.5 37.67 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 121.706 0.765 . . . . 0.0 111.615 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.8 pt -110.85 139.2 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.883 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -81.38 162.4 23.39 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.492 ' OE2' ' HA ' ' A' ' 22' ' ' VAL . 7.1 pt-20 -43.68 -44.24 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.463 1.105 . . . . 0.0 112.546 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -56.33 -44.83 80.38 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.64 1.576 . . . . 0.0 110.725 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.33 -48.05 82.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 9.3 p80 -74.02 -29.26 61.84 Favored 'General case' 0 C--O 1.197 -1.672 0 C-N-CA 118.061 -1.456 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.0 77.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.18 83.38 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.174 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -72.11 -34.81 68.89 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.211 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 56.5 mm-40 -62.33 -47.24 85.12 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.322 0.582 . . . . 0.0 109.555 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -75.06 -15.89 60.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.565 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -83.75 -27.12 29.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.782 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 72.61 47.65 26.34 Favored Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.462 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.74 164.58 25.12 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -46.46 -76.54 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 116.933 2.198 . . . . 0.0 116.933 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -173.66 130.79 1.91 Allowed Glycine 0 CA--C 1.498 -0.978 0 C-N-CA 119.029 -1.557 . . . . 0.0 113.213 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -129.19 159.37 36.26 Favored 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 122.418 0.287 . . . . 0.0 110.273 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 77.4 tttt -120.78 121.67 38.69 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.2 130.43 72.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.118 0.485 . . . . 0.0 111.058 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 26' ' ' VAL . 85.0 m-85 -107.04 138.97 42.2 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.72 115.97 9.57 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.62 -45.37 37.76 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.591 0.557 . . . . 0.0 112.285 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.19 95.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 O-C-N 123.988 0.805 . . . . 0.0 109.547 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 79.63 35.65 28.21 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.882 -1.152 . . . . 0.0 111.922 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.469 ' HE1' ' HB2' ' A' ' 213' ' ' LEU . 9.3 t90 -46.06 107.12 0.09 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.528 1.131 . . . . 0.0 110.368 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -82.78 71.53 9.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.11 15.16 67.12 Favored Glycine 0 C--N 1.31 -0.9 0 N-CA-C 117.587 1.795 . . . . 0.0 117.587 167.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 210' ' ' TRP . 92.1 mt -89.89 146.35 24.48 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 118.365 1.082 . . . . 0.0 109.875 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.1 134.09 35.16 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.244 0.778 0 O-C-N 124.335 1.022 . . . . 0.0 108.894 174.187 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.22 45.83 0.03 OUTLIER Glycine 0 CA--C 1.493 -1.321 0 N-CA-C 108.196 -1.961 . . . . 0.0 108.196 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m -103.55 13.67 32.88 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.885 -0.658 . . . . 0.0 111.662 -171.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -99.44 89.55 4.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.589 0.709 . . . . 0.0 111.407 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -107.79 -24.45 11.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.19 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -76.26 -26.13 55.65 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.918 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -81.16 84.47 6.54 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -177.42 -49.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.7 t60 67.18 -58.82 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.836 2.054 . . . . 0.0 113.606 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -76.7 82.79 3.33 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.938 0.495 . . . . 0.0 110.026 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -127.07 94.56 4.05 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -158.32 -36.35 0.07 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.049 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.46 -117.08 1.73 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 61.08 82.66 0.16 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.532 1.133 . . . . 0.0 112.021 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.5 t -111.11 106.36 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.82 95.49 0.24 Allowed 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.067 2.511 . . . . 0.0 113.393 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.37 84.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.998 1.319 . . . . 0.0 108.254 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.64 141.98 15.88 Favored Glycine 0 C--N 1.3 -1.465 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.689 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 m -83.47 95.6 8.32 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -116.1 130.14 56.66 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.031 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.2 ttm -69.7 118.68 12.87 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.89 109.52 26.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HG2' ' OE1' ' A' ' 188' ' ' GLU . 21.4 ptmt -93.15 154.43 18.08 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.34 135.46 50.36 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.368 0.604 . . . . 0.0 111.764 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -122.19 143.92 49.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.31 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.69 121.64 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -97.78 114.03 25.95 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.548 0.689 . . . . 0.0 111.038 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -135.26 150.86 50.14 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 173.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.42 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.6 ttt -86.54 84.67 7.37 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.09 113.69 3.0 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.96 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 34.1 tt0 -112.94 -66.97 1.03 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.95 -0.91 55.89 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.05 0.929 . . . . 0.0 109.5 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 79' ' ' TYR . . . -94.81 25.41 4.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.776 177.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' ' NE2' ' A' ' 82' ' ' GLN . . . 119.42 39.21 0.68 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 119.039 2.376 . . . . 0.0 119.039 168.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.635 ' CD1' ' HA ' ' A' ' 32' ' ' GLU . 11.3 m-85 -69.22 128.36 36.36 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 120.233 2.017 . . . . 0.0 112.889 170.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.517 HG12 ' CE2' ' A' ' 68' ' ' PHE . 9.4 mt -84.37 101.49 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.47 -59.62 3.03 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.924 0.869 . . . . 0.0 109.366 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' H ' ' ND2' ' A' ' 71' ' ' ASN . 13.7 mptt -108.7 162.26 14.33 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.285 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 5.8 mp -70.31 139.75 87.29 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 124.639 1.212 . . . . 0.0 114.054 -171.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 11.3 Cg_exo -74.8 166.43 29.3 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 123.449 2.766 . . . . 0.0 111.345 171.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -53.15 122.27 9.12 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.324 1.049 . . . . 0.0 112.856 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.01 7.22 70.69 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 114.734 0.654 . . . . 0.0 114.734 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 27.0 m -85.33 142.79 38.24 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HG2' HD22 ' A' ' 56' ' ' LEU . 1.6 Cg_endo -75.51 166.08 29.3 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.848 3.032 . . . . 0.0 111.139 172.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -52.92 148.85 7.08 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.37 -52.55 4.53 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 127.243 2.217 . . . . 0.0 114.894 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -85.68 -30.08 23.46 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.747 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 52.6 tptt -81.16 -12.21 59.26 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.387 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 88' ' ' ASN . 40.7 m-85 -44.29 -50.31 9.03 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.688 0.617 . . . . 0.0 111.952 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.482 ' NE2' ' HA ' ' A' ' 130' ' ' ASN . 65.3 m-70 -128.91 32.33 4.78 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.58 -0.848 . . . . 0.0 113.257 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 7.8 tm-20 -92.45 101.37 13.82 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.52 -8.83 17.47 Favored Glycine 0 CA--C 1.55 2.278 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.01 170.96 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.0 t -98.89 158.2 15.8 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 113.054 -1.884 . . . . 0.0 106.876 171.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.475 HD22 ' HG2' ' A' ' 45' ' ' PRO . 97.3 mt -113.07 15.5 19.53 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.14 -24.91 67.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.068 0.461 . . . . 0.0 110.916 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -88.23 -21.85 24.29 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.453 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -109.19 -22.6 12.03 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -107.83 140.09 21.27 Favored Pre-proline 0 C--N 1.298 -1.638 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.32 123.8 12.75 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.914 2.409 . . . . 0.0 112.73 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.451 HG22 HD22 ' A' ' 110' ' ' LEU . 22.4 t -100.89 117.09 45.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.91 14.99 61.92 Favored Glycine 0 C--N 1.318 -0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.55 -167.26 36.61 Favored Glycine 0 N--CA 1.432 -1.606 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.664 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.76 128.86 50.17 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 23.6 m -127.92 173.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.434 ' OG ' ' HB2' ' A' ' 115' ' ' LYS . 33.2 t -153.98 149.21 26.99 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' A' ' 37' ' ' ILE . 1.1 m-30 -76.76 128.86 35.42 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 167.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 71' ' ' ASN . 15.0 p -74.67 168.71 19.28 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 118.951 -1.099 . . . . 0.0 109.625 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -80.93 47.97 1.05 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 123.501 1.619 . . . . 0.0 109.355 176.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.473 ' ND2' ' H ' ' A' ' 39' ' ' LYS . 20.1 p30 -71.41 -34.1 70.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.589 -2.096 . . . . 0.0 110.597 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -125.19 109.94 26.9 Favored Pre-proline 0 N--CA 1.417 -2.099 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.39 124.11 13.67 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.759 2.306 . . . . 0.0 113.662 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 68.19 15.48 9.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.111 1.364 . . . . 0.0 113.464 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -66.86 134.59 52.38 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.32 -175.58 1.6 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 -163.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -76.45 -176.22 3.6 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.915 -176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD13 HG23 ' A' ' 122' ' ' VAL . 7.4 mp -98.0 151.84 19.9 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -167.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.493 ' CE2' ' HB1' ' A' ' 34' ' ' ALA . 5.9 m-85 -111.4 -163.35 0.84 Allowed 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.87 -45.06 96.06 Favored 'General case' 0 N--CA 1.509 2.502 0 CA-C-N 119.308 0.958 . . . . 0.0 110.611 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -121.13 145.31 47.95 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.539 ' NE2' ' HA3' ' A' ' 35' ' ' GLY . 27.8 tp60 -124.74 120.93 25.67 Favored Pre-proline 0 N--CA 1.416 -2.15 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.874 -178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.97 166.93 9.75 Favored 'Trans proline' 0 N--CA 1.439 -1.716 0 C-N-CA 122.846 2.364 . . . . 0.0 112.326 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -157.58 168.98 25.72 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.501 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.1 mt -90.0 0.52 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-O 122.759 1.266 . . . . 0.0 108.544 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.51 ' HB3' ' CE2' ' A' ' 50' ' ' PHE . 37.9 mtm -94.47 -147.33 0.26 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 36.8 p -144.99 27.26 1.31 Allowed 'General case' 0 C--O 1.242 0.679 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.552 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . 61.0 t30 -114.51 118.33 33.47 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 48.6 tp -85.13 141.36 30.26 Favored 'General case' 0 C--O 1.209 -1.074 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.751 -169.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 47.1 tp -108.75 123.05 48.41 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 129' ' ' LEU . 59.2 t -128.52 139.13 52.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.483 -173.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.1 p -78.89 175.33 10.62 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.972 0.509 . . . . 0.0 110.967 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.07 -37.59 73.17 Favored Glycine 0 C--O 1.239 0.423 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 94' ' ' ARG . 8.6 ptt180 -61.66 -47.73 84.04 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.524 0.729 . . . . 0.0 111.324 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -31.47 68.48 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.08 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -60.1 -42.74 95.35 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 122.736 0.414 . . . . 0.0 110.28 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -56.51 -45.5 81.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 124.221 0.951 . . . . 0.0 110.496 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 197' ' ' ALA . 4.6 mm? -58.8 -52.89 63.77 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.471 0.482 . . . . 0.0 111.797 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.9 mt -58.93 -44.47 90.96 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 C-N-CA 123.46 0.704 . . . . 0.0 111.776 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.21 -25.77 61.78 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.0 m -70.33 -26.35 63.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.34 -21.4 33.15 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.169 174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.7 48.0 7.49 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.62 109.96 4.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.24 0.543 . . . . 0.0 110.019 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.0 m -75.36 146.96 40.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.678 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 80.07 12.05 1.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.504 1.522 . . . . 0.0 112.873 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.43 113.93 25.68 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.2 tp10 -111.0 141.87 43.9 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -116.26 119.19 34.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.501 ' HG ' HD21 ' A' ' 130' ' ' ASN . 68.8 mt -109.33 100.71 42.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.42 139.53 18.52 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.58 2.186 . . . . 0.0 113.418 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -148.22 162.26 6.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 C-N-CA 124.552 1.141 . . . . 0.0 108.774 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.21 123.59 42.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -120.1 135.71 59.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -169.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 1.5 mptp? -98.09 150.63 21.23 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.613 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 1.3 p-10 -91.53 -163.05 0.98 Allowed 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.903 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -66.02 -36.96 84.67 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.908 0.883 . . . . 0.0 109.73 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.13 -19.25 47.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.32 14.69 29.77 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.722 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.613 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 17.2 ptpt -97.44 145.96 25.68 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.8 t -81.43 90.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.504 HG23 HD13 ' A' ' 78' ' ' LEU . 3.9 m -114.97 13.78 8.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.813 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.472 ' HA2' ' CD2' ' A' ' 126' ' ' TYR . . . -135.54 46.9 1.01 Allowed Glycine 0 CA--C 1.545 1.947 0 C-N-CA 120.085 -1.055 . . . . 0.0 114.879 176.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.09 -13.99 7.47 Favored 'Trans proline' 0 C--N 1.379 2.166 0 CA-C-N 121.565 2.682 . . . . 0.0 111.426 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -96.1 -4.13 43.4 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 125.784 1.634 . . . . 0.0 110.438 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.472 ' CD2' ' HA2' ' A' ' 123' ' ' GLY . 5.5 m-85 -98.89 149.51 22.85 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.66 -171.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.5 147.54 43.29 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.208 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -85.13 128.7 34.76 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.926 0.393 . . . . 0.0 110.55 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.472 HD12 HG21 ' A' ' 91' ' ' VAL . 4.5 tt -92.67 125.62 37.38 Favored 'General case' 0 C--O 1.272 2.272 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.852 -176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.501 HD21 ' HG ' ' A' ' 110' ' ' LEU . 35.7 m-80 -101.03 132.4 46.47 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.337 178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.91 114.47 28.77 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -97.25 172.6 7.69 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.855 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.68 16.86 80.4 Favored Glycine 0 C--N 1.311 -0.835 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.8 132.72 34.52 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.13 169.22 19.16 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.24 112.06 4.93 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -134.11 -17.71 2.09 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 117.24 2.311 . . . . 0.0 117.24 -165.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 32.7 mt -63.32 122.48 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 118.969 0.804 . . . . 0.0 111.023 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.49 128.14 35.52 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.189 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.425 ' HG2' ' OH ' ' A' ' 145' ' ' TYR . 63.2 mtt -119.53 10.35 11.78 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.709 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -99.66 -38.63 8.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.892 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -113.99 3.7 15.45 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.461 ' HB3' ' HB3' ' A' ' 162' ' ' ALA . 16.8 p -90.77 155.84 18.5 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 120.682 0.277 . . . . 0.0 111.396 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.443 ' CB ' ' HB2' ' A' ' 159' ' ' ASP . 64.6 mm-40 -122.04 106.04 10.84 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.425 ' OH ' ' HG2' ' A' ' 140' ' ' MET . 6.2 p90 -164.35 162.87 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.96 0.409 . . . . 0.0 111.938 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -121.61 125.79 47.54 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 85.8 mtp -91.05 153.46 20.1 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.307 17.9 t70 88.57 82.33 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.663 1.585 . . . . 0.0 113.152 -177.243 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.416 ' HB3' ' CA ' ' A' ' 156' ' ' GLY . 11.7 p -100.83 -56.08 2.42 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.123 171.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.0 mt -99.8 -45.3 5.78 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 11.9 pt-20 -155.46 176.11 13.01 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -70.97 -21.59 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 119.689 1.132 . . . . 0.0 113.691 -170.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.46 12.35 10.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.101 0.953 . . . . 0.0 110.534 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.538 ' NE2' ' HG2' ' A' ' 181' ' ' ARG . 22.8 mm-40 -125.38 115.82 20.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -84.65 147.13 5.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 149' ' ' SER . . . -110.77 -78.69 0.98 Allowed Glycine 0 CA--C 1.491 -1.431 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.698 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -78.28 123.01 26.47 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 44.0 mt -128.59 106.98 15.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 144' ' ' GLU . 20.2 m-20 -86.63 -34.73 19.72 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.04 110.61 2.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.293 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -84.26 124.01 30.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 143' ' ' SER . . . -99.37 147.04 25.65 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.62 139.44 55.5 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.117 0.886 . . . . 0.0 113.375 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.567 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 23.0 p-10 -93.61 3.51 55.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.06 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.9 p -66.22 -3.94 6.73 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.737 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.9 m -64.0 -39.95 95.27 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 123.534 0.733 . . . . 0.0 109.959 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -108.14 -32.82 7.36 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 118.601 -1.24 . . . . 0.0 111.269 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.422 HG13 ' CB ' ' A' ' 137' ' ' ALA . 74.0 mt -85.81 149.95 4.07 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.084 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.428 ' HB3' ' OD2' ' A' ' 171' ' ' ASP . 69.3 mtp180 -51.73 127.4 33.93 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 123.02 0.528 . . . . 0.0 112.01 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.93 -13.67 23.97 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.393 2.062 . . . . 0.0 111.33 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' HB3' ' A' ' 169' ' ' ARG . 7.9 p-10 -96.59 7.27 46.94 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.325 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 151.01 44.14 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.868 0.842 . . . . 0.0 109.78 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -102.19 -30.44 11.12 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.403 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.479 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.4 ttt -160.65 128.33 4.42 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -153.75 -179.2 7.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.128 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -137.05 139.24 41.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 60.4 m -72.75 146.64 46.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 123.767 0.667 . . . . 0.0 110.17 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 7.9 p -73.05 -50.42 23.09 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 116.958 2.206 . . . . 0.0 116.958 -173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -94.51 15.45 17.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -140.79 110.13 6.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.538 ' HG2' ' NE2' ' A' ' 154' ' ' GLN . 13.2 ptt180 -76.85 -22.36 53.63 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.807 -170.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -86.82 -16.63 35.61 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.289 -0.257 . . . . 0.0 110.948 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.6 tp -87.06 99.76 12.15 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.802 0.81 . . . . 0.0 111.484 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.23 123.78 59.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.16 133.18 52.78 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.041 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' A' ' 174' ' ' MET . 41.1 pt -121.58 158.61 24.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.989 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.617 ' HD3' ' OD1' ' A' ' 189' ' ' ASP . 9.1 ptp180 -85.07 162.06 19.45 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.504 ' OE1' ' HG2' ' A' ' 23' ' ' LYS . 8.9 pt-20 -54.13 -39.85 66.85 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.617 ' OD1' ' HD3' ' A' ' 187' ' ' ARG . 7.5 m-20 -52.53 -42.21 64.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.21 1.004 . . . . 0.0 111.304 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.04 -50.34 77.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.684 -175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.576 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 21.9 p80 -71.67 -31.06 66.39 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.525 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.97 73.31 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 111.025 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -72.43 -36.8 68.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.733 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -69.0 -35.57 76.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.345 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 18.8 mm-40 -55.65 -49.15 73.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 110.894 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -79.79 -22.8 42.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.295 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.428 ' HB2' HD11 ' A' ' 98' ' ' LEU . . . -75.32 -27.89 59.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.658 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 80.55 42.44 10.18 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.6 mt -83.46 166.53 18.25 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 17.1 p -57.75 -164.1 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.278 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.71 134.83 12.88 Favored Glycine 0 CA--C 1.49 -1.489 0 O-C-N 121.362 -0.836 . . . . 0.0 113.427 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -129.47 159.59 35.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -117.49 120.86 39.4 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 173.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.89 135.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -128.89 147.62 50.84 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.03 107.82 7.35 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.81 -33.95 77.21 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.684 0.793 . . . . 0.0 111.929 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.82 100.54 0.95 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.854 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 73.9 30.03 62.09 Favored Glycine 0 C--O 1.219 -0.824 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.424 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.65 104.58 0.19 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.182 0.993 . . . . 0.0 110.911 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -103.88 126.91 51.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.46 -25.58 0.27 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 119.362 2.505 . . . . 0.0 119.362 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 142.28 41.57 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -172.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.5 131.43 34.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.171 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 215' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.314 -0.935 0 CA-C-O 118.689 -0.672 . . . . 0.0 111.481 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.3 -165.7 48.89 Favored Glycine 0 C--O 1.253 1.309 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.8 m -91.75 91.62 8.04 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.501 0.667 . . . . 0.0 109.453 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 m -152.93 148.68 27.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -74.26 -57.51 3.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -152.61 -64.75 0.16 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -93.16 -20.5 20.42 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 64.91 11.81 7.3 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.818 0.847 . . . . 0.0 111.718 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . 0.383 28.6 m80 -92.23 75.54 5.35 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 -173.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -141.65 38.13 1.66 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 m -48.15 138.92 8.92 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.385 2.274 . . . . 0.0 114.698 -172.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.4 m -136.51 -156.0 0.67 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.54 93.27 0.2 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 173.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.86 95.53 10.33 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.8 t -113.18 109.18 52.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.788 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.34 97.74 1.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 121.92 1.747 . . . . 0.0 109.263 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -78.98 132.68 36.76 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.521 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.61 -66.32 2.91 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.3 p -67.31 -70.48 0.25 Allowed 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 123.74 0.816 . . . . 0.0 111.681 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 73.1 -35.82 0.34 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.45 1.5 . . . . 0.0 113.435 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 48.2 ttp 65.9 79.88 0.24 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.36 137.72 21.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 113.83 -1.532 . . . . 0.0 110.911 -173.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 7.4 ptpp? -108.11 146.06 33.2 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -118.88 143.96 46.67 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.038 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB3' ' HB ' ' A' ' 204' ' ' VAL . 97.6 m-85 -126.87 151.3 48.57 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.911 -176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 HD12 ' A' ' 183' ' ' LEU . 14.0 t -85.89 129.9 37.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -95.92 135.3 37.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -174.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -150.61 158.79 44.56 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.5 t -109.23 131.11 60.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.485 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 13.4 tmm? -103.54 105.87 16.23 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.521 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . . . 161.53 123.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.085 2.154 . . . . 0.0 108.662 173.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -86.84 -23.28 25.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.54 -13.94 62.31 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 113.811 -1.54 . . . . 0.0 109.394 176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . . . -73.32 -32.53 64.64 Favored 'General case' 0 C--O 1.189 -2.092 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 77.82 1.08 Allowed Glycine 1 N--CA 1.391 -4.3 0 C-N-CA 118.943 -1.599 . . . . 0.0 114.127 177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -63.71 136.02 57.14 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 68' ' ' PHE . 29.8 mt -68.36 104.3 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 40.1 mm-40 -54.29 -70.68 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 O-C-N 125.2 1.562 . . . . 0.0 111.283 -173.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -117.34 176.5 5.12 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.427 0.691 . . . . 0.0 110.022 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.8 mp -72.14 130.92 85.77 Favored Pre-proline 0 C--O 1.252 1.22 0 O-C-N 123.93 0.769 . . . . 0.0 111.044 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 1.1 Cg_endo -78.62 167.4 22.63 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.912 2.408 . . . . 0.0 111.658 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.03 129.33 41.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.686 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.76 0.72 90.34 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.712 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 m -84.97 137.39 37.71 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 117.172 0.486 . . . . 0.0 110.183 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.31 165.55 10.77 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 123.306 2.67 . . . . 0.0 112.238 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.9 p -55.66 155.09 6.03 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -45.28 -51.47 10.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 125.232 1.413 . . . . 0.0 111.595 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.611 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 27.1 p-90 -85.94 -16.48 38.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.042 -176.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . 0.423 54.4 mttt -86.75 -11.24 51.66 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.607 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 45.3 m-85 -49.87 -34.1 19.07 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 123.705 0.628 . . . . 0.0 111.944 173.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -128.04 20.33 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.579 -0.701 . . . . 0.0 112.616 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' TRP . 0.9 OUTLIER -93.03 101.17 13.49 Favored 'General case' 0 C--O 1.2 -1.525 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.179 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.16 -10.98 0.01 OUTLIER Glycine 0 CA--C 1.556 2.612 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 168.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.52 173.84 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 121.12 2.46 . . . . 0.0 112.277 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -85.93 141.97 29.17 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.8 mt -87.79 -2.78 58.84 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.495 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.38 66.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.227 0.537 . . . . 0.0 111.904 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -87.63 -39.18 15.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.138 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -94.93 -21.33 18.71 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -99.06 141.48 22.95 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.01 122.8 9.69 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.053 1.835 . . . . 0.0 111.898 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.36 110.18 23.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.26 21.17 39.17 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.45 -153.55 30.33 Favored Glycine 0 C--O 1.252 1.262 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 113' ' ' ALA . 35.4 mt-10 -141.61 139.1 33.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 28.9 m -133.73 166.44 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 m -144.09 150.31 37.95 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 120.771 0.32 . . . . 0.0 111.248 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' HG12 ' A' ' 37' ' ' ILE . 13.1 m-85 -80.52 120.58 24.68 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 38' ' ' GLU . 14.1 p -61.32 139.87 58.09 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 123.697 0.623 . . . . 0.0 109.918 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.14 43.17 0.77 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.617 0.723 . . . . 0.0 112.537 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -70.07 -30.18 67.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.854 0.835 . . . . 0.0 110.067 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CD1' ' HB2' ' A' ' 75' ' ' ASN . 2.7 t80 -106.92 113.15 62.94 Favored Pre-proline 0 N--CA 1.423 -1.775 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.98 -58.58 0.87 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.17 2.58 . . . . 0.0 113.202 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -112.91 92.28 3.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.79 0.805 . . . . 0.0 110.293 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 72' ' ' TYR . 36.2 t-20 -133.1 151.31 52.02 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 173.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.42 -165.89 1.41 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -164.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.22 -172.94 4.25 Favored 'General case' 0 C--O 1.194 -1.867 0 CA-C-N 113.625 -1.625 . . . . 0.0 111.438 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 4.6 mp -87.64 143.8 26.99 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -100.14 -178.72 3.92 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.19 0.596 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -60.56 -35.25 75.59 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.515 0.674 . . . . 0.0 110.116 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -129.58 126.98 39.75 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.613 ' NE2' ' HA ' ' A' ' 78' ' ' LEU . 7.0 tp60 -115.92 125.35 28.73 Favored Pre-proline 0 C--N 1.279 -2.462 0 O-C-N 123.515 0.509 . . . . 0.0 110.35 -174.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 175.34 8.71 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -163.37 166.63 22.7 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 123.261 0.624 . . . . 0.0 109.586 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -99.91 28.88 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.4 mtm -116.24 -79.86 0.59 Allowed 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.607 ' HB3' ' HB2' ' A' ' 50' ' ' PHE . 35.2 t -179.18 -50.15 0.01 OUTLIER 'General case' 0 C--N 1.349 0.565 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -77.66 164.45 25.29 Favored 'General case' 0 C--O 1.202 -1.4 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.598 -171.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.2 tp -105.29 141.48 36.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 118.451 0.569 . . . . 0.0 110.1 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 48.5 tp -110.8 125.26 53.38 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -125.42 147.09 30.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.2 p -77.91 170.2 17.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.742 0.306 . . . . 0.0 110.342 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.9 -18.7 79.4 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -74.31 -52.53 11.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.56 -23.61 63.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.472 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HA ' ' CH2' ' A' ' 109' ' ' TRP . 54.9 ttt180 -57.74 -43.97 85.74 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.041 174.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.6 mmpt? -65.07 -39.41 93.2 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.549 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.23 -54.58 45.13 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.368 0.418 . . . . 0.0 110.326 174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.1 -46.51 94.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.461 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.26 -26.91 65.0 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -72.66 -25.0 61.11 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.033 0.444 . . . . 0.0 111.156 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.1 -1.51 57.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.305 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.06 47.78 63.32 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.542 177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.4 t -73.69 112.73 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.3 m -80.27 141.19 35.76 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.739 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 78.32 15.85 1.3 Allowed 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 125.282 1.433 . . . . 0.0 112.263 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -80.62 113.97 19.18 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.416 ' HB3' ' ND2' ' A' ' 130' ' ' ASN . 8.4 tp10 -104.72 124.81 50.04 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.538 ' CH2' HD12 ' A' ' 129' ' ' LEU . 61.9 m95 -108.55 120.15 41.6 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.235 -174.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -109.75 94.13 16.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.72 133.57 12.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.601 2.201 . . . . 0.0 112.532 -176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.79 160.08 7.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 123.625 0.77 . . . . 0.0 109.977 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.462 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . . . -93.82 116.73 29.22 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 19.7 mt -108.96 136.98 43.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -100.06 146.47 26.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 120' ' ' LYS . 2.8 p-10 -90.12 -163.96 1.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.82 0.343 . . . . 0.0 110.766 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -67.16 -32.39 73.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.139 0.975 . . . . 0.0 111.138 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -83.59 -18.5 38.02 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.204 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.12 20.54 20.49 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.063 174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 20.0 ptmt -105.55 153.42 21.79 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.3 t -86.7 90.18 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.531 0.681 . . . . 0.0 109.24 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.26 13.23 6.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.088 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.509 ' HA2' ' CD1' ' A' ' 126' ' ' TYR . . . -127.78 39.72 1.87 Allowed Glycine 0 CA--C 1.552 2.361 0 C-N-CA 119.437 -1.364 . . . . 0.0 116.335 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -85.76 -0.58 8.7 Favored 'Trans proline' 0 C--N 1.375 1.923 0 CA-C-N 122.013 2.907 . . . . 0.0 112.624 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.54 -9.67 24.61 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.946 0.899 . . . . 0.0 110.662 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.509 ' CD1' ' HA2' ' A' ' 123' ' ' GLY . 16.5 m-85 -103.59 153.99 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.363 -165.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.28 142.81 35.68 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.6 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -80.29 122.33 26.76 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.538 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.4 tt -101.16 122.14 43.09 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.325 0.583 . . . . 0.0 110.007 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -125.36 140.02 53.17 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.393 172.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.52 141.05 29.5 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.309 -0.557 . . . . 0.0 109.52 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.37 173.55 6.26 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.08 11.51 72.85 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.987 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -90.02 132.99 35.08 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -137.36 170.22 16.45 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.24 113.21 1.47 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -139.38 -19.16 0.97 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -167.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.2 mt -64.17 112.86 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.279 0.561 . . . . 0.0 110.981 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -71.58 115.22 10.51 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.084 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 64.6 mtt -99.07 6.17 46.69 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.181 0.515 . . . . 0.0 110.594 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -84.7 -46.28 11.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.432 0.634 . . . . 0.0 110.381 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -102.72 -11.96 18.0 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.283 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.3 m -90.76 148.21 22.71 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.274 0.559 . . . . 0.0 110.833 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -135.0 112.75 10.85 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -158.17 173.17 17.11 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -127.19 138.16 53.07 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.052 0.541 . . . . 0.0 109.708 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 17.9 mmt -87.16 108.06 18.74 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -175.51 63.74 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 154' ' ' GLN . 22.9 m -102.82 -56.31 2.26 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.074 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 75.6 mt -134.58 -57.16 0.84 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.07 -173.69 2.31 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.581 -1.645 . . . . 0.0 107.902 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -95.07 4.83 53.28 Favored 'General case' 0 C--O 1.21 -1.018 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -103.59 16.52 26.23 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.553 HE22 ' HB2' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -133.34 125.01 28.24 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.255 -174.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 76.0 mt -84.47 119.68 33.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 123.365 0.416 . . . . 0.0 110.212 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -98.82 -62.68 0.85 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.246 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -97.76 133.1 42.74 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -113.32 -34.73 5.54 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.672 0.749 . . . . 0.0 109.892 176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.7 132.46 27.38 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.97 117.0 18.58 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -98.32 146.8 25.31 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.24 146.66 52.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.86 0.838 . . . . 0.0 112.012 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.475 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 18.5 p-10 -90.08 8.92 30.25 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.055 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 33.3 p -69.38 -6.27 28.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.343 172.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -60.96 -39.97 91.58 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 124.623 1.169 . . . . 0.0 109.662 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -31.98 6.65 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.263 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.56 141.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 62.9 mmt-85 -60.61 118.34 33.52 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 123.28 0.363 . . . . 0.0 110.132 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -5.37 11.25 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.977 3.118 . . . . 0.0 115.012 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.07 -9.71 58.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.431 0.158 . . . . 0.0 111.377 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.14 114.06 13.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -80.6 -8.69 59.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.415 ' HG3' HG22 ' A' ' 186' ' ' ILE . 27.0 ttt -152.64 118.75 5.49 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.422 ' HE2' ' OD1' ' A' ' 164' ' ' ASP . 35.9 p90 -148.48 -179.47 6.98 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.861 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -143.88 147.32 33.86 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 44.4 m -80.61 151.49 29.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 124.22 0.95 . . . . 0.0 111.19 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.1 p -81.42 -50.28 9.63 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -85.52 30.27 0.64 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.547 ' N ' HH21 ' A' ' 181' ' ' ARG . 0.3 OUTLIER -160.27 147.24 15.97 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 48' ' ' TRP . 8.7 mmp_? -91.18 -39.0 12.36 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -14.72 17.68 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.122 0.264 . . . . 0.0 110.785 -170.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.403 HD12 HG13 ' A' ' 26' ' ' VAL . 28.3 tp -70.03 100.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.243 1.02 . . . . 0.0 109.813 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.45 122.95 67.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 51.6 mt -107.39 130.02 54.85 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.182 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 174' ' ' MET . 46.5 pt -118.24 149.77 20.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.361 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -82.27 152.97 26.11 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.469 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 10.4 pt-20 -49.04 -41.23 34.3 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.419 0.688 . . . . 0.0 112.338 177.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -53.12 -40.86 64.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.628 1.571 . . . . 0.0 112.462 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 53.3 t -69.17 -49.3 62.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.891 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.56 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 25.5 p80 -71.42 -24.55 62.06 Favored 'General case' 0 C--O 1.198 -1.641 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.067 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.34 80.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.001 0.52 . . . . 0.0 110.604 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 196' ' ' GLN . . . -69.22 -33.2 72.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.188 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.466 ' CD2' ' HA ' ' A' ' 191' ' ' HIS . 16.6 m-85 -73.35 -32.83 64.75 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.879 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 59.2 mm-40 -63.24 -42.96 99.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 193' ' ' ALA . 2.8 pt20 -77.55 -24.69 49.8 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.159 -176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.92 -27.3 43.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.233 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.1 42.79 75.26 Favored Glycine 0 CA--C 1.503 -0.697 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.663 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.61 165.19 24.45 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.611 0.364 . . . . 0.0 110.995 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 2.9 p -39.14 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 -173.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -146.97 141.19 9.18 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.391 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.31 165.21 28.06 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 40.8 ttpt -157.29 121.84 4.38 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 25' ' ' PHE . 26.8 m -125.29 146.96 30.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.448 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -125.11 142.44 51.49 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.112 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -56.86 114.65 2.18 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.16 -35.03 61.65 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.81 94.55 2.77 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.812 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.72 35.12 7.42 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.19 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -67.77 97.49 0.64 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.14 0.495 . . . . 0.0 110.583 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.06 132.24 51.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.01 -25.44 0.25 Allowed Glycine 0 N--CA 1.479 1.55 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 165.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.85 127.13 32.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 117.777 0.788 . . . . 0.0 112.618 -172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.6 131.19 37.69 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.611 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 C--N 1.308 -1.227 0 O-C-N 124.026 0.829 . . . . 0.0 109.728 -178.238 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 C--O 1.218 -0.558 0 N-CA-C 110.685 -0.117 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.16 14.86 9.46 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 119.649 -1.262 . . . . 0.0 114.092 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -98.99 96.95 8.17 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -101.16 149.91 23.49 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -79.37 79.92 5.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.879 0.847 . . . . 0.0 110.591 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -90.42 135.03 33.94 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.205 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -126.81 103.82 7.72 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.628 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -78.55 -24.01 45.86 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.352 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -147.01 -86.12 0.1 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.634 168.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 50.45 65.02 1.57 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.345 1.458 . . . . 0.0 110.606 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.6 t -109.09 -162.97 0.84 Allowed 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.771 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.8 m 66.08 29.07 10.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.201 1.0 . . . . 0.0 111.029 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.85 73.08 0.63 Allowed Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -92.99 165.02 13.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.116 0.484 . . . . 0.0 111.262 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.67 91.46 25.48 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.44 117.51 5.16 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.104 1.869 . . . . 0.0 110.923 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -106.91 122.86 47.26 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.846 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.78 -53.07 3.29 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 52.0 m 64.11 160.08 0.1 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -179.09 174.24 1.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.6 ptm -72.13 99.29 2.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 119.528 1.058 . . . . 0.0 109.529 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG11 ' HD3' ' A' ' 187' ' ' ARG . 58.0 t -85.11 120.77 36.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.309 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -94.01 152.81 18.54 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.298 0.57 . . . . 0.0 111.635 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.7 140.73 43.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.523 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -124.0 151.08 44.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.467 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.26 118.04 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -92.18 117.99 30.4 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -136.47 139.81 42.62 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 83' ' ' PRO . 97.1 t -89.54 120.86 38.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-O 120.723 0.297 . . . . 0.0 110.422 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.454 ' HB2' ' HB2' ' A' ' 203' ' ' LYS . 49.6 ttp -82.44 86.42 6.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.0 0.905 . . . . 0.0 110.224 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 34' ' ' ALA . . . -144.79 112.76 6.37 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 176.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -119.47 -58.7 1.89 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.398 -173.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.94 -21.52 43.74 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.492 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . . . -67.02 -35.76 80.63 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 95.92 158.02 32.02 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 114.064 -1.426 . . . . 0.0 114.501 173.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 84' ' ' ASN . 46.4 m-85 -96.57 166.06 11.86 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 84' ' ' ASN . 21.9 mt -78.09 101.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 101.501 -3.518 . . . . 0.0 101.501 163.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -65.64 -44.29 86.86 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 124.055 0.847 . . . . 0.0 111.892 -167.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -132.44 176.03 8.77 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mp -69.72 119.55 71.86 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.622 0.769 . . . . 0.0 112.725 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -70.76 167.75 24.85 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.759 2.306 . . . . 0.0 113.02 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -42.47 114.54 0.59 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.138 1.775 . . . . 0.0 113.421 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.73 11.61 79.23 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.551 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 50' ' ' PHE . 39.6 m -85.54 139.62 35.81 Favored Pre-proline 0 C--N 1.304 -1.37 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.63 165.96 23.67 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 123.79 2.993 . . . . 0.0 111.554 172.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.7 p -49.15 146.33 3.65 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -37.83 -56.73 1.07 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 128.114 2.565 . . . . 0.0 113.595 -174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 52.1 p-90 -86.23 -22.06 27.09 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.825 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 52' ' ' GLU . 47.0 tptt -86.61 -12.24 49.14 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.398 -169.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.475 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 53.0 m-85 -44.05 -49.54 8.74 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.646 0.591 . . . . 0.0 112.571 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.279 30.8 m-70 -127.92 31.68 5.07 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 176.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 49' ' ' LYS . 2.1 tm-20 -92.84 100.71 13.13 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.36 -10.25 3.76 Favored Glycine 0 CA--C 1.556 2.615 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.52 174.76 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 120.354 2.077 . . . . 0.0 113.295 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 t -96.37 158.48 15.42 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.484 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -88.5 -13.33 40.51 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.845 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.07 -26.55 49.82 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -88.74 -20.17 25.12 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -116.51 -22.07 8.89 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.583 -174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -100.17 138.51 20.27 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.29 123.06 10.15 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.175 1.917 . . . . 0.0 112.581 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.41 114.85 29.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.26 18.28 59.34 Favored Glycine 0 C--N 1.311 -0.843 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.4 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -88.25 -161.84 37.52 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 121.178 -0.534 . . . . 0.0 111.985 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -129.14 131.75 47.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.38 170.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 t -147.11 147.13 30.27 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.4 110.25 2.2 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.838 171.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 p -62.31 123.86 19.35 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.975 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -85.63 81.26 8.72 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -65.47 -39.14 91.63 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.143 0.497 . . . . 0.0 110.827 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -170.84 -53.35 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.142 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.396 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.39 118.57 5.76 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 120.898 1.065 . . . . 0.0 111.494 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.47 99.75 8.93 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -100.6 178.49 4.7 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.674 -174.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -90.94 -154.25 0.34 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.606 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -86.2 -177.44 6.26 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.054 1.342 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.3 mp -88.15 150.45 23.33 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.855 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 20.8 m-85 -114.14 -166.68 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.69 -40.94 94.07 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.773 0.715 . . . . 0.0 111.844 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -118.58 147.71 43.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.608 174.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 24.8 mm-40 -132.54 126.77 20.29 Favored Pre-proline 0 C--O 1.249 1.039 0 C-N-CA 123.069 0.548 . . . . 0.0 110.361 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 63.4 Cg_endo -92.53 178.56 1.39 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.575 2.183 . . . . 0.0 112.503 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 6.5 p30 -163.94 173.74 12.28 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mt -91.62 -9.49 10.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 122.336 1.065 . . . . 0.0 109.619 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -95.25 -178.1 4.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.501 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 5.7 p -93.02 39.17 1.04 Allowed 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -127.9 159.56 34.54 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.433 ' HB2' ' NH2' ' A' ' 176' ' ' ARG . 53.6 tp -124.19 141.53 51.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.0 tp -109.15 118.33 36.46 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.44 144.28 29.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 p -75.08 167.37 22.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.08 -20.46 79.68 Favored Glycine 0 C--N 1.31 -0.868 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -70.79 -57.64 4.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -25.61 67.03 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.265 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 50.9 ttt180 -54.94 -51.1 67.16 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 124.02 0.928 . . . . 0.0 110.171 174.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -69.27 -25.32 64.2 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.749 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.26 -49.55 77.42 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.897 0.379 . . . . 0.0 110.189 170.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.1 -37.06 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.526 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 61.2 mt-10 -67.37 -33.34 75.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.205 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.0 m -65.74 -33.84 76.81 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.028 0.531 . . . . 0.0 111.548 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.38 -6.8 58.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.244 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.32 Favored Glycine 0 CA--C 1.492 -1.364 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.3 t -72.85 109.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.541 0.686 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.9 m -80.3 154.85 27.57 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 80.31 14.21 0.84 Allowed 'General case' 0 C--O 1.213 -0.828 0 C-N-CA 125.655 1.582 . . . . 0.0 110.599 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.76 114.11 27.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 130' ' ' ASN . 10.5 tp10 -112.91 138.93 49.03 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -119.75 116.31 25.67 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -172.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.7 mt -109.11 99.46 35.89 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.27 145.16 23.9 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.448 2.099 . . . . 0.0 112.584 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 64' ' ' GLY . 3.4 m -149.57 166.3 3.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 123.633 0.773 . . . . 0.0 109.226 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.05 28.59 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.43 HD12 ' HB2' ' A' ' 126' ' ' TYR . 32.3 mt -113.07 132.46 61.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -98.08 147.55 24.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 170.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -83.13 -160.66 0.43 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.477 ' CE1' ' HA3' ' A' ' 35' ' ' GLY . 67.0 m80 -74.63 -22.73 58.77 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 122.265 -0.272 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -87.56 -18.8 28.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.449 0.468 . . . . 0.0 110.194 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.65 36.92 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.033 173.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -101.8 148.49 25.23 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 117.634 0.717 . . . . 0.0 110.563 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.16 89.01 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.468 0.651 . . . . 0.0 110.493 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.4 m -115.6 13.43 7.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.433 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -132.19 49.96 0.9 Allowed Glycine 0 CA--C 1.541 1.678 0 C-N-CA 119.97 -1.109 . . . . 0.0 115.245 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.49 -8.28 9.58 Favored 'Trans proline' 0 C--N 1.376 2.025 0 CA-C-N 121.335 2.568 . . . . 0.0 111.458 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -92.06 -14.29 29.53 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.41 1.484 . . . . 0.0 110.788 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.43 ' HB2' HD12 ' A' ' 114' ' ' ILE . 4.3 m-85 -91.03 150.89 21.25 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.883 0.849 . . . . 0.0 112.958 -169.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -138.46 143.52 39.68 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.438 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.23 117.95 20.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.27 127.59 37.8 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.92 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 38.5 m-80 -110.42 127.54 55.15 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.655 -177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.33 125.59 47.98 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.31 172.9 6.55 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.04 -7.91 81.07 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.82 129.56 34.83 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.85 0.833 . . . . 0.0 109.153 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -148.56 170.11 18.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -46.4 108.82 0.15 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.988 0.805 . . . . 0.0 110.127 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 164' ' ' ASP . . . -126.34 -47.21 1.6 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -165.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.437 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 26.2 mt -61.69 118.82 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 119.353 0.979 . . . . 0.0 112.611 -172.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.76 127.92 34.31 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.713 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 61.4 mtt -94.46 -0.41 54.76 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.32 -50.63 5.55 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.559 0.695 . . . . 0.0 110.12 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -93.75 -9.36 37.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.216 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -108.14 140.5 41.25 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -120.73 100.51 7.15 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -145.74 165.03 30.0 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.703 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -120.82 147.72 44.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 124.167 0.917 . . . . 0.0 109.611 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . . . . . . . . . 53.0 mtt -100.47 154.18 18.75 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.291 36.3 t70 90.76 84.9 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 127.844 2.457 . . . . 0.0 112.108 -176.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.2 t -99.49 -36.62 9.49 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.611 -1.631 . . . . 0.0 107.621 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.9 mt -136.65 -54.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 12.7 pt-20 -137.32 -179.82 5.96 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.583 176.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -48.19 -49.48 32.65 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.302 1.841 . . . . 0.0 114.634 -171.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.526 ' HB2' HH21 ' A' ' 181' ' ' ARG . 7.7 p-10 -90.09 10.93 22.4 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -102.42 116.57 32.9 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.554 ' H ' ' HG2' ' A' ' 180' ' ' GLU . 70.2 mt -74.31 129.33 36.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -108.5 -60.14 0.54 Allowed Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.988 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -92.83 119.15 31.87 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.0 109.91 27.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.03 -34.31 16.85 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -150.75 138.95 20.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.86 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -130.8 114.85 15.84 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -100.78 147.64 25.83 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 140.42 57.33 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.816 0.817 . . . . 0.0 112.916 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 20.4 p-10 -94.65 16.14 16.36 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.286 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 168' ' ' ILE . 18.2 p -67.01 -5.77 14.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.034 175.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.8 m -64.65 -33.43 75.91 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.323 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.35 -32.95 6.34 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.249 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 165' ' ' THR . 66.7 mt -92.45 122.23 43.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -56.47 127.82 72.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 118.023 0.374 . . . . 0.0 111.504 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.06 -5.36 6.22 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.601 2.867 . . . . 0.0 115.427 -177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -80.24 -9.21 59.72 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.062 0.392 . . . . 0.0 111.13 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 127.2 31.82 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.112 0.482 . . . . 0.0 110.098 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -69.51 -36.75 76.76 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.036 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . 0.487 ' HG3' HG22 ' A' ' 186' ' ' ILE . 26.5 ttt -148.29 132.03 16.95 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.3 -179.79 7.85 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.507 0.504 . . . . 0.0 109.938 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.433 ' NH2' ' HB2' ' A' ' 89' ' ' LEU . 14.6 ttm180 -136.12 139.56 43.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.499 ' SG ' HD22 ' A' ' 183' ' ' LEU . 63.9 m -74.63 139.44 43.6 Favored 'General case' 0 N--CA 1.423 -1.823 0 O-C-N 124.062 0.851 . . . . 0.0 110.105 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 p -82.7 -12.75 57.35 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.437 ' HG3' ' HB ' ' A' ' 138' ' ' ILE . 72.8 mmtt -90.24 -5.0 56.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.866 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 155' ' ' ILE . 0.0 OUTLIER -151.32 142.77 23.49 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.526 HH21 ' HB2' ' A' ' 153' ' ' ASP . 17.5 mmt180 -89.35 -30.41 18.42 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -170.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -86.39 -25.35 25.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.093 0.473 . . . . 0.0 110.561 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.499 HD22 ' SG ' ' A' ' 177' ' ' CYS . 3.0 tt -75.18 102.54 5.01 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.812 -172.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.89 142.2 19.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 46.2 mt -118.31 127.92 54.17 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.376 0.608 . . . . 0.0 111.1 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.487 HG22 ' HG3' ' A' ' 174' ' ' MET . 44.9 pt -124.72 157.7 32.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.652 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.47 ' HD3' HG11 ' A' ' 22' ' ' VAL . 97.0 mtt180 -80.25 159.63 25.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.496 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 7.5 pt-20 -52.82 -37.56 60.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.729 0.812 . . . . 0.0 110.799 173.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.43 -42.93 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.282 1.833 . . . . 0.0 111.629 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.67 -45.16 81.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.771 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 195' ' ' GLU . 16.3 p80 -69.6 -30.56 68.34 Favored 'General case' 0 C--O 1.2 -1.538 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.811 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.426 ' HA ' ' OE1' ' A' ' 195' ' ' GLU . . . -61.35 -32.03 71.91 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.301 0.572 . . . . 0.0 111.044 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -75.2 -34.19 61.47 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.055 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 202' ' ' PHE . 21.4 m-85 -74.52 -33.91 62.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.956 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 191' ' ' HIS . 42.2 mt-10 -63.03 -48.89 76.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.149 0.58 . . . . 0.0 110.585 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -70.43 -18.57 63.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.926 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -89.59 -22.26 22.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.673 0.273 . . . . 0.0 111.294 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.25 46.12 66.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.58 158.72 20.05 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 38.4 p -106.31 139.69 40.4 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 108.29 56.41 0.58 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.732 176.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 194' ' ' PHE . 46.1 m-85 -135.36 142.16 45.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 118.62 1.21 . . . . 0.0 112.464 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 30' ' ' MET . 21.1 tptm -146.24 122.77 11.07 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 174.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.47 137.95 49.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 121.416 0.627 . . . . 0.0 111.999 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 215' ' ' LEU . 83.1 m-85 -129.0 143.68 50.95 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -73.48 114.22 11.47 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.75 0.309 . . . . 0.0 110.276 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.7 66.81 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -69.86 100.32 1.53 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.069 0.461 . . . . 0.0 110.556 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 83.07 28.03 38.71 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.566 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -54.85 102.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.604 1.161 . . . . 0.0 110.893 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -103.88 111.53 24.11 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.22 1.98 23.45 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 165.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 58.3 mt -95.06 131.57 40.89 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 118.452 1.126 . . . . 0.0 110.103 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -90.26 132.49 35.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.58 ' HA ' ' CE1' ' A' ' 205' ' ' TYR . 1.8 pt? . . . . . 0 C--N 1.305 -1.369 0 O-C-N 123.717 0.635 . . . . 0.0 111.904 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.78 -80.68 0.64 Allowed Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 p 57.19 179.06 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.344 1.457 . . . . 0.0 114.167 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -82.02 93.46 6.98 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -98.18 76.95 2.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.442 0.639 . . . . 0.0 109.59 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -166.97 34.85 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -81.78 74.85 8.74 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.903 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -61.67 162.4 8.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.34 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -100.78 133.76 44.77 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -87.2 135.96 33.11 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t 73.65 140.29 0.06 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.794 -176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 m -64.8 -32.22 73.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.911 -176.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 76.47 20.36 76.94 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.2 mt -128.36 128.05 43.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.6 t -117.09 117.73 36.66 Favored Pre-proline 0 C--N 1.298 -1.67 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.15 98.52 0.54 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.826 1.684 . . . . 0.0 110.388 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -76.87 -46.21 25.42 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.821 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.26 148.12 19.35 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -83.3 84.51 7.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.381 0.61 . . . . 0.0 110.814 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -83.47 114.66 21.63 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.5 mmt -70.54 -27.28 64.04 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -171.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' HA ' ' OE2' ' A' ' 188' ' ' GLU . 84.3 t -81.77 115.93 25.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.093 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.37 151.49 49.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 121.343 0.592 . . . . 0.0 110.587 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -111.22 134.54 52.73 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.028 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.3 144.09 44.27 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.151 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.1 119.16 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -91.55 124.89 36.06 Favored 'General case' 0 N--CA 1.422 -1.838 0 O-C-N 123.809 0.693 . . . . 0.0 109.454 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -150.3 159.28 44.56 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.424 HG13 ' CA ' ' A' ' 201' ' ' GLY . 91.3 t -101.69 129.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.8 ptp -69.85 160.91 30.92 Favored 'General case' 0 C--O 1.247 0.957 0 O-C-N 123.84 0.712 . . . . 0.0 111.139 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 70.76 118.96 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 124.996 1.435 . . . . 0.0 112.214 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' HA ' ' CE1' ' A' ' 36' ' ' TYR . 10.3 pt-20 -70.82 -20.12 62.6 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.008 0.909 . . . . 0.0 109.524 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.75 -16.29 62.75 Favored 'General case' 0 C--O 1.206 -1.21 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.972 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.57 -30.0 62.67 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.551 0.74 . . . . 0.0 112.63 -173.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 75' ' ' ASN . . . 105.56 79.0 1.24 Allowed Glycine 0 N--CA 1.403 -3.555 0 C-N-CA 119.412 -1.375 . . . . 0.0 112.043 177.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 32' ' ' GLU . 93.4 m-85 -69.66 151.9 45.33 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.473 HG12 ' CE2' ' A' ' 68' ' ' PHE . 28.7 mt -73.91 101.71 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 166.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' CB ' ' HB3' ' A' ' 71' ' ' ASN . 58.1 mm-40 -56.19 -41.64 75.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.863 -171.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -151.22 160.27 43.92 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -51.16 136.72 29.1 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HB2' ' HB ' ' A' ' 66' ' ' VAL . 33.3 Cg_endo -78.52 166.84 23.54 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.208 2.605 . . . . 0.0 111.606 173.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -53.94 117.02 2.87 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.54 1.136 . . . . 0.0 113.274 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.31 10.37 64.05 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 172.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 58.2 p -86.01 148.37 47.81 Favored Pre-proline 0 C--N 1.3 -1.583 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 23.8 Cg_exo -69.66 165.67 30.08 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.508 2.805 . . . . 0.0 110.212 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.3 p -59.88 155.6 16.09 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -39.93 -54.86 2.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 127.556 2.343 . . . . 0.0 114.015 -174.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 181' ' ' ARG . 34.6 p-90 -86.51 -20.9 27.35 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.379 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -86.43 -12.64 48.53 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.483 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.518 ' HB2' ' OG ' ' A' ' 87' ' ' SER . 52.4 m-85 -46.04 -34.27 3.99 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 88' ' ' ASN . 40.2 m-70 -129.82 15.54 5.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 121.047 -1.033 . . . . 0.0 110.515 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.31 101.82 14.07 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.072 -172.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.12 -9.99 2.75 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.64 172.9 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.63 1.715 . . . . 0.0 111.466 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 t -98.33 157.05 16.43 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.21 -16.73 48.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.637 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -23.67 58.78 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -86.86 -22.12 25.96 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 45' ' ' PRO . 10.0 m-20 -115.83 -22.87 8.88 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -96.85 135.62 22.04 Favored Pre-proline 0 C--N 1.299 -1.613 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.0 124.05 11.73 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.917 2.411 . . . . 0.0 112.176 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.2 t -97.61 125.6 50.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.94 23.01 62.51 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.756 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.501 ' H ' HG12 ' A' ' 112' ' ' VAL . . . -103.97 -157.05 24.18 Favored Glycine 0 C--O 1.25 1.131 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.154 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.4 130.86 46.53 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 41' ' ' PRO . 33.1 m -126.19 166.5 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 19.9 m -149.17 149.91 31.79 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 37' ' ' ILE . 11.1 m-30 -71.92 117.03 13.02 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 p -63.89 147.37 52.08 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.221 0.534 . . . . 0.0 112.228 -176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -69.59 76.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.562 1.173 . . . . 0.0 113.649 -173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.404 ' HB3' ' CB ' ' A' ' 38' ' ' GLU . 8.2 t30 -106.78 -37.32 6.43 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.812 -1.54 . . . . 0.0 106.878 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -142.75 124.64 8.69 Favored Pre-proline 0 N--CA 1.435 -1.181 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.964 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.79 15.64 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.86 2.374 . . . . 0.0 109.339 170.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -103.05 -164.87 1.12 Allowed 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.673 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' HB3' ' HA2' ' A' ' 35' ' ' GLY . 78.7 m-20 73.78 167.0 0.3 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.953 1.301 . . . . 0.0 112.213 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.7 mmm-85 -79.23 -173.93 3.89 Favored 'General case' 0 C--O 1.252 1.185 0 CA-C-O 121.901 0.858 . . . . 0.0 112.044 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -81.24 -171.96 3.53 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.146 175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.36 150.69 21.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.649 0.738 . . . . 0.0 111.859 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -113.92 -161.19 0.75 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 124.869 1.268 . . . . 0.0 107.783 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -75.08 -34.62 61.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 118.762 0.71 . . . . 0.0 111.127 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -119.25 134.35 55.26 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 33.4 tp60 -119.31 127.55 26.41 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -176.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -91.45 -179.79 1.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.042 2.495 . . . . 0.0 113.577 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.425 HD22 HD12 ' A' ' 37' ' ' ILE . 25.1 p30 -163.57 178.84 7.66 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.292 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.2 mt -103.85 34.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.5 mtp -129.56 -155.92 0.73 Allowed 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 50' ' ' PHE . 40.0 p -119.73 -11.06 9.44 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.473 ' HA ' ' NE2' ' A' ' 51' ' ' HIS . 25.9 p-10 -88.19 159.36 18.19 Favored 'General case' 0 C--O 1.201 -1.448 0 O-C-N 121.669 -0.644 . . . . 0.0 110.838 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.75 135.11 54.98 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 82' ' ' GLN . 61.1 tp -100.13 120.66 40.21 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.12 139.07 48.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.506 -174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.4 p -73.98 164.34 26.75 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.64 -21.65 77.84 Favored Glycine 0 C--N 1.327 0.074 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -75.4 -48.35 23.3 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.18 73.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.249 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 73.1 ttt180 -56.17 -44.16 79.08 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 124.382 1.073 . . . . 0.0 110.277 174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -46.68 83.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 124.071 0.857 . . . . 0.0 110.407 -177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.71 -55.24 31.93 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.312 1.008 . . . . 0.0 111.234 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.9 mt -59.13 -40.27 80.55 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 C-N-CA 123.692 0.797 . . . . 0.0 111.637 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 81.5 mt-10 -68.69 -35.12 76.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m -69.46 -30.47 68.38 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.785 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.17 -17.1 57.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.44 20.9 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.698 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.8 113.73 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.9 t -82.6 153.6 25.38 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 73.58 16.85 3.86 Favored 'General case' 0 CA--C 1.507 -0.687 0 C-N-CA 124.684 1.194 . . . . 0.0 112.227 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.47 113.5 26.9 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -105.38 143.45 33.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.459 ' CH2' HD12 ' A' ' 129' ' ' LEU . 58.9 m95 -117.35 119.78 36.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -174.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.1 mt -111.82 96.04 31.42 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.84 134.44 14.84 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.75 2.3 . . . . 0.0 113.031 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 64' ' ' GLY . 8.0 m -150.2 172.59 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.223 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.96 116.18 28.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 126' ' ' TYR . 4.3 mp -97.45 121.05 47.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.406 0.622 . . . . 0.0 111.145 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HG2' HG22 ' A' ' 121' ' ' VAL . 94.4 mttt -96.28 133.82 40.16 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 120' ' ' LYS . 3.4 p-10 -78.22 -160.31 0.2 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.258 0.551 . . . . 0.0 111.205 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -61.28 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.261 1.024 . . . . 0.0 110.765 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -84.66 -19.56 32.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.323 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.04 23.7 21.86 Favored Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.24 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.633 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 19.3 ptmt -102.99 142.31 34.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.504 HG22 ' HG2' ' A' ' 115' ' ' LYS . 24.3 t -83.7 84.31 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.526 0.679 . . . . 0.0 110.213 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.7 m -102.46 0.08 10.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.312 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.89 58.77 0.7 Allowed Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.902 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.52 -11.38 8.22 Favored 'Trans proline' 0 C--N 1.367 1.5 0 CA-C-N 120.623 2.211 . . . . 0.0 111.631 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.71 -5.28 39.12 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 124.837 1.255 . . . . 0.0 109.762 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.614 ' HB2' HD13 ' A' ' 114' ' ' ILE . 1.8 m-85 -93.14 152.23 19.37 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.608 -172.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -139.15 146.64 40.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.123 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.27 118.81 25.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.896 0.379 . . . . 0.0 110.305 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.459 HD12 ' CH2' ' A' ' 109' ' ' TRP . 6.5 tt -91.65 128.68 37.57 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.11 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.94 121.09 34.37 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.153 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.423 ' H ' ' CE1' ' A' ' 51' ' ' HIS . 2.8 mm? -79.58 128.47 33.43 Favored 'General case' 0 C--O 1.254 1.339 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.422 173.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mp -102.98 174.95 5.64 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 125.573 1.795 . . . . 0.0 107.625 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.6 20.55 63.7 Favored Glycine 0 CA--C 1.495 -1.212 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.542 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.59 131.95 36.65 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.84 158.1 43.92 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.71 106.83 0.39 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.265 0.939 . . . . 0.0 111.399 -172.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 164' ' ' ASP . . . -120.68 -18.44 7.72 Favored 'General case' 0 N--CA 1.41 -2.465 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -168.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.99 113.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.029 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.57 127.77 33.91 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.688 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 46.4 ttm -117.93 7.61 12.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.25 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HG3' ' HG2' ' A' ' 142' ' ' ARG . 10.2 pt-20 -95.34 -34.93 11.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.057 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.436 ' HG2' ' HG3' ' A' ' 141' ' ' GLU . 21.8 mmt85 -94.31 -31.48 14.04 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.6 m -75.71 158.51 32.2 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.748 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -137.09 105.52 5.77 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -159.04 165.63 33.52 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.771 0.319 . . . . 0.0 111.753 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 157' ' ' ASN . 19.1 mm-40 -118.18 134.29 55.14 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' MET . . . . . 0.477 ' SD ' HG12 ' A' ' 155' ' ' ILE . 11.5 mmt -74.01 156.38 37.59 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.145 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.567 ' HA ' ' O ' ' A' ' 151' ' ' GLU 0.336 16.3 t70 100.41 99.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 172.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.4 m -100.49 -55.78 2.51 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 165.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 87.7 mt -117.1 -42.94 2.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.795 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 148' ' ' ASP . 5.4 pt-20 -142.99 -178.59 5.9 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -46.37 -49.39 17.93 Favored 'General case' 0 C--O 1.197 -1.688 0 C-N-CA 125.87 1.668 . . . . 0.0 115.164 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -89.4 27.58 1.42 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.814 1.293 . . . . 0.0 112.318 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -123.71 115.78 21.98 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 104.654 -2.351 . . . . 0.0 104.654 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.477 HG12 ' SD ' ' A' ' 147' ' ' MET . 57.1 mt -84.63 124.92 40.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 118.388 0.54 . . . . 0.0 110.775 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -102.93 -66.94 0.75 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.131 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . 7.7 t30 -93.0 119.5 32.32 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.3 mt -125.12 125.12 68.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -103.86 -34.21 8.6 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.372 0.606 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.07 137.07 14.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -127.18 119.3 26.11 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.71 147.21 24.59 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.65 145.91 53.41 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.559 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 30.6 p-10 -89.42 4.54 48.72 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 124.156 0.983 . . . . 0.0 110.63 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.9 p -66.1 -6.48 13.32 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.374 1.07 . . . . 0.0 109.997 174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.6 m -59.3 -40.98 87.9 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.66 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . . . -112.77 -32.85 6.28 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 118.877 -1.129 . . . . 0.0 112.172 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 137' ' ' ALA . 81.0 mt -81.23 141.99 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.402 ' HB3' ' OD1' ' A' ' 171' ' ' ASP . 51.7 mtm180 -55.47 114.61 7.58 Favored Pre-proline 0 N--CA 1.45 -0.446 0 O-C-N 123.409 0.443 . . . . 0.0 110.763 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.45 -19.3 67.04 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 123.261 2.641 . . . . 0.0 113.867 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 169' ' ' ARG . 6.3 p-10 -73.59 -11.72 60.52 Favored 'General case' 0 C--O 1.25 1.112 0 C-N-CA 122.903 0.481 . . . . 0.0 112.074 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.41 48.53 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 123.654 0.597 . . . . 0.0 110.67 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -88.5 -38.56 14.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.9 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' MET . . . . . . . . . . . . . 26.7 ttt -141.47 125.27 16.99 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.46 -177.96 6.69 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.012 0.925 . . . . 0.0 108.64 -176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -142.65 151.63 41.62 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 118.444 0.565 . . . . 0.0 111.76 -177.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.591 ' SG ' HD22 ' A' ' 183' ' ' LEU . 67.2 m -82.86 129.98 35.07 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 124.157 0.911 . . . . 0.0 109.479 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.5 p -64.06 -51.07 65.82 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -171.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -89.31 22.91 2.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -138.32 139.68 39.18 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 48' ' ' TRP . 16.2 mmt180 -91.28 -27.29 18.52 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.924 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.69 -0.4 20.12 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.329 -172.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.591 HD22 ' SG ' ' A' ' 177' ' ' CYS . 1.8 tt -95.11 103.66 15.52 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.562 0.696 . . . . 0.0 109.315 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.2 mt -111.84 140.47 31.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.4 HD12 ' OD2' ' A' ' 164' ' ' ASP . 53.0 mt -116.78 137.24 52.34 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 118.584 0.629 . . . . 0.0 112.412 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 44.0 pt -129.36 151.8 36.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.653 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -80.29 163.44 23.95 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.739 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.471 ' HA ' ' CD2' ' A' ' 191' ' ' HIS . 0.2 OUTLIER -55.36 -42.08 73.41 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.493 0.717 . . . . 0.0 110.534 176.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -50.49 -39.72 49.14 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.872 1.669 . . . . 0.0 112.135 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.24 -46.88 76.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.922 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.501 ' O ' ' HG2' ' A' ' 195' ' ' GLU . 14.8 p80 -77.2 -21.94 53.13 Favored 'General case' 0 C--O 1.189 -2.12 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.089 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.67 80.07 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-O 121.523 0.678 . . . . 0.0 110.38 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -70.19 -35.47 73.97 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.093 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -71.71 -32.48 67.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.73 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 191' ' ' HIS . 47.0 mm-40 -57.1 -49.63 75.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -81.51 -7.02 59.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.88 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -91.57 -27.28 18.29 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 122.097 -0.377 . . . . 0.0 110.167 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 66.98 43.31 91.56 Favored Glycine 0 CA--C 1.507 -0.467 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 155.72 21.2 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 28.0 p -106.15 139.37 40.77 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.424 ' CA ' HG13 ' A' ' 29' ' ' VAL . . . 106.44 56.6 0.64 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.634 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -126.95 147.61 50.09 Favored 'General case' 0 CA--C 1.491 -1.306 0 CA-C-O 121.206 0.527 . . . . 0.0 111.862 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -156.85 121.76 4.56 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.6 139.53 51.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-O 121.229 0.538 . . . . 0.0 111.728 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 215' ' ' LEU . 97.3 m-85 -128.55 151.33 49.57 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 210' ' ' TRP . 20.3 mm-40 -64.66 121.28 14.12 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -78.54 -24.27 45.74 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.21 90.12 2.56 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.347 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 78.71 35.39 32.09 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.95 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 206' ' ' GLU . 19.6 t90 -58.77 105.35 0.3 Allowed 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.851 0.861 . . . . 0.0 110.618 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.84 105.55 15.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 68.8 -24.42 0.3 Allowed Glycine 0 N--CA 1.474 1.172 0 N-CA-C 119.177 2.431 . . . . 0.0 119.177 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.87 115.34 3.33 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.117 0.958 . . . . 0.0 110.567 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -74.52 125.6 28.95 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.583 ' HA ' ' CE2' ' A' ' 205' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.103 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -177.197 . . . . . . . . 2 2 . 1 stop_ save_